participant_id,age,gender,cancer_type,trial_arm,baseline_tumor_size_mm,post_treatment_tumor_size_mm,immune_response_score,treatment_duration_days,treatment_outcome
M200000,60,Other,Melanoma,mrna-4157 + keytruda,73.8,62.81,320.9,94,
M200001,44,Male,Melanoma,KEYTRUDA only,68.39,63.73,1205.86,74,Stable Disease
M200002,59,Female,Melanoma,KEYTRUDA only,79.15,28.99,1551.39,105,Progression
M200003,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.26,29.48,952.85,99,Progression
M200004,51,Other,Melanoma,KEYTRUDA only,65.33,59.48,1744.35,88,Stable Disease
M200005,50,Male,Melanoma,mrna-4157 + keytruda,40.41,24.3,725.05,93,Partial Response
M200006,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.39,49.6,971.46,96,Complete Response
M200007,29,Female,HPV-related Cancer,mrna-4157 + keytruda,37.04,27.08,2272.77,72,Stable Disease
M200008,40,Male,HPV-related Cancer,KEYTRUDA only,24.66,21.44,857.31,79,Progression
M200009,83,Male,Melanoma,KEYTRUDA only,37.94,28.04,825.3,90,Partial Response
M200010,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.75,22.1,1040.26,82,Partial Response
M200011,46,Female,HPV-related Cancer,mrna-4157 + keytruda,39.44,27.77,1466.8,98,Progression
M200012,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.75,23.35,1300.54,88,Stable Disease
M200013,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.97,36.62,450.67,102,Partial Response
M200014,25,Other,Melanoma,mrna-4157 + keytruda,35.75,22.01,835.08,97,Stable Disease
M200015,34,Other,Melanoma,KEYTRUDA only,56.3,72.33,1430.68,90,Stable Disease
M200016,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.22,18.05,1173.47,96,Stable Disease
M200017,25,Female,HPV-related Cancer,KEYTRUDA only,49.33,39.49,1072.29,94,Stable Disease
M200018,46,Female,Melanoma,mrna-4157 + keytruda,39.53,35.23,797.29,88,Partial Response
M200019,52,Other,HPV-related Cancer,mrna-4157 + keytruda,31.91,20.83,1514.9,99,
M200020,37,Male,HPV-related Cancer,KEYTRUDA only,64.19,32.85,437.23,90,Stable Disease
M200021,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.84,73.85,1154.77,97,Unknown
M200022,54,Male,HPV-related Cancer,KEYTRUDA only,46.91,31.65,962.6,94,Progression
M200023,71,Male,HPV-related Cancer,KEYTRUDA only,60.43,46.62,857.71,84,Stable Disease
M200024,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.97,27.12,991.05,94,Partial Response
M200025,45,Female,Melanoma,KEYTRUDA only,63.85,40.62,1394.85,95,Partial Response
M200026,75,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.98,41.22,584.88,88,Stable Disease
M200027,65,Male,Melanoma,mrna-4157 + keytruda,56.64,42.65,653.87,85,Progression
M200028,68,Female,Melanoma,mrna-4157 + keytruda,23.88,23.09,813.25,88,Partial Response
M200029,28,Female,Melanoma,mrna-4157 + keytruda,32.09,,1361.73,102,Complete Response
M200030,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.05,46.48,1198.86,110,Partial Response
M200031,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.82,64.02,130.11,90,Partial Response
M200032,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,77.11,54.71,1377.93,93,Stable Disease
M200033,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.39,64.47,834.98,95,Partial Response
M200034,25,Female,HPV-related Cancer,KEYTRUDA only,37.78,,583.82,88,Complete Response
M200035,72,Other,Melanoma,mrna-4157 + keytruda,47.56,54.02,1441.09,95,Partial Response
M200036,48,Female,Melanoma,mrna-4157 + keytruda,72.66,74.18,748.21,103,Stable Disease
M200037,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,75.42,54.85,1455.0,85,Complete Response
M200038,66,Female,HPV-related Cancer,mrna-4157 + keytruda,38.83,31.44,148.28,87,Partial Response
M200039,36,Other,Melanoma,KEYTRUDA only,-2.55,-1.34,497.01,99,Partial Response
M200040,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.1,27.96,1118.49,101,Partial Response
M200041,71,Female,Melanoma,mrna-4157 + keytruda,29.1,25.37,932.38,81,Unknown
M200042,30,Female,HPV-related Cancer,mrna-4157 + keytruda,34.82,12.9,-161.2,84,Stable Disease
M200043,66,Male,HPV-related Cancer,KEYTRUDA only,75.9,60.57,1302.38,88,Unknown
M200044,74,Female,Melanoma,KEYTRUDA only,67.07,64.24,1504.21,89,Stable Disease
M200045,84,Male,HPV-related Cancer,mrna-4157 + keytruda,69.25,41.59,1125.24,101,Partial Response
M200046,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.72,30.13,1099.66,100,Unknown
M200047,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.02,65.56,729.6,91,Progression
M200048,63,Female,Melanoma,mrna-4157 + keytruda,39.16,29.64,1525.9,92,Progression
M200049,38,Female,HPV-related Cancer,mrna-4157 + keytruda,78.1,58.68,1125.42,83,Stable Disease
M200050,62,Male,Melanoma,mrna-4157 + keytruda,62.23,67.83,1304.92,98,Progression
M200051,84,Other,Melanoma,mrna-4157 + keytruda,32.1,15.05,1523.04,81,Partial Response
M200052,74,Female,Melanoma,KEYTRUDA only,59.96,32.52,1068.51,75,Stable Disease
M200053,50,Female,Non-small Cell Lung Cancer,KEYTRUDA only,80.36,66.18,840.45,89,Progression
M200054,36,Male,HPV-related Cancer,mrna-4157 + keytruda,24.57,23.27,1050.35,95,Partial Response
M200055,80,Other,Melanoma,mrna-4157 + keytruda,73.75,92.33,818.9,94,Partial Response
M200056,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.74,41.99,,78,Partial Response
M200057,31,Male,HPV-related Cancer,mrna-4157 + keytruda,32.33,24.12,1089.1,96,Complete Response
M200058,41,Female,HPV-related Cancer,KEYTRUDA only,68.62,40.67,1754.04,90,Complete Response
M200059,54,Male,Melanoma,mrna-4157 + keytruda,44.57,45.71,-3.88,106,Complete Response
M200060,73,Male,Melanoma,KEYTRUDA only,55.84,46.29,852.9,92,Unknown
M200061,54,Female,HPV-related Cancer,mrna-4157 + keytruda,30.59,22.55,1125.57,86,Complete Response
M200062,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.37,37.13,1237.91,106,Complete Response
M200063,61,Male,Melanoma,mrna-4157 + keytruda,45.46,26.82,559.42,92,Partial Response
M200064,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.45,37.78,627.41,84,Partial Response
M200065,56,Male,Melanoma,mrna-4157 + keytruda,40.06,35.9,566.64,105,Stable Disease
M200066,74,Male,Melanoma,KEYTRUDA only,59.3,40.17,322.01,99,Complete Response
M200067,72,Female,HPV-related Cancer,mrna-4157 + keytruda,60.19,,967.75,88,Partial Response
M200068,62,Male,Melanoma,KEYTRUDA only,35.22,21.12,765.95,84,Progression
M200069,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,101.22,78.91,914.66,85,Stable Disease
M200070,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.72,34.0,1466.07,77,Complete Response
M200071,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.44,26.46,1268.46,97,Partial Response
M200072,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.46,46.62,1551.12,84,Progression
M200073,38,Other,Melanoma,mrna-4157 + keytruda,56.02,49.23,981.86,95,Partial Response
M200074,60,Male,Melanoma,mrna-4157 + keytruda,15.76,15.63,88.66,99,Progression
M200075,84,Other,HPV-related Cancer,KEYTRUDA only,48.1,20.89,,106,Complete Response
M200076,38,Other,HPV-related Cancer,KEYTRUDA only,46.77,30.66,551.48,101,Stable Disease
M200077,69,Male,HPV-related Cancer,mrna-4157 + keytruda,33.31,30.41,1839.81,68,Stable Disease
M200078,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.09,,1408.06,99,Partial Response
M200079,49,Female,HPV-related Cancer,mrna-4157 + keytruda,45.05,38.11,909.25,91,Stable Disease
M200080,56,Female,Melanoma,KEYTRUDA only,58.53,31.17,626.12,85,Partial Response
M200081,56,Female,HPV-related Cancer,mrna-4157 + keytruda,70.26,46.48,506.08,101,Progression
M200082,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.23,27.74,1100.28,97,Partial Response
M200083,35,Other,HPV-related Cancer,KEYTRUDA only,81.01,48.2,-200.98,81,Complete Response
M200084,62,Other,Melanoma,KEYTRUDA only,53.12,32.81,1231.76,76,Stable Disease
M200085,70,Male,Melanoma,KEYTRUDA only,59.35,48.06,1088.65,70,
M200086,58,Female,Melanoma,mrna-4157 + keytruda,56.88,37.24,1319.2,78,Partial Response
M200087,46,Female,HPV-related Cancer,KEYTRUDA only,67.17,59.44,1262.08,91,Progression
M200088,84,Male,Melanoma,KEYTRUDA only,85.93,55.69,918.9,92,Complete Response
M200089,69,Female,HPV-related Cancer,mrna-4157 + keytruda,43.12,45.64,732.48,92,Stable Disease
M200090,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.77,35.19,950.28,84,Partial Response
M200091,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.47,34.39,310.53,96,Partial Response
M200092,45,Male,Melanoma,KEYTRUDA only,32.65,29.08,986.67,89,Complete Response
M200093,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.02,59.55,-34.24,91,Progression
M200094,63,Other,HPV-related Cancer,KEYTRUDA only,73.75,40.1,1303.27,103,Complete Response
M200095,83,Other,Melanoma,mrna-4157 + keytruda,58.43,37.17,1592.5,77,Partial Response
M200096,25,Female,Melanoma,mrna-4157 + keytruda,65.46,54.04,840.81,88,Stable Disease
M200097,33,Other,Melanoma,KEYTRUDA only,50.97,35.52,667.58,81,Stable Disease
M200098,61,Male,HPV-related Cancer,mrna-4157 + keytruda,57.3,64.38,1848.06,101,
M200099,30,Male,Melanoma,KEYTRUDA only,38.32,25.43,700.54,89,Stable Disease
M200100,53,Male,Melanoma,mrna-4157 + keytruda,77.27,28.9,1198.04,94,Stable Disease
M200101,42,Other,Melanoma,KEYTRUDA only,89.84,53.69,1231.4,98,Stable Disease
M200102,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,82.66,,1048.82,94,Stable Disease
M200103,28,Other,HPV-related Cancer,KEYTRUDA only,28.44,30.0,1178.38,95,
M200104,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,60.77,52.53,692.98,78,Complete Response
M200105,70,Male,HPV-related Cancer,KEYTRUDA only,54.13,43.0,1465.87,72,Stable Disease
M200106,53,Other,Melanoma,KEYTRUDA only,39.91,22.45,1254.0,95,Partial Response
M200107,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.19,25.72,1179.12,87,Complete Response
M200108,84,Female,HPV-related Cancer,KEYTRUDA only,42.44,28.43,1755.79,89,Unknown
M200109,62,Other,Melanoma,mrna-4157 + keytruda,90.61,90.5,1027.3,74,Stable Disease
M200110,29,Other,Non-small Cell Lung Cancer,KEYTRUDA only,37.54,21.22,,94,Partial Response
M200111,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.69,20.98,956.57,89,Partial Response
M200112,30,Other,HPV-related Cancer,KEYTRUDA only,30.21,14.92,1014.39,95,Stable Disease
M200113,83,Other,Melanoma,mrna-4157 + keytruda,53.24,40.79,1107.36,87,Progression
M200114,37,Male,Melanoma,KEYTRUDA only,18.71,8.96,539.16,93,
M200115,71,Female,HPV-related Cancer,mrna-4157 + keytruda,63.97,77.57,1341.27,105,Progression
M200116,40,Male,Melanoma,KEYTRUDA only,-8.72,-5.95,894.85,90,Stable Disease
M200117,83,Female,HPV-related Cancer,KEYTRUDA only,51.09,35.4,,69,Partial Response
M200118,67,Female,HPV-related Cancer,mrna-4157 + keytruda,74.3,49.76,1600.6,93,Stable Disease
M200119,64,Male,Melanoma,mrna-4157 + keytruda,63.38,55.59,498.95,107,Partial Response
M200120,83,Other,Melanoma,mrna-4157 + keytruda,40.23,41.5,1322.44,89,Unknown
M200121,43,Female,HPV-related Cancer,mrna-4157 + keytruda,58.44,45.02,1136.45,87,Progression
M200122,77,Female,Melanoma,mrna-4157 + keytruda,53.28,43.84,1274.05,82,Stable Disease
M200123,33,Other,HPV-related Cancer,mrna-4157 + keytruda,73.6,61.11,1111.49,97,Partial Response
M200124,73,Other,Melanoma,mrna-4157 + keytruda,63.87,44.6,894.34,97,Partial Response
M200125,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.88,21.69,,93,Stable Disease
M200126,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.46,15.76,831.32,76,Unknown
M200127,69,Female,HPV-related Cancer,KEYTRUDA only,15.26,10.08,1230.44,84,Partial Response
M200128,83,Other,HPV-related Cancer,KEYTRUDA only,48.44,35.17,,99,Partial Response
M200129,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,28.41,24.81,,88,Unknown
M200130,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,94.19,68.77,1113.28,91,Partial Response
M200131,27,Female,Melanoma,mrna-4157 + keytruda,41.02,39.58,,93,Partial Response
M200132,61,Male,HPV-related Cancer,KEYTRUDA only,27.44,23.45,531.02,77,Partial Response
M200133,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.62,19.72,1255.71,99,Stable Disease
M200134,65,Male,Melanoma,mrna-4157 + keytruda,24.83,16.55,238.43,85,Stable Disease
M200135,46,Other,HPV-related Cancer,KEYTRUDA only,51.27,56.49,891.77,76,Complete Response
M200136,68,Other,Melanoma,mrna-4157 + keytruda,70.12,,2208.83,101,Stable Disease
M200137,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.24,,1333.44,91,Partial Response
M200138,83,Male,HPV-related Cancer,mrna-4157 + keytruda,41.44,44.65,,104,Stable Disease
M200139,29,Female,Melanoma,KEYTRUDA only,66.4,28.7,1287.63,99,Complete Response
M200140,25,Other,Melanoma,mrna-4157 + keytruda,47.36,43.59,506.37,74,Partial Response
M200141,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,70.52,48.08,491.66,111,Progression
M200142,78,Female,Melanoma,KEYTRUDA only,80.51,46.1,1432.91,98,Partial Response
M200143,42,Other,Melanoma,KEYTRUDA only,31.65,19.52,1588.9,87,Progression
M200144,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.21,67.29,1014.48,95,Stable Disease
M200145,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.71,28.83,1282.3,89,Partial Response
M200146,31,Female,HPV-related Cancer,mrna-4157 + keytruda,39.85,31.38,1149.45,96,Unknown
M200147,63,Female,HPV-related Cancer,mrna-4157 + keytruda,68.18,48.25,1155.25,115,Progression
M200148,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.59,30.99,478.89,93,Stable Disease
M200149,53,Male,HPV-related Cancer,KEYTRUDA only,67.65,46.22,864.25,101,Complete Response
M200150,55,Male,Melanoma,mrna-4157 + keytruda,67.84,61.9,1167.18,87,Stable Disease
M200151,26,Male,HPV-related Cancer,mrna-4157 + keytruda,21.7,9.76,1138.19,90,Stable Disease
M200152,42,Male,Melanoma,mrna-4157 + keytruda,65.64,43.37,1195.62,102,
M200153,33,Female,Melanoma,KEYTRUDA only,30.24,35.57,1030.39,81,Partial Response
M200154,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.06,45.97,143.38,82,
M200155,82,Other,Melanoma,KEYTRUDA only,42.89,26.32,898.17,90,Complete Response
M200156,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.94,77.74,919.59,76,Stable Disease
M200157,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.7,41.5,1102.21,94,Stable Disease
M200158,42,Male,Melanoma,KEYTRUDA only,51.83,35.81,1238.22,100,Partial Response
M200159,52,Female,Melanoma,mrna-4157 + keytruda,54.67,21.93,1561.99,93,Partial Response
M200160,61,Male,HPV-related Cancer,mrna-4157 + keytruda,44.38,51.24,781.41,100,Complete Response
M200161,45,Other,Melanoma,KEYTRUDA only,47.39,30.96,1125.36,99,Complete Response
M200162,30,Other,Melanoma,mrna-4157 + keytruda,50.66,47.69,857.35,109,Complete Response
M200163,59,Other,HPV-related Cancer,mrna-4157 + keytruda,15.49,17.98,566.53,86,Partial Response
M200164,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.0,30.35,1677.61,87,Progression
M200165,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.92,25.38,1924.59,83,Unknown
M200166,52,Female,HPV-related Cancer,KEYTRUDA only,33.5,,1199.2,89,Stable Disease
M200167,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.62,39.97,735.57,87,Progression
M200168,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.34,73.6,1470.7,96,
M200169,58,Other,HPV-related Cancer,KEYTRUDA only,58.07,51.5,1201.54,92,Stable Disease
M200170,49,Other,HPV-related Cancer,mrna-4157 + keytruda,55.38,,1292.01,104,Progression
M200171,60,Male,HPV-related Cancer,KEYTRUDA only,39.67,22.11,903.07,82,Complete Response
M200172,52,Other,HPV-related Cancer,mrna-4157 + keytruda,10.67,8.42,508.04,84,Partial Response
M200173,82,Male,Melanoma,mrna-4157 + keytruda,49.35,24.01,863.11,83,Stable Disease
M200174,45,Male,HPV-related Cancer,KEYTRUDA only,51.05,29.91,734.13,91,Partial Response
M200175,82,Male,HPV-related Cancer,mrna-4157 + keytruda,16.37,14.32,1170.84,93,Partial Response
M200176,64,Other,Melanoma,mrna-4157 + keytruda,29.83,17.91,1200.92,99,Stable Disease
M200177,39,Female,Melanoma,KEYTRUDA only,70.63,90.93,839.83,86,Partial Response
M200178,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.51,47.68,938.28,106,Partial Response
M200179,57,Other,HPV-related Cancer,KEYTRUDA only,48.92,46.93,1127.36,91,Complete Response
M200180,66,Female,HPV-related Cancer,mrna-4157 + keytruda,55.01,,758.39,95,Progression
M200181,81,Male,Melanoma,mrna-4157 + keytruda,35.7,32.61,703.54,110,Stable Disease
M200182,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.82,17.62,780.16,91,Stable Disease
M200183,37,Male,HPV-related Cancer,mrna-4157 + keytruda,67.45,66.86,1734.36,88,Progression
M200184,41,Other,Melanoma,mrna-4157 + keytruda,55.82,59.63,1064.8,96,Complete Response
M200185,59,Male,HPV-related Cancer,mrna-4157 + keytruda,58.08,41.58,1444.97,96,Stable Disease
M200186,72,Other,Melanoma,mrna-4157 + keytruda,71.93,27.51,1072.33,98,Partial Response
M200187,27,Male,Melanoma,KEYTRUDA only,12.21,-0.56,710.44,95,Stable Disease
M200188,77,Female,HPV-related Cancer,KEYTRUDA only,64.86,52.45,,102,Stable Disease
M200189,34,Female,Melanoma,mrna-4157 + keytruda,43.29,23.05,,93,Stable Disease
M200190,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.02,33.46,805.58,89,Partial Response
M200191,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.02,31.74,1045.06,96,Partial Response
M200192,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,69.28,45.05,833.35,90,Complete Response
M200193,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,100.35,78.65,1445.18,74,Partial Response
M200194,25,Female,HPV-related Cancer,mrna-4157 + keytruda,-0.96,-0.85,1121.93,71,Complete Response
M200195,25,Male,Melanoma,mrna-4157 + keytruda,69.1,43.45,983.47,98,Partial Response
M200196,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.27,39.37,1304.56,92,Stable Disease
M200197,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.04,73.31,1328.91,101,Progression
M200198,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.0,23.39,199.17,75,Complete Response
M200199,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.69,15.19,528.64,94,Stable Disease
M200200,77,Female,HPV-related Cancer,mrna-4157 + keytruda,67.41,55.25,801.62,95,
M200201,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.93,51.16,773.89,86,Complete Response
M200202,81,Other,HPV-related Cancer,KEYTRUDA only,73.37,52.99,1622.74,71,Stable Disease
M200203,52,Other,HPV-related Cancer,KEYTRUDA only,10.38,9.87,1062.84,88,Complete Response
M200204,56,Male,HPV-related Cancer,mrna-4157 + keytruda,56.3,45.86,1396.48,82,Unknown
M200205,31,Female,HPV-related Cancer,mrna-4157 + keytruda,70.64,46.0,1166.93,95,Stable Disease
M200206,82,Male,HPV-related Cancer,KEYTRUDA only,45.82,26.96,1845.63,96,Complete Response
M200207,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.48,90.94,-41.09,95,Progression
M200208,48,Other,Melanoma,KEYTRUDA only,71.49,47.29,212.97,82,Unknown
M200209,75,Male,HPV-related Cancer,mrna-4157 + keytruda,-19.07,-9.98,1331.84,79,Unknown
M200210,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,76.07,86.13,1392.54,75,Progression
M200211,30,Other,HPV-related Cancer,KEYTRUDA only,51.74,40.38,1102.74,83,Unknown
M200212,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.2,49.76,1158.77,86,Partial Response
M200213,81,Other,HPV-related Cancer,mrna-4157 + keytruda,77.24,57.4,445.65,98,Stable Disease
M200214,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,96.76,34.37,804.95,86,
M200215,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.72,,1615.65,80,Unknown
M200216,42,Male,HPV-related Cancer,mrna-4157 + keytruda,56.11,44.04,1497.41,95,Stable Disease
M200217,35,Female,HPV-related Cancer,mrna-4157 + keytruda,22.15,11.38,1605.37,93,Partial Response
M200218,53,Female,HPV-related Cancer,KEYTRUDA only,44.93,43.68,907.96,82,Partial Response
M200219,36,Male,Melanoma,KEYTRUDA only,69.27,68.51,1034.64,99,Partial Response
M200220,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.17,35.85,,69,Progression
M200221,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-2.64,-1.99,1064.52,94,Progression
M200222,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.43,33.69,1443.43,88,Progression
M200223,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.9,26.97,1197.9,92,Complete Response
M200224,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.88,49.83,628.54,79,Complete Response
M200225,71,Male,Melanoma,KEYTRUDA only,29.6,22.76,538.91,98,
M200226,28,Male,Melanoma,KEYTRUDA only,28.49,19.78,,97,Stable Disease
M200227,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.72,14.94,997.09,84,Partial Response
M200228,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.7,44.92,,106,Partial Response
M200229,72,Other,HPV-related Cancer,mrna-4157 + keytruda,16.71,23.2,,82,Progression
M200230,72,Female,HPV-related Cancer,KEYTRUDA only,40.46,25.73,955.06,84,Complete Response
M200231,75,Other,Melanoma,KEYTRUDA only,19.02,8.74,619.62,73,Complete Response
M200232,64,Other,HPV-related Cancer,KEYTRUDA only,95.48,51.93,139.97,85,Unknown
M200233,52,Female,HPV-related Cancer,mrna-4157 + keytruda,42.15,43.51,1624.13,86,Complete Response
M200234,73,Female,Melanoma,mrna-4157 + keytruda,46.58,36.21,712.2,76,Partial Response
M200235,71,Male,Melanoma,KEYTRUDA only,83.02,88.36,570.15,89,
M200236,82,Other,Melanoma,mrna-4157 + keytruda,55.88,46.12,864.22,106,Complete Response
M200237,73,Male,HPV-related Cancer,mrna-4157 + keytruda,-20.02,-13.46,1045.92,89,Partial Response
M200238,68,Other,HPV-related Cancer,mrna-4157 + keytruda,26.75,17.98,881.52,93,Partial Response
M200239,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.04,27.38,909.45,93,Stable Disease
M200240,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.0,77.42,1380.58,85,Stable Disease
M200241,82,Female,Melanoma,KEYTRUDA only,44.39,,,90,Progression
M200242,73,Male,Melanoma,mrna-4157 + keytruda,55.55,22.11,1289.16,94,Partial Response
M200243,74,Female,HPV-related Cancer,mrna-4157 + keytruda,33.85,28.06,1510.89,114,Stable Disease
M200244,53,Female,Melanoma,mrna-4157 + keytruda,79.15,59.66,1012.78,72,Partial Response
M200245,52,Male,Melanoma,KEYTRUDA only,70.16,,1196.7,92,Stable Disease
M200246,73,Male,Melanoma,mrna-4157 + keytruda,30.8,21.13,1586.37,90,
M200247,59,Male,HPV-related Cancer,mrna-4157 + keytruda,67.34,53.79,1479.55,87,Progression
M200248,25,Female,Melanoma,KEYTRUDA only,17.68,18.1,978.38,98,Complete Response
M200249,49,Female,Melanoma,mrna-4157 + keytruda,45.1,33.6,,92,Partial Response
M200250,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.18,36.65,873.76,86,Stable Disease
M200251,53,Other,HPV-related Cancer,mrna-4157 + keytruda,62.34,62.64,1270.93,92,Stable Disease
M200252,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.06,16.23,747.33,84,Stable Disease
M200253,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.4,36.67,920.52,85,Stable Disease
M200254,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.04,63.71,1197.54,107,Progression
M200255,55,Male,Melanoma,mrna-4157 + keytruda,35.86,38.69,1850.94,118,Progression
M200256,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,11.45,12.84,775.7,93,Unknown
M200257,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,9.28,5.89,1303.2,85,Progression
M200258,82,Other,Melanoma,mrna-4157 + keytruda,56.59,,1476.45,108,Unknown
M200259,37,Male,HPV-related Cancer,KEYTRUDA only,37.93,26.59,669.81,106,Progression
M200260,35,Female,HPV-related Cancer,mrna-4157 + keytruda,30.62,25.45,946.64,104,Stable Disease
M200261,48,Other,Melanoma,mrna-4157 + keytruda,59.06,33.36,895.04,91,Partial Response
M200262,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.87,43.3,634.87,69,Partial Response
M200263,80,Female,Melanoma,KEYTRUDA only,91.73,96.55,913.0,98,Stable Disease
M200264,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.5,40.67,562.98,77,Complete Response
M200265,54,Female,HPV-related Cancer,KEYTRUDA only,36.33,22.54,915.81,94,Partial Response
M200266,63,Other,HPV-related Cancer,mrna-4157 + keytruda,31.67,20.97,952.1,78,Stable Disease
M200267,36,Other,HPV-related Cancer,mrna-4157 + keytruda,23.78,15.35,1254.99,91,Unknown
M200268,27,Male,HPV-related Cancer,mrna-4157 + keytruda,81.87,68.55,,91,Progression
M200269,51,Other,Melanoma,KEYTRUDA only,42.88,29.84,450.99,101,Partial Response
M200270,50,Female,Melanoma,KEYTRUDA only,38.09,26.55,1458.31,89,Unknown
M200271,83,Male,HPV-related Cancer,KEYTRUDA only,49.13,,545.42,92,Progression
M200272,64,Other,HPV-related Cancer,mrna-4157 + keytruda,54.26,32.56,,88,Complete Response
M200273,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,71.99,63.65,404.79,98,Progression
M200274,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.58,57.97,1050.97,100,Partial Response
M200275,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,20.12,10.19,,93,Complete Response
M200276,62,Other,Melanoma,KEYTRUDA only,1.44,1.65,657.49,87,Stable Disease
M200277,46,Other,HPV-related Cancer,KEYTRUDA only,72.72,71.31,1198.51,86,Complete Response
M200278,84,Other,HPV-related Cancer,KEYTRUDA only,71.09,62.7,1272.92,90,Stable Disease
M200279,49,Other,Melanoma,mrna-4157 + keytruda,74.99,64.31,1108.56,100,Progression
M200280,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.9,32.63,732.77,91,Progression
M200281,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.79,35.26,1020.8,93,Partial Response
M200282,62,Other,Melanoma,mrna-4157 + keytruda,37.48,38.11,356.93,80,Progression
M200283,47,Female,Melanoma,KEYTRUDA only,60.43,55.02,712.8,110,Complete Response
M200284,64,Female,Melanoma,mrna-4157 + keytruda,53.4,20.49,885.72,106,Progression
M200285,62,Male,Melanoma,KEYTRUDA only,36.85,24.98,437.18,88,Stable Disease
M200286,44,Other,HPV-related Cancer,mrna-4157 + keytruda,65.67,43.32,981.33,84,Complete Response
M200287,73,Female,Melanoma,KEYTRUDA only,25.78,17.95,1078.31,73,Stable Disease
M200288,72,Other,Melanoma,KEYTRUDA only,41.38,45.48,1455.77,75,Stable Disease
M200289,69,Male,Melanoma,mrna-4157 + keytruda,57.56,65.08,774.25,116,Progression
M200290,33,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.05,55.76,1230.58,90,Stable Disease
M200291,72,Male,Melanoma,KEYTRUDA only,47.28,19.61,823.55,79,Partial Response
M200292,43,Male,HPV-related Cancer,KEYTRUDA only,35.38,15.14,1169.25,94,Partial Response
M200293,71,Male,Melanoma,mrna-4157 + keytruda,75.41,82.82,1227.34,91,Partial Response
M200294,66,Male,HPV-related Cancer,KEYTRUDA only,65.34,56.96,1415.3,92,Progression
M200295,68,Other,HPV-related Cancer,mrna-4157 + keytruda,80.48,75.3,882.07,88,Stable Disease
M200296,52,Male,Melanoma,KEYTRUDA only,88.62,30.64,955.0,96,Partial Response
M200297,53,Other,Melanoma,KEYTRUDA only,30.7,28.26,1217.41,95,Partial Response
M200298,67,Other,Melanoma,mrna-4157 + keytruda,41.94,45.32,693.91,78,Stable Disease
M200299,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.02,25.5,901.94,103,Partial Response
M200300,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.48,42.07,1156.74,75,Partial Response
M200301,53,Male,Melanoma,mrna-4157 + keytruda,55.51,41.35,878.4,78,Stable Disease
M200302,70,Other,HPV-related Cancer,KEYTRUDA only,70.58,48.53,299.16,106,Complete Response
M200303,68,Female,HPV-related Cancer,mrna-4157 + keytruda,47.32,50.33,942.02,86,Partial Response
M200304,45,Male,Melanoma,mrna-4157 + keytruda,45.96,33.89,665.74,77,Progression
M200305,66,Other,HPV-related Cancer,mrna-4157 + keytruda,5.74,4.84,1139.37,100,Partial Response
M200306,70,Female,HPV-related Cancer,KEYTRUDA only,85.53,88.43,872.19,79,Complete Response
M200307,37,Male,HPV-related Cancer,KEYTRUDA only,47.47,27.15,872.97,90,Stable Disease
M200308,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,30.46,35.75,1118.73,101,Progression
M200309,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.43,39.5,787.42,96,Complete Response
M200310,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,25.47,20.28,626.75,84,Complete Response
M200311,60,Other,HPV-related Cancer,mrna-4157 + keytruda,37.39,,985.65,83,Stable Disease
M200312,75,Male,Melanoma,mrna-4157 + keytruda,51.2,35.0,767.71,96,Partial Response
M200313,57,Male,HPV-related Cancer,KEYTRUDA only,64.79,60.6,1158.79,76,Partial Response
M200314,47,Male,Melanoma,KEYTRUDA only,40.67,34.5,691.35,101,Progression
M200315,45,Male,HPV-related Cancer,mrna-4157 + keytruda,57.4,37.42,1290.95,82,Unknown
M200316,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,76.06,77.55,236.67,96,Stable Disease
M200317,66,Male,Melanoma,mrna-4157 + keytruda,20.06,13.44,257.07,71,Partial Response
M200318,69,Male,HPV-related Cancer,mrna-4157 + keytruda,35.58,25.66,1131.54,94,Stable Disease
M200319,53,Male,HPV-related Cancer,KEYTRUDA only,72.74,51.48,896.51,69,Stable Disease
M200320,80,Female,HPV-related Cancer,KEYTRUDA only,59.46,48.1,1047.56,94,Complete Response
M200321,80,Other,Melanoma,KEYTRUDA only,77.91,58.56,1538.49,109,Stable Disease
M200322,30,Female,Melanoma,mrna-4157 + keytruda,56.74,24.28,441.67,84,Stable Disease
M200323,71,Male,Melanoma,mrna-4157 + keytruda,36.34,38.79,475.53,90,Partial Response
M200324,26,Female,HPV-related Cancer,mrna-4157 + keytruda,74.08,80.77,860.21,85,Stable Disease
M200325,71,Female,HPV-related Cancer,KEYTRUDA only,58.6,42.77,999.56,84,Stable Disease
M200326,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,28.03,19.19,1085.72,90,Progression
M200327,82,Male,Melanoma,KEYTRUDA only,74.95,38.19,,94,Partial Response
M200328,39,Female,HPV-related Cancer,mrna-4157 + keytruda,76.99,50.1,634.05,78,Stable Disease
M200329,76,Other,HPV-related Cancer,mrna-4157 + keytruda,35.64,24.71,666.55,88,Stable Disease
M200330,72,Female,HPV-related Cancer,mrna-4157 + keytruda,39.59,,700.02,100,Progression
M200331,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.44,34.34,1197.97,80,Partial Response
M200332,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.33,38.23,332.85,92,Progression
M200333,29,Male,HPV-related Cancer,mrna-4157 + keytruda,39.96,32.06,734.46,105,Stable Disease
M200334,58,Other,HPV-related Cancer,KEYTRUDA only,28.88,18.85,1657.11,74,Stable Disease
M200335,46,Male,HPV-related Cancer,KEYTRUDA only,33.97,32.36,1168.5,86,Stable Disease
M200336,66,Female,HPV-related Cancer,mrna-4157 + keytruda,37.38,41.32,785.07,90,Complete Response
M200337,50,Other,HPV-related Cancer,mrna-4157 + keytruda,44.36,36.16,,78,Complete Response
M200338,33,Female,HPV-related Cancer,mrna-4157 + keytruda,62.07,29.23,773.06,92,
M200339,83,Other,HPV-related Cancer,KEYTRUDA only,47.0,,1048.29,87,Progression
M200340,54,Female,Melanoma,mrna-4157 + keytruda,31.32,17.33,1261.39,92,Stable Disease
M200341,43,Other,HPV-related Cancer,KEYTRUDA only,23.18,9.73,1154.5,88,Partial Response
M200342,84,Other,Melanoma,mrna-4157 + keytruda,34.32,29.04,842.09,93,Progression
M200343,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.29,19.84,1016.23,84,Partial Response
M200344,30,Male,Melanoma,mrna-4157 + keytruda,44.27,45.27,1029.57,116,Stable Disease
M200345,81,Female,Melanoma,mrna-4157 + keytruda,80.17,76.57,1035.92,115,Stable Disease
M200346,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.45,21.01,804.94,97,Partial Response
M200347,52,Female,HPV-related Cancer,mrna-4157 + keytruda,49.92,22.71,1446.06,83,Partial Response
M200348,68,Other,HPV-related Cancer,mrna-4157 + keytruda,71.78,,1467.3,98,Unknown
M200349,55,Male,Melanoma,mrna-4157 + keytruda,58.86,52.97,885.95,87,Partial Response
M200350,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.62,28.72,292.96,77,Progression
M200351,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.43,28.98,793.88,97,Complete Response
M200352,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.94,53.84,898.03,92,Unknown
M200353,45,Female,Melanoma,mrna-4157 + keytruda,60.54,59.93,,95,Partial Response
M200354,29,Female,HPV-related Cancer,mrna-4157 + keytruda,40.45,31.66,976.09,87,Partial Response
M200355,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.83,76.65,1224.81,93,Stable Disease
M200356,43,Male,HPV-related Cancer,mrna-4157 + keytruda,75.48,62.63,1272.99,76,Partial Response
M200357,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.14,,367.46,86,Stable Disease
M200358,71,Male,Melanoma,KEYTRUDA only,69.99,28.99,1372.12,97,Stable Disease
M200359,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,28.6,10.67,495.84,92,Complete Response
M200360,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.81,27.6,1408.9,79,Stable Disease
M200361,40,Female,HPV-related Cancer,KEYTRUDA only,35.47,40.22,1487.75,94,Partial Response
M200362,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.67,32.45,628.32,77,Progression
M200363,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.09,40.84,813.66,94,Stable Disease
M200364,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.78,42.38,1155.64,100,Partial Response
M200365,61,Female,HPV-related Cancer,KEYTRUDA only,49.95,41.45,884.16,104,
M200366,33,Male,Melanoma,KEYTRUDA only,48.59,44.12,1288.92,92,Stable Disease
M200367,53,Other,Melanoma,mrna-4157 + keytruda,46.19,30.36,969.49,96,
M200368,77,Other,HPV-related Cancer,mrna-4157 + keytruda,32.69,19.02,894.39,89,Complete Response
M200369,63,Female,Melanoma,KEYTRUDA only,85.51,61.19,1135.98,79,Partial Response
M200370,61,Male,HPV-related Cancer,KEYTRUDA only,55.63,33.85,1142.77,86,Stable Disease
M200371,27,Female,HPV-related Cancer,mrna-4157 + keytruda,42.43,30.0,1190.04,86,Stable Disease
M200372,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.38,60.57,1469.5,80,Stable Disease
M200373,67,Male,HPV-related Cancer,mrna-4157 + keytruda,72.65,60.48,1134.08,95,Progression
M200374,36,Male,Melanoma,KEYTRUDA only,35.09,17.69,378.47,83,Partial Response
M200375,43,Other,Melanoma,KEYTRUDA only,70.16,54.25,917.34,101,Unknown
M200376,69,Female,Melanoma,mrna-4157 + keytruda,26.9,32.5,921.48,84,Complete Response
M200377,65,Other,HPV-related Cancer,mrna-4157 + keytruda,6.44,4.69,788.54,87,Stable Disease
M200378,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.42,30.55,944.03,68,Partial Response
M200379,46,Male,HPV-related Cancer,mrna-4157 + keytruda,75.18,33.09,897.16,79,Stable Disease
M200380,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.87,24.65,1427.24,93,
M200381,51,Other,HPV-related Cancer,mrna-4157 + keytruda,68.36,56.41,973.95,102,Partial Response
M200382,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.82,84.12,1099.55,87,Complete Response
M200383,64,Female,Melanoma,mrna-4157 + keytruda,36.04,22.18,427.65,111,Partial Response
M200384,52,Other,Melanoma,mrna-4157 + keytruda,59.04,56.96,994.0,109,Progression
M200385,26,Other,Melanoma,KEYTRUDA only,54.87,65.65,638.01,102,Stable Disease
M200386,29,Female,HPV-related Cancer,mrna-4157 + keytruda,27.68,23.22,344.13,92,Complete Response
M200387,34,Female,Melanoma,mrna-4157 + keytruda,124.14,72.37,,78,Progression
M200388,84,Other,Melanoma,mrna-4157 + keytruda,46.22,27.23,1303.59,89,Complete Response
M200389,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,47.85,40.02,1381.27,90,Complete Response
M200390,41,Female,HPV-related Cancer,mrna-4157 + keytruda,64.66,55.27,1338.25,94,Partial Response
M200391,42,Male,HPV-related Cancer,KEYTRUDA only,71.29,84.07,1008.85,104,Progression
M200392,50,Other,HPV-related Cancer,mrna-4157 + keytruda,5.78,4.92,897.16,98,Complete Response
M200393,28,Female,Melanoma,mrna-4157 + keytruda,29.1,,1127.23,105,Stable Disease
M200394,47,Other,Melanoma,KEYTRUDA only,48.12,37.44,1155.94,81,Complete Response
M200395,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.17,36.4,283.76,98,Partial Response
M200396,54,Other,HPV-related Cancer,mrna-4157 + keytruda,59.62,45.25,901.22,86,Partial Response
M200397,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.27,40.98,670.51,82,Stable Disease
M200398,36,Male,HPV-related Cancer,mrna-4157 + keytruda,65.33,43.31,1073.25,99,Progression
M200399,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.28,28.85,709.61,98,Partial Response
M200400,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.35,28.59,715.32,96,Stable Disease
M200401,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.82,49.04,595.37,88,Progression
M200402,36,Other,Melanoma,mrna-4157 + keytruda,50.34,24.69,959.29,92,Stable Disease
M200403,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,10.48,12.63,754.27,88,Unknown
M200404,81,Other,HPV-related Cancer,mrna-4157 + keytruda,71.95,,1256.49,91,Progression
M200405,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.56,44.82,988.87,89,Partial Response
M200406,83,Female,HPV-related Cancer,mrna-4157 + keytruda,49.43,36.65,222.64,102,Complete Response
M200407,46,Other,Melanoma,mrna-4157 + keytruda,19.12,10.59,420.86,81,
M200408,25,Male,Melanoma,KEYTRUDA only,75.26,42.18,1140.4,89,Complete Response
M200409,67,Male,HPV-related Cancer,mrna-4157 + keytruda,47.56,39.98,822.4,114,Stable Disease
M200410,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.19,61.08,656.87,100,Unknown
M200411,75,Other,Melanoma,mrna-4157 + keytruda,62.45,56.41,955.99,110,Stable Disease
M200412,79,Other,HPV-related Cancer,KEYTRUDA only,40.13,34.01,421.95,87,Stable Disease
M200413,32,Female,HPV-related Cancer,mrna-4157 + keytruda,29.26,27.94,1394.79,92,Progression
M200414,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.13,24.82,,77,Complete Response
M200415,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.23,36.29,991.51,93,Complete Response
M200416,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.25,44.11,1374.44,99,Stable Disease
M200417,50,Female,HPV-related Cancer,mrna-4157 + keytruda,53.87,53.03,1419.01,86,Progression
M200418,55,Female,HPV-related Cancer,KEYTRUDA only,50.9,58.96,927.45,105,
M200419,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.38,38.84,811.67,95,Progression
M200420,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.46,45.42,802.6,91,Complete Response
M200421,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,72.47,69.05,789.51,78,Progression
M200422,30,Male,Melanoma,KEYTRUDA only,62.28,47.37,595.59,85,Progression
M200423,42,Male,Melanoma,KEYTRUDA only,65.89,79.89,468.47,70,Partial Response
M200424,77,Male,Melanoma,mrna-4157 + keytruda,66.9,,756.74,101,Partial Response
M200425,79,Other,HPV-related Cancer,mrna-4157 + keytruda,91.38,85.89,2081.73,92,Partial Response
M200426,30,Other,HPV-related Cancer,KEYTRUDA only,80.35,47.49,1259.64,95,
M200427,80,Other,HPV-related Cancer,KEYTRUDA only,45.61,49.51,916.46,86,Complete Response
M200428,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.94,21.42,,87,Progression
M200429,39,Female,Melanoma,mrna-4157 + keytruda,79.85,67.3,1704.25,112,Stable Disease
M200430,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.5,85.59,1143.72,103,Complete Response
M200431,67,Female,Melanoma,mrna-4157 + keytruda,53.41,25.05,1349.61,99,Progression
M200432,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.53,25.94,1204.63,91,
M200433,44,Other,HPV-related Cancer,mrna-4157 + keytruda,36.78,25.73,1021.57,86,Complete Response
M200434,27,Female,Melanoma,mrna-4157 + keytruda,87.95,71.06,911.89,78,Partial Response
M200435,57,Other,Melanoma,KEYTRUDA only,49.49,30.92,1854.98,84,Stable Disease
M200436,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.89,48.45,1149.03,86,Unknown
M200437,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.62,63.9,,103,Stable Disease
M200438,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.01,28.52,514.96,81,Progression
M200439,65,Other,HPV-related Cancer,KEYTRUDA only,42.6,24.07,937.12,90,Stable Disease
M200440,64,Other,Melanoma,mrna-4157 + keytruda,47.69,36.88,1345.0,96,Partial Response
M200441,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.46,30.2,714.91,82,Stable Disease
M200442,64,Female,Melanoma,KEYTRUDA only,17.54,15.88,1282.4,91,Partial Response
M200443,34,Male,HPV-related Cancer,KEYTRUDA only,61.21,,1034.91,93,Stable Disease
M200444,79,Female,Melanoma,mrna-4157 + keytruda,80.09,47.4,940.27,103,Complete Response
M200445,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.57,22.41,833.27,94,Partial Response
M200446,33,Female,HPV-related Cancer,mrna-4157 + keytruda,46.09,41.39,821.92,91,Complete Response
M200447,66,Female,HPV-related Cancer,mrna-4157 + keytruda,70.64,43.42,1224.18,79,Progression
M200448,68,Male,Melanoma,mrna-4157 + keytruda,57.48,45.26,1400.53,83,Complete Response
M200449,35,Male,Melanoma,mrna-4157 + keytruda,73.88,,1313.58,95,Unknown
M200450,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,5.64,4.97,1036.1,99,Progression
M200451,48,Other,HPV-related Cancer,mrna-4157 + keytruda,36.79,27.88,1450.75,93,Complete Response
M200452,84,Male,Melanoma,mrna-4157 + keytruda,61.3,38.0,1945.0,97,Partial Response
M200453,56,Other,Melanoma,mrna-4157 + keytruda,64.21,71.26,627.18,94,Stable Disease
M200454,79,Male,Melanoma,mrna-4157 + keytruda,39.62,28.56,1211.71,109,Stable Disease
M200455,79,Male,Melanoma,mrna-4157 + keytruda,62.58,40.01,808.09,74,Stable Disease
M200456,61,Female,Melanoma,mrna-4157 + keytruda,61.7,37.65,,89,Progression
M200457,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.0,59.13,1086.83,89,Complete Response
M200458,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.25,33.95,349.69,88,Stable Disease
M200459,33,Male,HPV-related Cancer,KEYTRUDA only,13.18,8.34,546.6,98,Partial Response
M200460,35,Other,HPV-related Cancer,KEYTRUDA only,47.46,37.41,877.44,103,Partial Response
M200461,80,Female,Melanoma,mrna-4157 + keytruda,61.21,62.66,1281.31,75,Progression
M200462,70,Other,HPV-related Cancer,mrna-4157 + keytruda,39.4,24.27,599.81,73,Progression
M200463,47,Female,HPV-related Cancer,mrna-4157 + keytruda,62.21,42.78,1453.03,96,Progression
M200464,75,Male,Melanoma,mrna-4157 + keytruda,30.43,36.92,1114.75,87,Unknown
M200465,45,Male,HPV-related Cancer,KEYTRUDA only,33.05,25.8,1128.83,80,Stable Disease
M200466,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.72,71.45,854.89,102,Progression
M200467,45,Other,HPV-related Cancer,mrna-4157 + keytruda,56.27,27.76,942.83,92,Unknown
M200468,51,Male,HPV-related Cancer,mrna-4157 + keytruda,33.15,,1323.03,88,Stable Disease
M200469,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.06,54.45,695.47,85,Partial Response
M200470,29,Female,HPV-related Cancer,mrna-4157 + keytruda,60.88,56.5,1221.92,101,Complete Response
M200471,76,Other,HPV-related Cancer,mrna-4157 + keytruda,43.05,31.41,226.18,105,Complete Response
M200472,44,Female,Melanoma,mrna-4157 + keytruda,70.35,54.89,1130.87,85,Stable Disease
M200473,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.45,2.96,1138.81,85,Partial Response
M200474,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,17.15,14.49,1021.27,91,Stable Disease
M200475,60,Female,Melanoma,mrna-4157 + keytruda,65.73,45.99,959.37,105,Progression
M200476,80,Female,HPV-related Cancer,mrna-4157 + keytruda,76.2,41.45,796.76,83,Stable Disease
M200477,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.14,15.37,1287.92,86,Stable Disease
M200478,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.5,56.46,905.6,85,Partial Response
M200479,41,Male,Melanoma,KEYTRUDA only,52.23,,540.4,75,Complete Response
M200480,58,Other,Melanoma,KEYTRUDA only,33.21,27.68,1198.14,94,
M200481,27,Male,Melanoma,mrna-4157 + keytruda,46.99,28.89,1277.19,76,Stable Disease
M200482,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.83,40.37,902.53,97,Partial Response
M200483,79,Male,HPV-related Cancer,mrna-4157 + keytruda,30.9,29.41,1421.17,94,Progression
M200484,38,Male,HPV-related Cancer,mrna-4157 + keytruda,73.31,51.5,1536.18,89,Partial Response
M200485,74,Other,HPV-related Cancer,mrna-4157 + keytruda,43.77,37.42,902.1,87,Progression
M200486,28,Male,Melanoma,KEYTRUDA only,35.55,33.04,746.1,103,Partial Response
M200487,70,Female,Melanoma,KEYTRUDA only,67.32,42.3,2033.09,98,Progression
M200488,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.35,16.92,783.05,73,Complete Response
M200489,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.87,41.97,1051.99,115,Partial Response
M200490,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.82,20.84,912.73,92,
M200491,47,Male,HPV-related Cancer,mrna-4157 + keytruda,74.93,70.47,1006.27,80,Complete Response
M200492,27,Female,Melanoma,mrna-4157 + keytruda,69.51,51.59,1353.6,90,Progression
M200493,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.16,25.37,,90,Stable Disease
M200494,51,Male,Melanoma,mrna-4157 + keytruda,4.83,5.36,371.67,113,Complete Response
M200495,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.98,81.15,1249.38,89,
M200496,84,Female,Melanoma,KEYTRUDA only,34.5,25.56,,77,Partial Response
M200497,81,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.34,39.18,1267.9,72,Progression
M200498,55,Female,HPV-related Cancer,KEYTRUDA only,25.58,21.81,1077.67,81,Partial Response
M200499,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.35,41.97,878.51,104,Partial Response
M200500,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.91,22.89,1095.22,74,Complete Response
M200501,33,Male,HPV-related Cancer,KEYTRUDA only,31.32,30.58,982.74,98,Partial Response
M200502,65,Female,HPV-related Cancer,mrna-4157 + keytruda,41.07,45.3,879.35,98,
M200503,34,Female,HPV-related Cancer,mrna-4157 + keytruda,37.75,37.71,1110.98,103,Stable Disease
M200504,48,Female,HPV-related Cancer,KEYTRUDA only,8.57,9.03,608.47,99,Complete Response
M200505,51,Male,HPV-related Cancer,mrna-4157 + keytruda,47.11,33.71,1138.4,101,Stable Disease
M200506,69,Other,HPV-related Cancer,mrna-4157 + keytruda,46.88,30.78,1004.83,84,Partial Response
M200507,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.27,26.07,1109.79,78,Stable Disease
M200508,50,Female,HPV-related Cancer,mrna-4157 + keytruda,59.34,41.96,1059.05,83,Partial Response
M200509,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.13,22.58,1135.67,90,Partial Response
M200510,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.09,65.51,513.48,93,Progression
M200511,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.55,60.95,415.52,99,Stable Disease
M200512,33,Male,Melanoma,mrna-4157 + keytruda,44.82,28.24,1423.67,95,Stable Disease
M200513,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,87.68,63.77,1328.37,96,Stable Disease
M200514,61,Other,Melanoma,mrna-4157 + keytruda,-1.03,-0.71,157.65,100,Stable Disease
M200515,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.96,,688.44,102,Progression
M200516,69,Male,Melanoma,KEYTRUDA only,115.5,121.93,946.62,101,Partial Response
M200517,63,Female,Melanoma,KEYTRUDA only,56.29,41.6,458.13,83,Progression
M200518,33,Male,HPV-related Cancer,KEYTRUDA only,57.43,31.39,733.01,87,Partial Response
M200519,27,Other,HPV-related Cancer,mrna-4157 + keytruda,25.21,13.06,1049.85,69,Stable Disease
M200520,66,Female,HPV-related Cancer,mrna-4157 + keytruda,45.19,48.1,721.64,97,Partial Response
M200521,84,Male,Melanoma,mrna-4157 + keytruda,52.13,62.52,909.87,80,Stable Disease
M200522,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,30.59,23.36,1121.81,83,Unknown
M200523,63,Female,Melanoma,mrna-4157 + keytruda,54.29,56.81,875.55,76,
M200524,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.05,37.22,1311.22,85,Stable Disease
M200525,36,Male,Melanoma,KEYTRUDA only,83.86,47.29,48.98,96,Partial Response
M200526,46,Male,HPV-related Cancer,KEYTRUDA only,76.04,55.76,1303.3,94,Partial Response
M200527,27,Other,HPV-related Cancer,mrna-4157 + keytruda,40.37,25.13,986.69,87,Unknown
M200528,25,Female,Melanoma,mrna-4157 + keytruda,23.06,21.58,1445.0,94,Partial Response
M200529,37,Other,HPV-related Cancer,mrna-4157 + keytruda,42.52,46.7,,111,
M200530,33,Female,HPV-related Cancer,KEYTRUDA only,35.53,24.85,1452.4,95,Stable Disease
M200531,27,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.28,26.3,1169.41,82,Progression
M200532,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.0,21.57,1015.55,86,Progression
M200533,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.57,37.44,928.29,82,Partial Response
M200534,61,Female,HPV-related Cancer,KEYTRUDA only,86.57,80.14,989.57,92,Partial Response
M200535,68,Male,HPV-related Cancer,mrna-4157 + keytruda,43.66,29.13,859.07,81,Complete Response
M200536,38,Male,Melanoma,mrna-4157 + keytruda,51.95,30.22,396.07,99,Complete Response
M200537,46,Male,Melanoma,KEYTRUDA only,33.53,38.87,1030.64,94,Progression
M200538,70,Female,HPV-related Cancer,mrna-4157 + keytruda,47.18,54.91,1623.77,79,
M200539,31,Male,Melanoma,mrna-4157 + keytruda,39.21,,438.71,65,Progression
M200540,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.05,51.21,735.6,104,Stable Disease
M200541,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,36.54,27.91,905.69,90,Partial Response
M200542,26,Other,HPV-related Cancer,mrna-4157 + keytruda,38.73,36.34,678.41,98,Stable Disease
M200543,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.75,60.93,1304.62,94,Stable Disease
M200544,40,Male,HPV-related Cancer,KEYTRUDA only,73.1,72.34,1453.85,91,Complete Response
M200545,51,Other,Melanoma,mrna-4157 + keytruda,47.67,47.96,903.94,95,Partial Response
M200546,55,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.63,59.81,552.98,86,Stable Disease
M200547,25,Male,Melanoma,KEYTRUDA only,42.25,27.4,805.38,91,Partial Response
M200548,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.67,67.0,432.42,76,Stable Disease
M200549,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.33,41.29,1031.24,80,Unknown
M200550,39,Other,HPV-related Cancer,mrna-4157 + keytruda,44.2,41.99,836.44,74,Progression
M200551,36,Male,Melanoma,KEYTRUDA only,53.41,40.52,1745.31,89,Partial Response
M200552,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.67,57.21,1106.99,99,Progression
M200553,46,Female,Melanoma,mrna-4157 + keytruda,37.95,44.88,1385.49,100,Unknown
M200554,70,Female,Melanoma,mrna-4157 + keytruda,37.91,30.59,1019.37,74,Unknown
M200555,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.38,39.54,401.89,117,Partial Response
M200556,28,Other,HPV-related Cancer,KEYTRUDA only,36.32,38.38,1185.99,82,Complete Response
M200557,74,Female,Melanoma,KEYTRUDA only,32.09,,1231.22,97,Partial Response
M200558,55,Other,Melanoma,mrna-4157 + keytruda,36.65,32.16,1040.25,86,Complete Response
M200559,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.52,42.08,1189.03,85,Progression
M200560,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.72,60.92,1164.79,68,Partial Response
M200561,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.34,55.27,1201.42,84,Partial Response
M200562,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.8,33.23,1549.41,89,
M200563,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.23,31.93,1127.01,104,Progression
M200564,73,Other,Melanoma,mrna-4157 + keytruda,48.88,21.26,939.71,90,Complete Response
M200565,67,Female,HPV-related Cancer,KEYTRUDA only,26.18,12.67,1040.18,84,Progression
M200566,26,Male,HPV-related Cancer,KEYTRUDA only,50.38,61.37,1048.33,81,Progression
M200567,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,83.0,59.76,1340.47,104,Progression
M200568,57,Female,HPV-related Cancer,KEYTRUDA only,52.75,37.61,,91,Partial Response
M200569,53,Female,HPV-related Cancer,KEYTRUDA only,44.35,38.94,,85,Complete Response
M200570,37,Male,HPV-related Cancer,KEYTRUDA only,38.02,30.97,579.46,86,Progression
M200571,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.57,21.82,736.23,110,
M200572,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.99,14.1,1101.77,93,Stable Disease
M200573,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.38,30.04,1208.02,98,Stable Disease
M200574,26,Male,HPV-related Cancer,mrna-4157 + keytruda,7.02,7.79,817.8,75,Partial Response
M200575,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.04,22.92,1095.87,86,Complete Response
M200576,69,Other,HPV-related Cancer,mrna-4157 + keytruda,35.44,40.45,853.37,106,Stable Disease
M200577,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.27,,977.4,84,Partial Response
M200578,43,Female,Melanoma,KEYTRUDA only,34.62,,664.34,84,Partial Response
M200579,44,Other,Melanoma,KEYTRUDA only,62.41,29.84,1263.84,84,
M200580,45,Female,HPV-related Cancer,KEYTRUDA only,42.48,22.87,1269.48,89,Unknown
M200581,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.31,27.19,779.99,91,Progression
M200582,28,Male,Melanoma,mrna-4157 + keytruda,53.19,48.13,,94,Stable Disease
M200583,36,Male,Melanoma,mrna-4157 + keytruda,21.44,22.23,1022.67,88,
M200584,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.54,,486.77,92,Partial Response
M200585,40,Other,HPV-related Cancer,KEYTRUDA only,70.55,,1087.34,89,Partial Response
M200586,78,Male,Melanoma,mrna-4157 + keytruda,49.46,36.28,1395.83,82,Stable Disease
M200587,34,Female,Melanoma,mrna-4157 + keytruda,64.44,19.91,1181.92,95,Partial Response
M200588,60,Female,Melanoma,KEYTRUDA only,17.34,10.89,1050.52,87,Stable Disease
M200589,27,Male,HPV-related Cancer,KEYTRUDA only,23.57,15.52,1377.36,93,Unknown
M200590,77,Other,Melanoma,KEYTRUDA only,51.45,37.66,1654.66,83,Partial Response
M200591,75,Female,HPV-related Cancer,mrna-4157 + keytruda,54.31,,1324.96,77,Complete Response
M200592,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.38,40.29,1300.8,94,Stable Disease
M200593,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.79,49.98,990.69,91,Complete Response
M200594,55,Female,HPV-related Cancer,mrna-4157 + keytruda,31.87,24.22,,93,Stable Disease
M200595,82,Other,HPV-related Cancer,mrna-4157 + keytruda,80.3,55.48,1668.91,86,Stable Disease
M200596,54,Other,Melanoma,KEYTRUDA only,25.62,20.49,1495.01,95,Progression
M200597,51,Female,HPV-related Cancer,KEYTRUDA only,23.82,11.53,1165.34,85,Progression
M200598,52,Other,HPV-related Cancer,KEYTRUDA only,48.14,53.12,896.75,85,Partial Response
M200599,33,Female,HPV-related Cancer,mrna-4157 + keytruda,50.78,21.02,,83,Partial Response
M200600,52,Other,Melanoma,mrna-4157 + keytruda,46.51,34.61,1560.1,95,Stable Disease
M200601,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,96.36,82.2,874.62,90,Partial Response
M200602,76,Male,Melanoma,mrna-4157 + keytruda,24.85,17.82,818.85,103,
M200603,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,21.28,13.73,974.81,83,Partial Response
M200604,28,Female,HPV-related Cancer,mrna-4157 + keytruda,-6.63,-6.13,1690.92,94,Progression
M200605,37,Female,HPV-related Cancer,mrna-4157 + keytruda,27.47,,824.95,83,Stable Disease
M200606,64,Other,Melanoma,mrna-4157 + keytruda,41.4,28.3,830.44,84,Progression
M200607,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.18,17.65,651.19,74,Partial Response
M200608,35,Female,Melanoma,mrna-4157 + keytruda,75.69,66.58,500.0,93,Progression
M200609,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,85.74,56.76,940.36,92,Partial Response
M200610,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.93,4.48,2019.93,102,Complete Response
M200611,67,Other,Melanoma,mrna-4157 + keytruda,60.5,46.79,721.88,82,Partial Response
M200612,36,Other,HPV-related Cancer,mrna-4157 + keytruda,26.08,19.43,1340.44,87,Progression
M200613,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.01,72.52,,89,Partial Response
M200614,30,Female,Melanoma,mrna-4157 + keytruda,55.78,37.42,764.64,79,Stable Disease
M200615,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.1,46.89,291.63,93,Stable Disease
M200616,53,Other,HPV-related Cancer,mrna-4157 + keytruda,33.21,30.66,508.78,79,Stable Disease
M200617,69,Female,Melanoma,KEYTRUDA only,63.99,61.12,1236.69,102,Stable Disease
M200618,44,Female,Melanoma,mrna-4157 + keytruda,35.47,21.91,1082.68,94,Progression
M200619,30,Other,HPV-related Cancer,mrna-4157 + keytruda,44.76,36.01,763.65,88,Complete Response
M200620,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.11,29.14,1241.57,82,Progression
M200621,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.87,30.1,749.22,95,Partial Response
M200622,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.33,50.02,870.34,83,Complete Response
M200623,63,Male,Melanoma,mrna-4157 + keytruda,73.65,53.57,709.25,86,Progression
M200624,38,Other,Melanoma,mrna-4157 + keytruda,37.69,35.65,584.47,93,Progression
M200625,60,Female,Melanoma,mrna-4157 + keytruda,36.98,25.61,900.61,83,Stable Disease
M200626,80,Other,HPV-related Cancer,mrna-4157 + keytruda,39.66,26.58,1811.47,98,Stable Disease
M200627,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,30.85,,,101,Complete Response
M200628,82,Female,Melanoma,KEYTRUDA only,8.94,8.3,1480.3,91,Stable Disease
M200629,34,Other,Melanoma,mrna-4157 + keytruda,64.21,53.62,668.43,86,Partial Response
M200630,83,Female,Melanoma,KEYTRUDA only,55.92,52.5,1655.32,87,Stable Disease
M200631,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.21,17.99,451.82,108,Stable Disease
M200632,66,Other,Melanoma,KEYTRUDA only,55.27,45.58,1376.31,78,Partial Response
M200633,78,Male,Melanoma,KEYTRUDA only,44.63,31.02,660.71,89,Partial Response
M200634,50,Other,HPV-related Cancer,KEYTRUDA only,56.19,57.95,1381.85,93,Partial Response
M200635,58,Male,HPV-related Cancer,mrna-4157 + keytruda,18.05,14.04,1518.91,99,Complete Response
M200636,57,Other,Melanoma,KEYTRUDA only,45.45,47.82,1082.3,101,Partial Response
M200637,78,Male,Melanoma,mrna-4157 + keytruda,5.44,4.82,692.47,81,Stable Disease
M200638,75,Other,HPV-related Cancer,KEYTRUDA only,50.2,53.33,1104.55,99,Progression
M200639,80,Other,HPV-related Cancer,mrna-4157 + keytruda,75.69,62.28,365.05,83,Complete Response
M200640,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.01,30.77,1293.69,93,Complete Response
M200641,36,Female,HPV-related Cancer,KEYTRUDA only,59.73,47.59,1316.25,82,Stable Disease
M200642,47,Other,HPV-related Cancer,mrna-4157 + keytruda,42.02,45.47,1039.68,106,Partial Response
M200643,42,Female,HPV-related Cancer,KEYTRUDA only,38.96,23.77,1236.56,93,Progression
M200644,35,Female,HPV-related Cancer,mrna-4157 + keytruda,79.14,68.36,1368.51,106,Progression
M200645,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,16.06,14.39,1230.81,77,Partial Response
M200646,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.15,64.62,1237.64,83,Partial Response
M200647,59,Male,Melanoma,KEYTRUDA only,33.03,33.89,411.16,98,Progression
M200648,69,Male,HPV-related Cancer,KEYTRUDA only,38.2,23.83,956.9,87,Partial Response
M200649,56,Male,HPV-related Cancer,mrna-4157 + keytruda,23.69,26.59,1027.71,77,Complete Response
M200650,43,Male,Melanoma,KEYTRUDA only,31.88,30.64,1309.08,101,Progression
M200651,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.42,37.35,1109.29,99,Progression
M200652,55,Male,HPV-related Cancer,KEYTRUDA only,85.93,65.05,969.04,97,Stable Disease
M200653,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,79.26,48.36,2121.01,89,Complete Response
M200654,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.91,30.63,791.24,100,Stable Disease
M200655,44,Male,Melanoma,mrna-4157 + keytruda,54.53,27.41,1230.65,88,Progression
M200656,44,Female,HPV-related Cancer,mrna-4157 + keytruda,43.66,32.33,1306.81,83,
M200657,63,Other,HPV-related Cancer,KEYTRUDA only,47.98,47.2,853.07,93,Stable Disease
M200658,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.27,16.76,1047.27,82,Partial Response
M200659,35,Female,HPV-related Cancer,mrna-4157 + keytruda,31.45,29.69,1571.26,88,Stable Disease
M200660,48,Male,HPV-related Cancer,KEYTRUDA only,32.09,33.54,663.07,96,Partial Response
M200661,54,Other,Melanoma,mrna-4157 + keytruda,50.22,25.37,1059.11,91,Stable Disease
M200662,37,Other,HPV-related Cancer,mrna-4157 + keytruda,45.5,28.11,534.83,95,Partial Response
M200663,27,Female,HPV-related Cancer,mrna-4157 + keytruda,28.21,,474.56,82,Partial Response
M200664,35,Female,HPV-related Cancer,KEYTRUDA only,45.17,40.35,644.1,83,Progression
M200665,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.31,31.13,1668.78,76,Partial Response
M200666,81,Male,Melanoma,mrna-4157 + keytruda,66.79,66.56,1507.67,93,Stable Disease
M200667,73,Male,HPV-related Cancer,KEYTRUDA only,40.4,31.06,1649.01,102,Unknown
M200668,67,Female,Melanoma,mrna-4157 + keytruda,53.14,37.29,1372.22,98,Complete Response
M200669,80,Female,HPV-related Cancer,KEYTRUDA only,33.26,32.41,1172.17,98,Progression
M200670,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.38,53.13,1039.45,96,Progression
M200671,65,Female,HPV-related Cancer,mrna-4157 + keytruda,31.78,27.05,1595.4,119,Stable Disease
M200672,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,60.21,57.92,897.9,110,
M200673,25,Female,HPV-related Cancer,KEYTRUDA only,31.2,25.45,1114.07,97,Progression
M200674,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,87.71,73.39,1246.86,87,Complete Response
M200675,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.18,72.8,537.44,91,Partial Response
M200676,74,Other,HPV-related Cancer,KEYTRUDA only,26.45,17.99,1225.13,93,Progression
M200677,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.31,23.58,1730.05,100,Stable Disease
M200678,59,Male,HPV-related Cancer,mrna-4157 + keytruda,30.93,28.76,447.42,97,Partial Response
M200679,26,Female,Melanoma,mrna-4157 + keytruda,46.85,29.62,1381.21,94,Partial Response
M200680,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.81,42.38,1851.8,78,Complete Response
M200681,39,Female,HPV-related Cancer,KEYTRUDA only,42.27,34.52,699.75,103,Stable Disease
M200682,28,Other,HPV-related Cancer,mrna-4157 + keytruda,20.64,16.55,604.16,87,Partial Response
M200683,65,Female,HPV-related Cancer,mrna-4157 + keytruda,9.44,7.24,949.92,82,Partial Response
M200684,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-6.94,-6.47,1377.11,77,Progression
M200685,39,Male,HPV-related Cancer,mrna-4157 + keytruda,74.48,36.28,1246.04,88,Stable Disease
M200686,83,Other,Melanoma,mrna-4157 + keytruda,81.69,65.85,1170.73,85,Stable Disease
M200687,29,Male,HPV-related Cancer,KEYTRUDA only,48.97,39.25,1099.71,93,Progression
M200688,31,Other,Melanoma,KEYTRUDA only,74.87,59.96,973.52,84,Stable Disease
M200689,72,Male,HPV-related Cancer,mrna-4157 + keytruda,57.82,41.3,654.78,96,
M200690,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.73,40.32,1415.32,72,Progression
M200691,33,Male,HPV-related Cancer,KEYTRUDA only,59.31,,1211.3,89,Partial Response
M200692,74,Other,HPV-related Cancer,KEYTRUDA only,12.92,11.63,1065.04,92,Partial Response
M200693,57,Other,Melanoma,KEYTRUDA only,36.87,27.44,1751.9,90,
M200694,40,Other,HPV-related Cancer,KEYTRUDA only,54.34,37.94,918.76,89,Partial Response
M200695,76,Other,Melanoma,mrna-4157 + keytruda,33.19,27.47,826.89,85,Unknown
M200696,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,14.05,,1525.34,86,
M200697,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.5,53.7,888.65,104,Stable Disease
M200698,34,Other,Melanoma,mrna-4157 + keytruda,39.49,35.48,1427.65,108,Partial Response
M200699,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.15,69.59,785.07,82,Complete Response
M200700,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,71.13,47.05,1023.42,96,Complete Response
M200701,71,Other,Melanoma,KEYTRUDA only,30.83,23.35,888.44,100,Partial Response
M200702,62,Male,HPV-related Cancer,mrna-4157 + keytruda,38.05,34.49,1002.47,85,Partial Response
M200703,66,Male,Melanoma,mrna-4157 + keytruda,22.31,16.28,1169.32,83,Partial Response
M200704,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.96,36.65,810.31,101,Partial Response
M200705,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.93,41.69,902.27,106,Partial Response
M200706,39,Male,Melanoma,KEYTRUDA only,75.36,50.42,1574.55,76,Partial Response
M200707,27,Female,HPV-related Cancer,mrna-4157 + keytruda,90.44,64.6,186.28,59,Partial Response
M200708,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.6,22.23,1381.66,72,
M200709,34,Female,HPV-related Cancer,mrna-4157 + keytruda,36.44,29.79,1076.17,76,
M200710,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.62,76.35,1354.32,102,Complete Response
M200711,59,Male,HPV-related Cancer,mrna-4157 + keytruda,63.41,75.03,866.69,94,Partial Response
M200712,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,61.66,51.09,829.39,103,Partial Response
M200713,52,Female,Melanoma,KEYTRUDA only,47.34,36.42,1009.63,81,Progression
M200714,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.1,35.11,898.76,87,Stable Disease
M200715,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.92,59.57,942.01,84,Partial Response
M200716,47,Male,HPV-related Cancer,KEYTRUDA only,40.77,53.5,1201.35,104,Stable Disease
M200717,79,Other,HPV-related Cancer,KEYTRUDA only,69.09,60.3,989.46,101,Stable Disease
M200718,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.97,51.06,1132.79,77,Progression
M200719,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.29,61.04,1162.94,84,Stable Disease
M200720,84,Other,Melanoma,mrna-4157 + keytruda,38.73,39.01,-11.27,101,Stable Disease
M200721,79,Other,HPV-related Cancer,mrna-4157 + keytruda,67.41,47.82,841.99,102,Partial Response
M200722,82,Male,Melanoma,KEYTRUDA only,42.96,40.53,848.32,81,Stable Disease
M200723,73,Other,Melanoma,mrna-4157 + keytruda,48.42,47.22,1353.96,88,Progression
M200724,56,Female,Non-small Cell Lung Cancer,KEYTRUDA only,67.74,42.04,1563.95,78,Progression
M200725,53,Other,HPV-related Cancer,KEYTRUDA only,15.14,15.36,251.39,86,Stable Disease
M200726,41,Female,HPV-related Cancer,KEYTRUDA only,34.26,,1058.96,98,Progression
M200727,59,Female,HPV-related Cancer,KEYTRUDA only,42.55,43.12,1290.08,81,Stable Disease
M200728,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.89,38.13,1181.76,94,Stable Disease
M200729,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.49,46.33,932.63,76,Progression
M200730,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.85,56.79,672.11,90,Complete Response
M200731,29,Other,Melanoma,KEYTRUDA only,16.29,15.83,955.77,81,Partial Response
M200732,77,Other,HPV-related Cancer,KEYTRUDA only,37.93,29.77,1025.59,106,Complete Response
M200733,33,Male,HPV-related Cancer,KEYTRUDA only,36.91,27.73,815.35,90,Complete Response
M200734,33,Other,Melanoma,KEYTRUDA only,48.02,35.35,758.32,91,Progression
M200735,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.41,43.11,1499.35,96,
M200736,74,Other,HPV-related Cancer,mrna-4157 + keytruda,31.95,27.53,852.95,99,Partial Response
M200737,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,13.51,13.48,1413.85,78,Unknown
M200738,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.59,61.15,1016.55,91,Progression
M200739,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.66,16.17,1222.62,107,Stable Disease
M200740,27,Female,HPV-related Cancer,mrna-4157 + keytruda,10.18,9.53,1570.66,84,Progression
M200741,76,Female,HPV-related Cancer,mrna-4157 + keytruda,29.09,18.15,1105.63,86,Stable Disease
M200742,78,Male,Melanoma,KEYTRUDA only,52.66,56.17,714.57,80,Stable Disease
M200743,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.46,15.04,1270.85,86,Progression
M200744,83,Other,Melanoma,mrna-4157 + keytruda,70.37,81.58,1739.13,96,Partial Response
M200745,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.59,34.08,1100.33,82,Progression
M200746,52,Other,Melanoma,mrna-4157 + keytruda,78.2,49.33,891.14,93,Stable Disease
M200747,65,Male,Melanoma,mrna-4157 + keytruda,64.48,60.46,799.79,91,Progression
M200748,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.24,28.94,,86,Progression
M200749,39,Other,Non-small Cell Lung Cancer,KEYTRUDA only,76.82,58.87,1358.21,88,Unknown
M200750,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.02,32.33,1496.6,72,Unknown
M200751,47,Female,Melanoma,mrna-4157 + keytruda,54.56,47.26,914.19,98,Stable Disease
M200752,31,Male,HPV-related Cancer,KEYTRUDA only,54.19,52.29,1488.01,90,Stable Disease
M200753,47,Other,Melanoma,mrna-4157 + keytruda,49.56,33.17,501.48,96,
M200754,46,Other,HPV-related Cancer,mrna-4157 + keytruda,42.06,44.4,1030.58,81,Partial Response
M200755,79,Male,HPV-related Cancer,KEYTRUDA only,63.88,42.89,954.72,111,Partial Response
M200756,70,Male,HPV-related Cancer,mrna-4157 + keytruda,41.52,35.46,1230.41,79,Complete Response
M200757,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.93,25.51,1073.04,72,Partial Response
M200758,83,Other,HPV-related Cancer,KEYTRUDA only,32.2,20.9,,79,Progression
M200759,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,88.82,103.35,713.8,85,Stable Disease
M200760,79,Other,Melanoma,mrna-4157 + keytruda,43.04,,153.31,101,Stable Disease
M200761,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.93,56.19,949.43,104,Stable Disease
M200762,46,Other,HPV-related Cancer,mrna-4157 + keytruda,47.43,36.76,650.32,81,Progression
M200763,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.97,62.32,1217.95,90,Stable Disease
M200764,71,Other,HPV-related Cancer,KEYTRUDA only,78.78,31.14,1195.08,78,Complete Response
M200765,59,Female,Non-small Cell Lung Cancer,KEYTRUDA only,19.45,14.55,1111.02,100,Stable Disease
M200766,54,Other,Melanoma,mrna-4157 + keytruda,35.71,26.08,197.07,75,Unknown
M200767,74,Other,HPV-related Cancer,mrna-4157 + keytruda,34.78,,766.52,75,Stable Disease
M200768,47,Male,HPV-related Cancer,KEYTRUDA only,33.04,29.13,988.39,92,Stable Disease
M200769,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.52,45.67,787.03,93,Stable Disease
M200770,46,Other,Melanoma,KEYTRUDA only,45.14,28.96,1228.76,82,
M200771,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.66,37.28,680.84,80,Stable Disease
M200772,78,Other,HPV-related Cancer,mrna-4157 + keytruda,11.77,10.21,852.14,82,Partial Response
M200773,36,Female,HPV-related Cancer,mrna-4157 + keytruda,57.59,62.21,,98,Progression
M200774,50,Other,HPV-related Cancer,KEYTRUDA only,32.89,31.01,1302.02,92,Stable Disease
M200775,51,Male,HPV-related Cancer,mrna-4157 + keytruda,46.94,36.13,1317.61,90,Partial Response
M200776,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.26,28.56,848.98,102,Complete Response
M200777,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.23,36.99,746.07,84,
M200778,28,Female,Melanoma,mrna-4157 + keytruda,59.36,43.17,1023.66,61,Stable Disease
M200779,43,Other,Melanoma,KEYTRUDA only,50.96,46.0,1042.11,90,Stable Disease
M200780,62,Male,Melanoma,mrna-4157 + keytruda,53.15,29.93,661.83,79,
M200781,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.64,21.18,1671.73,85,Complete Response
M200782,78,Other,Melanoma,KEYTRUDA only,24.66,13.97,935.36,96,Progression
M200783,40,Female,HPV-related Cancer,mrna-4157 + keytruda,56.93,39.75,795.21,91,Progression
M200784,52,Female,Melanoma,mrna-4157 + keytruda,45.83,35.73,767.04,79,Complete Response
M200785,79,Other,HPV-related Cancer,KEYTRUDA only,61.25,29.36,983.56,95,Progression
M200786,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.33,21.39,244.32,81,Unknown
M200787,73,Female,HPV-related Cancer,mrna-4157 + keytruda,42.87,44.98,-111.63,101,Partial Response
M200788,60,Male,HPV-related Cancer,mrna-4157 + keytruda,45.71,26.52,543.88,97,Partial Response
M200789,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,79.27,70.89,662.27,93,Complete Response
M200790,43,Female,HPV-related Cancer,mrna-4157 + keytruda,51.1,41.54,1520.0,103,Progression
M200791,54,Female,HPV-related Cancer,KEYTRUDA only,24.95,14.77,737.1,106,Stable Disease
M200792,40,Other,HPV-related Cancer,mrna-4157 + keytruda,39.57,28.63,801.11,94,Partial Response
M200793,65,Male,HPV-related Cancer,mrna-4157 + keytruda,29.48,20.28,1570.71,97,Partial Response
M200794,77,Female,Melanoma,mrna-4157 + keytruda,71.21,75.12,1135.13,84,Progression
M200795,36,Other,HPV-related Cancer,KEYTRUDA only,62.62,53.94,958.16,105,Partial Response
M200796,52,Female,Melanoma,mrna-4157 + keytruda,63.73,,,102,Stable Disease
M200797,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.22,35.46,1488.91,107,Stable Disease
M200798,32,Male,Melanoma,mrna-4157 + keytruda,71.78,56.41,933.27,83,Progression
M200799,34,Male,Melanoma,KEYTRUDA only,63.01,42.35,1090.32,96,Complete Response
M200800,78,Female,HPV-related Cancer,mrna-4157 + keytruda,73.52,50.11,1186.07,84,
M200801,70,Female,HPV-related Cancer,mrna-4157 + keytruda,84.93,105.86,702.52,83,Partial Response
M200802,82,Male,HPV-related Cancer,mrna-4157 + keytruda,55.86,51.47,1164.08,93,Stable Disease
M200803,35,Female,HPV-related Cancer,mrna-4157 + keytruda,32.39,23.66,658.1,87,Stable Disease
M200804,40,Other,Melanoma,mrna-4157 + keytruda,73.79,75.0,721.69,88,Partial Response
M200805,69,Female,Melanoma,KEYTRUDA only,49.28,51.65,1014.35,77,Partial Response
M200806,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.42,73.08,362.19,78,Unknown
M200807,70,Female,HPV-related Cancer,mrna-4157 + keytruda,20.43,22.03,722.37,78,Stable Disease
M200808,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.74,111.4,616.63,103,Progression
M200809,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.06,25.42,960.55,104,Complete Response
M200810,25,Male,HPV-related Cancer,KEYTRUDA only,24.81,23.91,1053.59,85,Partial Response
M200811,28,Other,HPV-related Cancer,mrna-4157 + keytruda,73.47,59.95,408.68,81,
M200812,59,Male,Melanoma,KEYTRUDA only,70.17,43.61,506.31,82,Stable Disease
M200813,61,Female,HPV-related Cancer,KEYTRUDA only,26.0,10.76,882.03,85,Partial Response
M200814,28,Female,HPV-related Cancer,KEYTRUDA only,71.37,51.2,1017.64,81,Partial Response
M200815,82,Other,HPV-related Cancer,mrna-4157 + keytruda,71.16,33.96,1720.11,94,Stable Disease
M200816,39,Female,HPV-related Cancer,KEYTRUDA only,65.54,30.4,753.81,108,Stable Disease
M200817,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.19,25.5,279.2,87,Stable Disease
M200818,59,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.72,43.42,1184.29,93,Partial Response
M200819,69,Male,Melanoma,mrna-4157 + keytruda,99.28,57.34,1267.29,88,Partial Response
M200820,26,Female,Melanoma,mrna-4157 + keytruda,57.2,51.35,1310.34,100,Partial Response
M200821,60,Male,Melanoma,KEYTRUDA only,31.77,20.27,1573.74,95,Progression
M200822,66,Other,Melanoma,mrna-4157 + keytruda,48.79,47.51,997.71,79,Stable Disease
M200823,81,Male,Melanoma,mrna-4157 + keytruda,87.12,85.38,776.42,93,Partial Response
M200824,53,Other,HPV-related Cancer,mrna-4157 + keytruda,46.66,14.59,607.76,83,Complete Response
M200825,82,Other,HPV-related Cancer,KEYTRUDA only,0.28,0.25,1025.21,88,Partial Response
M200826,39,Female,HPV-related Cancer,mrna-4157 + keytruda,9.24,9.67,1090.04,83,Stable Disease
M200827,50,Other,HPV-related Cancer,mrna-4157 + keytruda,76.36,56.64,1001.58,74,Partial Response
M200828,61,Male,Melanoma,KEYTRUDA only,53.59,42.64,1801.8,100,Progression
M200829,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.27,34.74,742.13,86,Complete Response
M200830,53,Other,HPV-related Cancer,mrna-4157 + keytruda,36.74,25.93,174.91,79,Complete Response
M200831,43,Other,HPV-related Cancer,KEYTRUDA only,46.68,41.56,2015.75,89,Partial Response
M200832,32,Female,Melanoma,KEYTRUDA only,26.26,,802.67,96,Unknown
M200833,38,Other,HPV-related Cancer,KEYTRUDA only,29.94,29.86,641.59,96,Complete Response
M200834,83,Other,HPV-related Cancer,mrna-4157 + keytruda,36.54,33.61,1173.01,96,Complete Response
M200835,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.13,51.31,994.07,88,Unknown
M200836,79,Male,HPV-related Cancer,mrna-4157 + keytruda,31.81,,754.68,83,Progression
M200837,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.44,41.2,1346.5,93,Stable Disease
M200838,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.82,44.74,780.24,99,Stable Disease
M200839,50,Male,Melanoma,mrna-4157 + keytruda,85.51,91.3,776.91,88,Partial Response
M200840,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.82,,1205.28,94,Stable Disease
M200841,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,83.37,46.28,571.97,94,Partial Response
M200842,43,Female,Melanoma,mrna-4157 + keytruda,86.19,75.63,861.83,101,Stable Disease
M200843,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,70.89,41.04,899.18,95,Progression
M200844,81,Male,HPV-related Cancer,mrna-4157 + keytruda,64.51,57.93,516.91,81,Stable Disease
M200845,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.79,35.35,1890.73,68,Progression
M200846,53,Male,Melanoma,KEYTRUDA only,71.67,75.32,,110,Complete Response
M200847,62,Male,Melanoma,mrna-4157 + keytruda,72.18,71.72,1075.28,89,Unknown
M200848,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,65.73,39.91,770.52,101,Stable Disease
M200849,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.29,83.46,954.74,108,Partial Response
M200850,26,Female,Melanoma,mrna-4157 + keytruda,45.33,39.55,1480.24,86,Complete Response
M200851,29,Male,Melanoma,mrna-4157 + keytruda,40.23,29.69,453.21,100,Progression
M200852,38,Other,HPV-related Cancer,KEYTRUDA only,17.52,13.46,556.67,90,Stable Disease
M200853,53,Other,Melanoma,KEYTRUDA only,46.85,45.45,578.83,84,Partial Response
M200854,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.75,64.65,1147.05,72,Partial Response
M200855,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.31,50.27,778.67,98,Progression
M200856,74,Other,Melanoma,mrna-4157 + keytruda,32.88,34.27,892.89,84,Complete Response
M200857,35,Male,HPV-related Cancer,mrna-4157 + keytruda,64.42,44.97,917.62,89,Complete Response
M200858,40,Male,HPV-related Cancer,mrna-4157 + keytruda,52.66,41.58,919.8,84,Complete Response
M200859,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.91,65.76,1049.54,95,Complete Response
M200860,61,Male,Melanoma,KEYTRUDA only,35.34,32.3,1271.49,90,
M200861,47,Female,HPV-related Cancer,KEYTRUDA only,58.65,43.48,1026.32,89,Complete Response
M200862,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,106.16,99.18,924.75,105,Stable Disease
M200863,76,Male,Melanoma,mrna-4157 + keytruda,36.84,30.31,622.41,87,Stable Disease
M200864,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.68,33.88,695.42,85,Progression
M200865,45,Other,Melanoma,KEYTRUDA only,62.46,27.43,1387.28,91,Progression
M200866,43,Female,Melanoma,KEYTRUDA only,57.49,54.9,784.42,98,Stable Disease
M200867,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.93,,1198.67,87,Partial Response
M200868,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.0,51.55,1504.79,75,Stable Disease
M200869,74,Male,HPV-related Cancer,mrna-4157 + keytruda,40.13,24.81,1091.55,90,Complete Response
M200870,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.15,15.97,,78,Partial Response
M200871,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.27,51.98,1373.46,76,Partial Response
M200872,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,81.76,59.73,1691.74,89,Stable Disease
M200873,60,Female,Melanoma,mrna-4157 + keytruda,42.55,31.27,,91,Progression
M200874,78,Female,HPV-related Cancer,KEYTRUDA only,35.15,24.2,1413.79,91,
M200875,50,Female,Melanoma,KEYTRUDA only,33.8,21.95,1049.53,94,Complete Response
M200876,56,Other,Melanoma,KEYTRUDA only,71.59,51.65,1023.82,80,Partial Response
M200877,49,Female,Melanoma,KEYTRUDA only,39.72,28.95,1045.22,84,Complete Response
M200878,42,Other,Melanoma,mrna-4157 + keytruda,70.36,79.52,736.25,72,Unknown
M200879,59,Male,HPV-related Cancer,KEYTRUDA only,56.82,47.74,644.56,103,Progression
M200880,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.55,25.82,707.93,89,Partial Response
M200881,58,Female,HPV-related Cancer,KEYTRUDA only,42.93,17.55,1334.05,76,Partial Response
M200882,30,Male,Melanoma,mrna-4157 + keytruda,59.43,58.7,-88.74,88,Stable Disease
M200883,73,Other,HPV-related Cancer,mrna-4157 + keytruda,22.99,19.04,368.49,82,Partial Response
M200884,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.76,28.19,850.18,93,Progression
M200885,52,Other,HPV-related Cancer,mrna-4157 + keytruda,31.22,27.05,1699.14,80,Progression
M200886,52,Male,HPV-related Cancer,KEYTRUDA only,46.07,35.4,831.66,86,Partial Response
M200887,59,Male,Melanoma,KEYTRUDA only,19.73,11.97,1381.45,119,Partial Response
M200888,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,79.64,60.71,654.25,96,Complete Response
M200889,71,Male,Melanoma,KEYTRUDA only,62.89,61.18,1072.61,88,Unknown
M200890,71,Other,Melanoma,KEYTRUDA only,59.72,59.75,854.9,84,Progression
M200891,48,Male,Melanoma,KEYTRUDA only,43.24,,600.19,101,Stable Disease
M200892,71,Male,Melanoma,mrna-4157 + keytruda,71.42,44.36,1010.14,70,Progression
M200893,60,Other,Melanoma,mrna-4157 + keytruda,62.31,76.48,783.05,98,Partial Response
M200894,62,Other,HPV-related Cancer,mrna-4157 + keytruda,28.77,35.89,349.16,81,Progression
M200895,51,Other,Melanoma,KEYTRUDA only,69.49,61.1,637.37,90,Progression
M200896,66,Female,HPV-related Cancer,mrna-4157 + keytruda,20.94,17.95,650.9,94,Partial Response
M200897,35,Female,HPV-related Cancer,mrna-4157 + keytruda,45.15,31.82,799.34,83,Progression
M200898,41,Female,HPV-related Cancer,mrna-4157 + keytruda,41.53,38.14,,97,Stable Disease
M200899,41,Other,HPV-related Cancer,mrna-4157 + keytruda,30.32,28.42,753.8,97,Partial Response
M200900,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.47,40.79,961.61,96,Unknown
M200901,81,Male,HPV-related Cancer,KEYTRUDA only,45.06,33.51,405.18,91,Progression
M200902,77,Male,Melanoma,mrna-4157 + keytruda,79.28,61.22,193.6,85,Stable Disease
M200903,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.26,41.04,1080.68,116,Complete Response
M200904,55,Other,HPV-related Cancer,mrna-4157 + keytruda,44.49,27.56,783.34,82,Stable Disease
M200905,47,Other,HPV-related Cancer,KEYTRUDA only,70.44,57.01,1379.66,96,Partial Response
M200906,42,Other,HPV-related Cancer,mrna-4157 + keytruda,56.78,62.2,678.47,72,Complete Response
M200907,81,Female,HPV-related Cancer,mrna-4157 + keytruda,42.06,26.58,650.58,67,Complete Response
M200908,27,Male,Melanoma,mrna-4157 + keytruda,69.88,23.66,1331.27,74,Partial Response
M200909,77,Male,HPV-related Cancer,KEYTRUDA only,13.94,11.17,1454.73,92,Complete Response
M200910,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.75,34.55,1104.18,86,Partial Response
M200911,59,Male,HPV-related Cancer,mrna-4157 + keytruda,33.62,,1328.44,76,Complete Response
M200912,47,Other,HPV-related Cancer,mrna-4157 + keytruda,54.51,45.8,1423.41,80,Unknown
M200913,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.34,34.71,1690.81,101,Unknown
M200914,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.16,28.56,1353.31,97,Stable Disease
M200915,34,Male,HPV-related Cancer,mrna-4157 + keytruda,48.09,41.74,871.96,89,Partial Response
M200916,74,Male,Melanoma,mrna-4157 + keytruda,38.53,31.24,845.48,95,Stable Disease
M200917,80,Male,Melanoma,mrna-4157 + keytruda,37.84,26.86,444.04,103,Progression
M200918,83,Other,HPV-related Cancer,mrna-4157 + keytruda,62.31,68.05,1827.35,104,Stable Disease
M200919,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.54,52.3,510.6,91,Complete Response
M200920,68,Female,HPV-related Cancer,KEYTRUDA only,44.59,28.05,1590.17,84,Stable Disease
M200921,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.57,33.23,903.91,107,Partial Response
M200922,40,Other,HPV-related Cancer,mrna-4157 + keytruda,75.32,56.94,1255.83,107,Stable Disease
M200923,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.34,39.47,991.32,101,Partial Response
M200924,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.6,36.47,834.1,102,Complete Response
M200925,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.01,35.9,777.06,86,
M200926,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,83.44,57.83,1166.17,87,Complete Response
M200927,30,Female,HPV-related Cancer,mrna-4157 + keytruda,60.02,,1134.12,96,Stable Disease
M200928,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.83,34.87,1345.92,93,Progression
M200929,34,Other,HPV-related Cancer,mrna-4157 + keytruda,44.51,52.38,1643.26,99,Stable Disease
M200930,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.56,46.26,991.82,106,Unknown
M200931,83,Male,Melanoma,mrna-4157 + keytruda,51.29,38.28,,99,Stable Disease
M200932,78,Female,Melanoma,KEYTRUDA only,48.92,,969.91,100,Stable Disease
M200933,25,Other,Melanoma,KEYTRUDA only,61.46,33.02,982.32,77,
M200934,36,Other,HPV-related Cancer,mrna-4157 + keytruda,47.96,35.6,1120.69,83,Partial Response
M200935,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,33.48,28.61,306.3,98,Stable Disease
M200936,32,Male,HPV-related Cancer,KEYTRUDA only,54.58,52.5,630.08,92,Complete Response
M200937,69,Other,HPV-related Cancer,KEYTRUDA only,37.95,44.43,1102.06,83,Partial Response
M200938,27,Other,Melanoma,mrna-4157 + keytruda,47.86,26.63,,80,Unknown
M200939,32,Other,HPV-related Cancer,KEYTRUDA only,37.55,40.35,624.26,77,Progression
M200940,25,Other,Melanoma,KEYTRUDA only,53.17,28.86,6587.150000000001,83,Complete Response
M200941,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.44,32.24,756.81,85,Stable Disease
M200942,43,Female,Melanoma,KEYTRUDA only,46.48,11.88,1460.91,87,Stable Disease
M200943,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.85,66.51,-194.99,94,Complete Response
M200944,29,Male,Melanoma,mrna-4157 + keytruda,60.95,40.81,1428.17,86,Stable Disease
M200945,61,Other,HPV-related Cancer,mrna-4157 + keytruda,20.75,16.74,1686.15,74,Complete Response
M200946,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.68,20.65,1499.05,94,Progression
M200947,48,Other,HPV-related Cancer,KEYTRUDA only,42.47,27.71,1637.57,81,Partial Response
M200948,33,Other,HPV-related Cancer,KEYTRUDA only,49.95,54.1,494.01,92,Progression
M200949,34,Male,HPV-related Cancer,KEYTRUDA only,62.03,40.86,420.79,100,Progression
M200950,46,Other,HPV-related Cancer,mrna-4157 + keytruda,65.8,44.29,618.26,86,Progression
M200951,40,Female,HPV-related Cancer,KEYTRUDA only,93.92,73.49,1308.89,78,Progression
M200952,65,Female,Melanoma,mrna-4157 + keytruda,61.3,57.94,959.29,80,
M200953,63,Other,Melanoma,KEYTRUDA only,52.72,,1044.13,79,Partial Response
M200954,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.52,46.69,942.91,81,Partial Response
M200955,65,Other,Melanoma,mrna-4157 + keytruda,78.34,62.95,1292.47,91,Stable Disease
M200956,47,Other,HPV-related Cancer,mrna-4157 + keytruda,58.6,35.72,1885.52,82,Progression
M200957,83,Female,HPV-related Cancer,KEYTRUDA only,62.13,49.24,1220.56,76,Stable Disease
M200958,56,Female,Melanoma,mrna-4157 + keytruda,41.94,28.38,516.8,90,Stable Disease
M200959,54,Male,HPV-related Cancer,KEYTRUDA only,34.93,18.0,1188.8,90,Stable Disease
M200960,71,Male,Melanoma,mrna-4157 + keytruda,48.38,44.74,689.61,84,
M200961,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.64,12.43,819.41,71,Stable Disease
M200962,59,Female,Melanoma,KEYTRUDA only,29.7,22.1,1133.63,108,Progression
M200963,31,Other,HPV-related Cancer,mrna-4157 + keytruda,65.29,61.79,908.9,110,Progression
M200964,48,Female,Melanoma,KEYTRUDA only,53.02,29.8,,92,Stable Disease
M200965,49,Male,Melanoma,KEYTRUDA only,50.51,52.24,1190.81,84,Stable Disease
M200966,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.13,39.29,1089.16,91,Partial Response
M200967,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.58,36.61,1340.01,85,Partial Response
M200968,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.09,17.15,1312.15,83,Complete Response
M200969,51,Male,Melanoma,mrna-4157 + keytruda,77.47,42.76,1341.11,89,Unknown
M200970,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,80.39,74.75,321.17,96,Complete Response
M200971,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.9,27.87,,104,Complete Response
M200972,65,Male,HPV-related Cancer,mrna-4157 + keytruda,36.15,33.71,1214.36,100,Stable Disease
M200973,32,Male,Melanoma,mrna-4157 + keytruda,88.47,95.1,951.71,87,Stable Disease
M200974,72,Female,HPV-related Cancer,mrna-4157 + keytruda,41.71,24.39,359.69,85,Complete Response
M200975,48,Male,HPV-related Cancer,KEYTRUDA only,21.19,10.9,486.91,84,Progression
M200976,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,37.45,37.41,525.88,98,Partial Response
M200977,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.5,27.78,1308.38,72,Unknown
M200978,75,Other,Melanoma,mrna-4157 + keytruda,52.08,54.05,896.82,82,Partial Response
M200979,73,Other,HPV-related Cancer,KEYTRUDA only,50.63,64.72,888.52,99,Progression
M200980,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.89,35.23,11.8,92,Partial Response
M200981,52,Other,Melanoma,mrna-4157 + keytruda,76.81,65.37,903.44,81,Progression
M200982,43,Other,Melanoma,mrna-4157 + keytruda,43.93,27.99,1056.35,87,Complete Response
M200983,41,Male,HPV-related Cancer,mrna-4157 + keytruda,62.3,41.98,698.82,100,Partial Response
M200984,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.53,59.24,942.58,86,Partial Response
M200985,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.17,26.86,1382.53,99,Progression
M200986,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.71,43.64,465.9,87,Partial Response
M200987,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.22,34.62,4015.05,83,Partial Response
M200988,48,Other,Melanoma,mrna-4157 + keytruda,50.89,35.77,231.82,70,Partial Response
M200989,28,Male,Melanoma,mrna-4157 + keytruda,96.02,94.37,990.34,89,Stable Disease
M200990,78,Male,HPV-related Cancer,KEYTRUDA only,20.31,7.81,1092.53,81,Stable Disease
M200991,59,Female,Melanoma,KEYTRUDA only,90.31,76.82,879.19,106,Stable Disease
M200992,62,Male,Melanoma,mrna-4157 + keytruda,5.81,4.15,516.19,101,Stable Disease
M200993,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.42,34.36,752.3,97,Progression
M200994,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.98,44.39,1854.29,96,Progression
M200995,40,Female,HPV-related Cancer,KEYTRUDA only,30.95,34.65,851.09,83,Stable Disease
M200996,30,Other,HPV-related Cancer,KEYTRUDA only,51.87,,1457.29,88,Complete Response
M200997,45,Male,Non-small Cell Lung Cancer,KEYTRUDA only,29.67,18.79,913.31,84,Complete Response
M200998,70,Male,HPV-related Cancer,mrna-4157 + keytruda,68.84,55.13,1284.72,95,Complete Response
M200999,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.21,42.72,135.54,108,Partial Response
M201000,69,Female,HPV-related Cancer,mrna-4157 + keytruda,84.66,48.13,967.68,93,Stable Disease
M201001,54,Male,Melanoma,mrna-4157 + keytruda,17.51,4.75,1344.58,92,Progression
M201002,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.8,54.99,830.3,93,Stable Disease
M201003,59,Other,Melanoma,KEYTRUDA only,63.6,49.71,798.91,92,Stable Disease
M201004,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.87,34.86,1577.74,98,Unknown
M201005,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.64,40.16,714.98,100,Partial Response
M201006,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,92.83,84.71,763.15,97,Partial Response
M201007,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.32,44.05,1134.76,85,Stable Disease
M201008,25,Other,Melanoma,KEYTRUDA only,40.54,39.64,805.26,84,Partial Response
M201009,33,Other,Melanoma,mrna-4157 + keytruda,66.86,61.65,1645.47,86,Partial Response
M201010,28,Female,Melanoma,KEYTRUDA only,44.9,45.45,1424.81,93,Partial Response
M201011,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.03,48.47,1013.77,105,Unknown
M201012,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.64,55.8,1091.21,85,Progression
M201013,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.55,35.65,1086.14,87,Stable Disease
M201014,61,Male,Melanoma,KEYTRUDA only,64.57,60.53,1085.34,105,Partial Response
M201015,78,Other,Melanoma,KEYTRUDA only,45.33,19.45,729.99,89,Progression
M201016,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.34,64.29,77.83,105,Stable Disease
M201017,81,Female,HPV-related Cancer,mrna-4157 + keytruda,62.47,56.03,935.18,93,Unknown
M201018,40,Male,HPV-related Cancer,KEYTRUDA only,45.35,23.35,486.56,74,Progression
M201019,26,Other,Melanoma,mrna-4157 + keytruda,32.45,32.65,1422.27,77,Progression
M201020,78,Female,Melanoma,mrna-4157 + keytruda,63.84,40.94,1058.84,86,Progression
M201021,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.21,48.62,1261.09,103,Partial Response
M201022,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.27,29.5,741.24,88,Partial Response
M201023,39,Female,HPV-related Cancer,mrna-4157 + keytruda,41.86,44.83,741.08,98,Stable Disease
M201024,30,Female,HPV-related Cancer,KEYTRUDA only,59.91,56.18,589.49,91,Partial Response
M201025,69,Female,Melanoma,KEYTRUDA only,64.85,52.02,706.71,91,Progression
M201026,80,Female,HPV-related Cancer,KEYTRUDA only,35.73,22.18,543.91,99,Complete Response
M201027,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.77,38.6,790.07,76,Complete Response
M201028,63,Other,HPV-related Cancer,KEYTRUDA only,50.44,48.0,761.31,100,Partial Response
M201029,34,Female,Melanoma,mrna-4157 + keytruda,4.4,2.63,1114.16,96,Partial Response
M201030,66,Female,HPV-related Cancer,KEYTRUDA only,33.58,26.55,235.19,91,Complete Response
M201031,60,Male,HPV-related Cancer,mrna-4157 + keytruda,46.62,37.97,1201.33,94,Partial Response
M201032,35,Male,HPV-related Cancer,KEYTRUDA only,8.34,10.05,,81,Progression
M201033,75,Other,Non-small Cell Lung Cancer,KEYTRUDA only,28.51,24.14,909.18,92,Unknown
M201034,55,Female,Melanoma,mrna-4157 + keytruda,79.42,87.43,1705.83,83,Complete Response
M201035,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,78.18,40.72,1123.6,88,Partial Response
M201036,52,Other,Melanoma,KEYTRUDA only,63.15,50.35,1081.17,106,Partial Response
M201037,53,Female,Melanoma,mrna-4157 + keytruda,64.73,37.18,1134.62,97,Partial Response
M201038,62,Male,HPV-related Cancer,KEYTRUDA only,44.72,49.69,1284.84,103,Progression
M201039,50,Female,HPV-related Cancer,mrna-4157 + keytruda,52.89,43.27,904.7,98,Partial Response
M201040,27,Male,HPV-related Cancer,KEYTRUDA only,59.52,57.01,316.7,79,Stable Disease
M201041,72,Other,Melanoma,KEYTRUDA only,85.71,,1131.48,83,Progression
M201042,45,Female,Melanoma,KEYTRUDA only,48.9,41.5,1349.96,105,Stable Disease
M201043,65,Male,HPV-related Cancer,mrna-4157 + keytruda,47.27,40.88,1231.43,94,Progression
M201044,62,Male,HPV-related Cancer,mrna-4157 + keytruda,59.16,64.48,977.17,99,Stable Disease
M201045,52,Female,HPV-related Cancer,mrna-4157 + keytruda,80.72,83.14,1184.32,91,Progression
M201046,78,Female,Melanoma,mrna-4157 + keytruda,68.05,63.43,1129.69,91,Complete Response
M201047,74,Female,HPV-related Cancer,mrna-4157 + keytruda,63.84,42.47,1051.69,94,
M201048,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,86.38,79.18,1685.02,100,Stable Disease
M201049,56,Male,HPV-related Cancer,mrna-4157 + keytruda,69.34,40.69,,94,Partial Response
M201050,36,Female,HPV-related Cancer,mrna-4157 + keytruda,47.93,39.84,1928.26,103,Partial Response
M201051,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,13.02,11.66,686.3,103,Stable Disease
M201052,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.47,19.16,1217.04,86,Partial Response
M201053,57,Other,HPV-related Cancer,KEYTRUDA only,53.59,35.89,1164.82,94,Complete Response
M201054,33,Female,Melanoma,mrna-4157 + keytruda,16.39,7.54,829.65,98,Stable Disease
M201055,50,Male,HPV-related Cancer,KEYTRUDA only,58.66,34.36,,93,Progression
M201056,33,Female,Melanoma,KEYTRUDA only,83.45,66.96,912.78,114,Partial Response
M201057,68,Female,HPV-related Cancer,KEYTRUDA only,56.4,49.68,1357.37,69,Complete Response
M201058,59,Female,HPV-related Cancer,KEYTRUDA only,54.0,,1522.13,93,Progression
M201059,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.17,24.11,878.01,94,Progression
M201060,46,Male,HPV-related Cancer,KEYTRUDA only,44.2,32.88,659.39,108,Progression
M201061,47,Male,Melanoma,mrna-4157 + keytruda,20.89,15.62,606.69,77,Stable Disease
M201062,60,Female,HPV-related Cancer,mrna-4157 + keytruda,42.94,47.67,922.2,91,Stable Disease
M201063,75,Male,Melanoma,mrna-4157 + keytruda,64.52,47.93,1036.02,92,
M201064,48,Male,Melanoma,mrna-4157 + keytruda,58.69,36.78,356.55,78,Progression
M201065,78,Female,HPV-related Cancer,mrna-4157 + keytruda,30.6,21.07,1088.88,80,Progression
M201066,77,Female,Melanoma,mrna-4157 + keytruda,31.58,23.5,913.6,91,Unknown
M201067,40,Female,HPV-related Cancer,mrna-4157 + keytruda,60.37,40.56,740.03,99,Stable Disease
M201068,63,Other,HPV-related Cancer,mrna-4157 + keytruda,33.22,32.19,1239.17,82,
M201069,54,Female,HPV-related Cancer,KEYTRUDA only,42.93,40.59,452.46,101,Partial Response
M201070,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.76,51.06,746.5,94,
M201071,79,Female,Melanoma,KEYTRUDA only,45.33,18.93,1254.1,76,Stable Disease
M201072,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.17,34.69,1841.87,83,Stable Disease
M201073,57,Female,HPV-related Cancer,KEYTRUDA only,56.7,47.78,835.63,93,Partial Response
M201074,49,Male,Melanoma,KEYTRUDA only,31.72,10.78,1325.01,76,Partial Response
M201075,57,Other,HPV-related Cancer,mrna-4157 + keytruda,68.4,42.41,1061.37,88,Complete Response
M201076,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.73,20.23,987.25,85,Progression
M201077,58,Female,HPV-related Cancer,KEYTRUDA only,83.04,50.73,962.07,98,Partial Response
M201078,83,Male,Melanoma,KEYTRUDA only,61.52,43.36,,86,Progression
M201079,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.16,14.26,1095.29,86,Stable Disease
M201080,38,Male,Melanoma,mrna-4157 + keytruda,75.36,76.77,948.23,89,Stable Disease
M201081,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.29,22.06,-169.62,94,Partial Response
M201082,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,72.44,29.84,1203.57,105,Stable Disease
M201083,35,Female,HPV-related Cancer,mrna-4157 + keytruda,47.9,38.41,,85,Partial Response
M201084,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.08,9.04,530.96,85,Stable Disease
M201085,69,Female,HPV-related Cancer,KEYTRUDA only,84.26,59.21,553.4,81,Complete Response
M201086,80,Female,HPV-related Cancer,mrna-4157 + keytruda,51.22,24.02,1089.62,108,Partial Response
M201087,40,Other,Melanoma,mrna-4157 + keytruda,94.2,82.62,1298.51,82,Stable Disease
M201088,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.91,19.22,1183.24,81,Progression
M201089,84,Male,HPV-related Cancer,mrna-4157 + keytruda,65.28,55.31,769.94,82,Partial Response
M201090,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.35,47.22,1251.15,86,Progression
M201091,34,Other,HPV-related Cancer,KEYTRUDA only,26.7,23.97,,98,
M201092,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,102.45,84.73,742.4,79,Progression
M201093,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.21,24.64,908.76,87,Complete Response
M201094,32,Female,Melanoma,KEYTRUDA only,44.14,40.53,1719.17,78,
M201095,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.31,50.86,717.19,88,Stable Disease
M201096,51,Male,Melanoma,KEYTRUDA only,58.06,,419.14,94,Complete Response
M201097,46,Female,Melanoma,mrna-4157 + keytruda,73.4,51.0,3439.25,87,Progression
M201098,37,Male,HPV-related Cancer,mrna-4157 + keytruda,73.47,81.38,1372.91,85,Progression
M201099,48,Other,Melanoma,mrna-4157 + keytruda,17.55,,1125.37,99,Unknown
M201100,81,Other,Melanoma,KEYTRUDA only,78.29,75.57,411.09,102,Partial Response
M201101,74,Other,HPV-related Cancer,mrna-4157 + keytruda,74.28,46.48,946.22,97,Stable Disease
M201102,71,Other,HPV-related Cancer,mrna-4157 + keytruda,41.22,38.98,436.37,93,Progression
M201103,48,Female,Melanoma,KEYTRUDA only,40.55,33.34,1571.3,79,Complete Response
M201104,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.96,38.34,521.17,83,Partial Response
M201105,54,Other,Melanoma,mrna-4157 + keytruda,37.72,28.8,1234.33,95,Stable Disease
M201106,77,Other,Melanoma,mrna-4157 + keytruda,64.14,49.54,675.14,82,Partial Response
M201107,43,Male,Melanoma,KEYTRUDA only,59.16,60.89,,102,Stable Disease
M201108,41,Other,Melanoma,mrna-4157 + keytruda,72.27,67.15,619.73,95,Partial Response
M201109,28,Other,HPV-related Cancer,KEYTRUDA only,46.57,21.49,890.9,98,Stable Disease
M201110,32,Other,HPV-related Cancer,KEYTRUDA only,48.33,39.8,787.73,107,Complete Response
M201111,62,Other,HPV-related Cancer,KEYTRUDA only,67.36,,851.26,92,Complete Response
M201112,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.38,15.77,664.36,66,Stable Disease
M201113,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,95.56,28.12,1991.43,88,Progression
M201114,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.47,19.39,789.98,89,Partial Response
M201115,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.03,31.64,927.33,102,Stable Disease
M201116,50,Male,HPV-related Cancer,KEYTRUDA only,65.12,53.27,1167.08,92,Complete Response
M201117,76,Male,Melanoma,mrna-4157 + keytruda,73.1,74.66,1541.79,93,Complete Response
M201118,68,Female,Melanoma,mrna-4157 + keytruda,18.33,21.05,1076.86,80,Stable Disease
M201119,66,Male,HPV-related Cancer,mrna-4157 + keytruda,-8.24,-5.6,810.92,84,Progression
M201120,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,91.94,59.23,961.96,100,Stable Disease
M201121,46,Female,HPV-related Cancer,mrna-4157 + keytruda,44.6,36.76,1345.36,100,Stable Disease
M201122,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.46,38.3,838.13,84,Complete Response
M201123,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.91,47.97,1211.12,87,Progression
M201124,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.77,28.01,375.15,93,Progression
M201125,78,Female,HPV-related Cancer,mrna-4157 + keytruda,53.78,35.15,980.3,82,Progression
M201126,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.79,33.4,733.76,83,Stable Disease
M201127,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.43,40.03,1027.03,100,Partial Response
M201128,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.78,56.96,1025.79,68,Partial Response
M201129,45,Female,Melanoma,mrna-4157 + keytruda,73.32,34.35,940.83,81,Stable Disease
M201130,42,Female,HPV-related Cancer,mrna-4157 + keytruda,46.63,52.86,1600.7,97,Partial Response
M201131,33,Other,Melanoma,KEYTRUDA only,81.85,75.65,1044.09,95,Progression
M201132,67,Male,Melanoma,KEYTRUDA only,66.57,58.31,949.83,106,Stable Disease
M201133,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.36,11.18,1610.59,64,Complete Response
M201134,61,Female,HPV-related Cancer,mrna-4157 + keytruda,6.87,5.22,483.32,89,Stable Disease
M201135,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.35,17.15,1505.52,90,Complete Response
M201136,69,Other,Melanoma,KEYTRUDA only,40.27,32.55,1054.35,95,Partial Response
M201137,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.62,58.77,580.9,82,Complete Response
M201138,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,-6.56,-4.56,645.28,95,Partial Response
M201139,55,Female,HPV-related Cancer,mrna-4157 + keytruda,28.4,27.64,1392.89,79,Stable Disease
M201140,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.36,31.73,546.41,92,Partial Response
M201141,83,Male,Melanoma,KEYTRUDA only,77.56,54.64,1333.86,80,Progression
M201142,56,Female,HPV-related Cancer,KEYTRUDA only,36.02,29.65,1150.88,72,Partial Response
M201143,45,Other,HPV-related Cancer,mrna-4157 + keytruda,74.43,65.81,1264.57,94,Partial Response
M201144,26,Male,Melanoma,mrna-4157 + keytruda,67.94,58.46,1737.02,90,Partial Response
M201145,46,Other,Melanoma,mrna-4157 + keytruda,69.57,66.9,1064.12,69,Progression
M201146,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,-3.19,-2.67,496.13,78,Complete Response
M201147,67,Male,HPV-related Cancer,mrna-4157 + keytruda,15.92,19.67,1084.29,94,Stable Disease
M201148,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,95.16,93.72,1812.94,75,Unknown
M201149,26,Female,HPV-related Cancer,KEYTRUDA only,61.82,49.56,1179.39,90,Complete Response
M201150,62,Other,Melanoma,KEYTRUDA only,45.0,41.04,898.83,97,Partial Response
M201151,60,Female,Melanoma,mrna-4157 + keytruda,26.82,18.77,737.82,97,Complete Response
M201152,83,Male,HPV-related Cancer,mrna-4157 + keytruda,62.99,51.03,1265.39,86,Stable Disease
M201153,54,Male,Melanoma,mrna-4157 + keytruda,46.49,28.3,1286.77,87,Partial Response
M201154,58,Female,Melanoma,KEYTRUDA only,36.68,35.9,886.41,102,Stable Disease
M201155,40,Other,HPV-related Cancer,mrna-4157 + keytruda,33.52,26.17,896.12,101,Partial Response
M201156,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.71,36.2,1148.72,105,Unknown
M201157,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.16,23.91,686.21,105,Unknown
M201158,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,84.64,72.74,1144.66,93,Partial Response
M201159,41,Male,Melanoma,mrna-4157 + keytruda,35.36,34.95,472.69,89,Stable Disease
M201160,28,Male,Melanoma,mrna-4157 + keytruda,69.04,63.15,1324.03,86,Progression
M201161,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.16,23.05,1029.74,78,Partial Response
M201162,37,Female,Melanoma,KEYTRUDA only,28.59,12.71,1255.49,93,Partial Response
M201163,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.04,30.65,547.2,82,Partial Response
M201164,27,Female,Melanoma,mrna-4157 + keytruda,68.01,46.0,900.03,93,Progression
M201165,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.02,39.0,1445.52,89,Partial Response
M201166,43,Male,Melanoma,mrna-4157 + keytruda,56.05,46.43,622.42,104,Complete Response
M201167,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.6,58.78,962.45,102,Stable Disease
M201168,59,Female,Melanoma,mrna-4157 + keytruda,74.54,,792.19,95,Stable Disease
M201169,43,Other,HPV-related Cancer,mrna-4157 + keytruda,71.63,50.47,1113.6,81,Partial Response
M201170,67,Female,Melanoma,mrna-4157 + keytruda,32.23,26.17,952.06,73,Complete Response
M201171,43,Male,HPV-related Cancer,mrna-4157 + keytruda,32.04,27.41,1208.11,83,Unknown
M201172,35,Male,HPV-related Cancer,KEYTRUDA only,68.89,36.48,577.59,84,Stable Disease
M201173,31,Female,HPV-related Cancer,mrna-4157 + keytruda,40.46,40.69,688.57,76,Partial Response
M201174,75,Other,Melanoma,KEYTRUDA only,27.96,,892.83,95,Stable Disease
M201175,70,Male,HPV-related Cancer,KEYTRUDA only,40.01,26.59,798.56,85,Partial Response
M201176,30,Female,HPV-related Cancer,mrna-4157 + keytruda,36.4,25.07,1446.45,112,Partial Response
M201177,43,Male,Melanoma,KEYTRUDA only,29.06,22.4,584.22,90,Partial Response
M201178,26,Other,Melanoma,KEYTRUDA only,52.23,12.35,742.48,108,Partial Response
M201179,37,Other,HPV-related Cancer,mrna-4157 + keytruda,23.53,36.28,450.3,90,Complete Response
M201180,26,Female,HPV-related Cancer,mrna-4157 + keytruda,67.01,64.01,850.21,107,Progression
M201181,46,Female,Melanoma,KEYTRUDA only,32.97,16.85,361.23,91,Partial Response
M201182,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.77,26.44,1221.51,94,Stable Disease
M201183,56,Male,HPV-related Cancer,KEYTRUDA only,96.95,111.54,1254.12,102,Complete Response
M201184,35,Male,HPV-related Cancer,mrna-4157 + keytruda,16.18,12.94,1142.05,84,Stable Disease
M201185,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-7.95,-7.54,1461.78,81,Complete Response
M201186,50,Other,HPV-related Cancer,mrna-4157 + keytruda,56.51,57.17,743.78,98,Partial Response
M201187,25,Male,HPV-related Cancer,KEYTRUDA only,26.07,13.94,2045.78,80,Complete Response
M201188,37,Female,Melanoma,mrna-4157 + keytruda,44.04,35.67,979.66,94,Partial Response
M201189,39,Female,HPV-related Cancer,KEYTRUDA only,48.29,34.46,687.35,96,Complete Response
M201190,65,Male,Melanoma,KEYTRUDA only,41.06,38.01,1648.38,99,Complete Response
M201191,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.15,41.12,1419.62,84,Stable Disease
M201192,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.79,18.44,1708.54,83,Partial Response
M201193,46,Male,HPV-related Cancer,KEYTRUDA only,66.2,73.48,1148.25,92,Stable Disease
M201194,82,Male,Melanoma,mrna-4157 + keytruda,44.23,42.23,957.84,81,Stable Disease
M201195,78,Female,Melanoma,mrna-4157 + keytruda,104.98,117.55,1580.05,69,Stable Disease
M201196,42,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.35,30.49,697.29,78,Stable Disease
M201197,57,Other,Melanoma,mrna-4157 + keytruda,29.92,19.09,1203.65,80,Progression
M201198,46,Female,Melanoma,mrna-4157 + keytruda,16.41,14.19,1217.86,97,
M201199,44,Other,HPV-related Cancer,KEYTRUDA only,94.26,66.87,654.76,97,Complete Response
M201200,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.55,13.22,460.81,96,Stable Disease
M201201,82,Female,HPV-related Cancer,mrna-4157 + keytruda,34.08,19.48,1762.34,85,Stable Disease
M201202,30,Other,Melanoma,KEYTRUDA only,64.37,39.04,1254.27,84,Partial Response
M201203,39,Other,HPV-related Cancer,mrna-4157 + keytruda,56.36,28.99,,111,Progression
M201204,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.16,35.7,862.36,88,Stable Disease
M201205,84,Male,Melanoma,mrna-4157 + keytruda,29.59,21.79,1523.84,114,Partial Response
M201206,64,Other,HPV-related Cancer,mrna-4157 + keytruda,47.21,36.25,520.26,86,Partial Response
M201207,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.96,58.76,235.28,78,Progression
M201208,81,Other,Melanoma,mrna-4157 + keytruda,32.43,25.57,719.08,119,Progression
M201209,56,Male,Melanoma,KEYTRUDA only,79.04,78.32,695.85,95,Partial Response
M201210,73,Female,HPV-related Cancer,mrna-4157 + keytruda,77.45,,461.09,79,Unknown
M201211,35,Female,HPV-related Cancer,mrna-4157 + keytruda,44.0,39.68,560.83,93,Stable Disease
M201212,42,Other,HPV-related Cancer,mrna-4157 + keytruda,27.86,20.81,930.56,84,
M201213,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.64,38.06,856.72,75,Partial Response
M201214,42,Male,HPV-related Cancer,mrna-4157 + keytruda,64.24,43.75,818.14,96,Progression
M201215,40,Other,Melanoma,KEYTRUDA only,18.36,17.99,728.5,69,Progression
M201216,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.52,46.93,276.77,80,Complete Response
M201217,39,Male,Melanoma,mrna-4157 + keytruda,47.39,24.33,1090.95,86,
M201218,82,Female,Melanoma,KEYTRUDA only,35.48,22.63,45.17,91,Partial Response
M201219,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.66,40.08,1167.41,92,Partial Response
M201220,64,Male,HPV-related Cancer,mrna-4157 + keytruda,26.5,20.66,828.53,95,Stable Disease
M201221,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.52,16.9,1062.44,92,Stable Disease
M201222,46,Female,Melanoma,mrna-4157 + keytruda,56.44,52.29,469.8,93,Stable Disease
M201223,28,Male,Melanoma,mrna-4157 + keytruda,64.11,43.05,435.73,91,Partial Response
M201224,71,Other,HPV-related Cancer,KEYTRUDA only,42.25,32.36,,88,Stable Disease
M201225,44,Other,Melanoma,mrna-4157 + keytruda,25.33,12.89,1409.36,99,Progression
M201226,42,Female,Melanoma,mrna-4157 + keytruda,42.59,36.02,1700.74,106,Progression
M201227,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.95,24.22,1344.7,90,Complete Response
M201228,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.93,34.4,691.88,92,Stable Disease
M201229,80,Other,Melanoma,mrna-4157 + keytruda,63.45,58.94,388.7,56,Stable Disease
M201230,66,Male,Melanoma,mrna-4157 + keytruda,33.48,,935.9,87,Partial Response
M201231,42,Other,Melanoma,mrna-4157 + keytruda,74.53,95.5,1640.75,84,Stable Disease
M201232,72,Male,HPV-related Cancer,KEYTRUDA only,99.3,65.43,1000.99,92,Complete Response
M201233,25,Female,HPV-related Cancer,KEYTRUDA only,33.76,28.83,1595.03,91,Partial Response
M201234,41,Other,HPV-related Cancer,mrna-4157 + keytruda,39.74,,,78,Complete Response
M201235,78,Female,Melanoma,KEYTRUDA only,64.95,26.79,572.52,87,Partial Response
M201236,82,Male,Melanoma,KEYTRUDA only,24.11,16.24,1140.12,91,Unknown
M201237,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.3,40.42,1061.78,95,Partial Response
M201238,84,Female,HPV-related Cancer,mrna-4157 + keytruda,51.05,52.42,1335.56,84,Complete Response
M201239,83,Male,Melanoma,mrna-4157 + keytruda,65.81,41.28,1049.4,90,Stable Disease
M201240,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.55,17.07,1984.4,95,Progression
M201241,61,Other,Melanoma,mrna-4157 + keytruda,57.08,31.12,,103,Stable Disease
M201242,41,Other,HPV-related Cancer,mrna-4157 + keytruda,54.24,27.31,477.87,79,Complete Response
M201243,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.87,17.11,1467.07,97,Partial Response
M201244,66,Male,HPV-related Cancer,KEYTRUDA only,51.39,44.25,1299.04,90,Partial Response
M201245,73,Female,Melanoma,mrna-4157 + keytruda,43.48,30.23,764.16,97,Progression
M201246,59,Female,Melanoma,mrna-4157 + keytruda,50.13,43.89,1610.36,93,Stable Disease
M201247,67,Female,Melanoma,KEYTRUDA only,32.29,34.07,1028.49,90,Partial Response
M201248,25,Other,Melanoma,mrna-4157 + keytruda,90.9,76.21,1707.29,102,Complete Response
M201249,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,61.63,52.16,1369.12,108,Complete Response
M201250,54,Male,Melanoma,mrna-4157 + keytruda,90.92,71.43,1586.02,90,Unknown
M201251,56,Other,HPV-related Cancer,mrna-4157 + keytruda,73.52,53.16,,103,Partial Response
M201252,41,Other,Melanoma,KEYTRUDA only,51.93,52.23,646.45,105,Unknown
M201253,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-11.0,-8.07,577.25,77,Progression
M201254,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.25,20.86,1053.08,82,Complete Response
M201255,54,Male,Melanoma,mrna-4157 + keytruda,70.15,69.55,1382.39,98,Partial Response
M201256,40,Male,HPV-related Cancer,mrna-4157 + keytruda,65.98,41.6,931.8,88,
M201257,45,Male,HPV-related Cancer,mrna-4157 + keytruda,27.26,24.55,1075.42,95,Unknown
M201258,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,21.34,25.87,697.19,74,Stable Disease
M201259,42,Female,Melanoma,mrna-4157 + keytruda,63.53,47.18,966.77,95,Complete Response
M201260,42,Female,Melanoma,mrna-4157 + keytruda,55.18,62.14,,100,Stable Disease
M201261,32,Male,HPV-related Cancer,mrna-4157 + keytruda,70.02,,1388.77,97,Stable Disease
M201262,61,Other,Melanoma,mrna-4157 + keytruda,51.18,27.66,581.06,82,Progression
M201263,65,Other,Melanoma,KEYTRUDA only,69.34,40.23,863.79,74,Stable Disease
M201264,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.67,68.58,1761.55,80,Stable Disease
M201265,64,Female,HPV-related Cancer,KEYTRUDA only,70.0,57.01,315.41,92,Partial Response
M201266,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.78,37.37,1258.97,80,Partial Response
M201267,80,Other,Melanoma,mrna-4157 + keytruda,40.06,22.36,290.26,72,Partial Response
M201268,72,Other,Melanoma,mrna-4157 + keytruda,66.58,,1031.09,77,Partial Response
M201269,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.95,,1058.81,78,Stable Disease
M201270,33,Female,Melanoma,mrna-4157 + keytruda,30.17,19.43,1611.76,83,Complete Response
M201271,59,Other,HPV-related Cancer,KEYTRUDA only,85.32,32.83,623.76,88,Complete Response
M201272,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.81,43.94,,100,Stable Disease
M201273,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.83,24.83,1248.76,89,Partial Response
M201274,66,Female,HPV-related Cancer,mrna-4157 + keytruda,48.13,43.99,1630.51,92,Complete Response
M201275,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.47,26.74,845.72,84,Complete Response
M201276,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,76.56,69.16,471.19,92,Partial Response
M201277,73,Female,Melanoma,mrna-4157 + keytruda,46.4,30.3,1131.68,81,Progression
M201278,64,Other,Melanoma,KEYTRUDA only,28.6,22.97,1311.54,77,Complete Response
M201279,33,Other,Melanoma,mrna-4157 + keytruda,27.92,21.52,423.96,87,Stable Disease
M201280,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.68,48.11,358.24,100,Stable Disease
M201281,65,Male,HPV-related Cancer,mrna-4157 + keytruda,46.68,37.38,562.43,89,Stable Disease
M201282,67,Female,Melanoma,mrna-4157 + keytruda,78.8,47.25,924.41,83,Stable Disease
M201283,53,Male,HPV-related Cancer,mrna-4157 + keytruda,49.91,46.02,764.41,83,Complete Response
M201284,57,Other,Melanoma,KEYTRUDA only,24.45,23.7,1805.14,81,Partial Response
M201285,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.43,61.86,1470.7,82,
M201286,32,Female,HPV-related Cancer,mrna-4157 + keytruda,62.13,45.23,1144.71,80,Progression
M201287,72,Male,HPV-related Cancer,mrna-4157 + keytruda,15.18,14.51,576.6,91,Complete Response
M201288,82,Female,Melanoma,mrna-4157 + keytruda,24.14,22.41,983.16,83,Complete Response
M201289,61,Other,HPV-related Cancer,KEYTRUDA only,69.31,40.01,1780.42,94,Partial Response
M201290,67,Male,Melanoma,KEYTRUDA only,68.35,60.32,618.76,90,Complete Response
M201291,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.36,60.12,993.34,75,Stable Disease
M201292,35,Other,Melanoma,mrna-4157 + keytruda,47.78,35.79,1569.21,78,Partial Response
M201293,40,Female,Melanoma,mrna-4157 + keytruda,44.05,26.3,826.58,99,Stable Disease
M201294,29,Other,HPV-related Cancer,mrna-4157 + keytruda,46.25,33.07,783.02,103,Complete Response
M201295,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.25,,,103,Stable Disease
M201296,46,Other,HPV-related Cancer,KEYTRUDA only,56.74,38.12,777.99,74,Complete Response
M201297,37,Male,Melanoma,mrna-4157 + keytruda,12.83,11.83,889.05,94,Progression
M201298,33,Male,HPV-related Cancer,KEYTRUDA only,73.57,41.16,919.51,76,Stable Disease
M201299,80,Female,HPV-related Cancer,mrna-4157 + keytruda,44.05,56.31,669.25,82,Partial Response
M201300,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.75,30.16,959.85,90,Stable Disease
M201301,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.95,23.14,1504.06,91,
M201302,75,Male,Melanoma,mrna-4157 + keytruda,44.43,31.91,1121.12,71,Stable Disease
M201303,57,Female,Melanoma,mrna-4157 + keytruda,54.15,34.22,729.28,93,Unknown
M201304,28,Other,Melanoma,KEYTRUDA only,40.09,37.96,1245.43,111,Partial Response
M201305,65,Other,Melanoma,KEYTRUDA only,48.18,21.88,1156.67,96,Stable Disease
M201306,63,Other,Melanoma,KEYTRUDA only,29.19,25.71,915.97,94,Partial Response
M201307,81,Other,Melanoma,mrna-4157 + keytruda,5.06,4.89,914.78,88,Stable Disease
M201308,65,Female,Melanoma,mrna-4157 + keytruda,38.69,37.22,1303.04,84,Partial Response
M201309,59,Male,Melanoma,KEYTRUDA only,40.08,31.03,548.79,79,Partial Response
M201310,35,Other,HPV-related Cancer,mrna-4157 + keytruda,94.48,89.58,1202.36,92,
M201311,60,Male,Melanoma,KEYTRUDA only,74.58,69.02,988.61,92,Unknown
M201312,45,Female,Melanoma,mrna-4157 + keytruda,47.03,32.08,855.47,100,Progression
M201313,34,Female,Melanoma,mrna-4157 + keytruda,29.39,15.65,540.4,84,Partial Response
M201314,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.33,20.98,1669.03,84,Stable Disease
M201315,25,Female,Melanoma,mrna-4157 + keytruda,11.69,10.15,1236.77,90,
M201316,27,Female,HPV-related Cancer,mrna-4157 + keytruda,59.72,54.18,806.63,95,Partial Response
M201317,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.19,,367.84,96,Progression
M201318,65,Female,HPV-related Cancer,mrna-4157 + keytruda,34.75,29.88,1381.38,96,Stable Disease
M201319,33,Female,Melanoma,KEYTRUDA only,73.84,62.77,973.38,93,Stable Disease
M201320,74,Female,HPV-related Cancer,mrna-4157 + keytruda,35.14,29.01,1032.52,81,Partial Response
M201321,83,Female,Melanoma,KEYTRUDA only,73.12,80.17,1251.68,82,Stable Disease
M201322,70,Other,Melanoma,KEYTRUDA only,68.2,23.64,1378.03,79,Partial Response
M201323,42,Male,HPV-related Cancer,mrna-4157 + keytruda,60.16,24.89,1017.37,95,Progression
M201324,47,Male,Melanoma,mrna-4157 + keytruda,62.97,53.33,885.87,90,Stable Disease
M201325,29,Other,Melanoma,mrna-4157 + keytruda,64.41,56.16,838.16,86,Stable Disease
M201326,57,Other,Melanoma,mrna-4157 + keytruda,50.92,47.42,1193.49,77,Progression
M201327,36,Other,HPV-related Cancer,mrna-4157 + keytruda,21.73,17.06,653.3,91,Unknown
M201328,32,Female,HPV-related Cancer,mrna-4157 + keytruda,49.05,44.63,1190.92,79,Partial Response
M201329,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,87.51,77.24,650.75,100,Complete Response
M201330,45,Male,HPV-related Cancer,mrna-4157 + keytruda,36.05,28.23,853.22,104,Progression
M201331,82,Male,Melanoma,KEYTRUDA only,34.46,19.63,1483.25,88,Stable Disease
M201332,44,Male,Melanoma,KEYTRUDA only,30.33,27.76,571.32,105,Complete Response
M201333,47,Other,Melanoma,mrna-4157 + keytruda,49.8,31.79,1001.39,77,Complete Response
M201334,32,Female,Melanoma,KEYTRUDA only,37.92,39.24,726.21,78,Stable Disease
M201335,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.68,63.41,614.89,102,Unknown
M201336,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.26,22.1,680.17,88,Progression
M201337,31,Female,Melanoma,mrna-4157 + keytruda,55.54,27.81,1423.68,97,Progression
M201338,33,Other,Melanoma,mrna-4157 + keytruda,56.27,46.76,1882.65,90,Progression
M201339,39,Other,Melanoma,mrna-4157 + keytruda,66.59,59.13,1082.35,99,Stable Disease
M201340,83,Male,Melanoma,mrna-4157 + keytruda,61.39,40.62,971.15,88,Progression
M201341,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.8,45.78,1560.61,77,Stable Disease
M201342,72,Female,HPV-related Cancer,KEYTRUDA only,76.26,52.96,1188.41,92,Partial Response
M201343,43,Other,HPV-related Cancer,mrna-4157 + keytruda,57.25,58.64,538.74,88,Stable Disease
M201344,57,Female,Melanoma,mrna-4157 + keytruda,71.61,66.17,1577.91,97,Stable Disease
M201345,57,Male,Melanoma,mrna-4157 + keytruda,41.04,25.42,1375.28,84,Progression
M201346,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.7,47.34,883.14,93,Partial Response
M201347,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.17,33.73,1669.29,74,Partial Response
M201348,49,Female,HPV-related Cancer,KEYTRUDA only,59.74,52.16,,78,Partial Response
M201349,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.88,36.54,1487.45,90,
M201350,37,Female,Melanoma,mrna-4157 + keytruda,64.83,36.2,920.16,109,
M201351,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.2,19.27,,79,Unknown
M201352,56,Other,HPV-related Cancer,KEYTRUDA only,40.13,14.5,1427.82,89,Stable Disease
M201353,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.97,21.93,1046.72,93,Complete Response
M201354,45,Other,Melanoma,mrna-4157 + keytruda,66.89,51.37,1075.48,92,Stable Disease
M201355,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.87,53.58,1332.61,105,Partial Response
M201356,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.92,34.04,1719.41,102,Stable Disease
M201357,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.81,47.87,1231.75,96,Complete Response
M201358,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.88,47.29,,109,Partial Response
M201359,58,Male,HPV-related Cancer,mrna-4157 + keytruda,61.93,63.08,574.55,87,Partial Response
M201360,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.7,65.98,917.46,77,Partial Response
M201361,26,Other,Melanoma,mrna-4157 + keytruda,61.2,64.42,515.8,92,Partial Response
M201362,41,Female,HPV-related Cancer,mrna-4157 + keytruda,99.06,76.68,627.23,79,Partial Response
M201363,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.94,34.81,1555.53,78,Progression
M201364,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.92,38.94,942.63,80,Complete Response
M201365,41,Male,Melanoma,KEYTRUDA only,54.86,42.74,817.28,94,Partial Response
M201366,51,Male,Melanoma,mrna-4157 + keytruda,64.23,24.5,487.57,99,Partial Response
M201367,49,Male,HPV-related Cancer,mrna-4157 + keytruda,39.97,45.46,507.86,92,Complete Response
M201368,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.12,92.7,1251.36,85,Partial Response
M201369,56,Female,Melanoma,mrna-4157 + keytruda,46.99,23.73,1151.51,104,Partial Response
M201370,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.78,40.24,1618.67,90,Progression
M201371,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.5,46.35,1381.81,84,Partial Response
M201372,30,Female,Melanoma,mrna-4157 + keytruda,6.97,6.3,428.15,89,Stable Disease
M201373,47,Other,Melanoma,mrna-4157 + keytruda,68.72,73.82,1223.89,86,Partial Response
M201374,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.24,45.78,1684.92,86,Progression
M201375,64,Female,HPV-related Cancer,KEYTRUDA only,78.01,37.81,,75,Progression
M201376,56,Male,Melanoma,KEYTRUDA only,38.76,30.72,632.1,99,Partial Response
M201377,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.33,60.43,1150.83,74,Progression
M201378,51,Male,HPV-related Cancer,KEYTRUDA only,52.62,36.37,1083.3,87,Partial Response
M201379,25,Female,HPV-related Cancer,mrna-4157 + keytruda,78.29,60.37,1341.19,84,Stable Disease
M201380,59,Female,HPV-related Cancer,mrna-4157 + keytruda,64.22,40.69,560.88,86,Stable Disease
M201381,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.37,32.16,836.5,107,Stable Disease
M201382,73,Male,HPV-related Cancer,mrna-4157 + keytruda,23.61,8.18,560.43,87,Complete Response
M201383,39,Male,Melanoma,mrna-4157 + keytruda,65.06,37.95,783.36,89,Stable Disease
M201384,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.69,31.23,1387.43,86,Partial Response
M201385,71,Other,HPV-related Cancer,mrna-4157 + keytruda,29.58,,990.84,99,Stable Disease
M201386,26,Male,HPV-related Cancer,KEYTRUDA only,79.01,68.27,936.08,86,Stable Disease
M201387,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.8,44.79,,98,Partial Response
M201388,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.07,84.27,745.74,91,Partial Response
M201389,42,Male,Melanoma,KEYTRUDA only,29.29,37.4,1057.21,71,Stable Disease
M201390,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.29,45.39,606.51,112,Complete Response
M201391,45,Other,HPV-related Cancer,mrna-4157 + keytruda,66.73,88.14,1215.84,103,Progression
M201392,74,Other,HPV-related Cancer,mrna-4157 + keytruda,63.95,49.31,1160.72,80,
M201393,25,Other,HPV-related Cancer,mrna-4157 + keytruda,41.2,19.43,1077.24,101,Partial Response
M201394,41,Male,HPV-related Cancer,KEYTRUDA only,45.62,39.85,943.44,85,Stable Disease
M201395,73,Male,Melanoma,mrna-4157 + keytruda,27.13,16.16,1045.79,83,Stable Disease
M201396,45,Male,Melanoma,mrna-4157 + keytruda,46.15,28.46,1225.15,81,Progression
M201397,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.36,55.92,1033.63,81,
M201398,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,61.96,52.3,845.37,91,Partial Response
M201399,39,Other,Melanoma,KEYTRUDA only,95.26,65.21,1320.3,85,Stable Disease
M201400,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.57,37.89,554.79,81,Progression
M201401,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.12,37.34,1371.83,99,Stable Disease
M201402,63,Other,Melanoma,mrna-4157 + keytruda,79.8,56.77,687.85,98,Stable Disease
M201403,41,Other,Melanoma,mrna-4157 + keytruda,51.91,42.26,1138.69,99,Stable Disease
M201404,73,Other,HPV-related Cancer,mrna-4157 + keytruda,73.04,59.69,897.34,88,Stable Disease
M201405,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.06,39.11,1484.78,81,Stable Disease
M201406,54,Male,HPV-related Cancer,mrna-4157 + keytruda,37.56,24.0,817.71,102,
M201407,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.76,14.19,645.93,100,Partial Response
M201408,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.82,59.52,818.07,109,Stable Disease
M201409,69,Female,Melanoma,KEYTRUDA only,67.31,43.72,433.27,91,Progression
M201410,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.24,,189.72,76,Complete Response
M201411,67,Other,Melanoma,mrna-4157 + keytruda,64.6,,1290.2,100,Stable Disease
M201412,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.73,44.84,1047.45,101,Progression
M201413,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.84,53.31,478.15,80,Partial Response
M201414,53,Male,HPV-related Cancer,KEYTRUDA only,60.38,49.56,998.02,76,Partial Response
M201415,81,Female,Melanoma,mrna-4157 + keytruda,65.47,45.51,925.15,98,Stable Disease
M201416,46,Other,HPV-related Cancer,KEYTRUDA only,33.51,29.7,1676.77,99,Complete Response
M201417,26,Other,HPV-related Cancer,mrna-4157 + keytruda,56.71,37.03,1049.49,79,Partial Response
M201418,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.63,,868.8,82,Stable Disease
M201419,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.18,,1177.39,91,Progression
M201420,77,Female,HPV-related Cancer,KEYTRUDA only,65.4,42.77,1211.11,73,Partial Response
M201421,50,Other,HPV-related Cancer,mrna-4157 + keytruda,19.81,15.37,680.63,100,Stable Disease
M201422,31,Other,Melanoma,KEYTRUDA only,41.75,38.41,774.02,74,Unknown
M201423,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.21,,865.36,101,
M201424,34,Male,HPV-related Cancer,KEYTRUDA only,66.05,48.21,,115,Complete Response
M201425,70,Other,Melanoma,KEYTRUDA only,12.34,13.74,468.16,85,
M201426,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,12.67,10.09,1312.18,101,Partial Response
M201427,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.46,43.48,1095.77,90,Progression
M201428,83,Male,HPV-related Cancer,mrna-4157 + keytruda,49.94,33.09,429.99,93,Partial Response
M201429,68,Other,HPV-related Cancer,KEYTRUDA only,47.65,42.99,1082.29,112,
M201430,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.8,18.32,1552.15,89,Progression
M201431,36,Male,Melanoma,mrna-4157 + keytruda,54.17,51.96,1906.74,87,Partial Response
M201432,74,Female,Melanoma,mrna-4157 + keytruda,36.76,35.12,1505.64,101,Progression
M201433,55,Female,Melanoma,mrna-4157 + keytruda,44.3,34.07,909.17,94,Complete Response
M201434,27,Male,Melanoma,mrna-4157 + keytruda,17.29,19.91,1022.31,80,Stable Disease
M201435,55,Female,HPV-related Cancer,mrna-4157 + keytruda,13.48,11.81,1203.97,76,Stable Disease
M201436,75,Other,HPV-related Cancer,mrna-4157 + keytruda,72.55,39.68,1045.69,84,Progression
M201437,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.76,43.87,1566.84,92,Stable Disease
M201438,63,Female,Melanoma,mrna-4157 + keytruda,82.01,58.23,992.35,86,
M201439,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.89,,1244.54,91,Partial Response
M201440,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.15,38.31,493.09,88,Unknown
M201441,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,100.43,69.9,761.0,89,Stable Disease
M201442,44,Male,Melanoma,KEYTRUDA only,22.44,19.62,492.42,88,Stable Disease
M201443,63,Female,Melanoma,mrna-4157 + keytruda,54.82,56.89,845.63,96,Stable Disease
M201444,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,23.56,19.6,290.99,78,Partial Response
M201445,48,Male,HPV-related Cancer,KEYTRUDA only,89.14,71.67,1249.79,84,Stable Disease
M201446,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.7,9.67,400.91,93,Unknown
M201447,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.56,31.57,814.62,94,Partial Response
M201448,35,Female,Melanoma,mrna-4157 + keytruda,60.84,49.28,1157.72,97,Stable Disease
M201449,41,Male,Melanoma,mrna-4157 + keytruda,33.86,33.44,1502.13,84,Partial Response
M201450,28,Other,HPV-related Cancer,mrna-4157 + keytruda,37.46,27.21,1091.83,90,Partial Response
M201451,72,Female,Melanoma,KEYTRUDA only,58.5,49.65,514.53,79,Unknown
M201452,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.05,70.79,1328.4,82,Complete Response
M201453,45,Other,Melanoma,KEYTRUDA only,44.74,40.26,751.63,100,Complete Response
M201454,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.45,34.72,1043.56,94,Unknown
M201455,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.06,41.39,1409.0,104,Stable Disease
M201456,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.45,17.96,,94,Stable Disease
M201457,70,Other,Melanoma,KEYTRUDA only,74.31,46.48,501.57,100,Partial Response
M201458,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.37,52.34,941.14,111,Stable Disease
M201459,60,Male,HPV-related Cancer,mrna-4157 + keytruda,57.62,34.35,865.18,89,
M201460,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.08,46.51,789.26,78,Stable Disease
M201461,83,Male,Melanoma,KEYTRUDA only,53.84,36.82,464.66,98,Progression
M201462,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,61.32,55.7,,83,Partial Response
M201463,53,Male,Melanoma,mrna-4157 + keytruda,44.83,36.82,1202.77,87,Stable Disease
M201464,34,Female,HPV-related Cancer,mrna-4157 + keytruda,98.02,,1018.64,83,Complete Response
M201465,43,Female,HPV-related Cancer,KEYTRUDA only,50.62,42.23,771.91,99,Partial Response
M201466,27,Female,HPV-related Cancer,KEYTRUDA only,35.31,29.75,838.04,79,Complete Response
M201467,48,Male,HPV-related Cancer,KEYTRUDA only,24.38,14.83,847.22,105,Progression
M201468,40,Male,Melanoma,KEYTRUDA only,62.33,61.3,1170.18,90,Stable Disease
M201469,27,Other,Melanoma,KEYTRUDA only,63.32,38.88,1374.33,73,Partial Response
M201470,78,Female,HPV-related Cancer,mrna-4157 + keytruda,54.48,50.28,1678.66,86,Progression
M201471,80,Male,Melanoma,mrna-4157 + keytruda,32.0,,1111.3,76,Partial Response
M201472,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.72,21.95,1894.93,76,Progression
M201473,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.79,57.83,1135.75,87,Stable Disease
M201474,71,Female,HPV-related Cancer,mrna-4157 + keytruda,77.65,48.3,1160.05,94,Partial Response
M201475,45,Male,HPV-related Cancer,KEYTRUDA only,22.92,13.02,1496.12,101,Complete Response
M201476,60,Male,Melanoma,KEYTRUDA only,16.71,11.58,663.43,102,Partial Response
M201477,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.75,35.11,672.74,95,
M201478,49,Male,HPV-related Cancer,KEYTRUDA only,66.6,43.71,1258.7,102,Complete Response
M201479,77,Male,Melanoma,KEYTRUDA only,63.79,47.08,1004.16,99,Complete Response
M201480,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.2,32.88,954.69,79,Stable Disease
M201481,26,Other,HPV-related Cancer,mrna-4157 + keytruda,40.4,29.92,994.05,82,Partial Response
M201482,72,Male,HPV-related Cancer,KEYTRUDA only,59.25,41.29,947.56,104,Partial Response
M201483,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.18,58.46,538.55,89,Complete Response
M201484,52,Male,HPV-related Cancer,mrna-4157 + keytruda,67.63,63.08,1217.3,96,Partial Response
M201485,79,Female,Melanoma,mrna-4157 + keytruda,24.26,22.46,1455.52,93,Stable Disease
M201486,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.38,45.44,1238.66,104,Partial Response
M201487,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.91,35.21,814.19,82,Partial Response
M201488,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.27,54.16,610.53,102,Progression
M201489,78,Male,HPV-related Cancer,mrna-4157 + keytruda,29.81,22.68,966.58,89,Partial Response
M201490,36,Female,HPV-related Cancer,KEYTRUDA only,52.47,66.5,851.43,88,Stable Disease
M201491,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.76,46.7,1526.77,75,Partial Response
M201492,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.68,57.1,,92,Stable Disease
M201493,70,Other,HPV-related Cancer,KEYTRUDA only,54.74,42.72,635.48,106,Stable Disease
M201494,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,67.21,54.89,1249.8,85,Partial Response
M201495,45,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.71,30.72,1263.32,91,Progression
M201496,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.44,42.16,1190.42,86,Stable Disease
M201497,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.82,61.8,1587.41,88,Stable Disease
M201498,29,Male,Melanoma,mrna-4157 + keytruda,44.68,35.82,603.89,85,Progression
M201499,33,Other,HPV-related Cancer,KEYTRUDA only,43.09,33.82,1321.04,84,Stable Disease
M201500,54,Other,Melanoma,mrna-4157 + keytruda,44.84,,685.75,88,Partial Response
M201501,50,Female,HPV-related Cancer,mrna-4157 + keytruda,31.07,23.95,581.65,83,Progression
M201502,49,Male,HPV-related Cancer,KEYTRUDA only,58.75,47.01,660.29,76,Complete Response
M201503,36,Male,HPV-related Cancer,mrna-4157 + keytruda,38.94,40.21,1770.29,76,Complete Response
M201504,40,Male,HPV-related Cancer,mrna-4157 + keytruda,60.43,60.86,69.42,93,
M201505,75,Other,Melanoma,mrna-4157 + keytruda,67.66,72.94,711.12,87,Complete Response
M201506,76,Male,HPV-related Cancer,KEYTRUDA only,61.37,65.48,982.18,91,Complete Response
M201507,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.53,38.29,327.14,99,Stable Disease
M201508,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.46,29.73,1036.36,80,Unknown
M201509,84,Female,Melanoma,mrna-4157 + keytruda,17.17,,1323.01,83,Stable Disease
M201510,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.65,35.17,394.76,89,Partial Response
M201511,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.83,37.44,839.59,86,Stable Disease
M201512,31,Male,HPV-related Cancer,mrna-4157 + keytruda,83.68,52.28,472.99,90,Complete Response
M201513,66,Female,HPV-related Cancer,mrna-4157 + keytruda,68.98,75.37,1312.74,81,Partial Response
M201514,52,Other,HPV-related Cancer,KEYTRUDA only,44.64,46.66,1172.86,90,Partial Response
M201515,34,Female,Melanoma,mrna-4157 + keytruda,44.51,32.29,350.55,101,Stable Disease
M201516,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.8,76.19,689.79,87,Complete Response
M201517,37,Female,HPV-related Cancer,mrna-4157 + keytruda,61.8,53.09,460.69,88,Stable Disease
M201518,53,Other,Melanoma,mrna-4157 + keytruda,57.83,35.71,493.88,82,Stable Disease
M201519,30,Other,Melanoma,mrna-4157 + keytruda,44.27,32.36,829.37,101,Stable Disease
M201520,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,1.23,0.65,683.2,87,Partial Response
M201521,74,Female,Melanoma,mrna-4157 + keytruda,44.77,27.67,-38.96,95,Complete Response
M201522,62,Other,Melanoma,KEYTRUDA only,48.91,19.22,1479.09,94,Complete Response
M201523,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.56,52.1,886.38,84,Partial Response
M201524,57,Other,Melanoma,KEYTRUDA only,57.17,29.25,991.56,81,Partial Response
M201525,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.77,32.73,620.44,95,Unknown
M201526,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.28,22.61,746.06,73,Stable Disease
M201527,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.6,48.36,1449.57,95,Partial Response
M201528,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.94,23.65,595.29,95,Stable Disease
M201529,68,Female,Melanoma,mrna-4157 + keytruda,27.56,15.49,804.08,84,Progression
M201530,81,Female,HPV-related Cancer,mrna-4157 + keytruda,80.63,58.14,644.63,94,Partial Response
M201531,61,Female,HPV-related Cancer,mrna-4157 + keytruda,27.52,12.12,2914.95,96,Partial Response
M201532,61,Male,HPV-related Cancer,mrna-4157 + keytruda,69.72,39.24,955.78,78,Partial Response
M201533,57,Other,Melanoma,KEYTRUDA only,12.29,,1467.08,80,Partial Response
M201534,82,Female,Melanoma,KEYTRUDA only,59.91,37.47,841.02,102,Partial Response
M201535,37,Female,Melanoma,KEYTRUDA only,78.18,78.28,1706.72,91,Stable Disease
M201536,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.55,13.4,1134.31,92,Complete Response
M201537,62,Female,HPV-related Cancer,KEYTRUDA only,29.21,27.14,1417.21,83,Stable Disease
M201538,46,Male,HPV-related Cancer,mrna-4157 + keytruda,-1.73,-2.01,1611.38,106,Complete Response
M201539,44,Female,Melanoma,mrna-4157 + keytruda,50.95,45.08,1100.64,87,Complete Response
M201540,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.08,72.68,1172.8,92,Progression
M201541,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.8,39.06,1299.9,73,Partial Response
M201542,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,38.23,40.49,1370.95,79,Progression
M201543,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,78.69,50.79,1071.22,86,Stable Disease
M201544,46,Other,HPV-related Cancer,KEYTRUDA only,86.22,51.72,999.68,87,Progression
M201545,78,Female,HPV-related Cancer,mrna-4157 + keytruda,22.36,18.46,906.21,83,Stable Disease
M201546,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.49,84.7,929.49,90,Stable Disease
M201547,54,Other,Melanoma,mrna-4157 + keytruda,50.96,33.89,589.52,93,Partial Response
M201548,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,30.47,25.18,703.31,76,Unknown
M201549,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.06,56.39,1768.03,90,Stable Disease
M201550,84,Female,Melanoma,mrna-4157 + keytruda,25.33,17.39,,89,Stable Disease
M201551,63,Other,Melanoma,KEYTRUDA only,91.19,108.26,602.81,85,Progression
M201552,74,Male,Melanoma,mrna-4157 + keytruda,20.78,14.47,394.46,92,Complete Response
M201553,52,Other,Melanoma,mrna-4157 + keytruda,67.25,89.4,588.36,78,Progression
M201554,47,Female,HPV-related Cancer,mrna-4157 + keytruda,34.22,22.69,985.54,99,Partial Response
M201555,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.18,39.83,785.93,90,Complete Response
M201556,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.08,,1360.06,76,Partial Response
M201557,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.73,27.0,1161.03,104,Partial Response
M201558,58,Female,HPV-related Cancer,mrna-4157 + keytruda,56.39,37.28,883.53,81,Unknown
M201559,30,Male,HPV-related Cancer,mrna-4157 + keytruda,26.76,24.93,,74,Stable Disease
M201560,46,Female,HPV-related Cancer,mrna-4157 + keytruda,25.42,14.89,595.33,83,Complete Response
M201561,41,Female,HPV-related Cancer,KEYTRUDA only,45.66,39.99,,96,Stable Disease
M201562,27,Female,Melanoma,mrna-4157 + keytruda,64.95,61.29,1120.74,87,Partial Response
M201563,70,Female,HPV-related Cancer,KEYTRUDA only,32.5,19.58,1018.69,78,Progression
M201564,68,Female,Melanoma,KEYTRUDA only,64.57,52.62,1221.45,83,Partial Response
M201565,78,Male,Melanoma,mrna-4157 + keytruda,23.72,24.97,717.1,101,Complete Response
M201566,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.69,81.47,398.03,94,Partial Response
M201567,54,Male,Melanoma,mrna-4157 + keytruda,14.93,11.43,1095.44,89,Progression
M201568,44,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.98,43.24,1481.66,95,Complete Response
M201569,82,Female,Melanoma,mrna-4157 + keytruda,71.82,74.78,,93,Progression
M201570,31,Female,HPV-related Cancer,mrna-4157 + keytruda,87.12,74.83,1549.15,98,Stable Disease
M201571,69,Other,Melanoma,KEYTRUDA only,64.19,65.07,1108.26,94,Progression
M201572,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.13,45.57,988.27,78,Partial Response
M201573,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.44,25.74,1430.55,73,Complete Response
M201574,45,Female,Melanoma,mrna-4157 + keytruda,54.52,50.68,915.87,95,Partial Response
M201575,52,Other,Melanoma,KEYTRUDA only,66.77,37.54,818.74,92,Partial Response
M201576,47,Other,Melanoma,mrna-4157 + keytruda,47.58,44.84,1170.12,102,Partial Response
M201577,42,Other,HPV-related Cancer,KEYTRUDA only,19.91,15.87,1242.24,84,Partial Response
M201578,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,-3.26,-2.61,962.29,99,Complete Response
M201579,62,Male,HPV-related Cancer,KEYTRUDA only,23.81,24.82,857.85,71,Progression
M201580,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.06,44.05,1145.74,91,Partial Response
M201581,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.2,56.63,782.66,84,Stable Disease
M201582,53,Male,HPV-related Cancer,KEYTRUDA only,46.5,42.87,1146.07,117,Partial Response
M201583,83,Other,Melanoma,mrna-4157 + keytruda,54.09,52.83,884.51,114,Partial Response
M201584,31,Other,HPV-related Cancer,KEYTRUDA only,85.04,19.85,574.03,99,Stable Disease
M201585,66,Female,HPV-related Cancer,mrna-4157 + keytruda,67.55,50.07,469.29,95,Complete Response
M201586,48,Female,HPV-related Cancer,mrna-4157 + keytruda,80.38,51.25,1443.62,90,Partial Response
M201587,52,Other,Melanoma,mrna-4157 + keytruda,71.22,63.13,1355.32,76,Partial Response
M201588,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.53,39.13,1609.95,82,Progression
M201589,45,Other,HPV-related Cancer,KEYTRUDA only,62.41,47.14,1285.11,91,Partial Response
M201590,61,Female,Melanoma,KEYTRUDA only,44.82,23.69,559.69,93,Complete Response
M201591,59,Other,Melanoma,mrna-4157 + keytruda,32.17,23.96,1050.96,77,Progression
M201592,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.76,49.71,1487.64,109,Partial Response
M201593,70,Male,Melanoma,KEYTRUDA only,66.47,57.33,,105,Progression
M201594,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,16.98,18.56,1362.78,81,Stable Disease
M201595,72,Other,HPV-related Cancer,mrna-4157 + keytruda,72.3,51.43,592.86,79,Partial Response
M201596,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.2,74.67,387.99,90,Partial Response
M201597,38,Female,HPV-related Cancer,mrna-4157 + keytruda,45.56,34.07,994.58,85,Stable Disease
M201598,30,Male,HPV-related Cancer,KEYTRUDA only,62.4,,1608.04,95,Partial Response
M201599,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.81,52.1,1167.28,84,Stable Disease
M201600,28,Female,Melanoma,mrna-4157 + keytruda,25.47,19.09,371.55,95,Unknown
M201601,43,Other,HPV-related Cancer,mrna-4157 + keytruda,66.88,48.68,1066.56,78,Stable Disease
M201602,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.09,35.51,1520.4,97,Progression
M201603,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,74.23,56.77,653.57,105,Partial Response
M201604,68,Female,Melanoma,KEYTRUDA only,46.95,21.87,1209.62,92,Stable Disease
M201605,35,Other,Melanoma,KEYTRUDA only,56.49,45.67,666.95,94,Partial Response
M201606,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.48,26.5,1381.0,88,Stable Disease
M201607,56,Other,Melanoma,mrna-4157 + keytruda,52.01,34.77,1277.88,94,Complete Response
M201608,51,Female,Melanoma,KEYTRUDA only,31.37,16.19,1010.22,92,Complete Response
M201609,54,Female,Melanoma,KEYTRUDA only,34.21,32.92,357.43,64,Progression
M201610,53,Male,Melanoma,mrna-4157 + keytruda,41.83,24.08,1027.2,76,Partial Response
M201611,42,Other,HPV-related Cancer,mrna-4157 + keytruda,18.93,18.05,594.33,93,Stable Disease
M201612,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.78,23.16,818.77,82,
M201613,32,Other,Melanoma,mrna-4157 + keytruda,62.46,49.15,626.25,86,Progression
M201614,49,Female,HPV-related Cancer,KEYTRUDA only,32.27,25.21,1125.51,100,Partial Response
M201615,49,Male,Melanoma,KEYTRUDA only,60.99,51.94,1213.48,92,Complete Response
M201616,75,Male,HPV-related Cancer,mrna-4157 + keytruda,29.83,19.96,1267.37,80,Progression
M201617,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.82,58.53,1400.59,83,Partial Response
M201618,82,Male,HPV-related Cancer,mrna-4157 + keytruda,84.67,86.89,986.29,93,Partial Response
M201619,62,Male,HPV-related Cancer,mrna-4157 + keytruda,30.7,25.71,1023.93,81,Partial Response
M201620,81,Female,Melanoma,KEYTRUDA only,38.88,19.25,1703.44,86,Progression
M201621,84,Male,Melanoma,KEYTRUDA only,66.59,53.79,1213.79,69,Complete Response
M201622,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.97,30.93,743.57,93,Complete Response
M201623,46,Other,Melanoma,KEYTRUDA only,34.61,35.57,1677.93,101,Stable Disease
M201624,51,Female,Melanoma,mrna-4157 + keytruda,57.45,71.65,1330.05,89,Complete Response
M201625,82,Other,Melanoma,KEYTRUDA only,90.93,59.87,306.67,96,Partial Response
M201626,79,Male,Melanoma,mrna-4157 + keytruda,44.84,38.82,1139.74,86,Unknown
M201627,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.81,46.84,1419.74,88,Complete Response
M201628,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,78.49,65.25,1595.02,99,Partial Response
M201629,46,Male,HPV-related Cancer,KEYTRUDA only,17.4,12.7,552.42,74,Complete Response
M201630,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.49,27.22,516.92,86,Stable Disease
M201631,42,Male,Melanoma,KEYTRUDA only,75.92,38.41,566.86,77,Progression
M201632,43,Female,Melanoma,mrna-4157 + keytruda,3.14,1.66,1022.71,92,Complete Response
M201633,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.93,44.84,825.76,96,Partial Response
M201634,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.91,25.97,550.96,88,Partial Response
M201635,28,Female,HPV-related Cancer,KEYTRUDA only,61.89,46.58,1460.86,77,Complete Response
M201636,42,Female,HPV-related Cancer,mrna-4157 + keytruda,53.52,30.59,849.58,79,Progression
M201637,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,26.45,17.57,570.3,84,Complete Response
M201638,76,Male,Melanoma,KEYTRUDA only,19.57,20.3,1281.87,83,Stable Disease
M201639,49,Female,Melanoma,KEYTRUDA only,37.14,35.97,1381.91,105,Complete Response
M201640,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.06,46.18,605.7,91,Stable Disease
M201641,78,Female,Melanoma,KEYTRUDA only,68.01,67.18,1819.71,98,Complete Response
M201642,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.65,41.09,1046.29,94,Partial Response
M201643,29,Other,HPV-related Cancer,mrna-4157 + keytruda,40.13,24.56,853.61,91,Stable Disease
M201644,32,Other,HPV-related Cancer,mrna-4157 + keytruda,68.39,68.94,575.96,111,
M201645,53,Other,Melanoma,mrna-4157 + keytruda,19.87,15.72,837.33,95,Complete Response
M201646,62,Female,HPV-related Cancer,KEYTRUDA only,71.92,70.33,304.53,96,Partial Response
M201647,62,Male,Melanoma,KEYTRUDA only,25.83,33.57,1528.69,100,Stable Disease
M201648,58,Female,HPV-related Cancer,KEYTRUDA only,29.62,27.15,1056.3,95,Progression
M201649,43,Other,HPV-related Cancer,KEYTRUDA only,66.53,54.29,1116.95,117,Stable Disease
M201650,81,Other,HPV-related Cancer,KEYTRUDA only,47.3,42.11,2049.41,99,Stable Disease
M201651,84,Other,HPV-related Cancer,mrna-4157 + keytruda,40.07,34.44,826.64,93,Progression
M201652,60,Female,HPV-related Cancer,mrna-4157 + keytruda,72.95,74.05,1109.27,89,Complete Response
M201653,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.98,51.91,887.53,91,Partial Response
M201654,45,Male,HPV-related Cancer,KEYTRUDA only,30.28,,1359.48,109,Stable Disease
M201655,68,Female,HPV-related Cancer,KEYTRUDA only,35.75,44.31,332.69,88,Partial Response
M201656,82,Female,HPV-related Cancer,KEYTRUDA only,42.8,23.34,769.91,88,
M201657,28,Female,Melanoma,mrna-4157 + keytruda,40.39,41.85,1546.65,87,
M201658,76,Female,HPV-related Cancer,mrna-4157 + keytruda,26.82,26.06,957.02,88,Complete Response
M201659,65,Female,Melanoma,KEYTRUDA only,67.08,87.41,1213.96,102,Partial Response
M201660,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.51,43.99,1044.37,87,Stable Disease
M201661,49,Male,HPV-related Cancer,mrna-4157 + keytruda,86.83,54.36,677.97,90,Partial Response
M201662,65,Male,HPV-related Cancer,mrna-4157 + keytruda,54.71,41.92,1282.96,83,Stable Disease
M201663,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.43,51.64,1094.43,95,Stable Disease
M201664,34,Male,Melanoma,KEYTRUDA only,25.41,20.31,910.19,107,Stable Disease
M201665,52,Female,Melanoma,KEYTRUDA only,41.82,30.88,,77,Complete Response
M201666,43,Female,HPV-related Cancer,mrna-4157 + keytruda,49.23,36.55,455.68,73,Complete Response
M201667,50,Male,HPV-related Cancer,mrna-4157 + keytruda,51.85,54.53,1149.15,84,Progression
M201668,49,Other,Melanoma,KEYTRUDA only,72.04,67.66,1083.56,86,Stable Disease
M201669,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.62,23.34,1022.24,86,Complete Response
M201670,42,Other,HPV-related Cancer,KEYTRUDA only,78.72,63.0,863.03,94,Stable Disease
M201671,49,Female,Melanoma,mrna-4157 + keytruda,29.58,26.16,1104.12,83,Complete Response
M201672,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,29.9,26.34,829.53,84,Unknown
M201673,36,Other,Melanoma,mrna-4157 + keytruda,76.07,46.52,1195.33,88,Stable Disease
M201674,54,Female,Non-small Cell Lung Cancer,KEYTRUDA only,89.82,56.94,816.45,85,Unknown
M201675,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.78,45.26,1253.1,83,Unknown
M201676,29,Other,HPV-related Cancer,KEYTRUDA only,64.77,59.29,,96,Unknown
M201677,31,Male,Melanoma,mrna-4157 + keytruda,53.46,28.02,1623.47,74,Complete Response
M201678,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,21.19,12.29,443.36,72,Stable Disease
M201679,67,Male,Melanoma,KEYTRUDA only,54.46,55.55,685.79,105,Complete Response
M201680,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.75,65.72,1566.21,82,Stable Disease
M201681,40,Other,HPV-related Cancer,mrna-4157 + keytruda,58.34,57.1,,81,Complete Response
M201682,37,Other,HPV-related Cancer,mrna-4157 + keytruda,55.61,47.08,1300.06,93,Complete Response
M201683,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,29.71,21.0,740.97,96,Progression
M201684,62,Female,HPV-related Cancer,mrna-4157 + keytruda,48.19,49.77,273.09,87,Partial Response
M201685,31,Male,HPV-related Cancer,KEYTRUDA only,59.56,,1519.9,103,Partial Response
M201686,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.74,46.48,856.06,86,Stable Disease
M201687,29,Other,HPV-related Cancer,mrna-4157 + keytruda,32.61,23.81,891.46,91,Partial Response
M201688,63,Other,Melanoma,mrna-4157 + keytruda,7.57,5.64,829.58,83,Partial Response
M201689,42,Male,Melanoma,mrna-4157 + keytruda,1.99,1.94,1108.9,75,Stable Disease
M201690,69,Male,HPV-related Cancer,mrna-4157 + keytruda,68.04,46.22,994.89,104,Complete Response
M201691,26,Female,Melanoma,mrna-4157 + keytruda,41.37,39.6,1291.75,73,Stable Disease
M201692,56,Other,Melanoma,KEYTRUDA only,62.57,57.85,963.99,87,Complete Response
M201693,50,Other,Melanoma,mrna-4157 + keytruda,44.23,37.47,151.8,87,Unknown
M201694,44,Male,HPV-related Cancer,mrna-4157 + keytruda,58.22,51.25,1587.21,89,Partial Response
M201695,76,Other,HPV-related Cancer,mrna-4157 + keytruda,13.58,14.14,1363.35,93,Partial Response
M201696,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.84,41.38,962.7,98,Stable Disease
M201697,43,Male,Melanoma,mrna-4157 + keytruda,93.26,74.5,461.35,90,Partial Response
M201698,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.15,50.38,708.09,96,Progression
M201699,36,Other,HPV-related Cancer,mrna-4157 + keytruda,43.53,28.22,848.56,83,Stable Disease
M201700,31,Male,HPV-related Cancer,mrna-4157 + keytruda,61.72,36.25,466.08,101,Stable Disease
M201701,52,Other,HPV-related Cancer,mrna-4157 + keytruda,51.38,36.48,817.36,109,Unknown
M201702,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.01,32.08,1245.46,71,Partial Response
M201703,44,Female,Melanoma,mrna-4157 + keytruda,44.99,37.17,1511.78,73,Partial Response
M201704,42,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.63,68.15,1114.22,104,Partial Response
M201705,61,Male,HPV-related Cancer,mrna-4157 + keytruda,51.87,45.44,1060.43,80,Progression
M201706,25,Other,HPV-related Cancer,mrna-4157 + keytruda,49.63,37.69,1672.29,82,Progression
M201707,83,Other,HPV-related Cancer,KEYTRUDA only,75.91,55.33,855.5,89,Partial Response
M201708,75,Other,Melanoma,KEYTRUDA only,36.87,30.78,1084.32,90,Progression
M201709,31,Other,Melanoma,mrna-4157 + keytruda,14.34,14.77,1262.09,90,Unknown
M201710,62,Female,Melanoma,mrna-4157 + keytruda,47.56,37.9,581.52,104,Complete Response
M201711,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.6,33.82,,98,Partial Response
M201712,38,Male,HPV-related Cancer,mrna-4157 + keytruda,22.04,17.52,416.17,78,Progression
M201713,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,10.18,7.13,1038.05,83,
M201714,52,Female,HPV-related Cancer,mrna-4157 + keytruda,46.7,55.1,718.46,101,Progression
M201715,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,87.98,74.29,102.59,78,Stable Disease
M201716,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.45,48.27,2307.08,89,Stable Disease
M201717,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.33,,1494.58,86,Partial Response
M201718,78,Other,HPV-related Cancer,KEYTRUDA only,20.75,12.64,,94,Partial Response
M201719,31,Male,HPV-related Cancer,KEYTRUDA only,21.21,12.78,1254.88,97,Partial Response
M201720,26,Other,HPV-related Cancer,KEYTRUDA only,35.67,36.96,1673.9,81,Progression
M201721,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.12,17.28,605.03,101,Partial Response
M201722,32,Other,HPV-related Cancer,mrna-4157 + keytruda,61.4,33.17,,89,Unknown
M201723,31,Other,Melanoma,KEYTRUDA only,105.21,102.76,1184.14,86,Partial Response
M201724,59,Male,HPV-related Cancer,mrna-4157 + keytruda,48.8,38.02,1533.99,93,Stable Disease
M201725,67,Male,Melanoma,mrna-4157 + keytruda,78.56,61.38,1050.18,100,Stable Disease
M201726,41,Other,Melanoma,KEYTRUDA only,38.45,,1426.39,96,Partial Response
M201727,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.96,9.25,929.01,72,Stable Disease
M201728,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,75.48,87.83,991.67,95,Partial Response
M201729,29,Other,HPV-related Cancer,mrna-4157 + keytruda,65.86,30.89,1665.25,92,Complete Response
M201730,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.48,11.09,1215.71,88,Partial Response
M201731,37,Female,HPV-related Cancer,mrna-4157 + keytruda,72.2,78.05,,83,Stable Disease
M201732,84,Other,Melanoma,KEYTRUDA only,47.58,60.96,1034.96,96,Progression
M201733,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.25,34.23,553.76,101,Progression
M201734,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.04,80.34,1105.5,71,Progression
M201735,33,Male,Melanoma,mrna-4157 + keytruda,65.37,39.64,523.46,82,Progression
M201736,48,Female,HPV-related Cancer,mrna-4157 + keytruda,58.05,59.26,1152.0,92,Stable Disease
M201737,76,Other,Melanoma,mrna-4157 + keytruda,21.61,22.42,1174.9,93,Complete Response
M201738,72,Female,HPV-related Cancer,mrna-4157 + keytruda,44.81,34.76,1266.91,77,Progression
M201739,51,Male,HPV-related Cancer,mrna-4157 + keytruda,74.03,36.23,922.57,86,Stable Disease
M201740,51,Female,HPV-related Cancer,KEYTRUDA only,39.53,32.63,941.57,98,Stable Disease
M201741,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,105.81,93.34,914.23,86,Partial Response
M201742,57,Other,Melanoma,KEYTRUDA only,65.59,43.11,908.14,86,Partial Response
M201743,79,Female,Melanoma,mrna-4157 + keytruda,57.31,44.22,1011.22,81,Stable Disease
M201744,64,Female,HPV-related Cancer,mrna-4157 + keytruda,68.83,46.94,890.06,87,Complete Response
M201745,56,Female,HPV-related Cancer,KEYTRUDA only,60.58,32.86,1186.68,85,Partial Response
M201746,52,Male,Melanoma,mrna-4157 + keytruda,33.6,18.18,1326.99,114,Partial Response
M201747,52,Female,HPV-related Cancer,mrna-4157 + keytruda,42.69,27.69,-308.39,83,Partial Response
M201748,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.33,49.45,557.32,71,Complete Response
M201749,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.14,12.77,754.74,77,Stable Disease
M201750,61,Female,Melanoma,KEYTRUDA only,44.19,28.31,747.95,86,Partial Response
M201751,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.3,26.59,351.92,91,
M201752,69,Female,Melanoma,KEYTRUDA only,33.07,17.25,1169.35,99,Partial Response
M201753,27,Male,HPV-related Cancer,mrna-4157 + keytruda,58.44,46.66,1590.35,93,Stable Disease
M201754,43,Other,HPV-related Cancer,KEYTRUDA only,10.2,8.4,967.05,83,Partial Response
M201755,80,Other,Melanoma,mrna-4157 + keytruda,22.27,16.19,1465.26,82,Partial Response
M201756,75,Female,HPV-related Cancer,mrna-4157 + keytruda,56.18,,1192.66,92,Stable Disease
M201757,65,Female,HPV-related Cancer,KEYTRUDA only,79.49,41.27,491.35,84,Partial Response
M201758,74,Female,HPV-related Cancer,mrna-4157 + keytruda,22.78,,1389.91,83,Progression
M201759,78,Other,Melanoma,KEYTRUDA only,67.11,68.39,1455.88,91,Stable Disease
M201760,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.06,43.76,573.74,87,Partial Response
M201761,55,Female,Melanoma,mrna-4157 + keytruda,79.76,76.84,1436.92,90,Stable Disease
M201762,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.21,61.59,352.25,89,Stable Disease
M201763,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.56,21.52,599.95,80,Complete Response
M201764,51,Female,HPV-related Cancer,mrna-4157 + keytruda,42.69,38.41,997.55,83,Partial Response
M201765,81,Female,HPV-related Cancer,mrna-4157 + keytruda,61.31,46.1,960.97,88,Unknown
M201766,52,Female,Melanoma,mrna-4157 + keytruda,43.13,33.27,1461.29,107,Complete Response
M201767,30,Female,HPV-related Cancer,KEYTRUDA only,64.52,39.02,670.13,76,Partial Response
M201768,35,Other,Melanoma,mrna-4157 + keytruda,90.49,67.06,238.42,95,Partial Response
M201769,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.54,23.69,426.92,78,Unknown
M201770,80,Male,HPV-related Cancer,mrna-4157 + keytruda,38.82,23.63,876.4,78,Progression
M201771,40,Female,Melanoma,KEYTRUDA only,69.13,69.87,613.97,95,Partial Response
M201772,67,Male,HPV-related Cancer,mrna-4157 + keytruda,42.75,25.38,493.31,89,Complete Response
M201773,43,Other,HPV-related Cancer,mrna-4157 + keytruda,84.24,69.39,1244.89,100,Progression
M201774,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,9.95,6.88,604.34,111,Partial Response
M201775,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.61,40.06,1323.8,87,Stable Disease
M201776,45,Other,Melanoma,mrna-4157 + keytruda,81.45,83.84,945.06,90,Stable Disease
M201777,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.43,28.75,1260.22,94,Progression
M201778,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,73.35,61.87,801.14,111,Unknown
M201779,50,Other,Melanoma,KEYTRUDA only,40.83,27.43,783.3,89,Complete Response
M201780,28,Other,Melanoma,KEYTRUDA only,58.41,,330.47,87,Partial Response
M201781,32,Female,Non-small Cell Lung Cancer,KEYTRUDA only,78.14,38.71,1997.14,97,Partial Response
M201782,69,Male,HPV-related Cancer,mrna-4157 + keytruda,52.17,30.39,1198.07,78,Stable Disease
M201783,32,Male,Melanoma,mrna-4157 + keytruda,47.74,29.8,1270.21,88,Progression
M201784,73,Other,HPV-related Cancer,KEYTRUDA only,82.78,76.3,,91,Progression
M201785,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.47,,719.89,105,Partial Response
M201786,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.04,73.2,624.31,94,Stable Disease
M201787,66,Other,HPV-related Cancer,mrna-4157 + keytruda,48.48,21.04,665.51,93,Stable Disease
M201788,78,Other,HPV-related Cancer,mrna-4157 + keytruda,28.18,20.28,428.14,94,Partial Response
M201789,67,Female,Melanoma,mrna-4157 + keytruda,83.04,79.12,605.14,79,Progression
M201790,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.72,26.52,789.62,85,Unknown
M201791,68,Male,HPV-related Cancer,mrna-4157 + keytruda,66.5,46.82,942.37,104,Partial Response
M201792,83,Female,Melanoma,KEYTRUDA only,70.85,,,82,Complete Response
M201793,65,Male,Melanoma,mrna-4157 + keytruda,69.91,71.87,392.7,103,Stable Disease
M201794,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.39,42.75,409.39,88,Stable Disease
M201795,66,Female,Melanoma,KEYTRUDA only,34.9,32.2,579.83,83,Complete Response
M201796,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.76,40.3,629.41,107,Stable Disease
M201797,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.7,63.73,245.25,109,Stable Disease
M201798,47,Other,Melanoma,mrna-4157 + keytruda,26.46,23.73,1027.81,103,Stable Disease
M201799,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.18,78.38,1425.33,92,Progression
M201800,69,Female,HPV-related Cancer,mrna-4157 + keytruda,67.3,54.24,286.18,112,Complete Response
M201801,68,Male,Melanoma,mrna-4157 + keytruda,69.38,41.86,837.42,89,Progression
M201802,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.68,12.72,1031.35,78,Stable Disease
M201803,69,Other,HPV-related Cancer,mrna-4157 + keytruda,47.51,44.09,1514.18,82,Partial Response
M201804,47,Other,HPV-related Cancer,mrna-4157 + keytruda,21.06,17.22,590.63,104,Stable Disease
M201805,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.48,,1296.63,87,Partial Response
M201806,45,Other,Melanoma,KEYTRUDA only,73.85,75.25,1646.96,109,Progression
M201807,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.11,34.05,548.78,105,Stable Disease
M201808,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,94.31,107.16,800.6,93,Stable Disease
M201809,59,Female,HPV-related Cancer,mrna-4157 + keytruda,52.61,36.76,684.07,105,Complete Response
M201810,38,Other,HPV-related Cancer,KEYTRUDA only,70.74,48.97,1271.04,76,Stable Disease
M201811,45,Female,HPV-related Cancer,mrna-4157 + keytruda,46.49,49.05,588.03,84,Partial Response
M201812,83,Female,HPV-related Cancer,mrna-4157 + keytruda,2.31,2.59,877.51,85,Partial Response
M201813,58,Other,HPV-related Cancer,KEYTRUDA only,75.04,56.6,1531.12,74,Partial Response
M201814,59,Male,HPV-related Cancer,KEYTRUDA only,45.77,40.5,1240.74,99,Complete Response
M201815,31,Other,HPV-related Cancer,mrna-4157 + keytruda,61.8,30.49,559.01,91,Stable Disease
M201816,62,Female,Melanoma,KEYTRUDA only,74.02,77.26,1194.25,88,Complete Response
M201817,30,Other,Melanoma,KEYTRUDA only,101.38,92.08,,77,Partial Response
M201818,56,Female,HPV-related Cancer,mrna-4157 + keytruda,63.23,63.85,913.88,86,Stable Disease
M201819,51,Other,HPV-related Cancer,mrna-4157 + keytruda,25.5,21.72,1193.8,98,Progression
M201820,39,Other,HPV-related Cancer,mrna-4157 + keytruda,69.67,56.09,1216.4,90,Complete Response
M201821,62,Male,HPV-related Cancer,KEYTRUDA only,46.62,34.05,,89,Stable Disease
M201822,42,Female,HPV-related Cancer,KEYTRUDA only,62.58,,1451.08,81,Stable Disease
M201823,37,Other,HPV-related Cancer,mrna-4157 + keytruda,-1.28,-1.16,498.09,79,Stable Disease
M201824,36,Other,HPV-related Cancer,mrna-4157 + keytruda,8.37,6.09,1106.65,93,Partial Response
M201825,60,Female,HPV-related Cancer,mrna-4157 + keytruda,86.26,66.77,506.26,94,Partial Response
M201826,68,Female,HPV-related Cancer,mrna-4157 + keytruda,54.73,74.55,1573.61,101,Partial Response
M201827,82,Female,HPV-related Cancer,KEYTRUDA only,71.31,60.5,468.1,102,Stable Disease
M201828,67,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.65,19.69,763.49,86,Stable Disease
M201829,73,Other,HPV-related Cancer,mrna-4157 + keytruda,27.61,15.87,632.77,86,Stable Disease
M201830,53,Other,HPV-related Cancer,KEYTRUDA only,45.04,31.6,1566.23,99,Complete Response
M201831,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.46,64.72,945.34,97,Unknown
M201832,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.17,41.84,1142.88,96,Complete Response
M201833,72,Other,Melanoma,mrna-4157 + keytruda,27.85,20.01,1153.3,83,Partial Response
M201834,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.36,58.53,878.79,89,Partial Response
M201835,73,Male,Melanoma,mrna-4157 + keytruda,28.49,27.07,769.72,90,Complete Response
M201836,65,Other,HPV-related Cancer,mrna-4157 + keytruda,72.07,49.34,751.96,79,
M201837,41,Other,Melanoma,mrna-4157 + keytruda,47.23,29.38,406.08,95,Progression
M201838,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.23,47.2,223.49,99,Progression
M201839,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.46,70.67,907.64,81,Progression
M201840,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,0.37,0.27,869.21,88,Partial Response
M201841,26,Male,Melanoma,mrna-4157 + keytruda,31.82,24.46,703.38,91,Stable Disease
M201842,59,Female,HPV-related Cancer,mrna-4157 + keytruda,47.86,46.59,863.18,102,Partial Response
M201843,41,Other,HPV-related Cancer,KEYTRUDA only,40.98,24.4,1154.42,82,Progression
M201844,50,Other,HPV-related Cancer,KEYTRUDA only,56.01,36.77,959.72,97,Stable Disease
M201845,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,73.31,47.69,1132.24,73,Stable Disease
M201846,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.35,21.15,784.23,92,Partial Response
M201847,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.88,,1605.36,86,Stable Disease
M201848,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.75,34.96,1034.97,91,Partial Response
M201849,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.83,24.09,424.82,83,Partial Response
M201850,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.83,37.28,1265.64,103,Stable Disease
M201851,29,Other,Melanoma,KEYTRUDA only,34.46,26.89,475.94,94,Partial Response
M201852,41,Other,Melanoma,mrna-4157 + keytruda,71.13,66.59,803.74,91,Partial Response
M201853,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.64,36.84,683.73,84,Stable Disease
M201854,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.93,,737.58,103,Stable Disease
M201855,27,Other,HPV-related Cancer,mrna-4157 + keytruda,28.02,30.77,1604.63,98,Complete Response
M201856,47,Male,Melanoma,mrna-4157 + keytruda,67.71,34.19,680.54,112,Progression
M201857,70,Other,Melanoma,mrna-4157 + keytruda,24.68,14.53,413.53,74,Complete Response
M201858,47,Other,Melanoma,mrna-4157 + keytruda,60.22,36.87,267.34,103,Partial Response
M201859,84,Other,HPV-related Cancer,KEYTRUDA only,54.25,49.58,809.19,104,Unknown
M201860,38,Other,Melanoma,KEYTRUDA only,50.71,43.59,1543.84,70,Partial Response
M201861,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.4,49.8,1306.03,77,
M201862,83,Male,Melanoma,mrna-4157 + keytruda,33.97,24.52,1118.1,90,Unknown
M201863,38,Male,Melanoma,mrna-4157 + keytruda,45.14,42.53,744.08,93,Partial Response
M201864,77,Female,HPV-related Cancer,mrna-4157 + keytruda,32.51,23.42,666.6,78,Stable Disease
M201865,73,Male,Melanoma,KEYTRUDA only,23.4,25.64,470.6,86,Stable Disease
M201866,54,Female,HPV-related Cancer,KEYTRUDA only,34.81,20.56,1199.34,93,Stable Disease
M201867,27,Other,HPV-related Cancer,KEYTRUDA only,70.77,49.63,1072.91,77,Stable Disease
M201868,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.75,53.18,1379.05,83,Partial Response
M201869,48,Other,HPV-related Cancer,mrna-4157 + keytruda,77.99,61.89,1446.95,80,Stable Disease
M201870,46,Female,HPV-related Cancer,KEYTRUDA only,30.03,24.05,602.42,83,Stable Disease
M201871,32,Male,HPV-related Cancer,KEYTRUDA only,64.19,47.63,978.87,75,Complete Response
M201872,53,Female,HPV-related Cancer,mrna-4157 + keytruda,21.82,13.89,1448.69,81,Partial Response
M201873,60,Other,Melanoma,mrna-4157 + keytruda,59.57,45.61,1534.49,94,Progression
M201874,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.66,86.83,1470.94,73,Progression
M201875,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.78,26.41,1263.3,95,Progression
M201876,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.88,26.45,1719.66,92,Complete Response
M201877,52,Male,HPV-related Cancer,KEYTRUDA only,32.47,26.94,1001.41,77,Partial Response
M201878,52,Female,Melanoma,KEYTRUDA only,66.4,43.68,1737.66,87,Stable Disease
M201879,80,Male,HPV-related Cancer,mrna-4157 + keytruda,70.92,35.21,1554.57,96,Partial Response
M201880,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.57,17.59,891.13,94,Partial Response
M201881,27,Male,HPV-related Cancer,mrna-4157 + keytruda,41.09,23.6,941.94,79,Partial Response
M201882,53,Female,HPV-related Cancer,mrna-4157 + keytruda,46.65,39.99,1421.12,89,Complete Response
M201883,48,Female,Melanoma,KEYTRUDA only,27.15,17.75,740.26,101,Stable Disease
M201884,81,Male,Melanoma,mrna-4157 + keytruda,22.24,18.21,373.01,81,Unknown
M201885,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,73.39,76.88,622.37,101,Partial Response
M201886,29,Other,HPV-related Cancer,mrna-4157 + keytruda,51.49,30.75,624.3,81,Partial Response
M201887,55,Male,HPV-related Cancer,KEYTRUDA only,80.41,81.07,897.85,95,
M201888,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.76,24.28,1053.7,94,Partial Response
M201889,61,Male,HPV-related Cancer,mrna-4157 + keytruda,31.26,27.0,,112,Progression
M201890,43,Male,HPV-related Cancer,mrna-4157 + keytruda,51.25,25.41,859.69,87,Partial Response
M201891,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.52,25.47,879.83,88,Partial Response
M201892,52,Female,HPV-related Cancer,mrna-4157 + keytruda,35.81,34.03,980.56,97,Progression
M201893,43,Male,HPV-related Cancer,KEYTRUDA only,57.74,53.7,264.94,91,Progression
M201894,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.54,36.1,1493.44,100,Complete Response
M201895,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.71,22.17,1172.44,84,Partial Response
M201896,47,Other,HPV-related Cancer,mrna-4157 + keytruda,50.74,35.96,787.45,93,Stable Disease
M201897,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.86,56.94,812.71,80,Partial Response
M201898,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.06,50.76,1137.61,97,Stable Disease
M201899,67,Female,HPV-related Cancer,mrna-4157 + keytruda,52.22,53.13,1869.66,89,Progression
M201900,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.04,22.67,738.99,82,Complete Response
M201901,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.76,42.54,962.76,106,Stable Disease
M201902,84,Other,HPV-related Cancer,mrna-4157 + keytruda,37.46,33.88,963.57,98,Progression
M201903,75,Male,HPV-related Cancer,KEYTRUDA only,72.94,54.47,547.92,96,Complete Response
M201904,38,Female,HPV-related Cancer,mrna-4157 + keytruda,41.31,29.21,920.52,88,Partial Response
M201905,62,Other,Melanoma,mrna-4157 + keytruda,84.95,65.96,542.83,92,Partial Response
M201906,26,Male,Melanoma,mrna-4157 + keytruda,23.11,16.78,1146.8,97,Partial Response
M201907,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.61,,1225.11,89,Partial Response
M201908,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.01,41.7,1407.13,79,Progression
M201909,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.59,48.94,778.61,102,Unknown
M201910,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.32,33.78,826.42,86,Stable Disease
M201911,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.91,17.69,758.21,102,
M201912,81,Male,Melanoma,mrna-4157 + keytruda,22.87,13.93,791.97,94,Stable Disease
M201913,27,Female,Melanoma,mrna-4157 + keytruda,59.62,28.95,777.45,82,Stable Disease
M201914,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.36,31.78,1496.49,96,Stable Disease
M201915,80,Other,HPV-related Cancer,KEYTRUDA only,46.78,32.94,497.12,87,Stable Disease
M201916,33,Male,HPV-related Cancer,mrna-4157 + keytruda,49.65,41.26,294.33,82,Stable Disease
M201917,31,Other,Melanoma,mrna-4157 + keytruda,25.72,13.59,,81,Partial Response
M201918,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.74,53.25,3304.95,86,Stable Disease
M201919,76,Other,Melanoma,KEYTRUDA only,25.0,,870.53,89,Complete Response
M201920,59,Female,Melanoma,KEYTRUDA only,43.19,31.98,821.44,98,Complete Response
M201921,28,Male,Melanoma,mrna-4157 + keytruda,61.05,48.79,1519.0,92,Progression
M201922,33,Male,HPV-related Cancer,KEYTRUDA only,49.27,47.43,642.17,83,Progression
M201923,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.85,32.29,1359.17,73,Complete Response
M201924,34,Other,HPV-related Cancer,KEYTRUDA only,42.48,53.22,860.06,83,Complete Response
M201925,47,Male,HPV-related Cancer,KEYTRUDA only,60.74,,904.48,84,Progression
M201926,40,Male,Melanoma,mrna-4157 + keytruda,50.13,35.23,752.39,84,Partial Response
M201927,46,Female,Melanoma,mrna-4157 + keytruda,32.75,30.21,937.84,108,Stable Disease
M201928,57,Female,Melanoma,KEYTRUDA only,52.27,25.53,903.19,86,Complete Response
M201929,63,Female,Melanoma,KEYTRUDA only,55.82,64.93,1204.05,100,Progression
M201930,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.62,13.65,1240.81,74,Progression
M201931,79,Male,Melanoma,KEYTRUDA only,71.39,40.6,1090.35,89,Partial Response
M201932,35,Other,HPV-related Cancer,KEYTRUDA only,61.12,50.94,-208.52,97,Complete Response
M201933,58,Male,HPV-related Cancer,KEYTRUDA only,36.13,18.49,579.53,95,Stable Disease
M201934,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.21,58.45,634.23,80,Partial Response
M201935,37,Female,HPV-related Cancer,KEYTRUDA only,54.61,29.62,1395.19,87,Progression
M201936,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.16,39.27,961.26,102,Complete Response
M201937,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.0,8.36,77.88,101,Stable Disease
M201938,47,Male,HPV-related Cancer,KEYTRUDA only,66.52,,,96,Partial Response
M201939,63,Female,Melanoma,mrna-4157 + keytruda,44.09,36.6,420.46,87,Partial Response
M201940,61,Female,Melanoma,mrna-4157 + keytruda,57.05,28.49,657.82,82,Partial Response
M201941,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.5,25.65,385.11,103,
M201942,37,Male,Melanoma,KEYTRUDA only,38.42,18.52,757.25,90,Partial Response
M201943,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.21,47.64,1214.64,105,Complete Response
M201944,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.34,36.32,1322.47,97,Progression
M201945,34,Other,Melanoma,mrna-4157 + keytruda,26.74,10.24,1153.46,102,Unknown
M201946,63,Other,Melanoma,KEYTRUDA only,34.07,33.62,1712.91,88,Progression
M201947,60,Male,HPV-related Cancer,mrna-4157 + keytruda,54.64,42.02,1156.38,86,Complete Response
M201948,37,Other,HPV-related Cancer,mrna-4157 + keytruda,14.92,10.83,1195.52,100,Partial Response
M201949,50,Male,Melanoma,mrna-4157 + keytruda,35.94,27.8,761.55,77,Stable Disease
M201950,53,Female,HPV-related Cancer,KEYTRUDA only,63.5,46.16,841.52,115,Progression
M201951,44,Other,Melanoma,KEYTRUDA only,48.52,51.5,1155.65,106,Progression
M201952,50,Male,Melanoma,mrna-4157 + keytruda,37.63,39.69,1278.96,99,Stable Disease
M201953,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,65.47,52.8,706.59,82,Stable Disease
M201954,66,Female,Melanoma,KEYTRUDA only,17.31,11.1,631.25,102,Stable Disease
M201955,49,Male,Melanoma,KEYTRUDA only,55.94,29.9,1385.18,76,Partial Response
M201956,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.34,33.6,499.95,95,Partial Response
M201957,56,Female,HPV-related Cancer,mrna-4157 + keytruda,36.81,29.31,1653.79,105,Partial Response
M201958,65,Female,HPV-related Cancer,KEYTRUDA only,48.41,39.61,343.1,82,Stable Disease
M201959,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.73,57.82,1125.0,92,
M201960,68,Other,HPV-related Cancer,mrna-4157 + keytruda,46.58,48.62,943.15,93,Progression
M201961,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.18,55.18,243.28,76,Complete Response
M201962,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.59,40.69,624.9,92,Partial Response
M201963,55,Other,Melanoma,mrna-4157 + keytruda,13.44,,867.4,80,Complete Response
M201964,46,Other,Melanoma,mrna-4157 + keytruda,39.67,39.78,491.94,84,Partial Response
M201965,60,Male,HPV-related Cancer,mrna-4157 + keytruda,77.8,64.19,709.52,94,Progression
M201966,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.29,24.14,1280.28,76,Unknown
M201967,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.72,29.92,1134.31,98,Partial Response
M201968,60,Male,Melanoma,mrna-4157 + keytruda,50.48,44.11,1212.52,102,Stable Disease
M201969,67,Female,HPV-related Cancer,KEYTRUDA only,83.33,49.63,899.28,93,Complete Response
M201970,59,Male,Melanoma,KEYTRUDA only,43.61,52.69,955.31,83,Partial Response
M201971,62,Female,Melanoma,KEYTRUDA only,0.98,0.51,528.49,65,Stable Disease
M201972,74,Female,HPV-related Cancer,mrna-4157 + keytruda,52.28,19.03,1322.38,93,Stable Disease
M201973,84,Male,Melanoma,mrna-4157 + keytruda,36.12,20.98,1014.34,78,Stable Disease
M201974,72,Female,Melanoma,KEYTRUDA only,67.12,54.69,902.4,91,Stable Disease
M201975,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.03,34.12,1509.6,84,Partial Response
M201976,75,Female,Melanoma,mrna-4157 + keytruda,63.94,52.56,771.92,80,Complete Response
M201977,43,Male,HPV-related Cancer,mrna-4157 + keytruda,36.61,34.08,1331.53,87,Stable Disease
M201978,61,Male,Melanoma,mrna-4157 + keytruda,61.82,28.46,1102.61,69,Unknown
M201979,72,Female,HPV-related Cancer,mrna-4157 + keytruda,59.4,52.39,1071.61,90,Stable Disease
M201980,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.6,57.19,1279.65,98,Partial Response
M201981,54,Other,Melanoma,mrna-4157 + keytruda,36.98,32.87,916.65,72,Stable Disease
M201982,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,21.38,18.1,1066.33,87,Partial Response
M201983,32,Other,HPV-related Cancer,mrna-4157 + keytruda,69.51,54.71,1754.2,98,Complete Response
M201984,34,Female,HPV-related Cancer,mrna-4157 + keytruda,51.9,47.65,1256.23,96,Complete Response
M201985,61,Other,Melanoma,KEYTRUDA only,60.59,51.06,,92,Unknown
M201986,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.9,47.45,930.39,84,Partial Response
M201987,84,Male,HPV-related Cancer,mrna-4157 + keytruda,53.58,33.31,1104.82,87,Stable Disease
M201988,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.17,86.43,1677.67,93,Partial Response
M201989,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,22.33,18.86,,76,Stable Disease
M201990,31,Other,Melanoma,KEYTRUDA only,99.06,65.11,850.01,88,
M201991,34,Male,Melanoma,mrna-4157 + keytruda,79.07,53.97,1341.71,99,Stable Disease
M201992,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,93.3,74.78,1262.05,90,Unknown
M201993,53,Male,HPV-related Cancer,mrna-4157 + keytruda,28.73,21.42,930.09,91,Stable Disease
M201994,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-4.83,-4.08,699.69,89,Stable Disease
M201995,39,Male,HPV-related Cancer,mrna-4157 + keytruda,24.7,29.07,998.89,70,Stable Disease
M201996,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.16,29.41,586.32,106,Complete Response
M201997,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.55,,873.17,94,Stable Disease
M201998,60,Female,Melanoma,mrna-4157 + keytruda,47.02,36.27,627.52,85,Complete Response
M201999,62,Female,HPV-related Cancer,KEYTRUDA only,80.37,73.09,1345.03,89,Progression
M202000,25,Other,Melanoma,KEYTRUDA only,49.17,40.51,1415.87,91,Complete Response
M202001,72,Female,HPV-related Cancer,KEYTRUDA only,59.99,67.39,1204.56,84,Stable Disease
M202002,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.59,30.37,274.47,99,Partial Response
M202003,65,Male,HPV-related Cancer,KEYTRUDA only,96.55,63.43,1149.93,85,Partial Response
M202004,81,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.73,29.58,706.63,97,Partial Response
M202005,26,Other,Melanoma,KEYTRUDA only,45.49,,636.69,85,Partial Response
M202006,46,Other,Melanoma,KEYTRUDA only,52.69,45.56,,83,Stable Disease
M202007,54,Male,HPV-related Cancer,mrna-4157 + keytruda,63.63,52.94,1451.84,88,Stable Disease
M202008,62,Other,HPV-related Cancer,KEYTRUDA only,44.07,47.42,1074.07,80,
M202009,72,Female,Melanoma,KEYTRUDA only,63.63,,649.61,94,Progression
M202010,61,Female,Melanoma,KEYTRUDA only,12.55,8.85,1015.94,77,Progression
M202011,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.54,31.34,747.38,80,Progression
M202012,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.98,15.99,975.93,74,Partial Response
M202013,53,Male,Melanoma,KEYTRUDA only,86.26,85.14,1337.06,97,Progression
M202014,73,Male,HPV-related Cancer,KEYTRUDA only,52.67,,535.81,83,Complete Response
M202015,33,Male,HPV-related Cancer,KEYTRUDA only,63.8,83.75,1393.87,86,Progression
M202016,74,Male,Melanoma,mrna-4157 + keytruda,82.97,53.49,1501.51,103,Complete Response
M202017,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.52,15.08,185.31,90,Unknown
M202018,64,Male,HPV-related Cancer,mrna-4157 + keytruda,65.15,45.59,1267.89,95,Stable Disease
M202019,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.6,17.75,313.14,87,Progression
M202020,84,Male,HPV-related Cancer,KEYTRUDA only,38.07,34.35,1366.1,108,Partial Response
M202021,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.24,50.05,196.77,101,Progression
M202022,53,Other,HPV-related Cancer,mrna-4157 + keytruda,29.88,37.17,1127.49,104,Partial Response
M202023,60,Female,Melanoma,KEYTRUDA only,48.8,27.05,832.33,101,Stable Disease
M202024,59,Female,Melanoma,KEYTRUDA only,65.2,57.68,652.67,76,Partial Response
M202025,66,Other,HPV-related Cancer,KEYTRUDA only,21.04,21.68,1245.12,97,Partial Response
M202026,42,Female,Melanoma,mrna-4157 + keytruda,91.09,56.72,577.86,91,Complete Response
M202027,55,Other,HPV-related Cancer,mrna-4157 + keytruda,25.16,23.9,1005.12,104,Complete Response
M202028,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.66,32.59,1195.25,108,Partial Response
M202029,66,Male,HPV-related Cancer,mrna-4157 + keytruda,23.83,,1355.53,99,Stable Disease
M202030,79,Other,HPV-related Cancer,mrna-4157 + keytruda,74.57,70.17,310.36,88,Stable Disease
M202031,48,Other,HPV-related Cancer,mrna-4157 + keytruda,74.79,26.93,2101.34,97,Progression
M202032,30,Male,Melanoma,mrna-4157 + keytruda,41.45,26.56,1192.63,79,Stable Disease
M202033,44,Male,Melanoma,KEYTRUDA only,62.91,68.18,1060.25,99,Stable Disease
M202034,51,Female,Melanoma,KEYTRUDA only,68.7,54.97,1113.23,85,Complete Response
M202035,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,101.11,84.13,1270.46,96,Progression
M202036,54,Other,Melanoma,mrna-4157 + keytruda,46.11,26.73,1494.04,83,Stable Disease
M202037,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.53,59.51,1135.44,87,Complete Response
M202038,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.56,35.89,1257.15,60,Stable Disease
M202039,54,Female,Melanoma,mrna-4157 + keytruda,50.95,66.27,526.21,84,Stable Disease
M202040,78,Male,Melanoma,mrna-4157 + keytruda,58.64,44.0,1254.22,87,Stable Disease
M202041,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.6,36.77,1673.82,85,Partial Response
M202042,44,Female,HPV-related Cancer,mrna-4157 + keytruda,13.59,13.24,898.5,89,Progression
M202043,26,Male,HPV-related Cancer,mrna-4157 + keytruda,30.64,29.69,1637.5,89,Progression
M202044,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.35,50.36,594.12,84,Partial Response
M202045,61,Male,Melanoma,mrna-4157 + keytruda,42.09,16.83,1558.3,89,Progression
M202046,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.53,29.57,985.06,70,Stable Disease
M202047,58,Male,Melanoma,KEYTRUDA only,78.63,59.34,799.84,103,Partial Response
M202048,57,Male,HPV-related Cancer,mrna-4157 + keytruda,50.16,34.81,531.55,79,Complete Response
M202049,43,Female,Melanoma,mrna-4157 + keytruda,61.64,59.72,1920.37,100,Complete Response
M202050,54,Male,Melanoma,mrna-4157 + keytruda,39.5,24.14,904.42,93,Progression
M202051,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,65.89,65.14,1603.2,94,Complete Response
M202052,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.94,54.09,1203.18,80,
M202053,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.07,41.42,1613.18,91,Partial Response
M202054,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.99,42.71,1050.15,82,Unknown
M202055,64,Female,HPV-related Cancer,mrna-4157 + keytruda,33.23,31.04,458.03,101,Stable Disease
M202056,59,Female,Melanoma,KEYTRUDA only,27.91,11.64,615.42,84,Unknown
M202057,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.14,45.09,810.38,77,Progression
M202058,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.32,66.2,1030.25,90,Stable Disease
M202059,55,Female,HPV-related Cancer,mrna-4157 + keytruda,20.89,12.16,1388.47,118,Stable Disease
M202060,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.73,34.31,895.18,71,Progression
M202061,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.95,10.56,849.39,98,Stable Disease
M202062,27,Other,HPV-related Cancer,KEYTRUDA only,29.57,14.0,1566.74,98,
M202063,40,Male,Melanoma,mrna-4157 + keytruda,72.2,69.77,1367.62,93,Progression
M202064,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.09,31.96,,80,Progression
M202065,42,Female,HPV-related Cancer,mrna-4157 + keytruda,65.76,45.9,785.3,114,Stable Disease
M202066,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.32,53.54,1440.74,85,Progression
M202067,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,9.54,7.56,1979.64,85,Stable Disease
M202068,77,Other,HPV-related Cancer,mrna-4157 + keytruda,86.09,88.26,,93,Stable Disease
M202069,40,Female,Melanoma,mrna-4157 + keytruda,16.39,18.62,660.28,95,Partial Response
M202070,79,Male,Melanoma,mrna-4157 + keytruda,61.25,55.88,1336.85,86,Progression
M202071,50,Other,Melanoma,KEYTRUDA only,37.39,28.19,1112.11,103,Stable Disease
M202072,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.25,53.33,1002.35,103,Progression
M202073,67,Other,HPV-related Cancer,KEYTRUDA only,55.86,53.28,1596.55,85,Stable Disease
M202074,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.68,29.32,1262.27,92,Partial Response
M202075,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.26,51.43,799.28,74,Partial Response
M202076,77,Male,HPV-related Cancer,mrna-4157 + keytruda,13.67,12.6,1358.91,83,Partial Response
M202077,69,Other,HPV-related Cancer,mrna-4157 + keytruda,61.09,63.75,862.92,97,Stable Disease
M202078,81,Female,Melanoma,mrna-4157 + keytruda,32.23,35.12,,86,Complete Response
M202079,26,Male,HPV-related Cancer,mrna-4157 + keytruda,73.58,53.8,862.32,74,Stable Disease
M202080,53,Other,Melanoma,mrna-4157 + keytruda,30.57,28.24,873.43,96,Progression
M202081,74,Male,Melanoma,mrna-4157 + keytruda,77.69,83.56,1167.69,83,Partial Response
M202082,69,Female,Melanoma,KEYTRUDA only,38.89,23.19,406.93,96,Partial Response
M202083,45,Female,HPV-related Cancer,mrna-4157 + keytruda,43.28,,1272.62,99,Partial Response
M202084,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.27,19.67,1636.17,92,Complete Response
M202085,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.8,41.36,95.91,78,Stable Disease
M202086,51,Other,HPV-related Cancer,KEYTRUDA only,39.81,36.71,936.54,79,Progression
M202087,81,Female,Melanoma,mrna-4157 + keytruda,46.31,33.12,,83,Partial Response
M202088,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,3.58,3.34,1251.78,97,Progression
M202089,72,Female,HPV-related Cancer,KEYTRUDA only,28.16,19.82,,87,Stable Disease
M202090,50,Female,Melanoma,KEYTRUDA only,18.17,10.45,1585.62,98,Stable Disease
M202091,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,10.07,6.18,,101,Progression
M202092,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.99,32.39,2148.39,101,Stable Disease
M202093,69,Male,HPV-related Cancer,mrna-4157 + keytruda,43.38,40.97,1174.67,93,Stable Disease
M202094,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,78.33,98.28,646.19,79,Partial Response
M202095,76,Female,Melanoma,mrna-4157 + keytruda,49.15,30.82,1027.54,83,Progression
M202096,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.78,55.17,1599.28,88,Stable Disease
M202097,81,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.14,41.55,891.29,98,Unknown
M202098,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.7,25.76,852.34,87,Complete Response
M202099,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.37,35.65,1378.73,88,Partial Response
M202100,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.13,40.8,1027.45,98,Stable Disease
M202101,31,Male,Melanoma,KEYTRUDA only,28.2,18.45,228.52,90,Stable Disease
M202102,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.04,42.81,1098.51,91,
M202103,70,Other,Melanoma,KEYTRUDA only,29.98,17.62,1088.42,93,Unknown
M202104,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.14,50.73,,90,Stable Disease
M202105,40,Female,Melanoma,mrna-4157 + keytruda,31.02,26.62,1251.9,94,Progression
M202106,37,Other,Melanoma,mrna-4157 + keytruda,80.93,73.99,693.51,81,Stable Disease
M202107,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.27,56.44,1143.7,93,Progression
M202108,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,25.74,15.13,1315.89,93,Partial Response
M202109,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.46,38.81,1334.31,90,Complete Response
M202110,50,Female,Melanoma,mrna-4157 + keytruda,73.19,73.4,968.23,77,Stable Disease
M202111,68,Male,HPV-related Cancer,KEYTRUDA only,28.73,28.11,1771.04,94,Progression
M202112,36,Male,HPV-related Cancer,mrna-4157 + keytruda,68.5,65.59,1039.28,87,Complete Response
M202113,30,Other,HPV-related Cancer,mrna-4157 + keytruda,42.08,,777.46,87,Partial Response
M202114,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.07,28.38,1437.03,103,Stable Disease
M202115,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.66,42.67,982.22,91,Partial Response
M202116,60,Female,HPV-related Cancer,mrna-4157 + keytruda,9.75,,-68.04,102,
M202117,52,Other,HPV-related Cancer,KEYTRUDA only,31.71,26.33,1299.69,94,Partial Response
M202118,62,Female,HPV-related Cancer,mrna-4157 + keytruda,54.86,48.46,1569.74,102,Stable Disease
M202119,74,Other,Melanoma,mrna-4157 + keytruda,74.27,72.53,616.45,66,Partial Response
M202120,41,Male,Melanoma,KEYTRUDA only,43.57,17.93,956.27,91,Stable Disease
M202121,70,Female,Melanoma,mrna-4157 + keytruda,48.43,47.15,1518.19,86,
M202122,73,Female,HPV-related Cancer,mrna-4157 + keytruda,54.64,46.51,954.17,93,Progression
M202123,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.18,27.97,950.74,82,Stable Disease
M202124,71,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.58,45.3,939.58,89,Unknown
M202125,29,Male,Melanoma,KEYTRUDA only,78.17,56.37,613.2,87,Progression
M202126,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.74,25.64,1013.0,102,Stable Disease
M202127,40,Other,Melanoma,mrna-4157 + keytruda,59.94,32.78,760.02,87,Stable Disease
M202128,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.65,51.62,776.84,86,
M202129,44,Other,Melanoma,KEYTRUDA only,51.45,35.07,1160.96,84,Partial Response
M202130,54,Male,Melanoma,KEYTRUDA only,48.81,36.88,637.66,100,Partial Response
M202131,63,Male,HPV-related Cancer,KEYTRUDA only,54.46,64.96,,89,Stable Disease
M202132,81,Other,HPV-related Cancer,mrna-4157 + keytruda,55.68,35.86,424.75,83,Partial Response
M202133,34,Male,HPV-related Cancer,mrna-4157 + keytruda,29.94,31.89,1390.39,72,Progression
M202134,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.39,,1209.17,96,Stable Disease
M202135,58,Male,HPV-related Cancer,KEYTRUDA only,42.27,26.91,751.68,99,Progression
M202136,62,Male,HPV-related Cancer,mrna-4157 + keytruda,43.0,56.47,1359.56,101,Stable Disease
M202137,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.29,12.69,1371.08,86,Stable Disease
M202138,50,Female,HPV-related Cancer,KEYTRUDA only,41.06,20.42,,86,Partial Response
M202139,45,Female,HPV-related Cancer,mrna-4157 + keytruda,48.55,36.15,946.77,93,Partial Response
M202140,60,Female,Melanoma,mrna-4157 + keytruda,63.44,54.39,715.1,77,Progression
M202141,39,Female,Melanoma,KEYTRUDA only,24.09,14.64,537.03,87,Progression
M202142,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.87,41.66,838.88,92,Stable Disease
M202143,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.91,50.25,,91,Stable Disease
M202144,62,Other,HPV-related Cancer,mrna-4157 + keytruda,-15.88,-14.96,740.79,101,Progression
M202145,53,Male,HPV-related Cancer,KEYTRUDA only,65.42,47.3,869.04,96,Progression
M202146,45,Other,HPV-related Cancer,KEYTRUDA only,33.74,20.65,1234.93,94,Complete Response
M202147,79,Female,HPV-related Cancer,KEYTRUDA only,69.01,57.66,400.84,100,
M202148,45,Other,HPV-related Cancer,KEYTRUDA only,45.26,,911.02,90,
M202149,81,Other,Melanoma,mrna-4157 + keytruda,44.01,43.68,1541.14,97,Partial Response
M202150,69,Other,Non-small Cell Lung Cancer,KEYTRUDA only,15.82,13.53,1033.6,88,Progression
M202151,62,Male,Melanoma,mrna-4157 + keytruda,38.86,48.64,942.01,75,Stable Disease
M202152,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.99,24.19,1209.92,76,Partial Response
M202153,42,Male,HPV-related Cancer,KEYTRUDA only,39.91,41.23,1764.74,86,Progression
M202154,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.57,51.23,2294.19,102,Partial Response
M202155,53,Other,Melanoma,mrna-4157 + keytruda,27.43,22.47,1742.93,90,Complete Response
M202156,82,Male,Melanoma,mrna-4157 + keytruda,87.25,63.73,1051.94,94,Progression
M202157,37,Female,Melanoma,mrna-4157 + keytruda,61.1,71.32,913.97,93,Stable Disease
M202158,45,Other,HPV-related Cancer,KEYTRUDA only,52.37,37.46,1187.57,103,Partial Response
M202159,74,Male,HPV-related Cancer,mrna-4157 + keytruda,28.92,7.35,1618.74,96,Stable Disease
M202160,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.84,30.04,1237.22,82,Stable Disease
M202161,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.84,56.5,1312.89,115,Progression
M202162,63,Male,Melanoma,KEYTRUDA only,25.92,18.18,1140.65,87,
M202163,35,Male,HPV-related Cancer,KEYTRUDA only,34.96,32.74,548.39,86,Progression
M202164,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.44,25.5,877.98,99,Progression
M202165,31,Other,HPV-related Cancer,KEYTRUDA only,45.02,18.29,1059.57,96,Progression
M202166,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.67,40.69,1371.86,96,Partial Response
M202167,76,Male,Melanoma,mrna-4157 + keytruda,67.65,66.97,1526.06,89,Partial Response
M202168,26,Female,HPV-related Cancer,mrna-4157 + keytruda,35.8,17.4,1661.9,80,Progression
M202169,34,Male,Melanoma,KEYTRUDA only,55.41,74.95,1086.99,76,Stable Disease
M202170,33,Other,Melanoma,KEYTRUDA only,42.65,40.14,1490.06,92,Stable Disease
M202171,36,Female,HPV-related Cancer,mrna-4157 + keytruda,40.59,48.42,675.6,92,Stable Disease
M202172,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,75.24,42.6,604.58,106,Complete Response
M202173,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.74,49.18,1390.63,107,Partial Response
M202174,28,Male,HPV-related Cancer,mrna-4157 + keytruda,88.26,101.87,738.13,85,Partial Response
M202175,70,Female,Melanoma,mrna-4157 + keytruda,63.24,55.6,1228.67,88,Stable Disease
M202176,53,Female,HPV-related Cancer,mrna-4157 + keytruda,51.18,41.46,1620.26,74,Stable Disease
M202177,55,Other,HPV-related Cancer,mrna-4157 + keytruda,17.65,,1239.28,91,Complete Response
M202178,55,Female,Melanoma,KEYTRUDA only,60.1,56.95,928.86,105,Complete Response
M202179,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.51,37.11,414.83,83,Partial Response
M202180,79,Other,HPV-related Cancer,mrna-4157 + keytruda,24.3,20.29,1356.97,70,Progression
M202181,72,Other,Melanoma,KEYTRUDA only,6.69,4.28,794.73,80,Stable Disease
M202182,72,Other,HPV-related Cancer,KEYTRUDA only,28.94,19.06,664.33,80,Partial Response
M202183,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.19,68.03,1019.59,83,Partial Response
M202184,81,Other,Melanoma,KEYTRUDA only,75.6,63.05,1025.34,88,Stable Disease
M202185,50,Female,Melanoma,KEYTRUDA only,63.32,63.03,863.58,82,Stable Disease
M202186,72,Female,Melanoma,mrna-4157 + keytruda,80.0,82.68,885.89,94,Partial Response
M202187,74,Other,HPV-related Cancer,mrna-4157 + keytruda,26.71,14.89,1076.95,97,Partial Response
M202188,48,Female,HPV-related Cancer,mrna-4157 + keytruda,62.55,53.99,1296.52,95,Partial Response
M202189,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.35,75.02,853.76,90,Complete Response
M202190,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.37,,785.22,81,Progression
M202191,41,Female,HPV-related Cancer,mrna-4157 + keytruda,67.22,59.33,327.96,67,Partial Response
M202192,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.28,21.16,577.47,87,Progression
M202193,83,Female,HPV-related Cancer,KEYTRUDA only,31.73,28.15,1053.32,95,Partial Response
M202194,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,84.21,60.87,,101,Complete Response
M202195,26,Female,HPV-related Cancer,mrna-4157 + keytruda,62.35,44.39,,73,Partial Response
M202196,34,Other,Melanoma,mrna-4157 + keytruda,44.1,34.45,854.54,85,Progression
M202197,47,Other,HPV-related Cancer,KEYTRUDA only,40.58,42.38,1413.94,76,Stable Disease
M202198,35,Female,Melanoma,KEYTRUDA only,50.22,49.56,221.77,85,Stable Disease
M202199,69,Male,Melanoma,KEYTRUDA only,47.18,45.13,192.29,80,Stable Disease
M202200,47,Other,Non-small Cell Lung Cancer,KEYTRUDA only,23.6,25.38,1037.95,82,Complete Response
M202201,32,Male,HPV-related Cancer,KEYTRUDA only,61.61,41.97,1786.02,85,Partial Response
M202202,80,Male,Melanoma,mrna-4157 + keytruda,55.14,50.49,583.12,103,Stable Disease
M202203,42,Male,HPV-related Cancer,KEYTRUDA only,55.63,57.54,,76,Stable Disease
M202204,37,Other,Melanoma,mrna-4157 + keytruda,55.58,56.28,1714.11,96,Stable Disease
M202205,79,Female,Melanoma,mrna-4157 + keytruda,52.8,55.1,797.55,75,Stable Disease
M202206,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,21.57,13.51,532.18,96,Partial Response
M202207,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.71,6.86,502.31,83,Stable Disease
M202208,57,Female,HPV-related Cancer,KEYTRUDA only,36.41,25.46,1355.09,104,Partial Response
M202209,44,Other,HPV-related Cancer,mrna-4157 + keytruda,37.37,32.61,928.52,85,Partial Response
M202210,81,Female,HPV-related Cancer,mrna-4157 + keytruda,20.08,,1850.18,96,Unknown
M202211,52,Other,HPV-related Cancer,mrna-4157 + keytruda,89.81,73.03,681.03,97,Stable Disease
M202212,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.66,14.16,1177.73,87,Progression
M202213,48,Female,Melanoma,mrna-4157 + keytruda,9.01,7.07,745.73,90,Stable Disease
M202214,48,Other,Melanoma,KEYTRUDA only,29.01,22.43,1228.82,93,Partial Response
M202215,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.91,38.12,217.93,97,
M202216,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,20.21,14.71,986.85,112,Partial Response
M202217,49,Other,Melanoma,KEYTRUDA only,37.31,29.62,1783.63,77,Progression
M202218,40,Other,Melanoma,KEYTRUDA only,13.7,11.85,685.15,103,Partial Response
M202219,56,Female,HPV-related Cancer,KEYTRUDA only,10.24,8.13,1574.22,76,Partial Response
M202220,78,Other,HPV-related Cancer,mrna-4157 + keytruda,71.35,35.9,1388.16,94,Stable Disease
M202221,28,Male,HPV-related Cancer,KEYTRUDA only,81.46,74.87,1047.87,87,Partial Response
M202222,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.72,66.64,1151.2,80,Stable Disease
M202223,76,Other,HPV-related Cancer,mrna-4157 + keytruda,35.77,35.84,620.31,77,Partial Response
M202224,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.11,34.9,1429.35,83,Stable Disease
M202225,34,Female,Melanoma,mrna-4157 + keytruda,40.81,30.77,674.07,91,Partial Response
M202226,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.79,22.57,710.19,92,Stable Disease
M202227,36,Other,Melanoma,mrna-4157 + keytruda,54.98,70.21,678.37,79,Progression
M202228,71,Male,HPV-related Cancer,KEYTRUDA only,46.98,47.03,993.32,88,Complete Response
M202229,32,Female,Melanoma,mrna-4157 + keytruda,37.14,,1577.82,103,
M202230,39,Other,Melanoma,mrna-4157 + keytruda,73.66,81.21,716.32,92,Stable Disease
M202231,59,Other,Melanoma,KEYTRUDA only,39.31,15.3,5152.45,84,Progression
M202232,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.01,52.81,563.17,84,
M202233,48,Female,Melanoma,mrna-4157 + keytruda,65.04,65.39,,92,Partial Response
M202234,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.76,50.4,833.89,93,Partial Response
M202235,66,Female,Melanoma,KEYTRUDA only,57.15,51.7,437.89,92,Complete Response
M202236,81,Female,HPV-related Cancer,KEYTRUDA only,52.87,34.09,919.2,84,Progression
M202237,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.04,67.13,1252.74,104,Partial Response
M202238,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.34,34.23,762.01,88,Complete Response
M202239,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.36,56.5,1518.59,78,Partial Response
M202240,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.18,14.71,,98,Stable Disease
M202241,29,Male,HPV-related Cancer,KEYTRUDA only,75.15,54.68,1116.36,82,Progression
M202242,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.68,20.3,1253.27,92,Stable Disease
M202243,47,Other,Non-small Cell Lung Cancer,KEYTRUDA only,69.47,46.02,601.6,89,Unknown
M202244,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.8,,1543.27,86,Complete Response
M202245,33,Male,HPV-related Cancer,KEYTRUDA only,52.1,35.84,961.65,83,Complete Response
M202246,51,Other,HPV-related Cancer,KEYTRUDA only,32.62,30.05,978.89,83,Progression
M202247,67,Other,HPV-related Cancer,mrna-4157 + keytruda,22.05,13.91,1324.35,97,Complete Response
M202248,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.58,21.6,800.18,70,Complete Response
M202249,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.17,40.18,831.16,104,Unknown
M202250,61,Male,HPV-related Cancer,mrna-4157 + keytruda,17.05,13.1,860.04,70,Complete Response
M202251,73,Female,HPV-related Cancer,KEYTRUDA only,80.51,54.92,1074.79,95,Progression
M202252,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.53,73.9,649.25,78,Complete Response
M202253,68,Male,HPV-related Cancer,KEYTRUDA only,71.93,63.25,1158.32,79,Partial Response
M202254,55,Male,Melanoma,KEYTRUDA only,61.35,47.33,1882.94,120,Partial Response
M202255,51,Other,HPV-related Cancer,mrna-4157 + keytruda,72.74,55.06,1020.67,105,Stable Disease
M202256,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.16,68.25,881.74,87,
M202257,39,Male,HPV-related Cancer,mrna-4157 + keytruda,57.54,49.0,940.33,97,Partial Response
M202258,64,Other,Melanoma,mrna-4157 + keytruda,70.44,40.6,1538.05,104,Progression
M202259,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.0,33.02,,95,Progression
M202260,29,Female,Melanoma,KEYTRUDA only,82.63,69.74,681.62,84,Stable Disease
M202261,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.81,16.98,341.97,65,Complete Response
M202262,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.52,44.26,46.85,96,Stable Disease
M202263,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.29,20.73,1164.74,89,Complete Response
M202264,79,Other,HPV-related Cancer,mrna-4157 + keytruda,54.81,38.68,1390.85,77,Stable Disease
M202265,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,28.67,16.56,1043.4,101,Complete Response
M202266,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.26,26.8,816.06,87,Stable Disease
M202267,51,Other,HPV-related Cancer,KEYTRUDA only,70.14,52.28,1335.94,87,Stable Disease
M202268,29,Male,Melanoma,mrna-4157 + keytruda,44.53,46.71,1084.71,87,Partial Response
M202269,74,Female,Melanoma,KEYTRUDA only,41.72,31.97,832.27,88,Unknown
M202270,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.97,18.42,1837.28,89,Progression
M202271,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.55,45.67,780.37,98,Progression
M202272,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.92,42.08,1210.02,87,Complete Response
M202273,68,Female,Melanoma,KEYTRUDA only,16.28,16.09,605.73,89,Partial Response
M202274,76,Female,HPV-related Cancer,KEYTRUDA only,43.9,40.66,785.52,87,Partial Response
M202275,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.75,27.76,1358.04,88,Stable Disease
M202276,76,Male,Melanoma,mrna-4157 + keytruda,65.01,22.05,737.75,103,Complete Response
M202277,33,Other,HPV-related Cancer,KEYTRUDA only,54.9,42.19,435.38,97,
M202278,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.8,27.69,247.35,90,Stable Disease
M202279,35,Male,HPV-related Cancer,mrna-4157 + keytruda,84.28,67.87,1185.23,82,Stable Disease
M202280,69,Male,HPV-related Cancer,mrna-4157 + keytruda,13.93,10.3,1078.56,100,Partial Response
M202281,40,Female,Melanoma,mrna-4157 + keytruda,35.82,27.54,1819.37,76,Stable Disease
M202282,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.65,20.53,740.45,88,Partial Response
M202283,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.85,55.63,881.74,86,Unknown
M202284,33,Male,HPV-related Cancer,mrna-4157 + keytruda,54.96,37.44,778.73,91,Stable Disease
M202285,63,Female,HPV-related Cancer,mrna-4157 + keytruda,37.47,33.6,1097.88,80,Partial Response
M202286,55,Other,HPV-related Cancer,mrna-4157 + keytruda,67.43,64.43,,65,Unknown
M202287,53,Female,HPV-related Cancer,KEYTRUDA only,20.45,20.13,1135.27,90,Progression
M202288,52,Female,HPV-related Cancer,mrna-4157 + keytruda,34.33,22.13,1160.25,80,Stable Disease
M202289,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.58,41.48,,88,Stable Disease
M202290,61,Female,HPV-related Cancer,mrna-4157 + keytruda,61.4,48.91,1021.63,62,Progression
M202291,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.28,40.85,915.08,75,Stable Disease
M202292,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.41,41.22,1404.88,97,Progression
M202293,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.94,62.46,1202.55,81,Progression
M202294,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.71,70.93,1193.02,78,Complete Response
M202295,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.11,26.81,,95,Partial Response
M202296,38,Male,HPV-related Cancer,mrna-4157 + keytruda,34.36,36.8,1544.13,95,Progression
M202297,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.01,24.22,1032.32,88,Progression
M202298,43,Male,HPV-related Cancer,mrna-4157 + keytruda,25.17,20.63,491.2,87,Complete Response
M202299,70,Other,Melanoma,mrna-4157 + keytruda,34.16,25.34,1162.67,98,Stable Disease
M202300,53,Other,Melanoma,mrna-4157 + keytruda,38.57,,803.16,112,Partial Response
M202301,69,Other,Melanoma,KEYTRUDA only,77.9,47.06,1070.03,92,Stable Disease
M202302,35,Female,HPV-related Cancer,KEYTRUDA only,53.7,41.04,1386.47,85,Progression
M202303,67,Female,HPV-related Cancer,mrna-4157 + keytruda,87.58,44.63,810.57,95,Partial Response
M202304,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.0,64.52,883.82,72,Partial Response
M202305,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,28.87,21.0,368.64,93,Progression
M202306,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,20.66,20.42,315.09,82,Stable Disease
M202307,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.06,49.34,,104,Stable Disease
M202308,41,Male,HPV-related Cancer,mrna-4157 + keytruda,62.25,49.72,1284.15,85,Unknown
M202309,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.4,,-41.54,84,Stable Disease
M202310,42,Other,HPV-related Cancer,mrna-4157 + keytruda,118.3,121.85,,91,Complete Response
M202311,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.81,67.68,1054.76,92,Unknown
M202312,57,Male,HPV-related Cancer,mrna-4157 + keytruda,48.39,54.29,1247.22,94,Unknown
M202313,29,Female,HPV-related Cancer,mrna-4157 + keytruda,38.26,20.76,307.38,93,Complete Response
M202314,38,Female,Melanoma,KEYTRUDA only,32.11,20.57,587.78,92,Stable Disease
M202315,45,Male,HPV-related Cancer,mrna-4157 + keytruda,56.44,33.09,78.11,78,Partial Response
M202316,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.76,,736.89,85,Partial Response
M202317,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,17.16,15.18,1276.38,77,Stable Disease
M202318,53,Female,Melanoma,mrna-4157 + keytruda,70.68,72.73,1018.13,87,Stable Disease
M202319,34,Male,HPV-related Cancer,mrna-4157 + keytruda,26.58,22.26,760.53,103,Stable Disease
M202320,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.17,43.43,735.54,82,Partial Response
M202321,69,Other,Melanoma,KEYTRUDA only,27.49,23.01,1703.06,107,Stable Disease
M202322,77,Male,HPV-related Cancer,KEYTRUDA only,45.25,51.64,652.35,103,
M202323,69,Other,HPV-related Cancer,mrna-4157 + keytruda,31.25,20.66,982.57,95,Stable Disease
M202324,68,Male,HPV-related Cancer,KEYTRUDA only,65.28,39.32,1225.35,103,Stable Disease
M202325,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.96,42.71,889.6,96,Partial Response
M202326,60,Female,Melanoma,KEYTRUDA only,24.62,16.71,1031.8,97,Stable Disease
M202327,55,Female,HPV-related Cancer,KEYTRUDA only,60.06,45.98,950.38,102,Stable Disease
M202328,63,Male,Melanoma,KEYTRUDA only,27.66,14.39,965.35,98,Stable Disease
M202329,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,36.5,22.9,,87,Partial Response
M202330,27,Male,HPV-related Cancer,mrna-4157 + keytruda,60.78,28.94,1327.01,88,Progression
M202331,43,Female,Melanoma,KEYTRUDA only,59.26,40.72,854.46,97,Stable Disease
M202332,81,Female,Melanoma,mrna-4157 + keytruda,45.96,19.37,1017.34,87,Stable Disease
M202333,75,Other,HPV-related Cancer,mrna-4157 + keytruda,74.2,50.98,1133.39,79,Progression
M202334,78,Female,Melanoma,mrna-4157 + keytruda,57.64,44.44,1253.52,87,Progression
M202335,32,Female,HPV-related Cancer,mrna-4157 + keytruda,30.97,18.39,1342.44,83,Complete Response
M202336,27,Female,HPV-related Cancer,mrna-4157 + keytruda,41.62,40.5,827.9,70,Partial Response
M202337,36,Other,Melanoma,mrna-4157 + keytruda,44.17,42.79,1568.01,94,Partial Response
M202338,32,Other,HPV-related Cancer,KEYTRUDA only,6.03,3.58,1161.14,90,Progression
M202339,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.62,42.28,1066.78,84,Partial Response
M202340,41,Female,Melanoma,KEYTRUDA only,23.21,21.74,1109.54,84,Partial Response
M202341,68,Female,Melanoma,mrna-4157 + keytruda,49.22,36.59,858.61,88,Stable Disease
M202342,65,Other,HPV-related Cancer,mrna-4157 + keytruda,26.22,16.61,304.47,92,Partial Response
M202343,73,Male,Melanoma,KEYTRUDA only,49.32,48.56,691.87,74,Progression
M202344,49,Other,Melanoma,KEYTRUDA only,52.75,53.75,1526.39,78,Partial Response
M202345,30,Male,HPV-related Cancer,mrna-4157 + keytruda,62.99,,554.34,80,Complete Response
M202346,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,81.55,105.1,1092.47,95,Progression
M202347,73,Male,Melanoma,mrna-4157 + keytruda,48.08,52.94,272.58,99,Partial Response
M202348,39,Other,HPV-related Cancer,KEYTRUDA only,68.43,61.48,1147.78,102,Progression
M202349,72,Female,Melanoma,mrna-4157 + keytruda,33.22,31.04,1288.2,71,Stable Disease
M202350,67,Male,HPV-related Cancer,KEYTRUDA only,43.34,31.18,668.53,92,Stable Disease
M202351,52,Male,HPV-related Cancer,mrna-4157 + keytruda,70.36,38.9,1032.6,93,Partial Response
M202352,77,Other,HPV-related Cancer,KEYTRUDA only,69.97,41.23,1843.65,79,Stable Disease
M202353,62,Other,HPV-related Cancer,KEYTRUDA only,75.16,55.53,620.64,115,Stable Disease
M202354,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.67,20.78,793.35,94,Complete Response
M202355,67,Male,Melanoma,KEYTRUDA only,65.77,57.88,1333.08,101,Partial Response
M202356,34,Male,HPV-related Cancer,mrna-4157 + keytruda,69.0,53.39,1472.18,75,Stable Disease
M202357,46,Other,Melanoma,KEYTRUDA only,60.48,,1387.23,85,Partial Response
M202358,33,Female,HPV-related Cancer,KEYTRUDA only,62.49,46.83,825.45,73,Stable Disease
M202359,66,Male,HPV-related Cancer,mrna-4157 + keytruda,55.86,28.69,1049.05,92,Partial Response
M202360,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,0.34,0.32,791.0,104,Stable Disease
M202361,64,Male,Non-small Cell Lung Cancer,KEYTRUDA only,27.81,25.29,1083.2,70,Partial Response
M202362,46,Female,Melanoma,KEYTRUDA only,36.38,14.41,1028.52,103,Complete Response
M202363,64,Male,HPV-related Cancer,mrna-4157 + keytruda,4.13,1.91,697.93,89,Partial Response
M202364,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.61,65.23,1077.61,88,Partial Response
M202365,45,Other,Melanoma,mrna-4157 + keytruda,56.93,,624.16,81,Partial Response
M202366,37,Other,HPV-related Cancer,KEYTRUDA only,63.88,56.01,548.32,90,Partial Response
M202367,51,Female,Melanoma,mrna-4157 + keytruda,82.65,82.85,741.48,90,Complete Response
M202368,48,Male,Melanoma,mrna-4157 + keytruda,97.99,78.76,1187.14,81,Complete Response
M202369,30,Male,HPV-related Cancer,mrna-4157 + keytruda,44.67,27.32,770.19,96,Stable Disease
M202370,64,Other,HPV-related Cancer,mrna-4157 + keytruda,22.45,15.02,894.59,77,Partial Response
M202371,60,Other,HPV-related Cancer,KEYTRUDA only,50.94,,654.29,73,Partial Response
M202372,53,Male,Melanoma,KEYTRUDA only,54.27,30.97,,90,Partial Response
M202373,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.13,48.33,1231.58,81,Stable Disease
M202374,40,Other,HPV-related Cancer,mrna-4157 + keytruda,31.36,24.48,662.5,90,Partial Response
M202375,36,Female,HPV-related Cancer,mrna-4157 + keytruda,46.21,41.04,963.74,90,Complete Response
M202376,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.74,39.93,1145.24,78,Partial Response
M202377,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.67,18.95,1336.63,98,Stable Disease
M202378,36,Female,Melanoma,mrna-4157 + keytruda,0.6,0.45,893.36,94,Partial Response
M202379,59,Other,HPV-related Cancer,mrna-4157 + keytruda,91.3,83.63,-23.3,84,Stable Disease
M202380,32,Male,HPV-related Cancer,KEYTRUDA only,24.42,17.23,1320.53,85,Progression
M202381,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.96,47.69,847.56,95,Partial Response
M202382,53,Female,Melanoma,KEYTRUDA only,13.46,9.07,568.65,81,Stable Disease
M202383,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.73,26.19,905.17,92,Stable Disease
M202384,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.91,20.26,1177.36,118,Stable Disease
M202385,61,Other,Melanoma,mrna-4157 + keytruda,82.67,68.38,820.66,88,Partial Response
M202386,41,Female,Melanoma,mrna-4157 + keytruda,62.98,42.95,1051.31,74,Complete Response
M202387,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.07,21.12,1224.55,81,Partial Response
M202388,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.08,55.37,1304.91,101,Stable Disease
M202389,82,Male,HPV-related Cancer,mrna-4157 + keytruda,23.57,22.32,871.86,104,Partial Response
M202390,50,Female,Melanoma,KEYTRUDA only,77.64,63.73,-189.72,90,Partial Response
M202391,83,Female,HPV-related Cancer,KEYTRUDA only,92.6,93.3,646.49,80,Progression
M202392,36,Male,Melanoma,mrna-4157 + keytruda,50.06,39.29,1167.59,79,Stable Disease
M202393,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.15,54.61,1193.42,107,Progression
M202394,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.37,20.91,1118.02,96,Stable Disease
M202395,44,Female,HPV-related Cancer,KEYTRUDA only,58.66,43.2,1361.03,107,Progression
M202396,35,Female,HPV-related Cancer,KEYTRUDA only,51.48,49.39,827.85,82,Progression
M202397,45,Other,Melanoma,KEYTRUDA only,37.41,31.81,1211.38,94,Partial Response
M202398,64,Female,Melanoma,mrna-4157 + keytruda,-5.79,-3.29,1719.0,96,Partial Response
M202399,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.57,20.19,1795.84,83,Partial Response
M202400,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.42,38.95,809.99,96,Progression
M202401,70,Other,Melanoma,KEYTRUDA only,30.28,25.69,1043.26,74,Stable Disease
M202402,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.99,38.48,,89,Stable Disease
M202403,82,Female,Melanoma,KEYTRUDA only,44.31,,848.69,76,Partial Response
M202404,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,92.11,75.34,959.73,107,Complete Response
M202405,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.96,22.98,946.33,107,Stable Disease
M202406,47,Male,Melanoma,KEYTRUDA only,75.74,77.94,1146.42,84,Partial Response
M202407,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.53,45.78,611.5,91,Unknown
M202408,59,Other,HPV-related Cancer,KEYTRUDA only,12.07,10.5,831.01,72,Unknown
M202409,31,Other,HPV-related Cancer,KEYTRUDA only,39.73,41.79,1263.5,95,Progression
M202410,35,Female,Melanoma,KEYTRUDA only,60.98,59.39,733.98,108,Stable Disease
M202411,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.13,33.7,948.47,83,Progression
M202412,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.09,54.56,947.51,86,Progression
M202413,64,Female,Melanoma,mrna-4157 + keytruda,49.86,,465.18,97,Complete Response
M202414,54,Other,Melanoma,mrna-4157 + keytruda,31.38,28.5,1408.64,87,Partial Response
M202415,69,Female,HPV-related Cancer,mrna-4157 + keytruda,52.84,36.59,985.4,102,Partial Response
M202416,75,Female,Melanoma,mrna-4157 + keytruda,45.97,38.68,1401.46,92,Progression
M202417,72,Male,Melanoma,mrna-4157 + keytruda,7.05,3.92,1025.96,88,Stable Disease
M202418,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.41,35.67,470.1,81,Stable Disease
M202419,75,Other,Melanoma,mrna-4157 + keytruda,84.92,83.49,795.76,89,Complete Response
M202420,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.15,33.53,919.3,66,Partial Response
M202421,37,Male,HPV-related Cancer,mrna-4157 + keytruda,12.18,13.41,1010.41,100,Complete Response
M202422,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.47,17.64,2011.19,88,Complete Response
M202423,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.04,48.69,,74,Partial Response
M202424,29,Male,HPV-related Cancer,mrna-4157 + keytruda,76.45,86.07,1477.45,100,Stable Disease
M202425,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,73.1,66.74,1664.33,82,Unknown
M202426,51,Other,Melanoma,mrna-4157 + keytruda,57.01,51.77,1459.99,88,Complete Response
M202427,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.58,76.28,790.38,100,Stable Disease
M202428,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.65,35.96,,95,Partial Response
M202429,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,8.76,5.94,1045.52,79,Partial Response
M202430,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.65,52.0,1150.55,98,Progression
M202431,59,Other,HPV-related Cancer,KEYTRUDA only,16.1,17.11,,99,Unknown
M202432,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.26,46.81,1000.34,88,Partial Response
M202433,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.67,50.15,826.61,85,Partial Response
M202434,50,Male,Melanoma,mrna-4157 + keytruda,46.32,45.08,590.27,88,Stable Disease
M202435,47,Male,HPV-related Cancer,KEYTRUDA only,15.43,,348.53,84,Stable Disease
M202436,51,Female,Melanoma,KEYTRUDA only,46.19,51.65,1064.99,83,Partial Response
M202437,58,Other,Melanoma,KEYTRUDA only,36.33,22.28,887.25,84,Partial Response
M202438,33,Other,HPV-related Cancer,KEYTRUDA only,39.42,35.28,1219.71,82,Complete Response
M202439,62,Male,HPV-related Cancer,KEYTRUDA only,16.33,11.36,803.7,91,Stable Disease
M202440,37,Female,Melanoma,mrna-4157 + keytruda,21.79,21.33,1318.88,92,Partial Response
M202441,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.45,43.62,1487.48,81,Partial Response
M202442,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.33,16.55,384.85,92,
M202443,83,Female,HPV-related Cancer,mrna-4157 + keytruda,40.63,41.97,1160.0,98,Partial Response
M202444,57,Other,HPV-related Cancer,mrna-4157 + keytruda,67.76,70.82,220.81,88,Partial Response
M202445,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.04,32.02,867.9,82,Partial Response
M202446,67,Female,HPV-related Cancer,KEYTRUDA only,52.59,60.48,1130.19,97,Partial Response
M202447,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.36,56.48,1531.74,80,
M202448,39,Other,HPV-related Cancer,mrna-4157 + keytruda,64.46,31.82,-18.49,89,Stable Disease
M202449,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.8,15.29,522.38,92,Partial Response
M202450,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.92,40.98,1087.96,82,Stable Disease
M202451,56,Other,HPV-related Cancer,mrna-4157 + keytruda,44.57,34.98,1058.03,83,Progression
M202452,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.11,56.39,1126.28,80,Stable Disease
M202453,31,Female,Melanoma,KEYTRUDA only,80.07,52.48,920.89,87,Unknown
M202454,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.06,77.59,1275.03,82,Progression
M202455,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.05,30.87,561.66,78,Partial Response
M202456,77,Male,Melanoma,mrna-4157 + keytruda,21.98,11.13,370.35,79,Stable Disease
M202457,51,Other,Melanoma,mrna-4157 + keytruda,13.69,14.28,972.32,91,Stable Disease
M202458,47,Female,Melanoma,mrna-4157 + keytruda,73.97,64.91,840.77,84,Partial Response
M202459,37,Male,HPV-related Cancer,KEYTRUDA only,20.65,17.44,1134.41,85,Progression
M202460,44,Male,HPV-related Cancer,KEYTRUDA only,64.82,59.35,599.71,86,Stable Disease
M202461,35,Male,HPV-related Cancer,KEYTRUDA only,66.75,72.9,1272.03,83,Stable Disease
M202462,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.05,30.06,,89,Stable Disease
M202463,31,Female,HPV-related Cancer,mrna-4157 + keytruda,88.09,52.86,198.18,71,Partial Response
M202464,32,Female,Melanoma,mrna-4157 + keytruda,53.86,77.24,971.22,101,Partial Response
M202465,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.43,35.05,578.65,95,Partial Response
M202466,84,Male,HPV-related Cancer,mrna-4157 + keytruda,53.97,32.3,536.05,88,Stable Disease
M202467,47,Male,Melanoma,mrna-4157 + keytruda,89.01,58.02,869.85,110,Stable Disease
M202468,81,Male,HPV-related Cancer,mrna-4157 + keytruda,67.21,73.89,862.66,82,Complete Response
M202469,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,80.39,47.7,741.19,96,Stable Disease
M202470,53,Male,HPV-related Cancer,mrna-4157 + keytruda,22.24,16.09,307.82,85,Partial Response
M202471,77,Other,HPV-related Cancer,mrna-4157 + keytruda,59.34,32.84,856.56,92,Complete Response
M202472,63,Female,HPV-related Cancer,mrna-4157 + keytruda,17.24,15.3,1184.54,80,Complete Response
M202473,29,Female,HPV-related Cancer,KEYTRUDA only,59.49,32.06,1410.19,90,Progression
M202474,42,Other,Melanoma,mrna-4157 + keytruda,50.26,50.45,974.85,85,Stable Disease
M202475,68,Female,HPV-related Cancer,KEYTRUDA only,30.68,18.02,725.71,90,Stable Disease
M202476,25,Male,Melanoma,mrna-4157 + keytruda,77.25,71.34,1002.22,85,Partial Response
M202477,44,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.46,25.34,996.59,107,Partial Response
M202478,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.53,64.23,968.22,85,Partial Response
M202479,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,21.02,14.96,,95,Stable Disease
M202480,45,Female,HPV-related Cancer,mrna-4157 + keytruda,80.75,,1283.45,77,Unknown
M202481,79,Female,Melanoma,KEYTRUDA only,54.88,60.91,1301.09,104,Partial Response
M202482,59,Other,HPV-related Cancer,KEYTRUDA only,53.93,29.97,952.18,97,
M202483,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.44,40.14,924.86,93,Complete Response
M202484,34,Male,HPV-related Cancer,mrna-4157 + keytruda,58.68,49.48,1194.38,71,Partial Response
M202485,80,Other,Melanoma,mrna-4157 + keytruda,78.72,57.8,1328.7,90,Partial Response
M202486,56,Male,HPV-related Cancer,KEYTRUDA only,54.59,48.3,821.17,98,
M202487,37,Male,HPV-related Cancer,mrna-4157 + keytruda,57.44,54.22,937.79,100,Stable Disease
M202488,65,Male,Melanoma,KEYTRUDA only,80.51,43.45,720.29,73,Unknown
M202489,58,Female,Melanoma,mrna-4157 + keytruda,59.58,18.41,977.33,81,Complete Response
M202490,80,Male,HPV-related Cancer,mrna-4157 + keytruda,61.53,52.52,515.83,95,Partial Response
M202491,69,Female,Melanoma,KEYTRUDA only,51.43,41.27,752.81,80,
M202492,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.07,52.6,1270.41,84,Stable Disease
M202493,53,Male,HPV-related Cancer,mrna-4157 + keytruda,82.73,47.02,1813.75,74,Stable Disease
M202494,39,Female,HPV-related Cancer,mrna-4157 + keytruda,51.71,33.14,1253.75,97,Partial Response
M202495,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.28,17.55,1179.34,119,Partial Response
M202496,51,Female,HPV-related Cancer,mrna-4157 + keytruda,36.24,33.28,851.79,91,Complete Response
M202497,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.55,39.42,1139.31,87,Partial Response
M202498,36,Female,Melanoma,KEYTRUDA only,46.18,29.38,941.58,88,Partial Response
M202499,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.3,51.65,1162.26,103,Stable Disease
M202500,52,Female,Melanoma,mrna-4157 + keytruda,50.68,51.36,438.81,86,Partial Response
M202501,37,Other,Melanoma,mrna-4157 + keytruda,33.53,23.36,749.03,87,Progression
M202502,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.77,30.37,1362.58,103,Stable Disease
M202503,34,Male,HPV-related Cancer,KEYTRUDA only,59.61,36.58,1116.33,101,Partial Response
M202504,36,Female,HPV-related Cancer,mrna-4157 + keytruda,46.72,34.99,899.89,100,Partial Response
M202505,71,Male,Melanoma,mrna-4157 + keytruda,91.66,61.53,780.67,93,Stable Disease
M202506,36,Other,Melanoma,mrna-4157 + keytruda,59.28,64.62,651.64,104,Partial Response
M202507,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,75.54,71.51,964.6,89,Complete Response
M202508,41,Female,Melanoma,mrna-4157 + keytruda,56.45,40.32,755.27,79,
M202509,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.66,67.61,659.04,100,Stable Disease
M202510,51,Female,Melanoma,KEYTRUDA only,91.44,75.33,736.98,89,Progression
M202511,57,Female,HPV-related Cancer,KEYTRUDA only,27.93,,1133.29,85,Partial Response
M202512,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.28,61.9,1326.38,103,Complete Response
M202513,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.95,24.26,963.83,83,Stable Disease
M202514,33,Other,HPV-related Cancer,mrna-4157 + keytruda,101.65,95.18,35.83,81,
M202515,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.81,26.18,,86,Unknown
M202516,30,Other,Melanoma,mrna-4157 + keytruda,68.75,41.56,1808.05,74,Stable Disease
M202517,62,Other,Melanoma,mrna-4157 + keytruda,46.86,47.18,678.69,96,Stable Disease
M202518,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.61,56.12,949.53,80,Stable Disease
M202519,32,Male,Melanoma,mrna-4157 + keytruda,49.85,57.05,1144.69,76,Stable Disease
M202520,54,Male,Melanoma,KEYTRUDA only,22.35,,,104,Complete Response
M202521,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.59,61.16,756.88,87,Partial Response
M202522,70,Male,HPV-related Cancer,KEYTRUDA only,56.36,35.0,693.58,61,Stable Disease
M202523,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.21,14.88,1170.77,95,Stable Disease
M202524,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.17,32.36,884.69,88,Progression
M202525,68,Male,Melanoma,KEYTRUDA only,29.74,14.66,760.81,83,Complete Response
M202526,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.0,36.56,799.0,95,Complete Response
M202527,44,Female,Melanoma,KEYTRUDA only,40.49,29.42,1196.03,90,Partial Response
M202528,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.59,28.02,557.82,102,Partial Response
M202529,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.57,36.91,1618.58,109,Stable Disease
M202530,61,Other,Melanoma,mrna-4157 + keytruda,41.24,24.19,1394.35,100,Stable Disease
M202531,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,57.73,28.42,847.55,95,Progression
M202532,68,Other,HPV-related Cancer,KEYTRUDA only,41.47,,991.13,97,Partial Response
M202533,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.88,17.7,1479.71,95,Stable Disease
M202534,75,Female,HPV-related Cancer,KEYTRUDA only,21.39,12.67,925.32,89,Progression
M202535,28,Male,HPV-related Cancer,mrna-4157 + keytruda,66.59,51.47,1314.06,81,Complete Response
M202536,40,Male,HPV-related Cancer,KEYTRUDA only,39.64,35.34,1221.03,82,Stable Disease
M202537,70,Female,Melanoma,mrna-4157 + keytruda,46.29,42.44,1141.8,96,
M202538,74,Other,Melanoma,mrna-4157 + keytruda,56.92,35.57,415.15,100,Stable Disease
M202539,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.63,39.29,1657.85,114,Progression
M202540,67,Male,HPV-related Cancer,mrna-4157 + keytruda,89.13,46.67,569.51,106,Progression
M202541,77,Male,HPV-related Cancer,mrna-4157 + keytruda,61.31,50.92,683.49,86,Complete Response
M202542,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.97,,1047.21,95,Progression
M202543,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.1,33.01,1768.71,88,Partial Response
M202544,41,Female,HPV-related Cancer,KEYTRUDA only,74.11,66.72,1272.96,87,Stable Disease
M202545,57,Other,HPV-related Cancer,mrna-4157 + keytruda,62.74,50.01,1390.84,84,Partial Response
M202546,78,Female,Melanoma,KEYTRUDA only,75.86,60.12,1743.37,84,Partial Response
M202547,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,26.25,21.12,808.81,93,Partial Response
M202548,30,Other,Melanoma,mrna-4157 + keytruda,69.88,57.26,1089.59,103,Stable Disease
M202549,26,Male,HPV-related Cancer,mrna-4157 + keytruda,82.56,74.96,936.06,84,Unknown
M202550,81,Female,Melanoma,KEYTRUDA only,47.3,31.13,1022.11,94,Partial Response
M202551,78,Female,HPV-related Cancer,KEYTRUDA only,1.88,2.13,1160.34,88,Partial Response
M202552,78,Other,Melanoma,mrna-4157 + keytruda,47.88,50.08,970.54,90,Partial Response
M202553,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.23,12.11,566.64,85,Partial Response
M202554,27,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.81,43.63,697.65,88,Partial Response
M202555,56,Male,HPV-related Cancer,mrna-4157 + keytruda,47.5,28.22,1237.28,93,Complete Response
M202556,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,77.21,71.06,1290.63,73,Progression
M202557,72,Other,Melanoma,KEYTRUDA only,81.97,81.9,1280.74,68,Partial Response
M202558,28,Male,Melanoma,mrna-4157 + keytruda,66.02,,897.5,89,Partial Response
M202559,62,Other,Melanoma,mrna-4157 + keytruda,60.33,59.24,856.73,91,Unknown
M202560,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.96,26.65,1428.92,90,Partial Response
M202561,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.49,24.42,1592.53,94,Partial Response
M202562,45,Other,HPV-related Cancer,mrna-4157 + keytruda,95.95,114.0,1243.22,91,
M202563,71,Female,HPV-related Cancer,KEYTRUDA only,59.95,49.57,330.55,75,Progression
M202564,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,77.83,73.52,350.57,73,Stable Disease
M202565,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.83,47.78,896.42,88,Unknown
M202566,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.75,24.59,1161.28,92,Partial Response
M202567,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.49,43.04,717.4,111,Stable Disease
M202568,79,Male,HPV-related Cancer,KEYTRUDA only,46.01,61.67,629.84,95,Unknown
M202569,28,Other,Melanoma,KEYTRUDA only,64.46,43.53,620.04,93,Progression
M202570,50,Male,HPV-related Cancer,KEYTRUDA only,32.52,33.72,1163.12,101,Partial Response
M202571,44,Male,Melanoma,KEYTRUDA only,35.13,41.1,668.3,75,
M202572,54,Male,Melanoma,mrna-4157 + keytruda,45.2,41.79,1472.51,102,Partial Response
M202573,31,Other,HPV-related Cancer,mrna-4157 + keytruda,46.2,27.95,,86,Stable Disease
M202574,41,Male,HPV-related Cancer,mrna-4157 + keytruda,80.62,46.6,2015.1,97,Progression
M202575,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.24,39.72,1286.39,84,Partial Response
M202576,38,Male,Melanoma,KEYTRUDA only,26.96,25.16,997.06,87,Complete Response
M202577,69,Male,HPV-related Cancer,mrna-4157 + keytruda,50.97,32.31,946.65,106,Stable Disease
M202578,44,Male,Melanoma,mrna-4157 + keytruda,52.26,38.89,,78,Stable Disease
M202579,84,Other,Melanoma,mrna-4157 + keytruda,24.81,13.99,1499.08,73,Complete Response
M202580,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.4,48.81,495.87,78,Partial Response
M202581,36,Female,Melanoma,mrna-4157 + keytruda,29.14,24.17,974.29,79,Partial Response
M202582,42,Male,Melanoma,mrna-4157 + keytruda,52.03,32.45,727.75,78,Progression
M202583,71,Other,Melanoma,KEYTRUDA only,59.78,36.19,1261.48,79,Partial Response
M202584,47,Male,HPV-related Cancer,KEYTRUDA only,44.17,24.25,1007.5,81,Stable Disease
M202585,55,Male,Melanoma,mrna-4157 + keytruda,22.69,16.64,652.14,100,
M202586,27,Male,Melanoma,mrna-4157 + keytruda,47.39,43.85,1488.6,93,Progression
M202587,57,Other,Melanoma,mrna-4157 + keytruda,76.44,62.35,279.79,84,Partial Response
M202588,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.85,67.57,1109.13,89,Stable Disease
M202589,72,Male,Melanoma,KEYTRUDA only,44.3,28.03,884.46,96,Complete Response
M202590,46,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.11,61.46,851.03,73,Unknown
M202591,84,Female,Melanoma,mrna-4157 + keytruda,23.17,17.37,868.89,101,Stable Disease
M202592,62,Other,HPV-related Cancer,KEYTRUDA only,55.81,39.83,631.16,110,
M202593,29,Female,HPV-related Cancer,mrna-4157 + keytruda,40.41,18.14,1221.93,102,Partial Response
M202594,60,Female,Melanoma,KEYTRUDA only,50.52,41.79,588.33,103,
M202595,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.78,6.44,1129.19,100,Stable Disease
M202596,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.62,42.17,475.93,99,Progression
M202597,30,Male,HPV-related Cancer,mrna-4157 + keytruda,75.3,88.2,1471.25,104,Progression
M202598,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,56.45,30.65,1827.71,76,Stable Disease
M202599,71,Other,Melanoma,mrna-4157 + keytruda,60.41,43.04,1201.17,94,Partial Response
M202600,63,Male,Melanoma,mrna-4157 + keytruda,57.08,36.61,949.34,93,Partial Response
M202601,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-15.52,-13.12,1014.15,91,Complete Response
M202602,54,Other,HPV-related Cancer,mrna-4157 + keytruda,57.43,41.98,1076.68,101,Stable Disease
M202603,35,Other,Melanoma,mrna-4157 + keytruda,40.82,31.7,910.45,85,Unknown
M202604,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,21.83,16.48,1025.41,104,Stable Disease
M202605,48,Female,Melanoma,mrna-4157 + keytruda,52.56,52.17,1478.73,101,Partial Response
M202606,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.2,38.46,763.17,87,
M202607,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.18,25.78,1323.09,87,Stable Disease
M202608,70,Other,HPV-related Cancer,KEYTRUDA only,47.74,41.21,876.3,102,Partial Response
M202609,60,Other,Melanoma,mrna-4157 + keytruda,46.86,23.3,968.41,83,Stable Disease
M202610,71,Female,Melanoma,mrna-4157 + keytruda,62.79,65.24,1663.82,83,Partial Response
M202611,63,Female,HPV-related Cancer,KEYTRUDA only,35.54,32.02,878.86,83,Progression
M202612,83,Female,HPV-related Cancer,mrna-4157 + keytruda,72.14,50.4,351.5,92,Partial Response
M202613,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,80.78,95.53,167.24,85,Stable Disease
M202614,52,Female,Melanoma,mrna-4157 + keytruda,35.76,29.78,680.55,90,Partial Response
M202615,53,Female,HPV-related Cancer,mrna-4157 + keytruda,53.17,31.95,114.97,106,Partial Response
M202616,74,Female,Melanoma,mrna-4157 + keytruda,40.43,36.86,453.64,95,Complete Response
M202617,46,Female,HPV-related Cancer,mrna-4157 + keytruda,34.6,19.51,1716.24,86,Partial Response
M202618,81,Female,Melanoma,mrna-4157 + keytruda,65.41,57.32,996.96,94,Partial Response
M202619,81,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.27,27.74,1134.92,95,Stable Disease
M202620,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.56,69.53,359.53,90,Progression
M202621,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.55,23.89,1156.68,87,Stable Disease
M202622,45,Male,HPV-related Cancer,mrna-4157 + keytruda,49.51,27.39,1468.75,86,Stable Disease
M202623,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.15,42.51,876.5,76,Progression
M202624,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.57,15.04,1001.44,88,Complete Response
M202625,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.04,33.78,478.71,105,Stable Disease
M202626,70,Other,HPV-related Cancer,KEYTRUDA only,71.22,47.61,1782.9,99,Partial Response
M202627,27,Female,HPV-related Cancer,mrna-4157 + keytruda,73.02,58.2,1186.78,91,Complete Response
M202628,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.43,66.88,1483.68,89,Progression
M202629,78,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.6,25.9,1272.39,106,Partial Response
M202630,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.21,20.14,,104,Progression
M202631,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.65,40.42,1547.33,82,
M202632,29,Male,HPV-related Cancer,mrna-4157 + keytruda,55.34,24.19,1185.77,89,Progression
M202633,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.74,35.02,1158.23,86,Stable Disease
M202634,58,Female,Melanoma,mrna-4157 + keytruda,49.27,45.2,323.1,90,Stable Disease
M202635,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.61,35.53,652.3,57,Complete Response
M202636,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.84,22.82,1324.28,101,Progression
M202637,40,Male,Melanoma,mrna-4157 + keytruda,86.49,102.52,561.02,103,Partial Response
M202638,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.18,25.51,1092.1,86,Progression
M202639,26,Male,HPV-related Cancer,mrna-4157 + keytruda,20.76,16.33,1297.22,98,Progression
M202640,77,Other,HPV-related Cancer,mrna-4157 + keytruda,47.48,41.08,1414.97,87,Progression
M202641,79,Female,HPV-related Cancer,mrna-4157 + keytruda,57.56,55.46,1384.86,101,Partial Response
M202642,73,Other,Melanoma,mrna-4157 + keytruda,72.01,57.43,1145.5,95,Progression
M202643,73,Male,HPV-related Cancer,mrna-4157 + keytruda,58.26,38.35,2448.45,78,Partial Response
M202644,57,Male,Melanoma,mrna-4157 + keytruda,54.52,33.33,681.29,92,Progression
M202645,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.05,43.17,1130.14,95,Stable Disease
M202646,66,Female,Melanoma,mrna-4157 + keytruda,41.75,13.23,1412.17,87,Stable Disease
M202647,66,Male,HPV-related Cancer,KEYTRUDA only,27.57,22.12,875.49,87,Complete Response
M202648,66,Male,Melanoma,KEYTRUDA only,51.12,49.15,1162.61,86,Complete Response
M202649,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.46,72.63,952.99,103,Progression
M202650,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.9,12.84,1182.39,79,Stable Disease
M202651,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.96,65.8,1163.32,99,Partial Response
M202652,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.48,40.46,1635.45,92,Partial Response
M202653,50,Female,Melanoma,mrna-4157 + keytruda,8.8,6.11,,109,Partial Response
M202654,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.64,49.7,1353.82,96,Stable Disease
M202655,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.83,84.9,1277.54,77,Partial Response
M202656,61,Male,Melanoma,mrna-4157 + keytruda,54.87,47.92,1187.49,87,
M202657,83,Male,HPV-related Cancer,mrna-4157 + keytruda,89.06,91.57,980.52,101,Stable Disease
M202658,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.55,67.3,995.8,81,Stable Disease
M202659,43,Female,Melanoma,mrna-4157 + keytruda,65.35,44.23,1412.01,99,Stable Disease
M202660,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,33.57,29.38,934.7,86,Complete Response
M202661,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,26.5,23.16,709.2,100,Complete Response
M202662,28,Female,Melanoma,mrna-4157 + keytruda,56.64,50.06,1498.53,95,Complete Response
M202663,74,Female,Melanoma,mrna-4157 + keytruda,84.9,57.01,1259.08,87,Stable Disease
M202664,64,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.57,52.73,967.98,96,Partial Response
M202665,45,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.69,34.32,487.68,96,
M202666,78,Other,HPV-related Cancer,mrna-4157 + keytruda,37.39,35.02,,103,Partial Response
M202667,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.51,17.21,793.27,83,Stable Disease
M202668,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,2.22,1.27,454.46,115,Complete Response
M202669,56,Male,Melanoma,mrna-4157 + keytruda,46.6,34.54,872.7,92,Complete Response
M202670,51,Male,Melanoma,mrna-4157 + keytruda,51.16,33.17,848.48,96,Progression
M202671,44,Other,Melanoma,KEYTRUDA only,80.2,78.3,1361.71,94,
M202672,48,Female,HPV-related Cancer,mrna-4157 + keytruda,54.35,50.37,1422.86,76,
M202673,76,Female,Melanoma,mrna-4157 + keytruda,62.67,57.83,868.82,88,Stable Disease
M202674,60,Other,Melanoma,KEYTRUDA only,66.2,42.74,1003.24,84,Partial Response
M202675,44,Male,Melanoma,mrna-4157 + keytruda,51.82,57.37,481.79,65,Partial Response
M202676,36,Male,Melanoma,mrna-4157 + keytruda,58.47,79.44,809.45,85,Progression
M202677,58,Male,Melanoma,mrna-4157 + keytruda,60.07,,1437.81,93,Stable Disease
M202678,84,Female,Melanoma,mrna-4157 + keytruda,80.56,62.44,930.02,75,Stable Disease
M202679,74,Female,Melanoma,KEYTRUDA only,56.42,45.47,244.51,82,Partial Response
M202680,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.33,43.62,1911.88,89,Partial Response
M202681,54,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.01,58.39,830.94,108,Stable Disease
M202682,72,Female,HPV-related Cancer,mrna-4157 + keytruda,71.27,46.69,,97,Complete Response
M202683,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.7,19.92,90.01,90,Progression
M202684,32,Female,HPV-related Cancer,mrna-4157 + keytruda,35.31,30.78,780.16,102,Unknown
M202685,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.55,34.93,110.99,85,Partial Response
M202686,32,Male,HPV-related Cancer,mrna-4157 + keytruda,52.45,56.23,696.72,96,Stable Disease
M202687,35,Other,HPV-related Cancer,mrna-4157 + keytruda,36.99,36.53,1063.35,95,Partial Response
M202688,44,Female,Melanoma,mrna-4157 + keytruda,17.69,16.68,374.95,115,Progression
M202689,61,Other,Melanoma,KEYTRUDA only,44.26,25.9,1697.2,78,Progression
M202690,62,Male,Melanoma,KEYTRUDA only,60.72,50.3,1162.13,97,Complete Response
M202691,31,Female,Melanoma,mrna-4157 + keytruda,37.57,20.98,986.93,89,Complete Response
M202692,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.52,46.15,593.43,85,Partial Response
M202693,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.51,,1002.17,91,Complete Response
M202694,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.3,11.52,545.63,96,Stable Disease
M202695,83,Other,Melanoma,KEYTRUDA only,75.05,63.51,292.45,91,Progression
M202696,53,Female,Melanoma,mrna-4157 + keytruda,54.37,41.14,274.55,96,Stable Disease
M202697,60,Other,Melanoma,KEYTRUDA only,56.26,55.6,980.05,92,Progression
M202698,34,Female,HPV-related Cancer,mrna-4157 + keytruda,43.99,27.88,1266.6,91,Progression
M202699,56,Male,Melanoma,mrna-4157 + keytruda,33.25,38.42,79.92,101,Partial Response
M202700,34,Male,HPV-related Cancer,KEYTRUDA only,31.18,18.23,1053.96,84,Complete Response
M202701,53,Male,HPV-related Cancer,mrna-4157 + keytruda,45.52,37.0,759.43,91,Partial Response
M202702,78,Male,HPV-related Cancer,mrna-4157 + keytruda,74.19,67.65,431.65,103,Progression
M202703,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.59,34.4,1264.43,82,Progression
M202704,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.2,49.14,875.1,97,Unknown
M202705,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.56,22.45,1025.81,79,Complete Response
M202706,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.9,46.78,1161.79,95,Partial Response
M202707,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,93.41,68.85,1116.14,98,Partial Response
M202708,36,Other,Melanoma,mrna-4157 + keytruda,41.24,35.63,1234.58,96,Partial Response
M202709,59,Male,HPV-related Cancer,KEYTRUDA only,57.14,54.7,1496.28,108,Stable Disease
M202710,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.63,31.0,1103.38,101,Complete Response
M202711,61,Male,Melanoma,KEYTRUDA only,64.18,49.01,756.78,87,Partial Response
M202712,47,Male,HPV-related Cancer,KEYTRUDA only,64.95,68.32,562.9,84,Stable Disease
M202713,60,Female,HPV-related Cancer,KEYTRUDA only,42.51,38.23,1387.63,89,Progression
M202714,30,Other,Melanoma,mrna-4157 + keytruda,30.28,11.25,1003.75,82,Partial Response
M202715,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.87,34.51,264.7,81,Partial Response
M202716,68,Male,HPV-related Cancer,mrna-4157 + keytruda,52.68,48.03,476.05,90,Partial Response
M202717,55,Male,HPV-related Cancer,KEYTRUDA only,32.05,,827.09,78,Partial Response
M202718,54,Female,Melanoma,mrna-4157 + keytruda,51.16,40.78,1655.31,93,Progression
M202719,45,Male,HPV-related Cancer,mrna-4157 + keytruda,77.53,72.4,1416.08,90,Partial Response
M202720,36,Male,HPV-related Cancer,mrna-4157 + keytruda,61.0,34.46,720.06,91,Partial Response
M202721,27,Male,HPV-related Cancer,mrna-4157 + keytruda,75.24,77.59,851.39,90,Progression
M202722,27,Male,Melanoma,KEYTRUDA only,78.87,73.93,1589.89,110,Partial Response
M202723,67,Male,HPV-related Cancer,KEYTRUDA only,24.37,15.4,1211.74,82,Stable Disease
M202724,60,Male,HPV-related Cancer,mrna-4157 + keytruda,40.36,44.64,1976.27,103,Complete Response
M202725,78,Other,HPV-related Cancer,mrna-4157 + keytruda,31.85,18.98,1264.33,76,Partial Response
M202726,64,Other,Melanoma,mrna-4157 + keytruda,38.26,20.84,916.53,82,Partial Response
M202727,70,Female,HPV-related Cancer,KEYTRUDA only,43.21,46.67,1296.09,96,Progression
M202728,33,Other,HPV-related Cancer,mrna-4157 + keytruda,47.23,34.1,1072.55,70,Stable Disease
M202729,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,-1.81,-1.41,955.99,109,Complete Response
M202730,40,Other,Melanoma,mrna-4157 + keytruda,22.62,16.11,1772.86,73,
M202731,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.88,40.64,1157.55,98,Complete Response
M202732,27,Other,Melanoma,mrna-4157 + keytruda,63.86,70.04,1282.3,108,Stable Disease
M202733,79,Male,Melanoma,mrna-4157 + keytruda,41.66,,831.97,82,Complete Response
M202734,49,Other,HPV-related Cancer,KEYTRUDA only,64.9,,1145.36,75,Stable Disease
M202735,51,Male,Melanoma,KEYTRUDA only,52.82,37.52,817.92,82,Progression
M202736,47,Male,Melanoma,mrna-4157 + keytruda,15.86,12.17,1968.23,110,Complete Response
M202737,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.85,41.4,1079.6,101,Partial Response
M202738,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.37,18.62,1016.96,77,Partial Response
M202739,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.86,56.57,1986.06,78,Stable Disease
M202740,42,Male,Melanoma,mrna-4157 + keytruda,42.53,25.95,2339.51,96,Partial Response
M202741,47,Male,Melanoma,mrna-4157 + keytruda,55.52,47.29,1256.87,93,Stable Disease
M202742,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.26,43.17,1393.77,91,Progression
M202743,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.57,46.2,979.14,103,Partial Response
M202744,36,Other,HPV-related Cancer,KEYTRUDA only,55.47,36.48,1326.94,86,Partial Response
M202745,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.66,85.8,1318.94,81,Partial Response
M202746,70,Female,Melanoma,KEYTRUDA only,51.14,44.26,1268.43,99,Stable Disease
M202747,80,Male,HPV-related Cancer,KEYTRUDA only,73.76,54.59,779.83,82,Stable Disease
M202748,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.2,77.15,583.23,79,Complete Response
M202749,57,Other,Melanoma,mrna-4157 + keytruda,-1.74,-1.54,1804.76,90,Partial Response
M202750,67,Other,Melanoma,mrna-4157 + keytruda,45.0,36.86,1609.22,84,Partial Response
M202751,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.31,85.77,,78,Stable Disease
M202752,56,Male,HPV-related Cancer,mrna-4157 + keytruda,21.66,,448.74,86,Complete Response
M202753,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.51,54.37,743.75,70,Partial Response
M202754,80,Male,Melanoma,mrna-4157 + keytruda,73.88,56.73,1097.56,90,Partial Response
M202755,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.3,38.32,1019.03,94,Complete Response
M202756,40,Other,HPV-related Cancer,KEYTRUDA only,47.56,29.89,1280.94,74,Complete Response
M202757,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.75,59.57,777.67,84,Partial Response
M202758,55,Female,Melanoma,mrna-4157 + keytruda,27.62,24.72,780.89,86,Complete Response
M202759,44,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.02,62.36,903.21,91,Progression
M202760,64,Other,Melanoma,mrna-4157 + keytruda,51.4,51.94,1071.05,90,Partial Response
M202761,54,Male,HPV-related Cancer,mrna-4157 + keytruda,58.6,37.62,1073.58,103,Progression
M202762,78,Male,Melanoma,KEYTRUDA only,30.66,29.36,1018.08,100,Progression
M202763,66,Female,Melanoma,mrna-4157 + keytruda,30.31,37.08,,88,Stable Disease
M202764,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,19.7,18.55,828.41,94,Progression
M202765,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,10.7,5.87,931.61,88,Partial Response
M202766,40,Female,Melanoma,mrna-4157 + keytruda,20.26,17.47,753.68,88,Complete Response
M202767,37,Male,HPV-related Cancer,mrna-4157 + keytruda,57.89,38.35,1017.36,84,Stable Disease
M202768,31,Male,Melanoma,KEYTRUDA only,59.52,47.83,814.14,90,Partial Response
M202769,25,Other,HPV-related Cancer,mrna-4157 + keytruda,59.61,34.89,1080.75,86,Partial Response
M202770,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.93,37.18,906.8,72,Stable Disease
M202771,39,Male,HPV-related Cancer,mrna-4157 + keytruda,92.89,85.9,1252.08,89,Complete Response
M202772,39,Other,Non-small Cell Lung Cancer,KEYTRUDA only,18.94,14.96,1010.61,110,Stable Disease
M202773,36,Other,Melanoma,mrna-4157 + keytruda,57.95,47.09,1009.22,63,Stable Disease
M202774,38,Other,HPV-related Cancer,KEYTRUDA only,39.79,28.21,887.21,98,Partial Response
M202775,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.69,54.96,672.38,98,
M202776,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.88,57.18,1179.25,89,Partial Response
M202777,44,Female,HPV-related Cancer,KEYTRUDA only,19.3,11.46,1441.16,69,Partial Response
M202778,65,Male,HPV-related Cancer,mrna-4157 + keytruda,12.87,12.49,953.68,88,Stable Disease
M202779,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.72,15.45,955.85,99,Progression
M202780,51,Female,HPV-related Cancer,mrna-4157 + keytruda,26.58,24.05,1369.65,79,
M202781,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.54,34.22,741.07,104,Partial Response
M202782,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.75,38.17,2251.41,82,
M202783,36,Male,HPV-related Cancer,mrna-4157 + keytruda,30.61,31.49,,111,Progression
M202784,82,Female,HPV-related Cancer,KEYTRUDA only,50.08,25.61,1164.22,77,Unknown
M202785,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.69,21.37,972.21,98,Partial Response
M202786,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.8,52.24,793.2,73,Partial Response
M202787,45,Male,HPV-related Cancer,mrna-4157 + keytruda,52.26,44.28,,79,Stable Disease
M202788,76,Male,Melanoma,KEYTRUDA only,45.29,37.0,1484.54,94,Progression
M202789,52,Other,Melanoma,mrna-4157 + keytruda,64.17,55.74,1405.36,84,Stable Disease
M202790,57,Male,HPV-related Cancer,mrna-4157 + keytruda,40.46,39.31,1124.92,68,Complete Response
M202791,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.4,40.76,746.13,97,Progression
M202792,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.16,41.93,184.33,95,Stable Disease
M202793,56,Female,Melanoma,KEYTRUDA only,37.81,35.8,1706.79,78,Partial Response
M202794,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.95,36.23,1688.26,83,Complete Response
M202795,61,Male,HPV-related Cancer,KEYTRUDA only,33.19,26.76,820.38,94,Stable Disease
M202796,46,Male,HPV-related Cancer,mrna-4157 + keytruda,39.37,27.37,1579.52,88,Partial Response
M202797,44,Female,HPV-related Cancer,mrna-4157 + keytruda,47.08,47.07,693.97,87,Partial Response
M202798,41,Male,Melanoma,mrna-4157 + keytruda,11.28,10.13,837.71,95,Unknown
M202799,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.02,52.35,1485.24,93,Complete Response
M202800,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.92,39.49,1382.73,97,Partial Response
M202801,58,Male,HPV-related Cancer,mrna-4157 + keytruda,37.75,20.37,1261.68,85,Partial Response
M202802,27,Male,HPV-related Cancer,mrna-4157 + keytruda,53.34,44.55,1006.46,95,Stable Disease
M202803,67,Female,HPV-related Cancer,mrna-4157 + keytruda,73.71,47.56,91.6,84,Partial Response
M202804,56,Other,Melanoma,mrna-4157 + keytruda,31.91,22.15,1022.4,104,Complete Response
M202805,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.67,40.59,1031.62,83,Stable Disease
M202806,31,Female,Melanoma,KEYTRUDA only,37.04,43.4,1133.56,98,Partial Response
M202807,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.55,25.85,1059.48,88,Partial Response
M202808,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.42,35.49,594.53,97,Complete Response
M202809,64,Female,Melanoma,KEYTRUDA only,75.76,66.66,559.18,79,
M202810,32,Female,Melanoma,KEYTRUDA only,31.41,25.82,1836.86,109,Complete Response
M202811,75,Male,HPV-related Cancer,KEYTRUDA only,41.69,41.19,1545.47,91,Partial Response
M202812,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,82.88,102.23,660.38,102,Stable Disease
M202813,64,Female,Melanoma,mrna-4157 + keytruda,30.18,8.29,886.85,76,Stable Disease
M202814,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.63,2.18,1273.2,89,Stable Disease
M202815,35,Male,Melanoma,KEYTRUDA only,15.17,12.84,1135.84,109,Stable Disease
M202816,43,Female,Melanoma,mrna-4157 + keytruda,29.0,20.51,996.16,92,Complete Response
M202817,79,Male,HPV-related Cancer,KEYTRUDA only,46.73,16.25,1334.58,91,Partial Response
M202818,81,Male,Melanoma,mrna-4157 + keytruda,73.78,41.58,1189.97,75,Partial Response
M202819,79,Other,HPV-related Cancer,KEYTRUDA only,46.82,40.85,137.78,98,Complete Response
M202820,26,Male,Melanoma,mrna-4157 + keytruda,56.46,36.29,1187.63,94,Progression
M202821,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.85,29.55,564.98,98,Partial Response
M202822,27,Male,Melanoma,KEYTRUDA only,46.38,38.68,1228.63,95,Stable Disease
M202823,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.51,42.82,1052.92,90,Progression
M202824,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.98,52.54,902.33,114,Progression
M202825,52,Other,HPV-related Cancer,mrna-4157 + keytruda,5.45,4.92,811.03,102,Stable Disease
M202826,61,Other,Melanoma,mrna-4157 + keytruda,50.82,33.03,576.97,101,Partial Response
M202827,83,Female,Melanoma,mrna-4157 + keytruda,29.39,35.8,2235.88,79,Progression
M202828,30,Male,HPV-related Cancer,mrna-4157 + keytruda,77.16,87.63,,85,Progression
M202829,47,Female,HPV-related Cancer,KEYTRUDA only,34.47,23.37,1294.93,97,Partial Response
M202830,34,Female,Melanoma,KEYTRUDA only,20.24,12.94,392.56,82,Progression
M202831,38,Other,HPV-related Cancer,mrna-4157 + keytruda,13.08,11.97,831.73,100,Progression
M202832,61,Female,Melanoma,mrna-4157 + keytruda,68.85,38.0,482.06,102,Complete Response
M202833,55,Other,HPV-related Cancer,mrna-4157 + keytruda,53.89,38.75,1186.15,81,Progression
M202834,48,Other,HPV-related Cancer,KEYTRUDA only,41.08,32.31,,101,Progression
M202835,74,Other,Melanoma,mrna-4157 + keytruda,56.77,52.74,569.13,96,Partial Response
M202836,72,Other,Melanoma,mrna-4157 + keytruda,27.19,20.82,768.38,95,Progression
M202837,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.42,29.16,1515.31,84,Progression
M202838,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.95,29.06,1045.86,89,Complete Response
M202839,84,Other,Melanoma,mrna-4157 + keytruda,20.03,21.17,1037.47,104,Progression
M202840,83,Other,Melanoma,KEYTRUDA only,42.65,38.64,861.35,89,Stable Disease
M202841,41,Female,HPV-related Cancer,KEYTRUDA only,38.13,39.12,,83,Stable Disease
M202842,43,Other,HPV-related Cancer,mrna-4157 + keytruda,51.78,46.23,726.19,96,Unknown
M202843,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,17.2,18.69,796.96,89,Partial Response
M202844,36,Other,HPV-related Cancer,mrna-4157 + keytruda,26.57,16.29,580.85,82,
M202845,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.74,,570.39,84,Partial Response
M202846,33,Other,HPV-related Cancer,mrna-4157 + keytruda,4.4,3.08,795.3,92,Stable Disease
M202847,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.74,32.04,761.46,96,Complete Response
M202848,41,Female,HPV-related Cancer,KEYTRUDA only,69.9,30.92,1392.43,98,Progression
M202849,76,Female,Melanoma,mrna-4157 + keytruda,39.69,32.26,382.33,82,Progression
M202850,26,Female,HPV-related Cancer,mrna-4157 + keytruda,76.0,67.6,404.29,98,Unknown
M202851,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.11,23.68,1652.26,99,Stable Disease
M202852,28,Other,HPV-related Cancer,mrna-4157 + keytruda,51.13,42.37,1157.99,93,Progression
M202853,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.55,66.56,765.6,92,Partial Response
M202854,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.45,52.01,330.84,91,Complete Response
M202855,36,Female,Melanoma,KEYTRUDA only,24.92,19.65,268.89,82,Partial Response
M202856,81,Male,HPV-related Cancer,mrna-4157 + keytruda,84.43,59.44,-46.5,79,Progression
M202857,63,Male,HPV-related Cancer,mrna-4157 + keytruda,111.75,107.13,1699.04,93,
M202858,28,Male,HPV-related Cancer,KEYTRUDA only,53.08,39.37,1597.37,91,Progression
M202859,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.91,26.5,,85,Progression
M202860,66,Other,Melanoma,mrna-4157 + keytruda,69.14,65.23,1533.44,90,Complete Response
M202861,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,36.99,28.2,1306.91,101,Stable Disease
M202862,77,Male,Melanoma,mrna-4157 + keytruda,56.41,37.95,630.02,95,Stable Disease
M202863,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.68,34.09,320.21,93,Partial Response
M202864,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.42,23.66,1668.03,82,Stable Disease
M202865,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.13,6.46,,93,Unknown
M202866,36,Other,Melanoma,KEYTRUDA only,41.72,36.77,756.39,90,Progression
M202867,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.29,26.98,902.72,91,Stable Disease
M202868,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.99,84.83,1399.74,96,Stable Disease
M202869,51,Other,HPV-related Cancer,mrna-4157 + keytruda,58.16,51.51,812.36,90,Partial Response
M202870,59,Female,HPV-related Cancer,mrna-4157 + keytruda,75.45,61.42,1098.82,87,Complete Response
M202871,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.95,40.54,1227.37,78,Unknown
M202872,72,Other,Melanoma,KEYTRUDA only,57.87,46.69,1217.76,83,Partial Response
M202873,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.08,56.78,702.81,99,Stable Disease
M202874,46,Male,Melanoma,KEYTRUDA only,29.76,32.07,326.21,90,Partial Response
M202875,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.09,65.63,,77,Stable Disease
M202876,32,Male,HPV-related Cancer,mrna-4157 + keytruda,19.79,18.09,416.32,111,Unknown
M202877,41,Female,HPV-related Cancer,mrna-4157 + keytruda,77.0,66.81,1782.95,93,Unknown
M202878,47,Female,HPV-related Cancer,mrna-4157 + keytruda,37.01,20.61,1489.08,99,Unknown
M202879,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.97,73.46,1450.0,96,Progression
M202880,32,Female,HPV-related Cancer,mrna-4157 + keytruda,59.47,26.55,1363.41,90,Stable Disease
M202881,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.74,51.38,488.43,92,Partial Response
M202882,50,Male,Melanoma,KEYTRUDA only,50.56,38.91,974.8,83,Partial Response
M202883,43,Female,Melanoma,KEYTRUDA only,24.26,22.65,842.79,97,Stable Disease
M202884,35,Other,HPV-related Cancer,mrna-4157 + keytruda,45.9,44.31,1329.78,116,Unknown
M202885,26,Other,Melanoma,mrna-4157 + keytruda,69.5,59.7,1764.29,71,Partial Response
M202886,78,Female,Melanoma,KEYTRUDA only,29.48,13.06,1384.44,83,Stable Disease
M202887,77,Male,Melanoma,KEYTRUDA only,68.36,40.51,946.88,86,Stable Disease
M202888,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.55,,886.29,91,Unknown
M202889,61,Other,HPV-related Cancer,mrna-4157 + keytruda,64.26,34.73,,104,Progression
M202890,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.81,22.92,879.94,93,Stable Disease
M202891,68,Female,Melanoma,mrna-4157 + keytruda,49.58,42.25,1533.24,96,Progression
M202892,69,Male,HPV-related Cancer,KEYTRUDA only,66.01,62.96,844.08,91,Stable Disease
M202893,80,Other,HPV-related Cancer,mrna-4157 + keytruda,23.96,23.16,1031.56,97,Partial Response
M202894,60,Male,HPV-related Cancer,mrna-4157 + keytruda,40.61,26.46,1313.2,104,Stable Disease
M202895,43,Male,HPV-related Cancer,mrna-4157 + keytruda,33.22,29.12,712.38,88,Complete Response
M202896,41,Female,HPV-related Cancer,mrna-4157 + keytruda,36.84,30.99,1576.0,81,Complete Response
M202897,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.18,55.31,1268.39,73,Unknown
M202898,34,Female,Melanoma,mrna-4157 + keytruda,32.22,24.89,900.9,100,Progression
M202899,60,Other,Melanoma,KEYTRUDA only,36.46,,1274.41,80,Partial Response
M202900,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.39,40.05,1.83,82,Complete Response
M202901,30,Other,Melanoma,KEYTRUDA only,28.25,11.0,1069.79,86,
M202902,65,Female,HPV-related Cancer,KEYTRUDA only,27.39,14.99,1291.41,75,
M202903,82,Other,HPV-related Cancer,mrna-4157 + keytruda,42.49,43.67,1338.47,94,Partial Response
M202904,65,Other,HPV-related Cancer,KEYTRUDA only,57.17,31.66,880.5,80,Progression
M202905,43,Other,Melanoma,KEYTRUDA only,41.95,36.06,1320.84,98,Partial Response
M202906,69,Other,Melanoma,KEYTRUDA only,83.59,83.33,636.35,97,Complete Response
M202907,32,Male,HPV-related Cancer,KEYTRUDA only,60.2,42.97,861.18,91,Stable Disease
M202908,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,19.59,15.91,1756.4,95,Unknown
M202909,27,Other,HPV-related Cancer,mrna-4157 + keytruda,24.28,18.16,788.9,88,Partial Response
M202910,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.34,12.85,1503.66,94,Stable Disease
M202911,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.27,39.44,1485.78,97,Progression
M202912,51,Other,Melanoma,KEYTRUDA only,23.75,18.73,602.74,80,Progression
M202913,27,Female,Melanoma,KEYTRUDA only,91.97,99.73,1006.17,90,Partial Response
M202914,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.53,51.87,566.97,95,Stable Disease
M202915,33,Other,HPV-related Cancer,mrna-4157 + keytruda,81.15,63.88,1427.71,84,Stable Disease
M202916,70,Male,HPV-related Cancer,KEYTRUDA only,64.84,55.41,1167.41,84,Partial Response
M202917,49,Male,HPV-related Cancer,KEYTRUDA only,75.96,55.15,889.95,86,Complete Response
M202918,37,Other,HPV-related Cancer,mrna-4157 + keytruda,38.62,29.72,1130.03,101,Stable Disease
M202919,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.41,28.96,57.87,84,Partial Response
M202920,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.36,22.25,1213.71,90,Partial Response
M202921,49,Male,HPV-related Cancer,KEYTRUDA only,54.31,35.17,1602.72,79,Partial Response
M202922,63,Female,HPV-related Cancer,mrna-4157 + keytruda,49.31,45.95,,81,Stable Disease
M202923,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.92,30.35,,77,Partial Response
M202924,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.33,30.4,835.4,93,Stable Disease
M202925,66,Female,Melanoma,mrna-4157 + keytruda,36.9,15.06,826.0,103,Partial Response
M202926,53,Female,HPV-related Cancer,mrna-4157 + keytruda,69.03,42.72,1169.14,85,Stable Disease
M202927,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,30.69,18.11,999.46,98,Stable Disease
M202928,27,Other,Melanoma,KEYTRUDA only,86.94,72.74,1862.02,90,Progression
M202929,76,Female,Melanoma,mrna-4157 + keytruda,32.8,,550.44,101,Stable Disease
M202930,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.95,,380.53,91,Complete Response
M202931,77,Female,Melanoma,mrna-4157 + keytruda,41.67,38.9,968.57,83,Unknown
M202932,46,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.13,32.98,512.69,115,Stable Disease
M202933,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.59,34.21,1045.26,107,Stable Disease
M202934,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.77,72.85,,85,Progression
M202935,68,Female,Melanoma,KEYTRUDA only,67.45,55.34,419.03,99,Stable Disease
M202936,75,Female,HPV-related Cancer,mrna-4157 + keytruda,80.12,77.68,974.39,101,Stable Disease
M202937,54,Other,HPV-related Cancer,KEYTRUDA only,63.33,52.21,1071.11,111,Partial Response
M202938,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.35,30.7,1467.44,89,Progression
M202939,83,Female,HPV-related Cancer,KEYTRUDA only,54.75,45.14,1329.82,92,Complete Response
M202940,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.26,23.46,772.54,107,Progression
M202941,49,Male,HPV-related Cancer,mrna-4157 + keytruda,71.22,69.52,953.85,86,Stable Disease
M202942,78,Other,Melanoma,KEYTRUDA only,71.11,44.86,1089.02,87,Partial Response
M202943,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.96,26.07,842.5,83,Complete Response
M202944,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,82.8,76.63,1572.64,75,Partial Response
M202945,51,Male,HPV-related Cancer,mrna-4157 + keytruda,58.48,50.82,1248.98,87,Stable Disease
M202946,49,Male,HPV-related Cancer,mrna-4157 + keytruda,55.96,51.41,732.01,103,Stable Disease
M202947,30,Other,Melanoma,KEYTRUDA only,100.8,76.6,1344.43,81,Partial Response
M202948,27,Male,Melanoma,mrna-4157 + keytruda,67.41,57.83,1128.33,86,Stable Disease
M202949,52,Male,Melanoma,mrna-4157 + keytruda,56.21,24.24,521.48,88,Progression
M202950,41,Male,Melanoma,KEYTRUDA only,32.4,31.42,927.52,89,Stable Disease
M202951,45,Male,HPV-related Cancer,mrna-4157 + keytruda,34.58,21.43,1102.21,92,Stable Disease
M202952,31,Other,Melanoma,mrna-4157 + keytruda,50.48,46.91,,80,Complete Response
M202953,83,Male,Melanoma,mrna-4157 + keytruda,60.72,31.74,907.29,88,Unknown
M202954,34,Female,Melanoma,KEYTRUDA only,52.12,38.99,1015.79,81,Partial Response
M202955,83,Other,HPV-related Cancer,mrna-4157 + keytruda,33.52,42.91,930.7,91,Progression
M202956,44,Female,Melanoma,KEYTRUDA only,74.85,52.03,,97,Stable Disease
M202957,52,Other,Melanoma,mrna-4157 + keytruda,80.39,50.1,603.61,76,Progression
M202958,51,Other,HPV-related Cancer,mrna-4157 + keytruda,65.26,47.41,788.2,78,Partial Response
M202959,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.06,42.19,1046.4,99,Stable Disease
M202960,79,Male,Melanoma,mrna-4157 + keytruda,20.27,19.82,642.19,84,Complete Response
M202961,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.37,18.03,1161.4,93,Partial Response
M202962,45,Other,Melanoma,mrna-4157 + keytruda,74.27,,1122.47,86,Stable Disease
M202963,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.47,10.55,460.81,88,Partial Response
M202964,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,84.45,,898.99,89,Partial Response
M202965,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.85,45.32,964.85,91,Progression
M202966,71,Female,Non-small Cell Lung Cancer,KEYTRUDA only,56.26,32.85,786.73,93,Progression
M202967,56,Male,Melanoma,KEYTRUDA only,57.66,39.51,499.91,83,Partial Response
M202968,70,Other,HPV-related Cancer,KEYTRUDA only,74.54,68.92,522.06,91,Stable Disease
M202969,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.54,22.45,968.54,94,Stable Disease
M202970,41,Female,HPV-related Cancer,mrna-4157 + keytruda,33.75,23.69,525.95,86,Progression
M202971,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,88.26,,931.68,83,Stable Disease
M202972,55,Female,Melanoma,KEYTRUDA only,67.54,35.42,103.85,93,Progression
M202973,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.03,32.81,359.09,88,
M202974,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,97.71,68.64,238.18,106,Stable Disease
M202975,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.69,29.81,687.92,81,Complete Response
M202976,27,Male,Melanoma,mrna-4157 + keytruda,61.72,34.45,801.27,79,Partial Response
M202977,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.92,38.54,669.05,84,Stable Disease
M202978,47,Female,Melanoma,mrna-4157 + keytruda,50.7,52.77,704.66,89,Partial Response
M202979,49,Male,HPV-related Cancer,mrna-4157 + keytruda,64.0,51.41,565.23,90,Complete Response
M202980,43,Male,Melanoma,mrna-4157 + keytruda,42.97,37.03,727.12,91,Partial Response
M202981,79,Female,HPV-related Cancer,KEYTRUDA only,46.76,29.61,1389.48,93,Stable Disease
M202982,63,Other,HPV-related Cancer,KEYTRUDA only,77.78,48.3,1339.4,93,Partial Response
M202983,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.67,40.78,660.02,88,Complete Response
M202984,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.5,35.59,579.37,93,Unknown
M202985,35,Male,Melanoma,KEYTRUDA only,48.44,29.01,1477.64,89,Partial Response
M202986,73,Other,HPV-related Cancer,mrna-4157 + keytruda,71.34,59.91,650.37,87,Stable Disease
M202987,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.24,37.38,274.47,96,Partial Response
M202988,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.76,,1700.08,99,Stable Disease
M202989,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,26.47,20.72,,104,Partial Response
M202990,60,Male,Melanoma,mrna-4157 + keytruda,53.19,43.01,231.28,87,Unknown
M202991,27,Male,HPV-related Cancer,mrna-4157 + keytruda,21.05,21.02,487.51,102,Stable Disease
M202992,25,Female,HPV-related Cancer,mrna-4157 + keytruda,63.89,,956.24,73,Partial Response
M202993,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,72.58,44.46,1616.95,75,Partial Response
M202994,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.5,75.34,1150.55,92,Complete Response
M202995,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.93,30.32,1042.52,97,Progression
M202996,51,Other,Melanoma,mrna-4157 + keytruda,39.09,26.05,872.61,86,Stable Disease
M202997,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.83,75.96,1481.9,80,Progression
M202998,65,Female,HPV-related Cancer,mrna-4157 + keytruda,21.16,23.48,1458.18,96,Stable Disease
M202999,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.93,50.95,1190.7,90,Partial Response
M203000,39,Female,Melanoma,KEYTRUDA only,72.65,64.35,1611.62,87,Progression
M203001,47,Other,Melanoma,mrna-4157 + keytruda,26.62,14.83,1178.81,103,Partial Response
M203002,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.92,31.14,1569.91,104,Partial Response
M203003,83,Male,Melanoma,mrna-4157 + keytruda,64.17,51.74,848.6,103,Partial Response
M203004,58,Male,Melanoma,KEYTRUDA only,51.69,49.73,1083.22,94,Stable Disease
M203005,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.76,22.67,1256.24,102,Stable Disease
M203006,50,Male,Melanoma,mrna-4157 + keytruda,38.69,34.23,1801.93,70,Progression
M203007,48,Male,Melanoma,mrna-4157 + keytruda,19.22,11.05,1519.06,82,Complete Response
M203008,47,Female,HPV-related Cancer,KEYTRUDA only,62.41,42.43,,88,Stable Disease
M203009,63,Male,Melanoma,mrna-4157 + keytruda,59.47,50.78,1286.88,95,
M203010,36,Male,Melanoma,KEYTRUDA only,51.77,38.7,1147.35,77,Progression
M203011,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.44,18.57,1287.21,88,Complete Response
M203012,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.26,63.84,638.85,84,Stable Disease
M203013,84,Other,HPV-related Cancer,mrna-4157 + keytruda,32.14,16.76,1111.0,91,Partial Response
M203014,38,Male,HPV-related Cancer,KEYTRUDA only,39.45,37.6,1288.11,84,Stable Disease
M203015,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.18,,666.6,96,Partial Response
M203016,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.91,33.17,1633.85,98,Stable Disease
M203017,33,Male,HPV-related Cancer,KEYTRUDA only,29.45,15.0,609.11,101,Progression
M203018,29,Male,HPV-related Cancer,mrna-4157 + keytruda,34.52,20.33,1844.78,91,Partial Response
M203019,32,Female,HPV-related Cancer,mrna-4157 + keytruda,50.58,32.15,998.72,89,Progression
M203020,48,Male,Melanoma,mrna-4157 + keytruda,62.29,30.94,1247.43,89,Progression
M203021,68,Other,HPV-related Cancer,KEYTRUDA only,49.96,57.65,763.44,75,Complete Response
M203022,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.42,60.69,,73,Partial Response
M203023,39,Female,Melanoma,KEYTRUDA only,49.78,40.54,1237.52,75,Progression
M203024,78,Female,Melanoma,mrna-4157 + keytruda,48.62,32.84,,91,Partial Response
M203025,53,Other,Melanoma,mrna-4157 + keytruda,29.03,18.18,1603.79,91,Progression
M203026,57,Male,HPV-related Cancer,mrna-4157 + keytruda,49.7,40.26,1252.0,91,Partial Response
M203027,57,Other,HPV-related Cancer,KEYTRUDA only,65.09,54.35,1597.15,107,Partial Response
M203028,42,Male,HPV-related Cancer,KEYTRUDA only,50.17,46.59,731.23,85,Progression
M203029,30,Male,HPV-related Cancer,KEYTRUDA only,62.99,43.37,913.93,92,Partial Response
M203030,72,Male,HPV-related Cancer,KEYTRUDA only,35.2,33.07,871.34,80,Stable Disease
M203031,77,Other,HPV-related Cancer,mrna-4157 + keytruda,35.83,21.07,1269.47,84,Stable Disease
M203032,83,Female,Melanoma,KEYTRUDA only,68.67,45.52,276.06,119,Partial Response
M203033,25,Female,Melanoma,KEYTRUDA only,23.4,22.72,1147.15,104,Progression
M203034,64,Female,HPV-related Cancer,mrna-4157 + keytruda,64.67,50.09,814.24,85,Stable Disease
M203035,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.46,43.27,975.13,99,Stable Disease
M203036,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,0.09,0.04,1090.1,98,Stable Disease
M203037,36,Other,HPV-related Cancer,KEYTRUDA only,39.67,42.01,1390.08,83,Stable Disease
M203038,51,Other,HPV-related Cancer,mrna-4157 + keytruda,62.68,56.92,871.11,100,Partial Response
M203039,67,Other,HPV-related Cancer,mrna-4157 + keytruda,46.45,32.13,816.35,82,Stable Disease
M203040,44,Other,Melanoma,KEYTRUDA only,78.38,44.15,707.22,96,Partial Response
M203041,30,Other,HPV-related Cancer,mrna-4157 + keytruda,104.0,68.7,1322.09,90,Partial Response
M203042,47,Male,Melanoma,mrna-4157 + keytruda,65.64,75.62,1575.71,96,Stable Disease
M203043,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.21,28.78,1312.22,99,Partial Response
M203044,64,Other,HPV-related Cancer,mrna-4157 + keytruda,21.45,15.11,545.05,83,Complete Response
M203045,42,Other,Melanoma,mrna-4157 + keytruda,56.77,49.47,1242.89,108,Stable Disease
M203046,45,Other,HPV-related Cancer,KEYTRUDA only,31.31,19.25,995.67,95,Partial Response
M203047,61,Male,HPV-related Cancer,mrna-4157 + keytruda,50.89,25.93,897.34,92,Partial Response
M203048,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.78,16.63,1821.97,81,Complete Response
M203049,74,Male,HPV-related Cancer,KEYTRUDA only,41.1,29.06,852.07,80,Partial Response
M203050,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.63,37.32,698.68,87,Stable Disease
M203051,79,Male,Melanoma,mrna-4157 + keytruda,58.54,60.29,,81,Progression
M203052,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.47,11.36,740.56,84,Partial Response
M203053,51,Other,Melanoma,KEYTRUDA only,54.23,25.29,1242.48,113,Stable Disease
M203054,26,Male,Melanoma,mrna-4157 + keytruda,60.8,54.9,980.29,95,Partial Response
M203055,40,Male,HPV-related Cancer,KEYTRUDA only,19.49,19.47,1100.05,93,Unknown
M203056,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.69,52.9,1730.27,82,Complete Response
M203057,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.79,13.83,1111.0,95,Stable Disease
M203058,78,Female,Melanoma,mrna-4157 + keytruda,63.86,47.41,1038.74,86,Stable Disease
M203059,84,Other,HPV-related Cancer,mrna-4157 + keytruda,67.27,32.54,472.69,95,Partial Response
M203060,81,Male,Melanoma,mrna-4157 + keytruda,54.65,73.45,125.89,92,Partial Response
M203061,69,Female,Melanoma,mrna-4157 + keytruda,24.07,14.23,600.49,86,Stable Disease
M203062,53,Male,Melanoma,KEYTRUDA only,49.41,44.38,997.0,83,Stable Disease
M203063,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.32,,1768.9,78,Partial Response
M203064,54,Other,Melanoma,mrna-4157 + keytruda,68.98,,1073.92,60,Partial Response
M203065,79,Other,Melanoma,mrna-4157 + keytruda,39.87,19.63,1251.02,95,Complete Response
M203066,52,Other,HPV-related Cancer,KEYTRUDA only,30.82,26.2,735.51,80,Partial Response
M203067,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.41,26.76,1666.99,96,Partial Response
M203068,28,Male,HPV-related Cancer,mrna-4157 + keytruda,58.62,29.21,872.22,105,Partial Response
M203069,26,Other,HPV-related Cancer,KEYTRUDA only,83.68,71.87,829.35,82,Complete Response
M203070,60,Other,HPV-related Cancer,mrna-4157 + keytruda,83.98,78.28,1732.42,85,Progression
M203071,44,Male,HPV-related Cancer,mrna-4157 + keytruda,31.91,16.84,947.94,82,Complete Response
M203072,51,Other,Melanoma,KEYTRUDA only,36.23,23.98,1164.84,109,Stable Disease
M203073,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.33,73.83,1219.25,86,Unknown
M203074,36,Male,HPV-related Cancer,mrna-4157 + keytruda,16.51,18.18,1036.62,85,Partial Response
M203075,43,Male,HPV-related Cancer,KEYTRUDA only,104.32,45.83,1027.62,99,Stable Disease
M203076,61,Male,HPV-related Cancer,mrna-4157 + keytruda,51.8,43.14,761.18,89,Stable Disease
M203077,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.14,65.86,1105.58,92,Complete Response
M203078,71,Male,Melanoma,mrna-4157 + keytruda,97.98,91.47,1018.78,69,Stable Disease
M203079,70,Female,HPV-related Cancer,KEYTRUDA only,52.57,28.69,1747.91,96,Unknown
M203080,79,Other,Melanoma,mrna-4157 + keytruda,96.3,69.09,1046.13,98,Stable Disease
M203081,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.66,60.72,1102.03,94,Stable Disease
M203082,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.83,,1025.25,96,Progression
M203083,31,Female,HPV-related Cancer,mrna-4157 + keytruda,36.94,30.65,437.47,103,Stable Disease
M203084,54,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.34,67.4,810.35,93,Partial Response
M203085,55,Other,HPV-related Cancer,mrna-4157 + keytruda,59.69,,1200.03,101,Stable Disease
M203086,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.38,26.1,96.39,90,Complete Response
M203087,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.04,56.43,,94,Complete Response
M203088,57,Female,Melanoma,mrna-4157 + keytruda,55.87,34.57,620.05,92,Stable Disease
M203089,35,Female,Melanoma,KEYTRUDA only,72.42,31.64,1313.47,106,Partial Response
M203090,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.82,,718.02,76,Complete Response
M203091,37,Male,HPV-related Cancer,KEYTRUDA only,45.22,37.59,1169.06,91,Complete Response
M203092,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.94,32.42,284.03,97,Partial Response
M203093,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.14,63.93,1149.27,97,Complete Response
M203094,28,Male,Melanoma,mrna-4157 + keytruda,51.51,46.89,,93,Partial Response
M203095,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.21,33.38,932.13,90,Stable Disease
M203096,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.67,10.86,1405.1,75,Partial Response
M203097,42,Male,HPV-related Cancer,mrna-4157 + keytruda,31.15,34.88,1216.66,82,Partial Response
M203098,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.93,55.99,821.96,97,Unknown
M203099,77,Female,Melanoma,mrna-4157 + keytruda,35.34,19.34,957.43,93,Complete Response
M203100,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.23,17.14,503.89,98,Stable Disease
M203101,76,Female,Melanoma,KEYTRUDA only,20.88,14.94,-299.05,94,Stable Disease
M203102,40,Male,Melanoma,mrna-4157 + keytruda,52.34,39.9,1282.93,90,Partial Response
M203103,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.74,27.66,847.49,79,Progression
M203104,33,Male,Melanoma,KEYTRUDA only,50.54,28.33,,92,Progression
M203105,42,Other,HPV-related Cancer,mrna-4157 + keytruda,67.77,67.49,774.65,87,Partial Response
M203106,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.98,34.59,679.39,81,Complete Response
M203107,33,Female,Melanoma,KEYTRUDA only,48.08,42.97,1053.39,89,Stable Disease
M203108,73,Female,HPV-related Cancer,mrna-4157 + keytruda,59.34,28.13,587.81,87,Unknown
M203109,52,Female,HPV-related Cancer,KEYTRUDA only,52.06,30.09,1223.95,111,Progression
M203110,31,Other,Melanoma,KEYTRUDA only,52.78,48.55,1043.2,83,Complete Response
M203111,57,Female,HPV-related Cancer,mrna-4157 + keytruda,32.91,31.15,734.66,110,
M203112,43,Male,HPV-related Cancer,mrna-4157 + keytruda,28.67,24.89,913.92,97,Progression
M203113,48,Female,HPV-related Cancer,KEYTRUDA only,11.08,9.81,1338.33,88,Complete Response
M203114,44,Other,Melanoma,mrna-4157 + keytruda,45.37,25.44,812.68,102,Partial Response
M203115,57,Male,Melanoma,mrna-4157 + keytruda,63.37,43.74,1427.25,93,Progression
M203116,56,Female,HPV-related Cancer,mrna-4157 + keytruda,53.05,56.29,521.01,94,Partial Response
M203117,62,Other,Melanoma,KEYTRUDA only,84.12,59.93,744.42,91,Stable Disease
M203118,29,Other,Melanoma,mrna-4157 + keytruda,38.2,11.2,1314.12,97,Progression
M203119,71,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.01,34.89,1091.27,81,Unknown
M203120,36,Female,HPV-related Cancer,KEYTRUDA only,44.95,34.36,1574.64,100,Stable Disease
M203121,69,Female,HPV-related Cancer,KEYTRUDA only,61.2,61.24,1774.78,101,Progression
M203122,55,Female,Melanoma,KEYTRUDA only,67.89,40.8,1108.92,89,Stable Disease
M203123,67,Male,Melanoma,mrna-4157 + keytruda,51.04,40.2,1503.47,85,Partial Response
M203124,56,Male,Melanoma,mrna-4157 + keytruda,9.8,7.84,833.49,86,Partial Response
M203125,56,Female,Melanoma,KEYTRUDA only,5.86,4.07,1481.35,86,Progression
M203126,35,Female,HPV-related Cancer,mrna-4157 + keytruda,64.11,52.2,726.76,98,Stable Disease
M203127,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.63,74.61,743.57,84,Partial Response
M203128,72,Other,HPV-related Cancer,KEYTRUDA only,14.19,8.06,1111.55,89,Complete Response
M203129,41,Other,Melanoma,mrna-4157 + keytruda,24.08,25.93,318.43,83,Complete Response
M203130,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.2,,659.13,116,Partial Response
M203131,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.56,25.48,1156.8,90,Stable Disease
M203132,47,Other,HPV-related Cancer,mrna-4157 + keytruda,26.99,20.72,889.48,88,Partial Response
M203133,55,Female,HPV-related Cancer,KEYTRUDA only,47.01,31.25,,77,Progression
M203134,77,Male,Melanoma,mrna-4157 + keytruda,87.79,94.31,433.13,85,Progression
M203135,62,Other,Melanoma,KEYTRUDA only,62.0,34.58,765.76,93,Partial Response
M203136,71,Male,HPV-related Cancer,KEYTRUDA only,79.98,60.31,763.22,94,Complete Response
M203137,33,Other,HPV-related Cancer,KEYTRUDA only,45.19,34.05,1171.12,97,Stable Disease
M203138,47,Female,Melanoma,KEYTRUDA only,50.13,46.09,1129.77,79,Stable Disease
M203139,61,Male,Melanoma,KEYTRUDA only,78.19,49.8,1113.7,96,
M203140,46,Other,HPV-related Cancer,mrna-4157 + keytruda,5.43,5.69,,79,Complete Response
M203141,36,Other,Melanoma,mrna-4157 + keytruda,74.05,68.15,785.76,104,Progression
M203142,56,Female,Melanoma,mrna-4157 + keytruda,23.05,18.32,716.26,91,Unknown
M203143,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.72,68.02,974.46,88,Stable Disease
M203144,31,Male,HPV-related Cancer,mrna-4157 + keytruda,76.35,64.08,913.08,74,Progression
M203145,56,Female,Melanoma,mrna-4157 + keytruda,26.56,14.0,923.33,82,Complete Response
M203146,49,Female,HPV-related Cancer,mrna-4157 + keytruda,43.27,37.73,780.81,83,Partial Response
M203147,42,Other,HPV-related Cancer,mrna-4157 + keytruda,45.64,30.48,811.67,100,Partial Response
M203148,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.94,45.53,769.79,95,Stable Disease
M203149,36,Male,Melanoma,KEYTRUDA only,67.91,29.7,509.69,93,Partial Response
M203150,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,20.34,24.9,,97,Partial Response
M203151,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.34,30.91,677.92,78,Unknown
M203152,50,Female,HPV-related Cancer,mrna-4157 + keytruda,66.98,66.03,1404.65,105,
M203153,25,Male,HPV-related Cancer,KEYTRUDA only,63.17,71.92,1214.4,75,Complete Response
M203154,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,31.49,31.15,1469.77,83,Complete Response
M203155,70,Female,Melanoma,mrna-4157 + keytruda,25.48,16.54,615.32,100,Progression
M203156,43,Male,Melanoma,mrna-4157 + keytruda,63.21,54.55,569.23,81,Unknown
M203157,51,Other,HPV-related Cancer,KEYTRUDA only,40.73,30.71,1775.41,83,Stable Disease
M203158,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.79,45.71,1224.58,92,Partial Response
M203159,71,Female,Melanoma,KEYTRUDA only,73.56,30.54,1696.16,86,Progression
M203160,70,Male,HPV-related Cancer,KEYTRUDA only,31.06,26.24,400.23,91,Progression
M203161,80,Other,HPV-related Cancer,KEYTRUDA only,59.65,52.01,1488.82,86,Complete Response
M203162,35,Male,HPV-related Cancer,mrna-4157 + keytruda,24.76,10.27,1074.74,98,Partial Response
M203163,81,Female,Melanoma,mrna-4157 + keytruda,66.75,70.8,1269.09,95,Progression
M203164,28,Female,Melanoma,mrna-4157 + keytruda,46.51,51.75,1011.94,85,Stable Disease
M203165,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.73,27.93,1049.61,89,Stable Disease
M203166,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.11,35.84,518.38,109,Progression
M203167,63,Male,HPV-related Cancer,KEYTRUDA only,30.06,,1196.44,85,Progression
M203168,65,Other,HPV-related Cancer,KEYTRUDA only,68.66,49.97,759.99,78,Stable Disease
M203169,28,Female,HPV-related Cancer,KEYTRUDA only,53.22,,1070.73,86,Stable Disease
M203170,62,Female,HPV-related Cancer,mrna-4157 + keytruda,76.4,37.83,692.13,99,Partial Response
M203171,54,Male,Melanoma,mrna-4157 + keytruda,62.6,,1299.29,98,
M203172,48,Other,HPV-related Cancer,mrna-4157 + keytruda,58.24,62.01,1015.4,87,Stable Disease
M203173,77,Male,HPV-related Cancer,mrna-4157 + keytruda,48.23,45.41,1361.73,103,Partial Response
M203174,54,Female,HPV-related Cancer,KEYTRUDA only,76.16,57.19,854.54,96,Stable Disease
M203175,63,Female,Melanoma,KEYTRUDA only,45.57,42.27,,91,Progression
M203176,58,Female,Melanoma,mrna-4157 + keytruda,43.78,23.69,843.16,78,Progression
M203177,54,Other,Melanoma,mrna-4157 + keytruda,52.92,35.6,1429.32,92,Partial Response
M203178,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.81,25.73,1216.73,82,Progression
M203179,31,Other,HPV-related Cancer,KEYTRUDA only,62.29,34.51,742.87,97,Partial Response
M203180,49,Other,Melanoma,KEYTRUDA only,52.1,20.53,889.56,87,Complete Response
M203181,39,Female,Melanoma,mrna-4157 + keytruda,39.25,36.48,1696.52,87,Partial Response
M203182,49,Female,HPV-related Cancer,mrna-4157 + keytruda,49.29,30.8,1114.81,93,Stable Disease
M203183,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.99,,946.53,84,Unknown
M203184,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,47.53,,1413.38,95,Complete Response
M203185,43,Female,Melanoma,KEYTRUDA only,75.02,74.21,1435.46,86,Progression
M203186,38,Other,Melanoma,KEYTRUDA only,50.34,40.41,1750.09,89,Partial Response
M203187,53,Male,Melanoma,mrna-4157 + keytruda,75.38,,1292.35,86,Stable Disease
M203188,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.51,24.83,863.34,90,Progression
M203189,71,Other,HPV-related Cancer,KEYTRUDA only,56.1,19.23,1153.97,91,Partial Response
M203190,43,Other,HPV-related Cancer,KEYTRUDA only,31.97,23.98,886.44,87,Stable Disease
M203191,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.19,33.86,1212.88,94,Progression
M203192,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.73,19.75,1098.63,79,Progression
M203193,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,64.55,65.16,717.46,78,Stable Disease
M203194,81,Male,HPV-related Cancer,mrna-4157 + keytruda,17.94,11.72,1180.43,89,Partial Response
M203195,79,Male,HPV-related Cancer,mrna-4157 + keytruda,29.72,26.3,966.16,109,Stable Disease
M203196,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.88,40.54,675.0,95,Partial Response
M203197,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,10.12,5.79,,85,Partial Response
M203198,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.58,48.93,1382.6,85,Stable Disease
M203199,81,Other,Melanoma,mrna-4157 + keytruda,39.41,,1101.9,117,Stable Disease
M203200,25,Female,HPV-related Cancer,mrna-4157 + keytruda,39.14,29.35,1102.97,88,Complete Response
M203201,51,Female,Melanoma,mrna-4157 + keytruda,76.67,66.34,757.21,85,Complete Response
M203202,43,Female,Melanoma,mrna-4157 + keytruda,68.0,58.76,713.65,90,
M203203,33,Other,HPV-related Cancer,mrna-4157 + keytruda,47.96,24.18,1012.75,104,
M203204,71,Male,Melanoma,KEYTRUDA only,46.37,37.56,936.86,98,
M203205,44,Other,Melanoma,mrna-4157 + keytruda,66.29,73.21,673.42,78,Progression
M203206,48,Other,Melanoma,mrna-4157 + keytruda,35.86,25.53,1007.69,99,Complete Response
M203207,71,Male,Melanoma,KEYTRUDA only,48.12,29.93,1550.41,79,Partial Response
M203208,71,Male,Melanoma,mrna-4157 + keytruda,24.19,22.39,1531.27,98,Complete Response
M203209,26,Female,Melanoma,mrna-4157 + keytruda,63.94,54.43,974.57,102,Partial Response
M203210,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.79,54.67,2023.6,90,Partial Response
M203211,56,Female,HPV-related Cancer,mrna-4157 + keytruda,88.58,77.46,1584.07,78,
M203212,33,Male,Melanoma,mrna-4157 + keytruda,70.78,76.33,1511.91,84,Stable Disease
M203213,34,Male,HPV-related Cancer,KEYTRUDA only,43.51,33.44,769.0,87,Progression
M203214,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.5,12.29,559.58,72,Stable Disease
M203215,61,Female,HPV-related Cancer,mrna-4157 + keytruda,86.76,,967.93,82,Stable Disease
M203216,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.29,33.91,377.5,100,Partial Response
M203217,80,Male,Melanoma,mrna-4157 + keytruda,44.16,48.48,686.15,87,Progression
M203218,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.72,22.85,982.81,80,Stable Disease
M203219,72,Male,Melanoma,KEYTRUDA only,78.14,,528.84,88,Partial Response
M203220,47,Other,HPV-related Cancer,mrna-4157 + keytruda,68.08,84.03,1012.74,97,Partial Response
M203221,64,Male,Melanoma,mrna-4157 + keytruda,32.03,21.16,418.19,97,Unknown
M203222,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.17,52.3,1113.08,106,Partial Response
M203223,54,Female,Melanoma,KEYTRUDA only,70.04,74.74,861.04,92,Partial Response
M203224,73,Female,Melanoma,KEYTRUDA only,82.32,85.78,1399.2,87,Complete Response
M203225,59,Other,Melanoma,mrna-4157 + keytruda,46.82,38.77,57.87,107,Stable Disease
M203226,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,83.6,92.69,1287.18,93,Stable Disease
M203227,49,Male,Melanoma,KEYTRUDA only,71.28,66.16,1331.81,85,Stable Disease
M203228,72,Male,HPV-related Cancer,KEYTRUDA only,46.06,54.5,767.08,89,Stable Disease
M203229,30,Male,HPV-related Cancer,KEYTRUDA only,89.91,85.08,952.89,79,Complete Response
M203230,41,Female,Melanoma,mrna-4157 + keytruda,89.93,24.96,678.53,107,Stable Disease
M203231,29,Female,Melanoma,mrna-4157 + keytruda,28.59,36.85,334.1,87,Partial Response
M203232,81,Male,HPV-related Cancer,mrna-4157 + keytruda,75.57,53.62,1125.73,93,Partial Response
M203233,71,Other,HPV-related Cancer,KEYTRUDA only,61.97,53.09,944.93,87,Complete Response
M203234,78,Other,Melanoma,KEYTRUDA only,52.83,47.4,1275.3,76,Stable Disease
M203235,81,Male,Melanoma,mrna-4157 + keytruda,16.95,11.39,370.58,87,Complete Response
M203236,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.79,22.78,1026.48,81,Complete Response
M203237,46,Male,HPV-related Cancer,mrna-4157 + keytruda,38.41,37.37,193.52,72,Progression
M203238,64,Other,Melanoma,mrna-4157 + keytruda,80.75,61.27,1424.74,85,Complete Response
M203239,60,Male,HPV-related Cancer,KEYTRUDA only,75.63,45.55,1015.35,84,Partial Response
M203240,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.15,34.02,1124.59,79,
M203241,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.71,102.9,960.2,87,Unknown
M203242,63,Female,HPV-related Cancer,mrna-4157 + keytruda,28.59,19.75,888.89,90,Partial Response
M203243,77,Male,HPV-related Cancer,mrna-4157 + keytruda,29.21,14.84,512.4,96,Stable Disease
M203244,46,Other,HPV-related Cancer,mrna-4157 + keytruda,66.32,33.21,579.52,108,Stable Disease
M203245,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.79,61.99,915.94,85,Partial Response
M203246,50,Male,HPV-related Cancer,mrna-4157 + keytruda,48.96,42.01,1093.62,97,Stable Disease
M203247,27,Other,Melanoma,KEYTRUDA only,51.45,44.25,1377.04,85,Stable Disease
M203248,60,Other,Melanoma,mrna-4157 + keytruda,78.96,81.04,236.19,93,Partial Response
M203249,43,Female,Melanoma,KEYTRUDA only,76.14,54.76,1560.18,76,Progression
M203250,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.26,59.33,876.25,81,Progression
M203251,62,Other,HPV-related Cancer,mrna-4157 + keytruda,70.33,42.21,1155.08,84,Stable Disease
M203252,57,Other,Melanoma,mrna-4157 + keytruda,61.75,44.2,1314.07,87,Partial Response
M203253,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.68,37.62,1193.99,100,Progression
M203254,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.91,22.35,1718.79,84,Partial Response
M203255,51,Female,Melanoma,mrna-4157 + keytruda,54.17,44.17,1257.4,89,Progression
M203256,45,Female,HPV-related Cancer,KEYTRUDA only,38.54,36.01,646.94,90,Partial Response
M203257,31,Female,Melanoma,mrna-4157 + keytruda,16.3,12.59,1062.35,89,Partial Response
M203258,78,Other,Melanoma,mrna-4157 + keytruda,46.23,48.04,141.78,85,Partial Response
M203259,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,91.48,,,96,Stable Disease
M203260,45,Male,HPV-related Cancer,KEYTRUDA only,116.95,143.38,1011.83,97,Progression
M203261,36,Female,Melanoma,KEYTRUDA only,71.49,40.32,1046.53,85,Partial Response
M203262,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,36.1,26.37,1223.01,87,Stable Disease
M203263,35,Female,HPV-related Cancer,KEYTRUDA only,74.86,75.48,776.93,81,Stable Disease
M203264,76,Other,Melanoma,mrna-4157 + keytruda,28.38,22.85,849.96,91,Progression
M203265,25,Female,Melanoma,mrna-4157 + keytruda,54.33,45.72,1365.8,86,Partial Response
M203266,83,Male,HPV-related Cancer,mrna-4157 + keytruda,60.11,61.33,1342.82,103,Complete Response
M203267,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.15,25.14,637.64,87,Complete Response
M203268,43,Female,HPV-related Cancer,KEYTRUDA only,30.42,23.98,865.29,98,Stable Disease
M203269,81,Female,HPV-related Cancer,mrna-4157 + keytruda,75.88,50.21,874.8,92,Stable Disease
M203270,80,Female,Melanoma,KEYTRUDA only,33.91,20.31,985.77,72,
M203271,51,Female,Melanoma,KEYTRUDA only,34.96,25.01,1137.54,98,
M203272,47,Other,HPV-related Cancer,mrna-4157 + keytruda,55.87,44.0,5473.85,87,Stable Disease
M203273,61,Other,Melanoma,KEYTRUDA only,24.04,13.17,1278.84,94,Stable Disease
M203274,36,Female,HPV-related Cancer,mrna-4157 + keytruda,38.5,41.9,1187.07,79,Progression
M203275,37,Other,Melanoma,mrna-4157 + keytruda,60.35,24.1,865.89,85,Stable Disease
M203276,33,Female,Melanoma,KEYTRUDA only,32.05,32.88,1171.88,90,Stable Disease
M203277,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.85,25.68,769.66,113,Partial Response
M203278,26,Male,Melanoma,mrna-4157 + keytruda,52.73,41.85,763.52,80,Progression
M203279,84,Male,HPV-related Cancer,mrna-4157 + keytruda,59.48,53.88,1173.42,91,
M203280,36,Female,HPV-related Cancer,mrna-4157 + keytruda,53.79,53.25,505.89,74,Progression
M203281,53,Female,HPV-related Cancer,KEYTRUDA only,46.98,36.73,1119.08,98,Complete Response
M203282,42,Female,Melanoma,KEYTRUDA only,40.74,34.41,,101,Partial Response
M203283,35,Male,Melanoma,mrna-4157 + keytruda,49.53,50.81,790.23,94,Progression
M203284,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.85,33.78,829.48,100,Complete Response
M203285,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.61,26.62,1044.18,98,Progression
M203286,43,Female,HPV-related Cancer,mrna-4157 + keytruda,44.06,26.73,366.75,78,Progression
M203287,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.45,44.8,1989.07,96,Unknown
M203288,63,Female,Melanoma,mrna-4157 + keytruda,35.34,,1189.62,83,Stable Disease
M203289,50,Male,HPV-related Cancer,mrna-4157 + keytruda,30.95,32.07,1066.75,96,
M203290,37,Female,Melanoma,KEYTRUDA only,29.12,24.88,,89,Progression
M203291,44,Other,Melanoma,mrna-4157 + keytruda,87.0,64.34,1636.0,91,Partial Response
M203292,79,Female,Melanoma,mrna-4157 + keytruda,39.84,33.31,311.14,79,Stable Disease
M203293,69,Other,Melanoma,KEYTRUDA only,46.95,44.2,422.77,92,Partial Response
M203294,76,Male,HPV-related Cancer,KEYTRUDA only,60.56,38.26,1740.68,98,Stable Disease
M203295,65,Other,HPV-related Cancer,mrna-4157 + keytruda,52.51,38.75,635.77,99,Complete Response
M203296,37,Other,Melanoma,mrna-4157 + keytruda,66.75,30.67,1693.35,77,Stable Disease
M203297,49,Male,Melanoma,KEYTRUDA only,61.56,68.59,698.96,110,Stable Disease
M203298,62,Male,Melanoma,mrna-4157 + keytruda,41.9,41.28,1405.66,96,Partial Response
M203299,43,Other,Melanoma,mrna-4157 + keytruda,56.78,49.98,1286.83,87,Progression
M203300,56,Female,HPV-related Cancer,KEYTRUDA only,52.98,40.55,606.84,101,Progression
M203301,53,Male,HPV-related Cancer,mrna-4157 + keytruda,43.28,47.84,731.25,110,Partial Response
M203302,43,Male,HPV-related Cancer,KEYTRUDA only,71.19,56.78,1108.15,85,Unknown
M203303,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.42,38.08,662.83,96,Stable Disease
M203304,30,Other,HPV-related Cancer,mrna-4157 + keytruda,46.18,42.97,566.38,86,Stable Disease
M203305,72,Male,HPV-related Cancer,KEYTRUDA only,35.59,35.29,1406.25,89,Stable Disease
M203306,64,Female,Melanoma,mrna-4157 + keytruda,40.89,31.33,943.07,106,Progression
M203307,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.62,15.07,388.45,97,Stable Disease
M203308,31,Male,Melanoma,mrna-4157 + keytruda,63.92,36.84,813.37,115,Stable Disease
M203309,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.34,30.11,587.48,101,Progression
M203310,75,Female,Melanoma,mrna-4157 + keytruda,60.7,43.2,490.15,90,Partial Response
M203311,64,Male,HPV-related Cancer,KEYTRUDA only,30.83,21.07,1602.32,80,Progression
M203312,34,Female,Melanoma,mrna-4157 + keytruda,39.63,27.54,185.54,79,
M203313,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.55,63.48,606.67,91,Progression
M203314,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.82,20.83,467.6,90,Complete Response
M203315,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.53,49.71,695.6,83,Stable Disease
M203316,72,Male,HPV-related Cancer,mrna-4157 + keytruda,53.79,51.09,875.87,83,Stable Disease
M203317,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.48,40.46,600.44,91,Progression
M203318,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.28,63.36,994.39,76,Partial Response
M203319,59,Female,HPV-related Cancer,KEYTRUDA only,16.64,16.58,1037.77,109,Partial Response
M203320,67,Male,Melanoma,mrna-4157 + keytruda,20.9,16.49,1123.46,82,Stable Disease
M203321,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.84,53.65,1501.11,85,Progression
M203322,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.66,55.13,339.2,87,Partial Response
M203323,79,Other,HPV-related Cancer,KEYTRUDA only,88.43,85.46,445.4,78,Progression
M203324,78,Male,Melanoma,mrna-4157 + keytruda,28.46,18.89,1084.16,101,Stable Disease
M203325,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.83,36.95,1035.46,89,Partial Response
M203326,70,Male,Melanoma,mrna-4157 + keytruda,37.48,,941.31,92,Stable Disease
M203327,39,Female,Melanoma,mrna-4157 + keytruda,33.36,28.88,1218.89,82,Partial Response
M203328,67,Male,HPV-related Cancer,mrna-4157 + keytruda,27.98,11.33,893.27,90,Partial Response
M203329,54,Other,Melanoma,KEYTRUDA only,52.44,45.63,766.85,83,Complete Response
M203330,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.04,41.2,2044.56,86,Partial Response
M203331,74,Male,HPV-related Cancer,mrna-4157 + keytruda,16.46,10.53,705.2,81,Partial Response
M203332,39,Male,Melanoma,KEYTRUDA only,32.38,13.87,1028.62,90,Progression
M203333,29,Male,HPV-related Cancer,mrna-4157 + keytruda,30.7,,1236.4,87,Stable Disease
M203334,43,Other,Melanoma,mrna-4157 + keytruda,3.68,3.33,352.92,93,Complete Response
M203335,35,Male,HPV-related Cancer,mrna-4157 + keytruda,87.92,94.82,974.7,90,Stable Disease
M203336,48,Male,HPV-related Cancer,KEYTRUDA only,84.23,79.47,1090.21,98,Complete Response
M203337,35,Female,HPV-related Cancer,mrna-4157 + keytruda,88.19,57.11,682.07,75,Progression
M203338,32,Male,HPV-related Cancer,KEYTRUDA only,47.1,24.37,655.91,94,Stable Disease
M203339,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.67,47.59,1421.47,101,Complete Response
M203340,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.68,73.51,2102.8,89,Stable Disease
M203341,44,Male,HPV-related Cancer,mrna-4157 + keytruda,54.26,35.22,837.88,83,Progression
M203342,25,Male,Melanoma,KEYTRUDA only,63.71,,895.59,89,Progression
M203343,59,Other,HPV-related Cancer,mrna-4157 + keytruda,26.86,,1542.69,91,Progression
M203344,54,Female,HPV-related Cancer,mrna-4157 + keytruda,41.07,38.14,1000.54,94,Progression
M203345,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,84.35,55.76,293.16,92,Partial Response
M203346,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.36,70.05,719.15,88,Complete Response
M203347,66,Female,Melanoma,mrna-4157 + keytruda,87.0,65.47,1282.94,89,Partial Response
M203348,50,Other,HPV-related Cancer,mrna-4157 + keytruda,45.87,44.04,1572.52,94,Complete Response
M203349,53,Female,HPV-related Cancer,KEYTRUDA only,36.22,32.19,977.38,84,Stable Disease
M203350,43,Male,HPV-related Cancer,KEYTRUDA only,28.89,29.72,1709.03,84,Stable Disease
M203351,64,Male,HPV-related Cancer,mrna-4157 + keytruda,10.53,5.39,63.59,85,Complete Response
M203352,43,Other,HPV-related Cancer,KEYTRUDA only,28.94,27.43,1171.15,86,Complete Response
M203353,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.67,39.12,1094.65,97,Progression
M203354,60,Male,HPV-related Cancer,KEYTRUDA only,55.94,60.82,644.52,73,Progression
M203355,60,Male,HPV-related Cancer,mrna-4157 + keytruda,36.16,28.83,995.69,95,Partial Response
M203356,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.78,57.35,1136.69,93,Complete Response
M203357,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.65,,973.48,91,Partial Response
M203358,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,91.32,80.17,1637.25,106,Stable Disease
M203359,37,Female,Melanoma,mrna-4157 + keytruda,66.35,56.8,1206.73,104,Stable Disease
M203360,31,Other,Melanoma,mrna-4157 + keytruda,86.61,,1059.42,92,Stable Disease
M203361,48,Female,HPV-related Cancer,mrna-4157 + keytruda,38.02,25.8,190.86,81,Partial Response
M203362,51,Male,HPV-related Cancer,mrna-4157 + keytruda,-2.95,-2.84,1998.28,90,Partial Response
M203363,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.89,32.91,838.92,83,Complete Response
M203364,75,Other,HPV-related Cancer,mrna-4157 + keytruda,56.91,,720.69,90,Unknown
M203365,84,Other,Melanoma,mrna-4157 + keytruda,53.87,54.91,797.59,77,Partial Response
M203366,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.72,64.53,1342.28,80,Partial Response
M203367,63,Female,Melanoma,KEYTRUDA only,53.89,46.43,1682.31,85,Complete Response
M203368,57,Male,HPV-related Cancer,KEYTRUDA only,43.28,27.0,473.5,95,Partial Response
M203369,42,Other,HPV-related Cancer,mrna-4157 + keytruda,42.43,47.13,764.91,101,Progression
M203370,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.21,87.19,648.74,103,Progression
M203371,70,Other,Melanoma,mrna-4157 + keytruda,50.44,45.13,1559.02,98,Progression
M203372,39,Other,Melanoma,KEYTRUDA only,29.5,13.87,872.67,90,Progression
M203373,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.76,55.35,1244.59,75,Complete Response
M203374,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.18,23.92,895.17,91,Stable Disease
M203375,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,80.39,78.75,1513.14,74,Partial Response
M203376,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.63,53.17,1215.16,90,Stable Disease
M203377,39,Other,Non-small Cell Lung Cancer,KEYTRUDA only,26.49,15.85,979.98,93,Progression
M203378,65,Female,HPV-related Cancer,mrna-4157 + keytruda,43.91,38.74,1227.78,98,Complete Response
M203379,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.5,46.66,902.87,93,Progression
M203380,62,Male,HPV-related Cancer,mrna-4157 + keytruda,18.23,16.91,1001.19,82,Stable Disease
M203381,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.29,59.61,776.95,82,Progression
M203382,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.9,40.26,586.63,88,Progression
M203383,52,Male,Melanoma,mrna-4157 + keytruda,45.3,35.44,908.93,74,Progression
M203384,65,Male,Melanoma,KEYTRUDA only,39.06,31.28,818.18,105,Stable Disease
M203385,64,Other,HPV-related Cancer,mrna-4157 + keytruda,48.32,31.48,1331.13,100,Partial Response
M203386,70,Other,HPV-related Cancer,KEYTRUDA only,38.89,32.42,473.32,77,Partial Response
M203387,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.37,23.97,1019.67,78,Partial Response
M203388,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.33,34.3,713.59,86,Stable Disease
M203389,37,Other,HPV-related Cancer,mrna-4157 + keytruda,36.42,36.35,568.32,83,Progression
M203390,72,Female,Melanoma,mrna-4157 + keytruda,66.05,40.5,755.03,88,Complete Response
M203391,33,Other,Melanoma,KEYTRUDA only,34.81,11.66,1118.29,73,Partial Response
M203392,40,Female,Melanoma,mrna-4157 + keytruda,69.61,48.48,923.31,98,Progression
M203393,75,Male,Melanoma,KEYTRUDA only,67.27,73.21,757.53,93,Partial Response
M203394,67,Other,Melanoma,mrna-4157 + keytruda,48.13,31.26,1706.77,86,Partial Response
M203395,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.51,18.5,1098.83,89,Stable Disease
M203396,75,Female,Melanoma,KEYTRUDA only,62.95,46.21,821.81,72,Stable Disease
M203397,33,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.12,47.29,1147.56,78,Stable Disease
M203398,78,Male,Melanoma,KEYTRUDA only,73.52,62.16,887.18,95,Progression
M203399,38,Female,HPV-related Cancer,mrna-4157 + keytruda,35.92,26.96,942.95,79,Complete Response
M203400,70,Male,Melanoma,mrna-4157 + keytruda,29.61,29.18,1280.33,87,
M203401,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.05,34.04,,90,Progression
M203402,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.77,31.74,1123.33,85,Progression
M203403,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.41,34.46,,96,
M203404,43,Other,Melanoma,KEYTRUDA only,27.64,26.06,58.54,73,Stable Disease
M203405,49,Other,Melanoma,mrna-4157 + keytruda,54.17,40.86,827.75,81,Progression
M203406,57,Other,Melanoma,KEYTRUDA only,36.42,40.82,879.54,82,Stable Disease
M203407,25,Male,HPV-related Cancer,KEYTRUDA only,67.71,62.42,1235.62,94,Partial Response
M203408,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.74,51.92,1821.38,81,Partial Response
M203409,42,Other,HPV-related Cancer,KEYTRUDA only,61.82,48.23,568.56,93,Unknown
M203410,56,Female,HPV-related Cancer,mrna-4157 + keytruda,17.77,7.45,812.31,88,Partial Response
M203411,34,Other,Melanoma,mrna-4157 + keytruda,34.48,43.46,1041.1,91,Stable Disease
M203412,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.25,75.35,553.13,89,Partial Response
M203413,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.73,47.81,1245.59,81,Stable Disease
M203414,82,Male,Melanoma,mrna-4157 + keytruda,76.66,55.24,795.41,99,Complete Response
M203415,59,Other,Melanoma,KEYTRUDA only,33.55,47.64,1158.31,109,Partial Response
M203416,25,Male,HPV-related Cancer,KEYTRUDA only,55.49,32.73,1258.31,86,Partial Response
M203417,39,Other,Melanoma,mrna-4157 + keytruda,47.05,32.13,1173.36,94,Stable Disease
M203418,51,Male,Melanoma,mrna-4157 + keytruda,41.95,38.36,1616.45,97,Partial Response
M203419,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.45,29.23,870.78,90,Partial Response
M203420,58,Other,Melanoma,KEYTRUDA only,107.75,104.02,838.92,104,Progression
M203421,63,Female,HPV-related Cancer,KEYTRUDA only,72.68,53.65,1294.1,88,Stable Disease
M203422,56,Male,HPV-related Cancer,mrna-4157 + keytruda,34.57,29.77,1369.09,99,Partial Response
M203423,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.74,39.63,1536.67,87,Stable Disease
M203424,64,Female,HPV-related Cancer,KEYTRUDA only,43.84,34.25,,88,
M203425,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.31,44.1,1135.5,95,Partial Response
M203426,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.02,45.71,913.93,88,Complete Response
M203427,73,Female,Melanoma,KEYTRUDA only,21.54,17.65,991.87,107,Complete Response
M203428,79,Male,HPV-related Cancer,KEYTRUDA only,74.93,87.28,1573.93,92,Progression
M203429,58,Male,HPV-related Cancer,mrna-4157 + keytruda,46.7,26.13,1339.28,84,Progression
M203430,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.46,71.68,852.92,96,Unknown
M203431,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.9,47.92,752.66,97,Partial Response
M203432,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.76,,1427.89,72,Stable Disease
M203433,72,Male,HPV-related Cancer,mrna-4157 + keytruda,56.24,48.21,724.71,98,Partial Response
M203434,45,Other,HPV-related Cancer,KEYTRUDA only,59.0,47.55,1449.65,97,Stable Disease
M203435,70,Male,HPV-related Cancer,KEYTRUDA only,86.22,60.14,1470.23,90,Stable Disease
M203436,69,Female,Melanoma,mrna-4157 + keytruda,57.01,44.74,1472.56,96,Progression
M203437,26,Female,Melanoma,mrna-4157 + keytruda,76.43,63.52,1109.51,82,Stable Disease
M203438,26,Other,Melanoma,mrna-4157 + keytruda,26.17,19.96,515.06,88,Partial Response
M203439,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,21.87,7.02,1240.87,86,Progression
M203440,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.12,30.21,800.6,92,Progression
M203441,71,Male,Melanoma,mrna-4157 + keytruda,54.35,44.0,918.23,81,Progression
M203442,28,Male,Melanoma,mrna-4157 + keytruda,70.12,39.37,1019.27,95,Unknown
M203443,71,Male,Melanoma,mrna-4157 + keytruda,59.83,,959.75,105,Partial Response
M203444,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.04,56.84,935.26,88,Unknown
M203445,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.92,26.16,186.57,98,Partial Response
M203446,66,Male,Melanoma,mrna-4157 + keytruda,60.34,63.38,1584.45,92,Partial Response
M203447,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,14.95,13.14,735.04,93,Complete Response
M203448,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.12,51.92,456.43,100,Progression
M203449,43,Other,Melanoma,KEYTRUDA only,61.01,35.96,1150.17,102,Partial Response
M203450,63,Male,Melanoma,KEYTRUDA only,56.56,49.05,757.34,99,Stable Disease
M203451,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.49,30.47,661.08,86,Stable Disease
M203452,26,Female,HPV-related Cancer,mrna-4157 + keytruda,18.51,20.74,1287.84,82,
M203453,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.22,,1204.81,93,Stable Disease
M203454,67,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.42,36.32,1250.06,89,Partial Response
M203455,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.75,82.22,1525.41,74,Stable Disease
M203456,27,Other,Melanoma,mrna-4157 + keytruda,44.33,45.73,776.16,89,Complete Response
M203457,36,Male,Melanoma,mrna-4157 + keytruda,38.47,41.73,9.73,70,Complete Response
M203458,56,Male,Melanoma,mrna-4157 + keytruda,66.73,53.72,577.87,106,Stable Disease
M203459,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.72,68.61,1111.07,89,Complete Response
M203460,72,Male,Melanoma,mrna-4157 + keytruda,-2.44,-2.08,1044.64,85,Partial Response
M203461,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.15,25.5,1203.53,95,Partial Response
M203462,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,87.01,68.46,875.66,78,Partial Response
M203463,41,Other,HPV-related Cancer,mrna-4157 + keytruda,72.9,44.69,1309.17,84,Partial Response
M203464,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.09,43.18,1144.62,92,Complete Response
M203465,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,71.51,,,103,Progression
M203466,68,Male,Melanoma,mrna-4157 + keytruda,70.7,55.19,1047.15,92,
M203467,54,Male,HPV-related Cancer,KEYTRUDA only,47.14,42.36,851.42,89,Complete Response
M203468,62,Male,Melanoma,KEYTRUDA only,61.1,67.2,417.88,100,Partial Response
M203469,47,Other,Melanoma,mrna-4157 + keytruda,62.37,62.86,936.78,91,Stable Disease
M203470,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.52,32.19,1380.63,96,Complete Response
M203471,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.8,108.84,629.05,101,Partial Response
M203472,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.53,52.95,196.58,66,Complete Response
M203473,37,Other,HPV-related Cancer,mrna-4157 + keytruda,101.19,55.24,273.15,83,Partial Response
M203474,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,69.14,42.79,815.4,100,Stable Disease
M203475,65,Male,Melanoma,mrna-4157 + keytruda,42.4,,,94,Progression
M203476,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,80.12,61.22,1555.82,98,Partial Response
M203477,33,Other,HPV-related Cancer,mrna-4157 + keytruda,57.14,29.25,1338.45,95,Progression
M203478,45,Male,Melanoma,mrna-4157 + keytruda,49.29,29.32,774.05,80,Stable Disease
M203479,77,Female,Melanoma,mrna-4157 + keytruda,19.81,20.85,901.26,86,Partial Response
M203480,74,Female,HPV-related Cancer,KEYTRUDA only,62.96,48.2,1242.94,101,Stable Disease
M203481,77,Female,HPV-related Cancer,KEYTRUDA only,53.23,29.87,437.27,108,Complete Response
M203482,52,Other,Melanoma,KEYTRUDA only,41.01,23.88,1283.42,81,Stable Disease
M203483,30,Male,HPV-related Cancer,mrna-4157 + keytruda,50.88,35.53,1586.95,87,Complete Response
M203484,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.29,76.62,1222.69,88,Partial Response
M203485,78,Other,Melanoma,KEYTRUDA only,55.71,30.48,291.53,100,Complete Response
M203486,60,Male,HPV-related Cancer,KEYTRUDA only,16.49,14.56,599.57,55,Stable Disease
M203487,41,Female,Melanoma,mrna-4157 + keytruda,68.49,33.04,883.0,89,Progression
M203488,46,Other,Melanoma,KEYTRUDA only,42.41,30.51,637.02,86,Stable Disease
M203489,33,Male,Melanoma,mrna-4157 + keytruda,46.56,49.4,1035.62,85,Progression
M203490,36,Male,HPV-related Cancer,mrna-4157 + keytruda,17.37,18.7,487.04,75,Partial Response
M203491,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.81,22.82,639.77,90,Partial Response
M203492,81,Male,HPV-related Cancer,KEYTRUDA only,39.42,39.78,1013.73,83,Complete Response
M203493,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.21,15.37,1357.7,103,Stable Disease
M203494,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.45,38.41,1080.74,76,Partial Response
M203495,67,Male,HPV-related Cancer,mrna-4157 + keytruda,65.0,44.91,860.34,86,Progression
M203496,58,Other,Melanoma,mrna-4157 + keytruda,-7.12,,1031.79,82,Partial Response
M203497,71,Other,HPV-related Cancer,mrna-4157 + keytruda,81.43,70.71,288.78,87,Stable Disease
M203498,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.34,33.59,1105.25,95,Stable Disease
M203499,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.32,37.73,-68.47,97,Stable Disease
M203500,69,Other,HPV-related Cancer,mrna-4157 + keytruda,52.48,32.66,1244.74,99,Partial Response
M203501,55,Female,Melanoma,KEYTRUDA only,54.37,45.29,707.6,105,Progression
M203502,74,Male,HPV-related Cancer,mrna-4157 + keytruda,72.45,32.48,857.59,89,Complete Response
M203503,62,Other,Melanoma,KEYTRUDA only,7.18,6.71,,83,Stable Disease
M203504,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.8,80.07,499.47,91,
M203505,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.95,39.52,436.37,88,Complete Response
M203506,56,Female,Melanoma,mrna-4157 + keytruda,48.64,42.88,246.05,105,Complete Response
M203507,32,Female,Non-small Cell Lung Cancer,KEYTRUDA only,21.28,16.51,677.12,84,Progression
M203508,58,Male,HPV-related Cancer,mrna-4157 + keytruda,55.84,38.64,1263.93,86,Partial Response
M203509,81,Female,Melanoma,KEYTRUDA only,51.68,35.27,981.09,98,Progression
M203510,37,Female,HPV-related Cancer,mrna-4157 + keytruda,40.69,31.62,1050.96,79,Progression
M203511,31,Other,Melanoma,mrna-4157 + keytruda,79.18,,1302.34,73,Partial Response
M203512,79,Female,Melanoma,mrna-4157 + keytruda,42.15,32.24,866.07,96,Complete Response
M203513,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,72.85,72.5,877.17,89,Complete Response
M203514,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.01,31.97,1874.94,108,Stable Disease
M203515,50,Female,Melanoma,mrna-4157 + keytruda,45.76,32.47,1149.99,87,Stable Disease
M203516,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.0,45.04,1020.94,101,Stable Disease
M203517,57,Male,Melanoma,mrna-4157 + keytruda,57.04,42.56,445.87,79,Partial Response
M203518,43,Other,HPV-related Cancer,KEYTRUDA only,58.82,46.43,1731.88,78,
M203519,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.91,77.72,1147.52,90,Partial Response
M203520,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.63,34.85,,90,Unknown
M203521,31,Male,HPV-related Cancer,KEYTRUDA only,32.77,23.57,1353.26,92,Complete Response
M203522,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.33,35.53,1025.57,70,Complete Response
M203523,43,Other,Melanoma,mrna-4157 + keytruda,46.86,37.08,957.1,75,Stable Disease
M203524,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.92,,1123.2,80,
M203525,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.93,24.27,1033.62,95,Unknown
M203526,73,Other,HPV-related Cancer,mrna-4157 + keytruda,45.59,36.75,,101,Partial Response
M203527,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.21,20.96,1108.61,98,Stable Disease
M203528,81,Male,HPV-related Cancer,mrna-4157 + keytruda,75.75,81.11,,89,Partial Response
M203529,31,Male,HPV-related Cancer,KEYTRUDA only,47.49,32.14,565.62,85,
M203530,67,Male,Melanoma,KEYTRUDA only,58.9,54.78,1671.01,87,Stable Disease
M203531,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.68,57.19,680.78,72,Partial Response
M203532,26,Male,HPV-related Cancer,mrna-4157 + keytruda,61.9,38.64,1323.58,111,Stable Disease
M203533,74,Female,Melanoma,KEYTRUDA only,68.44,41.87,461.58,86,Complete Response
M203534,83,Other,Melanoma,mrna-4157 + keytruda,67.91,67.22,1105.06,98,Progression
M203535,51,Female,Melanoma,mrna-4157 + keytruda,60.43,28.5,790.04,90,Complete Response
M203536,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.65,47.9,363.43,94,Stable Disease
M203537,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.28,10.46,789.99,94,Complete Response
M203538,36,Other,Melanoma,KEYTRUDA only,65.17,59.74,957.8,102,
M203539,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.68,67.66,1308.08,95,Stable Disease
M203540,77,Female,HPV-related Cancer,mrna-4157 + keytruda,51.45,34.32,689.67,80,Stable Disease
M203541,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.94,47.3,1498.58,78,Stable Disease
M203542,79,Male,HPV-related Cancer,KEYTRUDA only,63.32,,1160.93,88,Progression
M203543,55,Other,HPV-related Cancer,mrna-4157 + keytruda,66.72,67.29,1318.39,102,Unknown
M203544,72,Other,Melanoma,mrna-4157 + keytruda,42.04,35.53,1071.98,85,Partial Response
M203545,29,Male,Melanoma,mrna-4157 + keytruda,70.05,63.65,1655.12,88,Stable Disease
M203546,79,Female,HPV-related Cancer,mrna-4157 + keytruda,37.04,22.14,1038.15,73,Stable Disease
M203547,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.79,35.34,1251.2,110,Progression
M203548,51,Male,Melanoma,KEYTRUDA only,48.74,39.24,255.41,84,Progression
M203549,45,Other,HPV-related Cancer,KEYTRUDA only,28.06,26.1,1025.73,107,Complete Response
M203550,42,Other,HPV-related Cancer,mrna-4157 + keytruda,27.14,29.54,1415.92,86,Unknown
M203551,45,Other,HPV-related Cancer,mrna-4157 + keytruda,72.7,69.01,1102.62,95,Stable Disease
M203552,30,Female,HPV-related Cancer,KEYTRUDA only,75.72,72.51,612.23,86,Partial Response
M203553,43,Other,HPV-related Cancer,mrna-4157 + keytruda,55.45,67.77,,61,Partial Response
M203554,68,Female,Melanoma,mrna-4157 + keytruda,14.61,9.22,710.94,99,Unknown
M203555,25,Other,Melanoma,mrna-4157 + keytruda,63.95,39.89,1039.17,90,Complete Response
M203556,70,Male,Melanoma,mrna-4157 + keytruda,41.8,27.15,678.1,87,Stable Disease
M203557,36,Other,Melanoma,mrna-4157 + keytruda,75.13,85.59,1598.99,78,Progression
M203558,60,Female,HPV-related Cancer,KEYTRUDA only,58.34,51.24,1218.11,103,Progression
M203559,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.73,66.3,1303.26,101,Partial Response
M203560,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.62,21.17,375.29,77,Partial Response
M203561,72,Male,Melanoma,mrna-4157 + keytruda,14.25,12.42,1074.31,93,Partial Response
M203562,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.91,39.82,428.44,103,Complete Response
M203563,56,Female,Melanoma,KEYTRUDA only,84.78,73.14,1297.73,91,Progression
M203564,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.66,63.18,353.92,90,Partial Response
M203565,57,Female,HPV-related Cancer,mrna-4157 + keytruda,54.87,21.24,1099.19,82,Stable Disease
M203566,82,Female,Melanoma,KEYTRUDA only,69.68,45.36,1426.25,106,Unknown
M203567,62,Female,HPV-related Cancer,KEYTRUDA only,62.4,43.56,1287.66,84,Partial Response
M203568,35,Other,Melanoma,mrna-4157 + keytruda,69.5,,835.32,79,Partial Response
M203569,63,Male,Melanoma,KEYTRUDA only,52.35,62.4,549.96,83,Partial Response
M203570,45,Male,Melanoma,mrna-4157 + keytruda,30.53,23.59,842.12,92,Complete Response
M203571,31,Male,HPV-related Cancer,KEYTRUDA only,67.56,73.74,761.64,94,Progression
M203572,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.4,45.63,,81,Stable Disease
M203573,57,Other,Melanoma,KEYTRUDA only,46.85,22.73,1028.62,84,Stable Disease
M203574,25,Female,HPV-related Cancer,mrna-4157 + keytruda,48.4,41.32,755.9,87,Progression
M203575,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.33,33.08,1495.12,93,Stable Disease
M203576,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.94,61.4,1136.81,81,Partial Response
M203577,40,Other,Melanoma,KEYTRUDA only,48.87,37.17,1179.77,92,Partial Response
M203578,70,Female,Melanoma,mrna-4157 + keytruda,77.64,44.45,874.27,79,Progression
M203579,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.84,44.48,763.92,83,Partial Response
M203580,60,Female,Melanoma,mrna-4157 + keytruda,45.85,39.09,710.18,83,
M203581,38,Male,HPV-related Cancer,KEYTRUDA only,49.51,45.76,1610.78,112,Partial Response
M203582,40,Other,HPV-related Cancer,KEYTRUDA only,37.33,33.31,1188.5,89,Partial Response
M203583,63,Other,Melanoma,mrna-4157 + keytruda,46.12,46.61,1006.6,80,Partial Response
M203584,49,Male,HPV-related Cancer,KEYTRUDA only,43.02,37.62,771.11,76,Complete Response
M203585,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-4.86,-3.02,1257.62,82,Complete Response
M203586,82,Female,Melanoma,mrna-4157 + keytruda,43.06,31.06,1546.66,99,Progression
M203587,65,Female,Melanoma,mrna-4157 + keytruda,75.03,59.98,1158.65,73,Progression
M203588,76,Other,Melanoma,mrna-4157 + keytruda,71.31,44.63,1316.49,106,Stable Disease
M203589,76,Female,Melanoma,mrna-4157 + keytruda,28.82,14.24,1262.05,93,Stable Disease
M203590,37,Female,HPV-related Cancer,mrna-4157 + keytruda,65.24,69.22,704.24,72,Partial Response
M203591,42,Female,HPV-related Cancer,mrna-4157 + keytruda,61.03,43.24,388.69,91,Stable Disease
M203592,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.1,34.23,872.85,79,Partial Response
M203593,26,Other,HPV-related Cancer,mrna-4157 + keytruda,93.85,72.91,596.55,82,Stable Disease
M203594,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.43,41.66,971.93,90,Partial Response
M203595,79,Other,HPV-related Cancer,KEYTRUDA only,19.28,,1159.74,76,Stable Disease
M203596,28,Male,HPV-related Cancer,KEYTRUDA only,64.02,57.49,1148.4,104,Complete Response
M203597,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.51,56.75,1095.41,90,Complete Response
M203598,30,Male,Melanoma,mrna-4157 + keytruda,57.92,68.35,746.85,95,Stable Disease
M203599,62,Female,HPV-related Cancer,mrna-4157 + keytruda,80.83,56.12,1458.22,69,Complete Response
M203600,25,Other,HPV-related Cancer,mrna-4157 + keytruda,57.27,52.3,936.97,106,Partial Response
M203601,69,Other,Melanoma,mrna-4157 + keytruda,79.26,68.78,503.69,99,Progression
M203602,41,Other,HPV-related Cancer,KEYTRUDA only,47.7,25.05,271.41,85,Stable Disease
M203603,59,Male,HPV-related Cancer,KEYTRUDA only,43.6,40.32,638.41,97,Unknown
M203604,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.18,55.78,1681.66,107,Stable Disease
M203605,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.99,49.69,633.04,97,Stable Disease
M203606,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.07,69.26,1002.18,100,Progression
M203607,83,Female,Melanoma,mrna-4157 + keytruda,64.57,52.22,738.11,85,Complete Response
M203608,37,Other,Melanoma,mrna-4157 + keytruda,76.33,74.22,467.91,83,
M203609,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.27,55.89,623.0,96,Complete Response
M203610,37,Other,HPV-related Cancer,mrna-4157 + keytruda,33.82,32.34,1286.61,87,Progression
M203611,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.73,38.53,1330.98,91,Partial Response
M203612,84,Male,HPV-related Cancer,KEYTRUDA only,44.96,23.46,1323.37,73,Progression
M203613,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,22.63,13.77,793.8,99,Progression
M203614,81,Other,Melanoma,mrna-4157 + keytruda,18.42,21.18,858.86,94,Progression
M203615,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.31,30.21,1558.09,99,Complete Response
M203616,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.31,43.62,1522.78,92,Partial Response
M203617,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,30.11,28.13,,99,Partial Response
M203618,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,96.84,60.08,,81,Partial Response
M203619,82,Other,HPV-related Cancer,KEYTRUDA only,40.35,29.34,1171.52,87,Partial Response
M203620,25,Other,Melanoma,mrna-4157 + keytruda,47.29,,732.19,93,Stable Disease
M203621,57,Male,Melanoma,KEYTRUDA only,59.02,49.14,1126.28,81,Partial Response
M203622,29,Male,Melanoma,mrna-4157 + keytruda,28.25,27.74,1041.16,101,Complete Response
M203623,70,Male,HPV-related Cancer,KEYTRUDA only,79.56,52.42,1032.83,93,Complete Response
M203624,39,Female,HPV-related Cancer,KEYTRUDA only,76.09,94.8,1219.43,107,Progression
M203625,40,Other,HPV-related Cancer,mrna-4157 + keytruda,63.86,43.71,492.21,88,
M203626,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.05,27.96,1114.91,89,Stable Disease
M203627,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.81,,1161.35,93,Partial Response
M203628,50,Female,HPV-related Cancer,KEYTRUDA only,69.05,49.67,795.45,83,Partial Response
M203629,65,Other,HPV-related Cancer,KEYTRUDA only,73.46,66.96,1168.73,92,Progression
M203630,64,Male,Melanoma,KEYTRUDA only,39.55,21.74,,91,Complete Response
M203631,55,Other,Melanoma,KEYTRUDA only,84.9,63.08,764.98,81,Progression
M203632,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.5,21.27,1760.81,100,Stable Disease
M203633,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.25,43.11,1168.52,77,Stable Disease
M203634,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.44,64.67,1588.84,94,Progression
M203635,47,Male,Melanoma,mrna-4157 + keytruda,23.5,27.88,525.75,92,Stable Disease
M203636,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.08,58.17,1320.69,111,Stable Disease
M203637,57,Other,Melanoma,mrna-4157 + keytruda,31.22,,723.02,72,Progression
M203638,26,Male,HPV-related Cancer,mrna-4157 + keytruda,44.64,37.13,773.96,86,Stable Disease
M203639,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.4,68.88,1243.68,102,Stable Disease
M203640,41,Other,HPV-related Cancer,KEYTRUDA only,39.5,25.53,1576.18,91,Partial Response
M203641,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.76,26.73,981.59,82,Complete Response
M203642,80,Other,HPV-related Cancer,KEYTRUDA only,51.86,39.56,1006.33,81,Stable Disease
M203643,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.52,32.39,1214.85,77,Partial Response
M203644,46,Female,HPV-related Cancer,KEYTRUDA only,59.66,52.58,,93,Stable Disease
M203645,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.96,10.13,1422.3,93,Stable Disease
M203646,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.37,56.05,1380.39,79,Stable Disease
M203647,45,Female,Melanoma,KEYTRUDA only,3.2,3.38,1283.17,86,Stable Disease
M203648,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,33.37,38.25,624.51,92,Partial Response
M203649,42,Male,HPV-related Cancer,mrna-4157 + keytruda,56.18,51.99,637.04,78,Partial Response
M203650,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.48,32.8,1532.65,105,Partial Response
M203651,52,Other,Melanoma,mrna-4157 + keytruda,57.19,37.67,1233.61,87,Stable Disease
M203652,29,Female,HPV-related Cancer,KEYTRUDA only,17.85,16.41,788.85,91,Stable Disease
M203653,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.39,32.68,1461.37,83,Stable Disease
M203654,26,Other,Melanoma,KEYTRUDA only,40.52,31.43,941.64,110,Stable Disease
M203655,65,Male,HPV-related Cancer,mrna-4157 + keytruda,31.13,12.67,301.96,99,Progression
M203656,78,Other,Melanoma,mrna-4157 + keytruda,65.69,70.73,1422.28,88,Progression
M203657,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.37,14.42,956.32,100,Progression
M203658,35,Female,Melanoma,KEYTRUDA only,74.37,74.26,618.15,79,Progression
M203659,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.67,41.51,1188.81,95,Progression
M203660,29,Male,Melanoma,KEYTRUDA only,50.24,40.32,1744.15,103,Complete Response
M203661,27,Male,Melanoma,mrna-4157 + keytruda,7.91,,,103,Stable Disease
M203662,58,Male,Melanoma,mrna-4157 + keytruda,70.85,,320.83,105,Progression
M203663,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,31.44,21.35,737.19,85,Partial Response
M203664,53,Female,HPV-related Cancer,mrna-4157 + keytruda,96.79,74.42,849.65,104,Stable Disease
M203665,60,Other,Melanoma,mrna-4157 + keytruda,26.09,,1529.12,101,Stable Disease
M203666,25,Female,HPV-related Cancer,mrna-4157 + keytruda,77.26,68.82,1246.34,84,Stable Disease
M203667,46,Female,Melanoma,mrna-4157 + keytruda,71.03,,300.93,81,Partial Response
M203668,64,Other,Melanoma,KEYTRUDA only,30.9,26.06,1054.69,68,Stable Disease
M203669,77,Other,Melanoma,mrna-4157 + keytruda,57.49,36.67,904.92,77,Stable Disease
M203670,45,Female,HPV-related Cancer,mrna-4157 + keytruda,59.87,47.79,419.11,107,Partial Response
M203671,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.5,28.4,199.83,100,Complete Response
M203672,47,Other,HPV-related Cancer,KEYTRUDA only,13.75,8.45,822.31,93,Progression
M203673,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.59,54.43,912.04,101,Unknown
M203674,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.26,63.26,620.96,81,Progression
M203675,50,Female,Melanoma,mrna-4157 + keytruda,23.59,20.2,804.82,95,Complete Response
M203676,43,Male,HPV-related Cancer,KEYTRUDA only,21.29,15.23,24.15,86,Partial Response
M203677,51,Other,Melanoma,KEYTRUDA only,6.01,5.45,1026.53,89,Complete Response
M203678,69,Other,Melanoma,KEYTRUDA only,64.08,70.42,1644.76,82,Partial Response
M203679,35,Male,HPV-related Cancer,KEYTRUDA only,56.3,63.19,509.86,81,Stable Disease
M203680,64,Female,HPV-related Cancer,KEYTRUDA only,57.59,40.81,849.72,88,Stable Disease
M203681,56,Other,Melanoma,KEYTRUDA only,56.53,,1108.4,119,Complete Response
M203682,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,7.51,3.63,1105.08,89,Stable Disease
M203683,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.27,54.78,544.77,99,Stable Disease
M203684,39,Male,HPV-related Cancer,mrna-4157 + keytruda,66.24,26.34,977.86,73,Stable Disease
M203685,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.95,11.19,992.73,92,Progression
M203686,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,11.64,9.46,991.79,68,Stable Disease
M203687,62,Other,HPV-related Cancer,KEYTRUDA only,43.45,36.57,1348.46,87,Stable Disease
M203688,83,Female,HPV-related Cancer,KEYTRUDA only,42.06,41.68,1762.27,80,
M203689,26,Female,HPV-related Cancer,mrna-4157 + keytruda,68.91,61.25,1421.79,77,Stable Disease
M203690,42,Male,HPV-related Cancer,mrna-4157 + keytruda,52.11,49.36,1159.47,81,Stable Disease
M203691,46,Other,HPV-related Cancer,mrna-4157 + keytruda,49.11,17.0,371.01,94,
M203692,37,Other,HPV-related Cancer,mrna-4157 + keytruda,66.91,61.23,,88,Progression
M203693,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.22,18.12,765.68,68,Stable Disease
M203694,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.78,47.81,1132.61,99,Progression
M203695,48,Other,HPV-related Cancer,KEYTRUDA only,57.27,26.16,,105,Progression
M203696,38,Male,Melanoma,KEYTRUDA only,61.33,66.59,1024.05,83,Stable Disease
M203697,68,Other,HPV-related Cancer,KEYTRUDA only,45.45,,769.53,90,Stable Disease
M203698,48,Female,HPV-related Cancer,KEYTRUDA only,46.06,55.19,1324.14,81,Partial Response
M203699,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.17,26.96,475.38,83,Progression
M203700,38,Male,HPV-related Cancer,KEYTRUDA only,75.31,59.3,480.74,71,Complete Response
M203701,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.64,,1709.2,87,Complete Response
M203702,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.77,42.51,1653.96,105,Partial Response
M203703,39,Male,HPV-related Cancer,mrna-4157 + keytruda,52.68,34.45,1246.88,91,Stable Disease
M203704,43,Other,Melanoma,KEYTRUDA only,19.26,16.6,680.56,96,Stable Disease
M203705,37,Female,HPV-related Cancer,KEYTRUDA only,71.04,77.16,1162.58,102,Stable Disease
M203706,51,Male,Melanoma,mrna-4157 + keytruda,22.73,20.75,1216.33,107,Complete Response
M203707,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,26.1,25.15,2132.34,80,Stable Disease
M203708,54,Male,HPV-related Cancer,mrna-4157 + keytruda,54.26,12.78,1130.39,84,Progression
M203709,65,Female,Melanoma,mrna-4157 + keytruda,30.2,23.15,764.35,79,Partial Response
M203710,74,Male,HPV-related Cancer,mrna-4157 + keytruda,14.47,11.53,1461.85,92,Partial Response
M203711,31,Other,HPV-related Cancer,mrna-4157 + keytruda,99.82,57.95,1597.26,84,Progression
M203712,29,Female,Melanoma,mrna-4157 + keytruda,63.29,57.1,505.2,95,Complete Response
M203713,82,Other,HPV-related Cancer,mrna-4157 + keytruda,12.45,12.21,1061.72,91,Progression
M203714,63,Male,Melanoma,KEYTRUDA only,-9.3,-7.0,1435.78,87,
M203715,27,Female,HPV-related Cancer,KEYTRUDA only,56.26,29.53,187.37,83,Partial Response
M203716,82,Male,HPV-related Cancer,KEYTRUDA only,42.73,48.58,148.06,94,Stable Disease
M203717,77,Other,Melanoma,KEYTRUDA only,42.2,21.68,849.98,104,Progression
M203718,29,Female,HPV-related Cancer,mrna-4157 + keytruda,28.73,18.42,1001.73,78,
M203719,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.47,25.98,1350.27,94,Partial Response
M203720,71,Female,HPV-related Cancer,mrna-4157 + keytruda,24.18,28.37,772.15,93,Partial Response
M203721,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.86,43.96,1449.31,98,Progression
M203722,32,Male,Melanoma,mrna-4157 + keytruda,33.36,23.13,1301.47,98,Partial Response
M203723,70,Female,Melanoma,mrna-4157 + keytruda,59.8,40.08,,81,Partial Response
M203724,82,Female,Melanoma,mrna-4157 + keytruda,78.67,54.25,1312.73,101,Unknown
M203725,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.03,36.62,834.34,89,Complete Response
M203726,79,Male,HPV-related Cancer,mrna-4157 + keytruda,42.94,30.62,352.23,82,Stable Disease
M203727,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.49,10.08,1323.03,82,Complete Response
M203728,58,Female,HPV-related Cancer,KEYTRUDA only,38.57,30.3,1925.15,97,Complete Response
M203729,65,Female,Melanoma,KEYTRUDA only,42.77,47.45,1230.91,76,Partial Response
M203730,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.08,15.76,,90,Stable Disease
M203731,57,Other,HPV-related Cancer,KEYTRUDA only,66.48,42.08,388.42,96,Stable Disease
M203732,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.48,33.31,1300.09,68,Partial Response
M203733,34,Other,HPV-related Cancer,KEYTRUDA only,25.78,20.95,1334.49,91,Unknown
M203734,75,Female,Melanoma,KEYTRUDA only,60.26,35.71,969.57,76,
M203735,67,Female,Melanoma,mrna-4157 + keytruda,57.59,46.11,1717.37,97,Progression
M203736,27,Female,HPV-related Cancer,mrna-4157 + keytruda,88.23,60.13,751.91,91,Stable Disease
M203737,55,Male,HPV-related Cancer,mrna-4157 + keytruda,54.0,46.22,661.0,87,Unknown
M203738,41,Female,Melanoma,mrna-4157 + keytruda,63.1,42.37,1277.65,114,Progression
M203739,38,Female,Melanoma,mrna-4157 + keytruda,42.42,21.78,996.12,110,Complete Response
M203740,58,Female,Melanoma,KEYTRUDA only,64.97,54.3,282.36,84,Partial Response
M203741,50,Female,Melanoma,KEYTRUDA only,33.15,23.04,709.38,82,Progression
M203742,74,Male,Melanoma,mrna-4157 + keytruda,62.76,42.35,904.71,91,Progression
M203743,52,Male,Melanoma,KEYTRUDA only,61.51,54.99,677.18,98,Partial Response
M203744,64,Other,Melanoma,KEYTRUDA only,81.75,38.06,1249.72,95,Progression
M203745,39,Female,Melanoma,mrna-4157 + keytruda,36.36,19.74,1197.19,98,Stable Disease
M203746,55,Male,Melanoma,KEYTRUDA only,51.02,40.04,611.37,92,Stable Disease
M203747,47,Other,Melanoma,KEYTRUDA only,54.78,50.68,1208.78,102,Partial Response
M203748,67,Other,HPV-related Cancer,mrna-4157 + keytruda,22.64,17.36,1046.9,75,Stable Disease
M203749,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.76,51.48,1373.89,99,Progression
M203750,50,Female,HPV-related Cancer,mrna-4157 + keytruda,50.08,43.28,1072.65,87,Partial Response
M203751,38,Other,Melanoma,KEYTRUDA only,36.91,33.94,471.69,84,Partial Response
M203752,49,Other,Melanoma,mrna-4157 + keytruda,51.75,34.97,561.93,92,Progression
M203753,60,Female,HPV-related Cancer,mrna-4157 + keytruda,20.48,7.27,942.32,81,Stable Disease
M203754,44,Female,Melanoma,mrna-4157 + keytruda,64.49,70.56,1314.2,73,Progression
M203755,51,Female,HPV-related Cancer,KEYTRUDA only,40.98,28.64,1077.82,85,Progression
M203756,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,31.12,21.4,770.3,87,Progression
M203757,25,Other,Melanoma,KEYTRUDA only,62.42,37.27,345.04,81,Partial Response
M203758,66,Other,Melanoma,KEYTRUDA only,54.77,51.48,,76,Partial Response
M203759,41,Other,Melanoma,mrna-4157 + keytruda,53.4,39.96,1409.42,88,Stable Disease
M203760,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.2,36.73,1068.12,82,Partial Response
M203761,36,Female,HPV-related Cancer,mrna-4157 + keytruda,70.18,35.91,1435.33,94,Partial Response
M203762,39,Other,Melanoma,mrna-4157 + keytruda,49.77,51.75,1198.1,106,Partial Response
M203763,45,Female,HPV-related Cancer,mrna-4157 + keytruda,35.14,38.13,1029.9,99,Partial Response
M203764,36,Female,Melanoma,mrna-4157 + keytruda,10.14,10.53,1332.34,87,Partial Response
M203765,57,Other,Melanoma,KEYTRUDA only,59.48,51.79,846.77,106,Complete Response
M203766,68,Other,HPV-related Cancer,KEYTRUDA only,26.14,20.66,905.76,90,Partial Response
M203767,60,Male,Melanoma,KEYTRUDA only,49.23,27.77,1304.31,89,Stable Disease
M203768,29,Female,Melanoma,mrna-4157 + keytruda,65.97,22.4,862.57,91,Partial Response
M203769,43,Male,HPV-related Cancer,mrna-4157 + keytruda,53.02,50.16,1375.5,78,Stable Disease
M203770,42,Other,Melanoma,mrna-4157 + keytruda,29.92,23.8,648.21,104,Progression
M203771,51,Female,HPV-related Cancer,KEYTRUDA only,36.49,26.38,959.35,94,Partial Response
M203772,49,Other,Melanoma,mrna-4157 + keytruda,54.97,38.42,945.71,88,Partial Response
M203773,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.95,31.23,911.99,96,Progression
M203774,31,Other,Melanoma,mrna-4157 + keytruda,56.25,38.2,353.95,89,Partial Response
M203775,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.3,53.1,748.0,73,Progression
M203776,44,Male,HPV-related Cancer,mrna-4157 + keytruda,39.01,37.45,1590.0,103,Complete Response
M203777,66,Female,Melanoma,mrna-4157 + keytruda,34.17,26.15,768.88,102,Complete Response
M203778,60,Male,Melanoma,KEYTRUDA only,57.41,53.81,772.29,98,Partial Response
M203779,73,Female,Melanoma,KEYTRUDA only,35.59,25.38,845.29,98,Stable Disease
M203780,41,Other,HPV-related Cancer,KEYTRUDA only,73.82,60.02,983.15,80,
M203781,30,Other,HPV-related Cancer,mrna-4157 + keytruda,46.51,40.48,422.44,68,Unknown
M203782,46,Other,HPV-related Cancer,mrna-4157 + keytruda,53.9,34.7,1230.62,79,Progression
M203783,75,Other,Melanoma,KEYTRUDA only,63.64,37.89,557.94,88,Partial Response
M203784,43,Male,Melanoma,mrna-4157 + keytruda,67.37,55.6,1257.18,88,Stable Disease
M203785,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.71,,1688.69,87,Complete Response
M203786,50,Male,HPV-related Cancer,mrna-4157 + keytruda,63.58,51.65,954.32,96,Stable Disease
M203787,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.16,15.43,933.5,77,Partial Response
M203788,26,Female,Melanoma,mrna-4157 + keytruda,56.28,47.2,117.37,89,Stable Disease
M203789,66,Female,HPV-related Cancer,mrna-4157 + keytruda,91.04,71.22,1496.0,73,Stable Disease
M203790,63,Other,Melanoma,mrna-4157 + keytruda,54.05,60.6,952.17,81,Stable Disease
M203791,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.93,55.11,924.86,93,Stable Disease
M203792,30,Other,HPV-related Cancer,mrna-4157 + keytruda,46.78,40.2,1289.82,91,Partial Response
M203793,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.15,31.24,1193.17,74,Complete Response
M203794,34,Female,HPV-related Cancer,mrna-4157 + keytruda,57.8,51.07,518.79,80,Unknown
M203795,29,Other,HPV-related Cancer,mrna-4157 + keytruda,45.99,35.89,1655.56,102,Partial Response
M203796,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,6.69,3.78,1041.94,78,Progression
M203797,60,Male,Melanoma,mrna-4157 + keytruda,53.43,36.45,973.11,100,Progression
M203798,25,Female,Melanoma,KEYTRUDA only,59.06,43.05,,82,Progression
M203799,80,Female,HPV-related Cancer,mrna-4157 + keytruda,45.95,30.44,591.9,73,Complete Response
M203800,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.91,60.05,795.81,92,Partial Response
M203801,49,Male,Melanoma,mrna-4157 + keytruda,49.17,42.92,841.24,85,Stable Disease
M203802,68,Female,HPV-related Cancer,mrna-4157 + keytruda,48.19,28.92,1206.33,86,Stable Disease
M203803,39,Male,HPV-related Cancer,KEYTRUDA only,71.9,73.5,1430.35,85,Complete Response
M203804,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.34,25.62,893.35,79,Progression
M203805,84,Female,Melanoma,KEYTRUDA only,42.59,37.35,1070.2,99,Stable Disease
M203806,60,Other,Melanoma,KEYTRUDA only,18.87,17.84,938.98,86,Partial Response
M203807,30,Other,HPV-related Cancer,KEYTRUDA only,75.47,48.82,1170.69,77,Stable Disease
M203808,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.68,23.77,157.05,65,Stable Disease
M203809,84,Female,Melanoma,mrna-4157 + keytruda,44.88,39.7,1115.01,90,Progression
M203810,79,Other,Melanoma,KEYTRUDA only,49.95,35.57,1271.47,94,Partial Response
M203811,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.44,42.91,1112.62,90,Stable Disease
M203812,30,Other,Melanoma,KEYTRUDA only,73.15,18.33,1139.66,87,Complete Response
M203813,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.85,68.94,1204.18,94,Unknown
M203814,74,Female,HPV-related Cancer,KEYTRUDA only,51.28,49.95,846.3,82,Partial Response
M203815,58,Female,Melanoma,mrna-4157 + keytruda,30.15,28.06,792.63,78,Partial Response
M203816,84,Other,HPV-related Cancer,KEYTRUDA only,32.02,23.87,677.13,88,Complete Response
M203817,41,Male,Melanoma,mrna-4157 + keytruda,28.85,20.57,1193.23,92,Partial Response
M203818,55,Other,Melanoma,mrna-4157 + keytruda,66.62,36.1,1771.84,77,Stable Disease
M203819,53,Female,Melanoma,mrna-4157 + keytruda,32.4,18.55,1401.58,85,Partial Response
M203820,52,Other,HPV-related Cancer,KEYTRUDA only,48.14,27.46,,80,Complete Response
M203821,27,Male,Melanoma,mrna-4157 + keytruda,85.94,60.73,860.43,89,Complete Response
M203822,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.74,12.36,1285.41,83,Unknown
M203823,38,Other,HPV-related Cancer,mrna-4157 + keytruda,64.41,37.25,779.23,93,Stable Disease
M203824,84,Female,HPV-related Cancer,KEYTRUDA only,55.1,56.22,708.9,87,Progression
M203825,72,Male,HPV-related Cancer,KEYTRUDA only,61.64,47.49,-181.39,94,Partial Response
M203826,41,Other,Melanoma,KEYTRUDA only,55.47,44.3,667.75,90,Progression
M203827,30,Male,HPV-related Cancer,KEYTRUDA only,50.75,48.04,1583.39,94,Stable Disease
M203828,63,Female,HPV-related Cancer,mrna-4157 + keytruda,52.25,38.14,7819.099999999999,97,Partial Response
M203829,83,Female,HPV-related Cancer,mrna-4157 + keytruda,12.36,5.62,362.24,119,Progression
M203830,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.74,50.04,1068.58,71,Progression
M203831,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.79,32.89,1125.04,101,Partial Response
M203832,34,Other,Melanoma,mrna-4157 + keytruda,68.87,38.76,468.0,97,Complete Response
M203833,64,Other,HPV-related Cancer,KEYTRUDA only,61.22,57.93,520.71,78,Partial Response
M203834,66,Female,HPV-related Cancer,mrna-4157 + keytruda,51.13,24.09,1756.47,91,Partial Response
M203835,52,Other,Melanoma,KEYTRUDA only,39.3,28.19,96.07,89,Stable Disease
M203836,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,10.28,5.26,1177.38,83,Unknown
M203837,46,Female,Melanoma,mrna-4157 + keytruda,37.36,32.98,1426.74,91,Partial Response
M203838,69,Female,Melanoma,KEYTRUDA only,59.73,61.64,491.64,78,Partial Response
M203839,54,Male,Melanoma,KEYTRUDA only,24.46,17.46,724.69,76,Partial Response
M203840,84,Female,Melanoma,mrna-4157 + keytruda,35.94,28.57,1269.39,93,Complete Response
M203841,33,Male,Melanoma,mrna-4157 + keytruda,41.66,41.77,713.95,95,Stable Disease
M203842,74,Male,HPV-related Cancer,mrna-4157 + keytruda,62.97,58.01,910.79,93,Partial Response
M203843,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.02,,1491.23,95,Stable Disease
M203844,80,Other,Melanoma,KEYTRUDA only,58.85,67.82,1172.31,91,Progression
M203845,37,Other,Melanoma,KEYTRUDA only,70.79,42.04,891.36,84,Unknown
M203846,45,Other,HPV-related Cancer,KEYTRUDA only,37.86,25.71,491.43,95,Complete Response
M203847,27,Female,HPV-related Cancer,KEYTRUDA only,44.32,28.87,1520.75,94,Progression
M203848,40,Male,HPV-related Cancer,KEYTRUDA only,75.7,61.1,1281.74,98,Complete Response
M203849,31,Male,HPV-related Cancer,KEYTRUDA only,81.81,,1084.29,94,Partial Response
M203850,59,Male,HPV-related Cancer,mrna-4157 + keytruda,46.42,60.3,463.76,89,Stable Disease
M203851,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.22,,1325.08,93,Complete Response
M203852,68,Female,HPV-related Cancer,mrna-4157 + keytruda,40.11,44.34,1558.96,95,Partial Response
M203853,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.7,52.08,1223.56,92,Partial Response
M203854,29,Female,Melanoma,mrna-4157 + keytruda,100.17,46.22,1528.41,89,Complete Response
M203855,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,84.97,59.51,816.43,95,Stable Disease
M203856,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.86,22.8,2148.08,89,Progression
M203857,55,Female,HPV-related Cancer,mrna-4157 + keytruda,64.76,73.3,1040.81,81,Progression
M203858,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.33,25.38,1537.26,72,Stable Disease
M203859,63,Other,HPV-related Cancer,KEYTRUDA only,79.95,80.91,484.93,83,Unknown
M203860,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.16,71.84,250.35,84,Progression
M203861,41,Other,Melanoma,KEYTRUDA only,57.49,34.76,865.96,100,
M203862,55,Female,HPV-related Cancer,KEYTRUDA only,37.11,25.8,1763.41,117,Stable Disease
M203863,47,Female,Melanoma,mrna-4157 + keytruda,16.37,8.57,1675.3,97,Stable Disease
M203864,59,Male,HPV-related Cancer,KEYTRUDA only,51.94,25.27,844.22,97,Stable Disease
M203865,84,Other,Melanoma,mrna-4157 + keytruda,60.82,45.61,421.51,81,Complete Response
M203866,73,Other,HPV-related Cancer,KEYTRUDA only,65.84,50.11,1288.37,72,Partial Response
M203867,68,Female,Melanoma,KEYTRUDA only,28.03,20.87,912.18,94,Progression
M203868,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,30.21,12.51,1921.76,73,Progression
M203869,65,Male,HPV-related Cancer,mrna-4157 + keytruda,34.14,22.4,1037.23,72,Unknown
M203870,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.15,73.64,748.94,93,Complete Response
M203871,45,Male,HPV-related Cancer,mrna-4157 + keytruda,49.4,28.4,1049.22,99,Partial Response
M203872,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,9.82,7.68,1542.41,84,Progression
M203873,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.33,49.5,1394.14,88,Progression
M203874,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.53,35.74,619.43,95,Progression
M203875,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.92,53.45,118.85,76,Complete Response
M203876,30,Other,Melanoma,mrna-4157 + keytruda,65.56,37.59,1065.73,80,Partial Response
M203877,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,27.4,14.99,1021.32,98,Stable Disease
M203878,78,Female,HPV-related Cancer,mrna-4157 + keytruda,85.85,74.66,1170.12,98,Stable Disease
M203879,26,Other,Melanoma,mrna-4157 + keytruda,56.58,61.14,1194.53,90,Progression
M203880,34,Other,Melanoma,KEYTRUDA only,53.28,24.6,785.85,73,Stable Disease
M203881,51,Other,HPV-related Cancer,mrna-4157 + keytruda,37.28,40.5,1513.76,78,Partial Response
M203882,30,Other,Melanoma,KEYTRUDA only,-7.21,-6.76,1262.13,84,Progression
M203883,52,Female,HPV-related Cancer,mrna-4157 + keytruda,103.6,71.25,855.05,92,Progression
M203884,33,Female,Melanoma,mrna-4157 + keytruda,39.26,34.34,356.94,104,Progression
M203885,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.94,40.41,998.51,93,Partial Response
M203886,83,Female,HPV-related Cancer,mrna-4157 + keytruda,43.99,28.85,1211.54,89,Stable Disease
M203887,77,Female,Melanoma,KEYTRUDA only,64.29,56.37,816.17,97,Partial Response
M203888,82,Female,HPV-related Cancer,KEYTRUDA only,76.55,22.78,1000.88,103,Stable Disease
M203889,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.47,34.23,1263.37,87,Stable Disease
M203890,67,Other,Melanoma,mrna-4157 + keytruda,39.61,26.47,841.04,102,Unknown
M203891,55,Male,Melanoma,mrna-4157 + keytruda,38.73,25.7,1000.52,90,Partial Response
M203892,66,Other,Melanoma,mrna-4157 + keytruda,64.14,53.87,1130.76,87,Complete Response
M203893,64,Other,HPV-related Cancer,mrna-4157 + keytruda,62.67,80.07,800.51,94,Stable Disease
M203894,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,22.47,17.0,728.39,81,Stable Disease
M203895,45,Female,Melanoma,mrna-4157 + keytruda,62.23,,1155.85,88,Stable Disease
M203896,52,Male,Melanoma,mrna-4157 + keytruda,71.32,50.64,-175.07,92,Stable Disease
M203897,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-7.34,-3.29,1037.62,92,Partial Response
M203898,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.25,33.41,1481.92,91,Partial Response
M203899,36,Other,HPV-related Cancer,KEYTRUDA only,55.51,45.12,239.13,101,Partial Response
M203900,72,Female,HPV-related Cancer,KEYTRUDA only,56.27,47.81,404.63,78,Stable Disease
M203901,59,Female,HPV-related Cancer,KEYTRUDA only,38.82,43.77,1253.63,89,Progression
M203902,71,Female,Melanoma,KEYTRUDA only,24.53,22.49,730.79,72,Complete Response
M203903,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.19,47.76,714.11,108,Stable Disease
M203904,47,Female,Melanoma,KEYTRUDA only,63.51,26.58,590.54,96,Stable Disease
M203905,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.31,63.55,1443.43,73,Partial Response
M203906,83,Male,HPV-related Cancer,mrna-4157 + keytruda,31.1,25.78,1086.64,95,Stable Disease
M203907,61,Male,HPV-related Cancer,KEYTRUDA only,11.67,10.87,850.46,69,Progression
M203908,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.1,37.31,1652.16,81,Stable Disease
M203909,58,Male,Melanoma,mrna-4157 + keytruda,66.4,43.24,,76,Partial Response
M203910,35,Other,Melanoma,mrna-4157 + keytruda,109.48,40.38,1490.45,95,Partial Response
M203911,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.11,36.67,1484.07,91,Unknown
M203912,76,Male,HPV-related Cancer,mrna-4157 + keytruda,47.02,,1538.29,85,Partial Response
M203913,55,Male,Melanoma,mrna-4157 + keytruda,64.62,50.42,585.55,96,Stable Disease
M203914,51,Other,Melanoma,KEYTRUDA only,77.86,39.92,1216.81,103,Complete Response
M203915,35,Male,HPV-related Cancer,KEYTRUDA only,86.95,83.41,1167.54,117,Partial Response
M203916,76,Female,HPV-related Cancer,KEYTRUDA only,64.93,57.37,824.29,91,Partial Response
M203917,35,Male,Melanoma,mrna-4157 + keytruda,69.58,61.79,,83,Stable Disease
M203918,61,Other,Melanoma,KEYTRUDA only,53.3,14.24,878.22,91,Stable Disease
M203919,68,Other,Melanoma,KEYTRUDA only,81.12,66.57,301.32,90,Progression
M203920,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.8,22.89,2077.99,85,Progression
M203921,74,Male,Melanoma,mrna-4157 + keytruda,57.75,42.94,930.53,87,Stable Disease
M203922,70,Other,HPV-related Cancer,KEYTRUDA only,31.92,22.31,1724.78,112,Progression
M203923,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,90.99,65.91,,78,Stable Disease
M203924,74,Male,HPV-related Cancer,KEYTRUDA only,40.46,42.55,1935.96,114,Unknown
M203925,59,Other,HPV-related Cancer,KEYTRUDA only,24.1,14.54,581.12,97,Stable Disease
M203926,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.43,31.0,758.52,75,Partial Response
M203927,48,Other,Melanoma,mrna-4157 + keytruda,39.67,,,80,Complete Response
M203928,51,Female,Melanoma,mrna-4157 + keytruda,35.59,17.76,306.66,90,Stable Disease
M203929,71,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.62,23.74,1206.2,86,Stable Disease
M203930,75,Female,Melanoma,mrna-4157 + keytruda,65.96,74.37,832.49,96,Progression
M203931,52,Male,Melanoma,mrna-4157 + keytruda,50.35,34.71,954.63,110,Stable Disease
M203932,30,Other,Melanoma,KEYTRUDA only,78.72,42.47,747.23,75,Partial Response
M203933,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.91,33.26,885.01,85,Stable Disease
M203934,43,Male,Melanoma,KEYTRUDA only,97.03,75.93,817.07,93,Stable Disease
M203935,54,Male,Melanoma,mrna-4157 + keytruda,39.53,37.28,1027.65,81,Stable Disease
M203936,78,Male,HPV-related Cancer,mrna-4157 + keytruda,29.62,16.65,1275.99,78,Unknown
M203937,75,Female,HPV-related Cancer,mrna-4157 + keytruda,9.33,6.39,697.45,101,
M203938,26,Male,HPV-related Cancer,mrna-4157 + keytruda,45.44,45.89,1149.42,72,Stable Disease
M203939,83,Male,Melanoma,KEYTRUDA only,75.62,65.72,1521.33,82,Complete Response
M203940,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.05,35.66,1208.88,89,Progression
M203941,30,Other,HPV-related Cancer,KEYTRUDA only,60.24,36.76,533.32,73,Partial Response
M203942,37,Male,Melanoma,KEYTRUDA only,57.41,63.79,1215.94,100,Partial Response
M203943,58,Other,HPV-related Cancer,mrna-4157 + keytruda,16.97,18.54,1020.3,86,Partial Response
M203944,26,Male,HPV-related Cancer,mrna-4157 + keytruda,34.03,24.41,891.49,75,Progression
M203945,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.23,56.18,1130.91,85,Progression
M203946,41,Male,HPV-related Cancer,KEYTRUDA only,29.02,32.1,351.67,84,Partial Response
M203947,37,Female,Melanoma,mrna-4157 + keytruda,52.93,47.46,915.75,118,Partial Response
M203948,50,Other,Melanoma,mrna-4157 + keytruda,75.15,48.28,1296.25,115,Unknown
M203949,67,Female,HPV-related Cancer,KEYTRUDA only,84.66,93.52,1139.63,103,Stable Disease
M203950,56,Other,HPV-related Cancer,KEYTRUDA only,56.52,38.99,820.91,95,
M203951,62,Female,HPV-related Cancer,mrna-4157 + keytruda,56.95,51.82,1294.83,80,Complete Response
M203952,59,Female,Melanoma,mrna-4157 + keytruda,9.89,8.96,870.2,92,Progression
M203953,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.85,14.93,1305.78,91,Stable Disease
M203954,50,Male,HPV-related Cancer,mrna-4157 + keytruda,96.2,112.61,1461.15,95,Stable Disease
M203955,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.11,71.01,992.97,84,Complete Response
M203956,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,8.27,5.87,1721.6,87,Partial Response
M203957,38,Male,Melanoma,KEYTRUDA only,32.13,31.37,,90,Stable Disease
M203958,27,Female,HPV-related Cancer,mrna-4157 + keytruda,47.23,25.08,1197.54,96,Progression
M203959,40,Other,HPV-related Cancer,mrna-4157 + keytruda,27.78,13.51,1273.29,90,Partial Response
M203960,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.93,26.43,830.81,72,Complete Response
M203961,69,Other,HPV-related Cancer,KEYTRUDA only,30.3,29.65,1010.79,91,Complete Response
M203962,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.43,50.19,1010.27,80,
M203963,76,Female,HPV-related Cancer,mrna-4157 + keytruda,31.31,28.22,1276.82,90,Stable Disease
M203964,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.84,31.19,661.71,82,Progression
M203965,64,Male,Melanoma,KEYTRUDA only,44.9,20.43,1273.55,90,Stable Disease
M203966,72,Male,Melanoma,KEYTRUDA only,41.62,22.8,1100.95,87,Stable Disease
M203967,65,Other,Melanoma,mrna-4157 + keytruda,31.27,20.47,1073.55,96,Progression
M203968,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.47,24.66,1396.58,103,Complete Response
M203969,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.66,26.46,1121.49,96,Progression
M203970,80,Other,Melanoma,mrna-4157 + keytruda,74.56,,579.25,66,Stable Disease
M203971,81,Female,Melanoma,mrna-4157 + keytruda,32.13,,-126.53,88,Partial Response
M203972,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.18,,914.15,92,
M203973,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.87,68.44,746.82,93,Stable Disease
M203974,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.94,,696.08,105,Stable Disease
M203975,77,Female,HPV-related Cancer,KEYTRUDA only,35.46,29.66,1222.15,102,
M203976,50,Other,HPV-related Cancer,mrna-4157 + keytruda,30.32,29.12,553.25,102,Complete Response
M203977,41,Other,Melanoma,mrna-4157 + keytruda,54.39,34.74,789.82,90,Complete Response
M203978,42,Male,HPV-related Cancer,KEYTRUDA only,79.01,38.46,1220.89,79,Partial Response
M203979,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.93,7.09,1556.79,98,Complete Response
M203980,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.5,60.98,986.4,95,Stable Disease
M203981,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,82.31,76.23,1354.9,91,Partial Response
M203982,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.86,35.51,1130.33,90,Complete Response
M203983,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.87,37.5,933.4,86,
M203984,62,Other,HPV-related Cancer,mrna-4157 + keytruda,32.27,25.61,,90,Stable Disease
M203985,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.36,29.21,,87,Progression
M203986,31,Other,Melanoma,KEYTRUDA only,90.25,54.55,1035.85,86,Stable Disease
M203987,28,Female,Melanoma,KEYTRUDA only,66.48,68.79,1163.72,109,Progression
M203988,47,Female,HPV-related Cancer,mrna-4157 + keytruda,61.55,43.25,1509.02,87,Partial Response
M203989,25,Female,Melanoma,mrna-4157 + keytruda,33.43,22.83,1473.76,80,Partial Response
M203990,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.82,34.42,944.67,111,Stable Disease
M203991,36,Female,HPV-related Cancer,KEYTRUDA only,55.51,26.28,1321.24,81,Progression
M203992,59,Female,Melanoma,KEYTRUDA only,66.95,39.83,1002.67,98,Complete Response
M203993,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.88,64.42,462.38,91,Progression
M203994,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.97,54.11,,86,Stable Disease
M203995,40,Female,Melanoma,mrna-4157 + keytruda,50.09,46.92,672.22,102,Partial Response
M203996,47,Female,HPV-related Cancer,KEYTRUDA only,63.5,71.63,652.03,92,Complete Response
M203997,35,Other,HPV-related Cancer,mrna-4157 + keytruda,33.12,,1281.98,90,Progression
M203998,43,Female,HPV-related Cancer,KEYTRUDA only,42.47,36.34,575.2,109,Partial Response
M203999,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.49,58.52,947.72,94,Unknown
M204000,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,75.87,37.32,1677.52,87,Partial Response
M204001,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.57,78.38,1161.06,90,Unknown
M204002,70,Other,Melanoma,KEYTRUDA only,25.92,13.34,1445.46,100,Unknown
M204003,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.02,25.81,,77,Stable Disease
M204004,59,Female,Melanoma,mrna-4157 + keytruda,41.41,20.35,905.5,90,Stable Disease
M204005,57,Male,HPV-related Cancer,KEYTRUDA only,23.27,17.82,721.12,93,Complete Response
M204006,59,Female,Melanoma,mrna-4157 + keytruda,23.92,17.98,1099.69,84,Progression
M204007,39,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.28,37.19,1368.78,94,Complete Response
M204008,74,Male,Melanoma,mrna-4157 + keytruda,47.55,38.94,,86,Partial Response
M204009,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.21,17.04,380.97,69,Progression
M204010,44,Female,HPV-related Cancer,mrna-4157 + keytruda,49.28,62.43,1247.73,97,Unknown
M204011,30,Female,Melanoma,KEYTRUDA only,49.17,,1012.62,77,Stable Disease
M204012,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.19,53.24,536.31,93,Stable Disease
M204013,41,Other,HPV-related Cancer,KEYTRUDA only,100.71,94.92,926.12,89,Stable Disease
M204014,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.1,31.89,638.76,83,Stable Disease
M204015,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.22,10.04,544.62,83,Complete Response
M204016,50,Female,HPV-related Cancer,KEYTRUDA only,47.41,46.11,1329.21,87,Partial Response
M204017,31,Female,Melanoma,mrna-4157 + keytruda,63.4,50.91,1293.15,86,Stable Disease
M204018,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.27,17.3,134.77,90,Complete Response
M204019,55,Male,Melanoma,mrna-4157 + keytruda,28.03,19.26,738.91,87,Progression
M204020,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.54,64.86,1266.71,84,Complete Response
M204021,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,47.35,38.37,1396.18,88,
M204022,72,Female,Melanoma,KEYTRUDA only,50.86,21.29,1335.2,88,Stable Disease
M204023,82,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.6,46.06,912.24,91,Partial Response
M204024,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,76.48,53.6,557.42,87,Partial Response
M204025,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.11,26.47,282.63,112,Partial Response
M204026,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.11,34.57,1311.27,86,Stable Disease
M204027,51,Female,HPV-related Cancer,mrna-4157 + keytruda,71.7,78.56,1101.53,90,Stable Disease
M204028,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.38,47.54,605.19,81,Complete Response
M204029,63,Other,HPV-related Cancer,mrna-4157 + keytruda,39.96,32.96,1270.06,89,Stable Disease
M204030,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.91,39.46,1050.0,91,Stable Disease
M204031,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.26,10.31,923.86,90,Unknown
M204032,40,Male,HPV-related Cancer,mrna-4157 + keytruda,46.24,35.91,1388.86,91,Partial Response
M204033,36,Male,HPV-related Cancer,mrna-4157 + keytruda,25.23,27.77,1684.98,91,Progression
M204034,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.25,29.87,700.15,82,Unknown
M204035,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.57,,859.49,89,Partial Response
M204036,51,Male,Melanoma,mrna-4157 + keytruda,57.2,41.0,1042.57,86,Partial Response
M204037,30,Male,Melanoma,mrna-4157 + keytruda,14.99,8.85,1115.93,97,Stable Disease
M204038,25,Male,HPV-related Cancer,KEYTRUDA only,87.03,60.54,871.1,88,Stable Disease
M204039,67,Other,Melanoma,KEYTRUDA only,104.63,78.32,851.89,92,Stable Disease
M204040,51,Other,HPV-related Cancer,mrna-4157 + keytruda,45.77,31.44,1173.36,86,Stable Disease
M204041,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.42,,205.93,85,
M204042,59,Other,Melanoma,KEYTRUDA only,25.21,12.37,797.6,75,Partial Response
M204043,25,Male,Melanoma,KEYTRUDA only,42.81,41.77,1491.89,78,Stable Disease
M204044,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.92,30.34,651.83,98,
M204045,44,Other,HPV-related Cancer,KEYTRUDA only,39.07,41.6,899.71,87,Progression
M204046,51,Male,HPV-related Cancer,KEYTRUDA only,71.49,37.75,1600.8000000000002,81,Progression
M204047,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.8,8.12,1151.25,96,Partial Response
M204048,57,Other,HPV-related Cancer,mrna-4157 + keytruda,46.74,47.59,1526.84,110,Stable Disease
M204049,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.2,19.25,1110.82,96,Progression
M204050,34,Male,HPV-related Cancer,mrna-4157 + keytruda,40.8,32.66,1410.88,101,Complete Response
M204051,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.57,27.43,,86,Partial Response
M204052,64,Other,HPV-related Cancer,mrna-4157 + keytruda,65.76,65.99,91.74,84,Progression
M204053,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.08,19.55,187.75,76,Partial Response
M204054,38,Other,HPV-related Cancer,mrna-4157 + keytruda,41.42,37.72,555.45,88,Complete Response
M204055,28,Male,Melanoma,KEYTRUDA only,25.78,28.15,967.6,101,Progression
M204056,37,Male,HPV-related Cancer,mrna-4157 + keytruda,32.44,25.01,1175.2,91,Partial Response
M204057,50,Male,HPV-related Cancer,mrna-4157 + keytruda,41.45,26.77,1305.19,97,Progression
M204058,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.52,61.56,471.68,91,Partial Response
M204059,78,Male,Melanoma,KEYTRUDA only,15.41,14.06,426.43,87,Stable Disease
M204060,62,Male,Melanoma,KEYTRUDA only,38.21,30.43,1457.67,87,Partial Response
M204061,73,Male,HPV-related Cancer,mrna-4157 + keytruda,91.7,56.85,,86,Complete Response
M204062,83,Female,HPV-related Cancer,mrna-4157 + keytruda,39.54,22.0,512.84,100,Partial Response
M204063,74,Female,Melanoma,KEYTRUDA only,58.96,49.16,1071.91,95,Stable Disease
M204064,65,Male,HPV-related Cancer,KEYTRUDA only,7.47,9.23,908.59,88,Stable Disease
M204065,70,Other,HPV-related Cancer,mrna-4157 + keytruda,91.68,57.66,560.55,86,Progression
M204066,76,Other,HPV-related Cancer,KEYTRUDA only,43.32,36.03,975.04,91,Stable Disease
M204067,34,Male,HPV-related Cancer,mrna-4157 + keytruda,42.96,34.37,969.66,114,Partial Response
M204068,34,Male,HPV-related Cancer,mrna-4157 + keytruda,48.16,,1017.16,87,Complete Response
M204069,32,Male,Melanoma,mrna-4157 + keytruda,47.06,45.83,744.84,77,Progression
M204070,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.52,19.53,1087.65,81,Stable Disease
M204071,36,Other,HPV-related Cancer,mrna-4157 + keytruda,36.4,27.0,718.29,94,Unknown
M204072,40,Other,Melanoma,KEYTRUDA only,39.7,57.86,1700.47,96,Complete Response
M204073,50,Female,Non-small Cell Lung Cancer,KEYTRUDA only,28.36,18.0,1082.78,85,Stable Disease
M204074,68,Male,HPV-related Cancer,KEYTRUDA only,50.78,47.94,,102,Complete Response
M204075,45,Female,Melanoma,mrna-4157 + keytruda,56.26,41.51,2474.91,102,Complete Response
M204076,56,Male,Melanoma,mrna-4157 + keytruda,25.51,17.08,1079.76,99,Progression
M204077,67,Female,Melanoma,mrna-4157 + keytruda,57.92,38.09,1272.74,86,Progression
M204078,29,Other,Melanoma,mrna-4157 + keytruda,20.93,22.19,572.74,80,
M204079,44,Male,Melanoma,mrna-4157 + keytruda,68.83,55.21,,72,Partial Response
M204080,61,Other,HPV-related Cancer,mrna-4157 + keytruda,77.35,61.69,1334.72,85,Complete Response
M204081,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,6.95,3.13,1644.93,82,Partial Response
M204082,84,Female,HPV-related Cancer,mrna-4157 + keytruda,32.16,25.26,1152.96,90,Partial Response
M204083,33,Male,HPV-related Cancer,mrna-4157 + keytruda,62.48,43.22,806.15,89,Unknown
M204084,66,Other,Melanoma,mrna-4157 + keytruda,94.16,79.43,507.36,93,
M204085,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.68,46.92,1213.12,75,Progression
M204086,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.86,35.48,,88,Partial Response
M204087,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.76,34.42,548.82,105,Partial Response
M204088,78,Female,Melanoma,mrna-4157 + keytruda,56.9,,565.18,74,Stable Disease
M204089,59,Male,Melanoma,KEYTRUDA only,56.97,40.71,1852.08,94,Unknown
M204090,58,Other,Melanoma,mrna-4157 + keytruda,27.24,20.05,1228.25,95,Progression
M204091,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.63,,-89.37,88,Partial Response
M204092,45,Other,Melanoma,KEYTRUDA only,25.97,14.96,322.18,101,Stable Disease
M204093,76,Female,Melanoma,mrna-4157 + keytruda,52.99,40.47,983.56,79,Stable Disease
M204094,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.92,17.41,890.01,82,Partial Response
M204095,66,Female,Melanoma,mrna-4157 + keytruda,63.74,48.7,408.05,105,Partial Response
M204096,78,Other,Melanoma,mrna-4157 + keytruda,68.3,55.55,971.35,87,Stable Disease
M204097,83,Male,HPV-related Cancer,mrna-4157 + keytruda,32.94,26.33,1065.86,91,Complete Response
M204098,27,Other,HPV-related Cancer,KEYTRUDA only,55.35,39.86,1981.19,106,Partial Response
M204099,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.87,80.42,1180.66,81,Stable Disease
M204100,53,Male,HPV-related Cancer,KEYTRUDA only,76.19,51.36,1147.67,97,Partial Response
M204101,67,Male,HPV-related Cancer,mrna-4157 + keytruda,62.49,45.76,,92,Unknown
M204102,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.18,30.42,962.87,92,Partial Response
M204103,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.62,26.27,1473.73,91,Unknown
M204104,79,Female,HPV-related Cancer,KEYTRUDA only,45.69,52.24,1125.76,82,Stable Disease
M204105,50,Female,Melanoma,mrna-4157 + keytruda,48.93,31.9,437.44,78,Progression
M204106,65,Female,Melanoma,mrna-4157 + keytruda,39.28,32.69,1676.61,104,Partial Response
M204107,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.19,47.34,1335.52,86,Progression
M204108,40,Other,Melanoma,mrna-4157 + keytruda,32.03,24.67,422.81,88,Partial Response
M204109,42,Other,Melanoma,mrna-4157 + keytruda,21.08,20.99,1316.92,85,Complete Response
M204110,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.84,8.19,1284.99,79,Complete Response
M204111,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.73,11.49,736.31,80,Unknown
M204112,43,Male,HPV-related Cancer,mrna-4157 + keytruda,87.95,76.21,,79,Partial Response
M204113,44,Male,HPV-related Cancer,mrna-4157 + keytruda,31.27,22.66,100.48,103,Complete Response
M204114,76,Male,Melanoma,KEYTRUDA only,35.73,,900.52,97,Partial Response
M204115,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.65,52.13,1618.82,90,
M204116,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.91,53.78,816.95,96,Stable Disease
M204117,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.08,32.14,1897.17,82,Unknown
M204118,59,Other,Melanoma,mrna-4157 + keytruda,31.37,12.58,1032.6,100,Stable Disease
M204119,45,Male,Melanoma,mrna-4157 + keytruda,41.58,46.5,473.15,80,Partial Response
M204120,67,Other,Non-small Cell Lung Cancer,KEYTRUDA only,72.55,28.55,298.84,80,Partial Response
M204121,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.66,44.95,1042.68,102,Complete Response
M204122,67,Male,Melanoma,KEYTRUDA only,57.51,50.96,1356.4,85,Stable Disease
M204123,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.54,20.17,1119.31,85,Stable Disease
M204124,61,Male,HPV-related Cancer,KEYTRUDA only,64.08,52.18,925.07,82,Partial Response
M204125,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.47,22.9,1414.11,110,
M204126,41,Male,HPV-related Cancer,mrna-4157 + keytruda,50.98,35.5,1059.97,87,Partial Response
M204127,25,Other,HPV-related Cancer,KEYTRUDA only,71.52,56.59,996.45,83,Progression
M204128,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.06,,1112.33,91,Stable Disease
M204129,56,Other,HPV-related Cancer,mrna-4157 + keytruda,60.25,69.83,920.06,107,Stable Disease
M204130,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.01,17.22,530.14,86,Stable Disease
M204131,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,86.3,,1123.6,79,Partial Response
M204132,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.0,31.6,813.11,82,Stable Disease
M204133,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.23,,1222.7,113,Progression
M204134,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.05,,,85,Stable Disease
M204135,27,Male,HPV-related Cancer,mrna-4157 + keytruda,36.14,42.49,761.84,91,Stable Disease
M204136,67,Other,Melanoma,KEYTRUDA only,71.19,42.58,2069.55,101,Complete Response
M204137,67,Male,Melanoma,mrna-4157 + keytruda,36.3,26.95,1410.73,83,Progression
M204138,57,Female,HPV-related Cancer,mrna-4157 + keytruda,39.2,24.43,1121.43,83,
M204139,78,Other,HPV-related Cancer,KEYTRUDA only,25.87,11.24,1482.69,98,Progression
M204140,40,Female,Melanoma,mrna-4157 + keytruda,47.0,41.59,1403.05,89,Stable Disease
M204141,63,Other,HPV-related Cancer,mrna-4157 + keytruda,33.29,,971.58,95,Progression
M204142,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,22.53,15.75,1108.11,104,Partial Response
M204143,72,Female,HPV-related Cancer,mrna-4157 + keytruda,83.11,42.34,534.68,75,Progression
M204144,43,Female,Melanoma,KEYTRUDA only,58.95,22.95,1436.05,82,Partial Response
M204145,37,Female,Melanoma,KEYTRUDA only,80.05,73.15,784.32,99,Progression
M204146,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.49,37.79,730.91,79,Partial Response
M204147,78,Female,HPV-related Cancer,KEYTRUDA only,103.05,59.2,970.85,87,Partial Response
M204148,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.29,18.57,1369.21,94,Progression
M204149,33,Male,HPV-related Cancer,mrna-4157 + keytruda,90.39,71.86,1581.13,86,Stable Disease
M204150,72,Other,Melanoma,KEYTRUDA only,9.75,8.05,1021.0,103,Stable Disease
M204151,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.51,70.97,816.15,84,Progression
M204152,78,Other,HPV-related Cancer,KEYTRUDA only,40.95,26.72,1132.15,82,Partial Response
M204153,30,Female,Melanoma,mrna-4157 + keytruda,73.42,67.58,1156.32,86,Partial Response
M204154,50,Female,Non-small Cell Lung Cancer,KEYTRUDA only,65.44,22.94,459.54,97,
M204155,47,Other,Melanoma,mrna-4157 + keytruda,66.96,52.15,1287.94,102,Partial Response
M204156,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.46,19.45,1045.85,78,Progression
M204157,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.73,56.33,1200.89,87,Stable Disease
M204158,45,Male,HPV-related Cancer,mrna-4157 + keytruda,90.94,65.68,700.04,96,Partial Response
M204159,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.13,49.66,1214.31,81,Partial Response
M204160,71,Female,HPV-related Cancer,mrna-4157 + keytruda,26.92,26.62,538.85,95,Partial Response
M204161,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,76.54,62.64,950.38,105,Complete Response
M204162,65,Other,HPV-related Cancer,KEYTRUDA only,40.65,37.74,1154.28,94,Partial Response
M204163,53,Female,Melanoma,KEYTRUDA only,32.59,19.18,1560.99,107,Partial Response
M204164,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,57.27,21.75,744.02,84,Progression
M204165,60,Other,Melanoma,KEYTRUDA only,52.16,32.91,794.23,88,Progression
M204166,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,103.06,95.46,1832.16,93,Partial Response
M204167,67,Other,Melanoma,mrna-4157 + keytruda,51.04,41.32,701.13,78,Complete Response
M204168,54,Other,HPV-related Cancer,KEYTRUDA only,26.51,20.96,1008.06,89,Complete Response
M204169,73,Other,HPV-related Cancer,mrna-4157 + keytruda,41.49,30.24,564.39,89,Progression
M204170,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.24,28.58,1291.63,75,Partial Response
M204171,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,7.8,7.7,1141.03,100,Complete Response
M204172,62,Other,HPV-related Cancer,KEYTRUDA only,80.95,71.42,1372.12,86,Partial Response
M204173,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.33,30.23,647.07,102,Partial Response
M204174,79,Male,HPV-related Cancer,mrna-4157 + keytruda,48.24,51.68,1349.3,92,Partial Response
M204175,48,Other,Melanoma,mrna-4157 + keytruda,41.42,38.09,867.09,93,Partial Response
M204176,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.92,21.77,76.58,103,Stable Disease
M204177,73,Male,HPV-related Cancer,KEYTRUDA only,53.61,41.89,,82,Progression
M204178,31,Male,Melanoma,mrna-4157 + keytruda,19.9,19.67,2090.5,87,Stable Disease
M204179,72,Female,HPV-related Cancer,KEYTRUDA only,47.74,35.8,2008.02,76,Stable Disease
M204180,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.39,33.87,586.92,88,Stable Disease
M204181,44,Other,Melanoma,KEYTRUDA only,48.33,31.7,1241.15,103,
M204182,57,Male,Melanoma,KEYTRUDA only,67.65,50.88,810.48,83,Progression
M204183,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.55,14.53,1504.8,92,Partial Response
M204184,48,Female,HPV-related Cancer,KEYTRUDA only,50.15,22.71,1077.59,104,Stable Disease
M204185,39,Other,Melanoma,KEYTRUDA only,55.24,45.98,1330.62,86,Complete Response
M204186,64,Other,Melanoma,KEYTRUDA only,33.43,32.41,1132.85,92,Partial Response
M204187,75,Male,Melanoma,KEYTRUDA only,63.6,53.79,717.28,61,Progression
M204188,81,Male,Melanoma,mrna-4157 + keytruda,53.36,27.22,,80,Complete Response
M204189,49,Other,HPV-related Cancer,mrna-4157 + keytruda,62.42,50.04,801.04,76,Complete Response
M204190,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.62,,1619.62,98,Stable Disease
M204191,78,Male,Melanoma,KEYTRUDA only,77.5,16.95,1162.74,76,Progression
M204192,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.32,54.25,1336.52,83,Complete Response
M204193,47,Female,Melanoma,mrna-4157 + keytruda,72.79,36.44,326.1,82,Unknown
M204194,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.27,37.96,638.55,93,Partial Response
M204195,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.92,69.41,1274.64,90,Stable Disease
M204196,69,Male,HPV-related Cancer,mrna-4157 + keytruda,67.22,49.67,1466.24,110,Partial Response
M204197,58,Female,HPV-related Cancer,mrna-4157 + keytruda,44.26,30.65,882.07,86,Partial Response
M204198,44,Male,HPV-related Cancer,KEYTRUDA only,47.49,30.95,1376.35,113,Partial Response
M204199,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.13,44.4,1131.01,97,Complete Response
M204200,25,Other,HPV-related Cancer,mrna-4157 + keytruda,55.67,51.66,954.27,94,Stable Disease
M204201,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.42,50.59,,116,Partial Response
M204202,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.96,68.39,-16.55,91,Progression
M204203,53,Male,HPV-related Cancer,KEYTRUDA only,70.63,58.6,,85,Progression
M204204,71,Male,HPV-related Cancer,mrna-4157 + keytruda,51.2,56.43,1165.94,93,Unknown
M204205,57,Other,Melanoma,mrna-4157 + keytruda,42.59,30.78,263.44,99,Partial Response
M204206,62,Male,Melanoma,mrna-4157 + keytruda,82.22,65.65,1741.82,91,Stable Disease
M204207,82,Other,Melanoma,mrna-4157 + keytruda,49.25,40.36,1309.8,63,Stable Disease
M204208,50,Male,Melanoma,KEYTRUDA only,64.55,36.99,1256.25,90,Partial Response
M204209,55,Other,HPV-related Cancer,mrna-4157 + keytruda,35.79,35.23,860.65,93,Unknown
M204210,59,Female,HPV-related Cancer,KEYTRUDA only,36.21,31.3,734.22,108,Stable Disease
M204211,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.33,33.14,1006.21,77,Partial Response
M204212,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,70.41,62.39,957.72,93,Partial Response
M204213,82,Female,Melanoma,KEYTRUDA only,40.44,32.3,1285.07,89,Partial Response
M204214,40,Male,Melanoma,KEYTRUDA only,14.55,12.76,,94,Progression
M204215,60,Female,HPV-related Cancer,KEYTRUDA only,41.02,34.75,1035.9,90,Partial Response
M204216,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.78,56.43,521.55,84,Stable Disease
M204217,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.98,40.38,484.5,80,Partial Response
M204218,84,Other,Melanoma,mrna-4157 + keytruda,60.32,61.03,1847.71,80,Complete Response
M204219,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,86.96,58.26,136.5,102,Partial Response
M204220,46,Female,Melanoma,mrna-4157 + keytruda,76.88,,338.83,82,Stable Disease
M204221,43,Other,Melanoma,mrna-4157 + keytruda,48.88,54.3,972.81,86,Stable Disease
M204222,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.03,17.96,1413.26,114,Partial Response
M204223,31,Male,HPV-related Cancer,KEYTRUDA only,53.55,55.5,324.76,89,Progression
M204224,35,Female,Melanoma,mrna-4157 + keytruda,47.65,34.71,864.64,82,Complete Response
M204225,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.82,40.03,1689.67,93,Partial Response
M204226,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.99,74.86,1108.2,101,Unknown
M204227,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.69,14.97,924.9,110,Partial Response
M204228,72,Male,HPV-related Cancer,mrna-4157 + keytruda,37.56,29.56,1089.87,97,Partial Response
M204229,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.51,29.65,920.91,101,Unknown
M204230,53,Female,Melanoma,KEYTRUDA only,50.29,42.84,1390.61,89,Progression
M204231,26,Male,HPV-related Cancer,mrna-4157 + keytruda,52.53,33.74,1494.49,96,Partial Response
M204232,77,Male,Melanoma,KEYTRUDA only,18.13,18.34,989.41,77,Complete Response
M204233,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.92,37.19,1053.77,83,Stable Disease
M204234,33,Other,Melanoma,mrna-4157 + keytruda,30.07,27.82,894.86,79,Complete Response
M204235,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.74,37.72,902.34,111,Unknown
M204236,51,Female,Melanoma,KEYTRUDA only,48.86,,1330.73,98,Complete Response
M204237,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.82,,746.72,98,Partial Response
M204238,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.51,21.16,1067.15,105,Partial Response
M204239,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.55,52.31,,96,
M204240,54,Male,HPV-related Cancer,mrna-4157 + keytruda,46.01,41.59,1288.34,79,Stable Disease
M204241,50,Other,HPV-related Cancer,mrna-4157 + keytruda,46.61,31.43,1010.62,102,Stable Disease
M204242,55,Male,Melanoma,mrna-4157 + keytruda,36.21,41.12,1308.99,91,Stable Disease
M204243,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.22,27.12,1417.48,91,Partial Response
M204244,56,Male,HPV-related Cancer,mrna-4157 + keytruda,46.16,31.06,1094.5,96,Partial Response
M204245,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.82,52.78,853.48,76,Progression
M204246,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.1,30.83,980.86,85,Progression
M204247,38,Male,Melanoma,mrna-4157 + keytruda,69.02,70.37,746.54,92,Stable Disease
M204248,66,Male,Melanoma,KEYTRUDA only,75.95,66.97,1730.15,94,Progression
M204249,75,Male,Melanoma,mrna-4157 + keytruda,46.71,37.86,1121.55,88,
M204250,31,Female,Melanoma,mrna-4157 + keytruda,76.13,52.8,700.99,76,Progression
M204251,35,Male,HPV-related Cancer,mrna-4157 + keytruda,49.81,22.54,685.37,97,Progression
M204252,49,Female,HPV-related Cancer,KEYTRUDA only,44.84,38.78,853.69,86,Stable Disease
M204253,57,Male,Melanoma,mrna-4157 + keytruda,-14.25,-8.43,,85,Complete Response
M204254,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.69,28.16,1308.33,95,Partial Response
M204255,74,Female,Melanoma,mrna-4157 + keytruda,73.99,59.51,,92,Partial Response
M204256,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.0,57.16,1072.26,102,
M204257,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.05,40.14,1595.03,88,Stable Disease
M204258,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.55,46.97,863.36,80,Partial Response
M204259,49,Male,HPV-related Cancer,KEYTRUDA only,37.32,25.19,827.9,89,
M204260,69,Other,Melanoma,mrna-4157 + keytruda,31.46,32.93,631.76,94,Partial Response
M204261,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.95,8.54,893.65,86,Progression
M204262,63,Other,HPV-related Cancer,KEYTRUDA only,42.78,37.15,1377.72,88,Complete Response
M204263,71,Other,HPV-related Cancer,mrna-4157 + keytruda,63.09,47.5,611.08,80,Progression
M204264,72,Male,Melanoma,mrna-4157 + keytruda,44.72,56.01,1127.39,84,Stable Disease
M204265,25,Other,Melanoma,mrna-4157 + keytruda,51.43,24.86,1488.04,77,Partial Response
M204266,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.06,59.9,-173.35,84,Partial Response
M204267,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.37,18.75,412.04,94,Partial Response
M204268,69,Female,Melanoma,mrna-4157 + keytruda,53.95,38.75,1335.14,88,Progression
M204269,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.78,16.0,1345.32,104,Complete Response
M204270,43,Other,Melanoma,mrna-4157 + keytruda,5.37,,488.28,101,Progression
M204271,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.88,13.44,1204.78,80,Stable Disease
M204272,47,Other,Melanoma,mrna-4157 + keytruda,72.14,49.18,1375.75,77,
M204273,84,Female,Melanoma,mrna-4157 + keytruda,42.03,39.44,1210.37,98,Partial Response
M204274,44,Male,HPV-related Cancer,KEYTRUDA only,47.6,50.8,821.53,94,Complete Response
M204275,29,Other,HPV-related Cancer,KEYTRUDA only,64.96,36.4,664.41,93,Stable Disease
M204276,71,Other,Melanoma,mrna-4157 + keytruda,29.16,27.97,1407.73,86,Stable Disease
M204277,45,Male,Melanoma,KEYTRUDA only,16.46,16.84,654.13,86,Progression
M204278,49,Other,HPV-related Cancer,KEYTRUDA only,47.62,39.02,1431.58,94,Partial Response
M204279,43,Other,HPV-related Cancer,mrna-4157 + keytruda,43.24,,1096.0,87,Progression
M204280,56,Other,HPV-related Cancer,mrna-4157 + keytruda,37.0,25.63,919.76,82,Partial Response
M204281,78,Male,Melanoma,mrna-4157 + keytruda,36.39,40.05,782.59,95,Partial Response
M204282,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.5,27.9,349.92,82,Stable Disease
M204283,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.98,52.23,1247.96,98,Progression
M204284,74,Other,HPV-related Cancer,mrna-4157 + keytruda,100.35,69.56,1724.88,90,Stable Disease
M204285,54,Female,Melanoma,mrna-4157 + keytruda,55.18,31.97,925.0,78,Partial Response
M204286,76,Female,HPV-related Cancer,mrna-4157 + keytruda,48.55,36.4,1111.52,80,Progression
M204287,47,Female,Melanoma,mrna-4157 + keytruda,32.36,25.07,514.26,93,Stable Disease
M204288,66,Male,Melanoma,KEYTRUDA only,41.31,29.69,1345.78,86,Stable Disease
M204289,32,Male,HPV-related Cancer,KEYTRUDA only,73.53,52.52,1550.36,81,Progression
M204290,55,Male,Melanoma,mrna-4157 + keytruda,42.6,38.63,997.8,66,Partial Response
M204291,30,Other,HPV-related Cancer,KEYTRUDA only,44.64,36.81,1181.49,90,Complete Response
M204292,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.48,23.85,1610.25,82,Partial Response
M204293,51,Other,HPV-related Cancer,KEYTRUDA only,32.9,31.97,1292.51,94,Complete Response
M204294,69,Other,Melanoma,KEYTRUDA only,73.85,85.22,764.81,73,Progression
M204295,35,Male,HPV-related Cancer,KEYTRUDA only,82.15,82.22,1103.52,83,Progression
M204296,39,Female,Melanoma,mrna-4157 + keytruda,44.32,,1330.09,92,Partial Response
M204297,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.87,46.7,1018.21,92,Stable Disease
M204298,79,Male,HPV-related Cancer,KEYTRUDA only,38.49,36.81,1058.35,92,Partial Response
M204299,56,Male,Melanoma,KEYTRUDA only,35.27,25.32,1006.15,91,Partial Response
M204300,41,Other,Melanoma,KEYTRUDA only,14.23,10.59,,99,Progression
M204301,38,Male,Melanoma,KEYTRUDA only,64.44,36.16,1171.55,87,Partial Response
M204302,35,Male,HPV-related Cancer,mrna-4157 + keytruda,75.24,40.31,1121.72,89,
M204303,37,Other,Melanoma,KEYTRUDA only,69.37,,1172.64,89,Partial Response
M204304,66,Female,Melanoma,KEYTRUDA only,59.43,56.56,1619.25,95,Stable Disease
M204305,54,Other,HPV-related Cancer,KEYTRUDA only,41.02,26.71,1597.58,94,Stable Disease
M204306,77,Male,Melanoma,KEYTRUDA only,75.62,56.01,581.58,90,Stable Disease
M204307,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.0,24.05,,80,Partial Response
M204308,28,Other,HPV-related Cancer,KEYTRUDA only,37.8,21.82,1069.66,93,Complete Response
M204309,32,Other,Melanoma,mrna-4157 + keytruda,50.27,43.79,1640.86,87,Stable Disease
M204310,52,Other,Melanoma,KEYTRUDA only,66.46,68.33,555.31,87,Stable Disease
M204311,71,Other,Melanoma,mrna-4157 + keytruda,46.74,39.91,1095.77,84,Complete Response
M204312,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.55,29.9,,93,Stable Disease
M204313,60,Male,HPV-related Cancer,mrna-4157 + keytruda,25.73,11.96,956.78,93,Stable Disease
M204314,28,Female,Melanoma,KEYTRUDA only,87.55,97.92,1107.79,77,Partial Response
M204315,35,Other,Melanoma,mrna-4157 + keytruda,58.49,39.83,657.85,80,Progression
M204316,74,Female,Melanoma,mrna-4157 + keytruda,65.92,,,96,Partial Response
M204317,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.17,,1142.7,76,Partial Response
M204318,77,Other,Melanoma,KEYTRUDA only,84.31,47.86,522.46,72,Unknown
M204319,40,Male,Melanoma,mrna-4157 + keytruda,55.83,50.87,792.88,96,Stable Disease
M204320,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.36,40.95,513.21,85,Partial Response
M204321,49,Female,HPV-related Cancer,KEYTRUDA only,71.72,76.15,64.6,81,Stable Disease
M204322,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.57,39.46,1150.93,99,Stable Disease
M204323,74,Male,Melanoma,mrna-4157 + keytruda,60.1,29.62,1293.26,96,Partial Response
M204324,34,Male,Melanoma,mrna-4157 + keytruda,67.5,55.49,1076.64,93,Progression
M204325,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.12,72.45,1393.14,87,Complete Response
M204326,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.0,51.0,1776.58,77,
M204327,49,Female,HPV-related Cancer,mrna-4157 + keytruda,36.87,34.89,1253.48,92,Partial Response
M204328,38,Other,HPV-related Cancer,mrna-4157 + keytruda,5.89,5.49,1358.49,97,Complete Response
M204329,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.99,33.13,1109.72,85,Progression
M204330,65,Male,HPV-related Cancer,mrna-4157 + keytruda,46.74,21.01,1350.08,89,Progression
M204331,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.01,,1510.03,104,Partial Response
M204332,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,7.19,6.58,1161.85,87,Progression
M204333,54,Other,HPV-related Cancer,KEYTRUDA only,70.89,33.69,1456.24,122,Progression
M204334,54,Other,HPV-related Cancer,mrna-4157 + keytruda,52.18,34.38,797.95,68,Partial Response
M204335,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.59,44.29,,101,Progression
M204336,37,Female,Melanoma,KEYTRUDA only,69.87,61.84,,97,Stable Disease
M204337,56,Other,Melanoma,mrna-4157 + keytruda,58.49,66.68,797.31,84,Stable Disease
M204338,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.3,61.88,1264.91,88,Partial Response
M204339,49,Male,Melanoma,mrna-4157 + keytruda,53.87,45.54,768.52,89,Stable Disease
M204340,57,Male,Melanoma,mrna-4157 + keytruda,30.25,24.6,870.45,87,Progression
M204341,31,Other,HPV-related Cancer,mrna-4157 + keytruda,50.53,46.19,1211.37,85,Stable Disease
M204342,72,Male,HPV-related Cancer,KEYTRUDA only,63.66,,1417.43,91,Partial Response
M204343,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.07,55.14,1261.81,82,Stable Disease
M204344,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,84.94,85.73,699.23,82,Unknown
M204345,63,Male,HPV-related Cancer,mrna-4157 + keytruda,72.13,64.03,588.71,90,Stable Disease
M204346,45,Other,HPV-related Cancer,mrna-4157 + keytruda,61.86,32.34,1468.12,84,Partial Response
M204347,81,Male,HPV-related Cancer,mrna-4157 + keytruda,57.57,41.8,253.92,76,Progression
M204348,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.1,40.74,1391.78,90,Unknown
M204349,50,Female,HPV-related Cancer,KEYTRUDA only,73.52,63.51,1518.3,94,Complete Response
M204350,48,Male,Melanoma,KEYTRUDA only,64.86,53.12,542.92,117,Stable Disease
M204351,67,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.94,61.09,1475.53,86,Unknown
M204352,59,Female,HPV-related Cancer,KEYTRUDA only,55.21,43.09,1225.78,99,Partial Response
M204353,77,Male,Melanoma,mrna-4157 + keytruda,18.33,10.27,1643.38,98,Stable Disease
M204354,48,Female,Melanoma,mrna-4157 + keytruda,55.79,31.85,803.8,84,Complete Response
M204355,75,Female,HPV-related Cancer,mrna-4157 + keytruda,47.49,54.01,1127.71,94,Complete Response
M204356,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.5,31.4,923.62,86,Stable Disease
M204357,79,Female,Melanoma,KEYTRUDA only,42.91,55.91,1326.69,84,Stable Disease
M204358,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.71,31.45,1171.97,103,Progression
M204359,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,91.25,74.81,1559.43,88,Partial Response
M204360,34,Male,HPV-related Cancer,mrna-4157 + keytruda,22.87,25.81,656.88,88,Stable Disease
M204361,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.05,58.58,,97,Partial Response
M204362,30,Other,HPV-related Cancer,KEYTRUDA only,26.47,15.2,864.98,90,Stable Disease
M204363,43,Female,Non-small Cell Lung Cancer,KEYTRUDA only,51.93,24.87,1209.09,93,Stable Disease
M204364,25,Female,Melanoma,KEYTRUDA only,79.87,50.25,1007.71,102,Stable Disease
M204365,35,Other,HPV-related Cancer,KEYTRUDA only,54.25,54.95,689.82,86,Partial Response
M204366,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.17,31.57,1088.71,86,Progression
M204367,25,Female,HPV-related Cancer,KEYTRUDA only,53.39,43.57,849.35,95,Stable Disease
M204368,60,Female,HPV-related Cancer,mrna-4157 + keytruda,23.33,17.21,654.1,87,Partial Response
M204369,38,Female,HPV-related Cancer,KEYTRUDA only,19.23,14.42,1482.37,90,Stable Disease
M204370,79,Other,Melanoma,KEYTRUDA only,74.47,85.9,1112.46,80,Partial Response
M204371,78,Other,Melanoma,mrna-4157 + keytruda,38.92,24.37,612.01,80,Unknown
M204372,38,Male,Melanoma,mrna-4157 + keytruda,63.43,68.93,908.33,92,Unknown
M204373,28,Female,HPV-related Cancer,KEYTRUDA only,65.47,52.81,1911.58,86,Partial Response
M204374,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.93,,1641.32,84,Partial Response
M204375,41,Female,Melanoma,KEYTRUDA only,60.2,46.45,1278.0,78,Partial Response
M204376,29,Female,HPV-related Cancer,mrna-4157 + keytruda,75.58,78.67,631.93,84,Stable Disease
M204377,30,Other,Melanoma,mrna-4157 + keytruda,47.6,42.11,764.28,81,Partial Response
M204378,32,Other,HPV-related Cancer,KEYTRUDA only,49.51,6.29,807.06,100,
M204379,27,Male,Melanoma,mrna-4157 + keytruda,64.21,47.16,1197.74,93,Stable Disease
M204380,54,Other,Melanoma,mrna-4157 + keytruda,54.92,47.41,191.27,87,Partial Response
M204381,56,Male,Melanoma,mrna-4157 + keytruda,94.74,77.95,1085.41,86,
M204382,84,Male,Melanoma,KEYTRUDA only,62.86,47.53,1323.31,81,
M204383,57,Other,HPV-related Cancer,KEYTRUDA only,13.78,15.12,862.79,105,Complete Response
M204384,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.3,34.76,1307.75,98,Stable Disease
M204385,51,Male,Melanoma,mrna-4157 + keytruda,37.33,36.9,1460.15,94,Partial Response
M204386,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.85,41.8,1614.78,92,Partial Response
M204387,78,Male,Melanoma,mrna-4157 + keytruda,78.7,32.71,749.64,95,Partial Response
M204388,67,Other,HPV-related Cancer,mrna-4157 + keytruda,49.82,49.58,1811.98,89,Progression
M204389,58,Female,Melanoma,mrna-4157 + keytruda,61.78,57.1,724.78,108,Stable Disease
M204390,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.17,28.66,530.14,94,Stable Disease
M204391,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.09,14.74,1345.87,105,Stable Disease
M204392,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.98,45.85,1055.25,81,Stable Disease
M204393,80,Male,Melanoma,KEYTRUDA only,86.81,66.87,1231.85,106,Progression
M204394,38,Other,Melanoma,mrna-4157 + keytruda,40.38,29.2,943.08,94,Stable Disease
M204395,72,Male,HPV-related Cancer,mrna-4157 + keytruda,21.94,24.08,338.66,103,Stable Disease
M204396,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.21,9.14,,72,Progression
M204397,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.16,31.97,1057.17,105,Stable Disease
M204398,79,Other,Melanoma,mrna-4157 + keytruda,32.19,21.61,1120.57,82,
M204399,55,Other,Melanoma,KEYTRUDA only,18.58,8.92,981.31,103,Partial Response
M204400,27,Other,HPV-related Cancer,mrna-4157 + keytruda,18.69,15.38,1440.62,92,Progression
M204401,36,Male,HPV-related Cancer,KEYTRUDA only,15.32,13.02,759.15,91,Complete Response
M204402,41,Other,Melanoma,mrna-4157 + keytruda,46.73,29.79,1033.97,80,Progression
M204403,45,Female,Melanoma,mrna-4157 + keytruda,60.75,41.79,1093.89,88,
M204404,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.46,19.59,1274.08,105,Stable Disease
M204405,31,Female,Melanoma,mrna-4157 + keytruda,23.95,,1253.39,76,Stable Disease
M204406,61,Other,HPV-related Cancer,mrna-4157 + keytruda,42.76,28.8,1150.16,94,Partial Response
M204407,71,Male,HPV-related Cancer,KEYTRUDA only,47.42,40.11,1142.0,79,Stable Disease
M204408,35,Female,HPV-related Cancer,mrna-4157 + keytruda,27.28,9.43,1086.3,87,Unknown
M204409,56,Female,Melanoma,mrna-4157 + keytruda,43.76,36.29,1178.2,89,Progression
M204410,75,Female,HPV-related Cancer,KEYTRUDA only,41.07,34.74,852.39,87,Partial Response
M204411,56,Male,HPV-related Cancer,KEYTRUDA only,52.16,36.67,,99,Complete Response
M204412,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.62,21.74,1168.28,86,Stable Disease
M204413,61,Female,Melanoma,KEYTRUDA only,63.68,71.89,1188.37,90,Partial Response
M204414,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.98,67.0,769.61,102,Partial Response
M204415,61,Female,HPV-related Cancer,KEYTRUDA only,68.47,44.05,,74,Partial Response
M204416,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.61,51.69,-242.51,99,Partial Response
M204417,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,10.12,8.03,1615.64,93,Partial Response
M204418,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.87,71.94,864.49,76,Progression
M204419,55,Other,Melanoma,mrna-4157 + keytruda,23.17,17.75,686.85,102,Partial Response
M204420,65,Female,HPV-related Cancer,mrna-4157 + keytruda,31.88,19.34,1106.31,96,
M204421,25,Male,HPV-related Cancer,KEYTRUDA only,65.44,60.44,1023.31,85,Complete Response
M204422,55,Female,HPV-related Cancer,KEYTRUDA only,54.36,47.7,627.42,87,Progression
M204423,76,Male,Melanoma,mrna-4157 + keytruda,50.92,27.82,1275.58,86,Stable Disease
M204424,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.36,45.31,1644.38,80,Partial Response
M204425,54,Other,Melanoma,KEYTRUDA only,36.99,27.58,1621.69,78,Partial Response
M204426,73,Female,HPV-related Cancer,KEYTRUDA only,38.4,26.78,1283.81,94,Progression
M204427,70,Male,Melanoma,KEYTRUDA only,37.63,27.21,611.6,98,Progression
M204428,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.6,42.71,1265.01,92,Partial Response
M204429,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,82.32,71.04,796.64,102,Partial Response
M204430,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,94.41,94.18,1257.83,92,Complete Response
M204431,33,Female,HPV-related Cancer,mrna-4157 + keytruda,56.89,52.31,490.62,84,Partial Response
M204432,54,Female,Melanoma,KEYTRUDA only,83.09,83.73,1061.53,86,Stable Disease
M204433,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,105.63,65.51,338.1,72,Complete Response
M204434,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.08,72.59,1027.12,98,Partial Response
M204435,82,Female,Melanoma,KEYTRUDA only,52.63,42.86,394.06,95,Progression
M204436,58,Female,Melanoma,mrna-4157 + keytruda,65.8,18.15,1217.83,84,Stable Disease
M204437,43,Female,Melanoma,mrna-4157 + keytruda,57.53,52.83,1175.4,78,Complete Response
M204438,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.78,44.99,1274.17,86,Partial Response
M204439,72,Male,HPV-related Cancer,mrna-4157 + keytruda,50.06,26.07,,113,Stable Disease
M204440,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.81,38.84,516.25,111,Progression
M204441,33,Male,HPV-related Cancer,mrna-4157 + keytruda,33.67,31.27,1692.12,82,Complete Response
M204442,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.59,32.59,37.96,107,Progression
M204443,59,Female,Non-small Cell Lung Cancer,KEYTRUDA only,26.26,17.21,1055.81,110,Partial Response
M204444,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.02,26.44,1725.89,85,Complete Response
M204445,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.41,44.33,1492.42,93,Partial Response
M204446,32,Other,Melanoma,mrna-4157 + keytruda,53.41,56.14,,118,Progression
M204447,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.92,30.75,461.22,97,
M204448,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.26,27.3,1024.7,96,Unknown
M204449,82,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.4,31.97,1160.41,101,Progression
M204450,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.16,41.03,617.96,100,Complete Response
M204451,32,Male,Melanoma,KEYTRUDA only,69.41,49.98,1103.75,63,Complete Response
M204452,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.3,27.38,555.14,91,Unknown
M204453,51,Male,HPV-related Cancer,KEYTRUDA only,53.21,42.07,769.64,89,Partial Response
M204454,81,Other,Melanoma,mrna-4157 + keytruda,18.02,14.39,1211.01,98,Unknown
M204455,30,Other,Melanoma,mrna-4157 + keytruda,60.2,,735.93,88,Stable Disease
M204456,62,Other,Melanoma,mrna-4157 + keytruda,27.79,15.48,932.3,98,
M204457,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.93,29.24,1362.54,68,Complete Response
M204458,51,Female,Melanoma,mrna-4157 + keytruda,46.23,32.37,1328.25,95,Progression
M204459,78,Female,HPV-related Cancer,mrna-4157 + keytruda,52.53,37.46,1821.53,85,
M204460,60,Male,HPV-related Cancer,mrna-4157 + keytruda,32.48,31.89,727.01,98,Partial Response
M204461,59,Other,HPV-related Cancer,mrna-4157 + keytruda,59.29,44.65,1239.47,81,Stable Disease
M204462,27,Other,Melanoma,KEYTRUDA only,36.71,21.12,1004.79,87,Complete Response
M204463,28,Other,Melanoma,KEYTRUDA only,45.05,30.4,1484.6,78,Complete Response
M204464,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.88,35.38,1003.71,96,Progression
M204465,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.42,39.79,955.02,88,Complete Response
M204466,45,Male,Melanoma,mrna-4157 + keytruda,41.63,32.15,-99.07,85,Partial Response
M204467,63,Female,HPV-related Cancer,mrna-4157 + keytruda,38.82,39.22,933.15,93,Unknown
M204468,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.87,39.9,704.53,89,Progression
M204469,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.95,37.55,1479.67,90,Partial Response
M204470,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.29,29.57,1013.18,95,Unknown
M204471,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.87,26.66,863.19,81,Stable Disease
M204472,53,Female,Melanoma,mrna-4157 + keytruda,76.33,71.34,896.04,93,Progression
M204473,81,Other,Melanoma,KEYTRUDA only,35.46,21.08,1109.92,86,Progression
M204474,78,Other,Melanoma,mrna-4157 + keytruda,79.23,62.69,1433.4,100,Partial Response
M204475,56,Female,HPV-related Cancer,KEYTRUDA only,77.42,80.0,856.36,88,Complete Response
M204476,43,Other,Melanoma,mrna-4157 + keytruda,36.98,44.61,1304.81,85,
M204477,81,Female,HPV-related Cancer,mrna-4157 + keytruda,39.48,35.41,1544.85,86,Stable Disease
M204478,78,Male,HPV-related Cancer,mrna-4157 + keytruda,36.95,25.13,915.9,90,Complete Response
M204479,67,Male,HPV-related Cancer,KEYTRUDA only,87.04,57.48,915.42,99,Progression
M204480,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.55,21.76,1512.6,100,Progression
M204481,82,Male,HPV-related Cancer,KEYTRUDA only,75.98,88.51,832.83,97,Stable Disease
M204482,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.44,23.42,232.02,80,Progression
M204483,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.42,30.73,1101.56,83,Complete Response
M204484,77,Female,Melanoma,mrna-4157 + keytruda,32.46,23.8,-231.31,72,Unknown
M204485,34,Male,Melanoma,mrna-4157 + keytruda,87.82,41.49,468.35,71,Partial Response
M204486,70,Other,HPV-related Cancer,KEYTRUDA only,62.75,57.09,1210.09,84,Partial Response
M204487,69,Other,HPV-related Cancer,mrna-4157 + keytruda,8.75,6.39,920.34,69,Stable Disease
M204488,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.71,9.67,822.08,78,Stable Disease
M204489,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.55,35.26,1608.23,87,Stable Disease
M204490,59,Female,HPV-related Cancer,mrna-4157 + keytruda,40.27,41.22,396.75,83,Partial Response
M204491,81,Female,HPV-related Cancer,mrna-4157 + keytruda,32.99,18.85,,87,Partial Response
M204492,52,Male,HPV-related Cancer,KEYTRUDA only,21.81,18.39,1583.33,83,Partial Response
M204493,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.29,41.79,1366.41,98,Complete Response
M204494,59,Female,Melanoma,KEYTRUDA only,63.86,61.13,286.96,101,Stable Disease
M204495,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.92,22.6,862.12,93,Progression
M204496,31,Other,Melanoma,KEYTRUDA only,86.95,78.66,795.76,80,
M204497,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.29,59.78,1107.14,100,Unknown
M204498,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.01,44.71,712.43,94,Progression
M204499,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.17,30.56,402.69,99,
M204500,80,Other,HPV-related Cancer,KEYTRUDA only,48.82,48.58,1194.56,97,Partial Response
M204501,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.15,43.69,1135.63,90,Partial Response
M204502,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.25,25.76,1562.82,83,Progression
M204503,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.74,,733.53,88,Complete Response
M204504,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.47,52.17,1275.34,82,Complete Response
M204505,54,Other,Melanoma,mrna-4157 + keytruda,74.72,42.43,979.19,94,Partial Response
M204506,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.8,22.85,1796.12,96,Progression
M204507,74,Male,HPV-related Cancer,mrna-4157 + keytruda,56.87,53.32,709.23,97,
M204508,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.34,64.18,875.93,83,Partial Response
M204509,76,Female,Melanoma,mrna-4157 + keytruda,59.09,39.75,295.31,84,Stable Disease
M204510,81,Male,HPV-related Cancer,mrna-4157 + keytruda,69.96,82.82,623.9,91,Partial Response
M204511,46,Male,Melanoma,mrna-4157 + keytruda,62.09,30.0,1073.43,90,Complete Response
M204512,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,86.56,76.54,566.39,92,Partial Response
M204513,44,Male,Melanoma,KEYTRUDA only,56.23,46.91,1382.18,85,Progression
M204514,47,Other,HPV-related Cancer,KEYTRUDA only,80.38,58.5,776.68,77,Stable Disease
M204515,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.03,41.87,915.99,92,Partial Response
M204516,48,Other,Melanoma,mrna-4157 + keytruda,90.7,98.0,1632.96,95,Complete Response
M204517,50,Female,Melanoma,KEYTRUDA only,49.74,23.99,1235.34,96,Stable Disease
M204518,53,Female,HPV-related Cancer,KEYTRUDA only,52.41,,,86,Progression
M204519,64,Other,HPV-related Cancer,mrna-4157 + keytruda,52.07,45.43,945.76,101,Partial Response
M204520,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.27,42.02,840.21,94,Progression
M204521,68,Other,Melanoma,KEYTRUDA only,47.62,43.19,1141.93,95,Stable Disease
M204522,73,Female,Melanoma,KEYTRUDA only,73.66,58.41,1192.24,101,Unknown
M204523,25,Other,Melanoma,KEYTRUDA only,75.78,78.26,,85,Progression
M204524,75,Female,Melanoma,mrna-4157 + keytruda,44.4,37.72,,86,
M204525,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.64,62.9,1171.61,83,Progression
M204526,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.94,47.19,906.64,108,
M204527,44,Female,Melanoma,KEYTRUDA only,44.48,47.67,1168.23,66,
M204528,82,Female,HPV-related Cancer,mrna-4157 + keytruda,65.47,67.91,1567.11,96,Stable Disease
M204529,64,Other,HPV-related Cancer,KEYTRUDA only,15.41,13.94,540.78,91,Partial Response
M204530,81,Female,HPV-related Cancer,KEYTRUDA only,35.6,35.0,819.81,90,Progression
M204531,72,Male,HPV-related Cancer,KEYTRUDA only,28.83,29.74,,94,Partial Response
M204532,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.22,34.74,911.78,92,Unknown
M204533,77,Female,Melanoma,mrna-4157 + keytruda,3.36,2.82,1064.69,85,Stable Disease
M204534,53,Female,HPV-related Cancer,KEYTRUDA only,38.27,33.13,888.0,90,Stable Disease
M204535,72,Other,HPV-related Cancer,KEYTRUDA only,50.79,43.67,429.79,87,Partial Response
M204536,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,72.61,51.5,,83,Stable Disease
M204537,67,Male,HPV-related Cancer,mrna-4157 + keytruda,49.56,31.88,1382.99,92,Complete Response
M204538,84,Male,HPV-related Cancer,KEYTRUDA only,21.42,21.47,,83,Partial Response
M204539,36,Female,HPV-related Cancer,KEYTRUDA only,60.35,60.13,599.8,89,Unknown
M204540,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,61.56,61.43,818.51,98,Partial Response
M204541,67,Other,HPV-related Cancer,mrna-4157 + keytruda,51.62,45.62,,82,Stable Disease
M204542,40,Other,Melanoma,KEYTRUDA only,67.78,53.21,983.54,90,Unknown
M204543,72,Male,HPV-related Cancer,mrna-4157 + keytruda,59.58,50.31,899.81,88,Stable Disease
M204544,38,Other,HPV-related Cancer,mrna-4157 + keytruda,54.55,47.59,1362.27,89,
M204545,49,Other,HPV-related Cancer,KEYTRUDA only,26.58,22.18,1152.36,69,Partial Response
M204546,49,Female,HPV-related Cancer,mrna-4157 + keytruda,70.6,58.36,1235.67,91,Progression
M204547,73,Other,Melanoma,KEYTRUDA only,66.94,44.52,975.53,78,Stable Disease
M204548,80,Male,HPV-related Cancer,KEYTRUDA only,37.84,19.85,1001.82,78,Stable Disease
M204549,48,Other,Melanoma,KEYTRUDA only,21.51,19.32,881.73,75,Stable Disease
M204550,80,Other,Melanoma,mrna-4157 + keytruda,31.69,,875.79,82,Stable Disease
M204551,81,Male,Non-small Cell Lung Cancer,KEYTRUDA only,51.41,46.78,1331.01,90,Stable Disease
M204552,31,Other,Melanoma,KEYTRUDA only,84.65,69.21,370.57,87,Partial Response
M204553,61,Female,Melanoma,mrna-4157 + keytruda,70.49,66.86,311.45,78,Progression
M204554,48,Other,HPV-related Cancer,mrna-4157 + keytruda,69.02,50.29,1123.81,85,Partial Response
M204555,33,Male,HPV-related Cancer,mrna-4157 + keytruda,47.74,33.1,1120.84,82,Partial Response
M204556,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,80.9,37.53,399.33,117,Partial Response
M204557,61,Female,HPV-related Cancer,KEYTRUDA only,52.09,30.31,830.79,87,Progression
M204558,41,Female,HPV-related Cancer,KEYTRUDA only,32.53,15.48,865.83,91,Progression
M204559,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.74,65.62,864.29,77,Progression
M204560,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.69,36.95,1696.47,113,Stable Disease
M204561,83,Female,Melanoma,KEYTRUDA only,47.85,32.84,795.69,95,Stable Disease
M204562,43,Female,Melanoma,KEYTRUDA only,57.78,51.51,527.6,90,
M204563,38,Male,Melanoma,mrna-4157 + keytruda,55.1,48.26,1721.91,89,Complete Response
M204564,44,Other,Melanoma,KEYTRUDA only,46.72,51.03,1066.43,97,
M204565,30,Female,HPV-related Cancer,KEYTRUDA only,26.55,19.78,,86,Unknown
M204566,64,Female,HPV-related Cancer,mrna-4157 + keytruda,37.06,17.17,444.56,93,Unknown
M204567,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.06,44.62,1138.75,86,Stable Disease
M204568,84,Female,HPV-related Cancer,KEYTRUDA only,69.65,59.8,1269.63,94,
M204569,38,Female,Melanoma,mrna-4157 + keytruda,74.73,65.32,1589.58,99,Stable Disease
M204570,54,Male,HPV-related Cancer,KEYTRUDA only,42.41,36.4,1212.26,108,Partial Response
M204571,50,Male,HPV-related Cancer,mrna-4157 + keytruda,37.3,19.22,1042.46,103,Progression
M204572,55,Female,Melanoma,KEYTRUDA only,52.22,46.41,935.89,91,Partial Response
M204573,30,Female,Melanoma,KEYTRUDA only,35.03,22.84,912.63,86,Partial Response
M204574,29,Other,Melanoma,mrna-4157 + keytruda,79.09,44.67,802.09,90,
M204575,40,Other,HPV-related Cancer,mrna-4157 + keytruda,28.22,28.37,796.9,92,Partial Response
M204576,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.43,28.05,637.46,71,Progression
M204577,62,Female,HPV-related Cancer,KEYTRUDA only,29.56,34.79,865.38,91,Progression
M204578,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.99,36.56,1700.31,102,Partial Response
M204579,54,Other,HPV-related Cancer,KEYTRUDA only,-9.87,-10.47,1133.21,116,Complete Response
M204580,63,Male,Melanoma,KEYTRUDA only,41.92,12.12,1024.13,97,Partial Response
M204581,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.97,27.1,1739.44,129,Complete Response
M204582,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.29,37.0,745.95,84,Stable Disease
M204583,81,Other,Melanoma,mrna-4157 + keytruda,75.46,44.42,330.75,75,Partial Response
M204584,62,Other,Melanoma,mrna-4157 + keytruda,71.8,,779.63,99,Partial Response
M204585,27,Female,HPV-related Cancer,KEYTRUDA only,58.4,53.79,280.33,101,
M204586,55,Female,HPV-related Cancer,KEYTRUDA only,61.15,52.39,702.17,104,
M204587,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.91,20.37,928.72,95,Partial Response
M204588,71,Female,Melanoma,mrna-4157 + keytruda,53.26,45.83,1021.15,86,Complete Response
M204589,74,Female,HPV-related Cancer,mrna-4157 + keytruda,45.0,42.22,1074.14,82,Partial Response
M204590,29,Male,Melanoma,KEYTRUDA only,22.94,10.08,1076.13,97,Partial Response
M204591,27,Other,HPV-related Cancer,mrna-4157 + keytruda,71.47,41.08,847.18,79,Stable Disease
M204592,64,Female,Melanoma,mrna-4157 + keytruda,76.91,64.47,1017.18,88,Stable Disease
M204593,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.46,29.84,1415.98,94,Progression
M204594,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,79.45,,388.25,86,Stable Disease
M204595,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.59,,1545.98,92,Stable Disease
M204596,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.55,66.19,953.08,87,Partial Response
M204597,46,Male,HPV-related Cancer,mrna-4157 + keytruda,76.11,63.15,1036.01,83,Complete Response
M204598,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.13,43.1,1929.11,76,Stable Disease
M204599,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-2.99,-2.63,1884.6,89,Stable Disease
M204600,73,Female,HPV-related Cancer,KEYTRUDA only,36.42,34.75,958.12,97,Complete Response
M204601,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.88,61.01,525.02,69,Partial Response
M204602,36,Other,HPV-related Cancer,KEYTRUDA only,25.93,,1350.06,98,Partial Response
M204603,62,Male,Melanoma,KEYTRUDA only,53.76,50.0,844.92,88,Progression
M204604,67,Female,Melanoma,mrna-4157 + keytruda,38.69,29.27,1416.33,95,Partial Response
M204605,63,Male,Melanoma,KEYTRUDA only,45.12,10.33,1704.13,104,Partial Response
M204606,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.74,16.88,1122.49,82,Progression
M204607,74,Female,Melanoma,mrna-4157 + keytruda,57.48,31.09,984.41,86,Partial Response
M204608,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.96,96.84,746.61,81,Partial Response
M204609,80,Male,Melanoma,mrna-4157 + keytruda,10.13,9.0,1043.46,107,Progression
M204610,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,97.39,56.3,1007.88,103,Stable Disease
M204611,57,Male,Melanoma,mrna-4157 + keytruda,35.52,34.66,1160.15,92,Complete Response
M204612,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.69,42.06,809.46,89,Stable Disease
M204613,49,Female,Melanoma,KEYTRUDA only,54.6,47.25,1281.44,103,Stable Disease
M204614,63,Other,Melanoma,KEYTRUDA only,71.35,50.63,1348.88,85,Partial Response
M204615,37,Female,HPV-related Cancer,mrna-4157 + keytruda,47.8,32.37,994.51,88,Partial Response
M204616,62,Other,HPV-related Cancer,mrna-4157 + keytruda,79.5,45.02,649.45,72,Progression
M204617,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.79,61.49,968.44,88,Stable Disease
M204618,74,Female,Melanoma,mrna-4157 + keytruda,75.99,79.82,1907.32,83,Partial Response
M204619,31,Other,Melanoma,mrna-4157 + keytruda,65.33,,1497.74,83,Progression
M204620,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.1,42.9,1074.85,101,Partial Response
M204621,71,Male,HPV-related Cancer,mrna-4157 + keytruda,39.72,31.75,607.93,88,Unknown
M204622,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.82,60.11,1092.13,89,Stable Disease
M204623,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.21,,1532.47,95,
M204624,73,Female,Melanoma,mrna-4157 + keytruda,59.7,50.61,1000.97,82,Progression
M204625,53,Female,Melanoma,mrna-4157 + keytruda,60.12,,85.72,76,Stable Disease
M204626,50,Other,Melanoma,mrna-4157 + keytruda,33.88,28.14,699.77,78,Partial Response
M204627,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.91,63.62,623.09,91,Partial Response
M204628,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.99,23.73,909.14,91,Stable Disease
M204629,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.25,,1231.47,88,Stable Disease
M204630,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.86,61.71,,71,Stable Disease
M204631,25,Other,Melanoma,KEYTRUDA only,85.07,57.42,1269.33,101,Stable Disease
M204632,51,Female,Melanoma,KEYTRUDA only,44.51,33.23,1192.62,92,Stable Disease
M204633,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.44,32.16,1205.34,98,Stable Disease
M204634,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.18,38.95,866.48,73,Stable Disease
M204635,26,Other,Melanoma,mrna-4157 + keytruda,54.15,47.74,865.19,107,Progression
M204636,28,Female,HPV-related Cancer,mrna-4157 + keytruda,37.23,24.72,363.65,74,Partial Response
M204637,56,Male,Melanoma,KEYTRUDA only,50.1,33.82,1598.9,80,Stable Disease
M204638,40,Male,HPV-related Cancer,KEYTRUDA only,27.52,26.65,1708.11,96,
M204639,68,Female,HPV-related Cancer,mrna-4157 + keytruda,58.95,,934.96,84,Partial Response
M204640,47,Other,Melanoma,mrna-4157 + keytruda,48.96,40.54,709.25,80,Progression
M204641,57,Male,Melanoma,mrna-4157 + keytruda,85.16,57.61,,95,Partial Response
M204642,30,Female,Melanoma,mrna-4157 + keytruda,48.13,35.34,597.62,100,
M204643,64,Female,HPV-related Cancer,KEYTRUDA only,43.44,44.55,1122.52,100,Progression
M204644,48,Other,HPV-related Cancer,mrna-4157 + keytruda,48.31,,1251.28,102,Stable Disease
M204645,68,Male,Melanoma,KEYTRUDA only,80.16,48.04,1111.42,66,Progression
M204646,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.21,26.5,559.98,86,Stable Disease
M204647,55,Other,Melanoma,mrna-4157 + keytruda,58.68,61.98,871.99,95,Progression
M204648,33,Male,HPV-related Cancer,mrna-4157 + keytruda,63.11,42.25,963.45,103,Progression
M204649,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.91,43.7,1509.42,83,Partial Response
M204650,25,Other,Melanoma,KEYTRUDA only,65.25,48.85,820.74,81,Partial Response
M204651,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.43,60.64,1127.4,94,Progression
M204652,57,Female,HPV-related Cancer,mrna-4157 + keytruda,72.32,24.57,1197.9,107,Stable Disease
M204653,74,Male,HPV-related Cancer,mrna-4157 + keytruda,62.31,53.9,1076.49,81,Partial Response
M204654,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,102.43,80.72,872.03,99,Partial Response
M204655,29,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.38,35.04,166.21,96,Partial Response
M204656,49,Female,Melanoma,KEYTRUDA only,85.4,84.61,1370.49,87,Complete Response
M204657,63,Other,Melanoma,mrna-4157 + keytruda,81.76,123.12,1137.18,95,
M204658,46,Male,HPV-related Cancer,mrna-4157 + keytruda,27.13,14.11,1013.94,91,Progression
M204659,62,Other,Melanoma,mrna-4157 + keytruda,66.93,71.15,394.74,86,Partial Response
M204660,58,Other,Melanoma,mrna-4157 + keytruda,56.94,50.99,248.75,89,Partial Response
M204661,35,Male,HPV-related Cancer,KEYTRUDA only,41.23,38.36,566.16,90,Stable Disease
M204662,73,Other,Melanoma,mrna-4157 + keytruda,49.81,41.73,1073.2,96,Stable Disease
M204663,66,Male,Melanoma,mrna-4157 + keytruda,68.86,16.44,1249.02,95,Stable Disease
M204664,84,Female,HPV-related Cancer,KEYTRUDA only,39.4,45.07,1151.84,86,Partial Response
M204665,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.24,45.57,1009.29,78,Stable Disease
M204666,55,Female,HPV-related Cancer,KEYTRUDA only,26.97,18.39,1386.61,88,Partial Response
M204667,26,Male,Melanoma,mrna-4157 + keytruda,45.41,38.87,574.6,91,Progression
M204668,69,Male,HPV-related Cancer,mrna-4157 + keytruda,63.54,42.6,622.9,101,Stable Disease
M204669,46,Male,HPV-related Cancer,mrna-4157 + keytruda,13.49,9.04,909.6,94,Partial Response
M204670,78,Male,Melanoma,mrna-4157 + keytruda,65.59,40.36,1680.77,87,Unknown
M204671,30,Other,HPV-related Cancer,mrna-4157 + keytruda,57.55,35.78,253.15,81,Stable Disease
M204672,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.21,7.42,1324.76,98,Stable Disease
M204673,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.88,44.52,,85,Complete Response
M204674,74,Male,Melanoma,KEYTRUDA only,34.74,33.65,447.46,89,Stable Disease
M204675,81,Male,Melanoma,mrna-4157 + keytruda,4.7,5.19,983.52,95,Progression
M204676,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.82,46.69,559.74,89,Stable Disease
M204677,61,Male,Melanoma,KEYTRUDA only,51.66,40.09,1198.05,101,Stable Disease
M204678,43,Other,Melanoma,mrna-4157 + keytruda,45.61,29.02,759.22,92,Stable Disease
M204679,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.27,57.07,895.52,102,Stable Disease
M204680,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,111.71,85.59,533.53,109,Progression
M204681,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.25,19.67,803.96,85,Stable Disease
M204682,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,87.75,69.25,1440.32,89,Complete Response
M204683,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.63,40.98,334.31,96,Progression
M204684,55,Male,HPV-related Cancer,mrna-4157 + keytruda,52.41,40.17,,93,Complete Response
M204685,71,Female,Melanoma,KEYTRUDA only,61.57,51.14,1607.01,92,Progression
M204686,27,Male,HPV-related Cancer,KEYTRUDA only,68.37,61.69,923.81,92,Complete Response
M204687,70,Male,HPV-related Cancer,KEYTRUDA only,44.69,36.06,1341.26,82,Stable Disease
M204688,72,Male,Melanoma,KEYTRUDA only,28.21,18.26,1376.18,72,Progression
M204689,33,Other,HPV-related Cancer,mrna-4157 + keytruda,48.9,59.03,431.64,92,Partial Response
M204690,28,Female,HPV-related Cancer,mrna-4157 + keytruda,48.06,46.46,,74,Stable Disease
M204691,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.23,51.04,408.57,87,Progression
M204692,69,Male,Melanoma,mrna-4157 + keytruda,44.37,46.06,367.82,87,Partial Response
M204693,64,Other,HPV-related Cancer,KEYTRUDA only,43.28,40.22,1023.13,90,Progression
M204694,64,Female,Melanoma,mrna-4157 + keytruda,11.33,11.56,605.33,101,Partial Response
M204695,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.43,26.76,555.11,86,Progression
M204696,50,Female,HPV-related Cancer,KEYTRUDA only,51.93,56.11,1591.76,72,Progression
M204697,43,Male,HPV-related Cancer,KEYTRUDA only,31.6,29.04,,94,Stable Disease
M204698,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,10.34,9.14,1290.52,101,Stable Disease
M204699,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.43,32.53,911.86,87,Stable Disease
M204700,46,Other,HPV-related Cancer,KEYTRUDA only,69.24,55.65,481.27,97,Progression
M204701,37,Female,Melanoma,mrna-4157 + keytruda,67.13,45.88,589.81,107,
M204702,42,Female,HPV-related Cancer,mrna-4157 + keytruda,69.98,48.58,449.45,89,Stable Disease
M204703,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.99,67.26,729.02,90,Unknown
M204704,32,Male,Melanoma,mrna-4157 + keytruda,37.44,33.42,1134.62,100,Stable Disease
M204705,79,Male,HPV-related Cancer,mrna-4157 + keytruda,43.55,,1218.68,84,Stable Disease
M204706,75,Male,Melanoma,KEYTRUDA only,43.86,41.2,1670.42,87,
M204707,46,Other,HPV-related Cancer,KEYTRUDA only,77.85,55.71,1002.4,89,Partial Response
M204708,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.9,65.06,1351.44,93,Partial Response
M204709,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.44,20.44,990.16,85,Partial Response
M204710,38,Male,HPV-related Cancer,KEYTRUDA only,74.56,80.42,952.9,67,Partial Response
M204711,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.24,31.12,929.19,91,Stable Disease
M204712,51,Other,Melanoma,mrna-4157 + keytruda,31.96,18.89,1336.58,75,Progression
M204713,63,Female,Melanoma,KEYTRUDA only,57.62,39.56,973.29,97,Partial Response
M204714,61,Male,Melanoma,KEYTRUDA only,72.8,48.21,1544.08,101,Complete Response
M204715,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.11,31.47,,107,Unknown
M204716,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.09,37.75,940.29,104,Partial Response
M204717,63,Other,Melanoma,KEYTRUDA only,36.05,23.85,1050.53,90,Stable Disease
M204718,38,Other,HPV-related Cancer,KEYTRUDA only,36.75,28.75,1354.58,87,Progression
M204719,62,Other,HPV-related Cancer,mrna-4157 + keytruda,99.84,77.81,1487.88,97,Stable Disease
M204720,47,Male,Melanoma,KEYTRUDA only,26.33,19.08,1443.25,82,Partial Response
M204721,71,Other,Melanoma,KEYTRUDA only,35.95,35.35,1216.21,83,Partial Response
M204722,39,Female,Melanoma,mrna-4157 + keytruda,47.92,40.46,1347.33,87,Progression
M204723,53,Female,HPV-related Cancer,KEYTRUDA only,76.21,76.51,995.61,88,Complete Response
M204724,58,Other,HPV-related Cancer,KEYTRUDA only,78.8,70.13,1048.1,84,Complete Response
M204725,50,Male,HPV-related Cancer,KEYTRUDA only,56.1,43.49,1194.34,91,Complete Response
M204726,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.35,21.5,810.04,83,Stable Disease
M204727,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,94.59,71.93,1286.87,80,
M204728,77,Other,HPV-related Cancer,mrna-4157 + keytruda,24.28,15.54,1489.59,109,Partial Response
M204729,39,Female,HPV-related Cancer,mrna-4157 + keytruda,61.42,37.35,1106.5,77,Stable Disease
M204730,48,Female,Melanoma,KEYTRUDA only,64.77,73.82,1275.12,93,Stable Disease
M204731,36,Other,HPV-related Cancer,KEYTRUDA only,55.61,50.23,761.5,86,Complete Response
M204732,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.31,40.3,777.88,62,Progression
M204733,48,Female,HPV-related Cancer,mrna-4157 + keytruda,69.82,61.55,1033.8,94,
M204734,49,Male,Melanoma,mrna-4157 + keytruda,22.12,17.77,1162.03,98,Stable Disease
M204735,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.75,34.3,770.55,108,Partial Response
M204736,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.89,36.81,1049.95,92,Partial Response
M204737,30,Female,Melanoma,KEYTRUDA only,14.94,7.74,1235.1,90,Stable Disease
M204738,36,Male,HPV-related Cancer,mrna-4157 + keytruda,40.1,31.62,1232.42,96,Unknown
M204739,67,Female,Melanoma,mrna-4157 + keytruda,13.19,11.17,1326.57,81,Partial Response
M204740,51,Other,HPV-related Cancer,KEYTRUDA only,62.59,44.55,,67,Stable Disease
M204741,32,Female,HPV-related Cancer,KEYTRUDA only,51.59,37.23,924.44,98,
M204742,50,Other,HPV-related Cancer,mrna-4157 + keytruda,18.75,20.47,1041.14,86,Complete Response
M204743,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.64,18.31,604.68,85,Partial Response
M204744,32,Female,Melanoma,KEYTRUDA only,35.25,10.93,1537.01,106,Partial Response
M204745,84,Male,HPV-related Cancer,KEYTRUDA only,67.16,50.56,861.68,88,Partial Response
M204746,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.33,44.09,1836.94,106,Stable Disease
M204747,73,Male,Melanoma,KEYTRUDA only,40.3,40.19,1155.97,95,Stable Disease
M204748,70,Other,HPV-related Cancer,KEYTRUDA only,17.17,16.31,807.02,96,Stable Disease
M204749,27,Female,Melanoma,mrna-4157 + keytruda,45.18,37.97,674.16,83,Complete Response
M204750,63,Female,Melanoma,KEYTRUDA only,85.72,71.63,1446.61,103,Partial Response
M204751,67,Female,HPV-related Cancer,mrna-4157 + keytruda,43.08,49.7,891.15,102,Partial Response
M204752,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.03,,906.18,90,Complete Response
M204753,40,Female,Melanoma,KEYTRUDA only,47.83,49.34,1262.23,98,Complete Response
M204754,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.4,36.28,500.4,76,Stable Disease
M204755,51,Female,HPV-related Cancer,mrna-4157 + keytruda,19.84,14.41,398.62,83,Stable Disease
M204756,73,Male,Melanoma,KEYTRUDA only,49.74,33.09,1598.82,87,Partial Response
M204757,27,Other,Melanoma,mrna-4157 + keytruda,71.47,42.79,706.48,88,Stable Disease
M204758,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.25,59.1,664.97,100,Partial Response
M204759,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.73,29.89,735.68,78,Partial Response
M204760,76,Other,Melanoma,mrna-4157 + keytruda,39.58,28.34,460.3,86,Stable Disease
M204761,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.97,8.86,1241.02,89,Progression
M204762,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.26,38.33,1329.8,99,Partial Response
M204763,82,Other,HPV-related Cancer,mrna-4157 + keytruda,34.54,23.03,811.47,91,Complete Response
M204764,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.82,32.62,662.85,83,Stable Disease
M204765,67,Female,HPV-related Cancer,KEYTRUDA only,20.88,20.92,,93,Unknown
M204766,39,Female,Melanoma,mrna-4157 + keytruda,63.89,29.74,910.74,87,Stable Disease
M204767,78,Other,Melanoma,KEYTRUDA only,61.26,35.79,832.33,105,
M204768,36,Other,Melanoma,KEYTRUDA only,53.57,42.44,1133.84,81,Partial Response
M204769,30,Female,HPV-related Cancer,KEYTRUDA only,30.24,23.3,1007.17,103,Progression
M204770,29,Female,Melanoma,mrna-4157 + keytruda,74.12,37.48,875.78,88,Partial Response
M204771,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.31,40.3,1376.12,88,Complete Response
M204772,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.23,25.58,1236.01,93,Stable Disease
M204773,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.69,11.59,1140.87,92,Stable Disease
M204774,84,Female,Melanoma,KEYTRUDA only,27.91,21.01,701.74,89,Partial Response
M204775,40,Other,Melanoma,KEYTRUDA only,24.67,12.01,1065.7,91,Progression
M204776,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.96,32.63,534.15,85,Stable Disease
M204777,48,Other,HPV-related Cancer,mrna-4157 + keytruda,45.61,24.65,1431.56,73,Partial Response
M204778,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.47,18.65,88.29,99,Stable Disease
M204779,35,Male,Melanoma,mrna-4157 + keytruda,58.44,30.03,,80,Progression
M204780,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.91,52.17,540.54,83,Partial Response
M204781,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.6,20.06,1182.35,90,Partial Response
M204782,84,Female,Melanoma,mrna-4157 + keytruda,36.76,29.77,764.53,89,Partial Response
M204783,82,Female,HPV-related Cancer,KEYTRUDA only,58.12,60.63,,86,Partial Response
M204784,81,Female,Melanoma,KEYTRUDA only,69.61,63.06,1569.81,85,Stable Disease
M204785,67,Female,Melanoma,KEYTRUDA only,30.03,15.7,663.54,83,Complete Response
M204786,34,Male,HPV-related Cancer,KEYTRUDA only,67.56,72.67,1106.71,98,Stable Disease
M204787,78,Female,HPV-related Cancer,mrna-4157 + keytruda,39.61,29.22,1048.45,96,Progression
M204788,61,Other,Melanoma,mrna-4157 + keytruda,63.85,34.29,1545.08,95,
M204789,29,Female,HPV-related Cancer,KEYTRUDA only,85.17,83.9,1025.26,101,Complete Response
M204790,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.11,65.77,1688.85,80,Complete Response
M204791,25,Female,HPV-related Cancer,mrna-4157 + keytruda,38.05,35.57,733.08,88,Stable Disease
M204792,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.74,37.74,440.98,85,Stable Disease
M204793,66,Other,HPV-related Cancer,KEYTRUDA only,70.23,51.64,1042.51,95,Progression
M204794,79,Male,Melanoma,KEYTRUDA only,59.08,51.84,922.27,96,Partial Response
M204795,42,Female,HPV-related Cancer,mrna-4157 + keytruda,30.19,34.12,1269.75,83,Stable Disease
M204796,61,Other,Melanoma,KEYTRUDA only,21.86,16.25,1766.56,86,Partial Response
M204797,26,Male,HPV-related Cancer,KEYTRUDA only,69.65,65.86,772.64,88,Partial Response
M204798,78,Other,Melanoma,KEYTRUDA only,65.71,52.05,682.16,84,Stable Disease
M204799,69,Male,Melanoma,mrna-4157 + keytruda,39.71,25.74,1104.87,91,Progression
M204800,43,Female,Melanoma,mrna-4157 + keytruda,76.06,55.47,1484.47,79,Stable Disease
M204801,30,Other,Melanoma,mrna-4157 + keytruda,43.68,29.37,1652.43,74,Stable Disease
M204802,74,Other,Melanoma,KEYTRUDA only,46.3,35.52,1403.86,106,Unknown
M204803,45,Male,Melanoma,KEYTRUDA only,82.17,39.08,1621.72,106,Stable Disease
M204804,39,Male,Melanoma,KEYTRUDA only,70.07,32.14,195.35,94,Progression
M204805,61,Male,Melanoma,KEYTRUDA only,32.8,23.18,1125.76,86,Partial Response
M204806,27,Other,Melanoma,mrna-4157 + keytruda,64.09,66.92,633.38,79,Stable Disease
M204807,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.09,51.72,1125.39,84,Progression
M204808,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.55,,1337.46,77,Partial Response
M204809,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.83,37.24,889.64,83,Partial Response
M204810,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.97,29.75,709.52,72,Progression
M204811,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.16,18.27,1169.99,107,Stable Disease
M204812,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.58,11.51,1124.2,94,Progression
M204813,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.18,28.95,991.41,82,Progression
M204814,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,30.07,24.03,784.43,106,Progression
M204815,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.27,15.31,1011.2,99,Partial Response
M204816,27,Other,Melanoma,mrna-4157 + keytruda,62.63,58.21,1334.8,102,Progression
M204817,33,Male,HPV-related Cancer,mrna-4157 + keytruda,68.16,50.05,904.3,92,Partial Response
M204818,57,Female,HPV-related Cancer,mrna-4157 + keytruda,52.47,40.06,1013.66,100,Stable Disease
M204819,66,Male,HPV-related Cancer,KEYTRUDA only,36.7,29.53,1086.16,79,Stable Disease
M204820,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.52,45.63,1417.98,101,Partial Response
M204821,57,Female,Melanoma,mrna-4157 + keytruda,35.66,29.61,,86,Complete Response
M204822,64,Female,Melanoma,mrna-4157 + keytruda,37.28,33.76,1685.03,85,Stable Disease
M204823,45,Other,HPV-related Cancer,mrna-4157 + keytruda,64.63,57.88,1234.59,93,Stable Disease
M204824,41,Female,HPV-related Cancer,KEYTRUDA only,57.95,63.06,772.44,81,Progression
M204825,61,Male,Melanoma,KEYTRUDA only,54.24,35.69,698.52,75,Unknown
M204826,36,Other,Melanoma,KEYTRUDA only,48.16,43.8,624.22,101,Progression
M204827,62,Male,HPV-related Cancer,KEYTRUDA only,37.8,32.55,1297.99,69,Complete Response
M204828,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.68,52.01,644.86,100,Partial Response
M204829,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.12,48.19,1557.07,74,Partial Response
M204830,51,Male,Melanoma,mrna-4157 + keytruda,57.75,43.54,856.14,83,Partial Response
M204831,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,3.18,3.82,1332.1,90,Stable Disease
M204832,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.29,13.59,1156.4,91,Stable Disease
M204833,45,Male,Melanoma,KEYTRUDA only,46.7,35.45,1530.7,79,Complete Response
M204834,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.3,89.01,1461.2,79,Partial Response
M204835,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.96,53.1,446.78,94,Partial Response
M204836,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.29,,1246.37,94,Stable Disease
M204837,62,Male,HPV-related Cancer,mrna-4157 + keytruda,23.52,13.27,852.53,92,Progression
M204838,58,Other,HPV-related Cancer,mrna-4157 + keytruda,25.12,15.13,1310.0,91,
M204839,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.95,32.18,1493.64,102,Partial Response
M204840,73,Other,HPV-related Cancer,mrna-4157 + keytruda,26.54,19.98,1072.92,89,Complete Response
M204841,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,78.7,56.3,1225.5,84,Stable Disease
M204842,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.53,42.2,1354.24,86,Stable Disease
M204843,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.96,32.84,538.16,99,Complete Response
M204844,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.0,36.96,889.32,95,Stable Disease
M204845,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.39,41.23,302.3,84,Partial Response
M204846,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.0,59.5,1041.41,81,Partial Response
M204847,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.69,33.92,1428.01,76,Partial Response
M204848,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.18,61.74,1028.3,97,Stable Disease
M204849,81,Male,HPV-related Cancer,KEYTRUDA only,40.33,24.13,313.66,83,Stable Disease
M204850,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.88,28.77,95.05,75,Stable Disease
M204851,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.88,51.44,1519.39,105,Complete Response
M204852,31,Other,HPV-related Cancer,KEYTRUDA only,58.49,41.97,1588.69,81,Progression
M204853,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.65,75.43,986.17,68,Partial Response
M204854,58,Male,Melanoma,KEYTRUDA only,46.52,29.72,,91,Partial Response
M204855,50,Other,HPV-related Cancer,KEYTRUDA only,46.36,40.91,1156.72,93,Progression
M204856,34,Other,Melanoma,KEYTRUDA only,65.77,53.91,949.66,86,
M204857,29,Other,HPV-related Cancer,mrna-4157 + keytruda,17.58,17.92,812.89,96,Progression
M204858,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.97,81.36,1496.45,85,Unknown
M204859,73,Other,HPV-related Cancer,mrna-4157 + keytruda,47.03,42.27,,59,Complete Response
M204860,31,Female,HPV-related Cancer,KEYTRUDA only,56.72,28.24,1575.43,80,Stable Disease
M204861,67,Other,Melanoma,KEYTRUDA only,25.24,22.4,1534.82,77,Progression
M204862,77,Other,Melanoma,mrna-4157 + keytruda,58.76,44.58,,89,Partial Response
M204863,64,Female,HPV-related Cancer,mrna-4157 + keytruda,84.97,38.86,,76,Partial Response
M204864,43,Female,Non-small Cell Lung Cancer,KEYTRUDA only,31.51,18.23,1868.42,93,Partial Response
M204865,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.61,51.47,1045.02,87,Progression
M204866,46,Female,Melanoma,KEYTRUDA only,10.99,8.14,1089.03,87,Complete Response
M204867,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.55,14.49,895.48,108,Stable Disease
M204868,38,Female,Melanoma,KEYTRUDA only,71.63,53.33,1556.21,92,Stable Disease
M204869,69,Female,Melanoma,KEYTRUDA only,50.79,32.78,1177.3,91,Complete Response
M204870,77,Female,Melanoma,mrna-4157 + keytruda,62.09,50.83,1612.84,76,Complete Response
M204871,70,Female,Melanoma,mrna-4157 + keytruda,63.07,54.07,950.85,98,Partial Response
M204872,33,Female,HPV-related Cancer,KEYTRUDA only,47.66,28.02,1665.72,100,Partial Response
M204873,73,Male,HPV-related Cancer,KEYTRUDA only,54.39,45.48,1166.99,89,Complete Response
M204874,55,Other,Melanoma,mrna-4157 + keytruda,68.47,57.09,1079.76,108,Partial Response
M204875,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.6,1.92,1376.91,94,Partial Response
M204876,30,Male,Melanoma,mrna-4157 + keytruda,41.8,38.7,1312.52,112,Progression
M204877,66,Male,HPV-related Cancer,mrna-4157 + keytruda,23.67,14.24,1213.02,86,Partial Response
M204878,40,Male,HPV-related Cancer,KEYTRUDA only,74.8,71.49,738.69,77,Complete Response
M204879,48,Male,HPV-related Cancer,KEYTRUDA only,49.29,52.34,1339.4,102,Stable Disease
M204880,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.58,26.81,1624.22,86,Complete Response
M204881,44,Female,HPV-related Cancer,mrna-4157 + keytruda,62.6,55.82,1390.99,101,Unknown
M204882,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.89,80.05,,87,Partial Response
M204883,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,65.7,63.5,1457.7,89,Progression
M204884,53,Female,HPV-related Cancer,KEYTRUDA only,38.12,29.71,1138.83,95,Stable Disease
M204885,46,Female,Melanoma,mrna-4157 + keytruda,72.23,78.49,,95,
M204886,45,Female,Melanoma,mrna-4157 + keytruda,65.35,32.04,693.93,80,Unknown
M204887,40,Other,HPV-related Cancer,mrna-4157 + keytruda,32.64,31.25,852.74,90,
M204888,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.67,42.37,550.52,81,Complete Response
M204889,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,8.21,7.85,1714.92,93,Stable Disease
M204890,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.66,28.55,1447.82,95,Partial Response
M204891,63,Female,HPV-related Cancer,KEYTRUDA only,38.43,27.14,1330.24,92,Stable Disease
M204892,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,12.36,12.27,882.94,87,Stable Disease
M204893,64,Male,HPV-related Cancer,KEYTRUDA only,52.33,41.06,1247.55,100,Complete Response
M204894,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.39,26.74,1492.14,100,Partial Response
M204895,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.82,36.21,507.47,91,Stable Disease
M204896,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.46,49.97,1141.41,93,Stable Disease
M204897,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.07,23.05,797.79,85,Progression
M204898,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.93,24.79,959.2,82,Stable Disease
M204899,65,Male,HPV-related Cancer,mrna-4157 + keytruda,34.19,23.73,383.94,86,
M204900,70,Male,HPV-related Cancer,KEYTRUDA only,40.97,39.36,739.49,90,Complete Response
M204901,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,72.4,59.18,,87,Progression
M204902,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.77,62.51,841.49,93,Partial Response
M204903,79,Male,HPV-related Cancer,KEYTRUDA only,36.95,27.98,300.51,94,Stable Disease
M204904,43,Male,Melanoma,KEYTRUDA only,60.13,40.03,434.56,89,Progression
M204905,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.47,58.89,937.62,82,Partial Response
M204906,38,Female,HPV-related Cancer,KEYTRUDA only,40.26,38.31,1127.03,81,Unknown
M204907,76,Female,HPV-related Cancer,mrna-4157 + keytruda,75.56,76.32,1548.38,92,Partial Response
M204908,28,Male,Melanoma,KEYTRUDA only,49.52,50.17,1112.39,86,Stable Disease
M204909,46,Male,HPV-related Cancer,mrna-4157 + keytruda,64.06,55.38,692.09,93,Unknown
M204910,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.3,45.39,1193.89,91,
M204911,31,Female,HPV-related Cancer,KEYTRUDA only,33.5,31.94,1656.47,84,Progression
M204912,28,Female,HPV-related Cancer,KEYTRUDA only,10.61,9.2,1535.56,90,Partial Response
M204913,28,Male,Melanoma,KEYTRUDA only,83.07,53.3,1110.85,102,Complete Response
M204914,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.77,37.61,695.96,97,Complete Response
M204915,37,Male,Melanoma,KEYTRUDA only,100.39,69.02,1414.25,86,Partial Response
M204916,74,Female,Melanoma,mrna-4157 + keytruda,52.36,43.84,987.28,86,Partial Response
M204917,75,Female,HPV-related Cancer,KEYTRUDA only,28.86,23.18,1694.97,108,Complete Response
M204918,54,Other,Melanoma,mrna-4157 + keytruda,24.51,21.53,895.08,86,
M204919,81,Female,Melanoma,mrna-4157 + keytruda,59.38,27.26,1722.33,98,
M204920,63,Other,HPV-related Cancer,mrna-4157 + keytruda,41.54,35.79,570.81,96,Progression
M204921,77,Male,HPV-related Cancer,KEYTRUDA only,48.81,31.56,1474.81,116,Stable Disease
M204922,83,Female,Melanoma,KEYTRUDA only,63.72,50.99,924.07,93,Stable Disease
M204923,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.61,56.4,412.66,101,Unknown
M204924,26,Female,HPV-related Cancer,mrna-4157 + keytruda,80.46,57.63,998.09,105,Stable Disease
M204925,76,Other,HPV-related Cancer,KEYTRUDA only,78.92,35.48,1510.97,88,Stable Disease
M204926,25,Male,HPV-related Cancer,mrna-4157 + keytruda,57.68,40.08,1055.04,86,Unknown
M204927,39,Female,Melanoma,KEYTRUDA only,29.29,20.21,359.4,81,Stable Disease
M204928,26,Other,Melanoma,KEYTRUDA only,54.33,50.43,990.67,91,Stable Disease
M204929,80,Other,HPV-related Cancer,mrna-4157 + keytruda,80.51,,492.32,89,Stable Disease
M204930,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.57,72.79,743.67,67,Stable Disease
M204931,66,Male,Melanoma,mrna-4157 + keytruda,15.79,13.01,931.37,81,Progression
M204932,28,Other,Melanoma,mrna-4157 + keytruda,73.32,74.79,835.11,90,Stable Disease
M204933,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.05,39.43,957.86,91,Partial Response
M204934,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.34,64.89,638.18,103,Progression
M204935,33,Male,Melanoma,KEYTRUDA only,58.33,47.09,927.13,95,Complete Response
M204936,40,Female,Melanoma,mrna-4157 + keytruda,37.68,28.21,999.13,85,Stable Disease
M204937,74,Female,HPV-related Cancer,KEYTRUDA only,24.72,11.0,1041.8,79,Stable Disease
M204938,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.17,45.48,752.25,96,Partial Response
M204939,80,Other,Melanoma,mrna-4157 + keytruda,42.86,40.53,630.17,69,Partial Response
M204940,60,Other,HPV-related Cancer,KEYTRUDA only,58.27,37.29,546.76,93,Stable Disease
M204941,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,75.94,69.42,1176.22,90,
M204942,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.75,59.41,1249.74,76,Stable Disease
M204943,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.94,,1163.25,102,Partial Response
M204944,64,Other,Melanoma,KEYTRUDA only,27.22,15.57,969.22,91,Complete Response
M204945,26,Male,Melanoma,mrna-4157 + keytruda,39.73,13.54,652.89,88,Partial Response
M204946,55,Male,Melanoma,mrna-4157 + keytruda,33.89,19.42,639.03,89,Complete Response
M204947,69,Female,HPV-related Cancer,KEYTRUDA only,1.29,1.2,1258.84,78,Stable Disease
M204948,37,Male,Melanoma,mrna-4157 + keytruda,50.93,42.75,1420.4,90,Progression
M204949,73,Other,HPV-related Cancer,mrna-4157 + keytruda,43.41,31.51,1381.07,79,Partial Response
M204950,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.75,48.73,821.77,93,Progression
M204951,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.27,32.53,453.47,87,Complete Response
M204952,65,Male,HPV-related Cancer,KEYTRUDA only,55.67,63.24,1080.01,98,Partial Response
M204953,52,Other,HPV-related Cancer,KEYTRUDA only,61.09,49.29,1629.42,92,Stable Disease
M204954,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.91,33.6,414.08,85,Partial Response
M204955,62,Male,Melanoma,mrna-4157 + keytruda,60.08,56.77,,72,Complete Response
M204956,66,Male,HPV-related Cancer,mrna-4157 + keytruda,54.11,,1015.69,73,Partial Response
M204957,40,Female,HPV-related Cancer,KEYTRUDA only,60.54,46.33,944.66,72,Partial Response
M204958,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,36.56,32.2,876.31,85,Progression
M204959,30,Female,Melanoma,KEYTRUDA only,1.91,,1294.61,91,Progression
M204960,69,Other,HPV-related Cancer,mrna-4157 + keytruda,46.86,47.19,2176.85,96,Partial Response
M204961,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.29,15.94,805.17,88,Stable Disease
M204962,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.59,66.02,1347.81,103,Partial Response
M204963,77,Other,Melanoma,mrna-4157 + keytruda,69.5,69.7,537.67,73,Stable Disease
M204964,49,Female,HPV-related Cancer,mrna-4157 + keytruda,57.54,39.37,1398.57,95,Progression
M204965,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.85,32.01,196.92,113,Stable Disease
M204966,66,Male,HPV-related Cancer,KEYTRUDA only,33.55,20.09,685.1,80,Progression
M204967,38,Male,Melanoma,mrna-4157 + keytruda,60.14,62.43,1053.74,89,Complete Response
M204968,77,Female,HPV-related Cancer,mrna-4157 + keytruda,72.21,27.2,906.02,92,Unknown
M204969,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.76,14.75,1141.63,100,Partial Response
M204970,77,Male,HPV-related Cancer,mrna-4157 + keytruda,38.71,29.41,1421.76,108,Unknown
M204971,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.82,48.87,1214.27,90,Partial Response
M204972,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.28,22.82,1325.58,88,Stable Disease
M204973,44,Female,Melanoma,KEYTRUDA only,49.28,21.71,,76,Partial Response
M204974,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,1.06,1.12,1315.55,79,Partial Response
M204975,60,Other,Melanoma,KEYTRUDA only,61.2,56.58,947.66,85,Complete Response
M204976,82,Female,HPV-related Cancer,KEYTRUDA only,58.01,51.85,1232.93,82,Complete Response
M204977,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.27,31.99,1390.16,88,Unknown
M204978,69,Male,HPV-related Cancer,mrna-4157 + keytruda,84.32,45.39,-239.48,87,Partial Response
M204979,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.55,19.85,437.83,92,Progression
M204980,45,Female,HPV-related Cancer,mrna-4157 + keytruda,61.47,41.71,641.46,104,Partial Response
M204981,31,Female,Melanoma,KEYTRUDA only,75.48,54.77,1225.2,94,Partial Response
M204982,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,30.98,13.41,,95,Partial Response
M204983,56,Female,Melanoma,KEYTRUDA only,95.41,43.64,501.59,83,
M204984,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,77.67,60.25,1080.29,78,Progression
M204985,57,Male,HPV-related Cancer,KEYTRUDA only,14.57,14.93,454.25,108,Progression
M204986,60,Other,HPV-related Cancer,mrna-4157 + keytruda,95.31,81.02,786.15,94,Partial Response
M204987,31,Other,Melanoma,KEYTRUDA only,45.07,28.79,1258.42,89,Stable Disease
M204988,33,Other,Melanoma,mrna-4157 + keytruda,41.29,24.35,356.49,102,Progression
M204989,68,Other,HPV-related Cancer,mrna-4157 + keytruda,87.06,89.9,1240.71,79,Complete Response
M204990,53,Other,HPV-related Cancer,mrna-4157 + keytruda,56.43,52.74,1092.47,87,Progression
M204991,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.48,54.51,904.73,77,Progression
M204992,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.11,16.09,1261.05,113,Progression
M204993,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.27,55.44,,95,Stable Disease
M204994,59,Female,HPV-related Cancer,mrna-4157 + keytruda,49.58,54.45,734.9,105,Progression
M204995,48,Female,Melanoma,mrna-4157 + keytruda,65.39,59.08,789.04,79,Progression
M204996,26,Male,Melanoma,KEYTRUDA only,39.3,32.5,325.39,92,Partial Response
M204997,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.83,34.8,1191.68,89,Complete Response
M204998,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,8.59,6.32,1423.91,92,Stable Disease
M204999,39,Other,HPV-related Cancer,KEYTRUDA only,51.9,47.07,669.51,87,Stable Disease
M205000,40,Male,Melanoma,KEYTRUDA only,49.53,33.14,1129.61,109,Partial Response
M205001,32,Male,Melanoma,KEYTRUDA only,63.56,57.42,1064.72,118,Partial Response
M205002,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.42,53.88,1234.75,88,Progression
M205003,72,Female,Melanoma,mrna-4157 + keytruda,51.34,52.69,402.37,90,Stable Disease
M205004,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.8,53.79,1339.67,76,Partial Response
M205005,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.97,58.14,956.02,90,Progression
M205006,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,26.11,15.03,982.2,93,Stable Disease
M205007,39,Other,Melanoma,mrna-4157 + keytruda,49.52,33.74,944.34,81,Complete Response
M205008,83,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.47,35.65,459.08,86,Progression
M205009,38,Male,Melanoma,mrna-4157 + keytruda,34.7,31.14,650.85,86,Partial Response
M205010,74,Other,HPV-related Cancer,mrna-4157 + keytruda,30.5,30.38,1341.47,96,Progression
M205011,57,Other,HPV-related Cancer,mrna-4157 + keytruda,30.34,30.2,1286.96,82,Partial Response
M205012,49,Female,Melanoma,mrna-4157 + keytruda,53.77,35.87,1252.88,100,Progression
M205013,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.86,25.3,1079.31,100,Progression
M205014,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.97,42.17,1092.52,93,Partial Response
M205015,32,Other,HPV-related Cancer,KEYTRUDA only,81.38,56.21,687.6,98,Stable Disease
M205016,31,Other,Melanoma,KEYTRUDA only,49.83,51.75,1013.69,100,Partial Response
M205017,79,Female,HPV-related Cancer,mrna-4157 + keytruda,28.34,36.02,265.39,86,Partial Response
M205018,50,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.64,34.86,1159.17,72,Partial Response
M205019,28,Female,HPV-related Cancer,mrna-4157 + keytruda,82.35,55.37,1444.39,94,Progression
M205020,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.39,56.08,367.5,92,Stable Disease
M205021,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.88,39.23,757.01,98,Partial Response
M205022,56,Other,Melanoma,mrna-4157 + keytruda,49.57,36.18,1288.97,102,Partial Response
M205023,45,Male,Melanoma,mrna-4157 + keytruda,55.86,57.95,968.43,81,Partial Response
M205024,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,6.31,3.83,520.8,90,Stable Disease
M205025,80,Female,HPV-related Cancer,KEYTRUDA only,12.37,10.72,1149.03,99,Stable Disease
M205026,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.72,22.47,1429.86,96,Stable Disease
M205027,67,Female,HPV-related Cancer,mrna-4157 + keytruda,31.28,25.57,923.54,89,Partial Response
M205028,49,Other,Melanoma,KEYTRUDA only,23.15,15.46,469.67,80,Partial Response
M205029,78,Other,Melanoma,mrna-4157 + keytruda,52.2,47.34,-72.31,93,Partial Response
M205030,35,Male,HPV-related Cancer,KEYTRUDA only,46.66,22.17,1104.25,85,Partial Response
M205031,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.04,69.26,872.96,87,Partial Response
M205032,76,Female,Melanoma,KEYTRUDA only,49.41,38.56,1154.27,80,Stable Disease
M205033,75,Male,Melanoma,mrna-4157 + keytruda,55.11,41.41,1205.93,93,
M205034,54,Male,Melanoma,KEYTRUDA only,55.98,52.57,1537.17,88,Partial Response
M205035,70,Other,Melanoma,mrna-4157 + keytruda,44.64,46.99,653.48,70,Partial Response
M205036,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.16,45.51,370.44,85,Partial Response
M205037,60,Other,Melanoma,KEYTRUDA only,27.21,29.94,1356.96,92,Progression
M205038,48,Female,HPV-related Cancer,KEYTRUDA only,73.59,45.58,1147.64,130,Partial Response
M205039,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.3,46.03,1384.55,98,Unknown
M205040,76,Male,Melanoma,mrna-4157 + keytruda,68.62,44.65,928.52,100,Progression
M205041,64,Female,HPV-related Cancer,mrna-4157 + keytruda,73.7,66.64,928.0,89,Progression
M205042,60,Male,HPV-related Cancer,mrna-4157 + keytruda,42.21,29.07,955.86,92,Partial Response
M205043,73,Male,Melanoma,mrna-4157 + keytruda,69.99,49.59,1612.5,98,Complete Response
M205044,81,Female,HPV-related Cancer,mrna-4157 + keytruda,46.62,,1381.02,98,Stable Disease
M205045,38,Other,HPV-related Cancer,KEYTRUDA only,46.16,36.87,,80,Partial Response
M205046,53,Female,HPV-related Cancer,KEYTRUDA only,77.5,73.87,1657.44,84,Complete Response
M205047,58,Other,HPV-related Cancer,mrna-4157 + keytruda,61.21,,823.61,92,Stable Disease
M205048,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.88,56.05,735.64,81,
M205049,82,Other,HPV-related Cancer,mrna-4157 + keytruda,45.55,43.41,1615.03,95,Complete Response
M205050,66,Other,HPV-related Cancer,KEYTRUDA only,4.56,2.66,943.64,77,Stable Disease
M205051,79,Female,Melanoma,KEYTRUDA only,35.74,21.37,912.84,94,Partial Response
M205052,47,Other,Melanoma,mrna-4157 + keytruda,32.44,25.74,1114.3,78,Partial Response
M205053,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.56,25.82,922.6,76,
M205054,55,Other,HPV-related Cancer,mrna-4157 + keytruda,25.24,12.57,683.08,86,Partial Response
M205055,33,Male,Melanoma,mrna-4157 + keytruda,76.77,60.39,1134.27,74,Stable Disease
M205056,36,Male,HPV-related Cancer,KEYTRUDA only,-5.59,-4.1,,83,Partial Response
M205057,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.44,42.95,987.64,84,Partial Response
M205058,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.24,16.12,581.21,81,Progression
M205059,40,Male,HPV-related Cancer,mrna-4157 + keytruda,44.3,43.95,797.16,94,Partial Response
M205060,57,Male,Melanoma,mrna-4157 + keytruda,39.32,33.86,1057.26,89,Partial Response
M205061,83,Female,HPV-related Cancer,KEYTRUDA only,53.27,42.62,345.41,81,Partial Response
M205062,64,Female,Melanoma,mrna-4157 + keytruda,41.67,28.71,568.38,89,Partial Response
M205063,51,Female,Melanoma,KEYTRUDA only,50.25,,831.32,92,Complete Response
M205064,41,Female,HPV-related Cancer,mrna-4157 + keytruda,41.71,36.67,828.74,87,Progression
M205065,84,Male,Melanoma,KEYTRUDA only,50.19,60.0,,79,Complete Response
M205066,26,Male,Melanoma,KEYTRUDA only,54.72,,938.18,90,
M205067,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,25.97,15.33,1658.08,97,Progression
M205068,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.79,69.89,1434.34,82,Partial Response
M205069,43,Other,HPV-related Cancer,mrna-4157 + keytruda,63.1,21.19,341.1,87,Stable Disease
M205070,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.72,26.91,1053.7,90,Complete Response
M205071,82,Female,HPV-related Cancer,KEYTRUDA only,90.93,57.21,,80,Complete Response
M205072,41,Male,HPV-related Cancer,KEYTRUDA only,33.91,,1030.75,100,Complete Response
M205073,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.06,30.83,1109.39,83,Partial Response
M205074,78,Male,Melanoma,mrna-4157 + keytruda,41.48,35.49,922.82,84,Progression
M205075,28,Other,Melanoma,KEYTRUDA only,41.66,43.59,1528.43,89,Complete Response
M205076,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.18,10.83,1384.31,89,Partial Response
M205077,46,Other,HPV-related Cancer,KEYTRUDA only,52.21,32.82,836.53,87,Progression
M205078,32,Female,Melanoma,KEYTRUDA only,20.42,14.49,1202.03,96,Partial Response
M205079,63,Other,HPV-related Cancer,KEYTRUDA only,32.98,27.18,,83,Complete Response
M205080,75,Female,Melanoma,mrna-4157 + keytruda,36.1,32.76,968.21,87,Partial Response
M205081,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,14.71,11.22,727.76,96,Progression
M205082,49,Male,HPV-related Cancer,mrna-4157 + keytruda,41.13,37.09,540.81,87,Partial Response
M205083,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.95,27.99,1196.83,76,Stable Disease
M205084,32,Other,Melanoma,KEYTRUDA only,75.68,84.5,546.82,90,Stable Disease
M205085,75,Male,HPV-related Cancer,KEYTRUDA only,68.5,39.26,,98,Partial Response
M205086,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.49,47.29,647.92,71,Complete Response
M205087,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.28,44.73,959.44,82,Stable Disease
M205088,51,Female,HPV-related Cancer,KEYTRUDA only,33.61,21.65,1539.83,76,Stable Disease
M205089,31,Female,HPV-related Cancer,KEYTRUDA only,70.0,62.12,1313.49,99,Stable Disease
M205090,30,Male,Melanoma,KEYTRUDA only,56.3,50.9,884.7,74,Progression
M205091,84,Male,Melanoma,mrna-4157 + keytruda,17.91,11.7,1374.61,86,Stable Disease
M205092,54,Male,HPV-related Cancer,KEYTRUDA only,34.78,34.22,-132.78,91,Stable Disease
M205093,80,Female,HPV-related Cancer,KEYTRUDA only,53.47,63.3,633.43,88,Stable Disease
M205094,55,Other,HPV-related Cancer,mrna-4157 + keytruda,84.05,81.63,1164.28,82,Partial Response
M205095,41,Female,HPV-related Cancer,KEYTRUDA only,43.98,30.86,1206.2,75,Unknown
M205096,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.36,46.06,1009.58,102,Stable Disease
M205097,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.59,36.86,1110.82,90,Complete Response
M205098,42,Other,HPV-related Cancer,KEYTRUDA only,57.85,34.95,1162.83,87,Progression
M205099,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.56,37.53,824.7,93,Progression
M205100,66,Male,HPV-related Cancer,mrna-4157 + keytruda,80.03,63.34,1280.67,90,Partial Response
M205101,72,Male,Melanoma,mrna-4157 + keytruda,71.92,66.49,592.83,89,Stable Disease
M205102,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.9,46.92,1488.03,90,Partial Response
M205103,83,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.63,24.68,1113.53,79,Complete Response
M205104,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.06,35.63,565.96,86,Partial Response
M205105,33,Male,Melanoma,KEYTRUDA only,34.03,31.02,1021.34,85,Partial Response
M205106,80,Male,HPV-related Cancer,mrna-4157 + keytruda,51.3,63.74,1214.06,74,Unknown
M205107,61,Other,HPV-related Cancer,KEYTRUDA only,59.9,47.59,366.79,111,Progression
M205108,54,Male,Melanoma,KEYTRUDA only,36.3,24.02,1124.92,84,Complete Response
M205109,33,Male,HPV-related Cancer,mrna-4157 + keytruda,3.98,2.76,1518.85,86,Progression
M205110,63,Other,HPV-related Cancer,KEYTRUDA only,66.44,51.93,1101.11,93,Progression
M205111,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.86,21.36,667.12,77,Partial Response
M205112,58,Other,HPV-related Cancer,mrna-4157 + keytruda,42.65,31.31,324.92,84,Stable Disease
M205113,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.79,58.97,1218.5,83,Partial Response
M205114,63,Male,Melanoma,mrna-4157 + keytruda,60.17,62.04,1008.68,79,
M205115,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.31,,876.13,107,Progression
M205116,29,Other,HPV-related Cancer,KEYTRUDA only,30.53,21.99,1283.14,91,Stable Disease
M205117,55,Female,HPV-related Cancer,mrna-4157 + keytruda,55.98,,1117.24,89,Complete Response
M205118,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,92.49,61.98,987.65,100,Stable Disease
M205119,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.38,66.23,932.95,84,Partial Response
M205120,59,Other,Melanoma,mrna-4157 + keytruda,19.31,18.21,654.33,74,Partial Response
M205121,61,Female,Melanoma,KEYTRUDA only,23.05,22.05,970.48,107,Stable Disease
M205122,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.48,61.19,979.13,98,Stable Disease
M205123,72,Other,HPV-related Cancer,KEYTRUDA only,88.69,59.41,208.43,105,Progression
M205124,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.19,44.89,1271.13,112,Progression
M205125,66,Male,Melanoma,mrna-4157 + keytruda,47.5,44.43,616.64,92,Progression
M205126,26,Male,HPV-related Cancer,mrna-4157 + keytruda,40.23,31.88,1205.53,100,
M205127,66,Female,HPV-related Cancer,mrna-4157 + keytruda,40.9,26.95,808.63,82,Complete Response
M205128,42,Other,Melanoma,mrna-4157 + keytruda,20.14,16.96,936.75,72,Progression
M205129,29,Female,HPV-related Cancer,KEYTRUDA only,64.17,67.25,868.09,94,Progression
M205130,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.3,39.51,500.67,83,Stable Disease
M205131,53,Male,HPV-related Cancer,mrna-4157 + keytruda,42.55,30.24,1583.94,88,Partial Response
M205132,33,Female,Melanoma,mrna-4157 + keytruda,54.13,36.43,943.49,90,Partial Response
M205133,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.0,37.55,856.53,91,Complete Response
M205134,67,Other,Melanoma,mrna-4157 + keytruda,57.35,19.32,1139.68,85,Progression
M205135,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.12,38.0,1029.9,92,Partial Response
M205136,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.92,84.13,1301.07,84,Stable Disease
M205137,31,Female,HPV-related Cancer,KEYTRUDA only,46.87,52.73,251.32,100,Complete Response
M205138,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,11.02,11.44,1355.86,93,Stable Disease
M205139,51,Female,HPV-related Cancer,mrna-4157 + keytruda,66.03,48.96,646.72,85,Partial Response
M205140,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,24.12,12.54,1001.6,68,Progression
M205141,25,Male,HPV-related Cancer,mrna-4157 + keytruda,49.49,34.56,718.03,103,Stable Disease
M205142,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.28,50.81,1103.8,79,Complete Response
M205143,46,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.44,50.1,873.94,94,Partial Response
M205144,41,Female,HPV-related Cancer,KEYTRUDA only,52.12,36.06,901.88,89,Progression
M205145,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.95,43.68,977.36,102,Progression
M205146,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.27,32.7,1136.93,92,Progression
M205147,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.57,41.2,1052.1,95,Unknown
M205148,46,Other,Melanoma,mrna-4157 + keytruda,21.87,17.47,1451.31,90,Progression
M205149,60,Male,Melanoma,mrna-4157 + keytruda,32.37,29.42,1859.7,96,Unknown
M205150,31,Other,Melanoma,mrna-4157 + keytruda,18.55,18.37,1358.78,79,Stable Disease
M205151,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.6,52.0,1388.28,86,Stable Disease
M205152,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,20.63,19.76,1261.06,91,Stable Disease
M205153,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.39,27.21,52.75,90,Stable Disease
M205154,81,Other,Melanoma,mrna-4157 + keytruda,38.62,29.83,1275.22,90,Partial Response
M205155,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.03,12.45,1280.24,90,Partial Response
M205156,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.87,34.09,1414.97,91,Partial Response
M205157,58,Male,Melanoma,mrna-4157 + keytruda,41.48,26.21,1629.76,76,Partial Response
M205158,31,Male,HPV-related Cancer,mrna-4157 + keytruda,46.69,39.14,996.51,76,Stable Disease
M205159,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.16,26.97,506.38,103,Partial Response
M205160,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.94,38.42,1687.12,102,Partial Response
M205161,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.85,38.28,1223.04,90,Progression
M205162,29,Female,Melanoma,mrna-4157 + keytruda,25.89,32.25,905.62,84,Partial Response
M205163,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.12,33.92,1660.8,79,Stable Disease
M205164,67,Female,Melanoma,mrna-4157 + keytruda,30.09,23.94,780.64,96,Progression
M205165,39,Male,HPV-related Cancer,KEYTRUDA only,72.57,64.8,593.17,100,
M205166,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.78,25.05,1715.51,88,Complete Response
M205167,84,Other,HPV-related Cancer,KEYTRUDA only,42.24,24.58,1379.79,100,Stable Disease
M205168,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.16,21.88,876.12,102,Stable Disease
M205169,47,Male,Melanoma,mrna-4157 + keytruda,62.18,71.51,364.15,93,Partial Response
M205170,76,Female,Melanoma,mrna-4157 + keytruda,16.76,13.84,369.02,100,Stable Disease
M205171,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.02,88.3,691.27,82,Partial Response
M205172,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.0,48.76,1213.98,64,Partial Response
M205173,72,Female,HPV-related Cancer,KEYTRUDA only,88.09,65.48,586.91,84,Stable Disease
M205174,38,Male,HPV-related Cancer,mrna-4157 + keytruda,31.78,20.66,151.69,98,Progression
M205175,74,Other,HPV-related Cancer,KEYTRUDA only,48.35,33.36,1241.62,103,Stable Disease
M205176,58,Male,HPV-related Cancer,KEYTRUDA only,76.94,38.29,883.44,88,Progression
M205177,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.95,45.95,102.31,107,Complete Response
M205178,49,Other,HPV-related Cancer,KEYTRUDA only,24.93,,1411.13,78,Stable Disease
M205179,80,Female,HPV-related Cancer,mrna-4157 + keytruda,59.91,47.98,896.06,92,Unknown
M205180,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.5,65.43,710.44,90,Stable Disease
M205181,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.76,18.3,985.69,99,Partial Response
M205182,62,Female,HPV-related Cancer,KEYTRUDA only,46.27,31.42,829.8,87,Stable Disease
M205183,63,Male,Melanoma,mrna-4157 + keytruda,60.71,41.47,1659.86,78,Partial Response
M205184,31,Female,HPV-related Cancer,KEYTRUDA only,41.59,32.21,1244.22,102,Complete Response
M205185,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.1,64.97,1236.23,88,Partial Response
M205186,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.72,,1183.6,98,Partial Response
M205187,67,Male,Melanoma,mrna-4157 + keytruda,69.88,52.66,1239.99,89,Progression
M205188,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,77.25,71.88,963.41,107,Stable Disease
M205189,42,Other,Melanoma,mrna-4157 + keytruda,11.99,11.58,473.98,95,Partial Response
M205190,58,Female,HPV-related Cancer,KEYTRUDA only,76.82,61.73,1334.75,87,Complete Response
M205191,48,Male,HPV-related Cancer,KEYTRUDA only,34.63,29.46,38.85,96,Progression
M205192,56,Female,Melanoma,KEYTRUDA only,17.71,20.36,1110.12,92,Unknown
M205193,56,Female,Melanoma,mrna-4157 + keytruda,61.73,25.29,999.56,102,Complete Response
M205194,68,Male,HPV-related Cancer,KEYTRUDA only,56.83,44.71,660.72,85,Stable Disease
M205195,78,Other,Melanoma,KEYTRUDA only,31.47,32.44,846.05,110,Complete Response
M205196,76,Male,Melanoma,KEYTRUDA only,16.64,17.24,5915.4,77,Complete Response
M205197,43,Other,HPV-related Cancer,mrna-4157 + keytruda,44.49,39.19,831.22,69,Partial Response
M205198,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.87,28.8,1325.83,94,Partial Response
M205199,63,Male,HPV-related Cancer,mrna-4157 + keytruda,70.3,74.68,834.25,89,Stable Disease
M205200,38,Other,HPV-related Cancer,mrna-4157 + keytruda,68.57,52.18,697.08,108,Progression
M205201,64,Male,HPV-related Cancer,KEYTRUDA only,33.71,33.86,1307.64,92,Progression
M205202,34,Female,HPV-related Cancer,KEYTRUDA only,30.5,26.58,1296.45,83,Partial Response
M205203,42,Male,HPV-related Cancer,mrna-4157 + keytruda,57.72,37.61,1115.96,76,Partial Response
M205204,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.21,33.07,807.56,99,Partial Response
M205205,68,Female,HPV-related Cancer,KEYTRUDA only,59.3,59.39,1334.97,85,Progression
M205206,27,Male,HPV-related Cancer,KEYTRUDA only,32.21,19.23,357.07,101,Partial Response
M205207,55,Male,Melanoma,KEYTRUDA only,46.63,39.6,715.89,74,Stable Disease
M205208,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.19,52.35,1754.51,81,Stable Disease
M205209,43,Male,HPV-related Cancer,mrna-4157 + keytruda,68.37,56.84,1549.62,96,Stable Disease
M205210,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.52,39.2,75.58,87,Partial Response
M205211,28,Other,HPV-related Cancer,KEYTRUDA only,54.71,32.93,1897.43,91,
M205212,45,Female,HPV-related Cancer,KEYTRUDA only,33.5,27.17,1261.23,92,Complete Response
M205213,66,Male,HPV-related Cancer,KEYTRUDA only,27.63,21.89,1117.87,100,Partial Response
M205214,56,Other,Melanoma,mrna-4157 + keytruda,47.18,31.15,-177.37,77,Stable Disease
M205215,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.95,47.9,432.51,81,Partial Response
M205216,42,Other,HPV-related Cancer,mrna-4157 + keytruda,16.09,14.34,1034.54,85,Stable Disease
M205217,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.41,35.2,524.95,95,Partial Response
M205218,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.62,22.09,1493.13,94,Complete Response
M205219,68,Female,Melanoma,KEYTRUDA only,54.12,39.91,470.57,92,Progression
M205220,72,Female,HPV-related Cancer,KEYTRUDA only,43.54,44.2,1032.97,96,Progression
M205221,68,Male,Melanoma,mrna-4157 + keytruda,28.08,13.15,1057.53,107,Partial Response
M205222,73,Female,Melanoma,mrna-4157 + keytruda,80.32,43.89,158.26,98,Stable Disease
M205223,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.85,37.94,987.98,90,Stable Disease
M205224,60,Male,Melanoma,KEYTRUDA only,58.88,39.46,1085.34,100,Stable Disease
M205225,28,Female,Melanoma,mrna-4157 + keytruda,72.08,82.25,786.88,84,
M205226,36,Female,Melanoma,mrna-4157 + keytruda,67.5,44.14,643.85,100,Stable Disease
M205227,78,Other,Melanoma,KEYTRUDA only,63.79,69.63,1340.75,86,Complete Response
M205228,42,Male,HPV-related Cancer,KEYTRUDA only,35.73,26.61,183.04,92,Partial Response
M205229,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,97.46,112.35,684.65,79,Partial Response
M205230,39,Female,Melanoma,mrna-4157 + keytruda,36.93,16.99,,83,Partial Response
M205231,71,Other,Melanoma,KEYTRUDA only,27.49,29.5,1009.98,80,Partial Response
M205232,32,Female,Melanoma,KEYTRUDA only,82.44,64.81,694.26,96,Partial Response
M205233,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.78,29.17,974.37,77,Partial Response
M205234,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.19,56.57,944.04,115,Progression
M205235,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,70.36,42.62,1098.33,94,Progression
M205236,36,Other,HPV-related Cancer,mrna-4157 + keytruda,62.09,28.27,823.79,83,Stable Disease
M205237,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.43,,1707.95,107,Stable Disease
M205238,54,Male,HPV-related Cancer,KEYTRUDA only,38.95,29.07,693.63,113,Partial Response
M205239,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.83,37.05,604.98,74,Stable Disease
M205240,49,Male,Melanoma,KEYTRUDA only,59.67,48.28,1091.08,82,Progression
M205241,31,Male,Melanoma,KEYTRUDA only,28.39,13.87,1411.63,97,Stable Disease
M205242,42,Male,Melanoma,KEYTRUDA only,82.86,41.28,412.08,94,Complete Response
M205243,81,Other,Melanoma,mrna-4157 + keytruda,47.33,20.38,1681.59,89,Partial Response
M205244,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.29,,731.73,100,Partial Response
M205245,76,Female,Melanoma,KEYTRUDA only,69.97,43.45,1056.96,80,Complete Response
M205246,39,Female,Melanoma,mrna-4157 + keytruda,65.33,42.76,1035.42,99,Progression
M205247,29,Female,Melanoma,mrna-4157 + keytruda,85.93,32.51,1479.11,87,Stable Disease
M205248,32,Female,Melanoma,mrna-4157 + keytruda,57.42,39.02,747.66,95,Stable Disease
M205249,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.52,38.12,748.9,101,Stable Disease
M205250,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.59,87.28,665.05,90,Partial Response
M205251,30,Male,Melanoma,mrna-4157 + keytruda,50.92,50.45,,94,Partial Response
M205252,62,Other,Melanoma,KEYTRUDA only,47.75,43.25,1651.91,83,Partial Response
M205253,72,Male,HPV-related Cancer,KEYTRUDA only,36.07,30.8,475.54,79,Progression
M205254,33,Female,HPV-related Cancer,mrna-4157 + keytruda,26.98,17.49,1678.57,114,Complete Response
M205255,52,Other,Melanoma,KEYTRUDA only,74.94,63.49,807.39,79,Complete Response
M205256,61,Male,HPV-related Cancer,mrna-4157 + keytruda,20.76,22.34,1056.95,102,Partial Response
M205257,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.84,38.81,273.2,83,Stable Disease
M205258,32,Other,HPV-related Cancer,mrna-4157 + keytruda,65.66,45.48,1079.67,94,Stable Disease
M205259,60,Female,HPV-related Cancer,KEYTRUDA only,47.41,35.53,1750.39,79,Progression
M205260,51,Male,Melanoma,KEYTRUDA only,36.69,31.42,1198.62,106,Partial Response
M205261,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.11,20.55,480.89,84,Stable Disease
M205262,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.61,55.98,,91,Progression
M205263,84,Male,HPV-related Cancer,mrna-4157 + keytruda,85.66,67.78,793.65,98,Unknown
M205264,55,Female,HPV-related Cancer,mrna-4157 + keytruda,43.32,31.33,425.44,91,Complete Response
M205265,78,Other,HPV-related Cancer,KEYTRUDA only,66.98,79.87,769.0,100,Stable Disease
M205266,66,Female,Melanoma,KEYTRUDA only,44.18,57.56,87.52,91,Complete Response
M205267,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.41,54.84,1149.34,79,Partial Response
M205268,36,Female,HPV-related Cancer,mrna-4157 + keytruda,7.75,7.52,1188.54,82,Progression
M205269,57,Other,Melanoma,KEYTRUDA only,62.44,66.56,423.12,99,Stable Disease
M205270,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.16,52.18,1172.19,106,Stable Disease
M205271,74,Female,Melanoma,KEYTRUDA only,78.19,73.87,1079.91,92,Progression
M205272,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.21,29.44,1290.38,75,Stable Disease
M205273,34,Other,HPV-related Cancer,mrna-4157 + keytruda,62.03,46.09,1026.64,82,Stable Disease
M205274,84,Female,Melanoma,KEYTRUDA only,68.68,36.75,538.78,94,Progression
M205275,61,Male,HPV-related Cancer,mrna-4157 + keytruda,79.59,87.46,,102,Partial Response
M205276,58,Male,Melanoma,mrna-4157 + keytruda,56.66,41.65,585.48,109,
M205277,60,Male,Melanoma,mrna-4157 + keytruda,57.85,52.6,765.84,85,Progression
M205278,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.82,28.79,1116.28,102,Unknown
M205279,26,Female,HPV-related Cancer,KEYTRUDA only,59.14,33.22,1190.31,90,Stable Disease
M205280,80,Male,HPV-related Cancer,mrna-4157 + keytruda,50.21,56.1,365.87,82,Partial Response
M205281,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.6,,860.54,87,Partial Response
M205282,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.7,67.77,1152.97,102,Stable Disease
M205283,82,Female,Melanoma,mrna-4157 + keytruda,69.1,30.66,1083.86,87,Stable Disease
M205284,44,Male,Melanoma,mrna-4157 + keytruda,31.87,21.01,1847.6,85,Complete Response
M205285,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.01,15.42,1410.5,105,Stable Disease
M205286,66,Female,HPV-related Cancer,mrna-4157 + keytruda,24.77,10.48,1400.14,82,Partial Response
M205287,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.47,62.59,982.88,79,Complete Response
M205288,45,Other,Melanoma,mrna-4157 + keytruda,67.48,41.83,298.37,95,Partial Response
M205289,25,Male,HPV-related Cancer,KEYTRUDA only,60.38,25.86,1874.36,87,Partial Response
M205290,29,Male,Melanoma,mrna-4157 + keytruda,52.5,47.58,1049.77,102,Partial Response
M205291,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,33.88,20.2,816.94,101,Stable Disease
M205292,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.07,74.0,864.77,94,Partial Response
M205293,74,Female,Melanoma,KEYTRUDA only,102.35,64.01,348.24,82,Partial Response
M205294,82,Male,HPV-related Cancer,mrna-4157 + keytruda,23.08,9.19,541.26,74,Partial Response
M205295,71,Female,Melanoma,mrna-4157 + keytruda,59.71,34.3,735.03,119,Stable Disease
M205296,71,Female,Non-small Cell Lung Cancer,KEYTRUDA only,95.88,96.67,793.61,98,Progression
M205297,81,Other,Melanoma,KEYTRUDA only,36.06,27.46,1174.91,88,Partial Response
M205298,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.72,26.13,-103.89,72,Stable Disease
M205299,65,Other,HPV-related Cancer,KEYTRUDA only,75.23,59.69,943.9,96,Complete Response
M205300,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.17,27.52,538.75,87,Stable Disease
M205301,29,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.72,34.91,962.44,81,Stable Disease
M205302,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.96,37.17,684.86,100,Partial Response
M205303,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.7,59.17,944.87,86,Complete Response
M205304,57,Female,HPV-related Cancer,mrna-4157 + keytruda,51.25,50.58,874.97,87,Partial Response
M205305,56,Other,Melanoma,mrna-4157 + keytruda,39.21,35.27,1492.4,101,Partial Response
M205306,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.92,41.49,1170.88,96,Complete Response
M205307,75,Other,HPV-related Cancer,KEYTRUDA only,60.36,53.2,2122.27,85,Complete Response
M205308,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.55,53.59,825.35,85,Complete Response
M205309,59,Other,Melanoma,mrna-4157 + keytruda,32.09,29.83,578.42,71,Complete Response
M205310,44,Other,Melanoma,KEYTRUDA only,49.71,25.95,655.89,96,Unknown
M205311,54,Other,Melanoma,mrna-4157 + keytruda,63.53,51.84,658.18,77,Stable Disease
M205312,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.86,34.46,814.5,84,Unknown
M205313,36,Female,Melanoma,mrna-4157 + keytruda,43.82,34.44,931.03,88,Complete Response
M205314,41,Male,Melanoma,KEYTRUDA only,59.78,,1331.07,75,Stable Disease
M205315,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.44,31.05,682.92,90,Partial Response
M205316,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.22,47.25,784.06,95,Progression
M205317,41,Other,Melanoma,mrna-4157 + keytruda,53.51,42.42,187.41,98,Partial Response
M205318,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.56,37.64,1163.68,92,Stable Disease
M205319,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.27,26.39,1031.3,85,Partial Response
M205320,34,Male,HPV-related Cancer,mrna-4157 + keytruda,52.45,41.0,1375.61,99,Partial Response
M205321,46,Other,HPV-related Cancer,mrna-4157 + keytruda,51.0,29.41,523.2,94,Complete Response
M205322,71,Female,Melanoma,mrna-4157 + keytruda,53.98,,1730.25,79,Progression
M205323,60,Female,Melanoma,mrna-4157 + keytruda,18.65,10.51,1414.81,104,Partial Response
M205324,77,Male,HPV-related Cancer,KEYTRUDA only,61.01,54.77,1036.35,99,Stable Disease
M205325,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,80.97,91.44,1097.76,93,Stable Disease
M205326,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.97,34.54,956.38,87,Progression
M205327,38,Male,Melanoma,mrna-4157 + keytruda,47.52,32.97,586.99,100,Progression
M205328,32,Other,HPV-related Cancer,KEYTRUDA only,80.16,63.99,865.07,102,Stable Disease
M205329,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.86,29.32,1782.25,96,Progression
M205330,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,19.24,15.45,501.05,95,Unknown
M205331,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,80.94,75.5,1467.56,95,Stable Disease
M205332,34,Other,HPV-related Cancer,mrna-4157 + keytruda,44.49,43.17,,84,Partial Response
M205333,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.64,50.43,-23.36,93,Progression
M205334,71,Male,Melanoma,mrna-4157 + keytruda,64.25,50.62,,93,
M205335,41,Male,HPV-related Cancer,KEYTRUDA only,32.09,14.55,891.3,99,Stable Disease
M205336,46,Other,Melanoma,KEYTRUDA only,37.96,36.94,247.47,82,Complete Response
M205337,72,Other,Melanoma,mrna-4157 + keytruda,24.37,15.06,867.34,96,Stable Disease
M205338,73,Female,HPV-related Cancer,mrna-4157 + keytruda,69.03,35.28,685.86,91,Unknown
M205339,83,Male,HPV-related Cancer,mrna-4157 + keytruda,62.78,41.25,1208.51,94,Stable Disease
M205340,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.11,51.8,684.15,91,Unknown
M205341,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.64,40.83,357.04,97,Stable Disease
M205342,29,Male,Melanoma,KEYTRUDA only,18.7,15.39,700.07,97,Partial Response
M205343,72,Male,HPV-related Cancer,KEYTRUDA only,13.4,11.95,1173.09,98,Partial Response
M205344,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.63,44.8,485.02,105,Stable Disease
M205345,26,Female,HPV-related Cancer,mrna-4157 + keytruda,56.65,31.94,1846.32,77,Unknown
M205346,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.39,54.54,1276.28,108,Stable Disease
M205347,57,Male,Melanoma,mrna-4157 + keytruda,39.21,24.98,980.16,100,Unknown
M205348,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.54,59.41,601.67,102,Partial Response
M205349,82,Female,Melanoma,KEYTRUDA only,105.75,99.81,1610.3,88,Stable Disease
M205350,65,Female,HPV-related Cancer,mrna-4157 + keytruda,61.18,33.51,1350.44,96,Complete Response
M205351,57,Male,HPV-related Cancer,KEYTRUDA only,50.66,36.53,620.02,100,Progression
M205352,71,Other,Melanoma,mrna-4157 + keytruda,60.71,42.77,696.82,88,Unknown
M205353,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.48,38.9,868.73,70,Progression
M205354,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,77.15,59.75,568.21,87,Unknown
M205355,83,Male,HPV-related Cancer,mrna-4157 + keytruda,70.67,48.51,2050.8,101,Stable Disease
M205356,61,Male,HPV-related Cancer,mrna-4157 + keytruda,47.58,28.29,1099.46,79,Partial Response
M205357,57,Male,Melanoma,KEYTRUDA only,30.91,27.95,1085.93,96,Partial Response
M205358,52,Other,HPV-related Cancer,mrna-4157 + keytruda,66.38,68.51,1161.81,83,
M205359,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.49,42.19,1404.1,80,Complete Response
M205360,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.72,35.73,1298.5,84,Partial Response
M205361,49,Other,HPV-related Cancer,KEYTRUDA only,61.19,33.88,1147.7,86,Partial Response
M205362,72,Female,Melanoma,mrna-4157 + keytruda,43.93,31.7,1042.98,94,
M205363,50,Male,HPV-related Cancer,KEYTRUDA only,34.37,31.38,1360.81,112,Progression
M205364,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.67,35.85,398.28,81,Stable Disease
M205365,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.87,42.28,975.9,94,Stable Disease
M205366,55,Male,HPV-related Cancer,mrna-4157 + keytruda,73.3,53.89,1078.39,107,Partial Response
M205367,79,Male,Melanoma,mrna-4157 + keytruda,32.12,19.04,1549.92,83,Stable Disease
M205368,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.77,43.2,1034.86,98,Progression
M205369,66,Male,Melanoma,KEYTRUDA only,63.07,27.68,942.75,80,Partial Response
M205370,50,Female,Melanoma,mrna-4157 + keytruda,58.83,45.36,1363.26,103,Partial Response
M205371,50,Female,HPV-related Cancer,mrna-4157 + keytruda,37.62,37.92,-40.24,97,Partial Response
M205372,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.47,49.7,826.07,79,Stable Disease
M205373,73,Male,HPV-related Cancer,KEYTRUDA only,43.05,26.77,1319.01,103,Complete Response
M205374,31,Male,HPV-related Cancer,mrna-4157 + keytruda,38.65,29.7,1077.6,90,
M205375,78,Male,HPV-related Cancer,mrna-4157 + keytruda,47.17,34.48,1430.52,88,Stable Disease
M205376,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.56,18.1,904.68,89,Complete Response
M205377,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.97,25.97,1636.41,76,Unknown
M205378,75,Other,Melanoma,KEYTRUDA only,11.63,7.88,385.37,105,Progression
M205379,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.42,38.51,709.06,76,Progression
M205380,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,22.91,15.08,1556.01,96,Partial Response
M205381,37,Male,HPV-related Cancer,mrna-4157 + keytruda,24.25,14.48,856.91,99,Complete Response
M205382,31,Other,Melanoma,mrna-4157 + keytruda,45.04,28.12,911.07,76,Partial Response
M205383,33,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.34,57.84,1336.16,95,Progression
M205384,46,Male,Melanoma,mrna-4157 + keytruda,104.04,73.07,1225.21,108,Progression
M205385,79,Male,Melanoma,mrna-4157 + keytruda,40.83,17.55,804.51,85,Progression
M205386,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,31.49,27.7,1074.53,83,Stable Disease
M205387,80,Other,HPV-related Cancer,KEYTRUDA only,71.18,63.28,1235.84,91,Stable Disease
M205388,68,Female,Melanoma,KEYTRUDA only,48.14,48.76,1204.23,91,Stable Disease
M205389,73,Male,Melanoma,mrna-4157 + keytruda,2.46,1.48,665.42,88,Partial Response
M205390,51,Female,HPV-related Cancer,mrna-4157 + keytruda,97.26,83.17,1631.15,84,
M205391,25,Other,Melanoma,mrna-4157 + keytruda,77.57,77.44,593.48,85,Progression
M205392,66,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.78,19.5,1276.29,79,Unknown
M205393,42,Female,HPV-related Cancer,mrna-4157 + keytruda,39.62,38.28,1298.11,89,Progression
M205394,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.48,28.61,1601.44,93,
M205395,29,Female,HPV-related Cancer,mrna-4157 + keytruda,45.65,45.62,592.02,95,Complete Response
M205396,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.27,25.97,1657.94,84,Complete Response
M205397,71,Other,Melanoma,KEYTRUDA only,67.75,67.21,759.62,91,Complete Response
M205398,52,Male,HPV-related Cancer,mrna-4157 + keytruda,85.39,103.66,1298.64,83,Progression
M205399,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,79.26,76.83,1053.49,103,Complete Response
M205400,37,Female,HPV-related Cancer,KEYTRUDA only,60.94,61.97,800.39,101,
M205401,59,Other,HPV-related Cancer,mrna-4157 + keytruda,47.57,41.46,772.36,91,Stable Disease
M205402,31,Other,HPV-related Cancer,KEYTRUDA only,85.91,18.26,662.11,76,Complete Response
M205403,76,Other,HPV-related Cancer,KEYTRUDA only,53.95,36.63,1255.34,90,Stable Disease
M205404,61,Female,HPV-related Cancer,mrna-4157 + keytruda,75.39,53.9,701.56,94,Complete Response
M205405,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.65,29.13,962.17,72,Complete Response
M205406,44,Male,Melanoma,KEYTRUDA only,87.95,90.22,424.62,77,
M205407,73,Other,Melanoma,KEYTRUDA only,63.93,56.53,778.29,80,Partial Response
M205408,51,Other,HPV-related Cancer,mrna-4157 + keytruda,54.41,32.53,1076.51,90,Stable Disease
M205409,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.46,47.36,554.88,76,Stable Disease
M205410,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.17,23.07,1181.15,71,Stable Disease
M205411,57,Other,Melanoma,mrna-4157 + keytruda,17.8,13.29,,77,Complete Response
M205412,83,Female,Melanoma,mrna-4157 + keytruda,51.63,38.02,668.41,91,Partial Response
M205413,49,Female,HPV-related Cancer,mrna-4157 + keytruda,75.03,75.94,1513.76,77,Partial Response
M205414,49,Male,HPV-related Cancer,mrna-4157 + keytruda,27.64,29.9,1271.94,83,Complete Response
M205415,54,Other,Melanoma,mrna-4157 + keytruda,50.47,36.46,466.72,95,Stable Disease
M205416,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.13,21.94,1339.69,88,Stable Disease
M205417,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.88,39.87,1206.88,120,Progression
M205418,41,Female,HPV-related Cancer,mrna-4157 + keytruda,40.21,26.53,473.36,88,Stable Disease
M205419,43,Female,HPV-related Cancer,mrna-4157 + keytruda,81.89,56.38,859.25,84,Stable Disease
M205420,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.79,65.44,729.69,82,Complete Response
M205421,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.21,1.68,1419.82,84,Stable Disease
M205422,59,Other,HPV-related Cancer,mrna-4157 + keytruda,46.84,19.5,1448.39,88,Partial Response
M205423,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.58,44.64,,98,Stable Disease
M205424,84,Male,Melanoma,mrna-4157 + keytruda,35.98,34.45,1687.5,91,Partial Response
M205425,31,Male,Melanoma,KEYTRUDA only,56.68,62.28,638.26,106,Partial Response
M205426,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.27,34.12,689.23,92,Complete Response
M205427,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.52,20.09,1222.55,80,Progression
M205428,47,Female,HPV-related Cancer,KEYTRUDA only,46.64,32.47,779.18,101,Progression
M205429,62,Female,HPV-related Cancer,mrna-4157 + keytruda,35.11,35.21,,106,Stable Disease
M205430,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.86,42.25,767.24,105,Partial Response
M205431,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.28,31.58,962.95,93,Progression
M205432,40,Female,HPV-related Cancer,KEYTRUDA only,52.9,43.39,1706.81,88,Stable Disease
M205433,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,110.22,89.33,1319.39,97,Progression
M205434,31,Male,HPV-related Cancer,mrna-4157 + keytruda,46.5,39.07,1630.41,87,Partial Response
M205435,80,Male,Melanoma,KEYTRUDA only,63.74,64.87,901.96,86,Stable Disease
M205436,36,Female,HPV-related Cancer,mrna-4157 + keytruda,49.09,48.33,160.32,82,Partial Response
M205437,64,Male,Melanoma,mrna-4157 + keytruda,56.1,44.02,1267.83,89,Unknown
M205438,31,Male,Melanoma,KEYTRUDA only,60.64,55.26,963.39,99,Complete Response
M205439,60,Other,HPV-related Cancer,mrna-4157 + keytruda,50.13,31.2,733.15,93,Unknown
M205440,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.19,30.87,1184.56,82,Progression
M205441,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.89,26.13,1064.54,94,Partial Response
M205442,47,Male,Melanoma,mrna-4157 + keytruda,56.44,48.3,1310.9,101,Progression
M205443,65,Other,HPV-related Cancer,mrna-4157 + keytruda,35.11,18.09,1271.2,74,Partial Response
M205444,54,Other,HPV-related Cancer,mrna-4157 + keytruda,47.02,48.23,865.1,81,Complete Response
M205445,74,Other,Melanoma,mrna-4157 + keytruda,45.32,16.82,412.51,82,Progression
M205446,57,Other,Melanoma,mrna-4157 + keytruda,40.52,29.47,965.55,97,Complete Response
M205447,74,Other,HPV-related Cancer,KEYTRUDA only,33.36,16.22,1286.06,94,Progression
M205448,54,Female,Melanoma,KEYTRUDA only,46.07,41.43,1382.04,88,Progression
M205449,58,Male,HPV-related Cancer,mrna-4157 + keytruda,32.58,27.07,1073.16,96,Complete Response
M205450,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.9,23.5,1337.4,93,Partial Response
M205451,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.24,89.0,573.27,83,Complete Response
M205452,84,Male,Melanoma,mrna-4157 + keytruda,34.96,25.92,772.29,93,Progression
M205453,42,Other,HPV-related Cancer,KEYTRUDA only,56.36,34.64,668.06,88,Partial Response
M205454,26,Female,HPV-related Cancer,mrna-4157 + keytruda,35.6,27.24,658.94,94,Partial Response
M205455,30,Other,Melanoma,KEYTRUDA only,40.3,20.42,910.62,110,Stable Disease
M205456,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.4,55.52,843.33,88,Partial Response
M205457,32,Other,HPV-related Cancer,KEYTRUDA only,52.35,50.56,1321.71,93,Stable Disease
M205458,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.26,2.42,857.52,116,Partial Response
M205459,45,Other,Melanoma,KEYTRUDA only,66.32,35.98,495.39,101,Partial Response
M205460,72,Female,Melanoma,mrna-4157 + keytruda,48.48,41.37,633.71,91,Complete Response
M205461,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.05,77.1,1171.93,98,Progression
M205462,42,Female,Melanoma,mrna-4157 + keytruda,86.42,60.28,953.81,84,Partial Response
M205463,29,Female,Melanoma,KEYTRUDA only,42.07,34.38,881.7,98,Progression
M205464,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.04,28.9,973.82,78,Partial Response
M205465,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.88,36.7,994.3,96,Stable Disease
M205466,83,Female,Melanoma,mrna-4157 + keytruda,71.4,32.99,,104,Complete Response
M205467,44,Other,Melanoma,KEYTRUDA only,44.04,36.53,978.94,103,Stable Disease
M205468,73,Male,HPV-related Cancer,KEYTRUDA only,47.57,58.42,1188.15,80,Progression
M205469,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.93,36.83,1164.67,84,Stable Disease
M205470,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,97.25,72.04,887.28,102,
M205471,38,Male,Melanoma,mrna-4157 + keytruda,66.0,52.42,929.34,90,Progression
M205472,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,57.87,41.93,706.9,88,Complete Response
M205473,78,Female,Melanoma,KEYTRUDA only,60.56,47.27,648.02,95,Progression
M205474,36,Male,HPV-related Cancer,KEYTRUDA only,90.42,74.29,1526.56,70,
M205475,27,Female,HPV-related Cancer,mrna-4157 + keytruda,56.89,46.01,274.51,85,Stable Disease
M205476,84,Other,HPV-related Cancer,mrna-4157 + keytruda,36.9,42.27,,100,Stable Disease
M205477,43,Male,HPV-related Cancer,mrna-4157 + keytruda,34.82,23.97,729.21,81,Stable Disease
M205478,51,Male,Melanoma,KEYTRUDA only,77.65,68.78,821.84,92,Partial Response
M205479,62,Male,Melanoma,mrna-4157 + keytruda,71.79,66.01,1130.16,96,Partial Response
M205480,46,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.73,43.92,531.09,70,Stable Disease
M205481,48,Female,Melanoma,KEYTRUDA only,49.27,30.81,1528.69,76,Complete Response
M205482,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,87.52,38.89,979.94,86,Partial Response
M205483,60,Male,HPV-related Cancer,KEYTRUDA only,73.36,68.0,754.22,91,Stable Disease
M205484,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.29,60.92,545.77,88,Partial Response
M205485,56,Male,Melanoma,KEYTRUDA only,19.1,,946.29,89,Complete Response
M205486,39,Female,Melanoma,mrna-4157 + keytruda,50.01,54.53,818.83,97,Partial Response
M205487,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.9,26.56,621.04,99,Unknown
M205488,80,Other,Melanoma,KEYTRUDA only,55.57,56.98,1119.41,90,Complete Response
M205489,53,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.89,57.82,367.18,88,Unknown
M205490,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.04,36.02,535.16,84,Complete Response
M205491,43,Male,Melanoma,KEYTRUDA only,58.78,65.4,735.75,108,Progression
M205492,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.79,29.9,1127.45,107,Partial Response
M205493,49,Female,Melanoma,KEYTRUDA only,46.37,36.87,1050.08,88,
M205494,28,Male,Melanoma,KEYTRUDA only,79.38,34.43,1201.47,101,
M205495,53,Female,Melanoma,mrna-4157 + keytruda,27.2,23.79,1244.81,97,Stable Disease
M205496,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.4,23.83,1089.61,79,Progression
M205497,59,Other,Melanoma,mrna-4157 + keytruda,32.57,23.84,1275.9,105,Complete Response
M205498,37,Male,HPV-related Cancer,mrna-4157 + keytruda,13.88,7.73,,94,Progression
M205499,26,Male,Melanoma,KEYTRUDA only,28.79,28.31,898.59,106,Progression
M205500,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.36,36.32,1493.91,97,Complete Response
M205501,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.42,25.56,842.82,90,Progression
M205502,36,Male,Melanoma,KEYTRUDA only,1.54,,379.59,95,Partial Response
M205503,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,98.21,60.71,,105,Partial Response
M205504,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.14,56.66,1346.06,102,Partial Response
M205505,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.22,16.42,1038.6,84,Complete Response
M205506,39,Other,Melanoma,KEYTRUDA only,77.83,70.92,469.61,97,Stable Disease
M205507,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.26,38.41,509.71,83,Stable Disease
M205508,30,Other,HPV-related Cancer,KEYTRUDA only,44.92,40.28,1492.69,86,
M205509,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,27.25,27.19,1456.82,99,Stable Disease
M205510,78,Other,Melanoma,KEYTRUDA only,39.72,35.49,1228.58,92,Unknown
M205511,43,Male,Melanoma,mrna-4157 + keytruda,54.58,44.51,1096.6,77,Progression
M205512,59,Female,Non-small Cell Lung Cancer,KEYTRUDA only,30.18,23.95,1506.97,82,Partial Response
M205513,50,Other,Melanoma,mrna-4157 + keytruda,63.34,34.18,1122.8,100,Progression
M205514,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.81,71.18,1459.02,88,Stable Disease
M205515,38,Other,Melanoma,mrna-4157 + keytruda,51.53,45.93,1269.37,97,Progression
M205516,78,Female,HPV-related Cancer,KEYTRUDA only,62.18,49.58,1629.37,91,Complete Response
M205517,28,Female,HPV-related Cancer,KEYTRUDA only,58.62,60.12,616.75,80,
M205518,82,Male,HPV-related Cancer,mrna-4157 + keytruda,16.9,14.35,1084.7,100,
M205519,59,Female,HPV-related Cancer,KEYTRUDA only,48.76,18.26,380.2,86,Progression
M205520,58,Female,HPV-related Cancer,mrna-4157 + keytruda,43.3,40.21,1296.21,80,Partial Response
M205521,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.65,46.74,350.7,82,Progression
M205522,63,Male,Melanoma,mrna-4157 + keytruda,26.73,18.64,,94,Complete Response
M205523,75,Other,HPV-related Cancer,mrna-4157 + keytruda,60.97,62.27,942.98,84,Partial Response
M205524,83,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.61,27.89,1221.34,73,Stable Disease
M205525,56,Male,Melanoma,KEYTRUDA only,71.54,79.98,892.42,98,Progression
M205526,28,Female,HPV-related Cancer,mrna-4157 + keytruda,51.71,22.32,1020.07,90,Stable Disease
M205527,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.9,27.51,959.58,89,Partial Response
M205528,34,Female,HPV-related Cancer,KEYTRUDA only,54.24,48.03,704.1,89,Stable Disease
M205529,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.28,61.81,1119.27,81,Partial Response
M205530,42,Female,Melanoma,mrna-4157 + keytruda,3.99,4.62,245.43,68,Stable Disease
M205531,29,Male,HPV-related Cancer,KEYTRUDA only,41.34,58.51,211.05,94,Progression
M205532,36,Other,HPV-related Cancer,mrna-4157 + keytruda,96.65,72.59,1120.92,84,Partial Response
M205533,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.59,28.8,,88,Stable Disease
M205534,77,Other,HPV-related Cancer,mrna-4157 + keytruda,20.9,10.33,937.74,86,Unknown
M205535,83,Female,HPV-related Cancer,mrna-4157 + keytruda,32.51,28.94,830.9,79,Stable Disease
M205536,43,Male,Melanoma,mrna-4157 + keytruda,50.6,17.19,1071.64,78,
M205537,33,Male,Melanoma,mrna-4157 + keytruda,80.41,73.48,927.89,86,Stable Disease
M205538,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,90.87,47.77,1709.01,94,Partial Response
M205539,50,Female,HPV-related Cancer,mrna-4157 + keytruda,35.21,32.31,1108.76,78,Unknown
M205540,60,Other,Melanoma,KEYTRUDA only,77.26,31.28,-89.84,95,Partial Response
M205541,32,Female,HPV-related Cancer,KEYTRUDA only,80.25,58.49,456.58,93,Stable Disease
M205542,70,Other,Melanoma,KEYTRUDA only,59.11,40.24,785.01,85,Partial Response
M205543,47,Other,HPV-related Cancer,KEYTRUDA only,72.92,69.7,1385.64,82,Progression
M205544,69,Female,Melanoma,KEYTRUDA only,53.79,61.56,915.35,115,Unknown
M205545,69,Female,HPV-related Cancer,mrna-4157 + keytruda,102.96,83.65,883.91,68,
M205546,30,Other,Melanoma,mrna-4157 + keytruda,43.01,38.04,1544.9,71,Stable Disease
M205547,61,Female,HPV-related Cancer,mrna-4157 + keytruda,65.79,36.82,1152.91,94,Partial Response
M205548,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.55,30.46,1352.77,85,
M205549,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.36,50.31,599.02,96,Complete Response
M205550,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,23.31,17.91,1876.91,111,Stable Disease
M205551,43,Other,Melanoma,mrna-4157 + keytruda,35.36,37.29,1185.71,98,Partial Response
M205552,30,Other,Melanoma,KEYTRUDA only,72.49,56.65,757.95,99,Partial Response
M205553,68,Female,Melanoma,mrna-4157 + keytruda,44.29,32.42,1363.24,90,Partial Response
M205554,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.21,44.9,275.07,89,Complete Response
M205555,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.91,46.48,1763.12,90,Unknown
M205556,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.38,64.22,225.62,90,
M205557,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.29,25.79,772.32,102,Stable Disease
M205558,32,Other,HPV-related Cancer,KEYTRUDA only,28.68,20.82,715.71,90,Partial Response
M205559,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.11,37.63,815.58,84,Complete Response
M205560,60,Male,Melanoma,KEYTRUDA only,65.07,44.87,906.76,110,Complete Response
M205561,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,-6.65,-4.89,1037.35,83,Partial Response
M205562,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.92,20.44,579.04,82,Progression
M205563,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-26.8,-34.81,920.03,90,Stable Disease
M205564,46,Other,Melanoma,mrna-4157 + keytruda,33.06,19.21,,83,Complete Response
M205565,25,Male,Melanoma,KEYTRUDA only,44.37,28.18,795.17,112,Unknown
M205566,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.62,30.75,549.19,84,Partial Response
M205567,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.77,19.58,2274.39,106,Partial Response
M205568,42,Other,HPV-related Cancer,mrna-4157 + keytruda,84.3,61.49,61.97,79,Progression
M205569,76,Female,Melanoma,mrna-4157 + keytruda,11.33,10.96,526.05,94,Progression
M205570,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.55,24.77,,92,Stable Disease
M205571,52,Male,HPV-related Cancer,mrna-4157 + keytruda,63.01,68.18,1072.07,100,Partial Response
M205572,33,Other,HPV-related Cancer,KEYTRUDA only,81.61,76.89,1783.5,101,Partial Response
M205573,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.81,34.34,696.71,99,Progression
M205574,33,Female,Melanoma,mrna-4157 + keytruda,43.85,22.07,1250.71,78,Progression
M205575,26,Male,HPV-related Cancer,mrna-4157 + keytruda,76.82,,855.62,88,Stable Disease
M205576,32,Female,HPV-related Cancer,KEYTRUDA only,36.39,27.03,642.47,88,Progression
M205577,67,Male,Melanoma,mrna-4157 + keytruda,24.65,24.91,874.65,108,Complete Response
M205578,38,Female,Melanoma,mrna-4157 + keytruda,49.25,45.99,595.65,92,Partial Response
M205579,56,Male,Melanoma,KEYTRUDA only,22.98,16.63,569.72,94,Progression
M205580,40,Male,Melanoma,mrna-4157 + keytruda,60.81,51.1,,85,Partial Response
M205581,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.27,48.37,1329.29,83,Stable Disease
M205582,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.66,64.59,43.17,101,Partial Response
M205583,84,Male,Melanoma,mrna-4157 + keytruda,68.74,70.46,672.7,94,Partial Response
M205584,43,Other,Melanoma,KEYTRUDA only,40.74,30.79,806.18,89,Progression
M205585,81,Male,Melanoma,mrna-4157 + keytruda,53.3,38.83,2066.83,96,Progression
M205586,59,Other,Melanoma,mrna-4157 + keytruda,67.63,33.26,1411.77,95,Progression
M205587,54,Male,Melanoma,mrna-4157 + keytruda,35.23,26.99,627.36,76,Progression
M205588,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.14,53.56,1368.11,71,Progression
M205589,51,Male,Melanoma,mrna-4157 + keytruda,55.68,49.7,626.6,86,Progression
M205590,71,Male,HPV-related Cancer,mrna-4157 + keytruda,68.68,45.1,874.74,79,Stable Disease
M205591,38,Male,HPV-related Cancer,KEYTRUDA only,24.45,18.88,1654.71,91,Stable Disease
M205592,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.41,25.45,474.39,83,Partial Response
M205593,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.15,10.31,329.15,102,Partial Response
M205594,72,Male,HPV-related Cancer,mrna-4157 + keytruda,56.1,56.22,1436.95,87,Progression
M205595,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.68,25.92,1352.7,94,Progression
M205596,47,Female,HPV-related Cancer,mrna-4157 + keytruda,73.76,70.0,1588.38,96,Stable Disease
M205597,38,Male,Melanoma,mrna-4157 + keytruda,18.9,8.01,129.85,112,Stable Disease
M205598,47,Male,HPV-related Cancer,KEYTRUDA only,73.77,19.8,-16.15,84,Complete Response
M205599,83,Male,Melanoma,mrna-4157 + keytruda,67.42,44.26,,95,Stable Disease
M205600,31,Male,HPV-related Cancer,mrna-4157 + keytruda,69.97,53.23,538.17,81,Partial Response
M205601,83,Other,Melanoma,mrna-4157 + keytruda,34.8,19.03,912.8,103,Partial Response
M205602,78,Male,Melanoma,mrna-4157 + keytruda,51.93,48.91,,66,
M205603,65,Male,HPV-related Cancer,KEYTRUDA only,59.62,42.03,1480.62,82,Complete Response
M205604,57,Other,Melanoma,mrna-4157 + keytruda,26.28,13.97,1073.32,84,Stable Disease
M205605,82,Other,Melanoma,mrna-4157 + keytruda,53.16,49.05,575.72,91,Progression
M205606,51,Female,HPV-related Cancer,mrna-4157 + keytruda,7.46,6.52,96.59,76,Stable Disease
M205607,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,94.13,58.56,1340.48,99,Partial Response
M205608,42,Female,Non-small Cell Lung Cancer,KEYTRUDA only,1.41,1.09,594.02,81,Partial Response
M205609,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,94.05,58.77,1298.93,88,
M205610,33,Male,HPV-related Cancer,mrna-4157 + keytruda,72.87,48.39,890.37,97,Complete Response
M205611,40,Other,Melanoma,KEYTRUDA only,73.61,76.78,1560.51,92,Complete Response
M205612,48,Male,Melanoma,KEYTRUDA only,39.47,38.45,1467.4,93,Stable Disease
M205613,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.26,89.02,1012.5,77,Partial Response
M205614,61,Male,HPV-related Cancer,KEYTRUDA only,65.32,68.24,1465.39,80,Stable Disease
M205615,55,Female,Melanoma,KEYTRUDA only,19.36,15.08,431.37,89,Stable Disease
M205616,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.48,35.75,714.31,72,Stable Disease
M205617,53,Male,HPV-related Cancer,KEYTRUDA only,62.95,78.95,1240.34,93,Complete Response
M205618,56,Other,HPV-related Cancer,mrna-4157 + keytruda,31.85,22.45,1090.61,79,Partial Response
M205619,74,Other,HPV-related Cancer,KEYTRUDA only,48.73,37.91,857.03,75,Stable Disease
M205620,84,Male,HPV-related Cancer,mrna-4157 + keytruda,52.44,60.29,1019.92,88,Unknown
M205621,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.32,49.41,972.16,87,Complete Response
M205622,72,Male,Melanoma,KEYTRUDA only,42.96,31.0,823.77,80,Stable Disease
M205623,79,Male,Melanoma,mrna-4157 + keytruda,43.59,39.59,857.34,86,Unknown
M205624,31,Other,Melanoma,KEYTRUDA only,58.73,57.42,1848.91,85,Stable Disease
M205625,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.75,64.35,1058.03,91,Partial Response
M205626,83,Other,HPV-related Cancer,mrna-4157 + keytruda,32.63,,534.8,105,Partial Response
M205627,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.51,39.31,1089.31,84,Progression
M205628,81,Other,Melanoma,mrna-4157 + keytruda,57.24,34.22,1357.69,89,Complete Response
M205629,47,Other,HPV-related Cancer,mrna-4157 + keytruda,50.78,50.62,,84,Stable Disease
M205630,29,Other,HPV-related Cancer,mrna-4157 + keytruda,34.79,32.32,394.67,101,Complete Response
M205631,52,Male,Melanoma,mrna-4157 + keytruda,56.99,26.83,1144.81,93,Stable Disease
M205632,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.54,42.93,1063.97,81,
M205633,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.23,13.46,,102,Partial Response
M205634,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.62,57.84,1932.7,88,Partial Response
M205635,38,Female,Melanoma,mrna-4157 + keytruda,41.58,33.35,1260.77,85,Stable Disease
M205636,82,Male,HPV-related Cancer,KEYTRUDA only,80.25,51.24,745.74,91,Progression
M205637,69,Female,HPV-related Cancer,KEYTRUDA only,44.2,28.47,1331.53,88,Complete Response
M205638,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.83,35.62,920.11,79,Partial Response
M205639,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.77,43.3,1236.44,91,Complete Response
M205640,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.58,27.37,1032.18,100,Complete Response
M205641,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.1,,1304.54,95,Partial Response
M205642,63,Female,HPV-related Cancer,mrna-4157 + keytruda,44.2,41.98,1523.87,91,Unknown
M205643,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,3.44,2.29,1944.01,81,Partial Response
M205644,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,87.37,85.03,681.49,99,Partial Response
M205645,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.37,16.68,1630.92,91,Partial Response
M205646,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.45,42.04,718.39,82,Complete Response
M205647,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.92,61.77,1376.41,85,Stable Disease
M205648,76,Other,Melanoma,mrna-4157 + keytruda,56.08,50.41,1549.95,84,
M205649,69,Female,HPV-related Cancer,mrna-4157 + keytruda,52.53,37.33,155.01,91,Complete Response
M205650,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.78,25.78,954.14,81,Stable Disease
M205651,31,Male,Melanoma,mrna-4157 + keytruda,57.49,35.5,911.87,94,Stable Disease
M205652,59,Female,Melanoma,KEYTRUDA only,44.2,39.48,602.36,96,Complete Response
M205653,69,Male,Melanoma,KEYTRUDA only,39.93,28.46,746.32,77,Progression
M205654,39,Female,HPV-related Cancer,mrna-4157 + keytruda,16.19,16.84,1235.98,96,Complete Response
M205655,45,Female,HPV-related Cancer,mrna-4157 + keytruda,52.22,40.77,1113.37,100,Stable Disease
M205656,48,Other,Melanoma,KEYTRUDA only,69.24,75.78,1881.64,76,Partial Response
M205657,60,Female,HPV-related Cancer,KEYTRUDA only,59.98,46.96,822.93,111,Stable Disease
M205658,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.32,,1512.86,81,Stable Disease
M205659,35,Other,Melanoma,KEYTRUDA only,69.38,47.02,996.43,90,Stable Disease
M205660,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.5,38.48,444.83,95,
M205661,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.58,49.19,1336.44,90,Stable Disease
M205662,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.13,47.37,1824.43,83,Progression
M205663,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,84.67,51.83,674.98,103,Stable Disease
M205664,83,Male,Melanoma,mrna-4157 + keytruda,53.19,45.05,448.14,82,Complete Response
M205665,63,Male,HPV-related Cancer,mrna-4157 + keytruda,64.1,39.2,1763.79,72,Stable Disease
M205666,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.35,19.07,1941.43,94,Partial Response
M205667,39,Male,Melanoma,mrna-4157 + keytruda,56.72,59.0,1025.03,92,Partial Response
M205668,26,Male,Melanoma,KEYTRUDA only,46.01,46.52,1089.99,90,Partial Response
M205669,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.89,52.92,-144.74,90,Stable Disease
M205670,68,Female,Melanoma,mrna-4157 + keytruda,56.79,55.5,749.0,96,Progression
M205671,43,Male,HPV-related Cancer,KEYTRUDA only,73.83,54.56,7970.299999999999,79,Progression
M205672,67,Other,Melanoma,mrna-4157 + keytruda,47.86,26.8,1259.82,71,Partial Response
M205673,35,Male,Melanoma,KEYTRUDA only,51.55,59.09,,97,Stable Disease
M205674,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.87,28.93,820.77,88,Complete Response
M205675,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.82,44.95,752.13,80,Stable Disease
M205676,40,Female,HPV-related Cancer,KEYTRUDA only,61.77,61.04,861.65,91,Progression
M205677,57,Male,HPV-related Cancer,mrna-4157 + keytruda,55.11,50.88,702.97,101,Progression
M205678,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.6,30.48,717.92,95,Progression
M205679,58,Female,HPV-related Cancer,mrna-4157 + keytruda,82.29,45.81,449.19,89,
M205680,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.63,67.41,790.93,96,Stable Disease
M205681,47,Male,HPV-related Cancer,mrna-4157 + keytruda,51.44,52.12,1117.59,105,Partial Response
M205682,73,Other,HPV-related Cancer,mrna-4157 + keytruda,42.79,51.37,934.75,101,Complete Response
M205683,58,Female,HPV-related Cancer,mrna-4157 + keytruda,30.17,27.78,969.9,89,Progression
M205684,78,Male,HPV-related Cancer,mrna-4157 + keytruda,42.37,40.09,1148.57,102,
M205685,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.74,28.6,1160.52,92,Unknown
M205686,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,51.38,26.58,1076.22,80,Complete Response
M205687,61,Other,HPV-related Cancer,mrna-4157 + keytruda,16.73,16.21,1044.01,90,Complete Response
M205688,58,Male,Melanoma,mrna-4157 + keytruda,36.41,25.73,837.59,74,Stable Disease
M205689,41,Female,HPV-related Cancer,mrna-4157 + keytruda,39.7,30.58,761.32,90,Stable Disease
M205690,33,Male,Melanoma,mrna-4157 + keytruda,92.74,116.09,1297.3,97,Partial Response
M205691,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.36,56.53,575.92,81,Stable Disease
M205692,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.45,6.62,396.44,89,Progression
M205693,45,Other,HPV-related Cancer,mrna-4157 + keytruda,41.28,24.13,1020.12,94,Partial Response
M205694,80,Male,Melanoma,mrna-4157 + keytruda,53.96,42.74,,91,Stable Disease
M205695,36,Other,HPV-related Cancer,KEYTRUDA only,47.2,48.31,1007.79,77,Partial Response
M205696,45,Other,Melanoma,mrna-4157 + keytruda,70.06,74.69,,98,Progression
M205697,36,Other,HPV-related Cancer,mrna-4157 + keytruda,64.59,53.59,1798.49,106,Partial Response
M205698,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.37,38.06,,83,Partial Response
M205699,30,Other,HPV-related Cancer,KEYTRUDA only,43.78,31.31,1311.71,94,Complete Response
M205700,62,Male,HPV-related Cancer,mrna-4157 + keytruda,32.05,16.76,1024.88,83,Unknown
M205701,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.92,48.13,1351.13,104,Complete Response
M205702,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.83,25.51,1422.1,82,Partial Response
M205703,39,Female,Melanoma,mrna-4157 + keytruda,53.97,34.45,1064.79,87,Partial Response
M205704,50,Other,HPV-related Cancer,mrna-4157 + keytruda,60.05,53.35,813.3,107,Progression
M205705,49,Other,Melanoma,mrna-4157 + keytruda,80.4,77.52,713.07,96,Stable Disease
M205706,57,Female,Melanoma,KEYTRUDA only,29.64,26.1,1242.99,95,Stable Disease
M205707,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.13,76.88,717.96,81,Unknown
M205708,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.24,,1116.44,82,
M205709,70,Female,Melanoma,KEYTRUDA only,84.25,59.3,1026.1,92,Stable Disease
M205710,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,85.15,111.12,777.36,96,Complete Response
M205711,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.27,36.72,916.33,92,Progression
M205712,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.74,48.93,994.37,89,
M205713,56,Male,Melanoma,KEYTRUDA only,58.37,31.91,918.71,87,Partial Response
M205714,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.54,54.43,1372.17,74,Partial Response
M205715,80,Other,HPV-related Cancer,mrna-4157 + keytruda,26.84,9.35,1456.19,104,Partial Response
M205716,64,Other,HPV-related Cancer,mrna-4157 + keytruda,49.84,47.85,812.03,81,Progression
M205717,34,Male,HPV-related Cancer,mrna-4157 + keytruda,52.76,34.26,813.03,85,Stable Disease
M205718,51,Other,Melanoma,mrna-4157 + keytruda,48.75,44.05,925.5,84,Stable Disease
M205719,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.37,25.59,1575.09,93,Complete Response
M205720,51,Male,Melanoma,KEYTRUDA only,63.29,,1008.02,86,Partial Response
M205721,74,Male,Melanoma,mrna-4157 + keytruda,59.76,37.51,634.34,84,Stable Disease
M205722,78,Other,Melanoma,KEYTRUDA only,42.3,28.95,800.31,104,Progression
M205723,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,9.89,8.33,1253.53,86,Stable Disease
M205724,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.64,33.55,1341.6,73,Stable Disease
M205725,81,Other,Melanoma,mrna-4157 + keytruda,72.27,47.29,899.92,93,Partial Response
M205726,70,Male,Melanoma,KEYTRUDA only,56.37,45.8,1114.96,100,Stable Disease
M205727,53,Female,Melanoma,KEYTRUDA only,42.86,21.28,896.81,87,Unknown
M205728,37,Other,HPV-related Cancer,KEYTRUDA only,66.88,54.2,1041.55,99,Partial Response
M205729,32,Other,Melanoma,KEYTRUDA only,18.81,13.45,408.4,90,Stable Disease
M205730,62,Other,Melanoma,mrna-4157 + keytruda,75.89,84.09,1139.8,96,Progression
M205731,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.88,,1357.79,76,Progression
M205732,75,Female,HPV-related Cancer,KEYTRUDA only,46.83,44.11,677.19,95,Progression
M205733,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.54,44.38,682.57,92,Stable Disease
M205734,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.47,26.99,1018.11,84,Progression
M205735,42,Male,Melanoma,mrna-4157 + keytruda,46.89,26.38,,91,Complete Response
M205736,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.77,35.7,1219.61,95,Stable Disease
M205737,67,Other,HPV-related Cancer,KEYTRUDA only,58.41,44.0,526.37,92,Partial Response
M205738,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.35,43.75,1078.65,92,Progression
M205739,60,Female,HPV-related Cancer,KEYTRUDA only,35.05,31.18,1523.48,87,Unknown
M205740,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.46,17.66,1148.22,102,Stable Disease
M205741,41,Female,Melanoma,mrna-4157 + keytruda,27.21,22.09,635.72,107,Complete Response
M205742,34,Male,HPV-related Cancer,KEYTRUDA only,47.39,34.64,1022.94,88,Stable Disease
M205743,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.16,51.03,114.22,80,Progression
M205744,83,Male,HPV-related Cancer,KEYTRUDA only,17.64,8.71,823.11,76,Partial Response
M205745,69,Male,Melanoma,mrna-4157 + keytruda,20.78,18.18,807.32,83,Partial Response
M205746,75,Other,HPV-related Cancer,KEYTRUDA only,16.4,15.06,744.97,74,Complete Response
M205747,47,Other,Melanoma,KEYTRUDA only,41.1,28.02,1049.58,94,Progression
M205748,37,Female,HPV-related Cancer,mrna-4157 + keytruda,39.77,21.38,826.39,71,Partial Response
M205749,45,Male,Melanoma,mrna-4157 + keytruda,65.64,51.53,403.59,98,Partial Response
M205750,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,99.63,114.3,1132.39,83,Complete Response
M205751,60,Male,Melanoma,mrna-4157 + keytruda,58.91,31.91,866.45,83,Stable Disease
M205752,25,Male,HPV-related Cancer,mrna-4157 + keytruda,29.9,29.51,1021.75,81,Unknown
M205753,69,Male,Melanoma,KEYTRUDA only,94.07,70.87,613.1,82,Stable Disease
M205754,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,60.87,32.17,903.28,84,Complete Response
M205755,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.52,,1000.82,97,Unknown
M205756,42,Male,HPV-related Cancer,mrna-4157 + keytruda,54.94,58.34,1136.66,92,Stable Disease
M205757,65,Other,HPV-related Cancer,mrna-4157 + keytruda,28.39,24.14,739.73,94,Stable Disease
M205758,53,Other,HPV-related Cancer,mrna-4157 + keytruda,17.29,13.99,472.79,89,Partial Response
M205759,78,Male,HPV-related Cancer,mrna-4157 + keytruda,76.98,56.15,1258.94,94,Progression
M205760,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.93,35.09,830.17,87,Partial Response
M205761,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.29,30.57,460.08,76,Partial Response
M205762,28,Other,HPV-related Cancer,mrna-4157 + keytruda,35.62,33.17,428.4,94,Partial Response
M205763,84,Other,HPV-related Cancer,mrna-4157 + keytruda,58.17,53.68,1235.01,92,Progression
M205764,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.67,51.06,1369.54,81,Partial Response
M205765,71,Female,Melanoma,KEYTRUDA only,26.38,19.3,593.03,94,Complete Response
M205766,31,Other,Melanoma,mrna-4157 + keytruda,33.87,16.44,1116.28,96,Unknown
M205767,56,Male,Melanoma,mrna-4157 + keytruda,15.87,13.03,1044.45,88,Stable Disease
M205768,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.2,63.94,853.98,84,Stable Disease
M205769,56,Other,HPV-related Cancer,mrna-4157 + keytruda,36.75,22.13,1412.58,80,Stable Disease
M205770,75,Female,HPV-related Cancer,mrna-4157 + keytruda,82.03,72.01,505.02,90,Progression
M205771,74,Male,Melanoma,mrna-4157 + keytruda,85.73,58.6,1130.01,104,Partial Response
M205772,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.44,,615.59,91,Progression
M205773,32,Female,HPV-related Cancer,mrna-4157 + keytruda,52.29,51.28,1482.83,89,Progression
M205774,65,Male,Melanoma,mrna-4157 + keytruda,58.58,,450.67,102,Progression
M205775,62,Other,Melanoma,KEYTRUDA only,-1.22,-1.02,1157.49,81,Stable Disease
M205776,48,Female,HPV-related Cancer,mrna-4157 + keytruda,48.64,47.63,138.88,81,Stable Disease
M205777,53,Female,HPV-related Cancer,mrna-4157 + keytruda,23.94,15.75,848.96,93,Progression
M205778,80,Female,Melanoma,mrna-4157 + keytruda,38.04,24.75,1675.99,86,Partial Response
M205779,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,29.78,14.34,1786.02,82,Complete Response
M205780,74,Female,HPV-related Cancer,mrna-4157 + keytruda,62.93,52.81,1276.61,98,Stable Disease
M205781,60,Other,Melanoma,mrna-4157 + keytruda,19.55,14.65,644.62,77,Partial Response
M205782,32,Female,HPV-related Cancer,mrna-4157 + keytruda,32.91,28.34,1157.14,93,Progression
M205783,30,Other,Melanoma,mrna-4157 + keytruda,38.2,34.7,1178.67,101,Stable Disease
M205784,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.87,46.11,618.13,69,Stable Disease
M205785,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.69,46.55,707.25,85,Complete Response
M205786,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.71,24.56,1567.06,79,Stable Disease
M205787,51,Other,Melanoma,mrna-4157 + keytruda,43.13,22.37,1559.47,98,Stable Disease
M205788,54,Other,HPV-related Cancer,mrna-4157 + keytruda,69.01,25.23,1008.67,80,Progression
M205789,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,8.06,3.33,487.4,89,Unknown
M205790,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.02,62.7,1360.97,87,
M205791,37,Other,Melanoma,mrna-4157 + keytruda,58.58,,1940.58,101,Stable Disease
M205792,57,Female,Melanoma,KEYTRUDA only,24.02,30.77,783.27,83,Partial Response
M205793,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.78,51.15,941.07,84,Stable Disease
M205794,58,Other,Melanoma,KEYTRUDA only,55.3,42.09,816.8,102,Progression
M205795,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.68,27.91,1397.99,87,Stable Disease
M205796,39,Female,HPV-related Cancer,mrna-4157 + keytruda,39.49,41.52,983.59,88,Unknown
M205797,29,Other,HPV-related Cancer,KEYTRUDA only,33.76,25.56,1556.27,91,Complete Response
M205798,34,Female,Melanoma,KEYTRUDA only,22.72,21.69,588.29,105,Progression
M205799,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.85,53.07,1170.84,100,Partial Response
M205800,50,Female,HPV-related Cancer,KEYTRUDA only,79.05,48.52,1695.75,100,Partial Response
M205801,30,Female,HPV-related Cancer,KEYTRUDA only,5.67,5.95,1132.71,82,Unknown
M205802,41,Other,HPV-related Cancer,mrna-4157 + keytruda,44.61,32.47,905.73,86,Partial Response
M205803,53,Female,HPV-related Cancer,mrna-4157 + keytruda,48.79,39.43,566.92,81,Complete Response
M205804,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.66,18.38,705.46,96,Partial Response
M205805,42,Female,HPV-related Cancer,mrna-4157 + keytruda,52.91,33.44,1038.87,91,Partial Response
M205806,76,Male,Melanoma,mrna-4157 + keytruda,22.47,17.69,947.76,85,Partial Response
M205807,39,Male,HPV-related Cancer,mrna-4157 + keytruda,59.65,42.29,1159.99,75,Stable Disease
M205808,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.82,38.96,702.36,93,Stable Disease
M205809,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.52,23.57,1131.02,98,Partial Response
M205810,65,Other,Melanoma,KEYTRUDA only,27.3,25.97,653.02,85,Partial Response
M205811,79,Female,HPV-related Cancer,KEYTRUDA only,46.43,40.44,933.59,93,Progression
M205812,63,Other,HPV-related Cancer,KEYTRUDA only,48.76,41.9,492.47,94,Progression
M205813,30,Female,Melanoma,mrna-4157 + keytruda,23.61,22.62,1013.71,97,Complete Response
M205814,27,Male,HPV-related Cancer,KEYTRUDA only,53.5,62.37,1364.3,92,Complete Response
M205815,56,Female,Melanoma,KEYTRUDA only,85.48,53.28,616.62,96,Progression
M205816,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.72,22.0,777.42,82,Partial Response
M205817,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.54,37.87,1061.98,96,Partial Response
M205818,43,Male,HPV-related Cancer,mrna-4157 + keytruda,30.96,21.86,1273.28,85,Partial Response
M205819,72,Male,Melanoma,KEYTRUDA only,57.41,45.38,,93,Partial Response
M205820,30,Other,HPV-related Cancer,mrna-4157 + keytruda,76.45,58.43,1040.09,106,Complete Response
M205821,32,Female,Melanoma,mrna-4157 + keytruda,68.34,,538.77,83,Stable Disease
M205822,82,Female,Melanoma,KEYTRUDA only,41.21,40.95,609.35,85,Stable Disease
M205823,51,Female,HPV-related Cancer,KEYTRUDA only,82.77,81.81,1276.19,87,Complete Response
M205824,31,Male,Melanoma,KEYTRUDA only,56.43,43.86,1298.55,93,Progression
M205825,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.18,60.64,1135.11,88,Complete Response
M205826,43,Other,HPV-related Cancer,KEYTRUDA only,80.48,94.29,747.37,91,Stable Disease
M205827,77,Male,Melanoma,KEYTRUDA only,54.68,50.07,891.56,80,Complete Response
M205828,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.17,28.45,1144.6,100,Progression
M205829,33,Female,HPV-related Cancer,mrna-4157 + keytruda,3.34,3.6,1916.31,84,Progression
M205830,55,Other,HPV-related Cancer,KEYTRUDA only,50.25,28.32,1178.74,85,Progression
M205831,63,Female,Melanoma,mrna-4157 + keytruda,39.65,30.99,1521.69,97,Stable Disease
M205832,79,Female,Melanoma,mrna-4157 + keytruda,43.18,30.87,622.64,99,Partial Response
M205833,49,Male,HPV-related Cancer,mrna-4157 + keytruda,8.99,8.74,1408.2,109,Partial Response
M205834,77,Other,HPV-related Cancer,mrna-4157 + keytruda,49.66,,1608.51,76,Progression
M205835,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.88,41.65,1162.0,81,Progression
M205836,27,Other,HPV-related Cancer,mrna-4157 + keytruda,81.71,68.04,1060.51,89,Partial Response
M205837,42,Male,HPV-related Cancer,mrna-4157 + keytruda,62.31,57.93,1550.98,98,Complete Response
M205838,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.68,39.44,782.27,92,Stable Disease
M205839,45,Other,HPV-related Cancer,mrna-4157 + keytruda,43.47,33.76,1524.25,102,Partial Response
M205840,75,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.74,29.48,799.7,88,Progression
M205841,62,Female,Melanoma,mrna-4157 + keytruda,42.59,33.13,966.15,85,Stable Disease
M205842,82,Female,Melanoma,mrna-4157 + keytruda,52.94,47.52,1376.2,93,Stable Disease
M205843,43,Male,Melanoma,KEYTRUDA only,44.19,37.62,-86.47,97,Stable Disease
M205844,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.05,25.4,1505.65,91,Partial Response
M205845,47,Female,HPV-related Cancer,mrna-4157 + keytruda,10.79,8.07,574.14,82,Partial Response
M205846,64,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.32,45.44,587.88,100,Complete Response
M205847,37,Other,Melanoma,mrna-4157 + keytruda,33.12,28.63,1035.6,82,Progression
M205848,64,Male,HPV-related Cancer,mrna-4157 + keytruda,42.09,43.08,718.49,96,Partial Response
M205849,34,Other,Melanoma,mrna-4157 + keytruda,59.93,,925.57,94,Complete Response
M205850,56,Other,Melanoma,KEYTRUDA only,41.37,25.41,764.29,93,Partial Response
M205851,65,Other,HPV-related Cancer,KEYTRUDA only,54.59,75.38,1113.93,101,Stable Disease
M205852,53,Other,HPV-related Cancer,mrna-4157 + keytruda,81.38,56.23,1595.57,100,Complete Response
M205853,62,Female,HPV-related Cancer,mrna-4157 + keytruda,33.85,25.31,1047.33,92,Partial Response
M205854,33,Other,Melanoma,mrna-4157 + keytruda,16.28,12.25,541.5,91,Progression
M205855,55,Male,Melanoma,mrna-4157 + keytruda,46.52,54.17,883.7,94,Partial Response
M205856,32,Other,Melanoma,KEYTRUDA only,74.56,48.96,794.6,88,Stable Disease
M205857,66,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.24,50.42,321.18,101,Stable Disease
M205858,77,Male,Melanoma,mrna-4157 + keytruda,56.16,52.83,289.66,101,Progression
M205859,74,Female,Melanoma,mrna-4157 + keytruda,28.24,25.07,839.31,89,
M205860,72,Male,Melanoma,KEYTRUDA only,71.5,44.83,-86.61,94,Stable Disease
M205861,76,Other,Melanoma,KEYTRUDA only,83.23,46.81,685.88,96,Partial Response
M205862,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.23,16.31,969.87,88,Stable Disease
M205863,36,Male,HPV-related Cancer,KEYTRUDA only,26.86,20.76,853.17,116,Progression
M205864,83,Male,HPV-related Cancer,KEYTRUDA only,-3.15,-2.34,1194.86,86,Stable Disease
M205865,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.96,26.24,652.43,74,Progression
M205866,66,Other,Melanoma,mrna-4157 + keytruda,31.55,34.52,546.71,103,Progression
M205867,50,Female,HPV-related Cancer,KEYTRUDA only,18.64,14.29,908.72,101,Stable Disease
M205868,46,Male,Melanoma,mrna-4157 + keytruda,39.55,36.27,1926.23,101,Unknown
M205869,42,Other,Melanoma,mrna-4157 + keytruda,72.62,34.58,490.38,97,Stable Disease
M205870,66,Female,HPV-related Cancer,KEYTRUDA only,12.73,14.66,949.0,91,Partial Response
M205871,29,Female,HPV-related Cancer,mrna-4157 + keytruda,52.96,39.65,750.7,87,
M205872,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.09,54.76,1060.68,80,Stable Disease
M205873,70,Other,Melanoma,mrna-4157 + keytruda,24.51,22.44,864.67,80,Complete Response
M205874,77,Female,HPV-related Cancer,mrna-4157 + keytruda,96.28,71.93,1547.28,94,
M205875,56,Female,HPV-related Cancer,KEYTRUDA only,55.21,51.61,1741.53,90,Stable Disease
M205876,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.77,25.86,1291.24,99,Stable Disease
M205877,33,Male,Melanoma,mrna-4157 + keytruda,54.31,54.48,212.19,109,Stable Disease
M205878,56,Other,HPV-related Cancer,mrna-4157 + keytruda,58.39,30.57,976.15,93,
M205879,68,Male,HPV-related Cancer,KEYTRUDA only,65.08,29.84,1724.07,89,Stable Disease
M205880,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.05,48.26,1220.55,83,Stable Disease
M205881,53,Female,HPV-related Cancer,mrna-4157 + keytruda,61.1,38.19,1125.05,109,Stable Disease
M205882,62,Female,Melanoma,mrna-4157 + keytruda,66.74,65.19,904.31,82,Partial Response
M205883,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.4,22.46,1348.16,78,Stable Disease
M205884,46,Male,HPV-related Cancer,mrna-4157 + keytruda,47.26,45.54,285.39,113,Partial Response
M205885,68,Male,Melanoma,mrna-4157 + keytruda,41.84,49.39,1221.4,92,Partial Response
M205886,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.13,51.89,878.25,109,Stable Disease
M205887,69,Other,HPV-related Cancer,KEYTRUDA only,7.52,6.19,1200.76,91,Complete Response
M205888,51,Male,HPV-related Cancer,mrna-4157 + keytruda,17.16,11.27,1110.8,105,Partial Response
M205889,79,Other,Melanoma,mrna-4157 + keytruda,21.31,15.38,743.0,84,Stable Disease
M205890,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.59,38.58,837.71,97,Complete Response
M205891,82,Female,HPV-related Cancer,KEYTRUDA only,52.9,56.93,984.97,83,Progression
M205892,42,Female,Melanoma,KEYTRUDA only,15.52,12.38,2004.92,101,Partial Response
M205893,67,Male,HPV-related Cancer,mrna-4157 + keytruda,83.96,90.04,1427.27,92,Partial Response
M205894,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.87,59.84,1175.39,81,Stable Disease
M205895,30,Other,Melanoma,KEYTRUDA only,62.88,51.88,1083.02,82,Stable Disease
M205896,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.68,36.72,939.23,85,Partial Response
M205897,76,Other,Melanoma,KEYTRUDA only,73.9,50.34,980.01,86,Progression
M205898,62,Female,HPV-related Cancer,KEYTRUDA only,41.32,43.71,84.07,86,Complete Response
M205899,76,Other,Melanoma,KEYTRUDA only,79.47,48.35,1597.97,89,Complete Response
M205900,63,Male,Melanoma,KEYTRUDA only,38.31,27.45,506.59,86,Partial Response
M205901,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.33,54.83,-154.35,71,
M205902,43,Female,Melanoma,KEYTRUDA only,69.14,64.46,976.96,83,Unknown
M205903,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.85,61.29,1144.46,85,Stable Disease
M205904,39,Female,Melanoma,mrna-4157 + keytruda,97.05,95.15,1391.59,95,Complete Response
M205905,63,Other,HPV-related Cancer,KEYTRUDA only,53.97,45.18,736.14,100,Complete Response
M205906,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.04,21.87,1481.42,89,Partial Response
M205907,46,Female,Melanoma,KEYTRUDA only,85.56,87.54,551.6,96,
M205908,67,Female,Melanoma,KEYTRUDA only,31.51,27.36,763.78,108,Progression
M205909,25,Male,HPV-related Cancer,KEYTRUDA only,55.04,33.07,1097.65,74,Complete Response
M205910,67,Other,HPV-related Cancer,mrna-4157 + keytruda,53.34,33.88,553.78,89,Partial Response
M205911,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.31,53.21,753.69,89,Complete Response
M205912,67,Other,Melanoma,mrna-4157 + keytruda,60.16,48.55,686.94,94,Stable Disease
M205913,43,Other,Melanoma,mrna-4157 + keytruda,61.35,50.62,1348.87,87,Partial Response
M205914,30,Male,Melanoma,mrna-4157 + keytruda,43.68,27.63,301.63,91,Stable Disease
M205915,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.72,27.59,1154.99,101,Stable Disease
M205916,84,Female,HPV-related Cancer,KEYTRUDA only,50.33,29.76,1289.58,80,Stable Disease
M205917,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,12.69,5.0,-51.33,86,Progression
M205918,56,Male,HPV-related Cancer,mrna-4157 + keytruda,72.28,45.06,1312.97,83,Unknown
M205919,78,Other,Melanoma,KEYTRUDA only,29.4,20.3,822.2,77,Progression
M205920,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.18,50.9,514.02,103,Partial Response
M205921,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,87.02,98.12,615.86,79,Partial Response
M205922,41,Male,HPV-related Cancer,mrna-4157 + keytruda,71.77,83.66,525.58,85,Partial Response
M205923,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.04,63.41,1036.9,84,Progression
M205924,27,Female,HPV-related Cancer,mrna-4157 + keytruda,48.0,19.75,982.96,91,Stable Disease
M205925,57,Female,HPV-related Cancer,mrna-4157 + keytruda,33.92,31.75,835.28,89,Stable Disease
M205926,66,Male,Melanoma,KEYTRUDA only,58.17,50.37,462.22,109,Unknown
M205927,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.92,34.6,726.59,100,Partial Response
M205928,37,Other,HPV-related Cancer,KEYTRUDA only,65.4,62.94,1258.3,106,Stable Disease
M205929,71,Male,Melanoma,KEYTRUDA only,39.9,18.76,735.81,67,Partial Response
M205930,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.76,58.56,917.07,97,Stable Disease
M205931,45,Other,Melanoma,mrna-4157 + keytruda,72.82,61.87,730.7,100,Progression
M205932,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,7.19,4.35,1055.55,99,Partial Response
M205933,42,Other,Melanoma,mrna-4157 + keytruda,49.82,42.95,1615.75,90,Stable Disease
M205934,26,Female,Melanoma,mrna-4157 + keytruda,37.46,24.23,,93,Progression
M205935,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.02,89.17,,94,Stable Disease
M205936,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.36,,663.42,76,Stable Disease
M205937,69,Female,Melanoma,mrna-4157 + keytruda,18.51,17.78,1540.53,97,Stable Disease
M205938,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.75,42.63,38.72,85,Partial Response
M205939,78,Other,Melanoma,KEYTRUDA only,53.59,48.67,1075.99,77,Partial Response
M205940,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.62,38.59,1075.62,98,Stable Disease
M205941,69,Other,Melanoma,KEYTRUDA only,43.39,40.63,1030.8,90,Stable Disease
M205942,83,Female,HPV-related Cancer,KEYTRUDA only,61.05,51.86,,91,Stable Disease
M205943,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.73,46.86,2041.52,99,Complete Response
M205944,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.58,48.82,1896.31,78,Complete Response
M205945,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,16.81,16.32,1229.07,95,Complete Response
M205946,29,Female,HPV-related Cancer,KEYTRUDA only,64.92,38.77,1332.8,82,Partial Response
M205947,44,Female,Melanoma,KEYTRUDA only,57.76,57.41,992.45,94,Stable Disease
M205948,58,Female,Melanoma,mrna-4157 + keytruda,15.69,12.83,865.13,91,Partial Response
M205949,74,Female,HPV-related Cancer,KEYTRUDA only,33.9,28.11,1295.28,87,Progression
M205950,45,Female,HPV-related Cancer,KEYTRUDA only,29.07,10.16,746.87,93,Partial Response
M205951,33,Other,Melanoma,KEYTRUDA only,17.88,9.49,1508.82,92,Partial Response
M205952,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.14,54.74,1683.09,78,Stable Disease
M205953,63,Female,HPV-related Cancer,KEYTRUDA only,56.19,46.41,597.78,89,Partial Response
M205954,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.49,33.78,1007.21,93,Complete Response
M205955,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.33,45.76,1385.66,81,Partial Response
M205956,60,Female,Melanoma,KEYTRUDA only,26.79,20.68,1427.68,93,Complete Response
M205957,59,Male,Melanoma,KEYTRUDA only,93.91,82.56,633.86,103,
M205958,54,Male,Melanoma,mrna-4157 + keytruda,42.22,37.97,1780.7,94,
M205959,40,Male,HPV-related Cancer,KEYTRUDA only,12.77,13.01,951.61,89,Progression
M205960,82,Male,HPV-related Cancer,mrna-4157 + keytruda,32.15,21.24,1464.25,78,Unknown
M205961,79,Female,HPV-related Cancer,mrna-4157 + keytruda,23.05,25.98,918.48,111,Partial Response
M205962,26,Other,Melanoma,mrna-4157 + keytruda,15.47,14.83,890.56,92,Progression
M205963,60,Male,HPV-related Cancer,mrna-4157 + keytruda,42.3,19.24,,94,Partial Response
M205964,40,Other,HPV-related Cancer,mrna-4157 + keytruda,75.78,61.3,477.81,75,Progression
M205965,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.31,35.08,380.82,113,Stable Disease
M205966,68,Male,Melanoma,mrna-4157 + keytruda,32.21,25.84,786.94,88,Partial Response
M205967,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.04,58.6,995.28,84,Stable Disease
M205968,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.87,16.89,713.94,100,Partial Response
M205969,71,Other,Melanoma,mrna-4157 + keytruda,76.66,58.6,1093.31,77,Complete Response
M205970,40,Other,Melanoma,mrna-4157 + keytruda,41.82,23.14,1023.01,84,Stable Disease
M205971,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.87,17.99,1846.56,79,Partial Response
M205972,81,Female,Melanoma,mrna-4157 + keytruda,78.86,81.9,1337.34,87,Stable Disease
M205973,37,Male,HPV-related Cancer,mrna-4157 + keytruda,39.62,28.61,828.22,104,Partial Response
M205974,28,Other,Melanoma,mrna-4157 + keytruda,39.38,23.01,1157.66,106,Partial Response
M205975,44,Other,HPV-related Cancer,KEYTRUDA only,25.69,17.12,880.97,81,Partial Response
M205976,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.65,24.6,1017.1,91,
M205977,29,Female,Melanoma,mrna-4157 + keytruda,67.95,,776.09,92,Progression
M205978,36,Other,Melanoma,mrna-4157 + keytruda,10.72,6.47,993.84,99,Progression
M205979,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,85.64,63.3,,99,Progression
M205980,80,Female,HPV-related Cancer,mrna-4157 + keytruda,67.2,19.16,-66.01,88,Progression
M205981,83,Other,HPV-related Cancer,KEYTRUDA only,24.91,14.5,1028.08,90,Partial Response
M205982,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.87,46.16,558.95,87,Partial Response
M205983,47,Male,HPV-related Cancer,KEYTRUDA only,39.9,25.08,1522.69,106,Progression
M205984,54,Female,HPV-related Cancer,mrna-4157 + keytruda,58.52,51.32,1008.79,79,Partial Response
M205985,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.23,44.69,277.57,71,Partial Response
M205986,28,Other,HPV-related Cancer,KEYTRUDA only,34.71,34.02,,94,Complete Response
M205987,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.34,,288.71,92,Stable Disease
M205988,63,Other,HPV-related Cancer,mrna-4157 + keytruda,70.62,39.52,785.95,100,Progression
M205989,44,Other,Melanoma,KEYTRUDA only,66.48,34.24,448.73,81,Stable Disease
M205990,64,Female,HPV-related Cancer,mrna-4157 + keytruda,40.02,27.36,1212.5,91,
M205991,61,Other,HPV-related Cancer,mrna-4157 + keytruda,23.64,22.4,1486.14,102,Partial Response
M205992,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.83,50.62,1085.54,93,Progression
M205993,33,Other,HPV-related Cancer,KEYTRUDA only,13.61,10.28,1590.93,76,Partial Response
M205994,78,Other,Melanoma,mrna-4157 + keytruda,31.13,11.08,1074.4,76,Stable Disease
M205995,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,28.16,14.47,,88,Progression
M205996,81,Male,Melanoma,KEYTRUDA only,29.08,22.75,1246.95,88,Complete Response
M205997,79,Male,HPV-related Cancer,mrna-4157 + keytruda,63.13,44.3,1157.73,83,Stable Disease
M205998,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.95,17.19,1302.92,84,Stable Disease
M205999,44,Male,HPV-related Cancer,mrna-4157 + keytruda,46.72,42.17,322.77,88,Partial Response
M206000,73,Male,HPV-related Cancer,KEYTRUDA only,43.24,27.88,338.94,80,Partial Response
M206001,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.08,35.15,1507.1,72,Progression
M206002,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.45,59.42,1163.08,90,Progression
M206003,28,Male,Melanoma,KEYTRUDA only,65.48,46.28,1162.51,104,
M206004,80,Other,Melanoma,mrna-4157 + keytruda,33.03,29.74,919.86,93,Partial Response
M206005,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,57.0,62.66,1211.95,103,Partial Response
M206006,51,Other,HPV-related Cancer,mrna-4157 + keytruda,90.73,66.1,1347.41,100,Partial Response
M206007,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.22,37.93,547.41,105,Partial Response
M206008,57,Other,HPV-related Cancer,mrna-4157 + keytruda,45.61,20.99,1163.56,89,Partial Response
M206009,50,Male,Melanoma,KEYTRUDA only,42.37,33.4,455.89,95,Stable Disease
M206010,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.83,52.53,,76,Progression
M206011,48,Male,Melanoma,mrna-4157 + keytruda,61.71,6.44,1433.31,83,Partial Response
M206012,47,Female,Melanoma,KEYTRUDA only,40.95,33.63,1448.34,89,Partial Response
M206013,68,Female,HPV-related Cancer,mrna-4157 + keytruda,36.09,26.31,2177.4,80,Partial Response
M206014,69,Other,HPV-related Cancer,KEYTRUDA only,27.88,25.59,1691.98,96,Partial Response
M206015,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.37,46.96,698.33,103,Partial Response
M206016,68,Female,HPV-related Cancer,mrna-4157 + keytruda,60.95,32.68,562.45,104,Progression
M206017,52,Male,Melanoma,mrna-4157 + keytruda,71.37,32.15,1137.45,85,Progression
M206018,75,Female,Melanoma,mrna-4157 + keytruda,56.75,48.1,869.28,104,Stable Disease
M206019,47,Female,Melanoma,KEYTRUDA only,61.93,45.4,665.57,87,Complete Response
M206020,61,Male,HPV-related Cancer,mrna-4157 + keytruda,39.06,36.2,812.73,93,Progression
M206021,69,Female,Melanoma,KEYTRUDA only,19.97,20.87,1379.89,84,
M206022,69,Other,Non-small Cell Lung Cancer,KEYTRUDA only,57.54,63.26,631.27,75,Complete Response
M206023,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.27,37.24,994.2,85,
M206024,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.05,56.24,1055.59,96,Progression
M206025,79,Male,HPV-related Cancer,mrna-4157 + keytruda,12.67,10.85,1472.74,101,Partial Response
M206026,70,Other,HPV-related Cancer,mrna-4157 + keytruda,5.07,6.1,724.73,97,Stable Disease
M206027,28,Other,Melanoma,KEYTRUDA only,29.27,22.87,631.77,101,Stable Disease
M206028,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.91,,1199.0,98,Partial Response
M206029,52,Female,HPV-related Cancer,mrna-4157 + keytruda,60.61,45.26,1458.95,90,Progression
M206030,36,Female,HPV-related Cancer,KEYTRUDA only,41.38,21.28,1567.54,107,Complete Response
M206031,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.64,58.74,1189.57,107,
M206032,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.02,50.18,702.08,106,Stable Disease
M206033,50,Female,HPV-related Cancer,KEYTRUDA only,23.35,18.11,1282.8,98,Stable Disease
M206034,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.6,18.24,984.5,83,Stable Disease
M206035,66,Other,Melanoma,mrna-4157 + keytruda,23.5,19.12,1275.88,97,Stable Disease
M206036,31,Female,Melanoma,mrna-4157 + keytruda,35.71,22.48,835.37,85,Stable Disease
M206037,50,Female,Melanoma,mrna-4157 + keytruda,37.81,36.01,1056.15,96,Stable Disease
M206038,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,60.22,34.5,1108.63,85,Progression
M206039,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.45,,1093.61,74,Partial Response
M206040,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.77,61.79,351.12,77,Partial Response
M206041,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.68,32.47,1390.08,79,Partial Response
M206042,51,Other,HPV-related Cancer,KEYTRUDA only,44.6,44.08,863.98,100,Partial Response
M206043,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.09,14.12,1216.92,97,Complete Response
M206044,39,Other,HPV-related Cancer,KEYTRUDA only,31.54,,1081.08,83,
M206045,69,Female,HPV-related Cancer,mrna-4157 + keytruda,57.94,37.22,1338.52,85,Complete Response
M206046,68,Female,Melanoma,mrna-4157 + keytruda,88.4,80.52,889.54,88,Complete Response
M206047,26,Female,HPV-related Cancer,mrna-4157 + keytruda,37.63,20.78,767.26,89,Partial Response
M206048,73,Female,HPV-related Cancer,KEYTRUDA only,46.49,50.04,1995.17,91,Partial Response
M206049,49,Other,HPV-related Cancer,KEYTRUDA only,47.6,38.43,,97,Complete Response
M206050,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.78,63.69,946.99,84,Progression
M206051,54,Male,HPV-related Cancer,mrna-4157 + keytruda,80.71,68.54,1457.56,98,Partial Response
M206052,65,Male,HPV-related Cancer,mrna-4157 + keytruda,57.86,,470.4,87,Complete Response
M206053,25,Female,HPV-related Cancer,mrna-4157 + keytruda,51.08,43.24,1117.94,83,Stable Disease
M206054,68,Male,HPV-related Cancer,KEYTRUDA only,22.98,12.41,1753.5,89,Partial Response
M206055,64,Other,HPV-related Cancer,KEYTRUDA only,32.35,23.58,678.19,75,Progression
M206056,35,Female,Melanoma,mrna-4157 + keytruda,44.82,30.15,1499.79,100,Partial Response
M206057,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.66,36.86,993.95,85,Partial Response
M206058,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.14,42.49,930.2,94,Progression
M206059,61,Female,Melanoma,mrna-4157 + keytruda,80.53,79.46,1190.2,80,Stable Disease
M206060,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.19,59.0,938.05,80,Partial Response
M206061,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,19.52,21.84,971.52,103,Complete Response
M206062,77,Female,Melanoma,mrna-4157 + keytruda,80.52,61.21,109.67,93,Progression
M206063,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.1,48.79,,94,Complete Response
M206064,62,Male,Melanoma,KEYTRUDA only,36.03,14.77,1638.99,105,Progression
M206065,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.29,40.04,630.59,85,Progression
M206066,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.28,49.53,1246.94,77,Stable Disease
M206067,64,Male,HPV-related Cancer,KEYTRUDA only,26.89,20.48,1384.11,73,Unknown
M206068,74,Other,HPV-related Cancer,mrna-4157 + keytruda,62.72,59.37,1169.24,97,Partial Response
M206069,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.25,,1069.3,84,Stable Disease
M206070,41,Male,HPV-related Cancer,KEYTRUDA only,28.59,29.73,1267.84,87,Partial Response
M206071,55,Male,Melanoma,KEYTRUDA only,50.35,41.87,497.61,74,Partial Response
M206072,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.95,31.79,1294.15,79,Partial Response
M206073,30,Male,Melanoma,mrna-4157 + keytruda,41.8,42.75,1382.11,100,Progression
M206074,47,Male,HPV-related Cancer,mrna-4157 + keytruda,43.33,46.47,784.23,96,Unknown
M206075,35,Female,Melanoma,mrna-4157 + keytruda,80.5,52.31,1071.94,99,Progression
M206076,39,Male,Melanoma,KEYTRUDA only,31.91,25.33,1926.61,88,Progression
M206077,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.93,27.96,1384.7,96,Unknown
M206078,31,Female,HPV-related Cancer,KEYTRUDA only,22.84,19.21,546.31,88,Stable Disease
M206079,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.81,32.22,1272.34,92,Complete Response
M206080,33,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.87,64.93,1755.28,103,Partial Response
M206081,59,Male,Melanoma,KEYTRUDA only,71.91,50.03,1218.58,94,Stable Disease
M206082,74,Female,HPV-related Cancer,KEYTRUDA only,48.06,46.61,1294.98,87,Stable Disease
M206083,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.88,24.84,1662.04,91,Complete Response
M206084,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.71,46.29,1071.24,77,Progression
M206085,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.21,,1572.05,109,Complete Response
M206086,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.4,49.85,999.34,88,Complete Response
M206087,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.18,34.68,773.19,87,Partial Response
M206088,66,Male,Melanoma,KEYTRUDA only,64.49,53.41,1309.6,103,Partial Response
M206089,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.45,57.98,1074.19,109,Progression
M206090,35,Female,HPV-related Cancer,mrna-4157 + keytruda,16.38,10.01,641.92,77,Progression
M206091,58,Other,Melanoma,KEYTRUDA only,81.18,37.1,781.13,92,Stable Disease
M206092,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.42,36.28,775.08,71,Progression
M206093,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.25,73.96,996.92,79,Progression
M206094,61,Other,HPV-related Cancer,mrna-4157 + keytruda,46.15,44.43,781.85,95,Stable Disease
M206095,45,Male,HPV-related Cancer,mrna-4157 + keytruda,76.22,82.75,1532.85,95,Partial Response
M206096,84,Other,Melanoma,mrna-4157 + keytruda,48.81,52.38,789.1,90,Unknown
M206097,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.15,49.05,735.77,91,Progression
M206098,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.61,38.01,991.08,80,Progression
M206099,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.87,,489.28,89,Complete Response
M206100,57,Male,HPV-related Cancer,KEYTRUDA only,31.27,30.64,593.92,84,Stable Disease
M206101,67,Female,Melanoma,mrna-4157 + keytruda,21.43,15.48,,65,Stable Disease
M206102,39,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.9,19.35,359.79,95,Stable Disease
M206103,55,Other,Melanoma,KEYTRUDA only,73.1,70.44,,100,
M206104,28,Female,HPV-related Cancer,KEYTRUDA only,60.49,81.04,1263.53,88,Partial Response
M206105,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.23,34.91,1299.43,103,Complete Response
M206106,60,Female,HPV-related Cancer,mrna-4157 + keytruda,51.69,47.4,723.61,78,Partial Response
M206107,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.23,34.28,1998.91,87,Stable Disease
M206108,65,Female,Melanoma,KEYTRUDA only,48.44,46.78,1150.68,104,Stable Disease
M206109,39,Other,Melanoma,KEYTRUDA only,58.45,25.87,488.94,86,Partial Response
M206110,80,Female,Melanoma,mrna-4157 + keytruda,29.88,30.72,1515.27,103,Stable Disease
M206111,54,Other,Melanoma,mrna-4157 + keytruda,25.36,8.92,1023.69,90,Stable Disease
M206112,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,90.12,92.05,1433.98,87,Unknown
M206113,49,Female,HPV-related Cancer,KEYTRUDA only,70.99,51.93,1519.74,96,Partial Response
M206114,28,Female,HPV-related Cancer,mrna-4157 + keytruda,38.37,35.25,569.5,99,Progression
M206115,52,Male,Melanoma,KEYTRUDA only,-2.84,-2.1,827.86,100,Partial Response
M206116,53,Male,HPV-related Cancer,mrna-4157 + keytruda,57.83,51.93,1048.45,109,Stable Disease
M206117,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.27,,,82,Partial Response
M206118,55,Female,HPV-related Cancer,mrna-4157 + keytruda,56.02,42.71,1220.9,81,Complete Response
M206119,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.35,44.82,1371.23,82,
M206120,30,Other,Melanoma,KEYTRUDA only,86.64,34.23,1444.33,104,Partial Response
M206121,34,Male,HPV-related Cancer,KEYTRUDA only,45.07,23.98,670.94,78,Complete Response
M206122,59,Female,HPV-related Cancer,mrna-4157 + keytruda,62.25,49.65,1138.59,93,Stable Disease
M206123,28,Other,HPV-related Cancer,mrna-4157 + keytruda,37.27,35.43,1204.11,81,Progression
M206124,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.64,15.48,180.01,82,
M206125,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.84,24.17,1085.6,97,Partial Response
M206126,42,Female,HPV-related Cancer,mrna-4157 + keytruda,57.31,44.39,1128.47,101,Partial Response
M206127,69,Female,HPV-related Cancer,KEYTRUDA only,43.64,32.97,509.72,92,Partial Response
M206128,74,Other,HPV-related Cancer,mrna-4157 + keytruda,39.77,28.29,980.56,95,Unknown
M206129,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.56,22.1,1341.93,95,Partial Response
M206130,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.9,35.38,431.96,91,Partial Response
M206131,46,Male,HPV-related Cancer,mrna-4157 + keytruda,16.56,12.43,1102.71,89,Stable Disease
M206132,78,Male,Melanoma,KEYTRUDA only,50.44,49.57,432.75,88,Complete Response
M206133,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.53,32.05,645.52,88,Stable Disease
M206134,41,Female,Melanoma,KEYTRUDA only,50.21,46.47,1170.93,93,Partial Response
M206135,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.08,31.65,1559.04,86,Progression
M206136,40,Female,HPV-related Cancer,mrna-4157 + keytruda,22.09,22.35,965.24,94,Unknown
M206137,74,Male,HPV-related Cancer,mrna-4157 + keytruda,36.72,24.5,1089.21,82,Partial Response
M206138,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.9,22.3,997.75,97,Partial Response
M206139,28,Male,Melanoma,mrna-4157 + keytruda,37.35,24.09,833.69,82,Progression
M206140,78,Female,Melanoma,KEYTRUDA only,54.41,40.9,300.3,72,Complete Response
M206141,69,Other,HPV-related Cancer,mrna-4157 + keytruda,56.64,46.4,1368.58,79,Unknown
M206142,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.92,76.39,1323.58,85,Progression
M206143,57,Other,Melanoma,mrna-4157 + keytruda,42.42,42.09,1265.92,87,Partial Response
M206144,38,Female,Melanoma,KEYTRUDA only,51.83,25.28,663.43,99,Stable Disease
M206145,50,Female,HPV-related Cancer,mrna-4157 + keytruda,53.23,31.5,1787.02,100,Stable Disease
M206146,69,Male,HPV-related Cancer,KEYTRUDA only,27.18,17.83,1281.67,94,Progression
M206147,59,Other,HPV-related Cancer,KEYTRUDA only,48.44,36.32,1258.83,84,Stable Disease
M206148,65,Male,Melanoma,KEYTRUDA only,71.05,57.52,1464.72,97,Stable Disease
M206149,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.99,41.59,1272.22,93,
M206150,57,Female,HPV-related Cancer,mrna-4157 + keytruda,25.53,22.45,1906.63,68,Complete Response
M206151,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.83,,672.18,95,Partial Response
M206152,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.81,14.9,914.24,82,Partial Response
M206153,67,Male,Melanoma,mrna-4157 + keytruda,34.79,35.07,1100.48,91,Partial Response
M206154,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.03,40.97,1971.48,100,Partial Response
M206155,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.71,61.62,773.71,89,Partial Response
M206156,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.92,25.7,456.25,91,Unknown
M206157,38,Male,HPV-related Cancer,mrna-4157 + keytruda,89.06,73.65,1109.79,113,Complete Response
M206158,54,Other,HPV-related Cancer,mrna-4157 + keytruda,23.05,11.97,1171.96,95,Progression
M206159,37,Female,Melanoma,KEYTRUDA only,97.25,71.13,990.82,94,Progression
M206160,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,92.63,82.69,1202.8,84,Complete Response
M206161,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.82,56.07,715.3,99,Complete Response
M206162,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.75,44.89,944.55,73,Partial Response
M206163,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,73.12,61.8,1397.39,90,Stable Disease
M206164,40,Male,HPV-related Cancer,mrna-4157 + keytruda,11.59,10.78,1334.28,86,Progression
M206165,28,Other,HPV-related Cancer,KEYTRUDA only,76.38,72.18,1034.77,85,Stable Disease
M206166,71,Other,Melanoma,KEYTRUDA only,65.86,,1218.47,93,Partial Response
M206167,47,Female,HPV-related Cancer,KEYTRUDA only,43.18,35.68,354.31,74,Partial Response
M206168,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.82,63.72,1401.55,72,Stable Disease
M206169,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.27,52.33,986.72,99,Stable Disease
M206170,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.86,4.88,1138.94,85,Complete Response
M206171,64,Other,HPV-related Cancer,KEYTRUDA only,55.93,36.46,1959.79,91,Progression
M206172,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.66,35.22,232.75,85,Partial Response
M206173,46,Male,Melanoma,KEYTRUDA only,26.47,26.04,755.34,81,Stable Disease
M206174,47,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.31,48.91,1142.04,104,Progression
M206175,67,Female,Melanoma,KEYTRUDA only,40.48,32.17,601.22,101,Stable Disease
M206176,26,Other,HPV-related Cancer,mrna-4157 + keytruda,60.68,,1334.19,92,Partial Response
M206177,83,Male,Melanoma,mrna-4157 + keytruda,78.57,63.41,609.69,92,Partial Response
M206178,50,Male,Melanoma,mrna-4157 + keytruda,60.96,49.01,548.05,80,Partial Response
M206179,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.82,53.39,1124.13,99,Partial Response
M206180,39,Male,HPV-related Cancer,mrna-4157 + keytruda,36.57,40.42,2255.43,93,Progression
M206181,76,Male,Melanoma,KEYTRUDA only,46.24,26.79,92.32,92,Progression
M206182,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.9,56.97,1005.56,97,Partial Response
M206183,46,Male,HPV-related Cancer,mrna-4157 + keytruda,67.15,,1681.8,107,Progression
M206184,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.76,39.13,1594.17,81,Stable Disease
M206185,55,Male,Melanoma,mrna-4157 + keytruda,38.81,30.81,623.38,88,Partial Response
M206186,43,Other,HPV-related Cancer,KEYTRUDA only,75.35,89.67,1243.95,93,Complete Response
M206187,47,Female,Melanoma,mrna-4157 + keytruda,39.15,28.85,1509.35,89,Partial Response
M206188,26,Female,Melanoma,mrna-4157 + keytruda,65.92,55.11,1203.17,103,Partial Response
M206189,28,Male,Melanoma,mrna-4157 + keytruda,49.46,49.56,1349.94,95,Progression
M206190,56,Male,HPV-related Cancer,mrna-4157 + keytruda,64.03,63.72,1592.03,94,Partial Response
M206191,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.58,13.53,1408.25,82,Unknown
M206192,50,Female,Melanoma,mrna-4157 + keytruda,63.28,61.22,999.3,99,Partial Response
M206193,84,Female,Melanoma,mrna-4157 + keytruda,45.97,41.61,1061.59,84,Progression
M206194,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.14,20.72,790.87,100,Partial Response
M206195,53,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.88,8.99,763.98,102,Partial Response
M206196,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.28,70.87,1379.96,99,Stable Disease
M206197,50,Other,HPV-related Cancer,KEYTRUDA only,65.44,45.04,2247.32,100,Partial Response
M206198,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.27,24.15,1751.69,90,Progression
M206199,60,Male,HPV-related Cancer,mrna-4157 + keytruda,68.73,,609.06,100,Partial Response
M206200,53,Other,HPV-related Cancer,mrna-4157 + keytruda,95.49,51.87,,80,Partial Response
M206201,29,Other,HPV-related Cancer,KEYTRUDA only,52.35,40.59,693.72,92,Partial Response
M206202,46,Male,Melanoma,mrna-4157 + keytruda,16.4,15.0,769.27,96,Complete Response
M206203,84,Male,HPV-related Cancer,mrna-4157 + keytruda,37.62,32.37,,76,Stable Disease
M206204,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.03,62.05,1010.06,87,Progression
M206205,55,Female,HPV-related Cancer,KEYTRUDA only,71.35,62.51,,93,Stable Disease
M206206,39,Other,HPV-related Cancer,KEYTRUDA only,64.28,49.3,1184.09,100,Partial Response
M206207,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.21,42.4,1009.77,89,Partial Response
M206208,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.46,17.3,1193.03,82,Partial Response
M206209,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.37,,1421.08,96,Partial Response
M206210,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.21,21.76,1473.41,121,Stable Disease
M206211,61,Male,HPV-related Cancer,KEYTRUDA only,62.44,28.88,1362.06,85,Progression
M206212,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.28,30.57,1235.33,99,Partial Response
M206213,59,Male,Melanoma,mrna-4157 + keytruda,38.86,27.51,941.21,102,Partial Response
M206214,84,Male,Melanoma,KEYTRUDA only,77.7,67.33,1299.47,92,Partial Response
M206215,25,Female,Melanoma,mrna-4157 + keytruda,51.29,52.28,1542.55,97,Progression
M206216,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.12,34.18,580.33,89,Progression
M206217,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.52,59.45,1677.2,101,Complete Response
M206218,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.23,37.81,512.89,89,Progression
M206219,59,Other,HPV-related Cancer,KEYTRUDA only,20.8,24.35,1828.37,88,Stable Disease
M206220,36,Other,HPV-related Cancer,mrna-4157 + keytruda,22.68,,407.27,90,Progression
M206221,79,Female,HPV-related Cancer,mrna-4157 + keytruda,50.84,32.09,1435.98,93,Complete Response
M206222,62,Female,HPV-related Cancer,KEYTRUDA only,33.08,32.34,1076.37,109,Stable Disease
M206223,71,Female,Melanoma,mrna-4157 + keytruda,35.09,17.96,945.16,71,Partial Response
M206224,58,Other,Melanoma,mrna-4157 + keytruda,72.31,50.42,1449.39,106,Unknown
M206225,78,Male,HPV-related Cancer,mrna-4157 + keytruda,72.52,,1032.98,85,Partial Response
M206226,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.13,24.8,816.6,96,Stable Disease
M206227,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.09,50.17,1085.11,92,Stable Disease
M206228,63,Female,Melanoma,mrna-4157 + keytruda,31.05,21.7,1046.6,88,Progression
M206229,63,Other,Melanoma,KEYTRUDA only,65.87,48.9,1245.36,87,Progression
M206230,67,Female,HPV-related Cancer,mrna-4157 + keytruda,69.55,48.6,275.56,103,Partial Response
M206231,68,Other,HPV-related Cancer,mrna-4157 + keytruda,31.92,27.77,1392.34,110,Stable Disease
M206232,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,9.13,6.98,-94.94,91,Progression
M206233,41,Male,HPV-related Cancer,mrna-4157 + keytruda,46.15,33.41,903.74,92,Progression
M206234,79,Male,HPV-related Cancer,mrna-4157 + keytruda,30.09,21.41,1699.89,96,Progression
M206235,77,Male,Melanoma,mrna-4157 + keytruda,31.06,16.01,441.11,80,Stable Disease
M206236,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,84.43,55.08,1152.23,90,Complete Response
M206237,79,Other,Melanoma,mrna-4157 + keytruda,65.1,47.32,929.71,89,Complete Response
M206238,62,Male,HPV-related Cancer,mrna-4157 + keytruda,31.08,22.43,561.34,102,Progression
M206239,34,Other,HPV-related Cancer,mrna-4157 + keytruda,38.69,23.27,963.19,89,Progression
M206240,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.91,26.73,294.44,101,Partial Response
M206241,29,Male,HPV-related Cancer,mrna-4157 + keytruda,45.25,27.65,1220.37,93,Unknown
M206242,42,Other,Melanoma,KEYTRUDA only,25.76,21.51,717.52,98,Progression
M206243,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.45,25.95,1666.76,75,Progression
M206244,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.66,20.31,1953.85,90,Partial Response
M206245,29,Female,Melanoma,KEYTRUDA only,35.92,36.88,287.56,100,Unknown
M206246,56,Female,Melanoma,mrna-4157 + keytruda,40.46,18.65,745.71,81,Progression
M206247,25,Female,Melanoma,KEYTRUDA only,63.98,53.98,991.29,110,Unknown
M206248,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.54,47.61,1329.06,78,Partial Response
M206249,39,Female,Melanoma,KEYTRUDA only,50.16,34.65,1187.45,111,Stable Disease
M206250,67,Other,HPV-related Cancer,KEYTRUDA only,35.29,27.81,1312.07,92,Complete Response
M206251,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,70.38,33.33,,92,Progression
M206252,39,Male,HPV-related Cancer,KEYTRUDA only,31.01,22.48,1422.34,104,Partial Response
M206253,83,Other,HPV-related Cancer,KEYTRUDA only,40.67,22.71,1368.2,90,Stable Disease
M206254,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,23.39,20.3,1400.36,81,Progression
M206255,34,Male,HPV-related Cancer,KEYTRUDA only,62.29,71.81,640.05,98,Partial Response
M206256,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.0,,400.26,97,Complete Response
M206257,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.04,47.91,481.37,91,Progression
M206258,34,Female,HPV-related Cancer,mrna-4157 + keytruda,74.9,40.71,964.13,92,Partial Response
M206259,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.13,50.51,773.29,99,Stable Disease
M206260,38,Other,HPV-related Cancer,KEYTRUDA only,50.81,54.39,673.68,95,Partial Response
M206261,66,Other,Melanoma,mrna-4157 + keytruda,71.14,61.48,1335.31,76,
M206262,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.45,57.67,,85,Partial Response
M206263,56,Female,Melanoma,mrna-4157 + keytruda,38.76,27.62,209.97,98,Stable Disease
M206264,45,Female,HPV-related Cancer,mrna-4157 + keytruda,80.61,58.51,991.27,88,Partial Response
M206265,29,Female,Melanoma,mrna-4157 + keytruda,35.91,46.48,1023.44,82,Partial Response
M206266,59,Other,HPV-related Cancer,KEYTRUDA only,35.63,25.63,716.28,107,Progression
M206267,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.65,24.5,123.99,99,Progression
M206268,39,Other,Melanoma,KEYTRUDA only,46.78,43.48,1459.17,100,Complete Response
M206269,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.13,15.36,,95,Stable Disease
M206270,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.55,22.39,710.31,76,Progression
M206271,83,Male,HPV-related Cancer,KEYTRUDA only,66.13,58.79,1064.07,96,Partial Response
M206272,43,Female,Melanoma,mrna-4157 + keytruda,20.39,27.89,22.9,80,Progression
M206273,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.32,37.73,1866.89,96,Stable Disease
M206274,52,Female,Melanoma,mrna-4157 + keytruda,56.51,47.07,1117.68,96,Partial Response
M206275,49,Other,HPV-related Cancer,KEYTRUDA only,47.41,44.42,,98,Stable Disease
M206276,50,Female,HPV-related Cancer,mrna-4157 + keytruda,69.29,35.79,1015.34,96,Progression
M206277,78,Other,HPV-related Cancer,KEYTRUDA only,66.37,68.83,1124.97,92,Progression
M206278,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,79.94,72.97,867.54,97,Complete Response
M206279,72,Male,HPV-related Cancer,mrna-4157 + keytruda,56.33,36.31,758.8,86,Stable Disease
M206280,70,Female,HPV-related Cancer,KEYTRUDA only,26.56,21.73,963.7,80,Partial Response
M206281,59,Female,HPV-related Cancer,KEYTRUDA only,35.14,30.7,1801.04,105,Progression
M206282,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.36,44.97,408.92,93,Complete Response
M206283,69,Male,Melanoma,KEYTRUDA only,74.71,53.45,191.13,98,Partial Response
M206284,84,Male,HPV-related Cancer,mrna-4157 + keytruda,71.75,71.65,1322.77,92,
M206285,78,Other,HPV-related Cancer,mrna-4157 + keytruda,34.17,35.89,1551.8,96,Stable Disease
M206286,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,27.63,19.01,920.9,104,Progression
M206287,28,Other,HPV-related Cancer,mrna-4157 + keytruda,92.31,69.04,761.52,90,Partial Response
M206288,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,32.25,35.51,860.62,86,Complete Response
M206289,26,Male,Melanoma,KEYTRUDA only,43.28,47.58,1256.8,106,Partial Response
M206290,37,Female,HPV-related Cancer,mrna-4157 + keytruda,73.24,39.25,1127.76,81,Complete Response
M206291,60,Male,HPV-related Cancer,mrna-4157 + keytruda,41.77,28.18,1301.1,90,Complete Response
M206292,35,Male,Melanoma,KEYTRUDA only,14.53,12.5,827.6,105,Progression
M206293,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.66,38.49,1228.51,93,Stable Disease
M206294,56,Other,HPV-related Cancer,KEYTRUDA only,74.66,62.43,742.15,79,Complete Response
M206295,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.62,75.29,1587.47,101,Progression
M206296,49,Female,HPV-related Cancer,mrna-4157 + keytruda,30.65,33.55,833.72,102,Stable Disease
M206297,84,Male,Melanoma,mrna-4157 + keytruda,10.37,,850.13,75,Stable Disease
M206298,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.92,44.17,4969.1,79,Stable Disease
M206299,61,Female,Melanoma,KEYTRUDA only,32.31,26.39,1332.74,102,Progression
M206300,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.32,40.27,627.59,113,Stable Disease
M206301,36,Male,Melanoma,mrna-4157 + keytruda,36.75,31.89,1538.63,96,Stable Disease
M206302,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.79,73.64,546.93,82,Partial Response
M206303,37,Other,HPV-related Cancer,mrna-4157 + keytruda,20.78,16.3,,92,Progression
M206304,26,Male,HPV-related Cancer,mrna-4157 + keytruda,36.13,32.99,413.0,104,Progression
M206305,33,Male,Melanoma,mrna-4157 + keytruda,76.0,57.63,695.33,99,Stable Disease
M206306,81,Male,HPV-related Cancer,mrna-4157 + keytruda,29.53,24.8,1616.51,88,Partial Response
M206307,81,Female,Melanoma,KEYTRUDA only,40.08,41.6,1086.5,100,Complete Response
M206308,69,Female,HPV-related Cancer,KEYTRUDA only,38.8,30.84,421.47,97,Complete Response
M206309,34,Female,Melanoma,mrna-4157 + keytruda,41.63,43.35,1797.42,87,Progression
M206310,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.68,56.26,510.46,88,Stable Disease
M206311,60,Female,Melanoma,mrna-4157 + keytruda,37.03,12.64,1302.4,97,Complete Response
M206312,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,51.87,33.44,463.9,80,Complete Response
M206313,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-1.76,-1.07,1034.37,94,Progression
M206314,66,Female,HPV-related Cancer,mrna-4157 + keytruda,84.2,80.51,1022.35,87,Stable Disease
M206315,26,Female,Melanoma,mrna-4157 + keytruda,26.21,17.23,1182.81,75,Progression
M206316,50,Female,HPV-related Cancer,mrna-4157 + keytruda,25.8,25.05,773.33,104,Stable Disease
M206317,35,Female,HPV-related Cancer,mrna-4157 + keytruda,65.96,52.2,838.28,101,
M206318,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.17,29.24,607.47,94,Stable Disease
M206319,74,Male,HPV-related Cancer,mrna-4157 + keytruda,56.9,41.41,1702.44,84,Complete Response
M206320,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.55,32.97,1139.21,79,Partial Response
M206321,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.83,59.62,625.4,82,Progression
M206322,33,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,99.86,122.98,1332.3,82,
M206323,78,Other,Melanoma,mrna-4157 + keytruda,36.74,41.26,1277.65,103,Partial Response
M206324,64,Male,HPV-related Cancer,KEYTRUDA only,16.7,10.46,967.75,101,
M206325,62,Other,Melanoma,mrna-4157 + keytruda,4.29,2.83,548.03,93,Complete Response
M206326,80,Other,Melanoma,KEYTRUDA only,51.41,24.37,804.73,79,Partial Response
M206327,47,Other,Melanoma,mrna-4157 + keytruda,11.39,9.44,725.16,89,Partial Response
M206328,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,72.5,50.5,1034.95,76,Progression
M206329,84,Other,HPV-related Cancer,KEYTRUDA only,3.9,3.28,654.0,92,Progression
M206330,35,Other,HPV-related Cancer,mrna-4157 + keytruda,33.8,29.41,1529.56,90,Stable Disease
M206331,72,Other,HPV-related Cancer,KEYTRUDA only,35.24,41.41,993.83,83,Unknown
M206332,34,Male,Melanoma,KEYTRUDA only,35.41,24.8,781.46,103,Complete Response
M206333,53,Other,HPV-related Cancer,KEYTRUDA only,55.33,,1285.95,82,Complete Response
M206334,30,Male,Melanoma,KEYTRUDA only,41.33,45.63,1372.94,72,Stable Disease
M206335,35,Female,HPV-related Cancer,KEYTRUDA only,58.77,28.73,1114.19,71,Partial Response
M206336,78,Female,HPV-related Cancer,KEYTRUDA only,41.77,14.83,1279.55,98,Progression
M206337,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.33,12.02,1193.83,96,Stable Disease
M206338,55,Other,HPV-related Cancer,KEYTRUDA only,32.64,17.91,818.29,99,Partial Response
M206339,71,Other,Melanoma,mrna-4157 + keytruda,56.92,37.44,928.94,102,Progression
M206340,25,Male,Melanoma,mrna-4157 + keytruda,61.38,,1463.71,110,Progression
M206341,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.79,32.46,969.56,83,Complete Response
M206342,31,Other,Melanoma,KEYTRUDA only,18.71,17.93,780.74,85,Partial Response
M206343,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.03,52.62,740.57,89,Progression
M206344,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,19.53,20.37,904.62,104,
M206345,67,Other,Melanoma,KEYTRUDA only,2.26,1.82,1044.55,108,Complete Response
M206346,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.61,30.64,1509.35,99,Stable Disease
M206347,39,Female,HPV-related Cancer,mrna-4157 + keytruda,78.15,56.46,999.54,80,Complete Response
M206348,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,12.11,8.53,961.59,92,Partial Response
M206349,31,Male,HPV-related Cancer,mrna-4157 + keytruda,67.4,46.91,,85,Partial Response
M206350,65,Other,HPV-related Cancer,KEYTRUDA only,74.04,54.59,192.42,83,Stable Disease
M206351,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,8.23,7.88,1437.11,85,Partial Response
M206352,25,Other,Melanoma,mrna-4157 + keytruda,47.87,14.52,1609.77,87,Partial Response
M206353,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.18,19.23,1159.91,111,Stable Disease
M206354,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.4,61.04,1225.08,88,Stable Disease
M206355,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.96,34.58,1343.93,100,Progression
M206356,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.26,10.56,954.22,110,Progression
M206357,37,Female,Melanoma,mrna-4157 + keytruda,61.67,37.79,965.63,87,Partial Response
M206358,35,Other,Melanoma,KEYTRUDA only,66.34,65.28,1216.43,80,Progression
M206359,60,Male,Melanoma,KEYTRUDA only,51.62,43.86,686.94,87,Partial Response
M206360,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.53,38.62,1065.21,86,
M206361,62,Female,Melanoma,mrna-4157 + keytruda,48.65,20.59,967.65,88,Complete Response
M206362,75,Female,HPV-related Cancer,KEYTRUDA only,23.01,16.39,747.86,103,Unknown
M206363,74,Male,HPV-related Cancer,mrna-4157 + keytruda,23.61,20.2,1239.84,96,
M206364,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.32,46.74,740.3,75,Partial Response
M206365,39,Female,Melanoma,mrna-4157 + keytruda,36.53,16.59,316.85,91,Complete Response
M206366,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.59,45.9,789.57,90,Partial Response
M206367,69,Other,HPV-related Cancer,mrna-4157 + keytruda,56.0,,531.76,95,Progression
M206368,71,Female,HPV-related Cancer,KEYTRUDA only,28.74,21.87,958.96,69,Progression
M206369,58,Female,HPV-related Cancer,KEYTRUDA only,39.03,33.9,926.17,92,Complete Response
M206370,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.84,44.91,915.24,85,Partial Response
M206371,79,Female,HPV-related Cancer,mrna-4157 + keytruda,76.61,78.66,1209.87,96,Partial Response
M206372,37,Other,HPV-related Cancer,mrna-4157 + keytruda,59.98,57.53,1001.86,86,Partial Response
M206373,60,Other,HPV-related Cancer,KEYTRUDA only,50.5,28.16,985.9,99,Complete Response
M206374,74,Female,HPV-related Cancer,KEYTRUDA only,42.66,32.1,747.24,105,
M206375,29,Female,Melanoma,KEYTRUDA only,47.41,35.35,730.74,105,Partial Response
M206376,35,Male,Melanoma,KEYTRUDA only,66.88,62.67,1149.15,88,Stable Disease
M206377,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.77,20.25,1180.79,80,Partial Response
M206378,33,Female,HPV-related Cancer,KEYTRUDA only,97.52,75.42,711.54,92,Progression
M206379,70,Male,HPV-related Cancer,KEYTRUDA only,49.39,45.4,1368.34,97,Stable Disease
M206380,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.38,43.11,843.54,94,Unknown
M206381,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.56,44.5,1267.39,112,Stable Disease
M206382,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.16,44.65,1016.47,83,Stable Disease
M206383,61,Female,Melanoma,KEYTRUDA only,17.56,13.78,983.69,81,Complete Response
M206384,61,Male,Melanoma,mrna-4157 + keytruda,60.56,60.29,1097.12,94,Complete Response
M206385,68,Female,Melanoma,mrna-4157 + keytruda,48.37,48.97,786.6,86,Partial Response
M206386,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.51,15.98,1253.1,85,Progression
M206387,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.54,10.75,1210.24,97,Progression
M206388,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.98,69.45,1126.57,100,Progression
M206389,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.98,46.39,681.41,82,Progression
M206390,60,Male,Melanoma,mrna-4157 + keytruda,56.97,46.85,582.09,88,Partial Response
M206391,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,10.93,13.65,624.36,92,Stable Disease
M206392,80,Other,HPV-related Cancer,mrna-4157 + keytruda,55.91,47.37,1391.45,81,Complete Response
M206393,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,83.82,60.65,926.64,86,
M206394,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.94,39.93,418.29,84,
M206395,77,Female,Melanoma,mrna-4157 + keytruda,18.76,14.5,1437.55,79,Stable Disease
M206396,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.59,35.05,,85,Complete Response
M206397,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.98,49.26,580.87,96,Complete Response
M206398,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.01,57.6,1017.37,92,Complete Response
M206399,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.28,48.12,840.48,102,Stable Disease
M206400,73,Male,HPV-related Cancer,mrna-4157 + keytruda,27.1,20.17,1088.07,108,Complete Response
M206401,65,Male,HPV-related Cancer,KEYTRUDA only,47.82,47.07,1296.33,67,Partial Response
M206402,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.21,31.3,403.11,82,Partial Response
M206403,29,Male,Melanoma,mrna-4157 + keytruda,22.55,16.05,323.32,79,Complete Response
M206404,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.32,42.47,964.7,87,Progression
M206405,67,Male,HPV-related Cancer,mrna-4157 + keytruda,38.04,17.23,1238.85,92,Stable Disease
M206406,78,Other,Melanoma,KEYTRUDA only,47.07,41.08,1177.53,88,Stable Disease
M206407,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.52,19.52,1199.0,82,Complete Response
M206408,61,Female,Melanoma,mrna-4157 + keytruda,71.81,65.24,1787.07,94,Stable Disease
M206409,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.2,56.65,772.78,102,Partial Response
M206410,31,Male,HPV-related Cancer,mrna-4157 + keytruda,56.91,36.96,790.22,80,Stable Disease
M206411,63,Female,HPV-related Cancer,mrna-4157 + keytruda,78.09,63.84,654.71,82,Progression
M206412,74,Other,HPV-related Cancer,KEYTRUDA only,26.16,15.95,,82,Complete Response
M206413,77,Female,Melanoma,KEYTRUDA only,21.56,21.4,1136.35,88,
M206414,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.72,4.36,974.51,103,Partial Response
M206415,28,Other,HPV-related Cancer,mrna-4157 + keytruda,34.29,23.02,,88,Stable Disease
M206416,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.68,82.33,582.41,99,Progression
M206417,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.73,53.21,233.21,78,Unknown
M206418,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.99,37.54,1969.3,95,Progression
M206419,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.85,61.37,1174.91,93,Stable Disease
M206420,45,Male,Melanoma,mrna-4157 + keytruda,54.39,40.6,728.77,78,Stable Disease
M206421,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.58,,1198.57,85,Progression
M206422,36,Other,HPV-related Cancer,KEYTRUDA only,39.39,36.04,1011.03,92,Stable Disease
M206423,54,Male,HPV-related Cancer,mrna-4157 + keytruda,46.36,48.56,984.54,85,Complete Response
M206424,64,Other,HPV-related Cancer,mrna-4157 + keytruda,88.21,94.6,2485.05,90,Progression
M206425,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.66,36.33,528.28,94,Stable Disease
M206426,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,75.33,80.88,1532.27,98,Partial Response
M206427,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,98.26,57.23,1086.54,93,Progression
M206428,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.85,40.61,1218.56,81,Progression
M206429,40,Male,Melanoma,KEYTRUDA only,24.72,21.21,1308.82,104,Partial Response
M206430,59,Other,Non-small Cell Lung Cancer,KEYTRUDA only,69.3,61.52,1572.21,94,Stable Disease
M206431,46,Other,Melanoma,mrna-4157 + keytruda,68.2,59.54,634.81,82,Complete Response
M206432,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.69,26.02,1268.6,87,Stable Disease
M206433,78,Other,Melanoma,KEYTRUDA only,51.21,46.57,937.33,92,Progression
M206434,49,Male,Melanoma,mrna-4157 + keytruda,54.48,38.34,660.66,79,
M206435,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,71.96,46.64,1178.03,109,Partial Response
M206436,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.97,12.12,1177.03,100,Complete Response
M206437,47,Other,HPV-related Cancer,mrna-4157 + keytruda,44.98,16.74,1317.05,85,Complete Response
M206438,74,Other,HPV-related Cancer,mrna-4157 + keytruda,56.41,43.68,207.25,93,Progression
M206439,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.67,20.07,1716.82,71,Stable Disease
M206440,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.2,52.54,1224.77,77,Progression
M206441,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.32,1.22,1200.27,108,Partial Response
M206442,62,Female,Melanoma,KEYTRUDA only,72.9,62.24,752.02,103,Progression
M206443,81,Other,Melanoma,mrna-4157 + keytruda,56.79,45.28,803.66,69,Progression
M206444,82,Female,HPV-related Cancer,mrna-4157 + keytruda,24.28,19.54,1069.27,90,Partial Response
M206445,68,Male,Melanoma,mrna-4157 + keytruda,58.6,51.47,855.16,86,Complete Response
M206446,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,77.32,54.5,1177.93,102,Stable Disease
M206447,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.51,52.9,973.12,94,Stable Disease
M206448,69,Female,Melanoma,mrna-4157 + keytruda,68.58,43.32,455.87,100,Stable Disease
M206449,48,Other,Melanoma,KEYTRUDA only,101.03,85.91,1038.71,97,Stable Disease
M206450,52,Male,Melanoma,KEYTRUDA only,84.0,83.94,1033.64,85,Progression
M206451,29,Female,HPV-related Cancer,KEYTRUDA only,75.44,33.01,674.53,95,Progression
M206452,33,Other,HPV-related Cancer,KEYTRUDA only,61.87,42.77,595.63,96,Stable Disease
M206453,57,Other,Melanoma,mrna-4157 + keytruda,68.37,58.06,647.66,101,Partial Response
M206454,79,Female,HPV-related Cancer,KEYTRUDA only,20.54,18.95,656.53,73,Partial Response
M206455,47,Male,HPV-related Cancer,mrna-4157 + keytruda,79.18,53.27,627.43,90,Complete Response
M206456,70,Male,Melanoma,KEYTRUDA only,47.23,32.4,1220.16,93,Partial Response
M206457,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.56,76.36,1429.42,76,
M206458,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,103.46,75.57,612.28,98,
M206459,31,Other,HPV-related Cancer,mrna-4157 + keytruda,87.1,78.09,1410.88,96,Progression
M206460,71,Other,HPV-related Cancer,mrna-4157 + keytruda,33.47,28.28,1397.0,91,Partial Response
M206461,52,Male,HPV-related Cancer,mrna-4157 + keytruda,18.72,12.13,896.1,89,
M206462,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.29,40.46,1427.84,78,Stable Disease
M206463,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.06,,1085.29,76,Progression
M206464,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.67,57.8,700.93,90,Unknown
M206465,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.76,50.91,810.51,85,Stable Disease
M206466,79,Other,Melanoma,KEYTRUDA only,95.4,71.55,699.53,78,Partial Response
M206467,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.21,64.66,,113,Partial Response
M206468,75,Male,HPV-related Cancer,KEYTRUDA only,109.53,61.15,869.69,87,Stable Disease
M206469,59,Female,HPV-related Cancer,mrna-4157 + keytruda,62.57,51.34,1394.87,92,Partial Response
M206470,71,Female,HPV-related Cancer,mrna-4157 + keytruda,42.75,30.14,1191.52,92,Partial Response
M206471,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.97,36.65,432.43,86,Unknown
M206472,49,Male,Melanoma,mrna-4157 + keytruda,30.78,20.29,1064.11,72,Stable Disease
M206473,41,Male,Melanoma,mrna-4157 + keytruda,46.39,27.58,948.57,83,Stable Disease
M206474,49,Other,Melanoma,KEYTRUDA only,16.64,18.87,,87,
M206475,41,Male,Melanoma,mrna-4157 + keytruda,61.03,62.0,600.57,85,Stable Disease
M206476,58,Other,Melanoma,mrna-4157 + keytruda,27.83,25.43,1457.21,83,Partial Response
M206477,55,Other,HPV-related Cancer,mrna-4157 + keytruda,44.98,32.03,1086.27,90,Progression
M206478,31,Female,HPV-related Cancer,KEYTRUDA only,72.82,50.08,59.82,97,Progression
M206479,58,Male,Melanoma,mrna-4157 + keytruda,22.79,14.52,941.66,86,Stable Disease
M206480,81,Female,HPV-related Cancer,mrna-4157 + keytruda,56.4,74.31,744.29,89,Stable Disease
M206481,84,Male,Melanoma,mrna-4157 + keytruda,77.73,67.19,836.78,87,Progression
M206482,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.36,43.7,1463.1,93,Progression
M206483,60,Male,HPV-related Cancer,KEYTRUDA only,52.13,43.82,515.46,96,Partial Response
M206484,79,Female,HPV-related Cancer,mrna-4157 + keytruda,78.09,,,72,Stable Disease
M206485,43,Other,HPV-related Cancer,KEYTRUDA only,18.29,19.17,1089.6,93,Stable Disease
M206486,25,Male,Melanoma,mrna-4157 + keytruda,57.1,56.62,516.85,93,Complete Response
M206487,68,Female,HPV-related Cancer,KEYTRUDA only,22.92,14.79,700.17,84,Stable Disease
M206488,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.28,30.88,883.64,95,Progression
M206489,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.7,66.03,836.94,82,
M206490,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,97.36,60.98,1433.71,98,Complete Response
M206491,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.13,29.74,1386.45,93,Stable Disease
M206492,29,Female,Melanoma,mrna-4157 + keytruda,58.19,22.72,2407.34,100,Partial Response
M206493,43,Male,HPV-related Cancer,mrna-4157 + keytruda,34.79,33.39,642.07,99,Stable Disease
M206494,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.28,48.98,802.21,94,Partial Response
M206495,74,Other,Melanoma,KEYTRUDA only,54.13,40.0,2056.85,92,Partial Response
M206496,58,Female,HPV-related Cancer,mrna-4157 + keytruda,84.8,90.73,795.7,83,Progression
M206497,44,Female,Melanoma,mrna-4157 + keytruda,88.8,79.59,617.51,89,Partial Response
M206498,48,Male,HPV-related Cancer,KEYTRUDA only,40.06,43.62,1179.5,97,Unknown
M206499,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,61.68,34.46,1230.22,84,Partial Response
M206500,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.47,33.14,1264.13,86,Stable Disease
M206501,66,Other,Melanoma,mrna-4157 + keytruda,43.21,41.18,408.79,95,Progression
M206502,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.51,65.3,808.68,79,Partial Response
M206503,74,Other,Melanoma,mrna-4157 + keytruda,71.33,65.7,1340.4,93,Partial Response
M206504,83,Other,HPV-related Cancer,mrna-4157 + keytruda,39.36,32.02,782.59,93,Partial Response
M206505,31,Other,HPV-related Cancer,KEYTRUDA only,21.09,25.88,1609.5,87,Partial Response
M206506,61,Other,Melanoma,KEYTRUDA only,66.86,30.98,,110,Stable Disease
M206507,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.65,51.48,967.29,95,Stable Disease
M206508,58,Female,Melanoma,mrna-4157 + keytruda,96.53,,834.17,76,Stable Disease
M206509,30,Female,HPV-related Cancer,KEYTRUDA only,45.74,44.63,367.13,96,Complete Response
M206510,31,Other,Melanoma,KEYTRUDA only,51.64,40.27,1128.16,92,Stable Disease
M206511,67,Male,HPV-related Cancer,mrna-4157 + keytruda,51.48,49.41,1606.3,105,Progression
M206512,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,73.39,61.22,260.86,75,Partial Response
M206513,68,Female,Melanoma,KEYTRUDA only,33.62,29.17,307.71,90,Stable Disease
M206514,31,Female,HPV-related Cancer,mrna-4157 + keytruda,75.36,67.25,1558.51,76,Unknown
M206515,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.74,38.83,532.78,104,Complete Response
M206516,84,Other,HPV-related Cancer,KEYTRUDA only,36.46,25.02,1815.33,103,Stable Disease
M206517,32,Female,Melanoma,KEYTRUDA only,32.79,,984.71,83,Progression
M206518,66,Other,HPV-related Cancer,mrna-4157 + keytruda,84.09,86.65,620.89,75,Stable Disease
M206519,81,Female,Melanoma,mrna-4157 + keytruda,69.99,45.23,-33.13,94,Complete Response
M206520,71,Male,Melanoma,KEYTRUDA only,25.65,13.82,968.26,86,Progression
M206521,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.79,14.16,635.43,96,Partial Response
M206522,57,Other,HPV-related Cancer,mrna-4157 + keytruda,34.47,33.59,977.09,81,Partial Response
M206523,69,Male,HPV-related Cancer,KEYTRUDA only,31.9,38.92,1391.58,95,
M206524,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.68,32.75,1134.03,96,Stable Disease
M206525,51,Male,Melanoma,mrna-4157 + keytruda,68.77,58.86,1069.2,76,
M206526,76,Other,HPV-related Cancer,KEYTRUDA only,52.81,,651.91,82,Partial Response
M206527,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.52,32.22,890.3,83,Progression
M206528,74,Male,Melanoma,mrna-4157 + keytruda,67.33,46.78,981.32,87,Stable Disease
M206529,31,Female,Melanoma,KEYTRUDA only,6.92,,1414.15,84,Partial Response
M206530,33,Male,Melanoma,mrna-4157 + keytruda,68.87,65.8,920.07,95,
M206531,47,Other,HPV-related Cancer,KEYTRUDA only,28.96,28.95,785.69,113,Stable Disease
M206532,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,27.67,24.59,1651.07,79,Progression
M206533,33,Male,HPV-related Cancer,mrna-4157 + keytruda,47.09,44.0,1279.06,91,Partial Response
M206534,28,Male,HPV-related Cancer,mrna-4157 + keytruda,66.66,56.83,1098.66,83,Stable Disease
M206535,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.7,51.22,816.03,105,Progression
M206536,77,Male,Melanoma,KEYTRUDA only,68.76,41.32,815.42,93,Partial Response
M206537,41,Female,HPV-related Cancer,KEYTRUDA only,16.02,16.48,1139.22,101,
M206538,26,Other,HPV-related Cancer,KEYTRUDA only,67.63,43.3,1035.23,104,Partial Response
M206539,59,Female,HPV-related Cancer,KEYTRUDA only,45.38,37.86,555.55,92,Partial Response
M206540,56,Other,Melanoma,KEYTRUDA only,40.95,33.7,649.33,113,Partial Response
M206541,80,Female,HPV-related Cancer,mrna-4157 + keytruda,33.9,31.11,965.69,108,Complete Response
M206542,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,82.74,65.47,1467.26,91,Stable Disease
M206543,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.12,68.26,1102.48,85,Progression
M206544,70,Female,HPV-related Cancer,mrna-4157 + keytruda,66.8,45.36,622.77,82,Partial Response
M206545,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,28.6,,913.4,99,Partial Response
M206546,82,Female,Melanoma,mrna-4157 + keytruda,30.9,23.8,866.16,90,Unknown
M206547,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.6,58.99,1240.63,93,
M206548,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.66,20.23,1194.36,83,Partial Response
M206549,67,Female,HPV-related Cancer,KEYTRUDA only,53.61,37.29,942.86,115,Stable Disease
M206550,82,Female,Melanoma,mrna-4157 + keytruda,44.12,35.61,716.95,106,Stable Disease
M206551,51,Other,Melanoma,mrna-4157 + keytruda,20.38,15.28,338.85,77,Partial Response
M206552,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.48,29.58,1656.45,98,Progression
M206553,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.38,31.03,,105,
M206554,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.46,18.33,856.88,79,Progression
M206555,34,Male,HPV-related Cancer,KEYTRUDA only,69.22,52.98,559.07,91,Partial Response
M206556,40,Male,HPV-related Cancer,KEYTRUDA only,67.29,38.46,1172.22,96,Complete Response
M206557,82,Other,Melanoma,mrna-4157 + keytruda,38.73,26.86,1170.47,78,Partial Response
M206558,44,Other,Melanoma,mrna-4157 + keytruda,39.0,26.16,657.21,90,Progression
M206559,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,7.65,7.1,1052.83,97,Partial Response
M206560,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.57,29.63,362.01,83,Partial Response
M206561,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,18.5,19.39,651.45,84,Partial Response
M206562,40,Male,Melanoma,KEYTRUDA only,47.66,42.46,1151.53,85,Stable Disease
M206563,68,Other,Melanoma,mrna-4157 + keytruda,36.19,45.23,1486.72,106,Partial Response
M206564,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.11,37.22,1295.55,93,Partial Response
M206565,70,Female,Melanoma,mrna-4157 + keytruda,32.94,19.14,704.69,70,Partial Response
M206566,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,1.15,0.9,,67,Progression
M206567,62,Male,Melanoma,KEYTRUDA only,66.17,47.94,892.63,97,Partial Response
M206568,34,Other,HPV-related Cancer,mrna-4157 + keytruda,51.98,71.36,540.26,84,Partial Response
M206569,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,0.78,0.53,1205.87,90,Partial Response
M206570,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.88,38.77,466.77,106,Stable Disease
M206571,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,89.95,86.56,1171.26,69,Complete Response
M206572,55,Female,HPV-related Cancer,mrna-4157 + keytruda,49.77,32.02,1016.0,93,Progression
M206573,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.16,56.4,855.71,88,Progression
M206574,41,Female,Melanoma,mrna-4157 + keytruda,-10.52,-6.6,1396.92,89,Stable Disease
M206575,66,Female,HPV-related Cancer,mrna-4157 + keytruda,64.74,46.74,815.54,99,Partial Response
M206576,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.03,25.58,1298.88,103,Unknown
M206577,34,Male,Melanoma,KEYTRUDA only,40.37,23.36,1061.9,96,Progression
M206578,32,Male,Melanoma,mrna-4157 + keytruda,40.48,31.89,1178.37,92,Stable Disease
M206579,78,Female,Melanoma,mrna-4157 + keytruda,51.78,42.68,687.83,99,Complete Response
M206580,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.72,44.41,651.47,73,Progression
M206581,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.98,53.66,,81,Progression
M206582,46,Female,Melanoma,KEYTRUDA only,31.58,21.48,1056.79,87,Progression
M206583,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.36,26.46,1521.25,93,Complete Response
M206584,73,Female,HPV-related Cancer,mrna-4157 + keytruda,53.44,59.67,1277.7,97,Stable Disease
M206585,77,Other,Melanoma,KEYTRUDA only,67.47,53.95,1109.55,103,
M206586,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.93,38.69,1596.16,77,Stable Disease
M206587,62,Female,Melanoma,mrna-4157 + keytruda,32.67,22.7,1025.37,103,Progression
M206588,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.45,1.76,873.95,88,Partial Response
M206589,71,Female,HPV-related Cancer,mrna-4157 + keytruda,43.7,39.18,943.08,105,Stable Disease
M206590,27,Other,Melanoma,KEYTRUDA only,43.27,30.22,1283.35,90,Partial Response
M206591,49,Female,Melanoma,KEYTRUDA only,66.54,52.62,2200.58,90,Partial Response
M206592,67,Other,HPV-related Cancer,KEYTRUDA only,52.69,44.51,759.72,89,Complete Response
M206593,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.26,48.55,1052.53,79,Stable Disease
M206594,55,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.8,53.1,927.53,86,Complete Response
M206595,31,Male,HPV-related Cancer,mrna-4157 + keytruda,37.19,32.56,1418.12,90,Stable Disease
M206596,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.99,13.63,500.34,96,Complete Response
M206597,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.67,57.3,1051.79,77,Unknown
M206598,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.79,39.69,1888.62,95,Complete Response
M206599,46,Male,HPV-related Cancer,mrna-4157 + keytruda,62.8,50.9,814.62,92,Complete Response
M206600,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.84,,1180.33,90,Complete Response
M206601,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.23,66.99,693.51,94,Stable Disease
M206602,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.16,61.59,1320.54,79,Progression
M206603,49,Male,Melanoma,KEYTRUDA only,57.34,51.41,521.62,114,Stable Disease
M206604,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.51,,1252.47,97,Partial Response
M206605,73,Female,HPV-related Cancer,mrna-4157 + keytruda,61.68,58.44,917.23,103,Progression
M206606,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.21,29.41,728.75,97,Stable Disease
M206607,57,Female,HPV-related Cancer,mrna-4157 + keytruda,78.34,35.44,476.27,94,Partial Response
M206608,67,Female,Melanoma,KEYTRUDA only,57.87,40.07,834.64,93,Stable Disease
M206609,63,Other,Melanoma,mrna-4157 + keytruda,69.89,54.8,758.05,107,Progression
M206610,26,Other,HPV-related Cancer,mrna-4157 + keytruda,46.84,37.45,1413.74,93,Complete Response
M206611,69,Other,Melanoma,KEYTRUDA only,56.2,23.94,1835.44,86,
M206612,55,Male,Melanoma,mrna-4157 + keytruda,70.46,51.53,537.8,82,Stable Disease
M206613,50,Male,Melanoma,mrna-4157 + keytruda,58.9,39.67,,84,Partial Response
M206614,42,Male,HPV-related Cancer,mrna-4157 + keytruda,24.26,27.41,1009.05,93,Stable Disease
M206615,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.48,35.01,703.97,86,Partial Response
M206616,62,Other,HPV-related Cancer,mrna-4157 + keytruda,87.75,40.68,1132.04,92,Stable Disease
M206617,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,29.17,15.84,1134.51,82,Partial Response
M206618,71,Other,Melanoma,mrna-4157 + keytruda,24.04,24.29,673.78,91,
M206619,64,Other,Melanoma,mrna-4157 + keytruda,86.26,37.32,990.35,87,Stable Disease
M206620,54,Other,Melanoma,KEYTRUDA only,28.45,29.54,818.51,109,Stable Disease
M206621,49,Other,Melanoma,KEYTRUDA only,77.5,71.64,866.91,96,Partial Response
M206622,47,Female,Melanoma,KEYTRUDA only,34.29,25.54,835.51,108,
M206623,78,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.13,26.96,1009.93,67,
M206624,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.01,17.06,259.75,78,
M206625,37,Male,HPV-related Cancer,mrna-4157 + keytruda,10.17,6.4,975.19,79,Unknown
M206626,30,Male,HPV-related Cancer,KEYTRUDA only,37.64,17.22,784.79,93,
M206627,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.91,46.75,1295.7,96,Complete Response
M206628,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,72.99,91.6,1170.01,106,Stable Disease
M206629,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.18,42.4,938.43,82,Stable Disease
M206630,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.05,17.51,1710.9,81,Stable Disease
M206631,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.36,,961.54,96,Partial Response
M206632,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.66,56.84,1236.4,97,Complete Response
M206633,60,Female,HPV-related Cancer,KEYTRUDA only,61.86,62.08,973.18,80,Partial Response
M206634,55,Male,Melanoma,KEYTRUDA only,77.84,,138.82,104,Stable Disease
M206635,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.44,80.21,738.63,76,Partial Response
M206636,51,Female,Melanoma,mrna-4157 + keytruda,42.07,25.6,1439.81,113,Partial Response
M206637,56,Male,HPV-related Cancer,KEYTRUDA only,67.85,48.44,1158.73,77,Partial Response
M206638,32,Other,HPV-related Cancer,KEYTRUDA only,72.76,66.81,965.95,83,Partial Response
M206639,71,Female,Melanoma,mrna-4157 + keytruda,74.61,12.34,1554.21,89,Complete Response
M206640,67,Other,Melanoma,mrna-4157 + keytruda,55.92,36.46,417.05,81,Partial Response
M206641,57,Other,Melanoma,mrna-4157 + keytruda,93.46,55.36,1010.75,106,Partial Response
M206642,50,Female,Melanoma,mrna-4157 + keytruda,67.29,70.45,1164.01,79,Unknown
M206643,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.54,,728.81,93,Partial Response
M206644,60,Other,HPV-related Cancer,KEYTRUDA only,93.76,102.68,1193.11,87,Complete Response
M206645,70,Other,HPV-related Cancer,mrna-4157 + keytruda,47.98,39.07,1074.95,93,Complete Response
M206646,82,Other,Melanoma,mrna-4157 + keytruda,53.23,46.26,1666.24,102,Partial Response
M206647,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,22.86,17.19,737.97,79,Progression
M206648,37,Other,Melanoma,mrna-4157 + keytruda,48.85,42.71,,90,
M206649,54,Female,Melanoma,KEYTRUDA only,46.08,44.14,558.47,87,Partial Response
M206650,30,Other,Melanoma,mrna-4157 + keytruda,35.0,14.59,694.01,84,Partial Response
M206651,82,Other,Melanoma,mrna-4157 + keytruda,14.11,9.0,1103.46,96,Unknown
M206652,59,Female,Melanoma,KEYTRUDA only,54.65,52.79,1101.89,113,Stable Disease
M206653,41,Female,HPV-related Cancer,mrna-4157 + keytruda,45.1,30.91,786.36,89,Stable Disease
M206654,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.62,37.74,1259.89,92,Stable Disease
M206655,27,Other,Melanoma,mrna-4157 + keytruda,47.91,,129.1,77,Stable Disease
M206656,43,Male,Melanoma,mrna-4157 + keytruda,16.52,13.49,895.88,102,Stable Disease
M206657,28,Other,HPV-related Cancer,mrna-4157 + keytruda,51.28,,187.11,74,Stable Disease
M206658,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.09,35.62,1567.39,86,Progression
M206659,63,Female,Melanoma,mrna-4157 + keytruda,82.0,75.03,,95,Stable Disease
M206660,30,Male,HPV-related Cancer,KEYTRUDA only,52.35,36.53,1217.09,87,Progression
M206661,63,Other,Melanoma,mrna-4157 + keytruda,79.52,41.49,1438.08,114,Stable Disease
M206662,56,Other,HPV-related Cancer,mrna-4157 + keytruda,63.28,49.87,1532.11,108,Stable Disease
M206663,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,86.23,66.82,1162.63,95,Progression
M206664,34,Male,HPV-related Cancer,KEYTRUDA only,27.28,13.74,309.62,101,Stable Disease
M206665,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,88.06,105.3,1072.0,89,Partial Response
M206666,32,Male,Melanoma,mrna-4157 + keytruda,47.78,29.72,662.6,88,Stable Disease
M206667,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.73,43.79,1476.12,90,Complete Response
M206668,35,Other,Melanoma,mrna-4157 + keytruda,72.73,42.87,576.81,83,Stable Disease
M206669,41,Female,HPV-related Cancer,KEYTRUDA only,48.46,39.23,,91,Complete Response
M206670,73,Female,Melanoma,KEYTRUDA only,71.83,27.27,972.79,101,Partial Response
M206671,75,Other,HPV-related Cancer,mrna-4157 + keytruda,30.94,26.9,603.3,99,Complete Response
M206672,59,Female,Melanoma,mrna-4157 + keytruda,48.02,52.52,1537.32,112,Complete Response
M206673,37,Male,HPV-related Cancer,mrna-4157 + keytruda,29.16,26.91,557.91,93,Progression
M206674,72,Other,Melanoma,mrna-4157 + keytruda,45.39,34.88,1339.71,80,Stable Disease
M206675,38,Male,Melanoma,mrna-4157 + keytruda,40.32,24.57,1509.0,89,Partial Response
M206676,38,Female,HPV-related Cancer,KEYTRUDA only,8.64,9.69,886.97,96,Partial Response
M206677,75,Female,HPV-related Cancer,mrna-4157 + keytruda,6.98,3.4,1412.56,84,Stable Disease
M206678,41,Other,Melanoma,KEYTRUDA only,51.46,34.48,1305.11,103,Partial Response
M206679,36,Male,HPV-related Cancer,mrna-4157 + keytruda,63.37,50.9,365.68,93,Partial Response
M206680,83,Male,HPV-related Cancer,KEYTRUDA only,25.01,26.58,814.66,80,Unknown
M206681,25,Female,HPV-related Cancer,KEYTRUDA only,71.38,76.25,,92,Unknown
M206682,31,Male,HPV-related Cancer,KEYTRUDA only,31.54,27.38,,77,Partial Response
M206683,45,Other,HPV-related Cancer,KEYTRUDA only,75.23,88.36,1158.38,106,Progression
M206684,53,Male,HPV-related Cancer,mrna-4157 + keytruda,71.1,,1213.2,94,Partial Response
M206685,52,Male,Melanoma,KEYTRUDA only,50.18,37.55,650.16,87,Complete Response
M206686,50,Other,HPV-related Cancer,KEYTRUDA only,41.72,23.78,1623.93,103,Stable Disease
M206687,47,Female,Melanoma,mrna-4157 + keytruda,56.94,,1372.69,92,Stable Disease
M206688,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.06,71.16,1097.48,84,Complete Response
M206689,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.04,65.66,1296.52,79,
M206690,84,Male,HPV-related Cancer,mrna-4157 + keytruda,68.77,69.63,543.76,98,
M206691,35,Other,HPV-related Cancer,mrna-4157 + keytruda,39.54,27.61,911.75,86,Progression
M206692,65,Other,Melanoma,KEYTRUDA only,34.63,21.82,922.51,78,Complete Response
M206693,70,Male,Melanoma,mrna-4157 + keytruda,90.72,100.76,1596.3,83,Partial Response
M206694,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.98,35.24,1438.93,73,Partial Response
M206695,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.71,36.9,718.95,88,Progression
M206696,35,Female,Melanoma,KEYTRUDA only,75.41,,1663.9,113,Complete Response
M206697,49,Other,Melanoma,KEYTRUDA only,44.37,47.4,788.99,90,Partial Response
M206698,53,Male,Melanoma,KEYTRUDA only,78.22,30.97,-143.22,82,Complete Response
M206699,76,Other,Melanoma,mrna-4157 + keytruda,46.41,48.92,1009.44,90,Partial Response
M206700,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.79,43.75,1465.95,102,Stable Disease
M206701,52,Male,HPV-related Cancer,KEYTRUDA only,40.06,44.38,1241.22,92,Complete Response
M206702,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.96,33.31,822.14,91,Stable Disease
M206703,75,Other,HPV-related Cancer,KEYTRUDA only,59.5,58.18,711.46,106,Stable Disease
M206704,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.22,37.5,709.25,89,Progression
M206705,56,Other,HPV-related Cancer,KEYTRUDA only,44.1,41.97,1123.17,84,Progression
M206706,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.89,29.36,1234.35,99,Stable Disease
M206707,73,Female,HPV-related Cancer,mrna-4157 + keytruda,36.89,32.36,1151.62,90,Stable Disease
M206708,59,Female,HPV-related Cancer,KEYTRUDA only,39.15,17.58,1282.49,92,Partial Response
M206709,46,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.3,49.46,1584.52,99,Progression
M206710,38,Male,Melanoma,mrna-4157 + keytruda,67.21,44.35,1273.14,92,Complete Response
M206711,43,Other,HPV-related Cancer,mrna-4157 + keytruda,66.85,39.63,1415.3,77,Progression
M206712,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.29,45.63,,85,Unknown
M206713,32,Male,Melanoma,mrna-4157 + keytruda,69.38,45.46,1214.69,64,Partial Response
M206714,43,Female,HPV-related Cancer,mrna-4157 + keytruda,13.78,8.7,1481.26,100,Complete Response
M206715,32,Male,Melanoma,mrna-4157 + keytruda,47.88,40.48,417.97,98,Partial Response
M206716,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.63,52.56,1490.54,99,
M206717,34,Male,HPV-related Cancer,mrna-4157 + keytruda,45.68,43.39,800.95,76,Partial Response
M206718,25,Other,HPV-related Cancer,KEYTRUDA only,51.35,34.19,764.29,91,Stable Disease
M206719,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.29,28.49,1355.58,100,Progression
M206720,34,Male,HPV-related Cancer,mrna-4157 + keytruda,51.45,54.39,611.41,83,Partial Response
M206721,44,Other,HPV-related Cancer,KEYTRUDA only,99.84,102.48,68.18,107,
M206722,47,Male,Melanoma,mrna-4157 + keytruda,59.64,52.76,1209.07,86,Complete Response
M206723,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.5,49.16,609.64,90,Stable Disease
M206724,81,Other,HPV-related Cancer,KEYTRUDA only,59.05,33.11,1175.2,93,
M206725,49,Male,Melanoma,KEYTRUDA only,35.44,28.85,688.05,79,Complete Response
M206726,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.89,39.63,1472.67,81,Partial Response
M206727,68,Female,Melanoma,KEYTRUDA only,71.78,65.94,665.8,106,Partial Response
M206728,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.18,92.52,666.57,82,
M206729,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,81.9,82.68,713.33,98,Complete Response
M206730,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,104.91,76.79,996.82,90,Progression
M206731,62,Male,HPV-related Cancer,KEYTRUDA only,72.17,66.7,1470.54,93,Partial Response
M206732,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.7,32.1,704.99,81,Stable Disease
M206733,44,Other,Melanoma,mrna-4157 + keytruda,37.17,29.47,388.9,93,Partial Response
M206734,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,93.67,68.46,,79,Progression
M206735,55,Female,HPV-related Cancer,mrna-4157 + keytruda,62.51,58.67,1718.52,107,Stable Disease
M206736,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.3,30.74,,97,Partial Response
M206737,33,Female,HPV-related Cancer,KEYTRUDA only,61.33,49.49,901.56,84,Partial Response
M206738,73,Male,HPV-related Cancer,KEYTRUDA only,58.19,40.78,1035.33,95,Stable Disease
M206739,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.55,29.26,647.12,95,Complete Response
M206740,58,Female,HPV-related Cancer,mrna-4157 + keytruda,63.61,35.0,1282.95,80,Stable Disease
M206741,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,61.19,37.79,448.56,102,Stable Disease
M206742,34,Female,HPV-related Cancer,mrna-4157 + keytruda,47.05,32.13,473.45,101,Complete Response
M206743,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.05,68.18,1143.87,101,Stable Disease
M206744,27,Other,HPV-related Cancer,KEYTRUDA only,60.65,41.03,635.51,86,Complete Response
M206745,47,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.71,38.25,960.51,91,Progression
M206746,28,Male,HPV-related Cancer,KEYTRUDA only,25.69,21.01,1427.73,87,Stable Disease
M206747,39,Male,Melanoma,KEYTRUDA only,30.71,9.59,797.26,102,Progression
M206748,65,Male,HPV-related Cancer,KEYTRUDA only,56.69,50.81,1300.18,96,Progression
M206749,57,Female,HPV-related Cancer,KEYTRUDA only,37.52,26.19,977.4,89,Partial Response
M206750,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.57,17.88,1086.17,94,Progression
M206751,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.4,36.41,1235.15,79,
M206752,73,Female,Melanoma,mrna-4157 + keytruda,40.82,28.95,844.52,85,Complete Response
M206753,49,Male,Melanoma,mrna-4157 + keytruda,85.97,61.39,1099.89,101,Complete Response
M206754,42,Male,HPV-related Cancer,mrna-4157 + keytruda,75.48,54.5,1266.34,95,Partial Response
M206755,53,Other,Melanoma,mrna-4157 + keytruda,75.75,65.88,1239.24,83,Progression
M206756,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,6.45,5.77,159.9,87,Complete Response
M206757,38,Male,Melanoma,mrna-4157 + keytruda,74.01,49.53,1201.37,98,Partial Response
M206758,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.98,36.44,1009.59,98,Partial Response
M206759,39,Other,HPV-related Cancer,mrna-4157 + keytruda,47.74,35.35,1296.39,80,Complete Response
M206760,35,Other,HPV-related Cancer,mrna-4157 + keytruda,36.58,35.44,1041.32,95,Stable Disease
M206761,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.23,40.47,450.75,91,
M206762,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.43,13.29,737.3,102,Progression
M206763,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,23.56,23.94,1021.46,105,Partial Response
M206764,57,Male,Melanoma,mrna-4157 + keytruda,63.21,66.0,1342.19,100,Stable Disease
M206765,40,Female,Melanoma,mrna-4157 + keytruda,41.05,48.44,879.42,90,Partial Response
M206766,83,Male,HPV-related Cancer,KEYTRUDA only,42.27,35.8,,111,Partial Response
M206767,27,Male,HPV-related Cancer,KEYTRUDA only,46.98,38.23,1461.62,93,Partial Response
M206768,29,Male,HPV-related Cancer,mrna-4157 + keytruda,24.83,24.1,151.58,100,Complete Response
M206769,60,Female,Melanoma,KEYTRUDA only,55.05,40.68,1629.43,81,
M206770,29,Female,Melanoma,mrna-4157 + keytruda,48.39,29.05,994.13,79,Stable Disease
M206771,58,Male,HPV-related Cancer,mrna-4157 + keytruda,24.33,14.11,1044.77,81,Partial Response
M206772,43,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.47,58.03,1056.08,87,Stable Disease
M206773,62,Male,HPV-related Cancer,mrna-4157 + keytruda,59.87,40.06,1031.69,82,Partial Response
M206774,30,Male,HPV-related Cancer,KEYTRUDA only,56.02,60.86,1490.15,80,Complete Response
M206775,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.0,85.72,1866.75,92,Stable Disease
M206776,60,Male,Melanoma,KEYTRUDA only,64.59,,1233.11,89,Partial Response
M206777,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.96,56.14,942.07,85,
M206778,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,24.82,21.42,941.99,86,Progression
M206779,63,Male,Melanoma,mrna-4157 + keytruda,63.22,64.05,1163.58,81,Partial Response
M206780,47,Male,Non-small Cell Lung Cancer,KEYTRUDA only,97.23,57.84,1055.59,95,Progression
M206781,60,Male,Melanoma,mrna-4157 + keytruda,80.13,29.44,1516.2,88,Stable Disease
M206782,43,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.76,20.73,1149.39,89,Complete Response
M206783,81,Female,HPV-related Cancer,mrna-4157 + keytruda,23.32,17.77,1441.9,95,Stable Disease
M206784,69,Female,Melanoma,mrna-4157 + keytruda,38.36,37.85,,77,Unknown
M206785,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,22.16,26.66,406.7,89,Progression
M206786,76,Male,Melanoma,mrna-4157 + keytruda,33.29,24.61,1038.5,84,Partial Response
M206787,30,Female,HPV-related Cancer,mrna-4157 + keytruda,30.41,33.09,1313.72,81,Unknown
M206788,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.74,,237.1,110,Partial Response
M206789,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.87,67.02,1379.12,81,Stable Disease
M206790,63,Other,Melanoma,KEYTRUDA only,32.7,21.22,818.96,92,Stable Disease
M206791,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.55,28.17,1162.15,93,Partial Response
M206792,55,Other,HPV-related Cancer,KEYTRUDA only,28.08,26.09,1155.53,78,Stable Disease
M206793,64,Male,Melanoma,mrna-4157 + keytruda,25.69,19.94,887.58,97,Stable Disease
M206794,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.96,25.55,484.05,95,
M206795,36,Other,HPV-related Cancer,mrna-4157 + keytruda,40.64,31.79,1029.13,91,Partial Response
M206796,55,Female,HPV-related Cancer,KEYTRUDA only,32.61,36.47,1347.3,73,Complete Response
M206797,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.24,16.78,516.93,89,Progression
M206798,25,Female,HPV-related Cancer,KEYTRUDA only,54.66,48.59,1002.27,87,Partial Response
M206799,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.75,40.02,406.58,80,Progression
M206800,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.96,35.76,1439.1,70,Partial Response
M206801,50,Female,HPV-related Cancer,mrna-4157 + keytruda,8.13,7.32,1120.9,103,Stable Disease
M206802,54,Other,Melanoma,mrna-4157 + keytruda,49.29,38.41,1435.44,90,Partial Response
M206803,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.75,25.57,1941.13,103,Partial Response
M206804,61,Female,Melanoma,KEYTRUDA only,15.48,10.56,909.32,81,
M206805,56,Male,Melanoma,mrna-4157 + keytruda,32.22,28.52,682.52,113,Stable Disease
M206806,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.36,36.35,1149.98,86,Partial Response
M206807,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.6,18.04,291.37,88,Stable Disease
M206808,40,Female,HPV-related Cancer,mrna-4157 + keytruda,52.9,54.69,734.8,86,Progression
M206809,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.28,60.36,1886.14,86,Stable Disease
M206810,37,Other,Melanoma,mrna-4157 + keytruda,51.43,44.98,871.9,96,Stable Disease
M206811,30,Female,Melanoma,KEYTRUDA only,32.36,24.16,793.8,88,Partial Response
M206812,37,Other,HPV-related Cancer,mrna-4157 + keytruda,94.1,92.55,547.39,98,Complete Response
M206813,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.6,45.41,353.39,104,Progression
M206814,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.61,18.22,576.57,90,Progression
M206815,72,Female,Melanoma,KEYTRUDA only,36.65,,553.14,99,Progression
M206816,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.21,24.62,1031.05,88,Stable Disease
M206817,61,Male,Melanoma,mrna-4157 + keytruda,73.25,51.63,672.52,89,Progression
M206818,69,Other,Melanoma,mrna-4157 + keytruda,40.55,44.88,357.63,92,Unknown
M206819,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.99,22.46,,90,Progression
M206820,32,Other,Melanoma,KEYTRUDA only,44.01,44.35,1142.54,90,Partial Response
M206821,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.33,15.08,99.5,97,Partial Response
M206822,33,Other,HPV-related Cancer,KEYTRUDA only,39.73,31.66,1075.45,91,Stable Disease
M206823,73,Other,Melanoma,KEYTRUDA only,61.31,60.39,1318.29,92,Progression
M206824,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.07,35.25,1521.68,86,Progression
M206825,49,Female,HPV-related Cancer,mrna-4157 + keytruda,68.43,51.55,1328.98,106,Progression
M206826,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.69,22.72,1316.66,77,Progression
M206827,62,Male,HPV-related Cancer,KEYTRUDA only,47.69,37.58,1260.71,96,Complete Response
M206828,26,Male,HPV-related Cancer,KEYTRUDA only,63.83,37.77,1138.69,105,
M206829,79,Other,HPV-related Cancer,KEYTRUDA only,67.53,57.18,1506.7,88,Partial Response
M206830,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.6,29.8,1635.45,109,Progression
M206831,56,Male,Melanoma,KEYTRUDA only,34.68,30.93,484.38,92,Progression
M206832,30,Female,HPV-related Cancer,mrna-4157 + keytruda,32.76,30.52,713.86,72,Partial Response
M206833,48,Other,Melanoma,KEYTRUDA only,68.71,51.62,678.22,73,Stable Disease
M206834,61,Other,HPV-related Cancer,mrna-4157 + keytruda,69.61,43.61,655.92,96,Partial Response
M206835,26,Female,HPV-related Cancer,KEYTRUDA only,26.52,29.39,590.8,99,Stable Disease
M206836,27,Male,Melanoma,KEYTRUDA only,52.58,25.55,1612.69,91,Partial Response
M206837,59,Other,Melanoma,KEYTRUDA only,16.56,16.3,786.43,95,Stable Disease
M206838,55,Male,HPV-related Cancer,KEYTRUDA only,50.53,37.22,741.6,93,Complete Response
M206839,29,Female,Melanoma,mrna-4157 + keytruda,13.73,10.28,1431.18,80,Progression
M206840,36,Male,HPV-related Cancer,KEYTRUDA only,56.36,,1163.9,94,Stable Disease
M206841,40,Other,HPV-related Cancer,mrna-4157 + keytruda,43.53,35.99,838.04,86,Partial Response
M206842,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.81,44.03,,83,Partial Response
M206843,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.25,49.68,1425.17,81,Stable Disease
M206844,84,Female,Melanoma,mrna-4157 + keytruda,32.56,18.85,988.29,86,Progression
M206845,44,Male,HPV-related Cancer,KEYTRUDA only,86.13,43.09,442.51,94,Stable Disease
M206846,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,71.59,57.06,1336.31,108,Partial Response
M206847,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.66,50.04,1082.86,87,Stable Disease
M206848,61,Other,HPV-related Cancer,mrna-4157 + keytruda,34.98,24.62,1211.48,89,Stable Disease
M206849,47,Male,Non-small Cell Lung Cancer,KEYTRUDA only,36.68,39.14,1783.44,85,
M206850,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.98,10.62,1060.53,106,Unknown
M206851,51,Other,Melanoma,KEYTRUDA only,43.31,34.71,1030.4,75,Stable Disease
M206852,72,Other,HPV-related Cancer,mrna-4157 + keytruda,50.79,38.62,1051.27,86,Partial Response
M206853,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.39,23.21,996.27,82,Stable Disease
M206854,69,Other,Melanoma,KEYTRUDA only,19.51,12.38,1489.62,92,Progression
M206855,41,Female,Melanoma,KEYTRUDA only,70.72,19.87,770.95,96,Stable Disease
M206856,46,Male,HPV-related Cancer,mrna-4157 + keytruda,32.79,34.15,,94,Partial Response
M206857,83,Female,Non-small Cell Lung Cancer,KEYTRUDA only,7.74,5.64,968.4,81,Complete Response
M206858,65,Male,HPV-related Cancer,KEYTRUDA only,39.2,23.86,1419.01,101,Progression
M206859,56,Male,Melanoma,mrna-4157 + keytruda,36.17,23.52,946.14,93,Progression
M206860,84,Female,HPV-related Cancer,KEYTRUDA only,36.4,22.92,760.85,96,Stable Disease
M206861,68,Female,Melanoma,KEYTRUDA only,27.59,26.43,219.4,74,Partial Response
M206862,71,Female,Melanoma,mrna-4157 + keytruda,32.91,22.02,638.7,93,Progression
M206863,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.21,48.0,851.56,100,Progression
M206864,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.73,20.14,709.2,76,Partial Response
M206865,52,Other,Melanoma,mrna-4157 + keytruda,70.56,72.41,837.97,103,Partial Response
M206866,60,Male,HPV-related Cancer,mrna-4157 + keytruda,31.48,21.52,892.01,83,Progression
M206867,84,Male,Melanoma,mrna-4157 + keytruda,49.25,51.53,779.0,105,Stable Disease
M206868,28,Other,Melanoma,mrna-4157 + keytruda,53.83,50.55,1149.68,100,Progression
M206869,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.05,46.87,1499.6,88,Stable Disease
M206870,41,Male,HPV-related Cancer,KEYTRUDA only,54.2,44.81,1025.36,95,Partial Response
M206871,80,Female,Melanoma,mrna-4157 + keytruda,69.04,59.49,856.58,85,Stable Disease
M206872,76,Other,Melanoma,KEYTRUDA only,36.81,19.58,787.27,94,Progression
M206873,56,Female,Melanoma,KEYTRUDA only,32.31,25.86,841.21,88,Complete Response
M206874,31,Male,Melanoma,mrna-4157 + keytruda,60.23,34.39,795.44,90,Progression
M206875,61,Other,HPV-related Cancer,mrna-4157 + keytruda,30.21,27.72,759.67,95,Partial Response
M206876,44,Female,HPV-related Cancer,mrna-4157 + keytruda,52.36,58.72,880.96,83,Unknown
M206877,77,Male,Melanoma,mrna-4157 + keytruda,32.96,19.27,,99,Stable Disease
M206878,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.33,37.64,1733.13,92,Progression
M206879,49,Male,HPV-related Cancer,mrna-4157 + keytruda,23.38,20.81,1612.43,100,Complete Response
M206880,40,Male,Melanoma,KEYTRUDA only,37.81,30.74,1399.91,86,Stable Disease
M206881,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.0,45.32,1412.95,84,Stable Disease
M206882,80,Other,HPV-related Cancer,mrna-4157 + keytruda,21.81,22.52,,86,Complete Response
M206883,70,Female,HPV-related Cancer,KEYTRUDA only,45.24,28.58,638.84,111,Progression
M206884,64,Male,Melanoma,mrna-4157 + keytruda,76.67,61.58,,89,Partial Response
M206885,65,Female,Melanoma,mrna-4157 + keytruda,31.79,17.53,1736.15,86,Partial Response
M206886,43,Male,HPV-related Cancer,mrna-4157 + keytruda,51.8,38.05,996.6,89,Stable Disease
M206887,48,Other,Melanoma,mrna-4157 + keytruda,29.4,21.45,1108.06,86,Partial Response
M206888,34,Other,HPV-related Cancer,mrna-4157 + keytruda,54.63,39.89,1039.46,94,Partial Response
M206889,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.31,38.78,700.43,87,Partial Response
M206890,53,Female,Melanoma,mrna-4157 + keytruda,48.11,49.33,694.71,89,Partial Response
M206891,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.31,31.24,1386.08,88,Progression
M206892,36,Other,HPV-related Cancer,mrna-4157 + keytruda,40.57,37.77,678.22,97,Partial Response
M206893,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.77,36.83,1635.62,97,Stable Disease
M206894,46,Female,Melanoma,KEYTRUDA only,64.79,57.66,1187.08,84,Stable Disease
M206895,29,Other,HPV-related Cancer,mrna-4157 + keytruda,71.86,62.32,891.03,95,Partial Response
M206896,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.93,31.59,845.01,89,Complete Response
M206897,60,Female,Melanoma,mrna-4157 + keytruda,70.02,85.9,435.57,92,Partial Response
M206898,32,Other,Melanoma,KEYTRUDA only,33.34,32.48,776.84,90,Partial Response
M206899,56,Female,Non-small Cell Lung Cancer,KEYTRUDA only,25.31,25.72,1524.79,99,Partial Response
M206900,31,Male,Melanoma,KEYTRUDA only,46.01,41.1,1177.33,98,Unknown
M206901,52,Male,Melanoma,KEYTRUDA only,47.15,40.5,710.34,92,Stable Disease
M206902,71,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.33,21.59,1097.79,102,Stable Disease
M206903,56,Male,HPV-related Cancer,mrna-4157 + keytruda,16.62,8.83,1594.32,96,Partial Response
M206904,51,Other,Melanoma,KEYTRUDA only,67.55,54.96,1752.86,80,Partial Response
M206905,74,Other,HPV-related Cancer,mrna-4157 + keytruda,66.99,49.61,1054.15,81,Stable Disease
M206906,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.86,58.9,1504.28,84,Progression
M206907,74,Female,Melanoma,mrna-4157 + keytruda,19.06,16.08,1658.47,81,Complete Response
M206908,41,Other,Melanoma,mrna-4157 + keytruda,93.28,100.79,719.99,77,Stable Disease
M206909,77,Female,HPV-related Cancer,mrna-4157 + keytruda,62.98,38.24,913.58,75,Stable Disease
M206910,39,Other,HPV-related Cancer,mrna-4157 + keytruda,50.63,42.34,737.6,78,Progression
M206911,38,Other,HPV-related Cancer,KEYTRUDA only,40.61,34.8,1136.59,92,Complete Response
M206912,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.98,50.01,1000.06,96,Progression
M206913,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,117.84,89.64,865.1,77,Stable Disease
M206914,68,Female,HPV-related Cancer,mrna-4157 + keytruda,69.71,51.85,699.67,94,Partial Response
M206915,37,Female,Melanoma,mrna-4157 + keytruda,39.34,34.87,729.19,96,Partial Response
M206916,44,Male,HPV-related Cancer,mrna-4157 + keytruda,56.47,54.45,1239.2,81,Stable Disease
M206917,60,Female,HPV-related Cancer,mrna-4157 + keytruda,70.59,36.68,1094.71,103,Stable Disease
M206918,48,Female,Melanoma,mrna-4157 + keytruda,50.73,40.97,1431.77,80,Unknown
M206919,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.12,12.38,,90,Partial Response
M206920,32,Female,HPV-related Cancer,KEYTRUDA only,67.33,57.68,790.72,95,Partial Response
M206921,48,Male,Melanoma,mrna-4157 + keytruda,51.93,41.16,935.35,73,Stable Disease
M206922,52,Male,HPV-related Cancer,mrna-4157 + keytruda,45.92,31.61,1683.49,94,Progression
M206923,58,Female,HPV-related Cancer,KEYTRUDA only,74.43,74.31,624.33,91,Complete Response
M206924,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.77,52.69,1102.76,90,Complete Response
M206925,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.37,46.91,1222.52,110,Stable Disease
M206926,42,Other,HPV-related Cancer,KEYTRUDA only,52.86,37.6,315.36,88,Partial Response
M206927,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.86,28.71,625.93,87,Complete Response
M206928,49,Other,Melanoma,mrna-4157 + keytruda,46.97,42.62,1366.82,79,Stable Disease
M206929,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.28,31.36,1048.96,85,Stable Disease
M206930,81,Female,HPV-related Cancer,KEYTRUDA only,55.64,58.28,607.39,81,Partial Response
M206931,78,Female,HPV-related Cancer,mrna-4157 + keytruda,15.88,17.31,1152.85,79,Unknown
M206932,40,Male,HPV-related Cancer,KEYTRUDA only,60.87,50.15,858.25,101,Stable Disease
M206933,31,Female,Melanoma,KEYTRUDA only,33.8,18.67,1429.03,95,Stable Disease
M206934,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.29,13.48,277.83,89,Stable Disease
M206935,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.77,49.48,671.65,88,Stable Disease
M206936,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.63,50.18,1727.62,92,Stable Disease
M206937,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.61,43.57,1343.18,102,Progression
M206938,82,Male,Melanoma,mrna-4157 + keytruda,37.36,30.69,1594.26,92,Partial Response
M206939,74,Female,HPV-related Cancer,KEYTRUDA only,31.11,25.04,1275.22,90,Stable Disease
M206940,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.1,67.52,680.04,101,Progression
M206941,75,Male,Melanoma,mrna-4157 + keytruda,25.64,21.63,584.28,84,Stable Disease
M206942,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.72,54.7,586.32,93,Progression
M206943,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.08,27.9,1271.47,72,Progression
M206944,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.1,29.65,1270.58,100,Stable Disease
M206945,57,Male,Melanoma,mrna-4157 + keytruda,70.34,,582.02,75,Stable Disease
M206946,56,Male,HPV-related Cancer,mrna-4157 + keytruda,39.36,29.35,744.96,95,Partial Response
M206947,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,101.59,86.39,638.06,95,Unknown
M206948,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.24,55.69,1028.71,100,Complete Response
M206949,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.33,48.83,534.82,97,Stable Disease
M206950,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.01,39.2,769.65,84,Complete Response
M206951,77,Other,HPV-related Cancer,KEYTRUDA only,40.37,30.79,501.33,96,Stable Disease
M206952,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,80.38,60.72,1019.57,90,Stable Disease
M206953,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.46,40.26,1783.35,84,Stable Disease
M206954,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.07,37.95,1266.37,105,Complete Response
M206955,66,Male,HPV-related Cancer,mrna-4157 + keytruda,58.02,86.31,1258.88,88,Stable Disease
M206956,31,Female,Melanoma,KEYTRUDA only,20.76,12.65,366.17,94,Progression
M206957,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.02,51.57,1585.2,69,Stable Disease
M206958,57,Female,Melanoma,mrna-4157 + keytruda,81.92,68.09,,94,Progression
M206959,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.7,48.12,1047.42,80,Progression
M206960,54,Other,HPV-related Cancer,KEYTRUDA only,59.44,35.83,937.28,84,Complete Response
M206961,60,Other,HPV-related Cancer,KEYTRUDA only,40.65,27.77,447.1,80,Stable Disease
M206962,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.04,37.24,1350.39,98,Complete Response
M206963,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.44,60.95,810.73,95,Complete Response
M206964,61,Male,HPV-related Cancer,mrna-4157 + keytruda,50.42,56.21,1062.26,91,Complete Response
M206965,84,Other,HPV-related Cancer,mrna-4157 + keytruda,34.0,25.1,581.04,101,Partial Response
M206966,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.77,9.17,460.47,79,Progression
M206967,27,Male,HPV-related Cancer,KEYTRUDA only,49.61,42.77,739.36,78,Partial Response
M206968,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.13,57.03,395.7,88,Stable Disease
M206969,29,Other,Melanoma,KEYTRUDA only,58.66,,1153.05,89,Stable Disease
M206970,34,Male,HPV-related Cancer,mrna-4157 + keytruda,33.52,26.1,936.3,92,Partial Response
M206971,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,3.6,2.51,762.16,77,Complete Response
M206972,26,Other,Melanoma,mrna-4157 + keytruda,51.33,28.2,-193.13,104,Complete Response
M206973,61,Other,Melanoma,mrna-4157 + keytruda,49.42,51.82,559.43,86,Stable Disease
M206974,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.77,19.41,1142.85,72,Stable Disease
M206975,28,Male,Melanoma,KEYTRUDA only,46.93,41.92,1278.18,78,Progression
M206976,41,Other,HPV-related Cancer,mrna-4157 + keytruda,52.66,20.74,1928.77,81,Stable Disease
M206977,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.67,15.97,1646.92,87,Progression
M206978,43,Male,Melanoma,mrna-4157 + keytruda,28.38,19.35,499.45,94,Partial Response
M206979,69,Other,Melanoma,mrna-4157 + keytruda,33.13,22.8,1536.72,107,Complete Response
M206980,39,Male,Melanoma,KEYTRUDA only,20.32,14.49,391.38,87,Stable Disease
M206981,60,Female,Melanoma,mrna-4157 + keytruda,32.85,23.13,1187.15,103,
M206982,60,Other,HPV-related Cancer,mrna-4157 + keytruda,65.93,18.62,416.44,83,Progression
M206983,57,Female,Melanoma,mrna-4157 + keytruda,32.91,19.22,1065.06,110,Progression
M206984,82,Male,HPV-related Cancer,KEYTRUDA only,35.79,22.43,980.4,99,Progression
M206985,61,Female,Melanoma,mrna-4157 + keytruda,23.97,18.59,627.27,62,Progression
M206986,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.4,38.64,985.22,83,Stable Disease
M206987,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.33,22.59,689.28,99,Stable Disease
M206988,56,Male,Melanoma,mrna-4157 + keytruda,62.96,59.6,445.72,90,Stable Disease
M206989,60,Female,HPV-related Cancer,KEYTRUDA only,39.12,35.85,236.11,82,Stable Disease
M206990,78,Female,Melanoma,mrna-4157 + keytruda,55.65,43.49,1201.4,87,Progression
M206991,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.32,27.83,1610.72,77,Partial Response
M206992,59,Female,HPV-related Cancer,mrna-4157 + keytruda,50.24,49.79,1367.58,106,Partial Response
M206993,84,Male,HPV-related Cancer,mrna-4157 + keytruda,72.63,65.5,1237.27,72,Stable Disease
M206994,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.0,,1212.97,86,Progression
M206995,36,Other,HPV-related Cancer,KEYTRUDA only,46.5,40.0,710.97,96,Partial Response
M206996,52,Other,HPV-related Cancer,KEYTRUDA only,40.51,34.97,1257.02,93,Stable Disease
M206997,84,Male,HPV-related Cancer,mrna-4157 + keytruda,40.66,33.87,669.38,91,Partial Response
M206998,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.37,,406.65,89,Complete Response
M206999,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.43,46.32,1852.4,102,Stable Disease
M207000,41,Female,HPV-related Cancer,KEYTRUDA only,58.74,53.83,954.51,92,Stable Disease
M207001,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.29,34.53,774.29,89,Partial Response
M207002,84,Female,Melanoma,mrna-4157 + keytruda,56.93,36.64,975.55,81,Stable Disease
M207003,73,Other,HPV-related Cancer,KEYTRUDA only,61.0,47.83,357.3,81,Partial Response
M207004,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.2,52.18,1187.26,82,Partial Response
M207005,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,13.29,8.49,605.2,81,Complete Response
M207006,56,Female,HPV-related Cancer,mrna-4157 + keytruda,63.58,71.17,1331.84,71,Partial Response
M207007,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,5.57,,1046.43,91,Progression
M207008,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.73,54.41,1586.58,66,Partial Response
M207009,40,Female,HPV-related Cancer,mrna-4157 + keytruda,27.37,14.53,954.13,100,Stable Disease
M207010,47,Female,HPV-related Cancer,mrna-4157 + keytruda,31.01,23.68,716.14,80,Unknown
M207011,83,Female,Melanoma,KEYTRUDA only,44.86,47.2,836.04,78,Stable Disease
M207012,48,Other,HPV-related Cancer,KEYTRUDA only,93.8,67.16,1011.84,80,Partial Response
M207013,57,Other,Melanoma,mrna-4157 + keytruda,43.24,39.54,214.71,81,Partial Response
M207014,80,Female,Melanoma,mrna-4157 + keytruda,36.46,16.82,913.67,89,Partial Response
M207015,44,Other,HPV-related Cancer,mrna-4157 + keytruda,41.62,21.65,832.4,100,Partial Response
M207016,26,Male,HPV-related Cancer,KEYTRUDA only,41.77,26.77,1053.36,90,Progression
M207017,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.71,43.46,754.75,89,Progression
M207018,83,Male,Melanoma,KEYTRUDA only,26.53,19.8,,108,Progression
M207019,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.57,39.82,1454.76,88,Complete Response
M207020,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.86,47.29,2082.6,92,Partial Response
M207021,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.5,27.49,738.34,80,Stable Disease
M207022,77,Male,HPV-related Cancer,KEYTRUDA only,68.64,72.48,1604.83,84,Complete Response
M207023,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,61.64,47.82,1018.09,100,Complete Response
M207024,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.81,34.26,961.91,89,Stable Disease
M207025,56,Female,HPV-related Cancer,mrna-4157 + keytruda,20.59,20.31,1193.4,84,Stable Disease
M207026,49,Female,Melanoma,KEYTRUDA only,49.3,53.51,870.79,98,Stable Disease
M207027,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.89,38.41,1646.44,72,Partial Response
M207028,34,Other,HPV-related Cancer,mrna-4157 + keytruda,55.17,52.73,560.5,84,Partial Response
M207029,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.49,19.26,977.05,84,Partial Response
M207030,48,Male,Melanoma,mrna-4157 + keytruda,54.56,26.62,595.28,99,Partial Response
M207031,34,Female,HPV-related Cancer,mrna-4157 + keytruda,49.13,52.77,1093.64,93,Partial Response
M207032,43,Other,Melanoma,mrna-4157 + keytruda,45.39,46.36,676.88,84,Stable Disease
M207033,33,Female,Melanoma,KEYTRUDA only,15.43,15.89,961.61,92,Partial Response
M207034,80,Other,HPV-related Cancer,KEYTRUDA only,52.51,39.96,964.51,99,Progression
M207035,72,Male,HPV-related Cancer,mrna-4157 + keytruda,-11.81,-11.52,727.19,98,Complete Response
M207036,47,Male,HPV-related Cancer,mrna-4157 + keytruda,58.2,50.51,507.06,74,Complete Response
M207037,51,Other,HPV-related Cancer,mrna-4157 + keytruda,28.28,29.39,856.6,89,Progression
M207038,84,Other,HPV-related Cancer,mrna-4157 + keytruda,16.9,12.12,229.33,85,Complete Response
M207039,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.17,55.3,870.84,78,Partial Response
M207040,52,Male,HPV-related Cancer,KEYTRUDA only,9.49,7.77,1747.61,92,Complete Response
M207041,42,Male,HPV-related Cancer,KEYTRUDA only,18.52,20.42,1230.21,90,Stable Disease
M207042,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.37,66.85,1163.7,82,Progression
M207043,62,Female,Melanoma,KEYTRUDA only,27.27,31.91,740.28,86,Progression
M207044,50,Male,HPV-related Cancer,KEYTRUDA only,35.81,18.9,1518.28,102,Stable Disease
M207045,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.96,,663.77,79,Partial Response
M207046,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.57,45.32,1402.58,81,Complete Response
M207047,79,Female,Melanoma,mrna-4157 + keytruda,50.56,36.41,965.93,90,Complete Response
M207048,25,Other,Melanoma,KEYTRUDA only,99.61,82.61,706.38,95,Partial Response
M207049,84,Male,Melanoma,KEYTRUDA only,69.08,51.71,947.18,92,Stable Disease
M207050,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.15,,583.38,102,Partial Response
M207051,39,Female,HPV-related Cancer,mrna-4157 + keytruda,126.83,101.56,852.92,89,Partial Response
M207052,73,Male,HPV-related Cancer,mrna-4157 + keytruda,42.54,22.27,841.91,94,Stable Disease
M207053,78,Male,HPV-related Cancer,mrna-4157 + keytruda,64.17,33.37,1118.03,91,Complete Response
M207054,78,Other,Melanoma,mrna-4157 + keytruda,41.5,31.87,,88,Stable Disease
M207055,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.69,,,88,Unknown
M207056,45,Other,Melanoma,mrna-4157 + keytruda,35.89,24.13,1226.16,83,Partial Response
M207057,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,5.51,4.04,1116.76,92,Partial Response
M207058,43,Female,HPV-related Cancer,mrna-4157 + keytruda,14.47,11.29,1395.73,93,Stable Disease
M207059,47,Other,HPV-related Cancer,KEYTRUDA only,33.84,24.02,1198.17,91,Partial Response
M207060,54,Male,Melanoma,mrna-4157 + keytruda,49.87,36.69,475.14,96,Stable Disease
M207061,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.74,49.14,1745.53,104,Complete Response
M207062,27,Female,Melanoma,mrna-4157 + keytruda,84.12,64.92,933.64,89,Partial Response
M207063,69,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.2,34.75,,105,Partial Response
M207064,82,Other,HPV-related Cancer,KEYTRUDA only,43.83,52.26,572.75,94,Partial Response
M207065,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.07,17.92,662.43,98,Complete Response
M207066,48,Other,HPV-related Cancer,mrna-4157 + keytruda,23.24,16.36,557.22,96,Unknown
M207067,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.23,29.28,1662.5,82,Complete Response
M207068,48,Female,Melanoma,mrna-4157 + keytruda,45.81,32.7,1220.46,105,Partial Response
M207069,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.25,28.57,570.0,76,Stable Disease
M207070,34,Other,HPV-related Cancer,mrna-4157 + keytruda,55.14,25.54,679.03,95,Stable Disease
M207071,51,Male,HPV-related Cancer,KEYTRUDA only,54.66,29.85,,80,Partial Response
M207072,37,Male,Melanoma,KEYTRUDA only,29.45,24.95,565.35,100,Stable Disease
M207073,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.77,40.64,232.49,99,Partial Response
M207074,73,Female,HPV-related Cancer,KEYTRUDA only,66.63,72.13,607.34,98,Stable Disease
M207075,63,Female,Melanoma,KEYTRUDA only,49.35,31.93,229.19,85,Partial Response
M207076,71,Other,HPV-related Cancer,mrna-4157 + keytruda,64.76,35.19,576.92,104,Unknown
M207077,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,28.17,19.42,1595.28,89,Stable Disease
M207078,33,Other,HPV-related Cancer,KEYTRUDA only,31.64,29.13,1181.43,75,Complete Response
M207079,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.06,28.35,1075.33,101,Complete Response
M207080,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.38,39.62,606.26,87,Stable Disease
M207081,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.04,38.1,842.54,93,Stable Disease
M207082,36,Male,HPV-related Cancer,KEYTRUDA only,63.4,62.21,635.93,105,
M207083,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,20.38,19.09,636.75,92,Stable Disease
M207084,46,Male,HPV-related Cancer,KEYTRUDA only,50.83,33.96,1182.65,79,Partial Response
M207085,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.87,29.98,1097.86,75,Complete Response
M207086,58,Other,Melanoma,mrna-4157 + keytruda,73.58,61.34,377.9,88,Partial Response
M207087,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.98,45.09,1148.72,81,Progression
M207088,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.79,34.2,700.9,85,Stable Disease
M207089,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.1,36.91,1213.09,97,Partial Response
M207090,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,81.27,68.09,962.72,102,Stable Disease
M207091,61,Other,Melanoma,mrna-4157 + keytruda,26.35,23.86,1319.2,76,Partial Response
M207092,42,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.79,27.43,1317.13,85,Complete Response
M207093,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,30.62,21.76,502.38,78,Progression
M207094,41,Other,Melanoma,mrna-4157 + keytruda,38.64,42.32,364.8,95,Progression
M207095,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.47,24.16,1539.75,92,Partial Response
M207096,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,85.91,87.39,958.84,87,Progression
M207097,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.02,24.72,1316.93,90,Stable Disease
M207098,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.46,47.73,978.77,92,Progression
M207099,71,Other,HPV-related Cancer,mrna-4157 + keytruda,62.62,65.32,666.69,89,Complete Response
M207100,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.29,31.85,1224.62,82,Stable Disease
M207101,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.43,17.66,518.37,90,Complete Response
M207102,27,Male,HPV-related Cancer,KEYTRUDA only,54.92,28.01,533.45,92,Partial Response
M207103,45,Male,HPV-related Cancer,mrna-4157 + keytruda,61.0,32.6,1037.16,92,Progression
M207104,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.23,51.72,1201.56,82,Stable Disease
M207105,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.3,48.15,1458.7,93,Partial Response
M207106,72,Other,HPV-related Cancer,mrna-4157 + keytruda,18.02,12.53,1116.75,80,Stable Disease
M207107,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.64,46.7,363.16,97,Complete Response
M207108,80,Other,HPV-related Cancer,KEYTRUDA only,56.6,55.81,1873.99,66,Stable Disease
M207109,31,Male,HPV-related Cancer,KEYTRUDA only,25.98,22.84,851.29,78,Partial Response
M207110,74,Female,Melanoma,KEYTRUDA only,43.38,45.81,716.27,97,Stable Disease
M207111,44,Other,Melanoma,KEYTRUDA only,68.46,46.15,1148.39,97,Partial Response
M207112,77,Other,HPV-related Cancer,mrna-4157 + keytruda,65.02,40.3,1941.06,79,Unknown
M207113,48,Female,Melanoma,KEYTRUDA only,77.84,63.34,698.55,99,Stable Disease
M207114,44,Male,HPV-related Cancer,mrna-4157 + keytruda,36.87,34.18,2003.83,96,Unknown
M207115,43,Male,HPV-related Cancer,mrna-4157 + keytruda,1.56,1.35,1034.49,82,Partial Response
M207116,26,Other,HPV-related Cancer,mrna-4157 + keytruda,61.43,53.13,1322.26,83,Stable Disease
M207117,61,Female,HPV-related Cancer,KEYTRUDA only,45.6,31.35,935.36,89,Stable Disease
M207118,36,Female,HPV-related Cancer,KEYTRUDA only,35.27,36.8,1235.13,105,Stable Disease
M207119,70,Other,HPV-related Cancer,mrna-4157 + keytruda,42.88,50.01,1792.34,96,
M207120,72,Other,HPV-related Cancer,mrna-4157 + keytruda,69.19,42.02,1120.6,98,Partial Response
M207121,62,Male,HPV-related Cancer,mrna-4157 + keytruda,60.29,44.07,1700.17,95,Progression
M207122,67,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.29,52.25,1487.38,92,
M207123,47,Other,HPV-related Cancer,KEYTRUDA only,51.43,43.32,1121.05,88,Complete Response
M207124,60,Female,Melanoma,KEYTRUDA only,69.01,35.81,789.94,86,Progression
M207125,51,Male,HPV-related Cancer,mrna-4157 + keytruda,24.98,27.04,581.42,85,Partial Response
M207126,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.06,29.75,1694.17,79,Stable Disease
M207127,77,Other,Melanoma,KEYTRUDA only,48.54,32.36,1509.2,87,Progression
M207128,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.32,,742.03,80,Progression
M207129,57,Male,HPV-related Cancer,KEYTRUDA only,27.98,9.49,1488.49,92,Complete Response
M207130,31,Male,HPV-related Cancer,mrna-4157 + keytruda,60.1,43.53,1226.91,93,Stable Disease
M207131,31,Female,Melanoma,mrna-4157 + keytruda,39.07,28.16,774.04,75,Partial Response
M207132,74,Female,Melanoma,mrna-4157 + keytruda,39.83,18.1,864.45,79,
M207133,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.59,39.42,1319.14,91,Stable Disease
M207134,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.03,34.84,614.31,79,Complete Response
M207135,66,Male,HPV-related Cancer,mrna-4157 + keytruda,75.56,50.58,495.2,98,
M207136,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.02,,,85,Partial Response
M207137,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.73,17.17,850.75,99,Unknown
M207138,68,Other,HPV-related Cancer,KEYTRUDA only,52.71,48.59,808.53,108,Stable Disease
M207139,47,Female,Melanoma,mrna-4157 + keytruda,79.77,,1170.38,103,Progression
M207140,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.7,40.11,252.6,93,Partial Response
M207141,79,Other,Melanoma,KEYTRUDA only,26.16,16.46,598.36,109,Progression
M207142,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.74,40.46,1179.79,81,Progression
M207143,81,Male,HPV-related Cancer,mrna-4157 + keytruda,56.33,56.71,909.47,98,Stable Disease
M207144,76,Male,HPV-related Cancer,mrna-4157 + keytruda,59.56,41.0,496.7,88,Partial Response
M207145,43,Female,Melanoma,KEYTRUDA only,37.37,28.25,378.81,79,Stable Disease
M207146,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.64,55.96,,81,Complete Response
M207147,28,Other,HPV-related Cancer,KEYTRUDA only,53.3,27.86,815.34,89,Unknown
M207148,37,Female,Melanoma,mrna-4157 + keytruda,73.79,61.97,1166.76,87,Stable Disease
M207149,47,Other,HPV-related Cancer,mrna-4157 + keytruda,66.33,49.42,631.45,103,Progression
M207150,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.29,83.12,896.24,85,Complete Response
M207151,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.44,57.54,245.78,89,Complete Response
M207152,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.98,12.1,1160.25,89,Unknown
M207153,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.76,41.06,1716.7,95,Stable Disease
M207154,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.88,56.2,,83,Partial Response
M207155,60,Female,Melanoma,mrna-4157 + keytruda,95.42,101.72,1280.28,83,Stable Disease
M207156,74,Male,HPV-related Cancer,KEYTRUDA only,94.12,79.15,1158.48,94,Unknown
M207157,69,Female,HPV-related Cancer,mrna-4157 + keytruda,68.27,28.18,1091.53,83,Progression
M207158,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.88,32.0,1152.47,85,Progression
M207159,40,Male,HPV-related Cancer,mrna-4157 + keytruda,15.91,9.03,601.34,90,Progression
M207160,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.09,53.24,1403.84,90,Progression
M207161,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.85,39.69,1237.12,81,Progression
M207162,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.05,70.78,1100.4,86,Partial Response
M207163,84,Male,HPV-related Cancer,mrna-4157 + keytruda,44.86,36.44,820.11,79,
M207164,39,Other,Melanoma,mrna-4157 + keytruda,53.0,24.13,500.85,97,Progression
M207165,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,76.5,63.98,922.27,96,Partial Response
M207166,37,Male,Melanoma,mrna-4157 + keytruda,44.95,,805.32,104,Unknown
M207167,69,Female,Melanoma,KEYTRUDA only,42.34,27.98,1162.32,80,Complete Response
M207168,34,Other,Melanoma,mrna-4157 + keytruda,43.19,38.48,973.51,86,Stable Disease
M207169,72,Male,HPV-related Cancer,mrna-4157 + keytruda,86.97,70.13,1478.03,84,Stable Disease
M207170,80,Female,Melanoma,KEYTRUDA only,59.15,60.02,722.45,104,Complete Response
M207171,69,Male,Melanoma,mrna-4157 + keytruda,4.5,2.56,1023.42,85,Stable Disease
M207172,37,Female,HPV-related Cancer,mrna-4157 + keytruda,7.69,6.84,1262.91,68,Partial Response
M207173,52,Male,Melanoma,KEYTRUDA only,31.7,13.49,723.78,83,Progression
M207174,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.16,,1240.32,101,Progression
M207175,55,Female,Melanoma,KEYTRUDA only,65.1,64.71,1056.51,92,Partial Response
M207176,63,Other,Melanoma,mrna-4157 + keytruda,55.94,49.37,700.11,100,Progression
M207177,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,91.23,56.34,1325.79,79,Stable Disease
M207178,70,Other,Melanoma,KEYTRUDA only,9.95,6.23,631.02,59,Stable Disease
M207179,28,Male,HPV-related Cancer,KEYTRUDA only,56.8,58.08,158.71,91,Stable Disease
M207180,58,Female,Melanoma,KEYTRUDA only,42.74,22.25,717.91,95,Progression
M207181,61,Other,HPV-related Cancer,KEYTRUDA only,41.6,16.56,1140.92,99,Complete Response
M207182,39,Male,HPV-related Cancer,mrna-4157 + keytruda,52.44,42.3,845.06,74,Stable Disease
M207183,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.9,50.24,1628.69,81,Stable Disease
M207184,42,Male,Melanoma,mrna-4157 + keytruda,61.55,64.17,1567.13,99,Stable Disease
M207185,37,Female,Melanoma,mrna-4157 + keytruda,48.1,38.55,1131.77,91,Stable Disease
M207186,40,Male,HPV-related Cancer,mrna-4157 + keytruda,65.52,52.65,,97,Partial Response
M207187,39,Female,HPV-related Cancer,mrna-4157 + keytruda,56.12,38.89,1489.69,89,Partial Response
M207188,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.5,49.6,1292.1,88,Progression
M207189,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.32,46.22,92.41,110,Partial Response
M207190,69,Male,HPV-related Cancer,mrna-4157 + keytruda,39.44,36.39,561.12,109,Stable Disease
M207191,80,Female,Melanoma,mrna-4157 + keytruda,94.58,99.23,1097.97,95,Progression
M207192,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.1,29.65,919.92,76,Stable Disease
M207193,75,Other,HPV-related Cancer,mrna-4157 + keytruda,35.29,,1465.59,78,Complete Response
M207194,31,Other,Melanoma,mrna-4157 + keytruda,81.83,25.75,1930.65,90,Complete Response
M207195,44,Female,Melanoma,mrna-4157 + keytruda,38.76,42.07,973.28,99,Partial Response
M207196,69,Male,Melanoma,KEYTRUDA only,42.26,15.01,990.49,91,Stable Disease
M207197,28,Other,HPV-related Cancer,KEYTRUDA only,5.03,3.85,663.99,88,Progression
M207198,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.08,16.5,882.59,69,Progression
M207199,77,Female,Melanoma,KEYTRUDA only,57.85,45.92,621.57,94,Partial Response
M207200,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,92.61,81.35,,74,Complete Response
M207201,58,Other,Melanoma,KEYTRUDA only,45.74,37.16,503.23,74,Partial Response
M207202,64,Male,HPV-related Cancer,mrna-4157 + keytruda,79.81,62.3,867.79,99,Stable Disease
M207203,70,Male,Melanoma,mrna-4157 + keytruda,95.3,68.61,1589.0,96,Complete Response
M207204,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.2,26.45,1611.29,64,Progression
M207205,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.83,40.43,806.85,89,Stable Disease
M207206,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.62,23.79,978.19,95,Progression
M207207,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,47.71,30.16,550.77,76,
M207208,53,Male,Melanoma,KEYTRUDA only,35.08,26.62,1397.39,77,Stable Disease
M207209,56,Male,Melanoma,mrna-4157 + keytruda,40.8,26.74,1904.61,70,Progression
M207210,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.39,51.28,1243.97,121,Progression
M207211,25,Male,HPV-related Cancer,mrna-4157 + keytruda,83.09,,933.66,98,Unknown
M207212,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.48,50.07,1140.19,78,Stable Disease
M207213,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,4.45,3.97,94.25,98,Complete Response
M207214,58,Male,Melanoma,mrna-4157 + keytruda,25.38,24.3,,102,Stable Disease
M207215,73,Female,HPV-related Cancer,mrna-4157 + keytruda,15.19,12.36,1041.78,84,Progression
M207216,44,Male,HPV-related Cancer,KEYTRUDA only,-8.56,-10.08,308.42,82,Partial Response
M207217,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.41,29.91,1222.58,87,Partial Response
M207218,62,Female,Melanoma,KEYTRUDA only,19.66,18.37,1437.14,91,Stable Disease
M207219,45,Other,HPV-related Cancer,mrna-4157 + keytruda,68.18,59.5,1243.21,79,Progression
M207220,60,Female,HPV-related Cancer,mrna-4157 + keytruda,18.73,19.93,1115.47,85,Progression
M207221,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.41,65.95,764.69,105,Complete Response
M207222,69,Other,Melanoma,KEYTRUDA only,2.78,2.09,730.9,91,Stable Disease
M207223,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.09,36.67,1371.37,85,Stable Disease
M207224,51,Other,Melanoma,mrna-4157 + keytruda,49.21,36.54,932.95,82,Complete Response
M207225,69,Female,Melanoma,mrna-4157 + keytruda,43.58,28.61,535.78,75,Complete Response
M207226,79,Female,HPV-related Cancer,KEYTRUDA only,40.44,20.61,1608.69,99,Partial Response
M207227,83,Other,Melanoma,mrna-4157 + keytruda,49.82,,8842.45,92,Progression
M207228,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.46,22.98,1283.09,81,Progression
M207229,42,Other,Melanoma,mrna-4157 + keytruda,75.97,77.38,1329.9,104,Unknown
M207230,76,Other,Melanoma,KEYTRUDA only,53.47,24.23,748.02,93,Stable Disease
M207231,34,Other,Melanoma,KEYTRUDA only,57.56,53.99,1496.51,89,Progression
M207232,75,Female,Melanoma,mrna-4157 + keytruda,44.16,20.33,1010.29,85,
M207233,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.53,34.97,680.6,81,Partial Response
M207234,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.37,39.27,680.18,104,Partial Response
M207235,31,Other,HPV-related Cancer,mrna-4157 + keytruda,29.99,13.94,1477.01,88,Stable Disease
M207236,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.39,7.58,1045.12,116,Complete Response
M207237,39,Other,Melanoma,mrna-4157 + keytruda,40.6,41.03,1292.59,89,Unknown
M207238,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,25.39,29.51,,94,Progression
M207239,45,Male,Melanoma,KEYTRUDA only,38.62,29.63,1368.38,86,Progression
M207240,81,Male,HPV-related Cancer,mrna-4157 + keytruda,54.24,51.2,1100.87,76,Progression
M207241,69,Other,HPV-related Cancer,mrna-4157 + keytruda,87.05,57.6,1347.68,81,Stable Disease
M207242,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,78.34,57.53,1044.4,74,Partial Response
M207243,66,Female,HPV-related Cancer,mrna-4157 + keytruda,19.85,23.74,1127.21,80,Stable Disease
M207244,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.6,28.89,695.12,83,Partial Response
M207245,30,Other,Melanoma,mrna-4157 + keytruda,7.07,6.21,958.25,94,Progression
M207246,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.81,50.02,1870.19,87,Progression
M207247,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,6.95,5.48,911.04,92,Partial Response
M207248,80,Female,HPV-related Cancer,mrna-4157 + keytruda,51.51,42.19,450.19,93,Stable Disease
M207249,45,Other,HPV-related Cancer,KEYTRUDA only,60.68,36.25,461.11,80,Partial Response
M207250,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.71,26.41,875.37,94,Progression
M207251,50,Female,Melanoma,KEYTRUDA only,34.25,25.17,373.64,87,Stable Disease
M207252,27,Female,Melanoma,KEYTRUDA only,61.83,42.26,1646.67,99,Progression
M207253,61,Female,HPV-related Cancer,mrna-4157 + keytruda,65.64,46.41,1610.73,81,Progression
M207254,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.22,,811.06,101,Partial Response
M207255,76,Male,HPV-related Cancer,mrna-4157 + keytruda,39.54,31.65,1678.49,88,Progression
M207256,40,Male,HPV-related Cancer,mrna-4157 + keytruda,51.98,43.99,1166.02,89,Partial Response
M207257,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.73,56.88,506.33,84,Partial Response
M207258,69,Male,HPV-related Cancer,mrna-4157 + keytruda,82.52,79.76,23.07,108,Partial Response
M207259,75,Male,HPV-related Cancer,mrna-4157 + keytruda,47.64,38.45,1106.47,87,Complete Response
M207260,45,Male,HPV-related Cancer,KEYTRUDA only,30.23,28.78,1070.68,89,Stable Disease
M207261,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.36,53.66,666.11,90,Stable Disease
M207262,60,Other,Melanoma,KEYTRUDA only,66.99,56.08,1067.87,85,Complete Response
M207263,69,Other,HPV-related Cancer,mrna-4157 + keytruda,48.96,,964.07,81,
M207264,35,Male,Melanoma,mrna-4157 + keytruda,48.72,35.99,1046.15,79,Complete Response
M207265,51,Other,Melanoma,mrna-4157 + keytruda,22.27,17.57,340.78,90,Stable Disease
M207266,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.16,57.03,1506.14,83,Unknown
M207267,26,Male,Melanoma,mrna-4157 + keytruda,75.32,45.26,1199.28,107,Stable Disease
M207268,55,Other,HPV-related Cancer,KEYTRUDA only,20.63,14.36,,86,Stable Disease
M207269,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.75,30.57,4455.1,81,Partial Response
M207270,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.9,9.18,529.01,88,Complete Response
M207271,25,Female,Melanoma,mrna-4157 + keytruda,67.4,54.19,1331.97,107,Progression
M207272,36,Male,Melanoma,mrna-4157 + keytruda,41.67,38.97,712.54,87,Partial Response
M207273,40,Male,HPV-related Cancer,KEYTRUDA only,26.28,29.87,570.0,110,Progression
M207274,35,Female,HPV-related Cancer,KEYTRUDA only,39.88,24.38,1190.73,96,Partial Response
M207275,44,Female,HPV-related Cancer,mrna-4157 + keytruda,65.73,78.22,,73,Unknown
M207276,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.81,,573.71,88,Stable Disease
M207277,57,Female,Melanoma,mrna-4157 + keytruda,28.98,,854.85,82,Complete Response
M207278,30,Male,Melanoma,mrna-4157 + keytruda,54.64,27.79,492.54,97,Complete Response
M207279,52,Female,Melanoma,mrna-4157 + keytruda,43.65,25.42,818.69,99,Stable Disease
M207280,61,Other,Melanoma,mrna-4157 + keytruda,63.02,46.69,,90,Stable Disease
M207281,35,Male,Melanoma,mrna-4157 + keytruda,72.33,39.6,771.26,93,Partial Response
M207282,64,Male,HPV-related Cancer,mrna-4157 + keytruda,44.3,22.82,1102.76,84,Partial Response
M207283,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.76,68.17,786.62,74,Stable Disease
M207284,29,Other,HPV-related Cancer,mrna-4157 + keytruda,53.39,26.54,470.92,92,Complete Response
M207285,63,Female,Melanoma,mrna-4157 + keytruda,67.99,61.14,990.95,86,Progression
M207286,43,Female,HPV-related Cancer,mrna-4157 + keytruda,59.51,,727.77,81,Stable Disease
M207287,37,Other,Melanoma,KEYTRUDA only,54.12,47.42,195.28,90,Progression
M207288,57,Other,HPV-related Cancer,mrna-4157 + keytruda,53.92,54.33,722.62,105,Stable Disease
M207289,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.51,37.88,,93,
M207290,28,Male,Melanoma,KEYTRUDA only,42.44,35.28,585.93,86,Partial Response
M207291,63,Female,Melanoma,mrna-4157 + keytruda,39.93,41.94,1551.9,86,Complete Response
M207292,68,Female,HPV-related Cancer,mrna-4157 + keytruda,82.92,85.28,1120.94,107,Partial Response
M207293,34,Female,Melanoma,mrna-4157 + keytruda,79.03,45.16,1037.7,106,Complete Response
M207294,37,Male,Melanoma,mrna-4157 + keytruda,30.53,24.34,1405.74,85,Unknown
M207295,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.26,36.89,1691.39,71,Stable Disease
M207296,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.23,23.68,301.88,85,Stable Disease
M207297,54,Female,Melanoma,mrna-4157 + keytruda,25.97,13.8,1413.21,93,Stable Disease
M207298,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.9,28.57,1072.63,87,Stable Disease
M207299,32,Male,HPV-related Cancer,mrna-4157 + keytruda,21.54,13.78,1149.91,95,Partial Response
M207300,64,Male,Melanoma,mrna-4157 + keytruda,44.82,53.24,882.95,91,Complete Response
M207301,83,Other,HPV-related Cancer,mrna-4157 + keytruda,45.58,46.5,680.82,85,Partial Response
M207302,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.99,22.14,854.32,98,Stable Disease
M207303,30,Female,HPV-related Cancer,KEYTRUDA only,68.27,42.27,1012.05,81,Stable Disease
M207304,62,Female,Melanoma,mrna-4157 + keytruda,13.35,10.89,937.54,108,Partial Response
M207305,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,5.57,5.58,812.57,93,Stable Disease
M207306,40,Male,Melanoma,KEYTRUDA only,62.86,19.36,968.2,94,Complete Response
M207307,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.65,9.79,-391.02,97,Partial Response
M207308,29,Female,Melanoma,mrna-4157 + keytruda,62.58,49.73,520.83,79,Stable Disease
M207309,77,Male,Melanoma,mrna-4157 + keytruda,45.43,34.05,740.65,100,Stable Disease
M207310,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.29,65.87,1090.51,97,Progression
M207311,57,Male,Melanoma,KEYTRUDA only,29.98,20.71,1546.11,83,Progression
M207312,59,Female,Melanoma,mrna-4157 + keytruda,55.11,,1107.36,107,Progression
M207313,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.75,47.08,330.36,88,Partial Response
M207314,80,Other,Melanoma,mrna-4157 + keytruda,45.71,22.54,1481.98,76,Stable Disease
M207315,69,Female,HPV-related Cancer,mrna-4157 + keytruda,49.81,57.02,1245.32,94,Stable Disease
M207316,76,Other,Melanoma,mrna-4157 + keytruda,65.52,,956.87,108,Partial Response
M207317,79,Female,HPV-related Cancer,mrna-4157 + keytruda,67.69,44.89,1372.91,106,Stable Disease
M207318,57,Other,Melanoma,mrna-4157 + keytruda,37.09,33.14,1633.8,86,Progression
M207319,59,Other,Melanoma,mrna-4157 + keytruda,49.66,24.26,1484.36,85,Stable Disease
M207320,69,Other,HPV-related Cancer,mrna-4157 + keytruda,69.29,40.17,,78,Unknown
M207321,47,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.29,18.95,928.84,95,Stable Disease
M207322,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.15,,1199.32,103,Partial Response
M207323,75,Male,HPV-related Cancer,mrna-4157 + keytruda,52.49,24.5,824.64,90,Partial Response
M207324,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.63,49.56,598.17,97,Partial Response
M207325,42,Female,Melanoma,mrna-4157 + keytruda,21.51,16.72,978.14,88,Stable Disease
M207326,62,Other,Melanoma,KEYTRUDA only,46.68,42.86,1442.55,83,Partial Response
M207327,66,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.88,41.25,1100.5,73,Stable Disease
M207328,54,Other,Melanoma,mrna-4157 + keytruda,19.54,17.32,1347.72,98,Stable Disease
M207329,55,Other,HPV-related Cancer,KEYTRUDA only,76.78,,368.82,108,Complete Response
M207330,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,90.12,68.35,-107.06,84,Partial Response
M207331,67,Other,Non-small Cell Lung Cancer,KEYTRUDA only,37.13,23.05,1960.45,83,Progression
M207332,34,Male,HPV-related Cancer,KEYTRUDA only,52.53,35.03,596.37,95,Stable Disease
M207333,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.86,23.06,1194.46,92,Progression
M207334,84,Female,Melanoma,KEYTRUDA only,20.35,16.27,6213.6,86,
M207335,68,Male,HPV-related Cancer,mrna-4157 + keytruda,57.37,54.18,1251.57,84,Complete Response
M207336,78,Other,Melanoma,KEYTRUDA only,36.44,21.69,494.77,87,Stable Disease
M207337,37,Other,HPV-related Cancer,mrna-4157 + keytruda,33.6,12.05,1311.03,100,Complete Response
M207338,35,Female,HPV-related Cancer,mrna-4157 + keytruda,13.4,11.11,864.79,102,Progression
M207339,42,Female,HPV-related Cancer,mrna-4157 + keytruda,38.87,32.32,1393.27,79,Progression
M207340,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.37,43.75,964.62,85,Stable Disease
M207341,36,Male,Melanoma,mrna-4157 + keytruda,9.35,9.29,333.41,77,Stable Disease
M207342,55,Female,HPV-related Cancer,mrna-4157 + keytruda,43.19,,1713.67,90,Partial Response
M207343,34,Other,Melanoma,mrna-4157 + keytruda,48.14,38.88,876.16,88,Partial Response
M207344,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.73,32.01,1080.18,90,Complete Response
M207345,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.52,30.65,1431.26,96,Complete Response
M207346,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.58,,825.73,86,Unknown
M207347,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.85,21.85,1675.77,96,Progression
M207348,78,Male,Melanoma,mrna-4157 + keytruda,24.01,21.78,1082.95,99,Partial Response
M207349,36,Female,HPV-related Cancer,KEYTRUDA only,28.19,23.71,,92,Stable Disease
M207350,37,Female,HPV-related Cancer,KEYTRUDA only,52.74,41.68,710.93,84,Partial Response
M207351,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.58,50.37,1006.54,99,Complete Response
M207352,29,Male,Melanoma,mrna-4157 + keytruda,72.62,79.74,1057.03,88,Complete Response
M207353,36,Other,HPV-related Cancer,KEYTRUDA only,53.88,21.87,222.95,101,Unknown
M207354,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.87,,383.85,89,Partial Response
M207355,41,Female,Melanoma,KEYTRUDA only,38.18,39.65,967.56,94,Progression
M207356,65,Other,HPV-related Cancer,mrna-4157 + keytruda,27.95,25.09,1534.75,109,Partial Response
M207357,35,Female,Melanoma,mrna-4157 + keytruda,35.24,35.09,1387.61,80,Progression
M207358,62,Female,Melanoma,KEYTRUDA only,35.53,37.08,1074.58,87,Complete Response
M207359,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.22,22.25,920.54,89,Stable Disease
M207360,46,Male,Melanoma,KEYTRUDA only,37.53,28.23,1129.01,80,Stable Disease
M207361,46,Male,HPV-related Cancer,mrna-4157 + keytruda,60.05,50.24,1044.47,96,Unknown
M207362,70,Female,HPV-related Cancer,mrna-4157 + keytruda,70.54,65.34,-113.52,91,
M207363,37,Other,HPV-related Cancer,mrna-4157 + keytruda,56.75,19.84,810.47,93,Stable Disease
M207364,71,Male,HPV-related Cancer,mrna-4157 + keytruda,57.25,31.96,1109.37,79,Complete Response
M207365,81,Female,HPV-related Cancer,KEYTRUDA only,86.98,54.93,1379.82,85,Progression
M207366,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.64,41.41,371.45,106,Progression
M207367,28,Female,HPV-related Cancer,KEYTRUDA only,37.43,17.23,859.89,83,Progression
M207368,82,Female,HPV-related Cancer,mrna-4157 + keytruda,6.44,4.88,1190.33,84,Stable Disease
M207369,79,Other,HPV-related Cancer,mrna-4157 + keytruda,71.85,72.19,-80.83,95,Stable Disease
M207370,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.07,14.14,1082.78,89,Stable Disease
M207371,84,Other,Melanoma,mrna-4157 + keytruda,23.85,19.12,979.09,94,Partial Response
M207372,54,Other,Melanoma,KEYTRUDA only,27.37,19.5,1446.21,78,Complete Response
M207373,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.64,25.33,,80,Complete Response
M207374,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.15,31.26,1370.88,93,Complete Response
M207375,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.91,21.67,367.24,93,Progression
M207376,36,Male,HPV-related Cancer,KEYTRUDA only,27.17,20.68,1117.03,88,Complete Response
M207377,49,Male,Melanoma,mrna-4157 + keytruda,56.82,30.9,1152.67,86,Partial Response
M207378,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.91,,421.24,88,Complete Response
M207379,70,Male,HPV-related Cancer,mrna-4157 + keytruda,65.5,41.49,1405.07,93,Partial Response
M207380,39,Male,Melanoma,KEYTRUDA only,40.4,,882.54,99,Complete Response
M207381,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.63,41.64,1457.49,84,Partial Response
M207382,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.47,19.1,1402.78,85,Stable Disease
M207383,66,Male,HPV-related Cancer,KEYTRUDA only,54.32,44.35,1023.95,103,Stable Disease
M207384,33,Male,Melanoma,mrna-4157 + keytruda,104.79,104.74,,89,Stable Disease
M207385,45,Male,HPV-related Cancer,mrna-4157 + keytruda,59.99,,1792.73,98,Progression
M207386,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.28,45.02,719.47,85,Unknown
M207387,80,Other,Melanoma,mrna-4157 + keytruda,56.04,58.39,776.4,104,Partial Response
M207388,32,Other,Melanoma,KEYTRUDA only,10.94,9.96,1163.22,77,Progression
M207389,43,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.57,31.6,958.17,81,Partial Response
M207390,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,87.92,31.1,899.33,96,Complete Response
M207391,58,Female,Melanoma,KEYTRUDA only,87.43,86.48,936.11,76,Progression
M207392,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.18,82.86,1360.77,78,Progression
M207393,82,Male,HPV-related Cancer,KEYTRUDA only,54.12,54.99,935.22,85,Complete Response
M207394,72,Other,Melanoma,KEYTRUDA only,43.14,21.54,1534.12,105,Partial Response
M207395,77,Female,Melanoma,KEYTRUDA only,33.38,19.85,1836.61,78,Complete Response
M207396,76,Female,HPV-related Cancer,KEYTRUDA only,63.74,75.58,844.08,91,Partial Response
M207397,38,Other,Melanoma,KEYTRUDA only,31.92,25.05,1167.38,89,Complete Response
M207398,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.67,28.52,810.64,73,Partial Response
M207399,52,Other,Melanoma,mrna-4157 + keytruda,13.45,11.54,692.39,102,Partial Response
M207400,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.1,22.34,847.4,84,Partial Response
M207401,67,Other,HPV-related Cancer,KEYTRUDA only,41.69,39.5,25.29,78,Partial Response
M207402,79,Female,Melanoma,KEYTRUDA only,48.57,33.28,1527.68,83,Stable Disease
M207403,39,Female,HPV-related Cancer,mrna-4157 + keytruda,20.15,8.79,1255.27,74,Partial Response
M207404,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.8,60.66,1012.76,86,Partial Response
M207405,80,Female,Melanoma,mrna-4157 + keytruda,69.09,64.11,1285.5,114,Stable Disease
M207406,77,Female,Melanoma,KEYTRUDA only,80.32,45.58,1455.6,94,Progression
M207407,35,Male,HPV-related Cancer,mrna-4157 + keytruda,75.03,47.28,1268.49,86,Partial Response
M207408,28,Female,Melanoma,KEYTRUDA only,75.84,64.3,752.7,77,Stable Disease
M207409,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.85,28.84,1042.25,89,Progression
M207410,78,Female,Melanoma,KEYTRUDA only,35.17,24.8,449.94,110,Progression
M207411,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,81.05,66.2,1594.42,80,Complete Response
M207412,41,Other,Melanoma,mrna-4157 + keytruda,56.78,45.58,1361.87,100,Complete Response
M207413,68,Male,Melanoma,mrna-4157 + keytruda,35.99,35.56,1091.78,81,Partial Response
M207414,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.73,23.76,1152.75,94,Progression
M207415,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.19,44.11,1335.9,93,Partial Response
M207416,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.22,72.32,642.58,107,Progression
M207417,42,Other,HPV-related Cancer,KEYTRUDA only,45.76,41.87,1958.36,86,Progression
M207418,69,Other,Melanoma,mrna-4157 + keytruda,41.38,47.85,1253.58,93,Stable Disease
M207419,59,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.59,36.06,541.12,81,Stable Disease
M207420,67,Other,Melanoma,mrna-4157 + keytruda,18.75,18.7,597.84,101,Progression
M207421,82,Other,HPV-related Cancer,KEYTRUDA only,65.38,67.7,645.93,84,Partial Response
M207422,34,Female,HPV-related Cancer,mrna-4157 + keytruda,11.67,9.1,990.39,92,Stable Disease
M207423,54,Other,HPV-related Cancer,mrna-4157 + keytruda,48.66,28.6,800.99,82,Stable Disease
M207424,43,Other,HPV-related Cancer,mrna-4157 + keytruda,29.38,18.49,1300.87,96,Stable Disease
M207425,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.49,35.74,995.08,95,Progression
M207426,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.82,36.0,5023.75,85,Stable Disease
M207427,41,Female,HPV-related Cancer,mrna-4157 + keytruda,57.32,49.27,1194.62,101,Partial Response
M207428,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.3,50.7,690.84,76,Complete Response
M207429,29,Other,HPV-related Cancer,KEYTRUDA only,64.04,48.38,751.64,92,Stable Disease
M207430,27,Female,Melanoma,KEYTRUDA only,63.96,64.16,1291.61,83,Stable Disease
M207431,39,Male,Melanoma,mrna-4157 + keytruda,58.88,37.92,794.31,92,Partial Response
M207432,76,Male,Melanoma,KEYTRUDA only,58.83,38.89,1088.85,89,Stable Disease
M207433,63,Male,Melanoma,KEYTRUDA only,11.69,11.96,978.15,99,Complete Response
M207434,78,Male,HPV-related Cancer,KEYTRUDA only,58.29,49.85,1143.83,82,Partial Response
M207435,80,Male,Melanoma,mrna-4157 + keytruda,45.58,30.04,814.96,100,Stable Disease
M207436,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.26,46.09,1467.44,83,Progression
M207437,41,Male,HPV-related Cancer,mrna-4157 + keytruda,68.77,78.4,651.11,99,Progression
M207438,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,21.8,24.07,1549.04,103,Stable Disease
M207439,37,Other,Melanoma,mrna-4157 + keytruda,50.6,31.6,913.02,84,Partial Response
M207440,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.76,33.4,758.59,102,Stable Disease
M207441,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,4.56,1.52,1394.06,103,Progression
M207442,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.4,,494.2,95,Partial Response
M207443,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.76,46.5,1037.15,91,Stable Disease
M207444,40,Other,HPV-related Cancer,KEYTRUDA only,29.27,25.26,858.13,91,Partial Response
M207445,64,Other,Melanoma,KEYTRUDA only,49.57,22.18,809.89,109,Partial Response
M207446,61,Female,Melanoma,KEYTRUDA only,58.29,31.58,1405.65,84,Partial Response
M207447,37,Other,HPV-related Cancer,mrna-4157 + keytruda,41.13,41.48,1276.1,75,Partial Response
M207448,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.13,23.83,-30.29,93,Progression
M207449,41,Female,Melanoma,mrna-4157 + keytruda,29.97,28.09,,83,Stable Disease
M207450,40,Female,HPV-related Cancer,KEYTRUDA only,65.79,37.17,1308.5,108,Stable Disease
M207451,32,Female,Melanoma,KEYTRUDA only,34.16,27.4,606.22,99,Partial Response
M207452,81,Male,HPV-related Cancer,mrna-4157 + keytruda,78.06,66.56,922.62,83,Partial Response
M207453,38,Other,Melanoma,mrna-4157 + keytruda,67.93,61.7,1294.99,85,Unknown
M207454,25,Other,HPV-related Cancer,mrna-4157 + keytruda,74.8,30.39,1261.04,84,Stable Disease
M207455,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,75.19,73.65,1201.04,100,Partial Response
M207456,29,Female,HPV-related Cancer,mrna-4157 + keytruda,89.29,79.87,1140.68,90,Stable Disease
M207457,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,72.26,62.44,1177.52,82,Complete Response
M207458,53,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.72,22.67,1132.07,98,Progression
M207459,75,Male,Melanoma,mrna-4157 + keytruda,44.71,,965.1,113,Stable Disease
M207460,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.1,26.35,1109.98,103,Complete Response
M207461,79,Other,Melanoma,KEYTRUDA only,28.99,28.46,,86,Partial Response
M207462,39,Other,HPV-related Cancer,mrna-4157 + keytruda,56.68,45.27,,91,Partial Response
M207463,65,Female,HPV-related Cancer,mrna-4157 + keytruda,64.29,42.01,285.23,104,Progression
M207464,31,Other,Melanoma,KEYTRUDA only,69.22,57.22,1004.91,88,Partial Response
M207465,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.68,51.82,505.26,104,Partial Response
M207466,50,Other,Melanoma,KEYTRUDA only,80.36,51.0,892.46,86,Partial Response
M207467,67,Female,Melanoma,KEYTRUDA only,50.38,47.27,1188.12,119,Progression
M207468,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.7,45.19,37.98,105,Stable Disease
M207469,46,Male,Melanoma,mrna-4157 + keytruda,48.9,44.2,215.96,87,Complete Response
M207470,52,Male,HPV-related Cancer,mrna-4157 + keytruda,69.24,41.92,203.4,105,Progression
M207471,59,Other,HPV-related Cancer,mrna-4157 + keytruda,31.62,27.64,,95,Stable Disease
M207472,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.2,48.99,1325.84,90,Complete Response
M207473,42,Female,Melanoma,mrna-4157 + keytruda,17.17,12.3,455.84,82,Complete Response
M207474,50,Female,HPV-related Cancer,mrna-4157 + keytruda,67.42,52.39,709.89,97,Partial Response
M207475,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.89,28.82,1483.14,111,Partial Response
M207476,83,Other,Melanoma,KEYTRUDA only,52.98,38.71,1712.7,108,
M207477,52,Male,HPV-related Cancer,KEYTRUDA only,14.66,10.41,1231.36,83,Complete Response
M207478,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,21.17,,1334.01,93,Stable Disease
M207479,51,Female,HPV-related Cancer,KEYTRUDA only,41.8,37.73,1169.66,101,Stable Disease
M207480,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.55,45.84,1446.92,97,Partial Response
M207481,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,76.19,44.23,1298.96,96,Stable Disease
M207482,74,Other,HPV-related Cancer,mrna-4157 + keytruda,76.15,44.55,946.67,85,Stable Disease
M207483,44,Female,Melanoma,mrna-4157 + keytruda,86.2,51.33,377.34,78,
M207484,44,Male,HPV-related Cancer,mrna-4157 + keytruda,36.49,25.09,816.0,80,Stable Disease
M207485,45,Other,HPV-related Cancer,KEYTRUDA only,73.97,67.99,1405.71,89,Partial Response
M207486,82,Male,Melanoma,mrna-4157 + keytruda,57.58,,,86,Stable Disease
M207487,42,Other,Melanoma,mrna-4157 + keytruda,34.27,17.16,1080.11,92,Stable Disease
M207488,31,Female,Melanoma,KEYTRUDA only,17.84,13.12,1348.01,84,Partial Response
M207489,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.58,40.87,1143.67,99,Partial Response
M207490,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.32,,796.43,101,Partial Response
M207491,38,Male,HPV-related Cancer,KEYTRUDA only,68.37,52.21,1014.0,106,Stable Disease
M207492,51,Male,Melanoma,KEYTRUDA only,40.07,30.17,1143.49,94,Unknown
M207493,36,Female,Melanoma,mrna-4157 + keytruda,28.8,27.91,640.86,92,Progression
M207494,44,Female,HPV-related Cancer,mrna-4157 + keytruda,66.17,56.62,964.03,93,Partial Response
M207495,56,Female,HPV-related Cancer,mrna-4157 + keytruda,32.42,19.32,1831.38,80,Partial Response
M207496,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.57,34.45,1015.11,76,Partial Response
M207497,51,Male,Melanoma,mrna-4157 + keytruda,48.29,40.46,922.52,95,Stable Disease
M207498,43,Female,Melanoma,KEYTRUDA only,41.2,46.43,1620.48,80,Partial Response
M207499,32,Other,HPV-related Cancer,mrna-4157 + keytruda,45.27,31.75,633.69,82,Partial Response
M207500,37,Other,HPV-related Cancer,mrna-4157 + keytruda,43.63,40.03,214.68,87,Progression
M207501,51,Female,Melanoma,KEYTRUDA only,64.96,47.36,1665.1,97,Complete Response
M207502,49,Male,Melanoma,mrna-4157 + keytruda,43.11,21.97,882.72,81,Progression
M207503,39,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.62,22.4,1087.47,82,Complete Response
M207504,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.52,46.99,1065.86,104,Stable Disease
M207505,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.69,28.81,637.83,86,Partial Response
M207506,32,Male,Melanoma,KEYTRUDA only,56.94,39.09,1235.55,96,Partial Response
M207507,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.75,21.03,655.54,83,Stable Disease
M207508,61,Male,Melanoma,mrna-4157 + keytruda,71.45,80.34,76.76,76,Progression
M207509,84,Other,Melanoma,mrna-4157 + keytruda,25.4,16.12,802.06,98,Stable Disease
M207510,79,Male,Melanoma,KEYTRUDA only,56.98,69.6,1445.68,101,Unknown
M207511,73,Male,HPV-related Cancer,mrna-4157 + keytruda,52.98,43.58,641.75,96,Partial Response
M207512,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.23,13.72,678.26,73,Unknown
M207513,43,Male,HPV-related Cancer,KEYTRUDA only,37.36,15.09,1155.7,94,Progression
M207514,70,Other,HPV-related Cancer,mrna-4157 + keytruda,53.84,57.38,879.06,88,Unknown
M207515,25,Other,HPV-related Cancer,mrna-4157 + keytruda,26.45,20.44,1153.04,95,Stable Disease
M207516,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,12.61,10.72,1507.64,93,Partial Response
M207517,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,22.39,22.48,836.82,88,Partial Response
M207518,39,Female,Melanoma,mrna-4157 + keytruda,26.12,10.34,773.78,92,Partial Response
M207519,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.73,66.96,1169.85,87,
M207520,51,Other,Melanoma,KEYTRUDA only,38.53,29.03,930.79,94,Stable Disease
M207521,65,Other,HPV-related Cancer,KEYTRUDA only,36.05,28.2,1395.37,84,Partial Response
M207522,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.8,58.15,1433.92,73,Stable Disease
M207523,76,Male,Melanoma,KEYTRUDA only,11.73,6.73,1343.0,95,Partial Response
M207524,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.03,43.5,1475.32,91,Unknown
M207525,28,Female,HPV-related Cancer,mrna-4157 + keytruda,62.76,39.43,1569.33,96,Progression
M207526,72,Male,Melanoma,KEYTRUDA only,29.66,32.79,1191.34,86,Partial Response
M207527,68,Female,HPV-related Cancer,mrna-4157 + keytruda,58.24,48.29,1075.64,85,Partial Response
M207528,41,Male,Melanoma,KEYTRUDA only,60.33,55.58,1049.66,91,Partial Response
M207529,74,Female,HPV-related Cancer,KEYTRUDA only,25.94,22.21,,112,Partial Response
M207530,25,Other,HPV-related Cancer,KEYTRUDA only,62.68,49.48,798.96,91,Progression
M207531,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.98,74.01,622.23,82,Partial Response
M207532,67,Other,HPV-related Cancer,KEYTRUDA only,44.08,41.25,1410.46,102,
M207533,68,Male,Melanoma,mrna-4157 + keytruda,86.0,86.61,,89,Partial Response
M207534,42,Other,HPV-related Cancer,KEYTRUDA only,16.6,6.6,356.04,91,Unknown
M207535,37,Other,Melanoma,mrna-4157 + keytruda,66.35,57.74,1390.13,79,Progression
M207536,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-20.92,-17.39,994.61,86,Stable Disease
M207537,77,Other,Melanoma,mrna-4157 + keytruda,58.44,52.02,1400.96,91,Unknown
M207538,76,Male,HPV-related Cancer,mrna-4157 + keytruda,39.86,21.05,1796.43,92,Progression
M207539,57,Female,Melanoma,mrna-4157 + keytruda,40.97,21.95,719.52,108,Stable Disease
M207540,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.31,54.83,1295.02,87,Stable Disease
M207541,72,Male,Melanoma,mrna-4157 + keytruda,35.13,31.79,,96,Partial Response
M207542,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.84,108.02,922.5,79,Stable Disease
M207543,42,Male,HPV-related Cancer,mrna-4157 + keytruda,51.78,51.27,1564.92,82,Partial Response
M207544,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.97,40.45,,97,Stable Disease
M207545,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.75,31.39,906.18,87,Stable Disease
M207546,33,Female,HPV-related Cancer,KEYTRUDA only,37.52,29.36,1576.81,99,Partial Response
M207547,66,Male,HPV-related Cancer,KEYTRUDA only,70.55,52.53,920.72,83,Complete Response
M207548,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.6,69.97,1060.69,79,Stable Disease
M207549,42,Other,Melanoma,mrna-4157 + keytruda,73.69,68.99,,96,Partial Response
M207550,31,Female,Melanoma,mrna-4157 + keytruda,78.54,68.02,827.85,88,Stable Disease
M207551,33,Other,HPV-related Cancer,mrna-4157 + keytruda,45.86,28.21,515.19,79,Progression
M207552,69,Female,Melanoma,KEYTRUDA only,35.41,,1499.78,98,Partial Response
M207553,63,Other,HPV-related Cancer,mrna-4157 + keytruda,27.91,15.25,1076.1,86,Stable Disease
M207554,56,Other,Melanoma,KEYTRUDA only,11.2,12.93,1089.18,89,Stable Disease
M207555,37,Male,Melanoma,mrna-4157 + keytruda,60.78,55.16,890.61,101,Stable Disease
M207556,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.86,,619.03,102,Partial Response
M207557,79,Female,Melanoma,mrna-4157 + keytruda,64.74,30.7,791.97,95,Stable Disease
M207558,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.51,21.49,731.03,105,Partial Response
M207559,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.68,19.72,1187.46,99,Complete Response
M207560,75,Other,Melanoma,KEYTRUDA only,36.55,42.98,1081.47,95,Stable Disease
M207561,60,Female,HPV-related Cancer,mrna-4157 + keytruda,64.86,,1865.34,98,Progression
M207562,52,Male,HPV-related Cancer,mrna-4157 + keytruda,59.51,38.74,,82,Stable Disease
M207563,42,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.91,26.66,554.18,72,Partial Response
M207564,33,Female,HPV-related Cancer,mrna-4157 + keytruda,60.94,63.85,1165.16,94,Stable Disease
M207565,76,Male,Melanoma,mrna-4157 + keytruda,51.76,31.63,646.32,89,Stable Disease
M207566,59,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.55,,968.49,78,Stable Disease
M207567,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.76,18.26,905.09,68,Progression
M207568,47,Male,Non-small Cell Lung Cancer,KEYTRUDA only,76.92,53.01,1700.47,99,Progression
M207569,64,Other,Melanoma,KEYTRUDA only,57.61,75.6,429.71,83,Partial Response
M207570,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.12,18.54,400.8,95,Progression
M207571,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.77,26.26,1210.36,98,Partial Response
M207572,67,Female,Melanoma,KEYTRUDA only,15.69,11.16,1462.58,78,Partial Response
M207573,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,81.5,64.41,1564.19,105,Progression
M207574,75,Female,Melanoma,mrna-4157 + keytruda,43.25,29.22,1536.69,95,Progression
M207575,30,Female,HPV-related Cancer,KEYTRUDA only,87.07,96.43,200.6,100,Unknown
M207576,51,Female,HPV-related Cancer,mrna-4157 + keytruda,57.15,59.12,1241.64,78,Unknown
M207577,76,Other,Melanoma,mrna-4157 + keytruda,53.48,39.85,1349.64,92,
M207578,39,Male,Melanoma,mrna-4157 + keytruda,32.18,20.67,423.79,108,Stable Disease
M207579,30,Male,Melanoma,mrna-4157 + keytruda,50.44,35.93,918.73,100,Complete Response
M207580,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.98,65.96,554.79,85,
M207581,58,Female,Melanoma,KEYTRUDA only,65.41,34.4,1741.51,98,Partial Response
M207582,66,Other,Melanoma,KEYTRUDA only,48.35,26.32,1925.66,84,Stable Disease
M207583,74,Other,HPV-related Cancer,mrna-4157 + keytruda,24.03,18.04,1233.7,85,Stable Disease
M207584,56,Female,Melanoma,mrna-4157 + keytruda,23.97,21.77,325.85,88,Progression
M207585,38,Other,HPV-related Cancer,mrna-4157 + keytruda,28.58,23.33,1156.85,80,Stable Disease
M207586,41,Other,Melanoma,KEYTRUDA only,71.72,59.36,1208.68,89,Partial Response
M207587,29,Other,HPV-related Cancer,KEYTRUDA only,57.06,51.44,1156.72,85,
M207588,26,Female,Melanoma,mrna-4157 + keytruda,44.92,35.93,728.25,96,Complete Response
M207589,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.89,89.16,1912.49,103,Unknown
M207590,30,Female,HPV-related Cancer,KEYTRUDA only,63.36,57.81,992.82,84,Stable Disease
M207591,41,Other,Melanoma,KEYTRUDA only,26.69,10.55,71.0,92,Stable Disease
M207592,50,Other,Melanoma,KEYTRUDA only,37.8,18.98,2111.91,77,Partial Response
M207593,56,Female,Melanoma,KEYTRUDA only,40.55,24.77,1453.41,99,Partial Response
M207594,71,Other,Melanoma,KEYTRUDA only,85.35,,735.89,104,Progression
M207595,58,Female,HPV-related Cancer,mrna-4157 + keytruda,43.02,36.16,928.93,91,Partial Response
M207596,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,84.04,83.2,723.26,87,Complete Response
M207597,35,Other,HPV-related Cancer,mrna-4157 + keytruda,20.8,15.49,1023.05,78,Stable Disease
M207598,57,Female,HPV-related Cancer,mrna-4157 + keytruda,90.67,84.26,974.33,87,Progression
M207599,44,Female,HPV-related Cancer,KEYTRUDA only,21.4,25.53,1010.23,93,Partial Response
M207600,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.76,91.49,1054.66,97,Stable Disease
M207601,51,Male,HPV-related Cancer,mrna-4157 + keytruda,50.27,52.27,956.21,81,Partial Response
M207602,51,Other,HPV-related Cancer,KEYTRUDA only,43.42,41.37,1905.75,105,Stable Disease
M207603,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.29,34.0,833.83,93,Partial Response
M207604,57,Male,Melanoma,mrna-4157 + keytruda,19.04,22.82,1120.03,70,Stable Disease
M207605,61,Female,Melanoma,KEYTRUDA only,52.19,42.51,511.55,87,Complete Response
M207606,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.53,39.25,1497.73,89,Partial Response
M207607,55,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.39,60.37,174.09,86,Partial Response
M207608,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.38,21.08,884.82,66,Unknown
M207609,76,Female,Melanoma,KEYTRUDA only,60.18,55.44,1243.17,89,Progression
M207610,52,Male,HPV-related Cancer,KEYTRUDA only,67.18,39.94,764.3,69,
M207611,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,94.71,65.95,1203.74,93,Stable Disease
M207612,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.3,36.46,1582.92,105,
M207613,73,Other,Melanoma,mrna-4157 + keytruda,68.3,47.12,,94,Complete Response
M207614,39,Other,HPV-related Cancer,mrna-4157 + keytruda,27.08,17.57,1197.88,111,Complete Response
M207615,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.05,53.56,983.13,82,
M207616,73,Male,Melanoma,mrna-4157 + keytruda,60.88,51.64,1397.72,93,Progression
M207617,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.19,40.64,279.99,77,Progression
M207618,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.37,37.16,505.01,82,Partial Response
M207619,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.68,77.08,1082.21,77,Stable Disease
M207620,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,51.57,47.38,161.64,96,Partial Response
M207621,46,Female,HPV-related Cancer,mrna-4157 + keytruda,42.31,34.6,1289.49,92,Stable Disease
M207622,51,Female,Melanoma,mrna-4157 + keytruda,59.84,53.06,1070.95,90,Partial Response
M207623,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.38,24.16,1042.73,92,Stable Disease
M207624,54,Female,Melanoma,KEYTRUDA only,59.86,46.24,581.69,97,Stable Disease
M207625,40,Male,Melanoma,mrna-4157 + keytruda,73.29,62.2,,80,Partial Response
M207626,26,Female,HPV-related Cancer,mrna-4157 + keytruda,44.13,37.25,1087.99,101,Partial Response
M207627,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.06,11.4,539.09,110,Partial Response
M207628,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.14,58.12,1011.89,94,Stable Disease
M207629,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.43,55.49,1038.41,84,Partial Response
M207630,61,Other,Melanoma,KEYTRUDA only,55.07,33.62,1724.04,87,Partial Response
M207631,29,Other,Melanoma,mrna-4157 + keytruda,57.47,42.3,574.12,95,Partial Response
M207632,47,Other,HPV-related Cancer,mrna-4157 + keytruda,42.55,38.92,666.76,94,Partial Response
M207633,50,Female,Melanoma,KEYTRUDA only,70.14,60.24,1647.58,89,Partial Response
M207634,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.33,34.14,265.36,99,Partial Response
M207635,34,Other,Melanoma,KEYTRUDA only,33.75,29.34,1009.37,84,Partial Response
M207636,78,Other,HPV-related Cancer,KEYTRUDA only,36.65,28.39,1032.49,105,Stable Disease
M207637,40,Male,HPV-related Cancer,mrna-4157 + keytruda,42.4,33.29,693.84,78,Stable Disease
M207638,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.94,54.24,807.97,92,Partial Response
M207639,81,Male,Non-small Cell Lung Cancer,KEYTRUDA only,92.14,37.89,855.01,105,Progression
M207640,50,Female,Melanoma,KEYTRUDA only,31.95,20.33,469.66,87,Partial Response
M207641,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.73,57.36,1171.21,85,
M207642,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.07,57.03,801.6,92,Partial Response
M207643,55,Female,HPV-related Cancer,mrna-4157 + keytruda,79.87,75.17,1070.53,89,Partial Response
M207644,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.22,,1427.42,96,Partial Response
M207645,43,Female,Non-small Cell Lung Cancer,KEYTRUDA only,-0.28,-0.15,386.7,103,Stable Disease
M207646,64,Female,HPV-related Cancer,mrna-4157 + keytruda,28.92,15.02,,85,Partial Response
M207647,56,Male,Melanoma,mrna-4157 + keytruda,23.96,15.79,1147.0,106,Complete Response
M207648,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.62,62.79,1210.27,89,Stable Disease
M207649,70,Male,Melanoma,mrna-4157 + keytruda,79.84,70.78,719.84,84,Complete Response
M207650,25,Female,Melanoma,KEYTRUDA only,50.55,34.0,838.66,101,Complete Response
M207651,77,Other,Melanoma,mrna-4157 + keytruda,33.04,32.22,873.99,90,Partial Response
M207652,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,95.38,85.29,1526.27,108,Stable Disease
M207653,63,Male,HPV-related Cancer,mrna-4157 + keytruda,60.78,65.59,1223.88,80,Stable Disease
M207654,66,Other,Melanoma,KEYTRUDA only,56.18,49.4,1350.38,98,Partial Response
M207655,37,Female,HPV-related Cancer,mrna-4157 + keytruda,58.05,44.61,826.38,67,Progression
M207656,60,Other,Melanoma,KEYTRUDA only,77.04,74.28,551.48,101,Stable Disease
M207657,82,Other,HPV-related Cancer,mrna-4157 + keytruda,79.53,68.34,1248.99,84,Partial Response
M207658,61,Male,HPV-related Cancer,mrna-4157 + keytruda,53.09,13.11,183.08,87,Partial Response
M207659,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.28,45.95,857.44,101,Partial Response
M207660,76,Other,HPV-related Cancer,mrna-4157 + keytruda,43.02,40.35,1321.18,96,Partial Response
M207661,57,Female,Melanoma,KEYTRUDA only,90.42,44.16,1080.67,82,Stable Disease
M207662,54,Female,HPV-related Cancer,mrna-4157 + keytruda,57.53,38.22,381.27,81,Progression
M207663,33,Male,Melanoma,KEYTRUDA only,22.32,16.05,388.96,92,Complete Response
M207664,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.83,44.33,,77,Progression
M207665,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.25,64.55,439.32,87,Progression
M207666,79,Female,HPV-related Cancer,KEYTRUDA only,69.02,52.37,761.18,101,Stable Disease
M207667,84,Male,Melanoma,mrna-4157 + keytruda,63.3,56.96,1458.85,103,Stable Disease
M207668,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,78.99,71.02,987.84,87,Complete Response
M207669,69,Other,HPV-related Cancer,mrna-4157 + keytruda,40.72,31.8,1222.73,90,Unknown
M207670,42,Male,Melanoma,KEYTRUDA only,66.98,,1495.47,101,Partial Response
M207671,81,Other,Melanoma,mrna-4157 + keytruda,44.28,28.03,792.59,86,Progression
M207672,60,Female,HPV-related Cancer,KEYTRUDA only,33.78,38.14,809.51,84,Partial Response
M207673,55,Male,HPV-related Cancer,mrna-4157 + keytruda,38.51,24.55,795.98,82,Progression
M207674,59,Female,Melanoma,mrna-4157 + keytruda,90.66,110.41,1342.97,97,
M207675,26,Other,Melanoma,mrna-4157 + keytruda,43.95,40.18,1028.17,92,Progression
M207676,42,Other,Melanoma,mrna-4157 + keytruda,72.77,56.57,327.31,95,Unknown
M207677,80,Other,HPV-related Cancer,mrna-4157 + keytruda,44.7,36.48,1066.11,83,Stable Disease
M207678,28,Male,Melanoma,KEYTRUDA only,53.64,42.56,1161.86,89,Stable Disease
M207679,60,Male,HPV-related Cancer,mrna-4157 + keytruda,42.47,22.46,777.19,87,Partial Response
M207680,38,Male,HPV-related Cancer,mrna-4157 + keytruda,52.46,36.36,1021.65,96,Stable Disease
M207681,44,Male,Melanoma,mrna-4157 + keytruda,78.52,62.97,1293.23,92,Stable Disease
M207682,32,Female,Melanoma,KEYTRUDA only,35.75,27.18,,92,Stable Disease
M207683,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.82,49.17,1066.69,91,Progression
M207684,74,Female,Melanoma,mrna-4157 + keytruda,56.5,53.44,,101,Partial Response
M207685,34,Male,HPV-related Cancer,mrna-4157 + keytruda,35.69,29.17,891.3,78,Complete Response
M207686,29,Male,Melanoma,mrna-4157 + keytruda,40.74,37.24,367.22,83,Stable Disease
M207687,60,Other,HPV-related Cancer,KEYTRUDA only,30.81,20.88,689.34,97,Stable Disease
M207688,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.22,58.79,939.77,73,Complete Response
M207689,34,Male,HPV-related Cancer,mrna-4157 + keytruda,79.51,113.39,-235.48,90,Progression
M207690,37,Female,Melanoma,mrna-4157 + keytruda,85.3,59.19,1230.4,112,Partial Response
M207691,31,Female,Melanoma,KEYTRUDA only,26.44,12.63,774.78,88,Partial Response
M207692,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.72,49.43,718.47,79,Progression
M207693,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.39,20.42,1096.49,97,Stable Disease
M207694,65,Male,Melanoma,mrna-4157 + keytruda,22.43,16.79,1484.85,95,Partial Response
M207695,39,Male,HPV-related Cancer,KEYTRUDA only,54.84,46.22,,97,Unknown
M207696,55,Other,Melanoma,mrna-4157 + keytruda,67.63,66.51,664.64,68,Stable Disease
M207697,65,Female,Melanoma,mrna-4157 + keytruda,59.56,65.76,927.04,87,Partial Response
M207698,52,Other,Melanoma,KEYTRUDA only,47.97,59.66,1952.55,94,Progression
M207699,69,Female,Melanoma,mrna-4157 + keytruda,38.7,32.07,112.3,93,Stable Disease
M207700,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.36,23.37,1478.11,92,Stable Disease
M207701,35,Female,Melanoma,KEYTRUDA only,12.82,6.1,558.77,103,Progression
M207702,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.21,33.89,1267.0,84,Stable Disease
M207703,55,Female,HPV-related Cancer,KEYTRUDA only,54.45,45.73,164.26,84,Complete Response
M207704,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.93,50.7,628.85,81,Stable Disease
M207705,45,Other,Melanoma,KEYTRUDA only,57.8,55.84,635.3,76,Complete Response
M207706,78,Male,Melanoma,KEYTRUDA only,25.86,14.42,1262.55,82,Partial Response
M207707,72,Other,HPV-related Cancer,mrna-4157 + keytruda,81.15,62.5,1582.14,94,Partial Response
M207708,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.95,50.2,1354.34,81,Partial Response
M207709,30,Other,HPV-related Cancer,mrna-4157 + keytruda,54.28,43.84,938.44,82,
M207710,45,Female,HPV-related Cancer,KEYTRUDA only,64.14,75.03,,92,Complete Response
M207711,28,Other,HPV-related Cancer,KEYTRUDA only,30.06,19.77,1133.88,75,Unknown
M207712,29,Other,Melanoma,mrna-4157 + keytruda,10.85,9.42,483.95,90,Unknown
M207713,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.7,50.83,789.25,82,Stable Disease
M207714,71,Male,HPV-related Cancer,mrna-4157 + keytruda,21.51,16.9,1017.04,98,Partial Response
M207715,83,Other,Melanoma,mrna-4157 + keytruda,88.52,74.08,675.03,102,Stable Disease
M207716,48,Female,HPV-related Cancer,mrna-4157 + keytruda,66.09,44.11,,77,Partial Response
M207717,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.19,,463.45,85,Stable Disease
M207718,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.26,44.7,826.42,95,Partial Response
M207719,76,Other,Melanoma,KEYTRUDA only,54.8,38.01,1169.88,97,Progression
M207720,55,Female,Melanoma,mrna-4157 + keytruda,27.37,23.27,272.28,94,Stable Disease
M207721,44,Other,Melanoma,KEYTRUDA only,71.71,72.8,1197.15,93,Complete Response
M207722,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,101.57,107.2,519.75,103,Stable Disease
M207723,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.45,41.72,859.43,94,Stable Disease
M207724,37,Other,Melanoma,mrna-4157 + keytruda,-2.46,-1.33,694.19,88,Stable Disease
M207725,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.4,31.11,937.4,72,Complete Response
M207726,31,Female,Melanoma,KEYTRUDA only,72.58,41.65,1199.06,91,Complete Response
M207727,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.64,48.38,1338.1,97,Progression
M207728,36,Female,HPV-related Cancer,mrna-4157 + keytruda,43.38,34.71,290.1,86,
M207729,32,Female,HPV-related Cancer,mrna-4157 + keytruda,81.92,,1439.68,85,Partial Response
M207730,31,Female,Melanoma,mrna-4157 + keytruda,55.1,43.18,1703.11,104,Stable Disease
M207731,40,Male,HPV-related Cancer,mrna-4157 + keytruda,36.3,24.71,1082.49,79,Stable Disease
M207732,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.6,31.84,681.56,85,Progression
M207733,80,Male,Melanoma,KEYTRUDA only,52.66,46.29,1060.4,80,
M207734,84,Female,HPV-related Cancer,mrna-4157 + keytruda,54.6,45.7,1508.39,100,Stable Disease
M207735,76,Male,Melanoma,mrna-4157 + keytruda,31.47,29.29,433.84,97,Stable Disease
M207736,38,Other,Melanoma,KEYTRUDA only,84.52,92.86,1237.78,106,Partial Response
M207737,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.72,33.64,1968.69,99,Stable Disease
M207738,71,Other,HPV-related Cancer,KEYTRUDA only,41.53,29.65,1130.67,114,Stable Disease
M207739,67,Male,Melanoma,mrna-4157 + keytruda,50.03,31.96,622.58,83,Complete Response
M207740,73,Male,Melanoma,mrna-4157 + keytruda,28.85,30.83,2241.25,98,Partial Response
M207741,46,Female,Melanoma,mrna-4157 + keytruda,65.62,46.29,552.77,89,Partial Response
M207742,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.82,38.98,1457.34,94,Stable Disease
M207743,50,Male,Melanoma,mrna-4157 + keytruda,49.72,,1153.06,89,Partial Response
M207744,50,Male,HPV-related Cancer,mrna-4157 + keytruda,11.07,6.8,1263.93,98,Stable Disease
M207745,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.95,14.74,1548.57,97,Complete Response
M207746,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,-5.46,-1.8,,82,Partial Response
M207747,78,Male,HPV-related Cancer,KEYTRUDA only,42.86,40.57,745.34,97,Stable Disease
M207748,66,Female,HPV-related Cancer,KEYTRUDA only,34.2,,705.15,106,Partial Response
M207749,38,Female,Melanoma,mrna-4157 + keytruda,-1.19,-0.51,1204.11,78,Unknown
M207750,62,Female,HPV-related Cancer,mrna-4157 + keytruda,45.03,23.53,981.54,106,Stable Disease
M207751,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.21,39.73,346.24,96,Stable Disease
M207752,50,Male,HPV-related Cancer,mrna-4157 + keytruda,29.05,34.9,1520.38,71,Partial Response
M207753,83,Other,HPV-related Cancer,KEYTRUDA only,42.4,40.4,1019.89,112,
M207754,35,Other,HPV-related Cancer,KEYTRUDA only,6.42,,1319.88,90,Complete Response
M207755,32,Male,HPV-related Cancer,KEYTRUDA only,44.19,34.01,1631.37,85,Progression
M207756,72,Male,HPV-related Cancer,mrna-4157 + keytruda,57.59,37.74,1243.0,88,Complete Response
M207757,65,Male,Melanoma,mrna-4157 + keytruda,51.7,50.19,,82,Progression
M207758,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.15,68.75,1121.89,81,Stable Disease
M207759,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.4,50.75,1169.91,95,
M207760,46,Other,HPV-related Cancer,mrna-4157 + keytruda,73.32,44.12,1006.32,99,Stable Disease
M207761,56,Male,HPV-related Cancer,mrna-4157 + keytruda,72.51,76.87,767.12,74,Progression
M207762,78,Female,Melanoma,mrna-4157 + keytruda,60.88,29.75,953.12,78,Partial Response
M207763,39,Male,Melanoma,mrna-4157 + keytruda,70.68,82.01,,95,Progression
M207764,56,Female,Melanoma,mrna-4157 + keytruda,51.6,39.18,1144.6,108,Partial Response
M207765,34,Other,Melanoma,mrna-4157 + keytruda,43.37,36.47,641.33,94,Unknown
M207766,58,Other,HPV-related Cancer,KEYTRUDA only,39.41,47.55,1262.65,87,Progression
M207767,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.2,64.46,1072.36,100,
M207768,43,Female,HPV-related Cancer,KEYTRUDA only,33.49,36.21,1020.03,86,Complete Response
M207769,43,Male,Melanoma,mrna-4157 + keytruda,37.29,25.22,1050.69,93,Progression
M207770,32,Male,Melanoma,KEYTRUDA only,37.37,33.52,601.41,85,Complete Response
M207771,60,Other,HPV-related Cancer,mrna-4157 + keytruda,52.45,39.48,1434.14,86,Stable Disease
M207772,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.09,58.86,918.69,79,Stable Disease
M207773,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.16,62.43,343.76,98,Progression
M207774,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.07,22.7,2232.32,98,Complete Response
M207775,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.31,43.73,446.79,95,Progression
M207776,55,Other,HPV-related Cancer,mrna-4157 + keytruda,42.69,20.8,1551.25,85,
M207777,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,51.54,47.12,983.87,84,Partial Response
M207778,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.87,42.13,412.76,78,Unknown
M207779,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.96,56.78,1639.82,102,Stable Disease
M207780,33,Other,HPV-related Cancer,mrna-4157 + keytruda,61.38,41.42,1414.08,85,Stable Disease
M207781,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.45,69.45,1095.6,80,Unknown
M207782,32,Female,HPV-related Cancer,KEYTRUDA only,42.15,40.58,711.1,81,Partial Response
M207783,74,Other,Melanoma,mrna-4157 + keytruda,39.07,35.32,754.35,93,
M207784,71,Male,HPV-related Cancer,KEYTRUDA only,13.33,7.41,836.03,72,Partial Response
M207785,39,Male,Melanoma,KEYTRUDA only,17.63,20.3,626.63,81,Stable Disease
M207786,41,Other,Melanoma,KEYTRUDA only,-9.0,-6.62,,83,Stable Disease
M207787,27,Other,HPV-related Cancer,mrna-4157 + keytruda,56.67,30.1,401.48,73,Stable Disease
M207788,51,Other,Melanoma,mrna-4157 + keytruda,46.75,,977.56,113,
M207789,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.28,43.73,1303.66,94,Complete Response
M207790,57,Male,HPV-related Cancer,mrna-4157 + keytruda,76.89,75.47,688.78,92,Stable Disease
M207791,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.65,68.96,125.09,106,Complete Response
M207792,27,Male,HPV-related Cancer,mrna-4157 + keytruda,15.99,13.81,1326.95,98,Stable Disease
M207793,47,Male,Melanoma,mrna-4157 + keytruda,62.67,63.0,706.03,91,Partial Response
M207794,79,Other,Melanoma,mrna-4157 + keytruda,60.45,58.66,1204.54,94,
M207795,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.46,39.11,956.98,97,Complete Response
M207796,45,Female,HPV-related Cancer,mrna-4157 + keytruda,19.2,14.03,193.71,105,Partial Response
M207797,47,Male,Melanoma,mrna-4157 + keytruda,110.96,71.01,,101,Partial Response
M207798,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.9,46.65,616.48,77,Partial Response
M207799,36,Other,HPV-related Cancer,mrna-4157 + keytruda,35.6,21.83,1107.4,86,
M207800,32,Male,HPV-related Cancer,mrna-4157 + keytruda,28.08,25.85,964.58,90,Stable Disease
M207801,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.91,37.66,1012.57,85,Stable Disease
M207802,67,Male,HPV-related Cancer,mrna-4157 + keytruda,45.53,29.32,799.25,86,Progression
M207803,67,Male,Melanoma,mrna-4157 + keytruda,42.75,35.0,1228.02,93,Partial Response
M207804,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,81.11,63.51,766.51,93,Stable Disease
M207805,49,Other,HPV-related Cancer,mrna-4157 + keytruda,45.77,33.35,561.28,83,
M207806,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,94.29,,1159.01,84,Unknown
M207807,82,Female,HPV-related Cancer,KEYTRUDA only,35.0,24.37,797.1,89,Unknown
M207808,66,Female,Melanoma,mrna-4157 + keytruda,74.02,51.57,1359.95,78,Stable Disease
M207809,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.45,58.52,979.34,104,Complete Response
M207810,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.21,43.18,886.12,94,Stable Disease
M207811,45,Other,HPV-related Cancer,mrna-4157 + keytruda,28.77,31.7,1471.51,82,Complete Response
M207812,46,Male,Melanoma,KEYTRUDA only,75.54,43.07,1509.54,106,Stable Disease
M207813,64,Other,Melanoma,mrna-4157 + keytruda,34.91,33.36,404.12,94,Partial Response
M207814,80,Female,HPV-related Cancer,mrna-4157 + keytruda,22.24,7.89,1105.35,90,Unknown
M207815,28,Female,HPV-related Cancer,mrna-4157 + keytruda,58.61,67.01,,108,Unknown
M207816,68,Male,HPV-related Cancer,mrna-4157 + keytruda,17.19,18.67,1855.79,95,Stable Disease
M207817,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.86,47.12,1472.18,102,Stable Disease
M207818,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.74,21.48,944.79,100,
M207819,28,Other,Melanoma,KEYTRUDA only,34.57,41.06,707.12,94,Unknown
M207820,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.76,42.52,693.98,94,Unknown
M207821,70,Other,HPV-related Cancer,KEYTRUDA only,55.95,38.27,1627.7,96,
M207822,49,Female,Melanoma,mrna-4157 + keytruda,56.99,33.24,1578.94,88,Partial Response
M207823,51,Male,Melanoma,mrna-4157 + keytruda,52.36,40.18,,93,Stable Disease
M207824,25,Other,Melanoma,mrna-4157 + keytruda,73.66,53.17,904.36,97,Partial Response
M207825,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.81,26.41,1134.95,105,
M207826,67,Female,HPV-related Cancer,mrna-4157 + keytruda,85.84,66.22,519.47,102,Stable Disease
M207827,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.62,49.86,504.0,76,Progression
M207828,70,Other,HPV-related Cancer,mrna-4157 + keytruda,58.34,45.73,1688.93,99,Complete Response
M207829,39,Male,HPV-related Cancer,mrna-4157 + keytruda,23.6,6.99,1074.54,94,Stable Disease
M207830,49,Male,HPV-related Cancer,KEYTRUDA only,68.47,54.25,733.8,81,Stable Disease
M207831,29,Other,HPV-related Cancer,KEYTRUDA only,31.26,37.55,1079.49,99,Partial Response
M207832,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.64,49.12,1068.31,84,Stable Disease
M207833,83,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.64,18.0,825.27,98,Complete Response
M207834,45,Male,Non-small Cell Lung Cancer,KEYTRUDA only,78.82,62.0,398.0,95,Stable Disease
M207835,61,Other,Melanoma,KEYTRUDA only,64.72,74.78,,105,Unknown
M207836,25,Other,HPV-related Cancer,mrna-4157 + keytruda,51.83,41.05,1540.43,109,Progression
M207837,41,Other,HPV-related Cancer,mrna-4157 + keytruda,86.24,60.89,1166.02,91,Partial Response
M207838,71,Female,Melanoma,mrna-4157 + keytruda,48.2,,1112.32,98,Partial Response
M207839,43,Male,Melanoma,KEYTRUDA only,40.75,47.12,1256.81,92,Stable Disease
M207840,73,Female,Melanoma,mrna-4157 + keytruda,31.62,27.18,975.67,90,Partial Response
M207841,27,Female,HPV-related Cancer,mrna-4157 + keytruda,45.17,39.84,1527.8,108,Stable Disease
M207842,60,Other,HPV-related Cancer,KEYTRUDA only,53.53,47.29,995.23,87,Partial Response
M207843,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.97,39.24,556.5,90,Complete Response
M207844,30,Male,Melanoma,mrna-4157 + keytruda,45.22,28.38,829.01,81,Complete Response
M207845,43,Male,HPV-related Cancer,mrna-4157 + keytruda,43.45,42.52,1685.12,96,Progression
M207846,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.44,25.97,1877.86,92,Progression
M207847,27,Female,Melanoma,mrna-4157 + keytruda,34.9,20.65,970.96,92,Progression
M207848,67,Other,HPV-related Cancer,mrna-4157 + keytruda,53.12,41.59,650.48,90,Progression
M207849,77,Other,HPV-related Cancer,KEYTRUDA only,51.0,55.53,1519.81,92,Stable Disease
M207850,65,Other,Melanoma,mrna-4157 + keytruda,72.21,68.58,779.07,90,Unknown
M207851,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,72.87,51.16,1144.13,86,Partial Response
M207852,51,Other,HPV-related Cancer,KEYTRUDA only,59.14,32.76,1690.11,106,Partial Response
M207853,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.49,46.32,1013.1,96,Partial Response
M207854,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.4,49.13,957.3,106,Progression
M207855,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.4,31.89,933.98,96,Progression
M207856,31,Male,HPV-related Cancer,KEYTRUDA only,61.18,72.16,941.68,91,Stable Disease
M207857,55,Other,HPV-related Cancer,mrna-4157 + keytruda,65.7,57.51,1506.88,87,Partial Response
M207858,28,Female,HPV-related Cancer,KEYTRUDA only,69.67,62.04,1074.65,81,Partial Response
M207859,44,Other,Melanoma,mrna-4157 + keytruda,46.84,48.87,886.61,92,Progression
M207860,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.74,75.54,1186.4,87,Complete Response
M207861,51,Other,Melanoma,KEYTRUDA only,76.32,86.53,1207.73,93,Partial Response
M207862,70,Female,Melanoma,KEYTRUDA only,58.03,41.99,-4.16,89,Stable Disease
M207863,66,Other,Non-small Cell Lung Cancer,KEYTRUDA only,12.95,13.02,1015.55,95,
M207864,31,Other,Melanoma,mrna-4157 + keytruda,40.85,,726.38,92,Progression
M207865,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,96.63,61.2,451.7,99,Partial Response
M207866,40,Female,HPV-related Cancer,mrna-4157 + keytruda,74.86,69.53,,77,Complete Response
M207867,72,Female,HPV-related Cancer,KEYTRUDA only,50.89,34.92,1615.56,90,Stable Disease
M207868,50,Other,HPV-related Cancer,mrna-4157 + keytruda,32.08,27.25,,97,Partial Response
M207869,51,Female,HPV-related Cancer,mrna-4157 + keytruda,36.85,23.85,1699.93,80,Unknown
M207870,26,Female,Melanoma,mrna-4157 + keytruda,8.89,6.08,,90,Progression
M207871,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.8,22.27,1271.22,92,Stable Disease
M207872,78,Male,Melanoma,KEYTRUDA only,38.99,19.55,700.69,94,Progression
M207873,79,Male,HPV-related Cancer,mrna-4157 + keytruda,39.31,29.0,842.28,85,Partial Response
M207874,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.62,24.09,755.73,95,Stable Disease
M207875,64,Male,HPV-related Cancer,KEYTRUDA only,76.15,68.58,1695.74,83,Partial Response
M207876,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,85.97,74.69,1249.31,86,Stable Disease
M207877,36,Male,Melanoma,mrna-4157 + keytruda,63.17,56.72,1172.04,87,Partial Response
M207878,69,Female,Melanoma,mrna-4157 + keytruda,78.34,76.43,58.9,95,Stable Disease
M207879,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,36.29,33.19,1278.47,91,Partial Response
M207880,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,56.04,54.05,452.79,112,Stable Disease
M207881,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.27,20.48,500.84,96,Progression
M207882,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.91,52.41,596.27,76,Partial Response
M207883,48,Other,HPV-related Cancer,mrna-4157 + keytruda,63.24,38.55,987.7,79,Stable Disease
M207884,77,Other,HPV-related Cancer,mrna-4157 + keytruda,29.62,19.49,1341.22,92,Complete Response
M207885,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.13,11.94,891.63,82,Progression
M207886,81,Male,HPV-related Cancer,mrna-4157 + keytruda,51.87,,1106.47,91,Partial Response
M207887,63,Other,Melanoma,KEYTRUDA only,65.53,40.45,435.58,92,Partial Response
M207888,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.24,50.21,1158.41,91,Partial Response
M207889,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.79,53.01,1178.96,91,Progression
M207890,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.68,28.55,1608.95,62,Stable Disease
M207891,60,Other,Melanoma,mrna-4157 + keytruda,57.62,,900.06,85,Progression
M207892,27,Other,HPV-related Cancer,mrna-4157 + keytruda,63.87,,1198.85,106,Stable Disease
M207893,59,Other,HPV-related Cancer,mrna-4157 + keytruda,18.45,17.3,1200.96,110,
M207894,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.92,,1050.35,91,Partial Response
M207895,82,Male,Melanoma,mrna-4157 + keytruda,53.32,26.79,517.82,101,Stable Disease
M207896,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.66,63.64,744.68,81,Complete Response
M207897,80,Other,Melanoma,mrna-4157 + keytruda,30.63,30.25,507.76,97,Unknown
M207898,75,Other,Melanoma,mrna-4157 + keytruda,59.75,63.87,1072.03,82,Complete Response
M207899,46,Male,HPV-related Cancer,mrna-4157 + keytruda,38.97,38.22,1509.07,105,Stable Disease
M207900,77,Male,HPV-related Cancer,KEYTRUDA only,39.31,22.39,1010.66,83,Partial Response
M207901,59,Other,HPV-related Cancer,KEYTRUDA only,101.53,101.59,888.85,83,
M207902,58,Male,HPV-related Cancer,mrna-4157 + keytruda,48.78,35.8,634.12,95,Partial Response
M207903,72,Male,HPV-related Cancer,KEYTRUDA only,47.04,42.97,1137.04,78,Stable Disease
M207904,76,Female,Melanoma,mrna-4157 + keytruda,66.0,48.0,497.03,84,
M207905,27,Other,Melanoma,mrna-4157 + keytruda,33.89,27.07,750.66,117,Complete Response
M207906,40,Female,Melanoma,mrna-4157 + keytruda,58.17,47.51,,81,Progression
M207907,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.11,73.51,1625.93,105,Stable Disease
M207908,79,Other,Melanoma,KEYTRUDA only,49.23,57.64,1196.88,89,Unknown
M207909,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.09,27.84,244.7,95,Partial Response
M207910,27,Female,HPV-related Cancer,KEYTRUDA only,65.77,62.96,,88,Progression
M207911,68,Other,Melanoma,mrna-4157 + keytruda,35.99,32.09,559.88,87,Unknown
M207912,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.52,,816.78,90,Stable Disease
M207913,45,Other,Melanoma,KEYTRUDA only,51.65,29.76,350.03,80,Complete Response
M207914,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.53,46.69,1562.37,93,Partial Response
M207915,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.47,75.94,522.49,75,Complete Response
M207916,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.84,36.83,1101.79,92,Partial Response
M207917,52,Male,HPV-related Cancer,KEYTRUDA only,21.92,20.35,966.94,88,Complete Response
M207918,74,Male,HPV-related Cancer,mrna-4157 + keytruda,68.13,41.02,858.06,88,Stable Disease
M207919,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.99,52.74,1383.27,88,Complete Response
M207920,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.59,73.39,1130.89,98,Partial Response
M207921,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.9,58.45,1647.73,84,Complete Response
M207922,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.22,99.91,644.5,93,Progression
M207923,78,Other,Melanoma,KEYTRUDA only,42.73,28.6,875.85,84,Complete Response
M207924,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.54,37.11,1067.75,87,Stable Disease
M207925,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.46,50.61,567.85,80,Unknown
M207926,58,Male,HPV-related Cancer,mrna-4157 + keytruda,40.07,32.84,604.67,98,Partial Response
M207927,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.62,25.68,829.61,93,Complete Response
M207928,73,Male,HPV-related Cancer,KEYTRUDA only,14.43,13.27,809.08,65,Partial Response
M207929,74,Male,HPV-related Cancer,mrna-4157 + keytruda,20.49,14.7,465.57,110,Stable Disease
M207930,56,Male,HPV-related Cancer,KEYTRUDA only,41.6,27.65,834.81,85,Partial Response
M207931,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,96.07,50.52,1586.75,94,Progression
M207932,47,Other,HPV-related Cancer,mrna-4157 + keytruda,26.25,21.57,717.47,79,Complete Response
M207933,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.7,27.39,348.06,92,Progression
M207934,78,Female,HPV-related Cancer,KEYTRUDA only,76.73,78.18,1014.28,99,Progression
M207935,33,Male,HPV-related Cancer,mrna-4157 + keytruda,59.28,43.55,988.23,95,Complete Response
M207936,69,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.59,15.1,888.82,102,Partial Response
M207937,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.92,23.74,1419.84,95,Partial Response
M207938,44,Other,Melanoma,mrna-4157 + keytruda,65.03,32.98,1371.9,79,Stable Disease
M207939,26,Female,HPV-related Cancer,mrna-4157 + keytruda,29.59,22.11,710.78,97,Progression
M207940,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.03,44.63,576.27,71,Partial Response
M207941,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.15,47.38,851.55,119,Stable Disease
M207942,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.89,37.98,,107,Stable Disease
M207943,43,Female,HPV-related Cancer,KEYTRUDA only,64.94,44.04,1512.07,66,Stable Disease
M207944,48,Female,HPV-related Cancer,KEYTRUDA only,29.38,25.47,1136.49,86,Stable Disease
M207945,82,Female,Melanoma,mrna-4157 + keytruda,31.14,26.55,1097.08,87,Stable Disease
M207946,78,Male,HPV-related Cancer,KEYTRUDA only,23.6,20.31,1790.42,100,Complete Response
M207947,54,Female,HPV-related Cancer,mrna-4157 + keytruda,50.8,37.54,794.87,102,Unknown
M207948,75,Other,HPV-related Cancer,mrna-4157 + keytruda,33.41,27.18,961.93,106,Stable Disease
M207949,61,Female,HPV-related Cancer,mrna-4157 + keytruda,28.52,22.77,1360.31,94,Complete Response
M207950,29,Other,HPV-related Cancer,mrna-4157 + keytruda,61.51,68.03,979.33,116,
M207951,57,Female,Melanoma,KEYTRUDA only,55.85,51.63,1045.17,105,Partial Response
M207952,75,Male,Melanoma,mrna-4157 + keytruda,27.67,28.41,407.81,88,Progression
M207953,72,Other,HPV-related Cancer,KEYTRUDA only,58.68,46.74,1397.88,71,Stable Disease
M207954,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.77,75.42,881.21,83,Partial Response
M207955,51,Other,HPV-related Cancer,mrna-4157 + keytruda,54.53,51.91,1952.97,88,Stable Disease
M207956,57,Other,HPV-related Cancer,mrna-4157 + keytruda,35.59,36.85,1027.55,91,Complete Response
M207957,41,Other,Melanoma,mrna-4157 + keytruda,50.17,49.13,656.84,98,Stable Disease
M207958,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.6,,716.24,86,Complete Response
M207959,25,Male,Melanoma,KEYTRUDA only,35.66,26.56,831.64,73,Complete Response
M207960,74,Other,HPV-related Cancer,KEYTRUDA only,38.46,31.96,1476.18,95,Partial Response
M207961,62,Male,HPV-related Cancer,mrna-4157 + keytruda,55.0,47.37,1278.17,81,Partial Response
M207962,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.57,35.11,1744.5,86,Complete Response
M207963,74,Female,HPV-related Cancer,KEYTRUDA only,26.41,21.04,1577.62,85,Partial Response
M207964,73,Other,HPV-related Cancer,mrna-4157 + keytruda,38.14,17.74,1614.18,97,Stable Disease
M207965,69,Male,HPV-related Cancer,mrna-4157 + keytruda,70.63,48.92,1040.36,100,Progression
M207966,37,Male,Melanoma,KEYTRUDA only,89.53,46.09,751.45,80,
M207967,84,Other,HPV-related Cancer,KEYTRUDA only,41.92,,237.2,74,Progression
M207968,48,Female,Melanoma,KEYTRUDA only,59.4,33.54,1750.94,103,Complete Response
M207969,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.79,45.74,1161.29,68,Partial Response
M207970,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,73.25,76.29,,86,Partial Response
M207971,67,Female,HPV-related Cancer,mrna-4157 + keytruda,41.79,40.05,746.8,90,Partial Response
M207972,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.56,35.4,1603.97,85,
M207973,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.34,27.15,721.68,103,Progression
M207974,47,Female,HPV-related Cancer,mrna-4157 + keytruda,45.41,44.28,,102,Progression
M207975,50,Other,HPV-related Cancer,KEYTRUDA only,42.06,32.27,1814.6,106,Stable Disease
M207976,69,Female,HPV-related Cancer,KEYTRUDA only,74.41,70.63,364.98,101,Partial Response
M207977,50,Female,Melanoma,mrna-4157 + keytruda,47.66,49.42,1279.96,77,Progression
M207978,61,Other,Melanoma,mrna-4157 + keytruda,27.88,29.08,355.43,94,Progression
M207979,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,78.95,72.87,798.61,100,Partial Response
M207980,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,80.75,82.89,843.21,92,Complete Response
M207981,48,Female,HPV-related Cancer,KEYTRUDA only,61.81,57.11,1221.26,93,Partial Response
M207982,53,Female,HPV-related Cancer,mrna-4157 + keytruda,73.88,60.77,1061.78,86,Partial Response
M207983,80,Male,HPV-related Cancer,KEYTRUDA only,19.05,15.49,632.95,92,Partial Response
M207984,70,Female,HPV-related Cancer,KEYTRUDA only,77.09,70.16,1163.71,103,Stable Disease
M207985,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.09,31.69,1611.95,86,Partial Response
M207986,80,Other,Melanoma,KEYTRUDA only,40.13,40.94,1472.71,88,Stable Disease
M207987,41,Male,Melanoma,mrna-4157 + keytruda,31.65,28.39,1295.78,83,Progression
M207988,64,Male,HPV-related Cancer,mrna-4157 + keytruda,49.99,64.94,802.41,87,Partial Response
M207989,68,Male,HPV-related Cancer,mrna-4157 + keytruda,64.39,55.78,611.27,83,Partial Response
M207990,32,Female,HPV-related Cancer,KEYTRUDA only,81.73,58.65,1037.26,85,Stable Disease
M207991,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.5,20.95,1130.03,105,Progression
M207992,78,Female,Non-small Cell Lung Cancer,KEYTRUDA only,2.7,2.49,561.55,98,Complete Response
M207993,50,Other,HPV-related Cancer,mrna-4157 + keytruda,63.81,70.12,868.95,107,Stable Disease
M207994,40,Other,Melanoma,mrna-4157 + keytruda,107.4,86.24,672.56,84,Stable Disease
M207995,32,Male,HPV-related Cancer,mrna-4157 + keytruda,62.26,43.93,389.26,84,Complete Response
M207996,33,Other,Melanoma,mrna-4157 + keytruda,47.87,,484.94,94,Partial Response
M207997,39,Female,Melanoma,KEYTRUDA only,42.45,25.99,1266.87,94,Progression
M207998,75,Other,HPV-related Cancer,mrna-4157 + keytruda,77.59,33.08,1534.95,78,Progression
M207999,72,Male,Melanoma,mrna-4157 + keytruda,42.33,24.75,1447.33,101,Progression
M208000,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.94,65.89,1390.1,86,Stable Disease
M208001,83,Male,HPV-related Cancer,mrna-4157 + keytruda,68.7,68.8,702.17,90,Complete Response
M208002,49,Other,HPV-related Cancer,mrna-4157 + keytruda,42.6,38.17,781.75,105,Partial Response
M208003,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.29,11.26,346.09,102,Partial Response
M208004,47,Female,Melanoma,mrna-4157 + keytruda,48.52,34.11,,65,Progression
M208005,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.82,20.66,959.39,85,Partial Response
M208006,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.76,41.6,1827.95,84,Stable Disease
M208007,62,Female,HPV-related Cancer,mrna-4157 + keytruda,35.79,37.78,1288.87,98,Progression
M208008,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.09,40.63,721.4,80,Partial Response
M208009,66,Other,Melanoma,mrna-4157 + keytruda,82.08,57.16,715.62,82,Progression
M208010,46,Female,HPV-related Cancer,KEYTRUDA only,-4.59,-4.91,1406.0,88,Partial Response
M208011,50,Female,HPV-related Cancer,mrna-4157 + keytruda,53.19,43.54,1238.76,101,Partial Response
M208012,34,Other,HPV-related Cancer,mrna-4157 + keytruda,97.23,72.41,2035.91,80,Partial Response
M208013,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.85,15.32,585.41,98,Stable Disease
M208014,43,Female,Melanoma,KEYTRUDA only,34.51,30.41,1470.28,113,Partial Response
M208015,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.87,44.71,352.42,86,Stable Disease
M208016,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.52,17.84,1367.52,83,Stable Disease
M208017,83,Other,Melanoma,KEYTRUDA only,55.5,21.09,1446.76,97,Partial Response
M208018,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.71,36.55,913.97,96,
M208019,31,Female,Melanoma,KEYTRUDA only,8.55,7.02,835.9,94,Stable Disease
M208020,41,Other,HPV-related Cancer,KEYTRUDA only,52.53,45.2,1130.71,92,Partial Response
M208021,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.56,48.07,1163.3,76,
M208022,64,Other,Melanoma,KEYTRUDA only,31.22,24.88,1058.33,88,Stable Disease
M208023,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.2,47.45,83.77,93,Stable Disease
M208024,75,Other,HPV-related Cancer,mrna-4157 + keytruda,64.49,25.76,,79,Progression
M208025,55,Female,HPV-related Cancer,KEYTRUDA only,36.16,31.39,1676.43,88,Progression
M208026,41,Female,HPV-related Cancer,mrna-4157 + keytruda,-4.36,-1.95,,94,
M208027,28,Male,HPV-related Cancer,KEYTRUDA only,30.63,24.13,683.41,73,Partial Response
M208028,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,65.24,53.2,953.71,96,Stable Disease
M208029,44,Female,Melanoma,KEYTRUDA only,47.74,39.61,146.56,82,Stable Disease
M208030,43,Other,Melanoma,mrna-4157 + keytruda,39.91,42.63,785.39,103,Stable Disease
M208031,84,Other,Melanoma,KEYTRUDA only,28.5,21.98,1514.33,87,Partial Response
M208032,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.31,41.62,1124.3,99,Progression
M208033,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.57,49.66,1348.44,85,Stable Disease
M208034,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,76.53,48.73,1153.05,90,Complete Response
M208035,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.74,39.52,1260.06,98,Progression
M208036,84,Other,Melanoma,KEYTRUDA only,68.87,,956.18,87,Complete Response
M208037,78,Female,Melanoma,KEYTRUDA only,4.25,,1054.0,97,Unknown
M208038,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.46,11.7,1587.08,97,Unknown
M208039,40,Other,Melanoma,mrna-4157 + keytruda,69.87,49.9,1312.68,83,Complete Response
M208040,63,Female,HPV-related Cancer,mrna-4157 + keytruda,68.04,48.33,292.27,86,Partial Response
M208041,32,Female,HPV-related Cancer,KEYTRUDA only,56.36,49.88,1165.85,94,Progression
M208042,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.9,18.6,1643.79,94,
M208043,84,Other,HPV-related Cancer,KEYTRUDA only,34.53,30.01,1107.81,99,Stable Disease
M208044,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.29,18.37,,98,Progression
M208045,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.95,37.5,719.1,71,Progression
M208046,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.75,50.45,669.49,79,Stable Disease
M208047,56,Male,HPV-related Cancer,KEYTRUDA only,48.19,36.51,472.26,99,Partial Response
M208048,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.64,66.45,1062.3,101,Complete Response
M208049,53,Other,Melanoma,KEYTRUDA only,56.13,44.06,1726.45,79,Complete Response
M208050,52,Female,Melanoma,mrna-4157 + keytruda,83.76,69.28,1553.95,86,Stable Disease
M208051,43,Male,Melanoma,mrna-4157 + keytruda,58.85,42.47,,89,Partial Response
M208052,34,Female,Melanoma,mrna-4157 + keytruda,55.65,23.71,718.16,104,Progression
M208053,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,56.53,43.74,1383.03,104,Stable Disease
M208054,79,Female,HPV-related Cancer,KEYTRUDA only,58.47,24.39,633.05,95,Stable Disease
M208055,35,Male,Melanoma,KEYTRUDA only,40.97,44.73,718.13,76,Unknown
M208056,45,Male,Melanoma,KEYTRUDA only,61.38,51.31,640.5,83,Progression
M208057,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,8.73,2.31,1183.29,106,Partial Response
M208058,31,Male,HPV-related Cancer,mrna-4157 + keytruda,24.87,22.55,686.95,96,Partial Response
M208059,62,Other,HPV-related Cancer,mrna-4157 + keytruda,54.99,55.89,1291.3,87,Progression
M208060,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,25.76,26.65,,81,Progression
M208061,47,Female,HPV-related Cancer,mrna-4157 + keytruda,68.26,53.79,,83,Complete Response
M208062,63,Other,HPV-related Cancer,mrna-4157 + keytruda,81.31,59.01,,95,Stable Disease
M208063,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.07,36.31,1142.12,81,Partial Response
M208064,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.95,27.26,490.09,77,Partial Response
M208065,64,Male,Melanoma,KEYTRUDA only,76.89,64.86,1354.88,95,Progression
M208066,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.67,,552.72,95,Partial Response
M208067,82,Male,Melanoma,mrna-4157 + keytruda,50.42,52.21,1526.64,86,Stable Disease
M208068,57,Other,HPV-related Cancer,mrna-4157 + keytruda,62.1,30.15,1685.6,93,Partial Response
M208069,32,Female,HPV-related Cancer,KEYTRUDA only,55.46,55.79,1593.98,76,Stable Disease
M208070,74,Male,HPV-related Cancer,mrna-4157 + keytruda,18.99,15.13,1318.54,97,Complete Response
M208071,31,Female,Melanoma,mrna-4157 + keytruda,61.05,32.0,918.55,59,Progression
M208072,77,Male,Melanoma,mrna-4157 + keytruda,34.08,27.78,-88.32,100,Stable Disease
M208073,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.97,62.42,,97,
M208074,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.22,50.73,372.71,99,Partial Response
M208075,80,Other,HPV-related Cancer,mrna-4157 + keytruda,65.16,53.87,1659.1,106,Stable Disease
M208076,29,Female,Melanoma,KEYTRUDA only,84.1,61.45,1326.77,92,Progression
M208077,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.94,39.92,1447.59,85,Progression
M208078,37,Male,Melanoma,mrna-4157 + keytruda,46.68,26.3,463.45,95,Stable Disease
M208079,45,Female,HPV-related Cancer,KEYTRUDA only,57.4,46.4,208.82,99,Stable Disease
M208080,50,Female,Melanoma,mrna-4157 + keytruda,50.73,30.75,1525.3,92,Partial Response
M208081,55,Other,HPV-related Cancer,mrna-4157 + keytruda,89.59,67.61,1391.37,82,Stable Disease
M208082,44,Male,Melanoma,mrna-4157 + keytruda,95.37,75.7,795.23,89,Progression
M208083,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,61.82,55.43,1085.24,104,Complete Response
M208084,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.62,49.82,2043.39,90,Partial Response
M208085,36,Female,Melanoma,mrna-4157 + keytruda,65.9,57.5,312.86,91,Complete Response
M208086,82,Female,Melanoma,mrna-4157 + keytruda,26.17,22.11,229.63,80,Partial Response
M208087,57,Male,HPV-related Cancer,KEYTRUDA only,32.49,25.59,809.78,89,
M208088,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,57.62,48.16,1485.65,79,Stable Disease
M208089,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.33,33.18,1129.45,81,Stable Disease
M208090,54,Female,Melanoma,mrna-4157 + keytruda,67.19,43.29,,91,Complete Response
M208091,76,Other,Melanoma,mrna-4157 + keytruda,45.33,33.17,1057.36,87,Stable Disease
M208092,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.98,32.3,1443.53,86,Progression
M208093,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.61,23.05,296.41,88,Unknown
M208094,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.53,,965.96,101,Stable Disease
M208095,80,Other,HPV-related Cancer,mrna-4157 + keytruda,70.71,30.72,1312.86,97,Partial Response
M208096,50,Female,HPV-related Cancer,KEYTRUDA only,62.36,59.77,1577.81,95,Progression
M208097,65,Female,Melanoma,KEYTRUDA only,63.77,25.8,2163.36,93,Progression
M208098,69,Other,HPV-related Cancer,KEYTRUDA only,36.03,25.31,,109,Stable Disease
M208099,75,Female,HPV-related Cancer,mrna-4157 + keytruda,64.91,,1166.08,87,Partial Response
M208100,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.28,35.06,834.98,109,Stable Disease
M208101,25,Female,HPV-related Cancer,mrna-4157 + keytruda,63.08,32.75,1077.78,92,Stable Disease
M208102,71,Other,Melanoma,mrna-4157 + keytruda,77.5,54.47,978.31,117,Stable Disease
M208103,59,Female,Melanoma,KEYTRUDA only,49.52,49.52,245.57,90,Unknown
M208104,65,Male,Melanoma,mrna-4157 + keytruda,71.71,78.85,1210.6,92,Stable Disease
M208105,71,Female,Melanoma,KEYTRUDA only,29.07,24.79,1019.99,97,Stable Disease
M208106,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.97,26.86,,93,Unknown
M208107,63,Female,HPV-related Cancer,mrna-4157 + keytruda,55.89,28.7,846.5,80,Partial Response
M208108,27,Other,HPV-related Cancer,mrna-4157 + keytruda,20.65,13.02,1170.09,93,Stable Disease
M208109,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.39,55.9,1368.47,91,Complete Response
M208110,55,Female,Melanoma,mrna-4157 + keytruda,44.17,15.37,514.91,90,Stable Disease
M208111,29,Other,HPV-related Cancer,mrna-4157 + keytruda,48.28,23.6,1215.95,89,Progression
M208112,54,Male,HPV-related Cancer,mrna-4157 + keytruda,75.25,96.85,867.06,81,Complete Response
M208113,35,Other,HPV-related Cancer,mrna-4157 + keytruda,49.67,54.93,1124.67,102,Partial Response
M208114,27,Male,HPV-related Cancer,mrna-4157 + keytruda,78.19,72.4,1361.36,87,Partial Response
M208115,77,Male,HPV-related Cancer,KEYTRUDA only,60.44,49.07,1593.62,93,Partial Response
M208116,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.74,32.1,1127.52,81,Progression
M208117,48,Other,Melanoma,mrna-4157 + keytruda,19.24,22.54,845.9,90,Complete Response
M208118,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.49,37.32,1270.91,102,Progression
M208119,57,Female,Melanoma,mrna-4157 + keytruda,84.21,92.54,1992.05,101,Complete Response
M208120,55,Female,HPV-related Cancer,KEYTRUDA only,30.04,31.98,446.96,85,Partial Response
M208121,40,Male,HPV-related Cancer,KEYTRUDA only,30.45,18.0,1426.37,90,Complete Response
M208122,57,Other,HPV-related Cancer,mrna-4157 + keytruda,24.69,21.89,1724.81,96,Partial Response
M208123,60,Female,Melanoma,mrna-4157 + keytruda,40.27,42.92,,75,Unknown
M208124,38,Other,HPV-related Cancer,KEYTRUDA only,57.98,32.3,915.09,100,Progression
M208125,65,Female,HPV-related Cancer,mrna-4157 + keytruda,66.43,41.71,1312.82,101,Stable Disease
M208126,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.3,34.19,1174.71,81,Progression
M208127,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.08,44.14,825.33,105,Stable Disease
M208128,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.43,43.08,1497.11,86,
M208129,49,Other,HPV-related Cancer,mrna-4157 + keytruda,70.7,58.48,809.94,81,Partial Response
M208130,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.24,23.07,-84.54,79,Stable Disease
M208131,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,9.72,7.44,956.93,69,Complete Response
M208132,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.75,59.08,776.33,78,
M208133,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.43,57.47,1053.77,82,Progression
M208134,49,Other,Melanoma,mrna-4157 + keytruda,43.39,51.72,703.47,82,Stable Disease
M208135,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.92,31.05,1240.61,89,Complete Response
M208136,81,Female,Melanoma,KEYTRUDA only,60.24,35.82,743.2,78,Partial Response
M208137,53,Other,HPV-related Cancer,mrna-4157 + keytruda,85.63,86.95,,88,Complete Response
M208138,61,Other,HPV-related Cancer,mrna-4157 + keytruda,57.97,55.39,965.16,91,Complete Response
M208139,64,Male,HPV-related Cancer,mrna-4157 + keytruda,37.85,26.39,1354.15,97,Progression
M208140,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.21,45.63,580.42,100,
M208141,42,Male,Melanoma,mrna-4157 + keytruda,44.02,33.27,1148.85,106,Progression
M208142,63,Other,Melanoma,mrna-4157 + keytruda,64.81,57.75,688.14,83,Partial Response
M208143,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.93,37.67,1038.53,96,Stable Disease
M208144,45,Female,HPV-related Cancer,mrna-4157 + keytruda,22.85,21.27,480.29,89,Progression
M208145,29,Other,Melanoma,KEYTRUDA only,40.98,22.0,1021.37,88,Progression
M208146,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.04,41.63,892.19,89,
M208147,77,Other,Melanoma,KEYTRUDA only,21.18,17.34,1249.25,92,Unknown
M208148,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.37,57.33,,100,Stable Disease
M208149,67,Male,Melanoma,mrna-4157 + keytruda,45.04,36.36,1404.46,94,Complete Response
M208150,77,Other,Melanoma,KEYTRUDA only,65.46,26.73,,96,Progression
M208151,65,Male,Melanoma,mrna-4157 + keytruda,53.22,30.77,309.03,83,Partial Response
M208152,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,75.57,56.71,1327.85,86,Partial Response
M208153,54,Female,HPV-related Cancer,mrna-4157 + keytruda,58.33,56.33,,98,Partial Response
M208154,25,Female,HPV-related Cancer,mrna-4157 + keytruda,53.41,47.79,1330.07,72,Progression
M208155,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.85,28.13,1247.84,101,Stable Disease
M208156,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.45,33.97,,88,Progression
M208157,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.33,72.3,948.92,90,Partial Response
M208158,31,Male,Melanoma,mrna-4157 + keytruda,43.52,30.1,1258.85,85,Complete Response
M208159,37,Other,Melanoma,KEYTRUDA only,56.58,45.99,255.25,107,Partial Response
M208160,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.95,40.41,838.41,99,Partial Response
M208161,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.51,43.99,1410.34,100,
M208162,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,78.74,37.85,1203.4,86,Stable Disease
M208163,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,65.5,64.05,1243.05,92,Stable Disease
M208164,48,Other,HPV-related Cancer,mrna-4157 + keytruda,101.56,80.68,680.04,85,Stable Disease
M208165,49,Female,HPV-related Cancer,mrna-4157 + keytruda,34.43,32.24,1323.3,86,Stable Disease
M208166,84,Male,HPV-related Cancer,mrna-4157 + keytruda,24.01,21.94,760.2,83,Stable Disease
M208167,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,61.89,69.63,1270.51,96,Progression
M208168,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.94,13.96,1231.28,96,Complete Response
M208169,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.72,47.36,454.37,75,Progression
M208170,35,Other,Melanoma,KEYTRUDA only,39.55,31.13,1195.62,95,Stable Disease
M208171,30,Male,HPV-related Cancer,KEYTRUDA only,66.44,41.89,,81,Partial Response
M208172,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.82,20.95,446.96,74,Stable Disease
M208173,68,Male,Melanoma,mrna-4157 + keytruda,69.0,59.19,1056.86,84,Stable Disease
M208174,73,Male,Melanoma,KEYTRUDA only,55.36,32.04,,102,Partial Response
M208175,76,Female,Melanoma,mrna-4157 + keytruda,42.0,17.55,1370.52,103,Stable Disease
M208176,44,Male,Melanoma,mrna-4157 + keytruda,31.62,31.34,1216.42,85,Stable Disease
M208177,67,Male,HPV-related Cancer,KEYTRUDA only,33.98,,1277.0,108,Partial Response
M208178,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,103.31,76.17,967.17,85,Progression
M208179,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.79,25.1,1224.32,88,Progression
M208180,30,Other,HPV-related Cancer,mrna-4157 + keytruda,66.81,47.5,886.3,84,Complete Response
M208181,49,Female,Melanoma,mrna-4157 + keytruda,66.43,53.74,1325.45,85,Partial Response
M208182,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.16,17.59,735.76,93,Complete Response
M208183,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.81,40.29,105.66,100,Progression
M208184,66,Other,HPV-related Cancer,mrna-4157 + keytruda,25.78,25.26,1459.05,117,Partial Response
M208185,62,Female,Melanoma,KEYTRUDA only,40.33,38.98,1119.4,77,Complete Response
M208186,47,Male,Melanoma,mrna-4157 + keytruda,14.51,11.67,332.51,101,Partial Response
M208187,83,Female,HPV-related Cancer,KEYTRUDA only,61.88,38.57,837.16,96,Stable Disease
M208188,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.63,26.99,,107,Partial Response
M208189,39,Other,HPV-related Cancer,mrna-4157 + keytruda,25.27,24.71,274.99,93,Complete Response
M208190,61,Male,Melanoma,mrna-4157 + keytruda,49.25,30.77,438.45,91,Complete Response
M208191,73,Female,Melanoma,mrna-4157 + keytruda,27.88,27.36,245.42,94,Partial Response
M208192,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.43,11.39,842.38,95,Partial Response
M208193,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.92,30.61,1330.06,84,Unknown
M208194,64,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.96,33.91,8816.2,92,Stable Disease
M208195,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.36,47.55,731.93,80,Partial Response
M208196,58,Female,Melanoma,mrna-4157 + keytruda,50.28,52.31,399.17,83,Progression
M208197,69,Male,HPV-related Cancer,mrna-4157 + keytruda,96.32,69.99,840.5,90,Partial Response
M208198,34,Other,HPV-related Cancer,mrna-4157 + keytruda,22.1,18.01,435.06,64,Partial Response
M208199,39,Female,Melanoma,KEYTRUDA only,47.95,,894.97,105,Progression
M208200,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.07,38.45,616.28,97,Partial Response
M208201,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.41,43.05,616.73,87,Partial Response
M208202,81,Female,Melanoma,mrna-4157 + keytruda,10.75,10.87,690.75,85,Progression
M208203,36,Male,Melanoma,KEYTRUDA only,76.01,71.81,1800.86,95,Stable Disease
M208204,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.37,63.52,1037.46,90,Stable Disease
M208205,81,Male,HPV-related Cancer,mrna-4157 + keytruda,55.11,57.93,665.25,70,Stable Disease
M208206,81,Other,Melanoma,mrna-4157 + keytruda,64.92,56.92,299.13,87,Partial Response
M208207,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.75,13.67,1633.5,75,Stable Disease
M208208,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.69,,1691.57,87,Partial Response
M208209,77,Other,HPV-related Cancer,KEYTRUDA only,39.74,39.9,1439.63,81,Stable Disease
M208210,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,38.16,14.74,355.74,88,Stable Disease
M208211,25,Female,Melanoma,KEYTRUDA only,73.07,68.39,1156.41,101,Complete Response
M208212,32,Other,HPV-related Cancer,mrna-4157 + keytruda,40.32,36.22,289.5,97,Partial Response
M208213,79,Female,Melanoma,mrna-4157 + keytruda,47.5,48.03,1504.27,68,Progression
M208214,28,Female,HPV-related Cancer,mrna-4157 + keytruda,69.19,67.29,1678.75,94,Progression
M208215,52,Other,HPV-related Cancer,mrna-4157 + keytruda,44.21,17.53,1085.14,88,Stable Disease
M208216,38,Other,Melanoma,KEYTRUDA only,58.0,36.91,1523.3,75,Stable Disease
M208217,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.98,30.05,384.8,87,Partial Response
M208218,35,Male,HPV-related Cancer,mrna-4157 + keytruda,66.14,41.81,362.0,87,Stable Disease
M208219,45,Male,Melanoma,mrna-4157 + keytruda,44.26,46.89,1315.97,97,Partial Response
M208220,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.91,,1252.45,72,Progression
M208221,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.48,21.77,820.9,78,Stable Disease
M208222,44,Male,Melanoma,KEYTRUDA only,58.15,,379.48,100,Unknown
M208223,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,105.03,94.63,663.7,77,Partial Response
M208224,26,Female,Melanoma,KEYTRUDA only,20.53,19.69,1658.79,85,Progression
M208225,83,Male,Melanoma,mrna-4157 + keytruda,91.94,98.51,505.12,101,Stable Disease
M208226,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.96,20.68,548.79,88,Stable Disease
M208227,53,Female,HPV-related Cancer,mrna-4157 + keytruda,45.7,42.62,658.32,89,Partial Response
M208228,35,Other,HPV-related Cancer,mrna-4157 + keytruda,44.69,23.47,615.88,87,Progression
M208229,40,Female,Melanoma,KEYTRUDA only,41.32,23.97,1409.24,106,
M208230,61,Other,Melanoma,mrna-4157 + keytruda,46.93,41.13,1049.34,86,Unknown
M208231,66,Female,Melanoma,mrna-4157 + keytruda,32.72,25.07,908.03,89,Stable Disease
M208232,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.84,13.94,1305.8,76,
M208233,83,Female,Non-small Cell Lung Cancer,KEYTRUDA only,38.94,29.02,176.94,90,Partial Response
M208234,26,Other,Melanoma,mrna-4157 + keytruda,30.45,23.03,-180.04,89,Stable Disease
M208235,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.28,98.48,624.9,100,Stable Disease
M208236,52,Male,HPV-related Cancer,KEYTRUDA only,67.58,52.08,350.4,98,Partial Response
M208237,63,Female,HPV-related Cancer,mrna-4157 + keytruda,66.53,53.6,1675.77,89,Stable Disease
M208238,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,76.38,77.31,1666.54,79,Stable Disease
M208239,28,Female,HPV-related Cancer,KEYTRUDA only,39.16,26.78,985.73,89,Partial Response
M208240,75,Male,Melanoma,mrna-4157 + keytruda,40.9,40.94,1369.79,91,Partial Response
M208241,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.72,59.39,513.09,80,Partial Response
M208242,52,Other,Melanoma,KEYTRUDA only,46.68,44.48,882.43,91,Progression
M208243,38,Other,Melanoma,mrna-4157 + keytruda,44.68,26.9,1631.54,95,Complete Response
M208244,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.15,41.56,2076.5,96,Unknown
M208245,59,Other,Melanoma,mrna-4157 + keytruda,9.84,8.72,762.11,87,Partial Response
M208246,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.94,95.76,1158.27,90,
M208247,46,Other,Melanoma,mrna-4157 + keytruda,61.18,59.01,903.61,69,Progression
M208248,78,Male,Melanoma,mrna-4157 + keytruda,33.96,27.03,1009.89,98,Unknown
M208249,60,Other,HPV-related Cancer,mrna-4157 + keytruda,4.6,3.13,967.32,101,Complete Response
M208250,59,Other,Melanoma,KEYTRUDA only,34.09,25.16,1500.71,83,Complete Response
M208251,76,Female,Melanoma,KEYTRUDA only,42.36,47.34,1747.86,89,Progression
M208252,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.53,37.07,1396.98,81,Progression
M208253,35,Female,HPV-related Cancer,mrna-4157 + keytruda,53.22,53.17,,97,Progression
M208254,57,Other,Melanoma,KEYTRUDA only,47.1,31.2,915.41,101,Progression
M208255,27,Female,Melanoma,mrna-4157 + keytruda,43.35,34.92,1222.04,94,Partial Response
M208256,81,Other,HPV-related Cancer,mrna-4157 + keytruda,73.87,57.37,486.12,84,Complete Response
M208257,33,Male,HPV-related Cancer,mrna-4157 + keytruda,49.95,57.1,504.98,98,Partial Response
M208258,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.13,47.55,476.94,95,Stable Disease
M208259,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.27,,934.1,79,Partial Response
M208260,59,Male,HPV-related Cancer,mrna-4157 + keytruda,63.32,48.61,978.61,83,
M208261,44,Female,Melanoma,mrna-4157 + keytruda,58.17,46.27,874.89,90,Unknown
M208262,44,Male,Melanoma,KEYTRUDA only,46.87,15.36,1329.13,72,Complete Response
M208263,55,Other,HPV-related Cancer,KEYTRUDA only,57.9,,1129.17,93,Progression
M208264,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.93,34.04,970.33,97,Stable Disease
M208265,77,Female,Melanoma,mrna-4157 + keytruda,43.88,42.44,898.69,84,
M208266,26,Other,Melanoma,KEYTRUDA only,71.63,57.27,282.7,85,Partial Response
M208267,69,Female,Melanoma,mrna-4157 + keytruda,58.96,43.49,1082.35,75,Partial Response
M208268,73,Female,HPV-related Cancer,mrna-4157 + keytruda,47.95,39.12,1000.82,83,Stable Disease
M208269,53,Male,HPV-related Cancer,mrna-4157 + keytruda,43.56,29.22,796.85,102,Unknown
M208270,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,21.5,17.36,368.63,79,Partial Response
M208271,83,Female,Melanoma,mrna-4157 + keytruda,57.46,36.61,1730.17,81,Stable Disease
M208272,35,Female,HPV-related Cancer,mrna-4157 + keytruda,50.78,46.61,155.81,98,
M208273,51,Male,Melanoma,KEYTRUDA only,77.51,73.66,731.62,89,Stable Disease
M208274,38,Male,Melanoma,KEYTRUDA only,48.64,39.34,593.79,73,Complete Response
M208275,77,Female,Melanoma,mrna-4157 + keytruda,55.42,39.99,736.79,82,Complete Response
M208276,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.45,56.65,865.65,90,Stable Disease
M208277,28,Female,Melanoma,KEYTRUDA only,4.09,4.36,922.48,87,
M208278,56,Male,Melanoma,KEYTRUDA only,28.67,23.98,1137.0,87,Progression
M208279,53,Other,Melanoma,KEYTRUDA only,71.69,56.43,1791.69,101,Progression
M208280,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.74,,936.8,95,Complete Response
M208281,55,Male,HPV-related Cancer,KEYTRUDA only,35.05,21.95,657.32,79,Unknown
M208282,76,Male,Melanoma,mrna-4157 + keytruda,39.02,34.75,1302.84,79,Stable Disease
M208283,41,Female,HPV-related Cancer,mrna-4157 + keytruda,56.74,58.51,1543.2,81,Partial Response
M208284,27,Male,HPV-related Cancer,mrna-4157 + keytruda,60.6,55.18,705.38,87,Partial Response
M208285,38,Female,Melanoma,mrna-4157 + keytruda,79.09,72.62,795.56,101,Stable Disease
M208286,47,Female,Melanoma,mrna-4157 + keytruda,-4.52,-4.04,2207.91,103,Stable Disease
M208287,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.98,37.47,1603.08,86,Partial Response
M208288,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.84,26.1,1822.46,84,Stable Disease
M208289,80,Male,Melanoma,mrna-4157 + keytruda,36.32,31.1,736.81,83,Stable Disease
M208290,78,Male,HPV-related Cancer,mrna-4157 + keytruda,8.3,4.29,1273.93,63,
M208291,73,Other,Melanoma,mrna-4157 + keytruda,23.7,21.14,645.19,80,Partial Response
M208292,27,Male,HPV-related Cancer,KEYTRUDA only,57.68,,1040.56,93,Partial Response
M208293,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.97,45.53,849.61,94,Partial Response
M208294,63,Female,HPV-related Cancer,mrna-4157 + keytruda,59.72,66.93,,91,Stable Disease
M208295,70,Female,Melanoma,KEYTRUDA only,20.76,20.38,1447.93,79,Partial Response
M208296,28,Male,Melanoma,KEYTRUDA only,40.18,36.79,1370.08,103,Partial Response
M208297,75,Other,HPV-related Cancer,mrna-4157 + keytruda,58.5,40.07,2336.14,94,Complete Response
M208298,58,Female,HPV-related Cancer,mrna-4157 + keytruda,40.56,16.75,947.42,83,Progression
M208299,57,Other,Melanoma,mrna-4157 + keytruda,50.44,37.17,1312.04,92,Stable Disease
M208300,84,Other,HPV-related Cancer,KEYTRUDA only,101.14,58.2,,76,Complete Response
M208301,52,Female,Melanoma,mrna-4157 + keytruda,63.48,44.66,738.08,113,Progression
M208302,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.84,42.38,1757.29,84,Partial Response
M208303,66,Other,HPV-related Cancer,KEYTRUDA only,50.18,27.16,1141.58,97,Partial Response
M208304,60,Other,HPV-related Cancer,KEYTRUDA only,65.0,53.68,360.63,90,Progression
M208305,69,Other,HPV-related Cancer,mrna-4157 + keytruda,34.5,25.23,1341.97,81,Complete Response
M208306,47,Male,Melanoma,KEYTRUDA only,33.69,30.09,966.89,94,Stable Disease
M208307,27,Male,HPV-related Cancer,mrna-4157 + keytruda,45.48,16.92,1250.53,83,Stable Disease
M208308,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.22,39.81,940.19,90,Partial Response
M208309,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.42,53.44,994.65,81,Stable Disease
M208310,50,Male,HPV-related Cancer,KEYTRUDA only,47.03,37.69,807.85,97,Stable Disease
M208311,64,Male,Melanoma,KEYTRUDA only,65.99,,1360.27,93,Stable Disease
M208312,82,Male,Melanoma,KEYTRUDA only,56.34,51.15,1061.17,85,Progression
M208313,26,Other,HPV-related Cancer,KEYTRUDA only,86.71,78.25,1252.17,91,Partial Response
M208314,51,Female,Melanoma,KEYTRUDA only,74.31,,1120.93,89,Progression
M208315,64,Female,HPV-related Cancer,mrna-4157 + keytruda,53.55,23.42,596.76,80,Progression
M208316,60,Female,Melanoma,mrna-4157 + keytruda,66.13,60.1,1184.8,82,Stable Disease
M208317,39,Other,Melanoma,mrna-4157 + keytruda,26.32,13.22,591.4,80,Progression
M208318,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.03,10.27,1000.57,78,Complete Response
M208319,76,Male,HPV-related Cancer,mrna-4157 + keytruda,41.26,30.23,1090.23,76,Stable Disease
M208320,63,Male,HPV-related Cancer,mrna-4157 + keytruda,57.48,17.74,905.82,87,Progression
M208321,42,Female,Melanoma,mrna-4157 + keytruda,54.72,48.95,215.33,88,Unknown
M208322,82,Male,Melanoma,mrna-4157 + keytruda,47.52,51.52,1135.34,97,Partial Response
M208323,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.35,24.18,907.69,85,Complete Response
M208324,42,Female,HPV-related Cancer,KEYTRUDA only,56.71,57.65,1407.42,102,Complete Response
M208325,47,Female,Melanoma,mrna-4157 + keytruda,35.46,37.45,693.58,101,Stable Disease
M208326,51,Male,HPV-related Cancer,mrna-4157 + keytruda,67.34,39.68,673.91,71,Stable Disease
M208327,81,Male,HPV-related Cancer,mrna-4157 + keytruda,46.69,33.85,1048.45,96,Complete Response
M208328,35,Other,Melanoma,mrna-4157 + keytruda,69.65,45.82,,87,Stable Disease
M208329,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.15,79.47,1167.85,93,Complete Response
M208330,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.33,52.79,663.17,75,Partial Response
M208331,78,Male,Melanoma,KEYTRUDA only,-0.75,-0.71,,89,
M208332,34,Other,HPV-related Cancer,mrna-4157 + keytruda,48.58,37.72,1174.94,98,Complete Response
M208333,48,Male,HPV-related Cancer,mrna-4157 + keytruda,60.88,50.76,972.62,86,Partial Response
M208334,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.1,58.04,938.73,83,Complete Response
M208335,73,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.15,57.65,1961.72,85,
M208336,35,Other,HPV-related Cancer,KEYTRUDA only,10.31,11.04,1794.9,84,Partial Response
M208337,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.71,23.92,729.36,66,Partial Response
M208338,53,Other,Melanoma,KEYTRUDA only,55.61,66.07,1249.34,95,Partial Response
M208339,60,Other,HPV-related Cancer,KEYTRUDA only,61.5,39.05,1051.55,109,Unknown
M208340,73,Other,Melanoma,mrna-4157 + keytruda,47.61,44.3,752.14,92,Partial Response
M208341,40,Female,HPV-related Cancer,mrna-4157 + keytruda,67.13,64.31,1416.35,93,Complete Response
M208342,29,Female,Melanoma,KEYTRUDA only,55.41,61.89,1232.34,89,
M208343,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.04,13.6,1266.53,96,Complete Response
M208344,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.48,32.75,765.63,92,Partial Response
M208345,30,Other,HPV-related Cancer,KEYTRUDA only,106.75,76.18,1048.32,93,Partial Response
M208346,37,Male,HPV-related Cancer,mrna-4157 + keytruda,48.59,59.38,1701.42,95,Partial Response
M208347,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.39,31.78,991.24,94,Progression
M208348,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.53,36.23,1016.11,95,Stable Disease
M208349,84,Female,HPV-related Cancer,mrna-4157 + keytruda,49.01,47.08,1717.99,97,Progression
M208350,80,Male,Melanoma,mrna-4157 + keytruda,89.76,73.71,,98,Stable Disease
M208351,45,Male,HPV-related Cancer,KEYTRUDA only,60.13,46.89,587.75,95,Partial Response
M208352,74,Female,HPV-related Cancer,mrna-4157 + keytruda,32.42,27.76,1536.07,89,Progression
M208353,84,Male,Melanoma,mrna-4157 + keytruda,69.81,,502.86,100,Partial Response
M208354,67,Male,Melanoma,mrna-4157 + keytruda,27.02,22.66,,109,Complete Response
M208355,26,Female,HPV-related Cancer,mrna-4157 + keytruda,36.06,21.69,820.36,85,Progression
M208356,70,Male,Melanoma,mrna-4157 + keytruda,42.28,32.64,1312.82,93,Progression
M208357,37,Female,HPV-related Cancer,mrna-4157 + keytruda,64.02,34.64,1195.6,110,Partial Response
M208358,31,Female,Melanoma,mrna-4157 + keytruda,67.44,63.19,1174.17,89,Partial Response
M208359,27,Other,Melanoma,KEYTRUDA only,24.93,19.52,1081.44,69,Partial Response
M208360,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.79,41.59,1272.86,86,Complete Response
M208361,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.98,34.97,1187.04,80,Progression
M208362,45,Female,Melanoma,KEYTRUDA only,32.54,30.05,401.23,102,Stable Disease
M208363,72,Other,Melanoma,KEYTRUDA only,11.92,8.56,1159.85,88,Partial Response
M208364,76,Male,Melanoma,KEYTRUDA only,54.87,,384.3,78,Progression
M208365,62,Male,Melanoma,mrna-4157 + keytruda,38.83,26.74,894.98,89,Partial Response
M208366,35,Other,HPV-related Cancer,KEYTRUDA only,26.34,17.39,1323.39,88,Partial Response
M208367,69,Female,HPV-related Cancer,mrna-4157 + keytruda,57.11,45.16,950.19,87,Partial Response
M208368,37,Female,Melanoma,KEYTRUDA only,69.67,34.72,1160.78,79,Complete Response
M208369,60,Male,Melanoma,mrna-4157 + keytruda,57.88,34.16,442.14,73,Progression
M208370,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.18,89.32,,87,
M208371,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.26,45.27,1143.98,82,Stable Disease
M208372,56,Male,Melanoma,KEYTRUDA only,24.56,23.81,877.4,92,Partial Response
M208373,79,Female,HPV-related Cancer,mrna-4157 + keytruda,35.03,39.35,1429.54,82,Partial Response
M208374,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.37,31.16,1016.67,88,Unknown
M208375,52,Other,Melanoma,mrna-4157 + keytruda,74.86,47.24,1493.45,83,Stable Disease
M208376,75,Female,HPV-related Cancer,KEYTRUDA only,29.87,26.24,992.83,81,Partial Response
M208377,53,Male,HPV-related Cancer,mrna-4157 + keytruda,56.26,27.42,953.55,100,Stable Disease
M208378,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,99.6,100.39,1199.34,106,Partial Response
M208379,71,Other,HPV-related Cancer,KEYTRUDA only,44.64,31.48,1124.85,114,Unknown
M208380,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.69,30.74,,70,Stable Disease
M208381,72,Other,Melanoma,KEYTRUDA only,49.35,32.57,524.57,71,Unknown
M208382,66,Female,Melanoma,mrna-4157 + keytruda,38.83,26.69,870.59,75,Partial Response
M208383,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.85,40.15,-45.6,84,
M208384,55,Male,Melanoma,mrna-4157 + keytruda,58.31,58.42,904.06,78,Complete Response
M208385,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.44,35.25,1173.22,99,Progression
M208386,36,Male,HPV-related Cancer,mrna-4157 + keytruda,40.98,31.64,319.59,78,Partial Response
M208387,80,Other,HPV-related Cancer,KEYTRUDA only,21.93,12.43,1015.83,103,Stable Disease
M208388,31,Other,Melanoma,mrna-4157 + keytruda,42.74,37.29,1407.11,90,Complete Response
M208389,56,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.38,39.49,1257.94,110,Progression
M208390,71,Male,Melanoma,mrna-4157 + keytruda,13.84,13.92,1289.69,73,Partial Response
M208391,75,Male,HPV-related Cancer,mrna-4157 + keytruda,68.95,39.64,596.72,92,Stable Disease
M208392,36,Other,HPV-related Cancer,mrna-4157 + keytruda,46.93,50.64,1713.7,89,Unknown
M208393,79,Male,Melanoma,KEYTRUDA only,38.62,28.76,,98,Progression
M208394,73,Male,Melanoma,KEYTRUDA only,20.57,18.56,679.43,108,Progression
M208395,71,Other,HPV-related Cancer,mrna-4157 + keytruda,61.95,56.68,916.88,85,Partial Response
M208396,33,Female,Melanoma,mrna-4157 + keytruda,57.32,44.25,604.21,92,Progression
M208397,78,Other,HPV-related Cancer,mrna-4157 + keytruda,57.57,44.33,1208.5,93,Partial Response
M208398,78,Female,HPV-related Cancer,mrna-4157 + keytruda,84.15,103.47,1219.57,95,Partial Response
M208399,69,Other,HPV-related Cancer,mrna-4157 + keytruda,37.53,21.52,863.2,77,Progression
M208400,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,69.85,40.24,1337.35,97,Progression
M208401,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.82,27.15,1732.3,96,Partial Response
M208402,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,79.13,43.78,1033.81,92,Partial Response
M208403,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.44,41.45,1178.07,79,
M208404,56,Male,HPV-related Cancer,mrna-4157 + keytruda,39.1,36.43,1140.82,77,Progression
M208405,35,Male,HPV-related Cancer,KEYTRUDA only,44.98,27.75,1249.83,92,Stable Disease
M208406,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,93.37,107.31,1327.73,81,Progression
M208407,37,Other,HPV-related Cancer,KEYTRUDA only,67.79,64.67,1006.96,79,Partial Response
M208408,33,Other,HPV-related Cancer,mrna-4157 + keytruda,70.07,45.44,1556.05,115,Progression
M208409,80,Female,HPV-related Cancer,mrna-4157 + keytruda,5.58,4.72,1372.05,103,Partial Response
M208410,55,Other,Melanoma,KEYTRUDA only,15.45,12.57,,90,Partial Response
M208411,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.49,20.64,666.77,78,Stable Disease
M208412,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.75,16.54,958.6,92,Complete Response
M208413,73,Female,HPV-related Cancer,mrna-4157 + keytruda,72.02,,1209.72,89,Partial Response
M208414,45,Male,HPV-related Cancer,mrna-4157 + keytruda,48.88,37.6,736.76,82,Partial Response
M208415,74,Other,Melanoma,KEYTRUDA only,10.91,11.52,1535.82,90,Stable Disease
M208416,60,Female,HPV-related Cancer,mrna-4157 + keytruda,48.34,45.32,313.86,81,Stable Disease
M208417,56,Female,Melanoma,KEYTRUDA only,93.73,78.8,625.78,80,Complete Response
M208418,77,Other,Melanoma,mrna-4157 + keytruda,75.68,53.32,1088.75,72,Progression
M208419,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.57,57.43,,83,Progression
M208420,36,Other,Melanoma,mrna-4157 + keytruda,71.46,66.2,1729.53,81,Stable Disease
M208421,40,Male,Melanoma,mrna-4157 + keytruda,28.34,,428.9,87,Complete Response
M208422,54,Female,Melanoma,mrna-4157 + keytruda,31.86,27.95,,74,Progression
M208423,26,Other,Melanoma,mrna-4157 + keytruda,57.89,58.24,1185.76,97,Stable Disease
M208424,70,Other,Melanoma,mrna-4157 + keytruda,55.64,41.11,769.62,84,Stable Disease
M208425,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,88.12,103.28,1069.88,90,Progression
M208426,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.33,29.51,567.43,80,Partial Response
M208427,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.56,18.98,636.36,96,Partial Response
M208428,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.55,37.17,,97,Partial Response
M208429,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.3,24.24,886.48,88,Partial Response
M208430,40,Female,Melanoma,KEYTRUDA only,30.77,23.04,813.89,89,Complete Response
M208431,28,Other,HPV-related Cancer,mrna-4157 + keytruda,43.87,38.89,418.98,91,Stable Disease
M208432,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,73.72,84.08,727.95,101,Partial Response
M208433,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,97.35,90.81,1053.24,108,Stable Disease
M208434,52,Female,Melanoma,KEYTRUDA only,53.78,24.01,1132.52,76,Complete Response
M208435,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.52,35.07,1643.08,90,Stable Disease
M208436,66,Male,Melanoma,mrna-4157 + keytruda,48.58,26.51,2084.64,93,Progression
M208437,38,Female,Melanoma,KEYTRUDA only,16.15,8.58,299.61,84,
M208438,72,Male,HPV-related Cancer,mrna-4157 + keytruda,67.42,54.96,389.21,90,Stable Disease
M208439,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.9,83.49,1802.07,72,Partial Response
M208440,67,Male,Melanoma,mrna-4157 + keytruda,59.28,46.25,665.43,84,Progression
M208441,50,Female,HPV-related Cancer,mrna-4157 + keytruda,31.12,15.09,890.45,99,Partial Response
M208442,79,Female,Melanoma,KEYTRUDA only,51.9,39.82,1529.08,80,Stable Disease
M208443,54,Other,Melanoma,KEYTRUDA only,59.92,28.97,1368.2,98,Stable Disease
M208444,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,33.3,22.75,1401.69,93,Stable Disease
M208445,34,Other,Melanoma,KEYTRUDA only,14.59,12.92,1006.0,93,Partial Response
M208446,55,Other,Melanoma,mrna-4157 + keytruda,46.63,25.72,872.47,80,Stable Disease
M208447,49,Female,Melanoma,KEYTRUDA only,46.67,24.55,1271.81,97,Partial Response
M208448,68,Other,Melanoma,KEYTRUDA only,30.35,16.69,732.65,90,Complete Response
M208449,26,Female,Melanoma,mrna-4157 + keytruda,46.07,40.81,992.08,84,Stable Disease
M208450,29,Male,Melanoma,KEYTRUDA only,29.61,14.31,760.73,87,Complete Response
M208451,59,Female,HPV-related Cancer,mrna-4157 + keytruda,45.35,24.87,822.28,76,Partial Response
M208452,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.14,37.67,1010.5,86,Progression
M208453,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.89,24.02,1176.08,85,Stable Disease
M208454,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.81,34.34,816.05,99,Complete Response
M208455,74,Other,Melanoma,mrna-4157 + keytruda,52.13,55.39,1619.49,112,Partial Response
M208456,77,Male,HPV-related Cancer,mrna-4157 + keytruda,38.27,42.79,527.49,89,
M208457,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.96,38.16,1690.73,93,Partial Response
M208458,29,Female,HPV-related Cancer,mrna-4157 + keytruda,32.36,31.59,604.79,83,Stable Disease
M208459,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.79,30.87,,92,Stable Disease
M208460,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,87.83,49.65,-16.09,80,Stable Disease
M208461,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.28,32.6,,81,Partial Response
M208462,44,Female,HPV-related Cancer,mrna-4157 + keytruda,25.86,26.31,1517.64,86,Progression
M208463,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.77,8.46,1171.04,83,Partial Response
M208464,76,Male,Melanoma,mrna-4157 + keytruda,55.66,58.08,1443.31,97,
M208465,64,Male,Melanoma,KEYTRUDA only,61.1,45.18,645.4,97,Unknown
M208466,29,Other,Melanoma,mrna-4157 + keytruda,58.14,55.42,1130.36,82,Complete Response
M208467,70,Female,Melanoma,KEYTRUDA only,28.75,33.18,848.9,82,
M208468,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.44,40.29,1750.58,100,Progression
M208469,33,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.06,51.02,1012.74,97,
M208470,52,Male,Melanoma,mrna-4157 + keytruda,77.83,50.01,1074.43,81,Stable Disease
M208471,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.81,35.76,1368.78,78,Partial Response
M208472,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.58,16.57,1202.57,89,Progression
M208473,74,Other,Melanoma,KEYTRUDA only,72.44,59.06,87.42,77,Partial Response
M208474,26,Other,HPV-related Cancer,mrna-4157 + keytruda,47.02,42.76,563.27,96,Progression
M208475,64,Male,HPV-related Cancer,KEYTRUDA only,31.29,20.28,1370.48,84,Stable Disease
M208476,56,Other,Melanoma,KEYTRUDA only,41.45,38.26,1026.77,88,Progression
M208477,42,Male,Melanoma,mrna-4157 + keytruda,62.59,53.98,621.06,96,Progression
M208478,33,Other,Melanoma,KEYTRUDA only,73.61,28.54,1185.39,89,Partial Response
M208479,71,Male,HPV-related Cancer,mrna-4157 + keytruda,64.75,55.24,896.84,84,Progression
M208480,76,Female,Melanoma,KEYTRUDA only,59.89,55.28,617.59,75,Partial Response
M208481,83,Male,Melanoma,KEYTRUDA only,65.4,56.8,785.62,98,Progression
M208482,78,Other,Melanoma,KEYTRUDA only,89.01,104.33,6009.95,87,Partial Response
M208483,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.17,21.67,562.9,77,Progression
M208484,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.42,39.44,525.13,88,Stable Disease
M208485,57,Female,HPV-related Cancer,KEYTRUDA only,47.65,47.73,1314.85,79,Stable Disease
M208486,31,Female,Melanoma,mrna-4157 + keytruda,26.82,17.81,1099.69,89,Partial Response
M208487,45,Female,Melanoma,mrna-4157 + keytruda,47.67,33.65,691.33,65,Progression
M208488,84,Female,Melanoma,KEYTRUDA only,95.95,47.48,765.9,82,Partial Response
M208489,65,Female,HPV-related Cancer,KEYTRUDA only,40.73,41.0,461.47,93,Partial Response
M208490,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.94,,536.09,81,
M208491,30,Other,HPV-related Cancer,KEYTRUDA only,62.82,77.8,1497.18,85,
M208492,61,Other,Melanoma,KEYTRUDA only,122.64,74.66,815.3,86,Stable Disease
M208493,59,Male,HPV-related Cancer,mrna-4157 + keytruda,53.79,41.11,427.76,90,Stable Disease
M208494,70,Male,HPV-related Cancer,mrna-4157 + keytruda,39.09,22.81,1100.65,83,Stable Disease
M208495,64,Other,Melanoma,mrna-4157 + keytruda,25.02,26.96,1090.61,69,Complete Response
M208496,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.99,38.03,722.95,90,Stable Disease
M208497,53,Female,HPV-related Cancer,mrna-4157 + keytruda,35.81,32.48,1215.54,101,Partial Response
M208498,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.53,37.26,1677.81,89,Progression
M208499,63,Male,HPV-related Cancer,mrna-4157 + keytruda,95.48,96.94,1026.64,97,
M208500,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.12,42.64,929.58,93,Stable Disease
M208501,29,Female,HPV-related Cancer,mrna-4157 + keytruda,57.07,64.42,579.21,91,Progression
M208502,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.4,21.92,656.32,92,Stable Disease
M208503,59,Other,Melanoma,KEYTRUDA only,40.93,31.72,992.16,83,Partial Response
M208504,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,73.33,63.83,1281.62,105,Progression
M208505,54,Male,HPV-related Cancer,mrna-4157 + keytruda,41.17,,1695.36,91,Progression
M208506,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.56,18.48,1512.52,84,Partial Response
M208507,72,Female,Melanoma,mrna-4157 + keytruda,74.28,55.81,924.27,93,Partial Response
M208508,74,Other,HPV-related Cancer,KEYTRUDA only,59.95,28.93,,78,Partial Response
M208509,51,Other,HPV-related Cancer,KEYTRUDA only,54.7,26.9,827.25,107,Partial Response
M208510,81,Male,HPV-related Cancer,mrna-4157 + keytruda,-0.76,-0.48,521.27,92,Stable Disease
M208511,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.34,46.14,855.42,104,Partial Response
M208512,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.76,53.75,660.0,77,Stable Disease
M208513,61,Male,Melanoma,mrna-4157 + keytruda,63.87,60.27,1361.18,69,Stable Disease
M208514,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.25,46.4,1381.0,101,Stable Disease
M208515,55,Male,Melanoma,KEYTRUDA only,40.88,39.14,852.02,93,Partial Response
M208516,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.31,24.65,1822.64,96,Stable Disease
M208517,25,Female,HPV-related Cancer,mrna-4157 + keytruda,14.06,3.33,1555.41,74,Unknown
M208518,42,Male,Melanoma,KEYTRUDA only,44.03,23.65,1108.52,85,Stable Disease
M208519,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,82.54,66.96,1047.3,83,Unknown
M208520,39,Other,HPV-related Cancer,mrna-4157 + keytruda,72.92,59.34,1208.54,98,Progression
M208521,39,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.1,37.68,1304.28,86,Stable Disease
M208522,25,Male,HPV-related Cancer,mrna-4157 + keytruda,51.12,47.41,1206.96,81,Stable Disease
M208523,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.15,31.35,482.18,96,Partial Response
M208524,51,Male,Melanoma,mrna-4157 + keytruda,57.47,40.45,700.32,82,Stable Disease
M208525,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.7,44.95,1054.08,104,Partial Response
M208526,42,Male,Melanoma,KEYTRUDA only,-1.68,-1.67,367.73,91,Stable Disease
M208527,55,Female,Melanoma,mrna-4157 + keytruda,50.38,34.32,619.26,84,Stable Disease
M208528,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.09,32.44,825.86,87,Progression
M208529,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.64,43.84,471.05,102,Stable Disease
M208530,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.97,40.19,854.15,112,Stable Disease
M208531,44,Other,Melanoma,mrna-4157 + keytruda,50.6,,1272.15,81,Complete Response
M208532,65,Male,Melanoma,KEYTRUDA only,41.66,24.19,1433.76,79,Progression
M208533,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.13,33.61,-269.73,110,Complete Response
M208534,65,Male,Melanoma,KEYTRUDA only,34.08,27.2,1175.38,91,Stable Disease
M208535,36,Female,Melanoma,KEYTRUDA only,3.41,2.76,1006.2,80,Unknown
M208536,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.37,22.11,1006.69,80,Unknown
M208537,36,Female,Melanoma,mrna-4157 + keytruda,43.82,,1018.96,85,
M208538,70,Other,Melanoma,KEYTRUDA only,54.21,35.19,1143.03,89,Progression
M208539,63,Other,HPV-related Cancer,mrna-4157 + keytruda,61.27,46.33,1858.52,96,Stable Disease
M208540,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.39,21.97,1078.5,99,Progression
M208541,48,Male,Melanoma,KEYTRUDA only,64.34,62.52,1462.99,94,Partial Response
M208542,47,Male,Melanoma,KEYTRUDA only,62.94,57.72,1563.01,98,Stable Disease
M208543,74,Other,Melanoma,KEYTRUDA only,39.36,34.76,344.64,93,Progression
M208544,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,114.57,102.14,860.27,77,Stable Disease
M208545,62,Female,Melanoma,mrna-4157 + keytruda,55.79,40.71,854.19,92,Progression
M208546,73,Other,HPV-related Cancer,mrna-4157 + keytruda,45.33,53.01,930.97,79,Complete Response
M208547,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.73,23.98,410.97,90,Stable Disease
M208548,75,Male,HPV-related Cancer,mrna-4157 + keytruda,50.57,47.64,1471.29,82,Stable Disease
M208549,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,89.39,61.5,598.17,100,Partial Response
M208550,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.4,32.97,1684.58,92,Complete Response
M208551,68,Male,HPV-related Cancer,KEYTRUDA only,33.53,23.94,862.72,81,Unknown
M208552,80,Male,HPV-related Cancer,mrna-4157 + keytruda,54.11,45.49,1178.35,108,Complete Response
M208553,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,102.46,72.38,546.54,101,Partial Response
M208554,65,Other,HPV-related Cancer,KEYTRUDA only,47.45,38.93,731.11,94,Progression
M208555,61,Female,HPV-related Cancer,mrna-4157 + keytruda,59.94,45.17,136.16,89,Stable Disease
M208556,25,Other,Melanoma,mrna-4157 + keytruda,32.52,23.03,1156.27,105,Stable Disease
M208557,81,Other,HPV-related Cancer,mrna-4157 + keytruda,50.51,40.28,1517.03,105,Complete Response
M208558,74,Other,Melanoma,KEYTRUDA only,74.17,76.84,1345.0,93,Partial Response
M208559,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.14,25.02,1032.25,88,Complete Response
M208560,62,Male,HPV-related Cancer,mrna-4157 + keytruda,51.58,48.13,1554.93,82,Progression
M208561,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,20.12,12.94,829.25,100,Partial Response
M208562,35,Other,Melanoma,KEYTRUDA only,60.82,58.57,1991.77,85,Stable Disease
M208563,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.4,41.29,1633.49,101,Partial Response
M208564,56,Other,Melanoma,mrna-4157 + keytruda,-28.42,-21.04,1502.97,86,Partial Response
M208565,70,Other,Melanoma,mrna-4157 + keytruda,42.33,32.01,521.11,77,Stable Disease
M208566,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.52,35.67,1085.93,71,Stable Disease
M208567,71,Male,Melanoma,mrna-4157 + keytruda,48.66,40.31,,86,Partial Response
M208568,83,Other,Melanoma,KEYTRUDA only,83.43,59.44,1086.99,91,Stable Disease
M208569,69,Female,HPV-related Cancer,KEYTRUDA only,22.22,6.38,1352.35,87,Stable Disease
M208570,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.88,55.27,983.64,102,Complete Response
M208571,66,Female,HPV-related Cancer,KEYTRUDA only,47.22,38.48,1138.91,98,Partial Response
M208572,69,Other,Melanoma,KEYTRUDA only,20.7,12.68,466.39,100,Partial Response
M208573,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.77,29.28,1913.42,78,Stable Disease
M208574,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,85.58,40.97,438.86,89,Unknown
M208575,40,Female,Melanoma,mrna-4157 + keytruda,63.82,20.3,1061.58,75,Progression
M208576,52,Other,Melanoma,mrna-4157 + keytruda,79.18,44.94,770.36,86,Stable Disease
M208577,29,Other,HPV-related Cancer,KEYTRUDA only,88.27,78.58,1310.38,83,Partial Response
M208578,59,Female,Melanoma,mrna-4157 + keytruda,41.28,24.98,646.12,91,Unknown
M208579,43,Male,HPV-related Cancer,mrna-4157 + keytruda,45.57,33.7,946.12,99,Stable Disease
M208580,44,Other,HPV-related Cancer,KEYTRUDA only,64.55,55.63,769.49,87,Unknown
M208581,68,Female,Melanoma,mrna-4157 + keytruda,62.67,72.36,1457.31,95,Stable Disease
M208582,59,Other,HPV-related Cancer,mrna-4157 + keytruda,22.12,19.26,1118.92,79,Stable Disease
M208583,68,Male,Melanoma,mrna-4157 + keytruda,54.2,56.77,1218.19,86,Progression
M208584,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.33,61.73,842.47,90,
M208585,40,Female,Melanoma,KEYTRUDA only,70.9,28.0,1819.89,98,Partial Response
M208586,28,Female,Melanoma,mrna-4157 + keytruda,44.8,33.34,1546.23,91,Progression
M208587,53,Other,Melanoma,KEYTRUDA only,56.24,28.46,830.84,91,Stable Disease
M208588,65,Male,HPV-related Cancer,mrna-4157 + keytruda,14.54,13.93,1701.99,81,Progression
M208589,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.49,35.34,1395.92,89,Stable Disease
M208590,73,Other,Melanoma,KEYTRUDA only,42.75,44.56,726.41,100,Stable Disease
M208591,38,Female,HPV-related Cancer,KEYTRUDA only,29.47,13.99,,93,Progression
M208592,31,Female,HPV-related Cancer,KEYTRUDA only,31.49,31.63,552.86,93,Partial Response
M208593,33,Other,Melanoma,mrna-4157 + keytruda,28.49,24.26,1031.76,113,
M208594,42,Male,HPV-related Cancer,KEYTRUDA only,100.76,67.34,,83,Stable Disease
M208595,47,Female,Melanoma,KEYTRUDA only,87.89,102.78,1226.38,95,Complete Response
M208596,74,Male,HPV-related Cancer,mrna-4157 + keytruda,33.82,27.53,,70,Partial Response
M208597,28,Other,Melanoma,KEYTRUDA only,40.8,41.19,555.19,85,Progression
M208598,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,22.46,11.0,711.21,112,Partial Response
M208599,39,Male,Melanoma,KEYTRUDA only,47.08,37.88,904.05,81,Progression
M208600,70,Other,HPV-related Cancer,KEYTRUDA only,38.08,,,90,Partial Response
M208601,84,Female,HPV-related Cancer,KEYTRUDA only,72.75,61.48,623.48,94,Partial Response
M208602,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.22,39.71,1305.45,93,Complete Response
M208603,83,Other,HPV-related Cancer,KEYTRUDA only,43.69,37.4,776.47,106,Complete Response
M208604,34,Other,Melanoma,mrna-4157 + keytruda,40.64,32.93,6753.25,91,Complete Response
M208605,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.53,31.53,146.23,98,
M208606,38,Female,HPV-related Cancer,KEYTRUDA only,60.34,34.22,736.33,94,Stable Disease
M208607,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.51,54.79,1298.15,94,
M208608,60,Male,HPV-related Cancer,mrna-4157 + keytruda,52.87,40.15,955.75,91,Partial Response
M208609,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,72.53,,1335.44,94,Progression
M208610,57,Male,Melanoma,mrna-4157 + keytruda,51.68,39.11,1399.08,98,Stable Disease
M208611,68,Other,Melanoma,mrna-4157 + keytruda,50.87,36.37,909.97,84,Progression
M208612,29,Female,HPV-related Cancer,KEYTRUDA only,36.97,25.35,679.17,116,Complete Response
M208613,31,Male,HPV-related Cancer,mrna-4157 + keytruda,45.51,45.91,1262.2,107,Progression
M208614,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.61,41.65,1439.74,91,Progression
M208615,66,Female,HPV-related Cancer,mrna-4157 + keytruda,31.77,24.57,684.17,95,Stable Disease
M208616,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,24.0,16.21,1207.13,91,Progression
M208617,28,Other,Melanoma,mrna-4157 + keytruda,43.16,48.56,365.48,87,Progression
M208618,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.4,68.83,934.35,88,Partial Response
M208619,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.63,26.0,1306.76,99,Progression
M208620,65,Male,HPV-related Cancer,KEYTRUDA only,75.71,22.85,1146.88,89,Partial Response
M208621,36,Male,Melanoma,mrna-4157 + keytruda,70.14,73.38,1195.82,88,Stable Disease
M208622,35,Male,HPV-related Cancer,mrna-4157 + keytruda,69.86,,819.41,93,Partial Response
M208623,79,Male,HPV-related Cancer,mrna-4157 + keytruda,53.22,49.01,1037.99,81,Stable Disease
M208624,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.28,32.03,1309.67,81,Partial Response
M208625,61,Male,HPV-related Cancer,mrna-4157 + keytruda,38.94,25.34,850.13,85,Partial Response
M208626,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.68,29.16,1218.67,104,Complete Response
M208627,41,Female,Melanoma,mrna-4157 + keytruda,70.1,27.58,1128.26,99,Stable Disease
M208628,73,Other,Melanoma,mrna-4157 + keytruda,56.86,36.77,976.12,73,Progression
M208629,64,Female,Melanoma,mrna-4157 + keytruda,46.25,41.56,757.13,91,Progression
M208630,61,Female,Melanoma,mrna-4157 + keytruda,59.83,48.08,1101.52,101,Complete Response
M208631,45,Other,HPV-related Cancer,mrna-4157 + keytruda,23.84,12.18,686.85,92,Partial Response
M208632,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.79,35.18,573.7,87,Progression
M208633,35,Other,HPV-related Cancer,mrna-4157 + keytruda,46.74,,1117.7,72,Progression
M208634,36,Female,HPV-related Cancer,KEYTRUDA only,72.64,45.85,1700.03,79,Complete Response
M208635,47,Female,Melanoma,mrna-4157 + keytruda,46.55,29.83,1285.92,85,Complete Response
M208636,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,79.67,67.56,1912.94,79,Progression
M208637,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.71,16.25,352.35,77,Stable Disease
M208638,53,Female,HPV-related Cancer,mrna-4157 + keytruda,32.21,32.0,1509.92,79,Partial Response
M208639,80,Female,Melanoma,mrna-4157 + keytruda,65.33,65.78,798.31,104,Partial Response
M208640,79,Female,Melanoma,KEYTRUDA only,38.36,31.83,1192.96,78,Partial Response
M208641,72,Male,HPV-related Cancer,mrna-4157 + keytruda,57.07,43.53,949.43,97,Partial Response
M208642,38,Female,Melanoma,KEYTRUDA only,54.75,48.39,1258.76,103,Partial Response
M208643,43,Female,Melanoma,KEYTRUDA only,69.71,25.55,1302.02,94,
M208644,81,Male,HPV-related Cancer,KEYTRUDA only,28.75,14.91,980.0,96,Partial Response
M208645,56,Female,HPV-related Cancer,mrna-4157 + keytruda,84.4,50.18,1204.33,86,Stable Disease
M208646,45,Male,Melanoma,mrna-4157 + keytruda,47.7,25.7,393.27,93,Stable Disease
M208647,46,Female,HPV-related Cancer,mrna-4157 + keytruda,27.34,23.2,1060.17,97,Stable Disease
M208648,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.55,26.08,733.33,89,Complete Response
M208649,25,Female,Melanoma,KEYTRUDA only,66.47,47.5,998.66,88,Stable Disease
M208650,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.08,31.06,696.42,80,Partial Response
M208651,70,Female,HPV-related Cancer,KEYTRUDA only,64.43,56.59,297.55,94,Progression
M208652,79,Male,Melanoma,mrna-4157 + keytruda,78.67,92.0,654.35,97,Partial Response
M208653,27,Male,HPV-related Cancer,mrna-4157 + keytruda,70.82,86.74,1037.21,104,Partial Response
M208654,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,32.59,17.16,855.39,100,Partial Response
M208655,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.32,79.26,1881.48,110,Partial Response
M208656,38,Female,HPV-related Cancer,mrna-4157 + keytruda,55.08,74.42,838.05,103,Partial Response
M208657,67,Male,HPV-related Cancer,mrna-4157 + keytruda,87.14,87.0,1261.04,82,Unknown
M208658,70,Female,Melanoma,mrna-4157 + keytruda,62.77,50.35,1033.23,98,Stable Disease
M208659,84,Female,HPV-related Cancer,mrna-4157 + keytruda,33.99,33.52,,81,Partial Response
M208660,77,Female,Melanoma,mrna-4157 + keytruda,73.78,62.19,1088.84,104,Partial Response
M208661,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.85,,361.59,100,Progression
M208662,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.2,50.47,499.58,93,Progression
M208663,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.35,,,92,Stable Disease
M208664,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.09,,1430.04,97,Partial Response
M208665,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,105.68,,318.43,77,Partial Response
M208666,35,Other,HPV-related Cancer,mrna-4157 + keytruda,58.11,49.89,53.94,100,Progression
M208667,59,Male,Melanoma,KEYTRUDA only,52.43,46.87,1322.62,101,Progression
M208668,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.97,44.16,-137.49,90,Unknown
M208669,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.6,41.44,813.99,105,Stable Disease
M208670,83,Male,Melanoma,mrna-4157 + keytruda,57.95,57.66,1055.8,91,Stable Disease
M208671,73,Male,Melanoma,mrna-4157 + keytruda,100.67,71.89,721.96,89,Stable Disease
M208672,63,Male,HPV-related Cancer,mrna-4157 + keytruda,18.73,12.39,619.94,91,Partial Response
M208673,81,Female,Melanoma,mrna-4157 + keytruda,50.78,32.51,765.26,80,Partial Response
M208674,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.68,,1639.69,86,Partial Response
M208675,55,Female,Melanoma,mrna-4157 + keytruda,55.54,54.32,415.85,76,Stable Disease
M208676,76,Female,HPV-related Cancer,KEYTRUDA only,54.24,50.85,867.27,90,Progression
M208677,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.91,52.5,642.09,93,Stable Disease
M208678,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.49,78.08,1377.56,85,Partial Response
M208679,54,Other,HPV-related Cancer,mrna-4157 + keytruda,70.81,54.77,556.5,99,Partial Response
M208680,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.49,32.91,764.17,96,
M208681,55,Other,Melanoma,mrna-4157 + keytruda,82.62,51.21,423.65,106,Partial Response
M208682,38,Other,HPV-related Cancer,mrna-4157 + keytruda,51.98,52.14,866.96,72,Complete Response
M208683,38,Other,HPV-related Cancer,mrna-4157 + keytruda,0.32,0.34,485.11,113,Stable Disease
M208684,35,Other,Melanoma,KEYTRUDA only,7.42,5.0,949.71,91,Stable Disease
M208685,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.32,33.12,991.31,99,Progression
M208686,35,Other,Melanoma,KEYTRUDA only,39.07,14.3,,104,Partial Response
M208687,67,Male,HPV-related Cancer,KEYTRUDA only,37.09,34.91,1815.6,86,Complete Response
M208688,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,84.6,50.73,480.91,99,Progression
M208689,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.38,25.28,1239.63,100,Partial Response
M208690,82,Male,HPV-related Cancer,mrna-4157 + keytruda,39.64,41.9,1032.91,85,Partial Response
M208691,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,-9.31,-9.39,914.62,84,Complete Response
M208692,80,Other,Melanoma,KEYTRUDA only,48.77,24.39,1098.59,93,
M208693,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.47,51.18,1013.33,92,Complete Response
M208694,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.53,45.79,952.76,89,Progression
M208695,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,12.35,13.24,1577.11,82,Stable Disease
M208696,38,Female,HPV-related Cancer,KEYTRUDA only,68.93,54.46,838.26,82,Stable Disease
M208697,68,Female,Melanoma,KEYTRUDA only,83.7,67.37,992.66,98,Stable Disease
M208698,83,Male,HPV-related Cancer,KEYTRUDA only,48.41,27.05,238.26,108,Partial Response
M208699,40,Male,HPV-related Cancer,mrna-4157 + keytruda,60.97,35.66,670.76,91,Unknown
M208700,70,Male,Melanoma,mrna-4157 + keytruda,74.46,71.24,535.91,94,Stable Disease
M208701,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.03,47.22,211.58,82,Progression
M208702,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.37,33.11,336.66,85,Complete Response
M208703,53,Female,Melanoma,mrna-4157 + keytruda,84.32,58.94,1148.63,100,Partial Response
M208704,39,Other,Melanoma,mrna-4157 + keytruda,51.94,,951.16,92,
M208705,74,Male,HPV-related Cancer,KEYTRUDA only,48.36,34.32,1487.05,81,Progression
M208706,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.36,34.93,1451.71,87,Complete Response
M208707,27,Female,HPV-related Cancer,KEYTRUDA only,52.36,36.8,844.24,93,Complete Response
M208708,64,Female,Melanoma,mrna-4157 + keytruda,-6.69,-7.1,1124.28,93,Partial Response
M208709,27,Other,Melanoma,KEYTRUDA only,52.74,24.38,538.93,92,Partial Response
M208710,56,Other,HPV-related Cancer,KEYTRUDA only,57.42,54.57,1406.98,81,Complete Response
M208711,73,Male,HPV-related Cancer,KEYTRUDA only,80.34,,1102.13,103,Unknown
M208712,76,Other,Melanoma,KEYTRUDA only,57.27,50.27,369.89,96,Partial Response
M208713,84,Other,HPV-related Cancer,KEYTRUDA only,76.81,50.37,863.84,91,Partial Response
M208714,57,Other,HPV-related Cancer,KEYTRUDA only,41.03,40.93,608.96,93,Partial Response
M208715,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.91,47.15,1435.27,101,Partial Response
M208716,47,Other,Melanoma,mrna-4157 + keytruda,91.37,71.65,793.03,96,Complete Response
M208717,53,Female,Melanoma,mrna-4157 + keytruda,51.82,62.1,,96,Complete Response
M208718,58,Female,Melanoma,KEYTRUDA only,19.32,11.96,1211.62,95,Progression
M208719,39,Male,HPV-related Cancer,KEYTRUDA only,53.81,45.37,615.67,117,Progression
M208720,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-7.31,-7.72,716.87,94,Partial Response
M208721,47,Other,Melanoma,mrna-4157 + keytruda,66.29,31.14,694.58,104,Stable Disease
M208722,64,Female,HPV-related Cancer,KEYTRUDA only,56.42,65.31,141.15,100,Stable Disease
M208723,68,Male,HPV-related Cancer,KEYTRUDA only,32.4,34.24,,77,Progression
M208724,36,Female,HPV-related Cancer,mrna-4157 + keytruda,37.91,35.83,854.05,89,Progression
M208725,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.02,25.51,764.54,98,Progression
M208726,30,Male,Melanoma,mrna-4157 + keytruda,53.51,27.25,278.69,85,Progression
M208727,81,Male,HPV-related Cancer,KEYTRUDA only,95.34,51.67,1105.59,68,Partial Response
M208728,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.13,,647.22,106,Progression
M208729,26,Male,HPV-related Cancer,mrna-4157 + keytruda,76.89,71.51,688.58,85,Progression
M208730,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.46,28.68,719.02,99,Partial Response
M208731,55,Male,HPV-related Cancer,mrna-4157 + keytruda,55.13,29.59,1590.07,98,Partial Response
M208732,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.11,40.0,,101,Progression
M208733,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,74.99,54.2,954.37,112,Partial Response
M208734,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.72,30.33,878.44,90,Stable Disease
M208735,78,Female,Melanoma,mrna-4157 + keytruda,22.3,21.85,752.68,83,Complete Response
M208736,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.83,55.4,1442.15,99,Complete Response
M208737,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.98,30.95,697.98,92,Partial Response
M208738,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.8,36.71,1588.36,83,Stable Disease
M208739,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.13,21.43,291.93,88,Progression
M208740,65,Male,HPV-related Cancer,KEYTRUDA only,18.77,12.86,1214.59,97,Partial Response
M208741,48,Male,HPV-related Cancer,mrna-4157 + keytruda,62.56,38.06,1250.27,92,Stable Disease
M208742,54,Female,HPV-related Cancer,mrna-4157 + keytruda,66.14,58.41,772.43,87,Complete Response
M208743,27,Male,Melanoma,KEYTRUDA only,75.53,56.33,367.81,89,Progression
M208744,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.21,38.52,957.61,87,Unknown
M208745,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-2.09,-1.22,767.67,75,Progression
M208746,48,Male,Melanoma,KEYTRUDA only,29.67,23.65,1335.05,79,Partial Response
M208747,50,Other,Melanoma,mrna-4157 + keytruda,26.66,23.21,1442.13,99,Stable Disease
M208748,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.73,41.3,506.49,96,Stable Disease
M208749,26,Other,HPV-related Cancer,KEYTRUDA only,53.03,26.2,1251.62,104,Partial Response
M208750,84,Female,HPV-related Cancer,mrna-4157 + keytruda,60.07,57.4,842.44,83,Progression
M208751,25,Other,Melanoma,mrna-4157 + keytruda,58.81,15.22,1356.07,105,Partial Response
M208752,73,Female,Melanoma,KEYTRUDA only,55.55,27.09,416.89,80,Complete Response
M208753,84,Male,Melanoma,KEYTRUDA only,39.02,24.99,1409.22,82,Progression
M208754,46,Female,Melanoma,KEYTRUDA only,61.67,51.49,1450.42,84,Partial Response
M208755,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.46,21.11,1070.09,88,Partial Response
M208756,60,Female,Melanoma,mrna-4157 + keytruda,23.83,29.27,911.5,87,
M208757,31,Female,HPV-related Cancer,KEYTRUDA only,28.72,23.66,887.17,90,Partial Response
M208758,44,Female,HPV-related Cancer,KEYTRUDA only,46.67,39.84,675.48,82,Progression
M208759,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,33.4,29.07,622.85,103,Progression
M208760,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.47,33.25,1072.52,90,Complete Response
M208761,79,Other,Melanoma,mrna-4157 + keytruda,49.05,34.95,,91,Stable Disease
M208762,36,Female,HPV-related Cancer,KEYTRUDA only,68.63,64.57,1291.35,95,Complete Response
M208763,69,Male,Melanoma,mrna-4157 + keytruda,49.39,45.08,1314.14,119,Partial Response
M208764,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.31,58.9,713.13,103,Partial Response
M208765,62,Female,HPV-related Cancer,KEYTRUDA only,51.77,40.26,980.29,85,Complete Response
M208766,61,Other,Melanoma,KEYTRUDA only,48.76,28.09,1030.25,89,Complete Response
M208767,43,Other,Melanoma,mrna-4157 + keytruda,73.21,53.37,773.23,82,Partial Response
M208768,67,Male,HPV-related Cancer,mrna-4157 + keytruda,39.29,36.18,1158.22,83,Progression
M208769,74,Female,Melanoma,mrna-4157 + keytruda,62.61,42.29,612.03,84,Partial Response
M208770,46,Other,Melanoma,mrna-4157 + keytruda,84.04,63.12,1012.23,106,Stable Disease
M208771,25,Male,Melanoma,mrna-4157 + keytruda,99.97,83.19,1155.28,82,Stable Disease
M208772,58,Other,HPV-related Cancer,mrna-4157 + keytruda,62.57,47.56,,71,Partial Response
M208773,71,Male,HPV-related Cancer,KEYTRUDA only,40.65,45.69,755.02,89,Progression
M208774,64,Male,Melanoma,mrna-4157 + keytruda,69.63,38.0,1112.75,103,Progression
M208775,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.12,10.47,182.15,89,Stable Disease
M208776,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.43,26.34,1268.34,100,Progression
M208777,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.12,46.13,1215.86,103,Stable Disease
M208778,37,Male,Melanoma,KEYTRUDA only,95.77,108.19,1571.15,82,Partial Response
M208779,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,60.21,42.18,2051.24,87,Partial Response
M208780,69,Other,HPV-related Cancer,mrna-4157 + keytruda,25.23,21.85,889.19,95,
M208781,75,Male,Melanoma,mrna-4157 + keytruda,73.89,43.91,1030.92,90,Partial Response
M208782,29,Male,Melanoma,mrna-4157 + keytruda,59.03,42.37,1288.19,100,Stable Disease
M208783,67,Female,Melanoma,KEYTRUDA only,23.34,12.74,1318.07,86,Stable Disease
M208784,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.86,13.09,993.57,79,Stable Disease
M208785,45,Female,Melanoma,mrna-4157 + keytruda,49.76,40.19,693.93,90,Stable Disease
M208786,42,Female,HPV-related Cancer,KEYTRUDA only,46.46,38.96,761.7,94,Partial Response
M208787,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.33,25.76,1137.98,87,Stable Disease
M208788,84,Other,HPV-related Cancer,mrna-4157 + keytruda,50.05,51.14,919.54,74,Stable Disease
M208789,52,Male,Melanoma,mrna-4157 + keytruda,33.89,22.77,567.52,106,Complete Response
M208790,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.07,26.46,1233.94,83,Partial Response
M208791,68,Male,HPV-related Cancer,mrna-4157 + keytruda,49.85,32.03,1043.5,73,Progression
M208792,67,Female,Melanoma,mrna-4157 + keytruda,86.26,73.87,974.49,77,Progression
M208793,31,Male,Melanoma,mrna-4157 + keytruda,63.34,54.83,608.79,69,Unknown
M208794,56,Other,Melanoma,mrna-4157 + keytruda,48.09,42.42,1659.98,94,Unknown
M208795,63,Female,HPV-related Cancer,KEYTRUDA only,62.18,71.43,1094.56,87,Progression
M208796,48,Female,Melanoma,KEYTRUDA only,49.92,28.6,,101,Stable Disease
M208797,70,Female,Melanoma,mrna-4157 + keytruda,42.54,47.13,589.95,96,Stable Disease
M208798,76,Male,Melanoma,mrna-4157 + keytruda,55.17,45.06,1062.72,85,Unknown
M208799,72,Other,HPV-related Cancer,KEYTRUDA only,81.42,80.86,1142.42,97,Partial Response
M208800,33,Other,Melanoma,KEYTRUDA only,86.9,81.19,545.41,85,
M208801,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.54,19.36,738.3,81,Partial Response
M208802,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.0,16.31,485.87,102,Partial Response
M208803,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.16,,1084.44,87,Complete Response
M208804,29,Female,Melanoma,mrna-4157 + keytruda,44.84,36.57,1929.36,97,Partial Response
M208805,34,Male,Melanoma,KEYTRUDA only,45.78,37.19,563.07,92,Progression
M208806,69,Female,Melanoma,KEYTRUDA only,82.81,76.22,1332.65,94,Partial Response
M208807,25,Other,HPV-related Cancer,mrna-4157 + keytruda,57.45,36.23,1120.32,104,Stable Disease
M208808,78,Other,HPV-related Cancer,mrna-4157 + keytruda,43.83,20.93,1583.31,97,Stable Disease
M208809,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.31,17.81,2015.13,85,Complete Response
M208810,26,Other,HPV-related Cancer,mrna-4157 + keytruda,58.97,55.79,1080.16,91,Partial Response
M208811,47,Other,Melanoma,KEYTRUDA only,76.79,61.99,1102.22,104,Partial Response
M208812,68,Male,Melanoma,mrna-4157 + keytruda,40.84,50.23,566.49,88,Stable Disease
M208813,62,Other,Melanoma,KEYTRUDA only,28.07,23.74,659.48,102,Stable Disease
M208814,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.5,24.68,474.71,90,Partial Response
M208815,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.68,39.85,304.97,78,Progression
M208816,54,Female,Melanoma,mrna-4157 + keytruda,48.6,32.5,1341.15,99,Partial Response
M208817,60,Male,HPV-related Cancer,mrna-4157 + keytruda,50.92,38.84,481.36,100,Progression
M208818,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.81,16.68,848.75,99,Partial Response
M208819,57,Other,HPV-related Cancer,KEYTRUDA only,50.04,29.18,1185.15,108,Complete Response
M208820,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.68,23.38,1808.28,82,Progression
M208821,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.16,55.94,1012.41,86,Stable Disease
M208822,53,Other,Melanoma,KEYTRUDA only,39.16,28.64,1489.91,83,Partial Response
M208823,44,Male,HPV-related Cancer,mrna-4157 + keytruda,31.45,,1146.46,97,Partial Response
M208824,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.52,53.5,758.5,100,Complete Response
M208825,70,Male,Melanoma,mrna-4157 + keytruda,80.48,46.89,1277.18,99,Stable Disease
M208826,82,Female,Melanoma,mrna-4157 + keytruda,45.14,27.9,908.51,91,Complete Response
M208827,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.3,62.57,506.59,79,Stable Disease
M208828,67,Female,HPV-related Cancer,KEYTRUDA only,29.48,27.96,910.61,87,Partial Response
M208829,42,Male,Melanoma,mrna-4157 + keytruda,70.02,24.07,670.45,81,Progression
M208830,84,Female,Melanoma,KEYTRUDA only,67.46,53.43,1168.14,100,
M208831,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.65,39.32,1269.56,73,Progression
M208832,56,Female,HPV-related Cancer,mrna-4157 + keytruda,51.45,69.27,896.37,78,Partial Response
M208833,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.58,23.58,1330.29,102,Stable Disease
M208834,53,Male,Melanoma,KEYTRUDA only,26.2,21.69,846.58,90,Complete Response
M208835,78,Other,Melanoma,mrna-4157 + keytruda,8.67,6.28,438.98,75,Partial Response
M208836,38,Other,Melanoma,mrna-4157 + keytruda,34.29,29.53,1393.3,87,Complete Response
M208837,64,Male,Melanoma,mrna-4157 + keytruda,54.31,35.53,1546.45,87,Partial Response
M208838,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,30.56,23.5,815.96,90,Progression
M208839,58,Other,HPV-related Cancer,KEYTRUDA only,49.44,38.92,720.49,107,Unknown
M208840,28,Male,Melanoma,mrna-4157 + keytruda,58.98,45.98,337.19,96,Progression
M208841,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.11,27.43,965.89,86,Complete Response
M208842,26,Female,HPV-related Cancer,KEYTRUDA only,30.3,36.86,1376.06,102,Partial Response
M208843,47,Female,Melanoma,mrna-4157 + keytruda,31.86,27.69,674.52,77,Progression
M208844,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.29,19.26,1195.48,79,Progression
M208845,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.19,19.63,132.96,97,
M208846,30,Female,HPV-related Cancer,KEYTRUDA only,55.77,33.09,726.82,105,Stable Disease
M208847,76,Other,HPV-related Cancer,KEYTRUDA only,9.67,7.2,732.12,80,Progression
M208848,47,Male,Melanoma,KEYTRUDA only,61.97,52.17,1244.18,97,Progression
M208849,39,Female,HPV-related Cancer,KEYTRUDA only,29.77,15.63,1249.09,93,Progression
M208850,41,Other,HPV-related Cancer,KEYTRUDA only,60.04,31.3,2008.72,97,Partial Response
M208851,27,Male,Melanoma,mrna-4157 + keytruda,60.93,21.62,1661.37,82,Complete Response
M208852,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,96.6,56.7,652.55,98,Stable Disease
M208853,44,Male,Melanoma,KEYTRUDA only,54.55,62.02,,71,Complete Response
M208854,36,Other,HPV-related Cancer,mrna-4157 + keytruda,61.83,51.93,1248.75,89,Partial Response
M208855,65,Male,HPV-related Cancer,KEYTRUDA only,13.7,9.16,762.43,85,Partial Response
M208856,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.95,83.21,1308.34,89,Partial Response
M208857,75,Female,Melanoma,mrna-4157 + keytruda,45.26,26.72,151.58,76,Complete Response
M208858,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.8,60.16,1575.4,90,Complete Response
M208859,53,Other,HPV-related Cancer,mrna-4157 + keytruda,76.32,62.7,966.42,108,Stable Disease
M208860,69,Male,HPV-related Cancer,KEYTRUDA only,38.19,28.53,0.24,89,Progression
M208861,58,Female,Melanoma,KEYTRUDA only,48.48,27.56,1098.36,98,Progression
M208862,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.32,15.0,1099.42,72,Progression
M208863,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.56,25.07,,71,Complete Response
M208864,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.91,61.73,444.01,95,Stable Disease
M208865,81,Other,HPV-related Cancer,KEYTRUDA only,74.59,82.04,1475.81,86,Complete Response
M208866,58,Male,HPV-related Cancer,mrna-4157 + keytruda,44.14,20.09,964.39,96,Unknown
M208867,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.0,48.85,1436.07,82,
M208868,30,Other,Melanoma,mrna-4157 + keytruda,71.59,75.26,1175.33,93,Stable Disease
M208869,37,Female,HPV-related Cancer,KEYTRUDA only,38.12,28.28,,80,Stable Disease
M208870,41,Other,HPV-related Cancer,mrna-4157 + keytruda,64.8,73.79,242.53,107,Complete Response
M208871,65,Other,HPV-related Cancer,mrna-4157 + keytruda,43.01,35.68,1837.53,98,Partial Response
M208872,71,Other,HPV-related Cancer,mrna-4157 + keytruda,-6.15,-2.32,788.09,96,Stable Disease
M208873,36,Other,Melanoma,mrna-4157 + keytruda,52.57,46.62,545.85,109,Progression
M208874,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.4,41.82,1890.89,85,Stable Disease
M208875,83,Male,Melanoma,KEYTRUDA only,43.31,31.23,825.12,98,Unknown
M208876,80,Other,HPV-related Cancer,KEYTRUDA only,15.63,12.81,1459.37,86,Partial Response
M208877,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.98,17.25,550.49,92,Progression
M208878,43,Other,HPV-related Cancer,mrna-4157 + keytruda,53.38,30.66,1329.32,78,Partial Response
M208879,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.82,33.03,564.7,96,Stable Disease
M208880,52,Female,Melanoma,KEYTRUDA only,63.47,,424.17,76,Stable Disease
M208881,50,Male,Melanoma,mrna-4157 + keytruda,43.85,33.53,1692.8,90,Complete Response
M208882,47,Male,Melanoma,mrna-4157 + keytruda,39.61,23.34,,95,Complete Response
M208883,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,78.03,64.94,843.37,93,Stable Disease
M208884,52,Female,HPV-related Cancer,mrna-4157 + keytruda,26.74,16.23,364.95,88,Progression
M208885,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.04,49.55,1070.84,97,Complete Response
M208886,42,Male,HPV-related Cancer,KEYTRUDA only,35.02,25.87,-20.72,97,Progression
M208887,30,Other,HPV-related Cancer,mrna-4157 + keytruda,54.03,58.33,1565.36,82,Complete Response
M208888,63,Male,Melanoma,KEYTRUDA only,31.67,23.44,1014.18,103,Partial Response
M208889,78,Other,Melanoma,mrna-4157 + keytruda,75.17,44.29,1056.48,87,
M208890,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.85,43.38,457.42,85,Progression
M208891,80,Other,HPV-related Cancer,KEYTRUDA only,58.71,45.32,1300.54,83,Complete Response
M208892,25,Other,Melanoma,mrna-4157 + keytruda,60.6,38.3,778.02,81,Partial Response
M208893,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,7.98,5.61,,90,Complete Response
M208894,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,98.16,60.45,1168.83,102,Unknown
M208895,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,76.41,61.57,486.32,96,Progression
M208896,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.88,29.22,1715.1,82,Partial Response
M208897,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.38,20.12,859.2,97,Partial Response
M208898,38,Female,Melanoma,KEYTRUDA only,28.2,21.0,958.39,90,Complete Response
M208899,31,Male,HPV-related Cancer,KEYTRUDA only,39.59,,1009.51,90,Complete Response
M208900,75,Female,HPV-related Cancer,KEYTRUDA only,52.88,37.31,1052.0,90,Partial Response
M208901,72,Male,Melanoma,mrna-4157 + keytruda,44.04,35.11,1451.64,90,Complete Response
M208902,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.42,,997.26,90,Stable Disease
M208903,61,Female,Melanoma,mrna-4157 + keytruda,73.68,26.07,753.19,80,Partial Response
M208904,48,Male,HPV-related Cancer,mrna-4157 + keytruda,43.64,23.95,1579.81,96,Partial Response
M208905,45,Male,HPV-related Cancer,mrna-4157 + keytruda,25.42,13.49,580.44,81,
M208906,30,Female,Melanoma,mrna-4157 + keytruda,35.99,26.12,1151.62,96,Complete Response
M208907,44,Male,Melanoma,KEYTRUDA only,17.28,21.95,,77,Stable Disease
M208908,74,Male,Melanoma,mrna-4157 + keytruda,1.92,1.36,420.14,103,Complete Response
M208909,71,Female,HPV-related Cancer,mrna-4157 + keytruda,64.33,54.83,1452.69,104,Unknown
M208910,28,Male,Melanoma,mrna-4157 + keytruda,56.78,43.21,819.35,85,Progression
M208911,47,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.55,17.76,731.94,82,Stable Disease
M208912,46,Female,Melanoma,mrna-4157 + keytruda,44.22,33.75,1584.32,94,Partial Response
M208913,43,Female,HPV-related Cancer,mrna-4157 + keytruda,49.23,30.64,1016.89,82,Stable Disease
M208914,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.06,25.42,896.08,89,Progression
M208915,30,Female,Melanoma,mrna-4157 + keytruda,7.4,6.02,643.26,77,Stable Disease
M208916,80,Female,HPV-related Cancer,mrna-4157 + keytruda,38.78,21.68,1131.56,78,Progression
M208917,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.94,26.53,1025.24,102,Progression
M208918,32,Female,HPV-related Cancer,KEYTRUDA only,56.16,56.81,1430.01,89,Partial Response
M208919,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,23.12,16.47,1271.05,108,Stable Disease
M208920,26,Other,Melanoma,mrna-4157 + keytruda,69.38,58.03,659.32,79,Stable Disease
M208921,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.09,43.19,,100,Partial Response
M208922,69,Male,Melanoma,mrna-4157 + keytruda,66.16,76.36,1488.25,88,Complete Response
M208923,31,Female,HPV-related Cancer,mrna-4157 + keytruda,50.37,49.73,1266.24,93,Partial Response
M208924,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.42,54.96,1145.92,73,Partial Response
M208925,35,Other,Melanoma,mrna-4157 + keytruda,59.4,41.35,1354.38,90,Partial Response
M208926,55,Other,HPV-related Cancer,mrna-4157 + keytruda,37.2,12.78,1390.31,90,Stable Disease
M208927,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.8,35.68,588.96,80,Partial Response
M208928,45,Female,Melanoma,KEYTRUDA only,27.97,29.24,,87,Complete Response
M208929,31,Male,Melanoma,KEYTRUDA only,31.54,24.56,1370.5,77,Partial Response
M208930,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,14.41,7.8,1699.84,108,Complete Response
M208931,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,9.13,6.01,1301.73,77,Partial Response
M208932,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,15.35,11.57,176.42,108,Complete Response
M208933,59,Male,HPV-related Cancer,KEYTRUDA only,72.2,,1577.31,91,Partial Response
M208934,80,Other,Melanoma,mrna-4157 + keytruda,50.26,56.35,,100,Progression
M208935,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.06,44.47,1042.36,75,Progression
M208936,82,Other,Melanoma,mrna-4157 + keytruda,32.35,26.53,734.26,88,Stable Disease
M208937,37,Other,HPV-related Cancer,mrna-4157 + keytruda,39.7,30.89,1355.89,97,Stable Disease
M208938,66,Male,Melanoma,mrna-4157 + keytruda,30.17,29.13,1242.39,88,
M208939,73,Other,HPV-related Cancer,KEYTRUDA only,36.73,43.13,870.59,95,Unknown
M208940,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.44,17.1,1244.17,104,Stable Disease
M208941,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.27,50.07,833.06,101,Complete Response
M208942,34,Female,Melanoma,mrna-4157 + keytruda,69.99,59.42,543.52,102,Complete Response
M208943,58,Male,Melanoma,KEYTRUDA only,76.08,60.37,1161.72,80,Partial Response
M208944,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.69,36.59,1131.32,76,Partial Response
M208945,55,Male,HPV-related Cancer,KEYTRUDA only,41.25,29.29,1305.38,89,Stable Disease
M208946,58,Male,HPV-related Cancer,mrna-4157 + keytruda,70.88,41.87,1706.02,96,Stable Disease
M208947,42,Other,Melanoma,mrna-4157 + keytruda,57.24,46.09,1268.9,70,Partial Response
M208948,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.79,68.06,,80,Stable Disease
M208949,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.38,29.49,473.09,90,Stable Disease
M208950,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.96,36.27,,82,Stable Disease
M208951,77,Male,Melanoma,mrna-4157 + keytruda,58.07,37.66,897.63,94,Progression
M208952,30,Female,Melanoma,mrna-4157 + keytruda,25.72,19.62,1406.87,85,Progression
M208953,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.58,52.89,739.79,71,Complete Response
M208954,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.22,50.95,1131.33,100,Partial Response
M208955,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.58,32.46,1208.9,83,Progression
M208956,50,Female,HPV-related Cancer,mrna-4157 + keytruda,25.78,14.83,1496.06,100,Stable Disease
M208957,55,Male,Melanoma,mrna-4157 + keytruda,49.31,47.26,1496.53,100,Stable Disease
M208958,35,Male,Melanoma,KEYTRUDA only,55.98,59.38,615.05,84,Unknown
M208959,50,Other,HPV-related Cancer,KEYTRUDA only,41.29,40.1,,90,Stable Disease
M208960,51,Other,Melanoma,KEYTRUDA only,75.31,,686.7,90,Stable Disease
M208961,35,Other,HPV-related Cancer,KEYTRUDA only,40.26,32.64,1900.79,75,Partial Response
M208962,66,Male,HPV-related Cancer,KEYTRUDA only,63.45,66.69,1590.42,89,Unknown
M208963,35,Other,HPV-related Cancer,KEYTRUDA only,50.58,54.67,685.74,66,Progression
M208964,62,Other,HPV-related Cancer,KEYTRUDA only,50.63,40.06,1171.45,76,Stable Disease
M208965,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.18,66.05,632.15,102,Stable Disease
M208966,29,Other,Melanoma,KEYTRUDA only,17.1,11.02,1443.8,94,Stable Disease
M208967,63,Male,HPV-related Cancer,mrna-4157 + keytruda,49.28,57.22,2243.44,84,Progression
M208968,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.83,47.6,806.75,95,Partial Response
M208969,52,Female,Melanoma,KEYTRUDA only,50.71,59.18,500.99,70,
M208970,56,Female,Melanoma,mrna-4157 + keytruda,33.27,26.89,1031.77,112,Stable Disease
M208971,43,Male,Melanoma,mrna-4157 + keytruda,41.55,33.88,938.41,99,Partial Response
M208972,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,30.4,34.09,628.45,88,Complete Response
M208973,34,Other,HPV-related Cancer,mrna-4157 + keytruda,56.97,40.08,924.05,88,Partial Response
M208974,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.07,50.5,881.58,94,Stable Disease
M208975,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,31.52,34.66,916.44,112,Progression
M208976,36,Male,Melanoma,KEYTRUDA only,50.74,39.42,842.18,100,Progression
M208977,26,Other,Melanoma,mrna-4157 + keytruda,62.86,53.37,682.61,105,Complete Response
M208978,58,Other,HPV-related Cancer,mrna-4157 + keytruda,63.91,47.28,1588.49,81,Complete Response
M208979,53,Other,HPV-related Cancer,KEYTRUDA only,44.99,32.26,1189.91,95,Partial Response
M208980,49,Male,HPV-related Cancer,KEYTRUDA only,49.71,34.16,812.24,94,Partial Response
M208981,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,95.38,85.84,877.41,73,Stable Disease
M208982,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,12.35,7.48,1046.8,95,Unknown
M208983,71,Male,Melanoma,mrna-4157 + keytruda,61.45,52.13,655.08,78,Stable Disease
M208984,41,Other,HPV-related Cancer,mrna-4157 + keytruda,28.57,24.92,,79,Partial Response
M208985,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,67.48,43.5,1253.4,84,Partial Response
M208986,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.05,53.01,1341.14,94,Stable Disease
M208987,50,Male,HPV-related Cancer,mrna-4157 + keytruda,33.71,38.52,1382.52,86,Progression
M208988,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.66,43.21,1020.14,88,Complete Response
M208989,52,Other,HPV-related Cancer,mrna-4157 + keytruda,31.71,29.31,510.4,92,Partial Response
M208990,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.99,41.21,1098.85,83,Stable Disease
M208991,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.28,75.26,846.57,89,Progression
M208992,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.94,48.3,1018.23,95,Partial Response
M208993,44,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.28,52.18,1644.6,93,Partial Response
M208994,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,7.08,7.09,777.83,90,Partial Response
M208995,51,Male,HPV-related Cancer,mrna-4157 + keytruda,49.55,33.42,1445.02,82,Stable Disease
M208996,48,Female,Melanoma,mrna-4157 + keytruda,52.25,61.46,513.43,98,Progression
M208997,54,Female,Melanoma,mrna-4157 + keytruda,46.3,31.58,1035.33,78,
M208998,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.9,48.02,469.14,95,
M208999,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.42,46.09,920.73,68,Stable Disease
M209000,45,Male,Melanoma,mrna-4157 + keytruda,30.87,26.87,,94,Progression
M209001,81,Female,Melanoma,mrna-4157 + keytruda,27.4,28.67,492.32,80,Partial Response
M209002,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,92.75,48.66,1278.75,97,Complete Response
M209003,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.42,41.22,957.82,91,Stable Disease
M209004,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.33,13.7,934.12,88,Stable Disease
M209005,78,Other,HPV-related Cancer,KEYTRUDA only,33.33,29.4,1211.91,70,
M209006,49,Male,Melanoma,KEYTRUDA only,3.62,2.94,,80,Stable Disease
M209007,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,32.8,24.67,1158.69,86,Partial Response
M209008,83,Other,Melanoma,KEYTRUDA only,57.61,66.72,275.88,91,Stable Disease
M209009,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,47.91,41.72,842.31,82,Progression
M209010,59,Male,HPV-related Cancer,KEYTRUDA only,31.45,43.39,1256.93,79,Partial Response
M209011,56,Male,Melanoma,mrna-4157 + keytruda,37.05,34.7,1574.0,102,Stable Disease
M209012,57,Female,HPV-related Cancer,mrna-4157 + keytruda,62.87,35.72,898.97,85,Stable Disease
M209013,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.34,29.24,530.24,92,Partial Response
M209014,65,Other,HPV-related Cancer,KEYTRUDA only,58.57,54.44,398.92,83,Complete Response
M209015,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.12,47.69,868.67,90,Progression
M209016,50,Other,HPV-related Cancer,mrna-4157 + keytruda,-1.06,-0.35,1150.05,112,Partial Response
M209017,25,Female,Melanoma,KEYTRUDA only,48.45,32.09,1166.5,94,Stable Disease
M209018,62,Male,Melanoma,mrna-4157 + keytruda,59.14,54.42,1174.04,88,Complete Response
M209019,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.93,36.48,686.52,104,Complete Response
M209020,65,Male,HPV-related Cancer,mrna-4157 + keytruda,49.61,25.78,1006.74,93,Stable Disease
M209021,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,73.58,45.77,1136.19,76,Partial Response
M209022,66,Male,HPV-related Cancer,mrna-4157 + keytruda,52.56,48.83,1388.48,96,Complete Response
M209023,76,Other,Melanoma,mrna-4157 + keytruda,40.93,28.9,798.93,95,
M209024,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.47,45.26,1205.78,108,Progression
M209025,45,Female,HPV-related Cancer,mrna-4157 + keytruda,18.65,16.21,852.34,88,Stable Disease
M209026,37,Male,Melanoma,KEYTRUDA only,44.42,27.01,911.36,85,Stable Disease
M209027,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,65.08,87.4,563.24,89,Partial Response
M209028,72,Female,Melanoma,KEYTRUDA only,79.66,39.14,532.39,94,Partial Response
M209029,80,Female,HPV-related Cancer,mrna-4157 + keytruda,39.22,36.0,999.02,87,Unknown
M209030,43,Female,Melanoma,KEYTRUDA only,77.22,59.34,604.36,108,Complete Response
M209031,25,Female,HPV-related Cancer,mrna-4157 + keytruda,18.4,19.9,908.22,92,Partial Response
M209032,70,Male,HPV-related Cancer,mrna-4157 + keytruda,88.58,71.71,1047.04,91,Complete Response
M209033,84,Female,Melanoma,KEYTRUDA only,65.05,54.71,1350.44,86,Stable Disease
M209034,78,Female,Melanoma,mrna-4157 + keytruda,78.71,53.4,1126.49,86,Partial Response
M209035,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.47,33.81,1602.67,94,Partial Response
M209036,65,Male,Melanoma,KEYTRUDA only,60.22,44.3,1538.06,104,Progression
M209037,52,Other,Melanoma,mrna-4157 + keytruda,17.5,16.15,796.46,84,Progression
M209038,55,Female,Melanoma,KEYTRUDA only,34.67,29.51,480.48,106,Complete Response
M209039,68,Female,Melanoma,KEYTRUDA only,56.29,39.97,908.67,96,Progression
M209040,77,Other,HPV-related Cancer,mrna-4157 + keytruda,77.47,62.84,791.23,88,Progression
M209041,73,Male,Melanoma,mrna-4157 + keytruda,31.56,25.1,598.39,83,Complete Response
M209042,41,Male,HPV-related Cancer,mrna-4157 + keytruda,41.57,37.86,339.23,94,
M209043,69,Other,HPV-related Cancer,mrna-4157 + keytruda,58.35,59.36,989.92,85,Stable Disease
M209044,39,Female,HPV-related Cancer,KEYTRUDA only,56.86,32.38,1241.18,75,Stable Disease
M209045,31,Female,HPV-related Cancer,mrna-4157 + keytruda,67.31,60.99,797.98,86,Stable Disease
M209046,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.31,37.37,1043.29,73,Partial Response
M209047,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.53,44.08,764.16,94,Partial Response
M209048,76,Female,Melanoma,KEYTRUDA only,67.05,31.75,1192.1,99,Stable Disease
M209049,36,Other,Melanoma,mrna-4157 + keytruda,25.03,20.43,1040.84,106,Complete Response
M209050,68,Other,HPV-related Cancer,KEYTRUDA only,91.05,104.5,558.08,80,Complete Response
M209051,28,Other,HPV-related Cancer,mrna-4157 + keytruda,44.17,25.51,1000.74,83,Stable Disease
M209052,30,Male,Melanoma,mrna-4157 + keytruda,37.06,33.31,1120.41,110,Progression
M209053,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.96,61.15,1143.09,97,Partial Response
M209054,76,Other,HPV-related Cancer,mrna-4157 + keytruda,60.31,44.56,1085.67,83,Stable Disease
M209055,46,Male,Melanoma,KEYTRUDA only,64.59,,532.47,96,Partial Response
M209056,55,Other,Melanoma,KEYTRUDA only,60.98,52.68,1103.34,106,Partial Response
M209057,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.37,49.44,629.87,79,Partial Response
M209058,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.23,28.15,4.81,94,Unknown
M209059,73,Female,HPV-related Cancer,KEYTRUDA only,70.72,81.57,1170.46,79,Stable Disease
M209060,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.09,50.1,882.43,70,Progression
M209061,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.52,13.1,245.26,70,Stable Disease
M209062,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.87,29.11,585.23,85,Stable Disease
M209063,70,Female,Melanoma,KEYTRUDA only,55.58,44.14,723.32,97,Partial Response
M209064,59,Other,HPV-related Cancer,KEYTRUDA only,67.45,72.78,1712.04,83,
M209065,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.67,65.92,984.35,93,Progression
M209066,55,Female,HPV-related Cancer,mrna-4157 + keytruda,41.72,23.37,1015.74,80,Progression
M209067,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,101.18,127.23,1320.57,86,Partial Response
M209068,70,Other,Melanoma,mrna-4157 + keytruda,54.55,37.77,1000.98,94,Stable Disease
M209069,45,Male,Melanoma,mrna-4157 + keytruda,51.19,49.73,888.91,104,Partial Response
M209070,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.18,49.89,1162.86,90,Partial Response
M209071,26,Female,Melanoma,KEYTRUDA only,27.98,22.32,1170.68,99,Progression
M209072,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,73.91,47.62,936.88,85,Stable Disease
M209073,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.68,46.05,1399.26,74,Partial Response
M209074,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.93,37.52,608.34,94,Stable Disease
M209075,40,Male,Melanoma,mrna-4157 + keytruda,75.51,65.83,1341.43,88,Stable Disease
M209076,64,Female,HPV-related Cancer,mrna-4157 + keytruda,38.05,44.89,,102,Unknown
M209077,30,Female,HPV-related Cancer,KEYTRUDA only,26.16,19.34,981.47,80,Partial Response
M209078,41,Male,HPV-related Cancer,mrna-4157 + keytruda,69.19,75.5,803.6,104,Stable Disease
M209079,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.5,,,106,Stable Disease
M209080,63,Female,Melanoma,mrna-4157 + keytruda,48.89,42.0,701.41,107,Stable Disease
M209081,36,Male,Melanoma,KEYTRUDA only,46.92,38.91,1063.25,91,Stable Disease
M209082,69,Male,HPV-related Cancer,KEYTRUDA only,33.8,34.45,,96,Stable Disease
M209083,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.78,81.76,1058.72,98,Progression
M209084,32,Other,Melanoma,mrna-4157 + keytruda,39.27,27.59,1001.13,92,Progression
M209085,80,Other,HPV-related Cancer,mrna-4157 + keytruda,29.34,13.14,1052.17,99,Complete Response
M209086,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.23,35.89,877.38,71,Stable Disease
M209087,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.8,19.77,1298.43,103,Unknown
M209088,59,Other,HPV-related Cancer,mrna-4157 + keytruda,45.09,19.8,1003.64,69,Progression
M209089,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.43,25.94,860.6,91,Progression
M209090,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.21,56.53,1203.1,88,Complete Response
M209091,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.68,43.33,258.49,96,Partial Response
M209092,59,Male,Melanoma,mrna-4157 + keytruda,50.48,42.69,502.13,89,Complete Response
M209093,71,Other,Melanoma,KEYTRUDA only,38.85,31.77,709.01,80,
M209094,84,Female,HPV-related Cancer,mrna-4157 + keytruda,39.94,26.1,1635.17,71,
M209095,40,Female,Melanoma,mrna-4157 + keytruda,38.68,11.71,-2.65,95,Partial Response
M209096,66,Male,HPV-related Cancer,mrna-4157 + keytruda,78.55,,,105,Partial Response
M209097,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.3,28.95,767.91,93,Complete Response
M209098,80,Male,HPV-related Cancer,KEYTRUDA only,59.92,27.49,1304.42,88,Complete Response
M209099,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.74,21.28,859.48,89,Complete Response
M209100,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.93,25.98,576.94,83,Stable Disease
M209101,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.8,34.72,353.99,81,Partial Response
M209102,69,Female,Melanoma,mrna-4157 + keytruda,44.38,26.39,774.43,105,Stable Disease
M209103,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.03,45.68,1754.76,93,Progression
M209104,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.66,26.51,1570.33,85,Stable Disease
M209105,75,Other,Melanoma,KEYTRUDA only,57.01,49.29,788.89,101,Stable Disease
M209106,78,Female,HPV-related Cancer,KEYTRUDA only,34.04,,1136.53,78,Stable Disease
M209107,53,Male,Melanoma,mrna-4157 + keytruda,25.59,19.22,623.57,93,Progression
M209108,71,Male,HPV-related Cancer,KEYTRUDA only,58.9,35.9,1082.79,88,Partial Response
M209109,71,Male,Melanoma,mrna-4157 + keytruda,70.2,67.45,226.26,91,Progression
M209110,31,Other,Melanoma,mrna-4157 + keytruda,53.12,38.25,1456.28,90,Partial Response
M209111,83,Other,Melanoma,KEYTRUDA only,-1.21,,1451.1,92,Stable Disease
M209112,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.52,42.5,1353.32,99,Stable Disease
M209113,77,Other,HPV-related Cancer,mrna-4157 + keytruda,54.76,46.27,1083.09,107,Partial Response
M209114,43,Other,HPV-related Cancer,KEYTRUDA only,56.19,60.08,336.1,86,Complete Response
M209115,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,77.31,61.71,541.26,89,Partial Response
M209116,65,Other,Melanoma,KEYTRUDA only,29.81,25.09,1893.72,84,Stable Disease
M209117,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.92,43.77,833.1,80,Partial Response
M209118,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.98,17.9,1271.96,98,Partial Response
M209119,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.1,31.7,894.46,88,Progression
M209120,48,Female,Melanoma,KEYTRUDA only,49.62,43.2,1169.75,85,Unknown
M209121,63,Female,Melanoma,mrna-4157 + keytruda,51.85,45.95,639.52,91,Stable Disease
M209122,28,Other,Melanoma,mrna-4157 + keytruda,52.05,30.79,,97,Progression
M209123,25,Other,Melanoma,mrna-4157 + keytruda,38.49,32.93,589.21,91,Progression
M209124,53,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.67,42.43,720.02,66,Stable Disease
M209125,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.59,30.33,963.94,72,Unknown
M209126,62,Female,Melanoma,mrna-4157 + keytruda,94.0,81.47,1352.0,80,Unknown
M209127,40,Female,Melanoma,mrna-4157 + keytruda,106.67,77.73,1100.45,105,Progression
M209128,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.21,23.11,976.09,96,Progression
M209129,77,Male,HPV-related Cancer,mrna-4157 + keytruda,78.38,34.33,1819.16,90,Stable Disease
M209130,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.93,56.54,1072.74,79,Complete Response
M209131,61,Male,Melanoma,mrna-4157 + keytruda,22.4,24.01,1190.75,102,Partial Response
M209132,33,Male,Melanoma,KEYTRUDA only,33.04,30.32,603.75,82,Partial Response
M209133,69,Male,Melanoma,mrna-4157 + keytruda,56.64,38.42,1038.37,86,Complete Response
M209134,61,Male,Melanoma,mrna-4157 + keytruda,39.33,,1634.6,80,Complete Response
M209135,31,Female,Melanoma,mrna-4157 + keytruda,62.3,51.3,1020.36,79,Complete Response
M209136,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.75,46.9,1046.14,83,Progression
M209137,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.51,34.15,,94,Stable Disease
M209138,63,Male,Melanoma,mrna-4157 + keytruda,21.87,17.25,1666.32,95,Partial Response
M209139,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,-7.66,-6.01,1280.9,92,Stable Disease
M209140,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.93,28.25,1449.13,103,Complete Response
M209141,66,Other,HPV-related Cancer,mrna-4157 + keytruda,53.6,22.15,537.58,95,Progression
M209142,77,Male,HPV-related Cancer,mrna-4157 + keytruda,53.51,40.15,1065.38,83,Partial Response
M209143,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,96.44,47.23,839.98,91,Partial Response
M209144,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.4,39.59,821.28,91,Stable Disease
M209145,65,Female,Melanoma,mrna-4157 + keytruda,29.88,16.81,549.8,78,Stable Disease
M209146,68,Other,HPV-related Cancer,mrna-4157 + keytruda,57.99,39.75,,81,Progression
M209147,32,Other,HPV-related Cancer,mrna-4157 + keytruda,28.7,22.01,1167.91,81,Complete Response
M209148,62,Other,HPV-related Cancer,KEYTRUDA only,47.92,17.73,1464.12,86,Partial Response
M209149,75,Other,HPV-related Cancer,mrna-4157 + keytruda,23.66,19.38,,87,Progression
M209150,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.49,49.71,1560.95,84,Complete Response
M209151,46,Female,HPV-related Cancer,KEYTRUDA only,56.23,53.39,721.14,99,Partial Response
M209152,67,Female,Melanoma,mrna-4157 + keytruda,45.72,32.18,564.75,100,Complete Response
M209153,53,Other,Melanoma,KEYTRUDA only,51.63,68.3,721.06,89,Complete Response
M209154,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.6,,985.62,99,Stable Disease
M209155,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.45,45.65,900.23,95,
M209156,51,Male,Melanoma,mrna-4157 + keytruda,41.26,26.64,1190.84,94,Progression
M209157,67,Female,Melanoma,mrna-4157 + keytruda,37.45,36.17,1272.34,101,Unknown
M209158,82,Other,HPV-related Cancer,mrna-4157 + keytruda,96.57,40.15,1472.04,91,Stable Disease
M209159,50,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.68,51.32,1233.52,82,Complete Response
M209160,54,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.97,37.24,1393.88,86,Progression
M209161,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.24,41.94,733.96,100,Stable Disease
M209162,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,37.17,37.0,1482.91,81,Progression
M209163,26,Male,HPV-related Cancer,KEYTRUDA only,42.77,43.7,,73,Partial Response
M209164,30,Male,HPV-related Cancer,KEYTRUDA only,56.05,55.67,735.82,84,Progression
M209165,75,Other,HPV-related Cancer,mrna-4157 + keytruda,76.38,55.54,1154.44,92,
M209166,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,112.4,101.98,1231.15,103,Stable Disease
M209167,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.79,45.85,679.89,87,Partial Response
M209168,76,Female,Melanoma,mrna-4157 + keytruda,74.47,91.84,528.14,89,Progression
M209169,46,Female,Melanoma,mrna-4157 + keytruda,46.55,39.57,,76,Stable Disease
M209170,83,Female,HPV-related Cancer,KEYTRUDA only,47.13,32.34,,98,Partial Response
M209171,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.46,26.15,605.22,84,Complete Response
M209172,72,Male,Melanoma,mrna-4157 + keytruda,101.12,73.34,662.3,90,Partial Response
M209173,48,Female,HPV-related Cancer,KEYTRUDA only,89.43,101.81,,97,Unknown
M209174,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.08,23.62,975.2,97,Stable Disease
M209175,57,Male,Melanoma,mrna-4157 + keytruda,32.6,29.66,821.99,86,Stable Disease
M209176,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.63,31.93,1337.43,70,Complete Response
M209177,45,Male,Melanoma,mrna-4157 + keytruda,52.05,45.06,904.0,81,Partial Response
M209178,58,Female,Melanoma,mrna-4157 + keytruda,24.55,21.68,1268.62,86,Progression
M209179,63,Female,HPV-related Cancer,mrna-4157 + keytruda,57.22,71.24,1250.86,105,Complete Response
M209180,66,Female,HPV-related Cancer,KEYTRUDA only,53.85,45.58,611.16,89,Partial Response
M209181,80,Female,HPV-related Cancer,mrna-4157 + keytruda,55.74,50.87,1668.98,96,Stable Disease
M209182,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.99,84.96,675.71,83,Partial Response
M209183,40,Male,HPV-related Cancer,mrna-4157 + keytruda,51.44,43.06,602.78,82,Partial Response
M209184,40,Male,Melanoma,mrna-4157 + keytruda,46.36,17.41,587.73,88,Stable Disease
M209185,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.95,32.59,953.16,88,Stable Disease
M209186,36,Male,HPV-related Cancer,mrna-4157 + keytruda,36.9,24.25,1373.11,83,Stable Disease
M209187,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.93,4.42,620.03,83,Partial Response
M209188,27,Male,HPV-related Cancer,KEYTRUDA only,65.61,48.09,1583.41,101,Progression
M209189,40,Female,HPV-related Cancer,KEYTRUDA only,31.1,19.3,-19.31,89,
M209190,53,Female,HPV-related Cancer,KEYTRUDA only,52.53,57.97,1285.26,85,Partial Response
M209191,50,Female,Melanoma,KEYTRUDA only,59.45,33.9,824.21,95,Partial Response
M209192,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.11,18.89,847.5,94,
M209193,54,Other,Melanoma,mrna-4157 + keytruda,39.18,28.36,1133.72,102,Partial Response
M209194,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.06,57.51,1307.93,83,Stable Disease
M209195,46,Female,Melanoma,mrna-4157 + keytruda,75.81,81.56,,95,Progression
M209196,70,Female,Melanoma,KEYTRUDA only,35.46,24.13,951.32,104,Progression
M209197,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.04,31.24,730.16,87,Complete Response
M209198,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.9,52.71,1859.89,111,Partial Response
M209199,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.28,26.44,1151.2,92,Complete Response
M209200,25,Male,HPV-related Cancer,mrna-4157 + keytruda,82.43,52.51,1028.55,95,Stable Disease
M209201,77,Other,HPV-related Cancer,mrna-4157 + keytruda,17.82,18.23,938.38,98,Unknown
M209202,65,Other,HPV-related Cancer,KEYTRUDA only,49.91,39.39,1099.42,103,Progression
M209203,48,Male,HPV-related Cancer,mrna-4157 + keytruda,48.77,38.89,,88,Partial Response
M209204,74,Female,HPV-related Cancer,mrna-4157 + keytruda,40.77,21.5,1051.24,93,Partial Response
M209205,81,Female,Melanoma,mrna-4157 + keytruda,49.5,39.82,406.28,83,Complete Response
M209206,30,Other,HPV-related Cancer,mrna-4157 + keytruda,75.56,71.86,1027.36,107,Complete Response
M209207,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.28,24.02,894.15,92,
M209208,76,Female,Melanoma,KEYTRUDA only,71.08,59.54,111.39,96,Complete Response
M209209,59,Female,HPV-related Cancer,KEYTRUDA only,66.34,59.52,348.21,88,Partial Response
M209210,61,Other,Melanoma,KEYTRUDA only,67.91,50.6,581.6,91,Partial Response
M209211,59,Female,HPV-related Cancer,mrna-4157 + keytruda,26.21,28.52,1179.9,101,Stable Disease
M209212,55,Other,Melanoma,mrna-4157 + keytruda,28.08,24.69,837.49,84,Complete Response
M209213,68,Female,HPV-related Cancer,mrna-4157 + keytruda,71.85,51.54,945.57,95,Partial Response
M209214,67,Female,HPV-related Cancer,KEYTRUDA only,25.43,23.86,1607.77,94,Partial Response
M209215,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.66,58.95,1431.16,81,Progression
M209216,27,Female,HPV-related Cancer,mrna-4157 + keytruda,31.04,31.28,711.71,94,Stable Disease
M209217,68,Other,Melanoma,mrna-4157 + keytruda,78.27,68.65,229.91,71,Stable Disease
M209218,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,2.32,2.03,330.45,70,Progression
M209219,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.66,20.64,714.56,101,Unknown
M209220,52,Female,HPV-related Cancer,mrna-4157 + keytruda,68.89,50.73,1200.84,91,Stable Disease
M209221,36,Other,Melanoma,mrna-4157 + keytruda,39.18,23.94,664.23,68,Partial Response
M209222,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.15,30.07,1345.02,98,Complete Response
M209223,52,Male,Melanoma,KEYTRUDA only,45.35,35.23,1322.83,81,Partial Response
M209224,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,88.42,57.16,5822.9,90,Stable Disease
M209225,30,Other,Melanoma,mrna-4157 + keytruda,62.25,67.18,677.16,92,Complete Response
M209226,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.93,15.53,1244.38,96,Stable Disease
M209227,32,Other,Melanoma,KEYTRUDA only,35.66,43.76,390.63,83,Partial Response
M209228,71,Male,HPV-related Cancer,KEYTRUDA only,72.95,73.66,437.54,85,Progression
M209229,73,Male,HPV-related Cancer,KEYTRUDA only,81.18,79.96,,112,Partial Response
M209230,43,Male,HPV-related Cancer,KEYTRUDA only,75.64,,1361.2,78,Progression
M209231,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.28,39.06,1527.87,92,Complete Response
M209232,67,Female,Melanoma,mrna-4157 + keytruda,-4.23,-1.7,1527.07,97,Stable Disease
M209233,45,Female,Melanoma,KEYTRUDA only,58.38,39.58,1361.24,94,Stable Disease
M209234,40,Female,HPV-related Cancer,mrna-4157 + keytruda,41.2,21.63,842.24,104,Partial Response
M209235,77,Male,HPV-related Cancer,KEYTRUDA only,26.53,22.8,1158.15,104,Partial Response
M209236,82,Male,Melanoma,mrna-4157 + keytruda,33.85,24.59,1696.4,84,Progression
M209237,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.59,49.4,816.03,90,Partial Response
M209238,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.96,22.61,735.94,90,Complete Response
M209239,55,Other,Melanoma,KEYTRUDA only,25.86,31.18,1058.73,80,Partial Response
M209240,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.96,24.97,891.87,91,Stable Disease
M209241,70,Other,HPV-related Cancer,KEYTRUDA only,55.74,47.38,968.1,93,Partial Response
M209242,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.51,55.1,1504.2,83,Stable Disease
M209243,81,Other,Melanoma,KEYTRUDA only,56.15,45.57,613.53,91,Partial Response
M209244,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.71,59.36,775.9,97,Partial Response
M209245,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.37,26.42,402.68,85,Progression
M209246,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.61,50.58,279.16,82,Complete Response
M209247,52,Male,HPV-related Cancer,mrna-4157 + keytruda,57.63,34.85,939.28,88,Stable Disease
M209248,66,Other,Melanoma,mrna-4157 + keytruda,101.83,57.62,1092.3,84,Complete Response
M209249,61,Other,Melanoma,mrna-4157 + keytruda,69.5,57.55,-149.04,81,Complete Response
M209250,29,Male,HPV-related Cancer,KEYTRUDA only,61.48,64.07,379.45,90,Partial Response
M209251,35,Male,Melanoma,mrna-4157 + keytruda,32.07,6.83,1115.17,75,Stable Disease
M209252,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.1,39.19,1233.18,89,Partial Response
M209253,30,Female,HPV-related Cancer,mrna-4157 + keytruda,26.18,22.96,743.23,90,Stable Disease
M209254,73,Female,Melanoma,KEYTRUDA only,42.81,31.52,868.36,96,Stable Disease
M209255,44,Other,Melanoma,mrna-4157 + keytruda,50.72,32.47,740.16,79,Partial Response
M209256,70,Female,Melanoma,mrna-4157 + keytruda,38.86,23.7,1152.38,98,Stable Disease
M209257,33,Female,HPV-related Cancer,mrna-4157 + keytruda,48.32,25.97,1137.43,79,Partial Response
M209258,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.36,51.4,,98,Partial Response
M209259,63,Female,HPV-related Cancer,KEYTRUDA only,38.77,31.02,874.25,87,Progression
M209260,63,Female,Melanoma,mrna-4157 + keytruda,43.14,35.27,1065.42,90,Stable Disease
M209261,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,28.62,24.91,1117.98,87,Stable Disease
M209262,35,Female,Melanoma,KEYTRUDA only,0.73,0.51,1440.18,85,Partial Response
M209263,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.34,29.87,533.98,70,Progression
M209264,51,Female,HPV-related Cancer,mrna-4157 + keytruda,45.42,35.33,1095.91,95,Progression
M209265,36,Other,HPV-related Cancer,KEYTRUDA only,34.73,19.45,1462.44,93,Partial Response
M209266,41,Male,HPV-related Cancer,mrna-4157 + keytruda,61.83,57.99,1131.96,89,Stable Disease
M209267,67,Male,Melanoma,KEYTRUDA only,70.07,49.61,934.17,82,Partial Response
M209268,43,Male,HPV-related Cancer,mrna-4157 + keytruda,37.08,32.2,934.28,87,Stable Disease
M209269,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.13,22.52,800.67,101,Unknown
M209270,60,Other,Melanoma,mrna-4157 + keytruda,54.84,55.97,660.55,85,Partial Response
M209271,76,Male,Melanoma,mrna-4157 + keytruda,66.42,52.77,961.01,88,Progression
M209272,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.58,,973.45,98,Stable Disease
M209273,61,Other,Melanoma,mrna-4157 + keytruda,66.01,28.23,1082.3,86,Partial Response
M209274,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.93,73.6,1300.34,84,
M209275,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,8.57,5.25,851.86,91,Stable Disease
M209276,82,Female,HPV-related Cancer,mrna-4157 + keytruda,74.26,54.6,2063.22,90,Stable Disease
M209277,60,Other,HPV-related Cancer,KEYTRUDA only,60.8,40.8,1385.61,84,Stable Disease
M209278,34,Female,Melanoma,mrna-4157 + keytruda,29.38,12.87,,104,Stable Disease
M209279,28,Female,HPV-related Cancer,KEYTRUDA only,59.3,52.33,1141.39,88,Partial Response
M209280,69,Other,Melanoma,mrna-4157 + keytruda,5.9,4.74,1321.44,87,Unknown
M209281,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.67,29.58,1160.53,111,Progression
M209282,72,Female,HPV-related Cancer,mrna-4157 + keytruda,58.57,58.91,1443.99,88,Partial Response
M209283,43,Male,HPV-related Cancer,mrna-4157 + keytruda,41.78,16.95,610.35,89,Stable Disease
M209284,56,Female,HPV-related Cancer,KEYTRUDA only,81.13,65.94,946.21,81,Stable Disease
M209285,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,28.53,24.36,201.84,93,Partial Response
M209286,77,Other,HPV-related Cancer,mrna-4157 + keytruda,80.5,42.95,2095.34,73,Complete Response
M209287,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.19,9.48,839.28,66,Stable Disease
M209288,66,Female,Melanoma,KEYTRUDA only,57.05,23.5,1215.54,98,Partial Response
M209289,77,Other,Melanoma,KEYTRUDA only,59.33,53.52,1268.36,112,Partial Response
M209290,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.15,19.43,897.97,87,Progression
M209291,48,Other,HPV-related Cancer,mrna-4157 + keytruda,45.95,29.45,1209.52,93,Stable Disease
M209292,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.23,19.55,656.36,108,Unknown
M209293,71,Male,Melanoma,mrna-4157 + keytruda,76.34,67.66,1143.91,91,
M209294,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.27,23.82,1231.89,85,Progression
M209295,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.5,27.08,1154.72,83,Partial Response
M209296,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.34,65.46,1504.16,78,Partial Response
M209297,70,Male,Melanoma,mrna-4157 + keytruda,65.74,62.13,1656.03,74,Complete Response
M209298,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.52,55.74,84.04,107,Complete Response
M209299,81,Male,HPV-related Cancer,mrna-4157 + keytruda,53.89,42.61,1142.09,88,Partial Response
M209300,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.36,50.06,1647.74,80,Complete Response
M209301,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.7,52.32,590.19,85,Stable Disease
M209302,44,Male,HPV-related Cancer,mrna-4157 + keytruda,79.31,49.13,,115,Stable Disease
M209303,51,Male,Melanoma,mrna-4157 + keytruda,31.99,15.54,1567.22,103,Progression
M209304,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.99,50.17,46.64,107,Stable Disease
M209305,60,Male,Melanoma,mrna-4157 + keytruda,37.46,29.47,1558.03,86,Stable Disease
M209306,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.31,19.74,1714.79,97,Partial Response
M209307,69,Male,Melanoma,KEYTRUDA only,17.9,15.74,1049.11,96,Progression
M209308,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.08,37.84,352.69,101,Stable Disease
M209309,51,Female,HPV-related Cancer,mrna-4157 + keytruda,39.59,41.95,189.69,72,Progression
M209310,45,Male,HPV-related Cancer,mrna-4157 + keytruda,60.4,57.91,1155.55,79,Complete Response
M209311,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.62,32.24,1264.94,111,Stable Disease
M209312,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.21,27.96,,94,Partial Response
M209313,45,Female,Melanoma,KEYTRUDA only,63.75,41.72,1199.06,81,Stable Disease
M209314,66,Male,Melanoma,KEYTRUDA only,-0.63,-0.52,726.04,101,Stable Disease
M209315,31,Other,HPV-related Cancer,mrna-4157 + keytruda,54.98,31.49,,78,Partial Response
M209316,67,Female,HPV-related Cancer,mrna-4157 + keytruda,50.29,45.89,1325.23,97,Progression
M209317,73,Other,Melanoma,KEYTRUDA only,73.23,43.72,1179.27,87,Stable Disease
M209318,63,Male,HPV-related Cancer,mrna-4157 + keytruda,75.18,44.57,810.13,79,Stable Disease
M209319,48,Male,HPV-related Cancer,mrna-4157 + keytruda,41.5,21.23,770.51,93,Partial Response
M209320,77,Male,Melanoma,mrna-4157 + keytruda,38.42,40.22,,72,Complete Response
M209321,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,73.43,70.03,1030.7,95,Unknown
M209322,55,Male,HPV-related Cancer,KEYTRUDA only,28.5,22.25,345.87,90,Partial Response
M209323,47,Male,HPV-related Cancer,mrna-4157 + keytruda,42.0,38.29,781.44,103,Stable Disease
M209324,41,Male,Melanoma,mrna-4157 + keytruda,31.85,22.41,1606.54,85,Stable Disease
M209325,83,Female,Melanoma,mrna-4157 + keytruda,59.78,60.97,965.93,91,Complete Response
M209326,84,Male,HPV-related Cancer,mrna-4157 + keytruda,68.1,47.92,,99,Stable Disease
M209327,37,Other,Melanoma,mrna-4157 + keytruda,53.54,28.52,1668.55,81,Partial Response
M209328,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.67,36.04,1557.23,96,Partial Response
M209329,47,Male,Melanoma,mrna-4157 + keytruda,61.97,33.79,1275.75,92,Partial Response
M209330,33,Male,Melanoma,mrna-4157 + keytruda,66.74,45.26,558.39,91,Complete Response
M209331,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.27,71.77,1370.34,91,Progression
M209332,75,Female,Melanoma,KEYTRUDA only,17.06,8.15,1273.39,81,Partial Response
M209333,45,Other,HPV-related Cancer,mrna-4157 + keytruda,42.41,34.17,537.23,112,Partial Response
M209334,83,Female,HPV-related Cancer,mrna-4157 + keytruda,58.51,38.3,,86,Partial Response
M209335,39,Female,Melanoma,mrna-4157 + keytruda,69.39,36.95,842.76,85,Stable Disease
M209336,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.93,29.03,1010.68,79,Partial Response
M209337,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.89,20.36,379.25,100,
M209338,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.32,31.16,1740.99,86,Stable Disease
M209339,38,Other,HPV-related Cancer,mrna-4157 + keytruda,23.54,14.42,1287.64,86,Unknown
M209340,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,65.95,77.19,1331.22,91,Unknown
M209341,27,Other,Melanoma,KEYTRUDA only,66.23,77.87,706.53,82,Partial Response
M209342,52,Male,HPV-related Cancer,mrna-4157 + keytruda,40.23,42.7,1612.44,96,Progression
M209343,41,Other,HPV-related Cancer,KEYTRUDA only,74.77,64.91,805.84,84,Stable Disease
M209344,40,Male,HPV-related Cancer,mrna-4157 + keytruda,64.6,29.62,1318.49,87,Partial Response
M209345,27,Male,HPV-related Cancer,mrna-4157 + keytruda,37.47,39.09,241.69,72,Progression
M209346,74,Female,Melanoma,mrna-4157 + keytruda,72.56,82.94,1208.97,78,
M209347,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.8,19.08,791.81,103,Progression
M209348,44,Other,HPV-related Cancer,mrna-4157 + keytruda,26.94,15.92,1031.34,91,Stable Disease
M209349,48,Other,HPV-related Cancer,mrna-4157 + keytruda,49.07,33.31,1401.95,94,Complete Response
M209350,57,Male,HPV-related Cancer,mrna-4157 + keytruda,60.14,36.16,655.08,104,Partial Response
M209351,84,Male,Melanoma,mrna-4157 + keytruda,34.49,26.62,1626.75,77,Complete Response
M209352,78,Other,HPV-related Cancer,mrna-4157 + keytruda,54.57,37.27,1755.87,92,Stable Disease
M209353,82,Male,Melanoma,mrna-4157 + keytruda,19.2,17.68,1240.02,91,Partial Response
M209354,43,Male,HPV-related Cancer,KEYTRUDA only,72.49,81.64,1179.43,90,Partial Response
M209355,43,Male,Melanoma,mrna-4157 + keytruda,77.87,40.96,345.77,108,Stable Disease
M209356,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.3,73.51,1278.31,62,Stable Disease
M209357,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.0,,1011.03,103,Complete Response
M209358,45,Male,HPV-related Cancer,mrna-4157 + keytruda,39.92,35.3,1041.31,93,Complete Response
M209359,83,Female,HPV-related Cancer,mrna-4157 + keytruda,62.56,63.93,1514.34,94,Stable Disease
M209360,56,Other,Melanoma,KEYTRUDA only,61.04,69.67,1417.5,96,Stable Disease
M209361,62,Male,Melanoma,mrna-4157 + keytruda,50.25,42.23,1199.65,83,Progression
M209362,27,Other,Melanoma,KEYTRUDA only,14.59,9.56,,91,Unknown
M209363,46,Male,Melanoma,mrna-4157 + keytruda,45.39,31.37,1015.57,102,Complete Response
M209364,75,Female,Melanoma,mrna-4157 + keytruda,53.93,37.49,1153.13,102,Stable Disease
M209365,73,Other,Melanoma,mrna-4157 + keytruda,43.96,36.41,781.38,81,Partial Response
M209366,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.25,49.95,,79,Stable Disease
M209367,35,Other,Melanoma,KEYTRUDA only,60.37,61.55,964.97,92,Progression
M209368,78,Male,HPV-related Cancer,mrna-4157 + keytruda,59.29,53.4,1446.44,86,Partial Response
M209369,67,Female,HPV-related Cancer,mrna-4157 + keytruda,40.41,11.08,450.0,94,Unknown
M209370,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.03,27.27,947.14,90,Complete Response
M209371,76,Female,HPV-related Cancer,KEYTRUDA only,76.77,12.75,730.22,93,Progression
M209372,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.51,18.11,1771.23,102,Partial Response
M209373,53,Male,Melanoma,KEYTRUDA only,45.28,45.72,1031.93,91,Stable Disease
M209374,78,Other,HPV-related Cancer,KEYTRUDA only,38.47,28.0,848.8,86,Stable Disease
M209375,54,Female,HPV-related Cancer,mrna-4157 + keytruda,28.83,26.79,2311.74,84,Complete Response
M209376,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.11,36.2,893.63,90,Stable Disease
M209377,55,Female,HPV-related Cancer,mrna-4157 + keytruda,29.95,29.31,1019.16,85,Partial Response
M209378,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.01,14.82,1209.86,90,Stable Disease
M209379,31,Male,HPV-related Cancer,mrna-4157 + keytruda,58.85,,1632.62,104,Unknown
M209380,43,Female,HPV-related Cancer,KEYTRUDA only,57.43,,1560.2,93,Partial Response
M209381,83,Male,Melanoma,mrna-4157 + keytruda,81.43,79.58,910.74,91,Partial Response
M209382,56,Male,Melanoma,KEYTRUDA only,17.07,12.73,331.33,93,Stable Disease
M209383,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.75,,620.61,80,
M209384,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.57,42.97,841.01,85,Partial Response
M209385,40,Male,HPV-related Cancer,mrna-4157 + keytruda,35.28,40.14,1049.36,92,Stable Disease
M209386,72,Male,Melanoma,KEYTRUDA only,75.99,93.91,1574.89,93,Partial Response
M209387,68,Female,HPV-related Cancer,KEYTRUDA only,81.75,47.76,1243.75,83,
M209388,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.41,26.85,2027.37,94,Stable Disease
M209389,32,Female,HPV-related Cancer,mrna-4157 + keytruda,27.14,,1008.76,81,Complete Response
M209390,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,31.17,32.06,833.02,89,Stable Disease
M209391,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.22,48.9,,107,Stable Disease
M209392,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.99,50.8,971.47,88,Complete Response
M209393,73,Male,HPV-related Cancer,mrna-4157 + keytruda,40.85,32.99,1217.85,79,Partial Response
M209394,64,Other,HPV-related Cancer,mrna-4157 + keytruda,48.24,33.46,1351.08,85,Partial Response
M209395,37,Other,HPV-related Cancer,mrna-4157 + keytruda,70.9,,927.34,92,Partial Response
M209396,38,Female,HPV-related Cancer,mrna-4157 + keytruda,87.22,91.95,1861.87,79,Partial Response
M209397,67,Other,Melanoma,mrna-4157 + keytruda,33.85,31.87,748.45,79,Progression
M209398,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.56,22.32,1105.83,99,Partial Response
M209399,78,Female,HPV-related Cancer,mrna-4157 + keytruda,78.67,30.56,65.11,92,Complete Response
M209400,30,Other,HPV-related Cancer,KEYTRUDA only,55.11,50.77,1005.56,93,Progression
M209401,61,Male,Melanoma,KEYTRUDA only,44.86,40.45,1031.05,93,Unknown
M209402,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.24,25.34,1014.74,94,Progression
M209403,48,Other,Melanoma,mrna-4157 + keytruda,60.54,33.39,734.4,93,Partial Response
M209404,55,Male,HPV-related Cancer,mrna-4157 + keytruda,88.51,,863.41,93,Complete Response
M209405,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.32,30.75,1027.41,74,Complete Response
M209406,58,Male,Melanoma,mrna-4157 + keytruda,35.73,17.18,605.66,84,Unknown
M209407,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.6,33.13,1076.96,100,Complete Response
M209408,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.92,38.24,977.04,83,Progression
M209409,82,Other,Melanoma,mrna-4157 + keytruda,28.42,17.93,1122.13,98,Stable Disease
M209410,48,Other,HPV-related Cancer,mrna-4157 + keytruda,36.68,21.24,489.04,98,Stable Disease
M209411,65,Male,HPV-related Cancer,mrna-4157 + keytruda,8.78,8.21,1389.08,87,Partial Response
M209412,40,Male,Melanoma,KEYTRUDA only,38.67,36.95,2077.28,80,Unknown
M209413,49,Male,HPV-related Cancer,mrna-4157 + keytruda,42.33,13.58,1079.52,104,Stable Disease
M209414,47,Female,Melanoma,KEYTRUDA only,63.99,64.74,612.82,93,
M209415,42,Male,Melanoma,KEYTRUDA only,47.87,27.91,1238.37,85,Progression
M209416,51,Male,HPV-related Cancer,mrna-4157 + keytruda,39.93,34.76,1188.87,96,Stable Disease
M209417,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.05,41.35,405.39,92,Stable Disease
M209418,55,Female,Melanoma,KEYTRUDA only,47.02,36.12,778.68,88,Complete Response
M209419,63,Male,Melanoma,mrna-4157 + keytruda,75.46,60.52,308.66,97,Partial Response
M209420,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.25,24.46,623.42,98,Stable Disease
M209421,40,Male,HPV-related Cancer,KEYTRUDA only,47.47,41.85,845.89,87,Stable Disease
M209422,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.37,59.68,875.96,66,Progression
M209423,44,Other,HPV-related Cancer,mrna-4157 + keytruda,28.43,31.66,913.72,97,Stable Disease
M209424,25,Other,HPV-related Cancer,KEYTRUDA only,47.65,28.95,732.37,93,Progression
M209425,33,Male,HPV-related Cancer,KEYTRUDA only,49.9,32.03,1470.3,92,Unknown
M209426,46,Male,HPV-related Cancer,KEYTRUDA only,-2.11,-2.22,1203.42,80,Complete Response
M209427,66,Male,HPV-related Cancer,mrna-4157 + keytruda,40.96,30.31,730.26,88,Partial Response
M209428,69,Female,HPV-related Cancer,KEYTRUDA only,26.42,22.14,820.32,100,Partial Response
M209429,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.58,42.67,575.78,100,Stable Disease
M209430,41,Other,Melanoma,mrna-4157 + keytruda,47.75,39.6,1101.39,88,Progression
M209431,28,Female,HPV-related Cancer,KEYTRUDA only,29.16,16.95,1292.96,74,Partial Response
M209432,70,Male,HPV-related Cancer,KEYTRUDA only,27.05,24.33,1096.76,84,Progression
M209433,67,Other,HPV-related Cancer,mrna-4157 + keytruda,83.97,62.51,794.85,88,Partial Response
M209434,60,Female,HPV-related Cancer,KEYTRUDA only,40.66,20.34,1080.57,81,Progression
M209435,81,Female,Melanoma,mrna-4157 + keytruda,57.92,56.21,943.18,90,Progression
M209436,68,Female,HPV-related Cancer,mrna-4157 + keytruda,29.31,19.59,1428.96,92,Progression
M209437,42,Male,Melanoma,mrna-4157 + keytruda,71.84,83.16,1042.71,76,Partial Response
M209438,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.36,37.32,1455.12,86,Progression
M209439,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.53,34.09,703.69,96,Partial Response
M209440,37,Other,Melanoma,mrna-4157 + keytruda,43.31,48.77,1066.61,87,Partial Response
M209441,80,Male,HPV-related Cancer,mrna-4157 + keytruda,55.61,38.98,973.85,85,Stable Disease
M209442,32,Female,Melanoma,KEYTRUDA only,52.97,27.98,853.0,104,Partial Response
M209443,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,61.6,50.19,442.22,99,Complete Response
M209444,31,Other,HPV-related Cancer,mrna-4157 + keytruda,74.77,45.8,1177.58,102,Partial Response
M209445,71,Other,HPV-related Cancer,mrna-4157 + keytruda,86.4,57.88,904.74,87,Progression
M209446,33,Male,HPV-related Cancer,mrna-4157 + keytruda,62.68,,795.95,91,Stable Disease
M209447,80,Male,Melanoma,mrna-4157 + keytruda,43.43,40.96,294.44,87,Partial Response
M209448,64,Female,Melanoma,KEYTRUDA only,58.27,44.92,1247.79,77,
M209449,43,Other,Melanoma,mrna-4157 + keytruda,59.17,43.59,961.97,105,Stable Disease
M209450,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.43,27.31,899.88,80,Progression
M209451,54,Other,Melanoma,KEYTRUDA only,38.55,47.74,277.82,86,Progression
M209452,74,Female,Melanoma,KEYTRUDA only,88.16,63.08,702.67,91,Unknown
M209453,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.04,61.44,1246.68,97,Complete Response
M209454,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.42,53.83,368.5,92,Stable Disease
M209455,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.77,36.94,1446.12,95,Stable Disease
M209456,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.14,57.46,611.59,89,Complete Response
M209457,25,Other,HPV-related Cancer,KEYTRUDA only,90.19,58.29,484.8,83,Complete Response
M209458,35,Other,HPV-related Cancer,KEYTRUDA only,43.17,36.66,1014.61,90,
M209459,28,Other,HPV-related Cancer,KEYTRUDA only,39.13,38.21,1258.04,96,Unknown
M209460,66,Other,Melanoma,mrna-4157 + keytruda,31.33,31.32,260.0,71,Partial Response
M209461,83,Female,HPV-related Cancer,mrna-4157 + keytruda,9.46,8.06,801.08,100,Progression
M209462,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.71,37.17,1573.48,85,Stable Disease
M209463,61,Female,HPV-related Cancer,KEYTRUDA only,74.45,64.34,1450.43,97,Progression
M209464,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.81,14.84,286.54,85,Stable Disease
M209465,43,Male,Melanoma,KEYTRUDA only,96.13,100.54,465.59,93,Partial Response
M209466,26,Female,Melanoma,mrna-4157 + keytruda,59.63,48.38,1100.6,82,Stable Disease
M209467,27,Other,HPV-related Cancer,KEYTRUDA only,7.33,5.98,451.94,95,Partial Response
M209468,76,Other,Melanoma,mrna-4157 + keytruda,52.46,34.28,659.19,108,Stable Disease
M209469,54,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.45,31.28,850.77,87,Stable Disease
M209470,54,Female,HPV-related Cancer,mrna-4157 + keytruda,98.51,103.94,1103.44,90,Partial Response
M209471,27,Female,HPV-related Cancer,mrna-4157 + keytruda,53.2,30.28,805.24,86,Partial Response
M209472,26,Female,Melanoma,KEYTRUDA only,45.53,49.83,1297.45,77,Partial Response
M209473,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.94,,1813.3,88,Stable Disease
M209474,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.57,28.48,1705.66,98,Stable Disease
M209475,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,75.41,81.2,,78,Complete Response
M209476,28,Other,Melanoma,mrna-4157 + keytruda,27.52,24.44,1330.38,88,Stable Disease
M209477,79,Other,Melanoma,mrna-4157 + keytruda,38.55,16.76,1340.0,75,Complete Response
M209478,47,Male,Melanoma,KEYTRUDA only,64.82,60.65,1090.98,93,Progression
M209479,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.38,83.06,1371.5,91,Partial Response
M209480,44,Other,Melanoma,mrna-4157 + keytruda,23.1,24.93,792.0,98,Unknown
M209481,49,Male,Melanoma,KEYTRUDA only,59.48,45.3,1069.46,97,Stable Disease
M209482,65,Male,HPV-related Cancer,mrna-4157 + keytruda,21.68,24.53,648.06,83,Stable Disease
M209483,61,Female,Melanoma,mrna-4157 + keytruda,18.36,21.75,719.63,88,Partial Response
M209484,36,Other,HPV-related Cancer,mrna-4157 + keytruda,52.68,51.59,823.79,97,
M209485,37,Other,Melanoma,mrna-4157 + keytruda,55.16,61.89,844.21,84,Complete Response
M209486,50,Other,Melanoma,KEYTRUDA only,67.09,52.29,1134.95,95,Stable Disease
M209487,70,Other,Melanoma,mrna-4157 + keytruda,53.37,26.38,1388.44,86,
M209488,30,Other,Melanoma,mrna-4157 + keytruda,57.79,50.39,364.07,88,Partial Response
M209489,74,Female,Melanoma,KEYTRUDA only,48.39,36.92,806.37,85,Stable Disease
M209490,80,Male,HPV-related Cancer,mrna-4157 + keytruda,58.18,56.45,354.58,100,Partial Response
M209491,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.15,36.95,1245.9,91,Progression
M209492,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,94.57,72.24,217.96,94,Complete Response
M209493,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.95,52.59,,88,Complete Response
M209494,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.67,19.4,1045.72,88,Unknown
M209495,59,Other,Melanoma,mrna-4157 + keytruda,82.41,70.2,1019.42,96,Stable Disease
M209496,25,Male,HPV-related Cancer,mrna-4157 + keytruda,72.08,75.49,1189.63,84,Progression
M209497,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.72,32.74,1262.4,93,Complete Response
M209498,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.3,58.79,1256.41,98,Stable Disease
M209499,56,Other,HPV-related Cancer,KEYTRUDA only,40.4,22.72,1906.95,87,Stable Disease
M209500,36,Male,HPV-related Cancer,KEYTRUDA only,59.7,60.11,1474.5,87,Progression
M209501,77,Male,Melanoma,mrna-4157 + keytruda,59.69,62.79,391.65,81,Progression
M209502,45,Other,Melanoma,KEYTRUDA only,38.83,36.94,1182.87,94,Stable Disease
M209503,35,Female,Melanoma,mrna-4157 + keytruda,58.46,49.32,1619.89,83,Partial Response
M209504,49,Female,HPV-related Cancer,KEYTRUDA only,29.32,19.2,1712.07,99,Unknown
M209505,39,Male,Melanoma,KEYTRUDA only,44.54,39.26,1189.81,102,Progression
M209506,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.0,19.23,1121.84,97,Partial Response
M209507,65,Female,Melanoma,KEYTRUDA only,64.35,75.73,1444.43,100,Stable Disease
M209508,27,Male,HPV-related Cancer,mrna-4157 + keytruda,58.43,53.27,1212.19,105,Partial Response
M209509,53,Other,Melanoma,mrna-4157 + keytruda,44.34,35.45,1204.66,102,Partial Response
M209510,81,Other,Melanoma,mrna-4157 + keytruda,69.99,57.13,541.96,85,
M209511,83,Other,Melanoma,mrna-4157 + keytruda,62.35,49.87,1471.91,94,Stable Disease
M209512,25,Female,Melanoma,mrna-4157 + keytruda,15.79,10.43,729.24,101,Complete Response
M209513,75,Male,HPV-related Cancer,mrna-4157 + keytruda,75.58,71.31,773.31,76,Partial Response
M209514,52,Female,Melanoma,KEYTRUDA only,78.88,,688.05,101,Partial Response
M209515,73,Male,Melanoma,mrna-4157 + keytruda,74.12,,1407.66,109,Progression
M209516,39,Female,Melanoma,KEYTRUDA only,52.25,59.47,1180.75,83,Partial Response
M209517,50,Other,Melanoma,KEYTRUDA only,25.06,15.16,,79,Partial Response
M209518,53,Female,HPV-related Cancer,mrna-4157 + keytruda,43.88,22.83,1116.28,89,Complete Response
M209519,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.93,54.4,2230.45,100,Partial Response
M209520,62,Male,Melanoma,mrna-4157 + keytruda,36.14,34.83,847.19,98,Partial Response
M209521,37,Female,HPV-related Cancer,mrna-4157 + keytruda,53.33,51.07,,90,Complete Response
M209522,35,Other,Melanoma,mrna-4157 + keytruda,46.19,32.79,342.35,74,Complete Response
M209523,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.17,17.91,968.78,98,Progression
M209524,30,Female,HPV-related Cancer,KEYTRUDA only,69.32,59.36,1588.12,87,Unknown
M209525,57,Male,HPV-related Cancer,mrna-4157 + keytruda,46.26,36.36,1531.9,96,Stable Disease
M209526,27,Female,HPV-related Cancer,KEYTRUDA only,80.76,73.97,961.43,85,Partial Response
M209527,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,14.26,9.96,177.81,103,Partial Response
M209528,81,Female,Melanoma,KEYTRUDA only,37.91,28.06,1234.28,74,Stable Disease
M209529,30,Other,Melanoma,KEYTRUDA only,46.05,38.71,622.21,86,Progression
M209530,33,Male,Melanoma,KEYTRUDA only,60.67,,837.03,93,Stable Disease
M209531,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.34,55.84,107.96,100,Partial Response
M209532,60,Other,HPV-related Cancer,KEYTRUDA only,11.98,,980.74,106,Complete Response
M209533,67,Other,Melanoma,KEYTRUDA only,75.91,54.5,879.92,88,Stable Disease
M209534,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.48,68.42,1109.76,101,Partial Response
M209535,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.52,12.01,482.64,77,Complete Response
M209536,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,91.45,108.16,1679.27,90,Complete Response
M209537,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.17,56.42,1042.66,90,Stable Disease
M209538,69,Female,HPV-related Cancer,mrna-4157 + keytruda,50.42,28.86,984.98,85,Complete Response
M209539,83,Female,HPV-related Cancer,mrna-4157 + keytruda,47.33,53.84,761.7,90,Partial Response
M209540,31,Female,HPV-related Cancer,mrna-4157 + keytruda,72.81,51.28,1753.59,99,Stable Disease
M209541,29,Other,Melanoma,KEYTRUDA only,53.59,,1189.92,106,Partial Response
M209542,28,Female,Melanoma,mrna-4157 + keytruda,38.75,27.16,573.92,96,Complete Response
M209543,84,Male,Melanoma,mrna-4157 + keytruda,13.26,12.94,955.3,86,Partial Response
M209544,26,Male,HPV-related Cancer,KEYTRUDA only,41.82,35.72,1456.83,83,Partial Response
M209545,83,Male,HPV-related Cancer,mrna-4157 + keytruda,30.1,15.95,731.18,100,Partial Response
M209546,81,Other,HPV-related Cancer,KEYTRUDA only,73.1,52.16,670.28,83,Stable Disease
M209547,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.71,42.46,1110.21,83,Progression
M209548,58,Female,Melanoma,mrna-4157 + keytruda,65.01,68.38,895.76,89,Partial Response
M209549,30,Female,Melanoma,mrna-4157 + keytruda,56.79,47.54,880.96,83,Stable Disease
M209550,83,Female,HPV-related Cancer,KEYTRUDA only,48.34,39.23,597.11,92,Stable Disease
M209551,34,Other,Melanoma,KEYTRUDA only,40.08,28.61,1089.75,74,Stable Disease
M209552,34,Male,HPV-related Cancer,mrna-4157 + keytruda,43.95,27.16,,76,Complete Response
M209553,34,Female,Melanoma,mrna-4157 + keytruda,83.43,85.52,811.52,74,Progression
M209554,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,78.17,77.92,,89,Complete Response
M209555,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,91.81,66.72,274.58,86,Stable Disease
M209556,31,Female,HPV-related Cancer,KEYTRUDA only,45.73,47.64,1275.13,114,Stable Disease
M209557,37,Other,Melanoma,KEYTRUDA only,57.11,51.93,838.73,102,Complete Response
M209558,75,Female,Melanoma,mrna-4157 + keytruda,59.6,53.4,1240.2,95,Stable Disease
M209559,40,Other,HPV-related Cancer,mrna-4157 + keytruda,42.84,34.84,1468.34,93,Stable Disease
M209560,26,Female,HPV-related Cancer,mrna-4157 + keytruda,23.2,12.5,1085.0,91,Partial Response
M209561,59,Other,Melanoma,mrna-4157 + keytruda,46.43,33.68,635.97,103,Partial Response
M209562,30,Female,Melanoma,mrna-4157 + keytruda,45.32,30.48,1196.95,85,
M209563,84,Male,HPV-related Cancer,mrna-4157 + keytruda,55.66,69.5,1299.2,94,Progression
M209564,34,Male,HPV-related Cancer,mrna-4157 + keytruda,49.04,32.94,769.21,83,Partial Response
M209565,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.32,47.97,412.3,82,Complete Response
M209566,82,Female,Melanoma,mrna-4157 + keytruda,28.12,27.73,960.33,105,Partial Response
M209567,81,Female,Melanoma,mrna-4157 + keytruda,50.65,35.91,,74,Partial Response
M209568,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.93,64.62,752.59,106,Partial Response
M209569,64,Male,Non-small Cell Lung Cancer,KEYTRUDA only,51.73,26.92,455.77,85,Partial Response
M209570,72,Other,HPV-related Cancer,mrna-4157 + keytruda,52.05,50.43,1149.42,97,Complete Response
M209571,47,Female,Melanoma,mrna-4157 + keytruda,36.81,28.96,1067.4,96,Complete Response
M209572,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.77,20.95,392.77,87,
M209573,80,Other,Melanoma,mrna-4157 + keytruda,34.77,26.86,1393.92,78,Stable Disease
M209574,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.35,49.07,1632.28,87,Stable Disease
M209575,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.21,8.59,1127.38,89,Unknown
M209576,47,Other,HPV-related Cancer,KEYTRUDA only,22.81,18.35,1002.99,89,Complete Response
M209577,35,Female,HPV-related Cancer,mrna-4157 + keytruda,51.88,38.66,800.07,93,Complete Response
M209578,48,Male,HPV-related Cancer,mrna-4157 + keytruda,50.47,38.68,504.29,78,Partial Response
M209579,63,Other,HPV-related Cancer,KEYTRUDA only,29.4,22.73,1165.77,82,Partial Response
M209580,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.18,37.03,632.31,86,Complete Response
M209581,71,Male,HPV-related Cancer,KEYTRUDA only,32.22,34.21,882.06,80,
M209582,39,Male,Melanoma,mrna-4157 + keytruda,66.82,41.51,749.13,73,Partial Response
M209583,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.75,55.17,,74,Unknown
M209584,28,Female,HPV-related Cancer,mrna-4157 + keytruda,39.05,36.0,1252.05,83,Progression
M209585,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.49,23.23,925.91,88,Progression
M209586,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.97,50.21,,87,Progression
M209587,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.79,46.64,404.72,73,
M209588,77,Female,Melanoma,mrna-4157 + keytruda,70.86,64.79,1335.6,83,Progression
M209589,79,Other,HPV-related Cancer,mrna-4157 + keytruda,39.19,32.63,209.92,89,
M209590,50,Other,Melanoma,mrna-4157 + keytruda,61.07,31.84,1075.13,91,Partial Response
M209591,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.45,,920.4,103,Partial Response
M209592,50,Male,HPV-related Cancer,mrna-4157 + keytruda,36.26,20.02,,66,Complete Response
M209593,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.72,38.06,563.52,92,Partial Response
M209594,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.01,,985.24,86,Partial Response
M209595,70,Female,Melanoma,mrna-4157 + keytruda,47.99,49.32,844.78,101,Stable Disease
M209596,39,Male,Melanoma,mrna-4157 + keytruda,24.66,30.9,998.27,90,Stable Disease
M209597,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.71,50.15,,88,Complete Response
M209598,76,Other,Melanoma,KEYTRUDA only,28.16,24.96,1321.21,102,Progression
M209599,39,Male,HPV-related Cancer,mrna-4157 + keytruda,21.68,27.88,304.55,77,Partial Response
M209600,27,Female,Melanoma,KEYTRUDA only,41.86,19.99,1238.4,97,Partial Response
M209601,39,Male,HPV-related Cancer,KEYTRUDA only,84.06,55.86,809.61,87,Partial Response
M209602,45,Female,Melanoma,mrna-4157 + keytruda,64.73,64.83,,101,Unknown
M209603,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.21,49.47,1828.34,87,Stable Disease
M209604,74,Male,Melanoma,KEYTRUDA only,69.8,49.32,1531.65,108,Unknown
M209605,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.25,37.42,834.33,91,Stable Disease
M209606,68,Female,Melanoma,mrna-4157 + keytruda,27.88,,,81,Stable Disease
M209607,68,Female,Melanoma,mrna-4157 + keytruda,59.22,59.45,1155.5,88,
M209608,39,Other,HPV-related Cancer,mrna-4157 + keytruda,21.02,20.83,1654.23,83,
M209609,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.18,62.68,583.29,96,Progression
M209610,37,Female,Melanoma,mrna-4157 + keytruda,86.28,60.59,713.13,81,Partial Response
M209611,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.78,,572.82,91,Stable Disease
M209612,63,Male,Melanoma,mrna-4157 + keytruda,77.61,62.34,1029.98,73,Partial Response
M209613,63,Other,HPV-related Cancer,mrna-4157 + keytruda,71.63,68.22,853.77,85,Stable Disease
M209614,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.03,,102.38,77,Stable Disease
M209615,29,Other,HPV-related Cancer,mrna-4157 + keytruda,73.41,49.47,563.08,99,Partial Response
M209616,26,Other,HPV-related Cancer,mrna-4157 + keytruda,46.09,37.09,853.05,93,Partial Response
M209617,56,Other,HPV-related Cancer,mrna-4157 + keytruda,61.8,20.6,155.25,105,Progression
M209618,77,Female,HPV-related Cancer,mrna-4157 + keytruda,84.97,96.28,,88,Complete Response
M209619,68,Female,Melanoma,mrna-4157 + keytruda,76.5,75.46,1002.84,97,Progression
M209620,82,Other,Melanoma,mrna-4157 + keytruda,54.17,45.45,1630.55,81,Complete Response
M209621,34,Male,Melanoma,KEYTRUDA only,40.16,22.58,363.36,94,Stable Disease
M209622,46,Male,Melanoma,KEYTRUDA only,70.55,33.3,1039.17,79,Stable Disease
M209623,46,Female,Melanoma,mrna-4157 + keytruda,53.66,53.94,618.57,107,Stable Disease
M209624,25,Other,HPV-related Cancer,mrna-4157 + keytruda,54.98,,1147.6,106,Complete Response
M209625,80,Male,Melanoma,KEYTRUDA only,48.66,44.44,1068.37,82,Progression
M209626,53,Female,HPV-related Cancer,mrna-4157 + keytruda,70.79,72.1,838.16,87,Stable Disease
M209627,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.87,27.31,1130.95,86,Partial Response
M209628,74,Other,HPV-related Cancer,mrna-4157 + keytruda,67.54,51.97,1116.5,76,Partial Response
M209629,32,Other,Melanoma,mrna-4157 + keytruda,27.86,17.36,1042.24,88,Progression
M209630,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.7,,1243.03,93,Partial Response
M209631,53,Male,Melanoma,mrna-4157 + keytruda,63.12,,651.22,100,Stable Disease
M209632,69,Female,HPV-related Cancer,mrna-4157 + keytruda,55.26,60.68,1038.83,93,Stable Disease
M209633,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.71,34.64,1141.49,75,Stable Disease
M209634,53,Other,HPV-related Cancer,mrna-4157 + keytruda,51.27,29.23,520.74,81,Progression
M209635,70,Other,HPV-related Cancer,mrna-4157 + keytruda,63.05,31.07,933.87,67,Complete Response
M209636,63,Female,Melanoma,KEYTRUDA only,26.5,32.58,591.15,100,Partial Response
M209637,76,Other,Melanoma,mrna-4157 + keytruda,67.41,55.94,624.1,80,Stable Disease
M209638,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.3,51.2,772.56,92,Complete Response
M209639,43,Other,Melanoma,KEYTRUDA only,77.13,69.66,526.42,86,Stable Disease
M209640,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.72,41.65,550.73,72,Complete Response
M209641,72,Female,Melanoma,mrna-4157 + keytruda,78.53,59.44,392.4,93,Complete Response
M209642,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.07,54.66,1229.69,104,Partial Response
M209643,61,Male,Melanoma,mrna-4157 + keytruda,17.53,19.98,697.15,94,Progression
M209644,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.94,34.65,1232.62,97,Partial Response
M209645,82,Male,HPV-related Cancer,mrna-4157 + keytruda,34.08,29.25,918.16,87,Partial Response
M209646,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,57.98,40.13,1170.76,115,Stable Disease
M209647,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.28,32.89,918.98,85,Partial Response
M209648,58,Female,Melanoma,mrna-4157 + keytruda,13.75,14.23,1517.22,71,Unknown
M209649,57,Male,Melanoma,mrna-4157 + keytruda,66.29,74.43,1696.53,91,Stable Disease
M209650,44,Female,HPV-related Cancer,mrna-4157 + keytruda,44.59,,932.04,88,Complete Response
M209651,40,Male,Melanoma,mrna-4157 + keytruda,71.24,44.03,1398.84,91,Stable Disease
M209652,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.68,22.07,688.78,91,Stable Disease
M209653,81,Other,HPV-related Cancer,mrna-4157 + keytruda,23.4,12.12,1569.71,89,Progression
M209654,68,Male,Melanoma,mrna-4157 + keytruda,89.18,74.86,965.3,88,Progression
M209655,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.33,43.0,814.09,81,Progression
M209656,47,Female,Melanoma,KEYTRUDA only,68.99,40.01,1423.56,86,Stable Disease
M209657,50,Other,Melanoma,KEYTRUDA only,42.98,25.17,560.55,94,Progression
M209658,48,Other,Melanoma,mrna-4157 + keytruda,91.07,63.47,741.86,79,Stable Disease
M209659,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.77,33.88,886.88,76,Progression
M209660,26,Male,Melanoma,KEYTRUDA only,58.74,30.63,599.3,89,Partial Response
M209661,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,107.3,82.66,1220.38,88,Stable Disease
M209662,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.35,12.92,,90,Stable Disease
M209663,32,Other,HPV-related Cancer,mrna-4157 + keytruda,31.29,17.77,1240.69,94,Partial Response
M209664,81,Male,HPV-related Cancer,mrna-4157 + keytruda,60.05,50.82,853.11,88,Stable Disease
M209665,28,Other,Melanoma,mrna-4157 + keytruda,81.65,45.67,865.07,105,Progression
M209666,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.14,24.61,1305.6,100,Stable Disease
M209667,84,Female,HPV-related Cancer,mrna-4157 + keytruda,26.82,25.67,924.2,74,Stable Disease
M209668,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.8,74.76,-60.22,73,Stable Disease
M209669,62,Male,Melanoma,mrna-4157 + keytruda,28.87,28.38,914.84,90,Complete Response
M209670,54,Female,HPV-related Cancer,KEYTRUDA only,39.73,6.48,513.85,88,Progression
M209671,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.76,72.09,567.29,100,
M209672,31,Other,Melanoma,mrna-4157 + keytruda,92.14,67.07,922.11,88,Partial Response
M209673,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,83.2,53.4,1730.5,92,Partial Response
M209674,36,Other,HPV-related Cancer,mrna-4157 + keytruda,58.9,24.32,466.37,97,Stable Disease
M209675,57,Other,HPV-related Cancer,mrna-4157 + keytruda,48.42,59.37,284.9,81,Complete Response
M209676,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.66,52.63,384.74,87,Partial Response
M209677,50,Other,Melanoma,KEYTRUDA only,53.25,48.02,1099.32,95,Partial Response
M209678,32,Other,HPV-related Cancer,mrna-4157 + keytruda,37.68,39.02,1913.81,84,Stable Disease
M209679,39,Male,HPV-related Cancer,mrna-4157 + keytruda,42.63,29.82,1125.71,89,Partial Response
M209680,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.08,28.5,535.08,91,Progression
M209681,51,Female,Melanoma,KEYTRUDA only,40.93,32.58,716.45,87,Partial Response
M209682,38,Male,Melanoma,KEYTRUDA only,65.76,53.56,1259.54,86,Stable Disease
M209683,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.3,40.19,377.95,97,Unknown
M209684,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.33,59.94,312.34,83,Partial Response
M209685,27,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.47,36.24,924.98,75,Stable Disease
M209686,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.95,32.36,860.21,74,Complete Response
M209687,43,Female,HPV-related Cancer,mrna-4157 + keytruda,92.77,70.02,1979.93,90,Stable Disease
M209688,46,Other,HPV-related Cancer,mrna-4157 + keytruda,54.73,24.82,,90,Complete Response
M209689,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.76,19.14,2060.59,98,Complete Response
M209690,52,Other,HPV-related Cancer,mrna-4157 + keytruda,82.96,61.6,1158.21,94,Partial Response
M209691,44,Other,Melanoma,KEYTRUDA only,46.82,32.09,825.94,71,Stable Disease
M209692,58,Female,Melanoma,mrna-4157 + keytruda,67.13,52.28,939.24,94,Complete Response
M209693,53,Male,Melanoma,mrna-4157 + keytruda,11.7,13.38,553.0,105,Partial Response
M209694,60,Female,Melanoma,KEYTRUDA only,74.72,59.47,1490.26,89,Partial Response
M209695,67,Other,Melanoma,KEYTRUDA only,30.8,18.66,925.45,97,Complete Response
M209696,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.67,34.75,930.24,93,Stable Disease
M209697,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.72,87.95,909.42,77,Partial Response
M209698,45,Other,Melanoma,mrna-4157 + keytruda,75.98,75.35,1073.88,69,Stable Disease
M209699,37,Other,HPV-related Cancer,KEYTRUDA only,27.27,18.79,1193.87,104,Partial Response
M209700,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.49,28.42,1365.48,85,Partial Response
M209701,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.91,32.77,1351.34,93,Partial Response
M209702,80,Male,HPV-related Cancer,mrna-4157 + keytruda,38.35,29.96,897.7,114,Unknown
M209703,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.68,65.1,1506.48,92,Stable Disease
M209704,26,Female,HPV-related Cancer,mrna-4157 + keytruda,72.47,36.96,1183.78,86,Partial Response
M209705,50,Male,HPV-related Cancer,mrna-4157 + keytruda,37.84,36.02,991.89,112,Stable Disease
M209706,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.42,50.41,338.44,88,Partial Response
M209707,61,Female,HPV-related Cancer,mrna-4157 + keytruda,21.74,19.21,1198.25,95,Stable Disease
M209708,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.56,44.61,1457.38,97,Stable Disease
M209709,83,Male,Melanoma,mrna-4157 + keytruda,52.72,,748.36,95,Stable Disease
M209710,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.99,42.43,1281.99,84,Progression
M209711,33,Other,HPV-related Cancer,KEYTRUDA only,67.22,49.55,1200.77,90,Partial Response
M209712,72,Male,Melanoma,mrna-4157 + keytruda,45.18,46.55,1206.74,98,Partial Response
M209713,69,Female,HPV-related Cancer,mrna-4157 + keytruda,46.46,40.96,1195.45,94,Stable Disease
M209714,49,Male,HPV-related Cancer,mrna-4157 + keytruda,30.05,22.91,1336.67,106,Complete Response
M209715,72,Female,Melanoma,mrna-4157 + keytruda,68.77,64.13,583.37,90,Stable Disease
M209716,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.58,43.41,1474.26,93,Partial Response
M209717,53,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.64,24.7,1186.06,98,Stable Disease
M209718,72,Female,HPV-related Cancer,KEYTRUDA only,45.57,39.48,819.61,83,Partial Response
M209719,51,Male,HPV-related Cancer,mrna-4157 + keytruda,25.6,12.89,1108.64,83,Stable Disease
M209720,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.28,33.93,172.32,94,Partial Response
M209721,55,Male,Melanoma,KEYTRUDA only,78.22,74.01,473.47,90,Progression
M209722,37,Female,HPV-related Cancer,KEYTRUDA only,38.18,24.88,674.67,81,Complete Response
M209723,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,99.68,67.44,907.45,68,Stable Disease
M209724,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.99,50.78,749.33,91,Stable Disease
M209725,61,Male,HPV-related Cancer,KEYTRUDA only,39.14,27.86,597.18,91,Complete Response
M209726,45,Other,HPV-related Cancer,KEYTRUDA only,23.54,18.59,1349.28,95,Complete Response
M209727,39,Female,HPV-related Cancer,KEYTRUDA only,50.56,36.36,912.24,92,Complete Response
M209728,25,Other,HPV-related Cancer,KEYTRUDA only,32.03,16.04,244.36,102,Partial Response
M209729,41,Other,HPV-related Cancer,KEYTRUDA only,71.6,70.65,,87,Progression
M209730,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.03,66.51,1449.72,100,Partial Response
M209731,76,Male,Melanoma,mrna-4157 + keytruda,53.29,63.68,1026.11,94,Partial Response
M209732,34,Female,Melanoma,KEYTRUDA only,11.26,6.39,115.97,89,Progression
M209733,56,Male,HPV-related Cancer,mrna-4157 + keytruda,48.01,39.64,1378.22,84,Stable Disease
M209734,74,Female,Melanoma,mrna-4157 + keytruda,15.78,,584.48,91,Progression
M209735,61,Female,Melanoma,KEYTRUDA only,50.42,35.91,949.36,88,Stable Disease
M209736,27,Other,Melanoma,mrna-4157 + keytruda,35.97,31.35,,90,Progression
M209737,27,Other,Melanoma,mrna-4157 + keytruda,42.23,30.95,872.64,88,Complete Response
M209738,51,Female,Melanoma,KEYTRUDA only,56.06,43.78,1298.72,91,Progression
M209739,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.27,30.42,857.79,87,Complete Response
M209740,74,Female,Melanoma,mrna-4157 + keytruda,18.45,16.62,347.54,102,Stable Disease
M209741,71,Male,Melanoma,KEYTRUDA only,22.32,14.31,699.19,101,Complete Response
M209742,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.08,66.16,595.33,101,
M209743,64,Female,Melanoma,KEYTRUDA only,71.03,35.77,976.29,87,Partial Response
M209744,62,Female,HPV-related Cancer,mrna-4157 + keytruda,59.2,47.72,997.95,86,Complete Response
M209745,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.71,28.77,724.08,108,Partial Response
M209746,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.46,,882.52,101,Unknown
M209747,25,Male,Melanoma,KEYTRUDA only,56.18,33.64,1024.7,75,Partial Response
M209748,31,Female,Melanoma,KEYTRUDA only,31.05,29.76,976.87,95,Partial Response
M209749,57,Male,Melanoma,mrna-4157 + keytruda,68.02,49.58,387.68,85,Stable Disease
M209750,84,Female,HPV-related Cancer,KEYTRUDA only,17.05,12.84,643.84,91,Complete Response
M209751,40,Male,HPV-related Cancer,mrna-4157 + keytruda,69.64,,829.18,68,Partial Response
M209752,76,Male,HPV-related Cancer,mrna-4157 + keytruda,65.73,45.9,694.81,91,Stable Disease
M209753,35,Male,HPV-related Cancer,KEYTRUDA only,53.66,52.53,1494.78,88,Progression
M209754,54,Female,HPV-related Cancer,mrna-4157 + keytruda,40.6,25.38,1046.56,71,Partial Response
M209755,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.18,30.79,1367.43,85,Partial Response
M209756,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.82,,914.5,95,Partial Response
M209757,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.55,37.22,1431.3,71,Stable Disease
M209758,43,Other,HPV-related Cancer,KEYTRUDA only,33.18,23.82,1196.84,75,Complete Response
M209759,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.47,44.07,892.04,95,Stable Disease
M209760,58,Female,Melanoma,mrna-4157 + keytruda,30.85,16.94,2248.38,85,Partial Response
M209761,71,Male,Melanoma,mrna-4157 + keytruda,45.45,33.83,1264.12,87,Stable Disease
M209762,84,Other,Melanoma,mrna-4157 + keytruda,28.92,20.65,901.11,84,Stable Disease
M209763,66,Male,HPV-related Cancer,mrna-4157 + keytruda,53.72,46.53,1001.13,95,Stable Disease
M209764,81,Male,HPV-related Cancer,KEYTRUDA only,65.84,52.33,1719.49,81,Partial Response
M209765,49,Male,HPV-related Cancer,mrna-4157 + keytruda,87.81,70.59,1324.96,78,Progression
M209766,59,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.13,31.6,1062.61,96,Partial Response
M209767,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.31,,798.4,91,Stable Disease
M209768,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.64,52.91,1407.93,81,Stable Disease
M209769,37,Male,Melanoma,KEYTRUDA only,53.81,45.31,61.87,95,Unknown
M209770,65,Female,HPV-related Cancer,mrna-4157 + keytruda,24.66,23.06,1753.86,101,Complete Response
M209771,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.38,,1598.37,79,Partial Response
M209772,51,Male,Melanoma,mrna-4157 + keytruda,42.74,37.36,568.18,91,Stable Disease
M209773,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.63,24.16,924.81,77,Complete Response
M209774,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.65,30.49,1542.74,86,Stable Disease
M209775,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.39,28.82,827.49,84,
M209776,66,Male,Melanoma,KEYTRUDA only,61.86,67.22,1128.37,96,Partial Response
M209777,77,Female,Melanoma,KEYTRUDA only,60.0,32.11,1146.78,86,Partial Response
M209778,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.36,35.7,893.49,97,Partial Response
M209779,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.72,34.83,1595.95,76,Progression
M209780,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.01,48.74,819.2,88,Progression
M209781,25,Other,HPV-related Cancer,mrna-4157 + keytruda,82.86,64.34,1294.91,74,Partial Response
M209782,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.42,38.12,619.07,88,Complete Response
M209783,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,8.56,4.64,1362.66,118,Stable Disease
M209784,64,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.7,25.76,1227.11,97,Stable Disease
M209785,51,Other,HPV-related Cancer,mrna-4157 + keytruda,68.78,50.75,1561.06,85,Progression
M209786,82,Female,HPV-related Cancer,KEYTRUDA only,50.16,38.66,1344.65,85,Partial Response
M209787,55,Other,HPV-related Cancer,mrna-4157 + keytruda,25.6,22.66,1070.22,76,Partial Response
M209788,56,Female,HPV-related Cancer,KEYTRUDA only,39.76,32.16,1558.22,71,Stable Disease
M209789,84,Female,Melanoma,mrna-4157 + keytruda,71.94,68.32,804.75,61,Stable Disease
M209790,68,Male,Melanoma,KEYTRUDA only,18.23,12.13,1097.5,91,Complete Response
M209791,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,80.41,69.12,-13.74,104,Stable Disease
M209792,76,Female,Melanoma,mrna-4157 + keytruda,83.74,,621.47,87,Partial Response
M209793,37,Female,HPV-related Cancer,KEYTRUDA only,61.94,,1130.34,88,Partial Response
M209794,81,Female,HPV-related Cancer,mrna-4157 + keytruda,53.46,60.27,948.73,87,Complete Response
M209795,35,Other,HPV-related Cancer,KEYTRUDA only,5.08,4.52,1143.19,96,Stable Disease
M209796,46,Female,Melanoma,mrna-4157 + keytruda,36.44,41.25,967.37,96,Complete Response
M209797,49,Male,Melanoma,mrna-4157 + keytruda,75.3,70.47,1353.69,86,Progression
M209798,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.14,20.14,101.56,77,Unknown
M209799,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.33,20.86,,101,Partial Response
M209800,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,65.0,29.01,1270.45,96,Partial Response
M209801,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.26,33.26,1596.52,87,Stable Disease
M209802,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.62,31.83,1438.52,89,Stable Disease
M209803,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.48,63.22,1741.4,87,
M209804,59,Other,HPV-related Cancer,mrna-4157 + keytruda,60.91,41.74,360.73,91,Complete Response
M209805,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.65,21.79,714.48,88,
M209806,80,Male,HPV-related Cancer,mrna-4157 + keytruda,19.9,,453.35,89,Progression
M209807,63,Male,HPV-related Cancer,mrna-4157 + keytruda,21.3,10.39,,93,Partial Response
M209808,41,Other,HPV-related Cancer,mrna-4157 + keytruda,50.0,,1536.77,78,Partial Response
M209809,29,Male,Melanoma,mrna-4157 + keytruda,53.2,35.96,2208.29,81,Partial Response
M209810,34,Male,Melanoma,mrna-4157 + keytruda,33.26,22.83,1304.07,77,Stable Disease
M209811,75,Female,HPV-related Cancer,mrna-4157 + keytruda,96.49,69.48,1607.35,98,Progression
M209812,75,Other,HPV-related Cancer,KEYTRUDA only,58.48,60.11,,87,Partial Response
M209813,58,Male,Melanoma,KEYTRUDA only,30.95,21.68,742.81,78,Partial Response
M209814,77,Other,Melanoma,mrna-4157 + keytruda,98.68,79.18,1176.85,89,Partial Response
M209815,27,Male,Melanoma,mrna-4157 + keytruda,67.16,66.47,942.01,86,Progression
M209816,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.89,42.76,922.35,85,
M209817,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.15,17.67,1619.82,87,Partial Response
M209818,63,Female,Melanoma,mrna-4157 + keytruda,76.04,67.29,387.91,84,Progression
M209819,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.62,87.94,762.4,86,Partial Response
M209820,40,Other,HPV-related Cancer,KEYTRUDA only,74.39,36.96,1567.89,91,Progression
M209821,81,Male,Melanoma,KEYTRUDA only,25.17,19.43,345.02,95,Partial Response
M209822,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.5,37.66,407.76,85,Stable Disease
M209823,74,Other,HPV-related Cancer,mrna-4157 + keytruda,50.35,47.63,594.48,111,Partial Response
M209824,73,Female,HPV-related Cancer,mrna-4157 + keytruda,18.28,7.97,1027.85,97,Complete Response
M209825,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.36,34.34,627.55,70,Partial Response
M209826,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.79,41.12,173.46,105,Stable Disease
M209827,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.68,19.03,749.57,98,Partial Response
M209828,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.72,49.49,1613.31,92,Partial Response
M209829,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.36,50.09,1488.58,98,Progression
M209830,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.59,49.65,836.28,86,Stable Disease
M209831,62,Female,Melanoma,KEYTRUDA only,12.66,5.75,,81,Progression
M209832,82,Other,Melanoma,mrna-4157 + keytruda,71.63,42.48,876.9,76,Partial Response
M209833,42,Female,HPV-related Cancer,mrna-4157 + keytruda,52.88,62.98,1180.48,103,Stable Disease
M209834,74,Female,HPV-related Cancer,mrna-4157 + keytruda,60.61,37.54,1070.36,92,
M209835,53,Female,Melanoma,mrna-4157 + keytruda,62.41,51.97,528.69,76,Complete Response
M209836,73,Female,HPV-related Cancer,mrna-4157 + keytruda,49.13,61.24,1318.25,76,Partial Response
M209837,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.3,36.5,1262.98,98,
M209838,36,Female,HPV-related Cancer,KEYTRUDA only,73.41,50.07,1519.59,101,Complete Response
M209839,36,Male,HPV-related Cancer,mrna-4157 + keytruda,35.31,31.71,423.52,92,Stable Disease
M209840,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.33,58.32,813.65,81,Stable Disease
M209841,52,Female,Melanoma,mrna-4157 + keytruda,60.12,,490.91,92,Stable Disease
M209842,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.83,,1440.59,93,Partial Response
M209843,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.32,51.85,1504.28,97,Partial Response
M209844,28,Male,Melanoma,KEYTRUDA only,20.0,12.91,822.63,91,Progression
M209845,41,Female,Melanoma,mrna-4157 + keytruda,26.33,22.38,1075.7,83,Progression
M209846,43,Other,HPV-related Cancer,KEYTRUDA only,59.9,32.14,1023.63,90,Partial Response
M209847,36,Other,HPV-related Cancer,mrna-4157 + keytruda,53.13,42.35,1069.14,77,Stable Disease
M209848,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.5,56.17,1776.67,94,Unknown
M209849,74,Male,Melanoma,mrna-4157 + keytruda,49.35,47.27,1694.66,86,Partial Response
M209850,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.69,,1242.24,84,Complete Response
M209851,76,Other,HPV-related Cancer,KEYTRUDA only,71.37,,961.76,97,Unknown
M209852,77,Male,Melanoma,KEYTRUDA only,54.06,34.53,656.06,90,Complete Response
M209853,56,Other,HPV-related Cancer,mrna-4157 + keytruda,18.82,15.9,1505.24,96,Complete Response
M209854,50,Female,Melanoma,mrna-4157 + keytruda,56.02,45.2,1065.2,92,Partial Response
M209855,66,Female,HPV-related Cancer,mrna-4157 + keytruda,68.91,42.51,1466.9,96,Stable Disease
M209856,73,Female,HPV-related Cancer,mrna-4157 + keytruda,35.54,36.39,902.87,90,Progression
M209857,44,Female,Melanoma,KEYTRUDA only,23.22,26.53,1109.47,83,Progression
M209858,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,103.51,93.08,1530.55,100,Complete Response
M209859,42,Female,HPV-related Cancer,KEYTRUDA only,48.48,35.71,865.91,98,Progression
M209860,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.43,21.74,1096.06,84,Progression
M209861,64,Female,HPV-related Cancer,mrna-4157 + keytruda,49.9,43.14,600.0,77,Partial Response
M209862,67,Male,Melanoma,KEYTRUDA only,4.89,4.1,1637.98,104,Partial Response
M209863,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.29,60.22,,84,Stable Disease
M209864,79,Other,HPV-related Cancer,KEYTRUDA only,85.31,61.02,1121.26,98,Partial Response
M209865,80,Other,Melanoma,mrna-4157 + keytruda,45.61,39.27,944.83,87,Complete Response
M209866,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.85,21.83,1685.62,84,Partial Response
M209867,63,Male,HPV-related Cancer,mrna-4157 + keytruda,73.83,62.21,1348.46,82,Partial Response
M209868,83,Other,Melanoma,mrna-4157 + keytruda,49.76,39.21,1613.69,91,Partial Response
M209869,55,Male,Melanoma,mrna-4157 + keytruda,34.03,26.2,1310.36,86,Unknown
M209870,70,Male,Melanoma,mrna-4157 + keytruda,24.3,13.38,1320.51,89,Complete Response
M209871,51,Other,HPV-related Cancer,KEYTRUDA only,29.85,22.62,641.86,110,Stable Disease
M209872,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,47.75,21.65,279.03,74,Stable Disease
M209873,66,Male,Melanoma,mrna-4157 + keytruda,66.33,65.03,-7.38,102,Partial Response
M209874,36,Male,HPV-related Cancer,mrna-4157 + keytruda,51.61,51.69,,86,Stable Disease
M209875,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,73.2,38.78,1496.73,85,Partial Response
M209876,65,Other,Melanoma,KEYTRUDA only,45.28,40.66,960.35,85,Partial Response
M209877,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.17,38.32,1039.6,82,Complete Response
M209878,45,Female,Melanoma,mrna-4157 + keytruda,44.82,40.89,617.42,95,Complete Response
M209879,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,72.05,47.01,1068.95,113,Complete Response
M209880,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.2,19.47,1754.93,88,Partial Response
M209881,53,Other,HPV-related Cancer,KEYTRUDA only,7.75,7.4,531.14,82,Stable Disease
M209882,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.13,60.27,1414.51,75,Stable Disease
M209883,54,Other,HPV-related Cancer,mrna-4157 + keytruda,10.19,7.11,1201.89,97,Progression
M209884,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.66,,715.36,99,Partial Response
M209885,41,Male,HPV-related Cancer,KEYTRUDA only,50.06,46.21,704.24,87,Partial Response
M209886,44,Male,HPV-related Cancer,KEYTRUDA only,48.31,44.16,411.87,88,Stable Disease
M209887,77,Other,HPV-related Cancer,mrna-4157 + keytruda,50.41,25.33,648.75,82,Unknown
M209888,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.62,29.19,634.42,83,Progression
M209889,44,Male,Melanoma,mrna-4157 + keytruda,-4.61,-4.51,757.51,94,Partial Response
M209890,27,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.96,30.78,1343.28,96,Progression
M209891,68,Other,HPV-related Cancer,mrna-4157 + keytruda,57.99,67.59,965.75,100,Partial Response
M209892,70,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.11,32.67,1157.2,95,Partial Response
M209893,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.62,46.36,1206.75,91,Complete Response
M209894,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.25,23.52,1237.42,96,Stable Disease
M209895,31,Female,HPV-related Cancer,mrna-4157 + keytruda,40.78,35.82,1032.34,90,Progression
M209896,66,Male,HPV-related Cancer,mrna-4157 + keytruda,28.51,18.27,,95,Stable Disease
M209897,60,Male,HPV-related Cancer,mrna-4157 + keytruda,49.57,32.33,443.73,103,Stable Disease
M209898,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.59,56.81,1205.18,94,Partial Response
M209899,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.65,46.64,955.26,82,Stable Disease
M209900,54,Female,Melanoma,mrna-4157 + keytruda,46.85,58.08,1531.69,80,Stable Disease
M209901,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.8,16.98,683.84,73,Stable Disease
M209902,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.62,,1068.65,92,Partial Response
M209903,33,Female,Melanoma,mrna-4157 + keytruda,36.04,,443.23,90,
M209904,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,65.68,67.78,265.87,83,Progression
M209905,60,Male,Melanoma,KEYTRUDA only,45.57,40.1,775.75,93,Stable Disease
M209906,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.15,51.25,637.61,81,Complete Response
M209907,82,Other,HPV-related Cancer,KEYTRUDA only,56.76,46.31,619.29,87,Partial Response
M209908,39,Female,HPV-related Cancer,mrna-4157 + keytruda,50.2,35.85,1239.74,88,Stable Disease
M209909,84,Other,HPV-related Cancer,mrna-4157 + keytruda,62.83,65.05,1764.57,89,Stable Disease
M209910,68,Other,Melanoma,KEYTRUDA only,73.3,60.96,736.27,96,Stable Disease
M209911,63,Female,Melanoma,mrna-4157 + keytruda,56.17,37.38,1150.37,107,Partial Response
M209912,73,Male,HPV-related Cancer,KEYTRUDA only,46.61,23.6,1197.7,86,Partial Response
M209913,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.51,58.74,1098.49,76,Stable Disease
M209914,65,Other,Melanoma,KEYTRUDA only,22.59,15.28,1050.18,91,Partial Response
M209915,42,Male,Melanoma,KEYTRUDA only,61.32,51.9,255.21,86,Stable Disease
M209916,73,Male,Melanoma,mrna-4157 + keytruda,16.64,12.38,653.76,69,Partial Response
M209917,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.39,21.78,1130.44,84,Progression
M209918,42,Other,HPV-related Cancer,KEYTRUDA only,31.19,21.92,1427.34,96,Progression
M209919,72,Other,Melanoma,mrna-4157 + keytruda,35.59,21.87,560.64,86,Stable Disease
M209920,62,Female,Melanoma,mrna-4157 + keytruda,47.65,34.2,328.13,95,Progression
M209921,42,Female,HPV-related Cancer,mrna-4157 + keytruda,61.85,59.3,860.52,105,Progression
M209922,30,Other,HPV-related Cancer,mrna-4157 + keytruda,31.12,,1652.48,74,Unknown
M209923,57,Male,HPV-related Cancer,KEYTRUDA only,35.47,26.45,482.72,66,Partial Response
M209924,36,Female,HPV-related Cancer,mrna-4157 + keytruda,58.47,42.45,7917.65,90,Progression
M209925,45,Female,HPV-related Cancer,KEYTRUDA only,84.11,73.42,966.07,92,Partial Response
M209926,65,Female,HPV-related Cancer,mrna-4157 + keytruda,38.53,37.55,609.61,94,Stable Disease
M209927,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,105.86,64.59,633.03,81,Progression
M209928,46,Other,Melanoma,KEYTRUDA only,69.45,51.56,1193.18,80,Partial Response
M209929,37,Female,HPV-related Cancer,KEYTRUDA only,66.3,49.61,1324.78,95,Progression
M209930,45,Other,HPV-related Cancer,mrna-4157 + keytruda,29.61,30.49,1196.37,99,Unknown
M209931,40,Other,HPV-related Cancer,KEYTRUDA only,45.45,39.77,1097.26,102,Progression
M209932,29,Female,Melanoma,mrna-4157 + keytruda,59.44,56.85,367.17,87,Progression
M209933,47,Female,HPV-related Cancer,KEYTRUDA only,16.46,15.51,820.91,90,Progression
M209934,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,73.96,52.92,1204.01,83,Unknown
M209935,36,Other,HPV-related Cancer,mrna-4157 + keytruda,51.72,35.2,1517.64,100,Partial Response
M209936,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.19,44.02,842.94,90,Stable Disease
M209937,42,Other,HPV-related Cancer,KEYTRUDA only,67.14,50.94,616.93,88,Complete Response
M209938,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.66,38.57,670.9,109,Complete Response
M209939,80,Male,HPV-related Cancer,mrna-4157 + keytruda,32.67,22.48,301.14,76,Partial Response
M209940,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.17,27.68,1213.56,110,Stable Disease
M209941,43,Male,Melanoma,mrna-4157 + keytruda,98.8,60.36,1021.55,71,Partial Response
M209942,33,Female,HPV-related Cancer,mrna-4157 + keytruda,19.73,17.53,1103.58,97,Complete Response
M209943,67,Other,Melanoma,mrna-4157 + keytruda,77.37,44.96,1386.56,93,Stable Disease
M209944,55,Other,Melanoma,mrna-4157 + keytruda,65.59,39.25,967.39,82,Progression
M209945,49,Male,Melanoma,mrna-4157 + keytruda,40.25,27.81,504.56,83,Complete Response
M209946,30,Female,Melanoma,mrna-4157 + keytruda,19.64,14.77,905.6,93,Stable Disease
M209947,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.0,39.09,531.06,97,Stable Disease
M209948,65,Other,HPV-related Cancer,KEYTRUDA only,36.28,25.45,875.44,79,Partial Response
M209949,26,Other,Melanoma,mrna-4157 + keytruda,58.91,71.07,650.49,88,
M209950,56,Male,HPV-related Cancer,KEYTRUDA only,49.47,,602.96,101,Partial Response
M209951,81,Other,HPV-related Cancer,KEYTRUDA only,15.22,14.06,1295.52,91,Partial Response
M209952,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.48,,1278.1,102,Partial Response
M209953,84,Female,HPV-related Cancer,mrna-4157 + keytruda,84.31,70.83,804.09,83,Progression
M209954,31,Male,HPV-related Cancer,mrna-4157 + keytruda,66.9,59.31,1357.9,94,Complete Response
M209955,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.7,85.09,444.69,82,Partial Response
M209956,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.71,29.56,900.11,91,Partial Response
M209957,61,Female,HPV-related Cancer,KEYTRUDA only,42.01,25.67,944.2,91,Stable Disease
M209958,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.17,39.11,1383.92,92,Stable Disease
M209959,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.19,27.11,705.16,70,Partial Response
M209960,84,Male,HPV-related Cancer,KEYTRUDA only,79.02,47.89,1975.46,65,Partial Response
M209961,41,Other,HPV-related Cancer,mrna-4157 + keytruda,81.3,,571.14,81,Stable Disease
M209962,64,Female,HPV-related Cancer,mrna-4157 + keytruda,79.68,40.65,1223.15,86,Progression
M209963,81,Male,Melanoma,mrna-4157 + keytruda,21.75,22.67,1323.42,92,Progression
M209964,66,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.42,22.95,1039.47,92,Progression
M209965,68,Other,Melanoma,mrna-4157 + keytruda,62.31,69.48,1200.58,92,Stable Disease
M209966,52,Female,Melanoma,KEYTRUDA only,27.65,23.73,1072.79,85,Complete Response
M209967,81,Female,Melanoma,KEYTRUDA only,48.8,45.97,588.08,88,Progression
M209968,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.55,25.31,1303.02,73,Complete Response
M209969,84,Other,HPV-related Cancer,KEYTRUDA only,61.78,56.12,1138.1,89,
M209970,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.86,21.62,835.75,83,Complete Response
M209971,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.74,30.17,1291.4,102,
M209972,39,Female,Melanoma,mrna-4157 + keytruda,62.47,61.62,2136.85,79,Progression
M209973,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,19.3,13.72,1054.37,95,Stable Disease
M209974,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.0,45.43,989.23,92,Partial Response
M209975,34,Male,Melanoma,mrna-4157 + keytruda,91.04,,410.67,75,Complete Response
M209976,82,Other,HPV-related Cancer,KEYTRUDA only,73.99,55.03,2234.19,113,Unknown
M209977,26,Male,Melanoma,KEYTRUDA only,42.61,36.17,792.79,97,Complete Response
M209978,29,Other,Melanoma,mrna-4157 + keytruda,47.22,38.11,1063.84,94,Partial Response
M209979,35,Other,Melanoma,mrna-4157 + keytruda,56.71,32.03,1304.61,93,Complete Response
M209980,25,Female,HPV-related Cancer,KEYTRUDA only,32.2,21.49,545.99,94,Stable Disease
M209981,42,Male,HPV-related Cancer,mrna-4157 + keytruda,53.65,39.18,382.94,106,Stable Disease
M209982,79,Female,Melanoma,mrna-4157 + keytruda,112.84,91.22,1699.04,103,Partial Response
M209983,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.67,20.2,1330.36,92,Complete Response
M209984,53,Other,Melanoma,KEYTRUDA only,21.93,,1270.63,87,Stable Disease
M209985,63,Male,HPV-related Cancer,mrna-4157 + keytruda,40.01,36.4,769.15,82,Stable Disease
M209986,76,Other,HPV-related Cancer,KEYTRUDA only,76.58,34.24,1676.9,81,Complete Response
M209987,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.32,21.76,869.3,87,Stable Disease
M209988,64,Female,Melanoma,mrna-4157 + keytruda,38.74,35.05,1497.4,103,Complete Response
M209989,81,Other,Melanoma,KEYTRUDA only,31.32,25.36,717.15,91,Progression
M209990,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,23.45,24.43,1768.34,84,Progression
M209991,41,Other,Melanoma,mrna-4157 + keytruda,7.33,4.51,1039.19,90,Partial Response
M209992,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.43,55.88,956.59,103,Partial Response
M209993,53,Other,HPV-related Cancer,mrna-4157 + keytruda,25.99,22.38,1179.92,111,Complete Response
M209994,53,Female,HPV-related Cancer,mrna-4157 + keytruda,37.65,27.51,1121.4,87,Stable Disease
M209995,25,Female,Melanoma,mrna-4157 + keytruda,76.71,64.46,424.64,90,Progression
M209996,47,Female,HPV-related Cancer,KEYTRUDA only,57.73,57.3,,83,Stable Disease
M209997,45,Male,Melanoma,mrna-4157 + keytruda,26.89,14.91,1541.69,85,Progression
M209998,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.95,41.79,572.79,86,Stable Disease
M209999,59,Female,HPV-related Cancer,KEYTRUDA only,47.62,47.58,447.83,75,Progression
M210000,76,Male,Melanoma,mrna-4157 + keytruda,19.42,22.95,880.85,85,Complete Response
M210001,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.83,31.16,,86,Partial Response
M210002,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.25,48.08,367.15,78,Partial Response
M210003,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.73,40.64,308.77,88,Partial Response
M210004,26,Female,HPV-related Cancer,KEYTRUDA only,57.22,46.08,1404.93,95,Stable Disease
M210005,31,Male,HPV-related Cancer,mrna-4157 + keytruda,18.13,15.67,599.54,102,Partial Response
M210006,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.01,50.11,1037.07,99,Partial Response
M210007,43,Male,Melanoma,mrna-4157 + keytruda,73.78,41.21,770.26,75,Progression
M210008,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,10.89,6.36,644.37,87,Stable Disease
M210009,40,Female,Melanoma,mrna-4157 + keytruda,56.67,51.69,1248.21,77,Partial Response
M210010,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.63,29.35,,95,Partial Response
M210011,49,Female,HPV-related Cancer,KEYTRUDA only,51.58,40.66,790.68,100,Complete Response
M210012,69,Other,Melanoma,mrna-4157 + keytruda,42.25,32.41,989.25,75,Stable Disease
M210013,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.08,30.2,1401.58,90,Partial Response
M210014,25,Other,Melanoma,KEYTRUDA only,29.86,28.09,1435.66,87,Progression
M210015,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.73,57.85,1528.31,102,Partial Response
M210016,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.2,41.64,695.98,71,Stable Disease
M210017,37,Male,Melanoma,KEYTRUDA only,61.26,49.48,1619.64,93,Progression
M210018,80,Female,HPV-related Cancer,KEYTRUDA only,25.6,16.32,1015.3,99,
M210019,75,Other,HPV-related Cancer,mrna-4157 + keytruda,33.46,34.78,736.8,92,Progression
M210020,46,Male,Melanoma,mrna-4157 + keytruda,43.69,38.98,779.15,93,Stable Disease
M210021,34,Male,Melanoma,mrna-4157 + keytruda,38.83,36.51,1538.52,83,Progression
M210022,48,Male,Melanoma,KEYTRUDA only,59.0,57.35,740.23,82,Partial Response
M210023,79,Male,HPV-related Cancer,mrna-4157 + keytruda,33.77,24.37,1842.62,74,
M210024,55,Female,HPV-related Cancer,mrna-4157 + keytruda,47.86,40.77,261.08,84,Stable Disease
M210025,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.74,21.89,1314.74,96,
M210026,61,Male,Melanoma,KEYTRUDA only,82.76,73.28,883.2,100,Stable Disease
M210027,34,Male,HPV-related Cancer,mrna-4157 + keytruda,22.17,16.94,794.5,90,Complete Response
M210028,75,Male,HPV-related Cancer,KEYTRUDA only,70.51,,804.25,115,Partial Response
M210029,77,Male,Melanoma,mrna-4157 + keytruda,73.59,58.02,2222.26,90,
M210030,67,Female,Melanoma,KEYTRUDA only,75.46,59.33,1773.56,83,Partial Response
M210031,77,Male,HPV-related Cancer,KEYTRUDA only,51.76,45.39,1186.16,97,Stable Disease
M210032,83,Other,Melanoma,mrna-4157 + keytruda,80.35,63.76,1827.48,84,Stable Disease
M210033,79,Other,Melanoma,mrna-4157 + keytruda,44.69,44.86,1114.5,104,
M210034,69,Female,Melanoma,mrna-4157 + keytruda,15.56,13.99,1018.77,96,Partial Response
M210035,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.93,,1664.22,98,Partial Response
M210036,25,Male,HPV-related Cancer,KEYTRUDA only,80.56,78.61,42.26,92,Complete Response
M210037,81,Other,Melanoma,mrna-4157 + keytruda,49.47,36.31,1299.45,109,Partial Response
M210038,25,Male,HPV-related Cancer,KEYTRUDA only,44.34,35.25,844.85,97,Complete Response
M210039,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.11,44.16,1101.78,95,Unknown
M210040,74,Male,HPV-related Cancer,KEYTRUDA only,80.4,62.19,1672.83,72,Unknown
M210041,43,Female,HPV-related Cancer,KEYTRUDA only,39.87,52.72,1255.71,84,Stable Disease
M210042,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.64,57.97,892.44,107,Partial Response
M210043,73,Male,HPV-related Cancer,mrna-4157 + keytruda,61.28,62.7,1742.87,84,Stable Disease
M210044,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.3,57.62,1076.87,79,Stable Disease
M210045,53,Female,Melanoma,mrna-4157 + keytruda,62.27,74.51,1300.17,83,Partial Response
M210046,61,Other,HPV-related Cancer,mrna-4157 + keytruda,48.6,44.1,1148.61,99,Complete Response
M210047,79,Female,Melanoma,mrna-4157 + keytruda,63.32,41.83,942.8,83,Progression
M210048,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.34,49.51,506.16,108,Partial Response
M210049,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.78,24.15,604.77,96,Stable Disease
M210050,60,Other,HPV-related Cancer,mrna-4157 + keytruda,11.89,4.37,1067.4,70,Stable Disease
M210051,72,Other,Melanoma,KEYTRUDA only,56.95,53.57,518.79,100,Partial Response
M210052,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.87,59.28,71.87,95,Progression
M210053,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.46,39.4,959.25,89,Progression
M210054,76,Other,Melanoma,mrna-4157 + keytruda,77.41,65.12,,87,Partial Response
M210055,71,Female,HPV-related Cancer,mrna-4157 + keytruda,56.03,32.79,1194.76,92,Progression
M210056,29,Female,HPV-related Cancer,KEYTRUDA only,61.76,60.14,729.6,90,Partial Response
M210057,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.92,40.38,913.69,94,Stable Disease
M210058,77,Female,Melanoma,mrna-4157 + keytruda,53.18,31.01,1600.38,87,Complete Response
M210059,35,Male,HPV-related Cancer,mrna-4157 + keytruda,46.33,33.75,575.76,99,Partial Response
M210060,37,Female,HPV-related Cancer,mrna-4157 + keytruda,63.64,64.08,524.65,82,Complete Response
M210061,50,Other,Melanoma,KEYTRUDA only,44.06,43.85,631.91,89,Stable Disease
M210062,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.82,35.35,1882.91,106,Stable Disease
M210063,83,Female,Melanoma,KEYTRUDA only,44.48,34.24,,90,Stable Disease
M210064,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.51,,910.08,91,Partial Response
M210065,73,Other,HPV-related Cancer,mrna-4157 + keytruda,26.79,33.59,627.0,89,Progression
M210066,34,Female,HPV-related Cancer,KEYTRUDA only,42.41,27.7,737.18,84,Complete Response
M210067,84,Male,HPV-related Cancer,mrna-4157 + keytruda,42.42,30.21,962.05,88,Partial Response
M210068,55,Female,HPV-related Cancer,mrna-4157 + keytruda,49.82,43.41,413.43,78,Stable Disease
M210069,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.08,22.81,621.08,73,Progression
M210070,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.82,55.87,460.59,94,Partial Response
M210071,78,Male,HPV-related Cancer,KEYTRUDA only,34.56,24.56,1588.33,78,Partial Response
M210072,55,Other,HPV-related Cancer,KEYTRUDA only,50.74,64.43,1466.0,88,Progression
M210073,41,Male,Melanoma,mrna-4157 + keytruda,19.43,15.25,506.8,87,Partial Response
M210074,62,Female,Melanoma,mrna-4157 + keytruda,47.65,32.88,1863.78,83,Complete Response
M210075,37,Female,Melanoma,mrna-4157 + keytruda,31.94,24.57,1371.22,99,Stable Disease
M210076,51,Male,Melanoma,mrna-4157 + keytruda,52.22,41.18,1223.47,100,Stable Disease
M210077,49,Male,Melanoma,KEYTRUDA only,53.39,46.89,1440.29,102,Partial Response
M210078,45,Female,HPV-related Cancer,KEYTRUDA only,77.83,72.42,1299.67,104,Stable Disease
M210079,39,Female,HPV-related Cancer,mrna-4157 + keytruda,69.77,63.14,1588.33,91,Partial Response
M210080,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.37,44.34,749.02,83,Partial Response
M210081,36,Female,HPV-related Cancer,mrna-4157 + keytruda,47.22,32.66,671.94,92,Stable Disease
M210082,71,Male,Melanoma,KEYTRUDA only,57.4,33.68,411.26,87,Complete Response
M210083,48,Female,HPV-related Cancer,mrna-4157 + keytruda,48.35,,466.46,92,Progression
M210084,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.28,63.22,998.58,109,Partial Response
M210085,76,Male,HPV-related Cancer,mrna-4157 + keytruda,92.32,78.43,659.88,110,Stable Disease
M210086,45,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.19,63.23,438.09,83,Stable Disease
M210087,29,Other,Non-small Cell Lung Cancer,KEYTRUDA only,100.35,100.87,1376.58,78,Partial Response
M210088,43,Other,HPV-related Cancer,KEYTRUDA only,43.02,29.96,929.9,107,Partial Response
M210089,45,Male,Melanoma,mrna-4157 + keytruda,72.89,70.99,800.13,89,Unknown
M210090,82,Other,HPV-related Cancer,mrna-4157 + keytruda,37.3,20.04,,112,Partial Response
M210091,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.5,22.44,1176.04,87,Stable Disease
M210092,29,Male,Melanoma,KEYTRUDA only,50.33,36.31,915.62,88,Complete Response
M210093,61,Other,HPV-related Cancer,mrna-4157 + keytruda,33.59,34.08,1086.63,92,Partial Response
M210094,55,Male,HPV-related Cancer,mrna-4157 + keytruda,79.79,66.09,880.34,101,Partial Response
M210095,43,Other,HPV-related Cancer,mrna-4157 + keytruda,15.26,12.81,1581.25,88,Stable Disease
M210096,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.04,52.09,,86,Partial Response
M210097,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.51,20.77,476.65,96,Stable Disease
M210098,34,Other,Melanoma,KEYTRUDA only,111.16,,860.81,108,Complete Response
M210099,59,Male,Melanoma,mrna-4157 + keytruda,57.96,35.55,203.86,102,Stable Disease
M210100,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.35,15.11,536.56,80,Stable Disease
M210101,82,Other,HPV-related Cancer,KEYTRUDA only,28.89,16.93,1194.86,101,Complete Response
M210102,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.28,48.06,785.59,97,Partial Response
M210103,83,Other,HPV-related Cancer,KEYTRUDA only,72.23,60.99,626.81,100,Partial Response
M210104,79,Female,Melanoma,KEYTRUDA only,71.01,61.17,1547.23,88,Partial Response
M210105,52,Male,Melanoma,mrna-4157 + keytruda,58.45,45.53,842.68,76,Complete Response
M210106,40,Male,Melanoma,KEYTRUDA only,65.87,47.95,1037.61,100,Progression
M210107,54,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.29,13.6,1104.76,94,
M210108,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.91,37.85,985.63,72,Complete Response
M210109,65,Other,Melanoma,mrna-4157 + keytruda,44.86,30.97,245.28,79,Partial Response
M210110,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.15,65.69,1451.43,96,Complete Response
M210111,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,86.34,56.58,1180.04,113,Partial Response
M210112,79,Female,Melanoma,mrna-4157 + keytruda,52.87,,604.88,90,Stable Disease
M210113,60,Female,Melanoma,mrna-4157 + keytruda,3.89,2.86,1111.07,87,Stable Disease
M210114,75,Female,Melanoma,KEYTRUDA only,45.28,42.41,1316.36,93,Progression
M210115,41,Female,Melanoma,mrna-4157 + keytruda,57.35,34.01,176.76,91,Partial Response
M210116,69,Other,Melanoma,KEYTRUDA only,62.75,63.92,1107.07,94,Partial Response
M210117,47,Male,Melanoma,KEYTRUDA only,38.92,37.81,374.87,92,Stable Disease
M210118,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.22,54.62,1041.02,84,Progression
M210119,62,Female,HPV-related Cancer,mrna-4157 + keytruda,27.72,19.11,614.82,94,Complete Response
M210120,68,Male,HPV-related Cancer,mrna-4157 + keytruda,31.36,23.1,1157.8,117,Complete Response
M210121,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.32,,841.98,68,Progression
M210122,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.31,,676.36,81,Stable Disease
M210123,59,Other,Melanoma,mrna-4157 + keytruda,15.55,10.52,916.56,82,Progression
M210124,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.19,46.76,1108.61,77,Partial Response
M210125,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,16.04,12.88,1471.52,78,
M210126,61,Female,HPV-related Cancer,KEYTRUDA only,30.43,34.93,1739.86,84,Progression
M210127,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,73.08,44.98,424.32,93,Complete Response
M210128,73,Male,HPV-related Cancer,mrna-4157 + keytruda,48.16,56.34,1185.27,100,Complete Response
M210129,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.61,16.96,1025.63,83,Stable Disease
M210130,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.76,46.43,1377.87,88,Progression
M210131,55,Male,Melanoma,mrna-4157 + keytruda,50.54,32.13,951.33,78,Progression
M210132,46,Other,HPV-related Cancer,KEYTRUDA only,74.06,44.67,1298.53,98,Stable Disease
M210133,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.05,16.69,765.24,102,Stable Disease
M210134,32,Male,HPV-related Cancer,mrna-4157 + keytruda,32.75,25.15,383.91,73,Complete Response
M210135,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,87.19,,1197.03,79,Partial Response
M210136,32,Other,Melanoma,mrna-4157 + keytruda,59.8,64.78,740.9,93,Stable Disease
M210137,48,Male,HPV-related Cancer,mrna-4157 + keytruda,10.49,3.73,408.09,103,Stable Disease
M210138,43,Male,HPV-related Cancer,mrna-4157 + keytruda,64.94,45.69,258.84,88,Progression
M210139,65,Male,HPV-related Cancer,mrna-4157 + keytruda,49.95,42.22,759.4,103,
M210140,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,7.47,8.2,1284.05,93,Unknown
M210141,39,Female,HPV-related Cancer,mrna-4157 + keytruda,32.24,27.87,875.0,84,Stable Disease
M210142,45,Other,Melanoma,mrna-4157 + keytruda,81.46,59.89,1140.44,92,Partial Response
M210143,83,Male,HPV-related Cancer,KEYTRUDA only,72.12,31.39,340.46,86,Progression
M210144,56,Other,HPV-related Cancer,KEYTRUDA only,48.52,65.9,1211.24,88,Complete Response
M210145,33,Other,Melanoma,KEYTRUDA only,63.33,55.78,810.52,94,Complete Response
M210146,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.72,33.82,1704.67,101,Stable Disease
M210147,28,Other,HPV-related Cancer,KEYTRUDA only,77.36,90.9,,86,Partial Response
M210148,61,Male,Melanoma,KEYTRUDA only,51.23,48.9,478.28,78,Partial Response
M210149,46,Other,Melanoma,mrna-4157 + keytruda,48.7,40.99,518.12,105,Progression
M210150,75,Male,Melanoma,KEYTRUDA only,42.23,,1428.72,98,
M210151,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.51,49.8,1518.58,103,Progression
M210152,35,Other,HPV-related Cancer,KEYTRUDA only,19.92,17.2,1306.25,86,Complete Response
M210153,27,Female,Melanoma,mrna-4157 + keytruda,41.79,35.01,1711.78,98,Progression
M210154,51,Male,Melanoma,mrna-4157 + keytruda,45.25,37.74,2134.97,97,Progression
M210155,54,Female,Melanoma,KEYTRUDA only,13.99,13.32,1083.6,85,Stable Disease
M210156,53,Male,HPV-related Cancer,mrna-4157 + keytruda,64.58,44.52,487.33,99,Progression
M210157,47,Female,Melanoma,KEYTRUDA only,70.77,35.64,307.02,82,Partial Response
M210158,65,Other,HPV-related Cancer,mrna-4157 + keytruda,74.05,40.63,442.93,104,Complete Response
M210159,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.05,68.96,1431.67,97,Stable Disease
M210160,84,Female,HPV-related Cancer,KEYTRUDA only,8.16,5.02,1451.9,95,Complete Response
M210161,57,Other,Melanoma,KEYTRUDA only,33.93,31.91,,82,Stable Disease
M210162,33,Other,HPV-related Cancer,mrna-4157 + keytruda,81.82,,424.02,73,Unknown
M210163,57,Male,Melanoma,mrna-4157 + keytruda,57.77,52.82,1078.84,100,Progression
M210164,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.53,,1268.62,93,Partial Response
M210165,49,Female,HPV-related Cancer,KEYTRUDA only,38.3,31.77,671.37,83,Partial Response
M210166,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.54,22.28,1326.97,98,Partial Response
M210167,33,Other,Melanoma,mrna-4157 + keytruda,32.59,34.22,1584.35,87,Partial Response
M210168,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.55,38.61,,96,Partial Response
M210169,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.77,65.5,854.67,106,Progression
M210170,81,Other,HPV-related Cancer,mrna-4157 + keytruda,43.05,35.45,838.77,94,Partial Response
M210171,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.54,36.29,545.75,92,Stable Disease
M210172,52,Other,HPV-related Cancer,mrna-4157 + keytruda,27.64,20.77,,85,Stable Disease
M210173,31,Female,Melanoma,KEYTRUDA only,27.98,20.63,1448.98,77,Unknown
M210174,54,Male,Melanoma,mrna-4157 + keytruda,33.88,27.0,613.58,82,Complete Response
M210175,36,Other,Melanoma,mrna-4157 + keytruda,45.12,46.19,73.33,89,Stable Disease
M210176,31,Male,Melanoma,mrna-4157 + keytruda,27.06,12.98,1566.29,111,Unknown
M210177,51,Male,HPV-related Cancer,mrna-4157 + keytruda,60.14,46.56,2141.19,94,Progression
M210178,28,Female,HPV-related Cancer,mrna-4157 + keytruda,44.83,44.97,866.64,77,Stable Disease
M210179,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.49,,919.24,90,Stable Disease
M210180,38,Male,HPV-related Cancer,mrna-4157 + keytruda,61.59,38.59,857.81,94,Partial Response
M210181,77,Male,HPV-related Cancer,mrna-4157 + keytruda,41.47,37.26,1446.24,81,Partial Response
M210182,76,Male,Melanoma,mrna-4157 + keytruda,44.0,39.74,488.39,81,Complete Response
M210183,28,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.3,7.8,582.98,93,Complete Response
M210184,53,Female,HPV-related Cancer,mrna-4157 + keytruda,61.72,47.06,1399.53,87,Partial Response
M210185,78,Male,Melanoma,KEYTRUDA only,58.29,43.81,820.55,84,Partial Response
M210186,67,Male,Melanoma,mrna-4157 + keytruda,30.97,22.82,1420.56,87,Stable Disease
M210187,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.69,32.43,896.94,68,Partial Response
M210188,57,Female,HPV-related Cancer,mrna-4157 + keytruda,56.66,70.4,1260.96,85,Partial Response
M210189,69,Other,Melanoma,KEYTRUDA only,30.12,25.58,759.5,91,Stable Disease
M210190,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.37,17.85,860.68,90,Partial Response
M210191,52,Other,Melanoma,KEYTRUDA only,98.31,50.69,1212.42,93,Complete Response
M210192,49,Female,Melanoma,mrna-4157 + keytruda,50.57,,743.98,81,Unknown
M210193,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.17,64.82,981.19,92,Partial Response
M210194,31,Male,Melanoma,KEYTRUDA only,59.01,68.73,139.75,103,Progression
M210195,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.68,69.01,1164.41,107,Complete Response
M210196,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.2,60.7,-58.95,92,Partial Response
M210197,68,Other,Melanoma,KEYTRUDA only,29.01,13.72,1270.88,96,Complete Response
M210198,75,Male,HPV-related Cancer,KEYTRUDA only,57.53,37.77,685.98,94,
M210199,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.01,69.14,319.5,78,Partial Response
M210200,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.86,61.59,1296.31,93,Partial Response
M210201,47,Male,Melanoma,KEYTRUDA only,66.66,,974.07,86,Unknown
M210202,72,Female,HPV-related Cancer,KEYTRUDA only,49.21,55.61,,97,Stable Disease
M210203,65,Female,Melanoma,mrna-4157 + keytruda,77.11,42.59,1542.12,91,Stable Disease
M210204,36,Other,Melanoma,KEYTRUDA only,67.32,,476.51,100,Partial Response
M210205,64,Male,Melanoma,mrna-4157 + keytruda,31.63,24.63,756.66,82,Progression
M210206,38,Female,Melanoma,KEYTRUDA only,83.77,62.65,1141.55,98,Progression
M210207,32,Other,HPV-related Cancer,KEYTRUDA only,17.57,6.22,1125.44,88,Stable Disease
M210208,82,Female,HPV-related Cancer,KEYTRUDA only,68.61,45.55,1404.62,114,Partial Response
M210209,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.02,42.58,1738.43,99,Partial Response
M210210,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.3,45.37,1033.4,104,Progression
M210211,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.75,62.1,2118.86,87,Unknown
M210212,61,Male,HPV-related Cancer,KEYTRUDA only,42.11,35.6,542.58,93,Progression
M210213,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.96,51.84,1455.64,91,Partial Response
M210214,50,Female,Melanoma,KEYTRUDA only,46.82,31.67,849.84,101,Complete Response
M210215,49,Other,HPV-related Cancer,mrna-4157 + keytruda,32.32,30.41,1117.2,86,Stable Disease
M210216,45,Other,Melanoma,mrna-4157 + keytruda,55.77,45.4,1226.34,76,Stable Disease
M210217,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.89,47.36,1111.3,92,Stable Disease
M210218,35,Female,Melanoma,KEYTRUDA only,45.85,20.59,,91,Unknown
M210219,81,Female,HPV-related Cancer,mrna-4157 + keytruda,35.49,28.68,1420.48,82,Stable Disease
M210220,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.77,29.78,,83,Stable Disease
M210221,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.08,27.41,1248.51,82,Partial Response
M210222,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.39,14.82,1174.26,97,Stable Disease
M210223,32,Other,HPV-related Cancer,mrna-4157 + keytruda,53.31,41.65,979.26,84,Progression
M210224,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.62,32.26,1590.24,101,Partial Response
M210225,38,Other,HPV-related Cancer,mrna-4157 + keytruda,11.06,9.06,957.19,83,Progression
M210226,80,Female,HPV-related Cancer,KEYTRUDA only,32.83,28.63,1459.7,82,Partial Response
M210227,66,Other,Melanoma,mrna-4157 + keytruda,26.41,15.73,348.5,79,Partial Response
M210228,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.76,45.12,1136.78,101,Partial Response
M210229,56,Female,HPV-related Cancer,mrna-4157 + keytruda,59.3,32.36,384.94,97,Partial Response
M210230,73,Male,HPV-related Cancer,KEYTRUDA only,62.15,71.51,1383.9,95,Progression
M210231,73,Other,HPV-related Cancer,KEYTRUDA only,23.93,20.69,420.95,93,Stable Disease
M210232,76,Female,Melanoma,mrna-4157 + keytruda,62.57,,1090.9,94,Stable Disease
M210233,56,Female,HPV-related Cancer,mrna-4157 + keytruda,31.93,25.22,713.97,90,Partial Response
M210234,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.64,22.75,883.01,75,Complete Response
M210235,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.58,70.38,1197.15,95,
M210236,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.57,49.1,889.91,89,Stable Disease
M210237,84,Male,HPV-related Cancer,KEYTRUDA only,90.66,56.97,1237.5,102,Partial Response
M210238,27,Female,Melanoma,KEYTRUDA only,74.04,52.87,,84,Complete Response
M210239,64,Other,Melanoma,mrna-4157 + keytruda,77.2,70.0,1962.42,93,Partial Response
M210240,79,Male,HPV-related Cancer,KEYTRUDA only,50.18,35.13,1028.21,105,Complete Response
M210241,52,Other,Melanoma,mrna-4157 + keytruda,53.5,21.42,402.1,81,Partial Response
M210242,37,Other,Melanoma,mrna-4157 + keytruda,42.06,25.96,1278.47,112,Stable Disease
M210243,60,Female,Melanoma,mrna-4157 + keytruda,75.15,72.02,1065.76,94,Complete Response
M210244,35,Male,Melanoma,KEYTRUDA only,29.65,19.64,1588.18,79,Partial Response
M210245,58,Male,HPV-related Cancer,mrna-4157 + keytruda,94.77,,1149.66,86,Progression
M210246,70,Other,HPV-related Cancer,mrna-4157 + keytruda,77.39,76.08,1000.28,88,Unknown
M210247,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.99,42.06,1136.91,92,Progression
M210248,65,Male,Melanoma,KEYTRUDA only,44.42,45.66,1279.6,90,Partial Response
M210249,73,Other,HPV-related Cancer,KEYTRUDA only,28.47,21.67,1093.28,96,Stable Disease
M210250,70,Female,HPV-related Cancer,KEYTRUDA only,37.71,25.26,2123.23,78,Complete Response
M210251,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.91,54.73,779.72,91,Unknown
M210252,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.78,30.87,202.59,76,
M210253,70,Female,HPV-related Cancer,mrna-4157 + keytruda,59.94,61.46,767.61,88,
M210254,78,Female,Melanoma,mrna-4157 + keytruda,75.59,62.97,946.53,96,Stable Disease
M210255,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.28,36.21,247.04,86,Stable Disease
M210256,26,Male,HPV-related Cancer,KEYTRUDA only,60.96,38.95,746.52,81,Stable Disease
M210257,77,Female,HPV-related Cancer,KEYTRUDA only,15.78,,445.34,69,Unknown
M210258,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.5,21.56,1231.28,75,Complete Response
M210259,66,Female,Melanoma,mrna-4157 + keytruda,36.28,32.34,1094.42,100,Partial Response
M210260,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.93,63.01,93.46,81,Partial Response
M210261,69,Female,HPV-related Cancer,mrna-4157 + keytruda,61.53,59.08,928.54,75,Stable Disease
M210262,63,Male,HPV-related Cancer,KEYTRUDA only,90.45,105.92,1255.18,86,Stable Disease
M210263,42,Other,HPV-related Cancer,KEYTRUDA only,22.01,22.23,964.72,68,Partial Response
M210264,66,Female,Melanoma,KEYTRUDA only,34.62,23.33,1361.86,100,Partial Response
M210265,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.57,46.08,477.59,86,Progression
M210266,45,Female,Melanoma,mrna-4157 + keytruda,31.82,34.19,1037.2,89,Partial Response
M210267,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,86.69,,1361.28,66,Partial Response
M210268,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.14,51.95,389.17,71,Stable Disease
M210269,48,Male,HPV-related Cancer,mrna-4157 + keytruda,40.25,26.55,794.04,93,Partial Response
M210270,65,Other,Melanoma,mrna-4157 + keytruda,8.49,6.95,960.28,91,Complete Response
M210271,70,Other,Non-small Cell Lung Cancer,KEYTRUDA only,82.08,95.06,861.2,104,Partial Response
M210272,53,Female,HPV-related Cancer,KEYTRUDA only,77.31,77.03,898.28,100,Partial Response
M210273,78,Other,HPV-related Cancer,mrna-4157 + keytruda,65.72,70.14,1056.28,92,Partial Response
M210274,50,Other,HPV-related Cancer,KEYTRUDA only,65.39,64.31,644.48,88,Stable Disease
M210275,61,Male,Melanoma,mrna-4157 + keytruda,59.18,34.71,967.24,69,Complete Response
M210276,39,Female,HPV-related Cancer,mrna-4157 + keytruda,9.65,6.41,1209.01,98,Partial Response
M210277,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.31,34.09,760.59,79,Stable Disease
M210278,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,90.82,106.27,1658.7,97,Partial Response
M210279,63,Female,Melanoma,mrna-4157 + keytruda,64.47,36.98,1060.53,99,Stable Disease
M210280,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.39,32.73,1287.98,81,
M210281,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.91,41.67,736.8,100,
M210282,81,Other,HPV-related Cancer,KEYTRUDA only,63.6,46.49,795.76,75,
M210283,72,Other,HPV-related Cancer,mrna-4157 + keytruda,75.16,63.14,422.0,95,Stable Disease
M210284,41,Female,Melanoma,KEYTRUDA only,-4.15,-4.39,713.52,111,Stable Disease
M210285,38,Other,HPV-related Cancer,mrna-4157 + keytruda,71.25,61.88,1334.51,91,Stable Disease
M210286,62,Male,Melanoma,mrna-4157 + keytruda,73.01,59.7,1448.98,91,Complete Response
M210287,54,Male,Melanoma,mrna-4157 + keytruda,47.1,45.62,,87,Partial Response
M210288,44,Male,HPV-related Cancer,KEYTRUDA only,33.71,20.87,1066.38,93,Progression
M210289,35,Male,HPV-related Cancer,KEYTRUDA only,53.91,45.11,1404.81,86,Complete Response
M210290,75,Male,HPV-related Cancer,KEYTRUDA only,50.56,55.4,351.9,96,Stable Disease
M210291,64,Female,Melanoma,KEYTRUDA only,79.25,77.43,1357.48,78,Partial Response
M210292,72,Other,HPV-related Cancer,mrna-4157 + keytruda,38.3,31.48,1006.94,92,Partial Response
M210293,71,Male,HPV-related Cancer,KEYTRUDA only,13.26,11.01,1401.33,76,Partial Response
M210294,84,Female,HPV-related Cancer,KEYTRUDA only,40.21,40.17,759.74,99,Progression
M210295,74,Female,Melanoma,KEYTRUDA only,50.6,34.66,1256.41,85,Partial Response
M210296,39,Female,Melanoma,mrna-4157 + keytruda,53.05,40.88,802.97,86,Complete Response
M210297,47,Male,Melanoma,mrna-4157 + keytruda,28.52,19.63,1092.81,88,Complete Response
M210298,81,Female,HPV-related Cancer,KEYTRUDA only,55.85,52.42,564.43,94,Complete Response
M210299,69,Female,HPV-related Cancer,mrna-4157 + keytruda,21.01,23.3,1255.69,96,Stable Disease
M210300,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.85,28.05,574.07,81,Partial Response
M210301,33,Other,HPV-related Cancer,mrna-4157 + keytruda,59.74,,1289.77,87,Progression
M210302,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,79.87,68.05,1252.46,74,Partial Response
M210303,59,Other,Melanoma,mrna-4157 + keytruda,65.15,60.7,155.12,92,Partial Response
M210304,70,Other,HPV-related Cancer,mrna-4157 + keytruda,76.44,53.27,1291.3,85,Progression
M210305,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.25,14.27,1509.35,88,Partial Response
M210306,83,Female,Melanoma,KEYTRUDA only,61.9,54.55,816.93,97,Stable Disease
M210307,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.86,78.4,1377.72,100,Stable Disease
M210308,57,Male,Melanoma,mrna-4157 + keytruda,63.57,41.62,623.52,95,Partial Response
M210309,75,Female,HPV-related Cancer,KEYTRUDA only,61.1,80.48,694.77,87,Unknown
M210310,58,Female,Melanoma,mrna-4157 + keytruda,68.3,,834.8,102,Stable Disease
M210311,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.83,78.9,348.87,98,
M210312,43,Female,HPV-related Cancer,KEYTRUDA only,44.9,37.28,,94,Unknown
M210313,53,Other,Melanoma,KEYTRUDA only,70.89,82.45,1516.45,89,Progression
M210314,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.88,35.36,774.56,96,
M210315,56,Female,Non-small Cell Lung Cancer,KEYTRUDA only,65.42,24.04,911.45,81,Progression
M210316,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.12,44.8,515.98,82,Partial Response
M210317,77,Other,HPV-related Cancer,mrna-4157 + keytruda,49.35,40.24,107.68,81,Partial Response
M210318,84,Male,Melanoma,KEYTRUDA only,58.2,51.0,1304.74,105,Complete Response
M210319,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.06,60.26,1030.87,84,Partial Response
M210320,71,Female,Melanoma,mrna-4157 + keytruda,67.19,51.27,1144.2,86,Stable Disease
M210321,67,Other,HPV-related Cancer,KEYTRUDA only,88.54,69.68,1508.63,96,Partial Response
M210322,54,Other,Melanoma,mrna-4157 + keytruda,54.22,25.99,953.32,88,Complete Response
M210323,29,Male,Melanoma,mrna-4157 + keytruda,86.6,50.33,1180.51,88,Stable Disease
M210324,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.55,33.41,1285.24,102,Stable Disease
M210325,55,Male,Melanoma,mrna-4157 + keytruda,37.43,25.24,509.61,83,Unknown
M210326,67,Female,Melanoma,mrna-4157 + keytruda,63.23,23.03,1237.57,72,Partial Response
M210327,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.59,13.77,1054.32,92,Partial Response
M210328,49,Female,Melanoma,KEYTRUDA only,64.04,45.14,1364.27,104,Stable Disease
M210329,70,Male,Melanoma,KEYTRUDA only,56.45,39.5,,77,Partial Response
M210330,55,Female,Melanoma,mrna-4157 + keytruda,58.29,45.8,1261.88,109,Stable Disease
M210331,52,Female,HPV-related Cancer,KEYTRUDA only,62.65,50.9,1095.7,97,Partial Response
M210332,48,Other,HPV-related Cancer,mrna-4157 + keytruda,32.09,,858.78,68,Progression
M210333,70,Other,HPV-related Cancer,mrna-4157 + keytruda,79.61,66.82,1729.29,81,Progression
M210334,52,Other,HPV-related Cancer,mrna-4157 + keytruda,72.99,74.98,631.89,92,Stable Disease
M210335,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.1,23.43,1234.11,90,Stable Disease
M210336,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.36,22.89,718.63,79,Stable Disease
M210337,32,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.09,43.29,1454.49,96,Partial Response
M210338,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.96,42.1,1138.36,100,Progression
M210339,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.75,53.55,365.46,77,Stable Disease
M210340,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.51,55.63,,97,Progression
M210341,65,Male,Melanoma,mrna-4157 + keytruda,24.56,12.14,1162.84,93,Partial Response
M210342,29,Other,Melanoma,mrna-4157 + keytruda,48.41,20.11,819.81,85,Progression
M210343,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.46,48.55,1353.13,71,Partial Response
M210344,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,25.68,31.73,307.58,103,Progression
M210345,27,Male,HPV-related Cancer,mrna-4157 + keytruda,48.11,39.18,1198.22,109,Complete Response
M210346,73,Male,Melanoma,mrna-4157 + keytruda,54.5,23.9,,81,Stable Disease
M210347,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.53,25.28,783.12,98,Progression
M210348,54,Female,Melanoma,KEYTRUDA only,42.13,26.57,947.32,96,Complete Response
M210349,25,Other,HPV-related Cancer,mrna-4157 + keytruda,58.7,36.33,820.61,80,Stable Disease
M210350,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.28,8.65,1289.61,81,Stable Disease
M210351,39,Male,Melanoma,mrna-4157 + keytruda,86.57,62.99,836.03,75,Stable Disease
M210352,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.64,30.0,1132.57,98,Stable Disease
M210353,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.0,22.16,485.46,83,Complete Response
M210354,43,Female,HPV-related Cancer,mrna-4157 + keytruda,52.95,65.73,941.91,89,Progression
M210355,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.32,32.72,1137.59,84,Partial Response
M210356,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.41,34.38,941.04,81,Stable Disease
M210357,74,Male,Melanoma,mrna-4157 + keytruda,48.34,54.54,667.9,96,Stable Disease
M210358,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.88,22.45,1130.28,96,Unknown
M210359,31,Other,Melanoma,mrna-4157 + keytruda,36.62,28.39,1045.71,77,Progression
M210360,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.57,58.29,852.0,87,Unknown
M210361,52,Other,HPV-related Cancer,KEYTRUDA only,35.63,,668.13,94,Stable Disease
M210362,53,Other,Melanoma,mrna-4157 + keytruda,49.05,35.56,782.38,89,Partial Response
M210363,74,Male,HPV-related Cancer,KEYTRUDA only,94.19,66.88,278.48,79,Complete Response
M210364,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.64,,1270.76,85,Stable Disease
M210365,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,16.62,16.99,1432.74,85,Progression
M210366,71,Other,HPV-related Cancer,KEYTRUDA only,49.75,40.86,1214.1,86,Partial Response
M210367,30,Other,Melanoma,mrna-4157 + keytruda,61.38,54.61,1181.83,87,Stable Disease
M210368,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.77,40.22,1154.62,93,Stable Disease
M210369,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.17,56.24,984.13,89,Progression
M210370,73,Male,HPV-related Cancer,mrna-4157 + keytruda,34.66,25.5,689.13,85,Stable Disease
M210371,47,Other,Melanoma,KEYTRUDA only,76.3,95.02,748.94,85,Complete Response
M210372,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.61,34.14,774.03,76,Complete Response
M210373,39,Female,Melanoma,mrna-4157 + keytruda,56.54,36.38,1345.31,78,Complete Response
M210374,80,Male,Melanoma,mrna-4157 + keytruda,51.44,40.38,1374.82,85,
M210375,56,Male,HPV-related Cancer,KEYTRUDA only,81.83,77.84,934.2,84,Progression
M210376,58,Other,Melanoma,mrna-4157 + keytruda,65.1,53.91,1152.98,83,Progression
M210377,40,Male,Melanoma,mrna-4157 + keytruda,51.36,49.53,1165.1,104,Stable Disease
M210378,67,Female,HPV-related Cancer,KEYTRUDA only,86.59,64.86,1371.47,102,Progression
M210379,55,Female,HPV-related Cancer,mrna-4157 + keytruda,13.33,15.73,1651.36,87,Stable Disease
M210380,31,Male,Melanoma,mrna-4157 + keytruda,46.72,34.21,2066.45,77,
M210381,69,Female,Melanoma,mrna-4157 + keytruda,86.41,73.37,1468.01,84,Progression
M210382,33,Female,HPV-related Cancer,KEYTRUDA only,41.72,26.06,1604.08,91,Progression
M210383,77,Other,HPV-related Cancer,KEYTRUDA only,78.31,54.23,,95,Unknown
M210384,75,Other,HPV-related Cancer,KEYTRUDA only,39.67,,1066.79,91,Complete Response
M210385,40,Male,Melanoma,mrna-4157 + keytruda,55.44,47.23,558.18,95,Stable Disease
M210386,80,Other,Melanoma,mrna-4157 + keytruda,53.66,51.42,755.36,99,Stable Disease
M210387,79,Other,Melanoma,mrna-4157 + keytruda,82.8,73.46,,105,Stable Disease
M210388,73,Male,Melanoma,mrna-4157 + keytruda,50.41,47.16,823.92,95,Partial Response
M210389,28,Other,Melanoma,mrna-4157 + keytruda,22.59,23.94,1229.62,81,Progression
M210390,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.9,,903.77,93,Stable Disease
M210391,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.08,30.85,1658.0,98,Partial Response
M210392,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,25.45,23.39,216.11,91,Progression
M210393,39,Female,HPV-related Cancer,mrna-4157 + keytruda,38.91,30.04,,86,Stable Disease
M210394,41,Other,Melanoma,KEYTRUDA only,58.61,58.54,1269.47,96,Partial Response
M210395,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.36,81.94,1638.59,96,
M210396,25,Female,Melanoma,mrna-4157 + keytruda,47.62,40.14,687.77,76,
M210397,76,Other,HPV-related Cancer,KEYTRUDA only,37.34,40.7,923.23,105,Partial Response
M210398,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.2,33.33,966.45,96,Stable Disease
M210399,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.07,41.1,1262.61,97,Progression
M210400,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.04,,1304.69,100,Complete Response
M210401,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,69.83,45.42,1083.06,102,Complete Response
M210402,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.18,36.42,738.91,84,Complete Response
M210403,82,Male,Melanoma,KEYTRUDA only,48.62,22.34,1308.8,95,Complete Response
M210404,30,Male,Melanoma,KEYTRUDA only,39.48,34.23,949.22,80,Unknown
M210405,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.66,44.03,728.12,83,Unknown
M210406,40,Female,Melanoma,mrna-4157 + keytruda,26.81,14.04,1167.33,86,Progression
M210407,43,Female,HPV-related Cancer,mrna-4157 + keytruda,47.96,42.57,1191.4,77,Partial Response
M210408,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.89,35.31,1488.43,89,Progression
M210409,34,Female,HPV-related Cancer,mrna-4157 + keytruda,60.35,55.18,1131.4,84,Progression
M210410,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.4,50.9,787.12,79,Stable Disease
M210411,25,Male,Melanoma,mrna-4157 + keytruda,53.92,34.94,1048.09,92,Stable Disease
M210412,82,Female,HPV-related Cancer,mrna-4157 + keytruda,60.1,,435.47,91,Partial Response
M210413,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.81,77.59,1011.49,104,Progression
M210414,68,Other,HPV-related Cancer,KEYTRUDA only,57.56,56.79,791.16,87,Unknown
M210415,83,Male,Melanoma,KEYTRUDA only,48.75,41.82,651.53,86,Stable Disease
M210416,68,Other,HPV-related Cancer,KEYTRUDA only,49.11,43.3,692.67,79,Stable Disease
M210417,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.62,55.77,1349.89,98,Partial Response
M210418,29,Male,HPV-related Cancer,mrna-4157 + keytruda,50.55,37.48,831.06,106,Unknown
M210419,25,Female,HPV-related Cancer,mrna-4157 + keytruda,56.08,61.17,,85,Partial Response
M210420,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.54,67.63,944.13,92,Progression
M210421,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.99,69.27,635.68,114,Stable Disease
M210422,82,Other,HPV-related Cancer,mrna-4157 + keytruda,57.52,37.55,1979.09,93,Stable Disease
M210423,28,Other,Melanoma,KEYTRUDA only,63.93,58.8,600.05,100,Unknown
M210424,75,Female,Melanoma,mrna-4157 + keytruda,47.98,39.13,1076.37,92,Stable Disease
M210425,81,Female,HPV-related Cancer,mrna-4157 + keytruda,84.04,83.8,,100,Stable Disease
M210426,37,Other,Melanoma,KEYTRUDA only,49.25,63.23,1007.67,88,
M210427,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.6,,1198.21,105,Partial Response
M210428,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.04,55.55,,76,Progression
M210429,38,Male,Melanoma,mrna-4157 + keytruda,41.17,30.44,1117.34,107,Partial Response
M210430,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.13,31.61,158.16,88,Partial Response
M210431,29,Male,Melanoma,KEYTRUDA only,27.31,23.03,1072.33,96,Partial Response
M210432,31,Female,HPV-related Cancer,mrna-4157 + keytruda,41.48,33.89,1363.93,101,Partial Response
M210433,63,Male,Melanoma,KEYTRUDA only,39.49,23.49,1354.86,91,Stable Disease
M210434,53,Female,Melanoma,mrna-4157 + keytruda,33.63,19.96,1180.38,107,Partial Response
M210435,58,Male,Melanoma,KEYTRUDA only,71.54,53.06,971.72,89,Partial Response
M210436,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.37,51.05,980.38,96,Stable Disease
M210437,26,Other,HPV-related Cancer,mrna-4157 + keytruda,58.51,55.65,927.59,103,Stable Disease
M210438,29,Male,Melanoma,mrna-4157 + keytruda,53.82,41.07,,88,Unknown
M210439,34,Female,HPV-related Cancer,mrna-4157 + keytruda,46.71,45.0,559.07,96,
M210440,30,Other,HPV-related Cancer,mrna-4157 + keytruda,48.04,38.16,628.32,70,Complete Response
M210441,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.93,21.03,1255.36,72,Stable Disease
M210442,38,Other,HPV-related Cancer,KEYTRUDA only,37.57,26.95,1349.67,106,Stable Disease
M210443,69,Female,Melanoma,mrna-4157 + keytruda,73.48,45.84,1208.87,85,Partial Response
M210444,75,Male,Melanoma,KEYTRUDA only,59.6,45.77,1183.87,89,
M210445,47,Female,Melanoma,KEYTRUDA only,50.75,32.46,559.59,88,Stable Disease
M210446,50,Other,HPV-related Cancer,KEYTRUDA only,19.2,11.8,979.46,103,Partial Response
M210447,57,Female,HPV-related Cancer,mrna-4157 + keytruda,27.56,,1287.81,88,Progression
M210448,37,Female,HPV-related Cancer,mrna-4157 + keytruda,42.54,24.59,1796.0,97,Unknown
M210449,53,Male,HPV-related Cancer,mrna-4157 + keytruda,50.91,59.12,978.74,91,Progression
M210450,75,Other,Melanoma,KEYTRUDA only,48.8,39.03,7268.85,85,Partial Response
M210451,47,Female,HPV-related Cancer,KEYTRUDA only,40.14,21.94,974.96,95,Stable Disease
M210452,48,Female,Melanoma,mrna-4157 + keytruda,67.1,,930.43,95,Stable Disease
M210453,43,Other,HPV-related Cancer,mrna-4157 + keytruda,84.69,40.64,1024.23,85,Partial Response
M210454,29,Other,Melanoma,mrna-4157 + keytruda,47.36,47.5,724.23,112,Progression
M210455,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.68,32.67,1880.42,99,Partial Response
M210456,69,Male,Melanoma,mrna-4157 + keytruda,62.29,19.27,1648.24,88,Partial Response
M210457,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.32,57.26,803.8,81,Complete Response
M210458,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.56,18.43,1061.29,101,Progression
M210459,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.63,45.17,489.99,108,Stable Disease
M210460,72,Male,Melanoma,KEYTRUDA only,52.24,41.57,603.4,98,Unknown
M210461,59,Female,HPV-related Cancer,mrna-4157 + keytruda,44.96,28.54,910.62,96,Stable Disease
M210462,26,Female,Melanoma,KEYTRUDA only,69.94,58.24,1366.68,102,Progression
M210463,36,Male,HPV-related Cancer,mrna-4157 + keytruda,66.44,41.84,951.71,84,Partial Response
M210464,39,Female,HPV-related Cancer,KEYTRUDA only,54.81,38.66,1124.33,86,Complete Response
M210465,36,Male,Melanoma,KEYTRUDA only,40.5,36.92,318.88,76,Complete Response
M210466,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.1,52.1,1096.16,100,
M210467,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.65,50.79,1574.36,97,Partial Response
M210468,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.01,65.93,299.61,98,Stable Disease
M210469,32,Male,HPV-related Cancer,mrna-4157 + keytruda,18.47,18.54,813.87,105,Stable Disease
M210470,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.53,44.88,1576.74,88,Partial Response
M210471,55,Male,HPV-related Cancer,mrna-4157 + keytruda,15.8,11.94,850.27,106,Stable Disease
M210472,71,Male,Melanoma,mrna-4157 + keytruda,82.96,69.79,1013.86,90,Complete Response
M210473,68,Other,Melanoma,mrna-4157 + keytruda,35.07,28.5,491.26,93,Progression
M210474,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.02,11.44,1393.34,88,Stable Disease
M210475,81,Other,HPV-related Cancer,mrna-4157 + keytruda,28.67,15.92,1490.83,81,Complete Response
M210476,70,Other,Melanoma,mrna-4157 + keytruda,-3.98,-3.19,1171.21,113,Stable Disease
M210477,61,Male,HPV-related Cancer,mrna-4157 + keytruda,56.27,39.58,424.52,90,Partial Response
M210478,57,Other,HPV-related Cancer,KEYTRUDA only,82.07,65.57,1227.22,97,Partial Response
M210479,53,Female,Melanoma,KEYTRUDA only,48.1,38.27,512.87,92,Stable Disease
M210480,43,Male,HPV-related Cancer,KEYTRUDA only,65.21,23.07,1246.6,87,Progression
M210481,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.37,48.88,728.26,93,Progression
M210482,77,Other,Melanoma,mrna-4157 + keytruda,95.63,68.55,857.21,106,Stable Disease
M210483,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.27,45.7,1409.56,94,Stable Disease
M210484,37,Other,Melanoma,KEYTRUDA only,70.59,60.74,869.99,109,
M210485,31,Male,Melanoma,mrna-4157 + keytruda,31.82,29.95,1636.55,87,Partial Response
M210486,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,82.61,68.16,697.28,110,Progression
M210487,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.56,58.0,797.48,83,Stable Disease
M210488,79,Male,HPV-related Cancer,mrna-4157 + keytruda,53.92,45.61,1457.18,90,Stable Disease
M210489,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.58,53.1,526.46,102,Unknown
M210490,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.44,,665.35,93,
M210491,47,Female,HPV-related Cancer,mrna-4157 + keytruda,65.95,37.77,1283.06,91,Complete Response
M210492,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,16.8,21.69,621.65,73,Stable Disease
M210493,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,108.18,49.79,1122.27,87,Progression
M210494,73,Female,HPV-related Cancer,mrna-4157 + keytruda,109.14,120.03,771.07,90,Partial Response
M210495,31,Male,Melanoma,KEYTRUDA only,56.62,56.59,690.97,73,Progression
M210496,31,Female,HPV-related Cancer,KEYTRUDA only,49.26,35.35,1256.25,82,Partial Response
M210497,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.01,47.5,1188.52,82,Stable Disease
M210498,79,Male,HPV-related Cancer,KEYTRUDA only,82.28,47.72,1213.77,94,Partial Response
M210499,55,Female,HPV-related Cancer,mrna-4157 + keytruda,52.71,45.81,738.26,89,Stable Disease
M210500,78,Male,HPV-related Cancer,mrna-4157 + keytruda,36.3,30.9,333.52,94,Unknown
M210501,80,Male,Melanoma,KEYTRUDA only,51.73,,1164.25,99,Partial Response
M210502,46,Female,Melanoma,KEYTRUDA only,28.32,18.43,1768.14,101,
M210503,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.39,47.65,97.8,79,Partial Response
M210504,62,Other,Melanoma,KEYTRUDA only,59.38,68.49,820.89,85,Partial Response
M210505,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.62,45.97,740.95,78,Stable Disease
M210506,83,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.93,32.11,4998.2,90,Complete Response
M210507,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.55,27.31,884.7,96,Stable Disease
M210508,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.39,35.24,744.73,89,Partial Response
M210509,67,Male,Melanoma,mrna-4157 + keytruda,1.45,0.69,1273.16,104,Stable Disease
M210510,72,Male,Melanoma,KEYTRUDA only,24.93,12.77,685.19,88,Complete Response
M210511,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.0,61.89,747.76,95,Complete Response
M210512,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.01,72.66,1259.07,99,Stable Disease
M210513,47,Male,Melanoma,KEYTRUDA only,25.67,25.49,1893.91,108,Partial Response
M210514,63,Male,Melanoma,mrna-4157 + keytruda,23.54,19.14,719.14,109,Stable Disease
M210515,79,Male,Melanoma,mrna-4157 + keytruda,77.22,65.76,1422.47,103,Partial Response
M210516,44,Female,HPV-related Cancer,mrna-4157 + keytruda,43.03,27.13,1463.12,83,Partial Response
M210517,27,Other,HPV-related Cancer,mrna-4157 + keytruda,37.69,,783.37,104,Stable Disease
M210518,32,Male,Melanoma,mrna-4157 + keytruda,55.17,40.24,,81,Partial Response
M210519,52,Female,Melanoma,KEYTRUDA only,19.13,13.23,1680.71,76,
M210520,40,Male,Melanoma,KEYTRUDA only,55.63,,-64.36,82,Partial Response
M210521,28,Female,Melanoma,mrna-4157 + keytruda,16.62,16.71,878.8,85,Complete Response
M210522,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,87.6,59.95,687.09,101,Stable Disease
M210523,31,Male,HPV-related Cancer,KEYTRUDA only,56.17,22.24,1273.77,88,Complete Response
M210524,52,Other,HPV-related Cancer,KEYTRUDA only,41.3,41.67,810.6,93,Progression
M210525,61,Female,Melanoma,mrna-4157 + keytruda,83.18,,1051.7,96,Stable Disease
M210526,55,Other,Melanoma,mrna-4157 + keytruda,88.5,82.16,1582.83,79,Progression
M210527,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.5,12.72,289.65,87,Unknown
M210528,61,Female,Melanoma,mrna-4157 + keytruda,45.04,42.25,1020.08,113,Partial Response
M210529,44,Female,HPV-related Cancer,mrna-4157 + keytruda,48.01,34.08,1710.06,87,Partial Response
M210530,69,Female,Melanoma,KEYTRUDA only,83.95,82.81,1865.72,104,Partial Response
M210531,72,Female,HPV-related Cancer,mrna-4157 + keytruda,30.11,26.18,933.18,103,Partial Response
M210532,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.71,51.29,823.12,99,Progression
M210533,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.91,44.11,1376.21,80,Progression
M210534,40,Other,HPV-related Cancer,KEYTRUDA only,72.87,49.92,683.61,84,Progression
M210535,47,Female,HPV-related Cancer,mrna-4157 + keytruda,53.28,68.51,895.87,100,Partial Response
M210536,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.88,68.94,908.97,86,Stable Disease
M210537,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.37,63.71,964.55,109,Progression
M210538,34,Female,Melanoma,mrna-4157 + keytruda,37.99,8.15,1105.84,93,Stable Disease
M210539,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.9,46.85,454.91,90,Partial Response
M210540,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.49,42.38,1198.77,109,Stable Disease
M210541,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.14,,559.28,81,Partial Response
M210542,39,Male,HPV-related Cancer,mrna-4157 + keytruda,33.47,27.04,1042.49,75,Partial Response
M210543,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.71,9.21,309.57,86,Complete Response
M210544,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,7.7,6.84,1084.23,81,Stable Disease
M210545,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.22,57.62,285.38,68,Progression
M210546,25,Female,HPV-related Cancer,KEYTRUDA only,71.54,75.3,1982.79,105,
M210547,73,Other,HPV-related Cancer,mrna-4157 + keytruda,45.42,40.89,1027.79,81,Partial Response
M210548,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.2,38.87,1486.91,84,Complete Response
M210549,62,Female,HPV-related Cancer,KEYTRUDA only,59.09,50.16,1014.88,71,Progression
M210550,44,Female,HPV-related Cancer,KEYTRUDA only,60.04,71.27,890.91,83,Stable Disease
M210551,80,Male,Melanoma,KEYTRUDA only,29.44,17.34,1707.7,95,Stable Disease
M210552,50,Male,HPV-related Cancer,mrna-4157 + keytruda,66.79,49.47,615.85,98,Progression
M210553,27,Female,Melanoma,KEYTRUDA only,38.16,39.23,976.07,83,Complete Response
M210554,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.78,40.77,465.49,78,Stable Disease
M210555,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,38.55,41.84,762.98,98,Partial Response
M210556,72,Other,Melanoma,KEYTRUDA only,45.67,37.24,646.1,88,Complete Response
M210557,53,Other,Melanoma,mrna-4157 + keytruda,51.16,28.86,1310.98,105,Partial Response
M210558,29,Other,HPV-related Cancer,KEYTRUDA only,51.62,24.65,1603.23,96,Progression
M210559,57,Other,HPV-related Cancer,KEYTRUDA only,50.57,40.03,1429.18,80,Stable Disease
M210560,73,Female,HPV-related Cancer,KEYTRUDA only,51.38,54.44,713.5,93,
M210561,38,Other,Melanoma,KEYTRUDA only,75.5,61.06,928.82,90,Stable Disease
M210562,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.2,60.99,1026.5,96,Complete Response
M210563,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,11.04,9.4,713.82,94,Progression
M210564,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.1,20.94,853.1,103,Unknown
M210565,39,Other,HPV-related Cancer,mrna-4157 + keytruda,45.88,30.39,1173.55,100,Complete Response
M210566,52,Female,HPV-related Cancer,KEYTRUDA only,47.73,40.28,1399.37,65,Complete Response
M210567,45,Female,HPV-related Cancer,mrna-4157 + keytruda,55.22,53.53,,91,Stable Disease
M210568,56,Other,Melanoma,KEYTRUDA only,32.76,38.84,274.81,89,Complete Response
M210569,27,Female,HPV-related Cancer,mrna-4157 + keytruda,71.0,59.59,1863.29,81,Stable Disease
M210570,71,Female,HPV-related Cancer,mrna-4157 + keytruda,50.03,27.71,1275.83,106,Stable Disease
M210571,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,24.43,16.0,1188.45,94,Stable Disease
M210572,50,Male,HPV-related Cancer,KEYTRUDA only,87.11,69.37,1224.46,112,Partial Response
M210573,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.15,46.37,1158.51,63,Stable Disease
M210574,47,Male,Melanoma,mrna-4157 + keytruda,41.08,33.68,561.91,84,Partial Response
M210575,36,Other,Melanoma,mrna-4157 + keytruda,89.13,84.65,1284.12,92,Stable Disease
M210576,62,Other,Melanoma,mrna-4157 + keytruda,70.06,38.02,927.04,68,Progression
M210577,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.77,87.75,53.13,106,Partial Response
M210578,77,Male,HPV-related Cancer,mrna-4157 + keytruda,57.89,39.39,987.15,70,Stable Disease
M210579,43,Male,Melanoma,mrna-4157 + keytruda,37.2,30.26,796.23,95,Stable Disease
M210580,55,Female,Melanoma,mrna-4157 + keytruda,59.53,47.4,697.52,84,Stable Disease
M210581,53,Male,Melanoma,mrna-4157 + keytruda,70.56,65.69,904.42,80,Complete Response
M210582,47,Female,HPV-related Cancer,KEYTRUDA only,44.3,40.84,,88,Progression
M210583,59,Male,HPV-related Cancer,mrna-4157 + keytruda,90.39,58.15,414.97,80,Partial Response
M210584,72,Other,HPV-related Cancer,mrna-4157 + keytruda,11.33,12.39,717.56,107,Partial Response
M210585,39,Male,Melanoma,KEYTRUDA only,44.76,38.16,954.82,74,Progression
M210586,42,Male,Melanoma,mrna-4157 + keytruda,49.71,42.14,1038.74,88,Partial Response
M210587,76,Other,HPV-related Cancer,mrna-4157 + keytruda,49.55,26.89,1032.09,91,Progression
M210588,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.03,26.95,1186.44,66,Complete Response
M210589,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.65,27.76,676.09,82,Partial Response
M210590,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.04,28.36,565.77,107,Progression
M210591,50,Other,Melanoma,mrna-4157 + keytruda,60.11,58.12,739.38,90,Progression
M210592,57,Female,HPV-related Cancer,mrna-4157 + keytruda,56.54,73.88,986.16,76,Partial Response
M210593,40,Female,Melanoma,mrna-4157 + keytruda,7.32,5.95,1377.25,93,Partial Response
M210594,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.5,28.59,1205.96,95,Progression
M210595,39,Male,HPV-related Cancer,mrna-4157 + keytruda,22.64,18.8,1101.93,84,Partial Response
M210596,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,22.11,16.2,983.28,85,Progression
M210597,41,Female,Melanoma,mrna-4157 + keytruda,86.26,88.87,1395.1,89,Partial Response
M210598,77,Other,Melanoma,mrna-4157 + keytruda,37.74,30.51,785.95,86,Partial Response
M210599,59,Male,HPV-related Cancer,mrna-4157 + keytruda,53.48,29.02,947.91,108,Partial Response
M210600,76,Other,Melanoma,KEYTRUDA only,92.28,60.48,,93,Partial Response
M210601,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.82,27.31,,86,Progression
M210602,65,Female,Melanoma,KEYTRUDA only,37.14,22.09,1758.49,88,Progression
M210603,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,25.39,27.63,238.09,97,
M210604,36,Male,Melanoma,mrna-4157 + keytruda,46.94,29.55,,99,Stable Disease
M210605,54,Other,HPV-related Cancer,mrna-4157 + keytruda,64.8,39.42,726.02,93,Complete Response
M210606,26,Male,HPV-related Cancer,mrna-4157 + keytruda,70.29,82.5,852.84,73,Stable Disease
M210607,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,31.81,21.7,1080.01,93,Partial Response
M210608,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.87,28.1,1544.94,90,Stable Disease
M210609,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.57,32.09,601.79,99,Stable Disease
M210610,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.52,42.07,726.76,109,Partial Response
M210611,59,Female,Melanoma,KEYTRUDA only,54.39,44.21,1064.79,80,Stable Disease
M210612,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.62,40.38,297.72,98,Partial Response
M210613,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.83,53.6,716.19,106,Partial Response
M210614,68,Other,HPV-related Cancer,mrna-4157 + keytruda,33.15,24.31,1069.13,88,Progression
M210615,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.76,,,79,Unknown
M210616,62,Female,HPV-related Cancer,mrna-4157 + keytruda,62.77,62.06,1157.51,94,Stable Disease
M210617,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.81,72.84,1805.9,93,Partial Response
M210618,78,Female,Melanoma,KEYTRUDA only,22.5,11.08,1241.16,106,Progression
M210619,29,Female,Melanoma,mrna-4157 + keytruda,78.1,54.95,1046.55,87,Progression
M210620,47,Female,HPV-related Cancer,mrna-4157 + keytruda,66.29,29.24,508.45,82,Stable Disease
M210621,73,Female,Melanoma,mrna-4157 + keytruda,44.31,45.86,1154.42,80,Stable Disease
M210622,28,Other,HPV-related Cancer,KEYTRUDA only,44.39,44.76,1066.02,97,
M210623,48,Other,HPV-related Cancer,KEYTRUDA only,66.44,41.57,953.05,105,Stable Disease
M210624,48,Female,Melanoma,KEYTRUDA only,65.72,36.18,1163.41,94,Unknown
M210625,50,Female,HPV-related Cancer,KEYTRUDA only,68.82,63.24,1295.28,98,
M210626,27,Female,Melanoma,mrna-4157 + keytruda,37.9,37.15,1086.7,94,Stable Disease
M210627,39,Male,Melanoma,mrna-4157 + keytruda,24.81,,990.79,81,Partial Response
M210628,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.31,18.45,438.87,100,Partial Response
M210629,64,Female,Melanoma,KEYTRUDA only,81.19,77.27,1404.57,97,
M210630,51,Male,HPV-related Cancer,mrna-4157 + keytruda,48.21,54.8,1491.57,92,Complete Response
M210631,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.36,25.66,1570.71,70,
M210632,76,Other,HPV-related Cancer,mrna-4157 + keytruda,58.05,42.74,1155.87,100,Unknown
M210633,59,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.37,49.83,855.21,98,
M210634,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.06,16.38,767.65,80,Complete Response
M210635,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.24,40.63,1004.19,97,
M210636,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,90.67,69.85,1645.4,91,Progression
M210637,78,Male,HPV-related Cancer,KEYTRUDA only,49.97,32.67,725.75,91,Progression
M210638,66,Female,Melanoma,mrna-4157 + keytruda,69.41,30.42,1063.52,97,Partial Response
M210639,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.48,35.06,633.19,75,Unknown
M210640,72,Other,HPV-related Cancer,mrna-4157 + keytruda,62.1,29.3,889.71,94,Progression
M210641,35,Female,HPV-related Cancer,mrna-4157 + keytruda,72.41,55.38,790.61,90,Progression
M210642,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,103.65,87.89,838.92,84,Progression
M210643,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.18,,1244.85,92,Partial Response
M210644,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.68,44.5,,91,Complete Response
M210645,48,Female,HPV-related Cancer,mrna-4157 + keytruda,44.87,35.2,1513.42,108,Partial Response
M210646,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.31,44.82,,114,Complete Response
M210647,62,Male,Melanoma,mrna-4157 + keytruda,31.61,21.09,925.01,98,Stable Disease
M210648,77,Female,HPV-related Cancer,KEYTRUDA only,63.89,61.37,768.07,87,Partial Response
M210649,73,Male,Melanoma,KEYTRUDA only,36.58,27.69,1215.51,91,Progression
M210650,67,Male,HPV-related Cancer,mrna-4157 + keytruda,69.52,49.34,797.47,84,Partial Response
M210651,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.88,15.86,452.23,84,Complete Response
M210652,31,Female,HPV-related Cancer,mrna-4157 + keytruda,55.1,38.29,1025.63,76,Complete Response
M210653,55,Female,HPV-related Cancer,KEYTRUDA only,63.43,47.11,1373.67,108,Progression
M210654,47,Female,Melanoma,KEYTRUDA only,50.41,41.51,-136.46,86,Progression
M210655,80,Male,Melanoma,KEYTRUDA only,39.91,25.37,,82,Stable Disease
M210656,29,Other,HPV-related Cancer,mrna-4157 + keytruda,23.24,15.99,1081.52,82,Partial Response
M210657,45,Female,HPV-related Cancer,KEYTRUDA only,61.61,52.09,1261.06,73,Stable Disease
M210658,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.23,39.05,768.56,86,Complete Response
M210659,31,Male,HPV-related Cancer,KEYTRUDA only,50.77,48.09,730.54,95,Complete Response
M210660,65,Male,Melanoma,mrna-4157 + keytruda,70.74,33.0,934.91,88,Complete Response
M210661,47,Male,Non-small Cell Lung Cancer,KEYTRUDA only,23.18,21.22,664.3,98,Partial Response
M210662,81,Male,Melanoma,mrna-4157 + keytruda,34.34,28.18,944.17,90,Stable Disease
M210663,36,Other,Melanoma,KEYTRUDA only,51.43,61.52,1351.62,89,Partial Response
M210664,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.61,51.77,1239.78,83,Progression
M210665,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.92,29.14,208.04,91,Progression
M210666,61,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.96,42.33,973.75,85,Progression
M210667,52,Male,Melanoma,KEYTRUDA only,24.27,8.05,1204.29,89,Unknown
M210668,29,Female,Melanoma,KEYTRUDA only,49.29,30.33,552.65,99,Partial Response
M210669,81,Other,Non-small Cell Lung Cancer,KEYTRUDA only,20.93,23.55,373.48,100,Unknown
M210670,80,Female,Melanoma,mrna-4157 + keytruda,4.59,,982.83,87,Partial Response
M210671,69,Female,HPV-related Cancer,mrna-4157 + keytruda,55.74,38.9,906.4,98,Stable Disease
M210672,54,Male,HPV-related Cancer,KEYTRUDA only,29.24,20.88,239.14,92,Partial Response
M210673,56,Male,HPV-related Cancer,KEYTRUDA only,54.27,34.88,958.79,81,Progression
M210674,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.33,18.14,942.02,90,Unknown
M210675,52,Other,HPV-related Cancer,KEYTRUDA only,51.37,44.02,1205.45,77,Partial Response
M210676,72,Male,HPV-related Cancer,KEYTRUDA only,41.48,28.63,787.08,91,Partial Response
M210677,42,Male,Melanoma,mrna-4157 + keytruda,55.68,37.12,1253.43,84,Stable Disease
M210678,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.02,50.78,1538.45,87,Stable Disease
M210679,67,Female,Melanoma,KEYTRUDA only,52.76,29.38,866.89,87,Unknown
M210680,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.71,23.51,1353.97,93,Complete Response
M210681,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.27,53.89,622.21,86,Stable Disease
M210682,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.41,42.99,1183.86,88,Complete Response
M210683,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.47,43.78,1062.04,87,Progression
M210684,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,81.22,63.42,1374.25,95,Partial Response
M210685,60,Other,HPV-related Cancer,KEYTRUDA only,64.99,43.53,1827.15,96,Progression
M210686,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.34,51.51,1118.17,82,Partial Response
M210687,81,Male,HPV-related Cancer,mrna-4157 + keytruda,71.44,,1508.06,95,Progression
M210688,67,Male,HPV-related Cancer,mrna-4157 + keytruda,62.89,58.22,1202.65,94,Progression
M210689,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.57,52.18,1260.94,79,Partial Response
M210690,57,Female,Melanoma,KEYTRUDA only,55.91,55.67,550.32,96,Partial Response
M210691,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.82,25.24,348.14,99,Partial Response
M210692,64,Other,HPV-related Cancer,KEYTRUDA only,36.18,21.1,1688.87,83,Stable Disease
M210693,32,Male,HPV-related Cancer,mrna-4157 + keytruda,50.08,24.69,595.74,103,Stable Disease
M210694,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.67,73.63,1565.73,93,
M210695,54,Female,HPV-related Cancer,mrna-4157 + keytruda,59.26,29.73,640.25,97,Complete Response
M210696,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.56,,1559.18,91,Stable Disease
M210697,52,Female,Melanoma,mrna-4157 + keytruda,45.48,35.02,415.78,99,Progression
M210698,42,Other,Melanoma,KEYTRUDA only,46.92,39.69,656.59,92,Progression
M210699,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.08,21.2,939.47,92,Complete Response
M210700,69,Other,Melanoma,KEYTRUDA only,40.42,21.21,305.76,88,Stable Disease
M210701,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.65,31.46,253.79,89,Stable Disease
M210702,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.67,31.88,1083.58,113,Complete Response
M210703,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,51.15,38.32,395.99,98,Complete Response
M210704,35,Other,HPV-related Cancer,mrna-4157 + keytruda,62.82,42.48,672.28,99,Unknown
M210705,71,Male,Melanoma,KEYTRUDA only,31.85,27.07,1410.21,82,Progression
M210706,38,Other,HPV-related Cancer,mrna-4157 + keytruda,50.1,,816.93,93,Stable Disease
M210707,74,Other,Melanoma,mrna-4157 + keytruda,50.33,26.95,1014.7,64,Stable Disease
M210708,69,Female,Melanoma,mrna-4157 + keytruda,45.48,27.77,1357.33,100,Stable Disease
M210709,61,Male,Melanoma,KEYTRUDA only,34.19,27.15,727.35,101,Progression
M210710,66,Female,HPV-related Cancer,KEYTRUDA only,46.9,50.54,1831.67,92,Complete Response
M210711,36,Other,Melanoma,KEYTRUDA only,41.46,25.59,1324.06,80,Progression
M210712,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.37,59.6,1251.57,97,Progression
M210713,80,Female,HPV-related Cancer,mrna-4157 + keytruda,77.32,44.67,734.19,88,Complete Response
M210714,69,Other,Melanoma,mrna-4157 + keytruda,35.8,24.18,1096.2,86,Partial Response
M210715,74,Other,HPV-related Cancer,mrna-4157 + keytruda,34.2,33.73,1276.03,93,Progression
M210716,30,Other,Melanoma,mrna-4157 + keytruda,40.05,26.46,1404.1,82,Unknown
M210717,59,Female,HPV-related Cancer,mrna-4157 + keytruda,57.11,49.3,954.34,97,Stable Disease
M210718,48,Female,HPV-related Cancer,KEYTRUDA only,50.17,72.4,1302.69,95,Partial Response
M210719,28,Female,Melanoma,mrna-4157 + keytruda,34.45,18.89,857.87,93,Unknown
M210720,38,Female,HPV-related Cancer,mrna-4157 + keytruda,56.47,36.89,317.63,93,Complete Response
M210721,74,Male,Melanoma,mrna-4157 + keytruda,54.16,40.66,1098.09,102,Stable Disease
M210722,27,Female,HPV-related Cancer,KEYTRUDA only,17.95,15.84,659.96,75,Progression
M210723,51,Female,HPV-related Cancer,KEYTRUDA only,24.75,18.43,1159.29,93,Stable Disease
M210724,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.15,52.41,206.1,85,Progression
M210725,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.03,36.0,873.99,102,Stable Disease
M210726,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,19.94,15.24,993.0,91,Stable Disease
M210727,49,Female,Melanoma,KEYTRUDA only,32.36,28.45,1472.15,91,Progression
M210728,60,Male,Melanoma,mrna-4157 + keytruda,67.24,63.46,1311.0,103,Partial Response
M210729,58,Male,HPV-related Cancer,mrna-4157 + keytruda,47.38,43.77,1440.9,90,Stable Disease
M210730,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,94.75,75.95,972.12,93,Progression
M210731,38,Female,Melanoma,mrna-4157 + keytruda,33.19,23.11,1522.44,87,Partial Response
M210732,37,Male,Melanoma,mrna-4157 + keytruda,67.9,52.13,545.9,93,Partial Response
M210733,50,Other,Melanoma,mrna-4157 + keytruda,44.45,42.86,1022.98,82,Unknown
M210734,55,Female,HPV-related Cancer,mrna-4157 + keytruda,55.33,40.23,1236.39,91,Stable Disease
M210735,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.25,21.22,1038.69,96,Unknown
M210736,28,Male,Melanoma,mrna-4157 + keytruda,41.12,29.61,840.47,89,
M210737,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.96,48.96,392.24,99,Complete Response
M210738,38,Female,Melanoma,KEYTRUDA only,48.13,57.83,246.23,92,Partial Response
M210739,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.28,33.49,817.38,111,Stable Disease
M210740,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.82,25.44,813.71,109,Progression
M210741,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.08,65.52,828.5,92,Stable Disease
M210742,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.95,35.31,358.54,86,Stable Disease
M210743,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.49,31.38,1230.32,89,Partial Response
M210744,48,Female,Melanoma,KEYTRUDA only,8.16,7.85,468.01,91,
M210745,25,Female,HPV-related Cancer,KEYTRUDA only,62.24,26.7,1377.59,98,Stable Disease
M210746,32,Other,Melanoma,mrna-4157 + keytruda,57.31,24.79,1006.49,83,Partial Response
M210747,30,Female,Melanoma,KEYTRUDA only,44.75,,1016.39,104,Complete Response
M210748,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,43.84,27.79,529.04,74,
M210749,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.79,16.77,678.6,80,Partial Response
M210750,59,Other,HPV-related Cancer,mrna-4157 + keytruda,76.26,48.24,1343.21,87,Stable Disease
M210751,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.39,24.64,876.05,101,Stable Disease
M210752,56,Female,Non-small Cell Lung Cancer,KEYTRUDA only,99.19,48.13,605.73,97,Partial Response
M210753,71,Other,Melanoma,KEYTRUDA only,53.96,42.13,1431.7,82,Partial Response
M210754,76,Male,Melanoma,mrna-4157 + keytruda,9.88,9.35,1337.04,84,Partial Response
M210755,74,Female,HPV-related Cancer,mrna-4157 + keytruda,55.01,37.71,1320.47,93,Progression
M210756,60,Male,HPV-related Cancer,mrna-4157 + keytruda,28.74,9.41,1203.8,101,Partial Response
M210757,42,Other,Melanoma,mrna-4157 + keytruda,41.91,46.04,78.27,90,Stable Disease
M210758,53,Male,HPV-related Cancer,mrna-4157 + keytruda,27.98,21.75,1154.21,101,Stable Disease
M210759,52,Male,HPV-related Cancer,mrna-4157 + keytruda,33.52,36.56,201.46,85,Progression
M210760,61,Female,Melanoma,KEYTRUDA only,34.32,38.88,791.71,74,Complete Response
M210761,36,Other,HPV-related Cancer,mrna-4157 + keytruda,49.06,36.05,,92,Complete Response
M210762,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.61,48.59,1360.66,72,Partial Response
M210763,37,Female,Melanoma,KEYTRUDA only,71.46,56.31,870.76,92,Stable Disease
M210764,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.22,43.57,556.98,96,Complete Response
M210765,84,Female,HPV-related Cancer,KEYTRUDA only,80.86,49.87,1295.61,102,
M210766,58,Female,HPV-related Cancer,mrna-4157 + keytruda,54.95,42.2,1231.4,79,Stable Disease
M210767,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.35,44.18,683.89,82,Progression
M210768,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.21,33.32,409.83,87,Partial Response
M210769,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.33,12.97,1344.55,92,Partial Response
M210770,42,Male,Melanoma,mrna-4157 + keytruda,43.52,33.35,1439.41,96,Partial Response
M210771,39,Other,HPV-related Cancer,mrna-4157 + keytruda,54.44,44.55,1177.03,98,Progression
M210772,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.32,48.31,1178.89,109,Partial Response
M210773,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.72,42.02,891.75,96,Progression
M210774,39,Other,HPV-related Cancer,mrna-4157 + keytruda,80.38,87.92,1780.51,101,
M210775,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.62,,588.89,94,Partial Response
M210776,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,30.28,33.37,1089.76,88,Stable Disease
M210777,27,Female,Melanoma,KEYTRUDA only,3.06,3.08,854.77,79,Progression
M210778,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.91,16.09,781.36,93,Partial Response
M210779,29,Other,Melanoma,KEYTRUDA only,74.46,55.76,1143.92,100,Partial Response
M210780,62,Male,Melanoma,KEYTRUDA only,60.54,33.97,979.58,85,Stable Disease
M210781,41,Female,HPV-related Cancer,mrna-4157 + keytruda,48.96,11.53,1390.7,90,Partial Response
M210782,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.73,15.94,1273.31,85,Complete Response
M210783,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.19,,572.51,103,Complete Response
M210784,27,Other,HPV-related Cancer,mrna-4157 + keytruda,56.46,18.34,985.46,109,Complete Response
M210785,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,10.02,7.76,1312.27,82,Partial Response
M210786,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.94,72.56,969.57,78,Stable Disease
M210787,38,Male,Melanoma,KEYTRUDA only,49.75,40.33,,96,Partial Response
M210788,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.27,45.65,1363.13,86,Complete Response
M210789,75,Other,HPV-related Cancer,mrna-4157 + keytruda,65.83,46.88,1015.49,90,Complete Response
M210790,37,Other,Melanoma,mrna-4157 + keytruda,54.66,48.84,1290.31,101,Complete Response
M210791,71,Female,Non-small Cell Lung Cancer,KEYTRUDA only,76.57,48.54,,91,Stable Disease
M210792,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.72,37.31,478.29,86,Progression
M210793,62,Male,Melanoma,mrna-4157 + keytruda,48.43,45.19,1283.13,93,
M210794,79,Male,HPV-related Cancer,mrna-4157 + keytruda,18.06,12.0,1356.23,84,Progression
M210795,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.26,41.25,949.42,79,Partial Response
M210796,39,Other,Melanoma,mrna-4157 + keytruda,55.96,29.61,1832.3,88,Progression
M210797,64,Female,Melanoma,mrna-4157 + keytruda,46.44,35.03,997.32,78,Partial Response
M210798,32,Female,HPV-related Cancer,mrna-4157 + keytruda,45.8,48.33,1452.77,82,Stable Disease
M210799,74,Other,HPV-related Cancer,mrna-4157 + keytruda,80.3,47.97,1011.97,96,Partial Response
M210800,61,Female,Melanoma,KEYTRUDA only,54.25,54.07,1067.61,91,Stable Disease
M210801,64,Female,HPV-related Cancer,mrna-4157 + keytruda,72.89,68.17,1382.25,91,Partial Response
M210802,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.0,24.52,816.67,91,Partial Response
M210803,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.81,55.35,1307.47,100,Partial Response
M210804,52,Other,HPV-related Cancer,mrna-4157 + keytruda,48.48,44.72,1612.88,83,Partial Response
M210805,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,91.9,78.88,1041.96,83,Stable Disease
M210806,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,59.2,24.52,1139.27,84,Stable Disease
M210807,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.84,46.85,579.32,87,Complete Response
M210808,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.51,46.76,1546.76,75,Partial Response
M210809,73,Female,HPV-related Cancer,mrna-4157 + keytruda,74.35,31.85,500.21,86,Partial Response
M210810,34,Other,HPV-related Cancer,mrna-4157 + keytruda,77.66,76.69,621.1,84,Complete Response
M210811,57,Other,HPV-related Cancer,KEYTRUDA only,9.51,8.48,1309.65,102,Complete Response
M210812,31,Other,HPV-related Cancer,mrna-4157 + keytruda,36.77,14.36,962.75,93,Partial Response
M210813,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.52,25.31,859.94,93,Progression
M210814,25,Other,Melanoma,KEYTRUDA only,40.19,25.24,462.66,84,Partial Response
M210815,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.94,23.33,375.75,77,Progression
M210816,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.66,49.64,1171.66,82,Complete Response
M210817,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.9,45.2,1007.72,96,Stable Disease
M210818,33,Male,Melanoma,mrna-4157 + keytruda,27.97,23.39,639.66,91,Complete Response
M210819,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.8,43.5,412.41,88,Complete Response
M210820,41,Male,Melanoma,KEYTRUDA only,58.58,54.18,842.0,87,Progression
M210821,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.38,47.44,509.6,93,Stable Disease
M210822,49,Female,Melanoma,KEYTRUDA only,54.42,36.42,621.86,101,Complete Response
M210823,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.53,33.55,1390.67,81,Partial Response
M210824,74,Other,HPV-related Cancer,mrna-4157 + keytruda,54.97,44.73,928.16,86,Partial Response
M210825,65,Other,Melanoma,mrna-4157 + keytruda,75.22,60.58,843.76,93,Progression
M210826,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.75,32.55,739.55,83,Partial Response
M210827,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,29.14,28.75,1601.86,89,Unknown
M210828,69,Male,HPV-related Cancer,KEYTRUDA only,57.69,47.5,707.07,75,Complete Response
M210829,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.04,14.65,707.87,97,Complete Response
M210830,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.02,43.16,973.53,84,Stable Disease
M210831,57,Male,HPV-related Cancer,KEYTRUDA only,63.29,39.0,786.58,85,
M210832,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.11,42.2,957.64,82,Stable Disease
M210833,51,Other,Melanoma,mrna-4157 + keytruda,70.4,73.95,27.32,90,Progression
M210834,35,Male,HPV-related Cancer,mrna-4157 + keytruda,72.73,48.2,1150.2,83,Complete Response
M210835,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.7,39.43,962.98,97,Progression
M210836,58,Other,HPV-related Cancer,mrna-4157 + keytruda,38.64,31.51,1122.06,105,Stable Disease
M210837,77,Other,Melanoma,mrna-4157 + keytruda,33.24,26.99,544.58,67,Progression
M210838,60,Female,Melanoma,mrna-4157 + keytruda,38.5,30.6,,95,Partial Response
M210839,74,Male,Melanoma,KEYTRUDA only,99.23,67.62,,86,Progression
M210840,47,Other,Melanoma,mrna-4157 + keytruda,62.37,66.34,1183.79,94,Stable Disease
M210841,59,Male,HPV-related Cancer,mrna-4157 + keytruda,20.65,,1409.96,104,Unknown
M210842,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.61,36.27,990.61,92,Progression
M210843,57,Other,HPV-related Cancer,mrna-4157 + keytruda,63.93,39.65,828.53,83,Partial Response
M210844,82,Female,Melanoma,KEYTRUDA only,50.74,42.37,640.86,83,Partial Response
M210845,62,Female,Melanoma,mrna-4157 + keytruda,37.21,32.13,888.89,93,Complete Response
M210846,26,Male,HPV-related Cancer,KEYTRUDA only,61.79,49.12,1099.65,87,Progression
M210847,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.27,21.85,1657.72,109,Progression
M210848,47,Other,HPV-related Cancer,mrna-4157 + keytruda,25.03,16.59,864.77,85,Progression
M210849,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.3,36.65,799.51,92,Stable Disease
M210850,68,Female,Melanoma,KEYTRUDA only,26.2,23.1,771.38,71,Partial Response
M210851,68,Female,Melanoma,KEYTRUDA only,72.11,,,83,Progression
M210852,44,Other,Melanoma,mrna-4157 + keytruda,76.36,37.01,1072.26,89,Stable Disease
M210853,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.7,70.44,212.49,82,Partial Response
M210854,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.96,26.94,438.7,83,Complete Response
M210855,36,Female,HPV-related Cancer,mrna-4157 + keytruda,84.24,80.64,493.95,73,
M210856,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.21,43.54,1000.93,81,Stable Disease
M210857,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,12.92,,674.46,93,Progression
M210858,72,Other,HPV-related Cancer,mrna-4157 + keytruda,73.74,41.01,1213.45,99,Stable Disease
M210859,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.56,36.56,1046.16,81,Complete Response
M210860,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.07,35.58,1055.55,83,Stable Disease
M210861,57,Other,Melanoma,mrna-4157 + keytruda,28.98,12.94,624.65,81,Stable Disease
M210862,76,Other,Melanoma,mrna-4157 + keytruda,2.39,0.8,592.29,108,Partial Response
M210863,57,Other,Melanoma,KEYTRUDA only,61.89,69.19,975.68,99,Progression
M210864,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.26,59.25,1234.63,73,Complete Response
M210865,73,Other,Melanoma,mrna-4157 + keytruda,20.4,14.57,1168.38,84,
M210866,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,105.98,143.25,569.52,96,Partial Response
M210867,67,Other,Melanoma,mrna-4157 + keytruda,24.97,17.2,973.38,106,Partial Response
M210868,47,Female,HPV-related Cancer,mrna-4157 + keytruda,52.09,30.53,3005.8999999999996,88,Progression
M210869,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.65,59.4,623.23,89,Progression
M210870,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.97,54.8,1091.36,99,Progression
M210871,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.71,30.76,1089.54,80,Partial Response
M210872,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,5.24,4.62,1751.58,94,Stable Disease
M210873,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.1,31.94,1636.12,90,Complete Response
M210874,68,Female,HPV-related Cancer,KEYTRUDA only,51.0,46.56,940.61,73,Partial Response
M210875,43,Male,HPV-related Cancer,mrna-4157 + keytruda,50.87,35.3,1317.13,88,Unknown
M210876,41,Other,Melanoma,mrna-4157 + keytruda,37.81,25.85,1205.32,87,Stable Disease
M210877,64,Female,HPV-related Cancer,mrna-4157 + keytruda,96.06,78.47,699.37,89,Partial Response
M210878,36,Male,HPV-related Cancer,KEYTRUDA only,53.84,26.22,593.39,105,Complete Response
M210879,39,Male,HPV-related Cancer,KEYTRUDA only,26.6,26.62,537.28,102,Stable Disease
M210880,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.74,55.46,1176.43,115,Progression
M210881,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.91,37.38,-229.43,79,Partial Response
M210882,29,Other,HPV-related Cancer,mrna-4157 + keytruda,53.68,30.76,851.51,92,Partial Response
M210883,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.82,44.02,674.76,85,Partial Response
M210884,46,Male,Melanoma,KEYTRUDA only,31.97,29.53,1109.12,77,Stable Disease
M210885,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,16.36,10.61,1083.63,88,Complete Response
M210886,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,82.86,59.93,1461.34,83,Progression
M210887,42,Male,Melanoma,mrna-4157 + keytruda,50.32,29.66,1140.28,83,Progression
M210888,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.09,47.38,1061.01,74,Stable Disease
M210889,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,51.61,47.68,1417.19,88,Complete Response
M210890,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,100.74,61.16,911.45,82,Stable Disease
M210891,50,Female,Melanoma,KEYTRUDA only,29.95,21.48,1136.9,73,Stable Disease
M210892,28,Male,HPV-related Cancer,KEYTRUDA only,27.3,18.58,1225.12,92,Partial Response
M210893,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.44,26.12,774.96,83,Stable Disease
M210894,59,Female,HPV-related Cancer,KEYTRUDA only,38.4,24.41,316.66,99,Partial Response
M210895,32,Male,Melanoma,KEYTRUDA only,33.46,33.57,454.03,82,Complete Response
M210896,70,Female,HPV-related Cancer,KEYTRUDA only,86.02,63.48,1315.24,92,Partial Response
M210897,46,Female,HPV-related Cancer,KEYTRUDA only,61.64,77.94,443.71,102,Unknown
M210898,34,Other,HPV-related Cancer,mrna-4157 + keytruda,69.97,48.92,,79,Complete Response
M210899,71,Female,Melanoma,KEYTRUDA only,41.82,,1236.14,86,Progression
M210900,60,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.66,22.7,569.74,103,Stable Disease
M210901,72,Female,HPV-related Cancer,mrna-4157 + keytruda,71.47,69.17,857.04,93,Stable Disease
M210902,46,Male,HPV-related Cancer,mrna-4157 + keytruda,76.97,52.56,862.41,85,Progression
M210903,32,Male,Melanoma,mrna-4157 + keytruda,59.21,37.52,1645.06,80,Stable Disease
M210904,55,Other,Melanoma,mrna-4157 + keytruda,58.67,28.5,679.91,78,Complete Response
M210905,67,Female,Melanoma,mrna-4157 + keytruda,35.0,30.77,653.86,92,
M210906,33,Female,Melanoma,mrna-4157 + keytruda,40.13,36.93,1091.1,91,Stable Disease
M210907,81,Other,HPV-related Cancer,mrna-4157 + keytruda,18.32,12.11,1128.21,102,Progression
M210908,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.72,29.99,1725.93,100,Stable Disease
M210909,55,Other,Melanoma,mrna-4157 + keytruda,66.89,55.79,1118.75,95,Partial Response
M210910,65,Female,Melanoma,KEYTRUDA only,39.93,42.97,1056.1,80,Stable Disease
M210911,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,98.21,113.22,715.42,93,Stable Disease
M210912,46,Other,Melanoma,mrna-4157 + keytruda,45.41,38.49,130.75,76,Partial Response
M210913,58,Other,Melanoma,mrna-4157 + keytruda,33.75,34.17,1962.15,87,Unknown
M210914,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.9,62.51,,99,Stable Disease
M210915,47,Male,HPV-related Cancer,mrna-4157 + keytruda,43.32,43.19,1326.89,89,Progression
M210916,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.06,25.61,,94,Stable Disease
M210917,81,Other,Melanoma,mrna-4157 + keytruda,23.85,16.96,1113.98,80,Complete Response
M210918,78,Other,Melanoma,KEYTRUDA only,84.81,61.99,1089.41,90,Partial Response
M210919,59,Female,Melanoma,KEYTRUDA only,44.53,,569.16,82,Progression
M210920,74,Male,HPV-related Cancer,KEYTRUDA only,49.69,27.71,627.01,80,Stable Disease
M210921,29,Male,HPV-related Cancer,KEYTRUDA only,66.61,31.84,960.17,91,Complete Response
M210922,68,Male,HPV-related Cancer,KEYTRUDA only,24.06,19.92,1586.48,83,Partial Response
M210923,79,Male,HPV-related Cancer,mrna-4157 + keytruda,63.01,59.04,998.49,77,Stable Disease
M210924,54,Female,Melanoma,mrna-4157 + keytruda,33.53,19.64,899.21,96,Partial Response
M210925,69,Female,HPV-related Cancer,mrna-4157 + keytruda,55.24,57.51,729.23,94,Unknown
M210926,45,Male,HPV-related Cancer,mrna-4157 + keytruda,34.06,,,105,Progression
M210927,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,25.09,8.62,1325.3,96,
M210928,55,Female,HPV-related Cancer,KEYTRUDA only,46.3,42.33,1193.8,81,
M210929,30,Female,Melanoma,KEYTRUDA only,33.19,24.82,764.21,83,
M210930,64,Other,Melanoma,mrna-4157 + keytruda,59.99,61.92,1475.79,89,Progression
M210931,68,Male,HPV-related Cancer,KEYTRUDA only,70.33,55.39,699.98,98,Progression
M210932,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.23,61.77,273.51,80,Stable Disease
M210933,66,Other,HPV-related Cancer,mrna-4157 + keytruda,42.57,35.71,1507.34,82,Progression
M210934,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.82,32.06,976.07,85,Progression
M210935,81,Other,Melanoma,KEYTRUDA only,44.81,,753.03,88,Partial Response
M210936,48,Male,Melanoma,mrna-4157 + keytruda,59.92,56.79,1674.98,89,Progression
M210937,50,Female,Melanoma,mrna-4157 + keytruda,43.7,43.14,1704.93,98,Stable Disease
M210938,77,Other,Melanoma,KEYTRUDA only,33.39,29.13,,90,Stable Disease
M210939,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.98,11.69,712.89,98,Stable Disease
M210940,75,Female,HPV-related Cancer,mrna-4157 + keytruda,43.51,,,83,Unknown
M210941,31,Female,HPV-related Cancer,mrna-4157 + keytruda,51.58,39.7,453.05,92,Stable Disease
M210942,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.49,54.08,261.03,75,Stable Disease
M210943,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.14,56.3,469.47,79,Partial Response
M210944,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.14,37.81,1307.49,98,Partial Response
M210945,29,Male,HPV-related Cancer,mrna-4157 + keytruda,30.27,29.36,1059.65,92,Progression
M210946,69,Male,Melanoma,KEYTRUDA only,51.21,15.98,581.46,89,Complete Response
M210947,83,Female,HPV-related Cancer,KEYTRUDA only,23.31,20.44,796.83,109,Progression
M210948,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.3,44.56,700.88,90,Complete Response
M210949,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,12.29,12.84,621.89,81,Stable Disease
M210950,65,Female,HPV-related Cancer,KEYTRUDA only,52.52,35.66,1015.79,80,Complete Response
M210951,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,6.67,5.89,366.4,87,Progression
M210952,43,Female,HPV-related Cancer,mrna-4157 + keytruda,101.17,81.26,171.54,101,Complete Response
M210953,76,Female,HPV-related Cancer,mrna-4157 + keytruda,39.51,27.91,1270.7,86,Partial Response
M210954,27,Female,HPV-related Cancer,mrna-4157 + keytruda,48.36,25.15,1246.87,99,Unknown
M210955,70,Male,HPV-related Cancer,KEYTRUDA only,20.31,16.87,1195.1,106,Partial Response
M210956,84,Other,HPV-related Cancer,mrna-4157 + keytruda,66.33,,1213.33,91,Complete Response
M210957,44,Other,HPV-related Cancer,mrna-4157 + keytruda,75.93,58.32,1600.98,104,Partial Response
M210958,51,Female,HPV-related Cancer,KEYTRUDA only,27.37,26.85,1831.76,81,Stable Disease
M210959,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.67,35.21,845.95,88,Partial Response
M210960,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.5,55.7,943.59,81,Unknown
M210961,78,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.55,40.35,595.43,72,Progression
M210962,83,Male,Melanoma,KEYTRUDA only,87.9,90.64,605.0,77,Stable Disease
M210963,53,Other,HPV-related Cancer,mrna-4157 + keytruda,33.24,15.03,428.4,105,Partial Response
M210964,63,Male,HPV-related Cancer,mrna-4157 + keytruda,38.66,36.66,1314.14,90,Stable Disease
M210965,46,Other,HPV-related Cancer,mrna-4157 + keytruda,51.11,45.53,703.07,101,Stable Disease
M210966,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.24,17.53,895.16,91,Progression
M210967,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.6,,687.45,88,Stable Disease
M210968,78,Female,HPV-related Cancer,mrna-4157 + keytruda,21.0,22.83,879.13,87,Stable Disease
M210969,83,Female,HPV-related Cancer,KEYTRUDA only,30.31,18.79,1846.34,99,Partial Response
M210970,28,Male,HPV-related Cancer,mrna-4157 + keytruda,44.35,32.97,921.36,90,Complete Response
M210971,26,Other,Melanoma,mrna-4157 + keytruda,42.05,31.21,426.78,101,Stable Disease
M210972,64,Other,HPV-related Cancer,KEYTRUDA only,47.09,42.54,986.82,82,Progression
M210973,49,Female,HPV-related Cancer,mrna-4157 + keytruda,57.84,46.27,1179.57,98,Unknown
M210974,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.35,11.95,1445.91,89,Stable Disease
M210975,42,Female,HPV-related Cancer,KEYTRUDA only,50.75,52.18,1166.4,91,Unknown
M210976,75,Other,Melanoma,KEYTRUDA only,71.52,65.73,1262.6,112,Stable Disease
M210977,60,Male,HPV-related Cancer,mrna-4157 + keytruda,57.95,50.54,401.42,105,Partial Response
M210978,48,Male,HPV-related Cancer,KEYTRUDA only,83.66,68.56,1240.34,87,Stable Disease
M210979,41,Male,Melanoma,KEYTRUDA only,51.67,49.73,1453.26,75,Partial Response
M210980,78,Other,Melanoma,mrna-4157 + keytruda,75.81,50.01,480.12,100,Progression
M210981,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.99,52.08,433.53,93,
M210982,37,Other,Melanoma,mrna-4157 + keytruda,54.32,45.75,1077.84,90,Partial Response
M210983,44,Male,HPV-related Cancer,mrna-4157 + keytruda,79.23,45.14,,98,Complete Response
M210984,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,28.46,29.17,849.41,78,Stable Disease
M210985,37,Male,HPV-related Cancer,mrna-4157 + keytruda,49.44,41.21,1712.96,114,Progression
M210986,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.79,62.37,520.23,88,Complete Response
M210987,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.85,42.24,843.19,90,Partial Response
M210988,82,Female,Melanoma,KEYTRUDA only,52.01,37.05,1332.57,90,Stable Disease
M210989,52,Female,HPV-related Cancer,mrna-4157 + keytruda,23.47,15.33,1366.36,86,Partial Response
M210990,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.42,9.41,550.97,97,
M210991,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,30.13,28.34,1233.46,96,Partial Response
M210992,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,-9.21,-6.42,635.87,97,Partial Response
M210993,66,Female,HPV-related Cancer,mrna-4157 + keytruda,52.04,43.08,655.03,76,Stable Disease
M210994,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.95,43.69,1737.04,87,
M210995,69,Female,HPV-related Cancer,KEYTRUDA only,47.02,45.43,508.59,97,Progression
M210996,37,Female,HPV-related Cancer,mrna-4157 + keytruda,55.2,46.15,1315.26,93,Stable Disease
M210997,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.24,24.16,557.5,70,Stable Disease
M210998,73,Female,Melanoma,KEYTRUDA only,40.56,27.85,1540.97,99,Stable Disease
M210999,50,Male,HPV-related Cancer,mrna-4157 + keytruda,64.91,60.88,1293.34,109,Progression
M211000,59,Female,Non-small Cell Lung Cancer,KEYTRUDA only,30.44,22.28,947.63,94,Progression
M211001,39,Female,HPV-related Cancer,mrna-4157 + keytruda,42.4,36.1,979.06,87,Partial Response
M211002,49,Female,Melanoma,KEYTRUDA only,60.86,54.32,773.98,86,Complete Response
M211003,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,9.39,6.81,1679.88,99,Complete Response
M211004,40,Female,Melanoma,mrna-4157 + keytruda,60.2,58.73,962.25,91,Progression
M211005,69,Other,HPV-related Cancer,mrna-4157 + keytruda,50.28,42.07,1536.21,68,Stable Disease
M211006,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.61,48.57,357.85,96,Stable Disease
M211007,69,Male,Melanoma,mrna-4157 + keytruda,5.48,,1391.65,104,Partial Response
M211008,58,Other,HPV-related Cancer,mrna-4157 + keytruda,52.94,40.13,811.11,90,Complete Response
M211009,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,21.95,10.5,931.26,99,Partial Response
M211010,75,Male,HPV-related Cancer,mrna-4157 + keytruda,33.75,31.5,619.39,73,Stable Disease
M211011,65,Other,Melanoma,KEYTRUDA only,53.17,43.31,340.05,89,Unknown
M211012,51,Male,HPV-related Cancer,mrna-4157 + keytruda,28.04,14.96,1194.25,88,Partial Response
M211013,55,Other,Melanoma,mrna-4157 + keytruda,43.89,44.97,1252.96,93,Complete Response
M211014,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.65,16.01,743.49,87,Complete Response
M211015,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.3,32.86,289.07,89,Stable Disease
M211016,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,9.08,9.86,428.73,98,Stable Disease
M211017,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,29.72,28.34,1197.98,104,Partial Response
M211018,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,91.82,86.66,1525.35,89,
M211019,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.94,22.31,727.13,96,Stable Disease
M211020,26,Other,HPV-related Cancer,mrna-4157 + keytruda,68.08,,651.25,74,Partial Response
M211021,56,Female,HPV-related Cancer,KEYTRUDA only,55.08,42.33,1220.67,94,Progression
M211022,30,Other,HPV-related Cancer,mrna-4157 + keytruda,50.67,44.77,817.16,94,Partial Response
M211023,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,88.77,105.74,,109,Stable Disease
M211024,27,Other,HPV-related Cancer,mrna-4157 + keytruda,42.79,32.99,1119.49,86,Stable Disease
M211025,39,Female,HPV-related Cancer,mrna-4157 + keytruda,39.07,,835.27,79,
M211026,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.14,21.13,1143.27,81,Progression
M211027,61,Other,Melanoma,mrna-4157 + keytruda,50.72,18.53,985.48,94,Stable Disease
M211028,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,62.17,46.46,1742.29,84,Partial Response
M211029,51,Female,HPV-related Cancer,KEYTRUDA only,26.92,19.54,886.24,103,Stable Disease
M211030,78,Female,HPV-related Cancer,mrna-4157 + keytruda,82.19,77.87,1376.88,72,Stable Disease
M211031,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.8,34.25,1219.79,91,Stable Disease
M211032,67,Male,Melanoma,mrna-4157 + keytruda,8.21,5.67,763.76,85,Stable Disease
M211033,25,Female,Melanoma,KEYTRUDA only,71.7,64.08,,62,Progression
M211034,34,Other,Melanoma,KEYTRUDA only,32.02,35.11,1495.6,100,Complete Response
M211035,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,16.23,12.18,397.26,84,Progression
M211036,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.7,23.51,1379.12,99,Stable Disease
M211037,33,Female,HPV-related Cancer,mrna-4157 + keytruda,6.77,4.31,881.74,104,Partial Response
M211038,38,Other,Melanoma,KEYTRUDA only,61.47,68.63,1139.79,99,Unknown
M211039,66,Other,Melanoma,mrna-4157 + keytruda,19.69,9.08,930.4,83,Complete Response
M211040,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,3.29,2.05,1000.53,81,Stable Disease
M211041,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.19,32.53,824.24,112,Stable Disease
M211042,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.12,38.69,919.19,94,Progression
M211043,83,Female,HPV-related Cancer,mrna-4157 + keytruda,61.81,,1273.38,83,Partial Response
M211044,56,Female,HPV-related Cancer,mrna-4157 + keytruda,55.54,34.9,766.95,81,Partial Response
M211045,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.02,58.08,1331.4,83,Partial Response
M211046,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.91,20.27,1778.85,87,Progression
M211047,78,Other,Melanoma,mrna-4157 + keytruda,49.85,30.22,820.22,96,Progression
M211048,41,Other,Melanoma,mrna-4157 + keytruda,53.83,41.59,817.89,102,Partial Response
M211049,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.08,35.43,1001.77,85,Stable Disease
M211050,32,Other,HPV-related Cancer,KEYTRUDA only,24.04,18.02,1138.61,105,Progression
M211051,27,Male,Melanoma,mrna-4157 + keytruda,30.44,28.16,269.27,105,Partial Response
M211052,80,Other,Melanoma,mrna-4157 + keytruda,29.94,9.76,1210.13,97,Partial Response
M211053,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.82,33.02,219.77,81,Stable Disease
M211054,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.17,33.67,1039.98,97,Partial Response
M211055,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.77,41.24,991.48,102,Complete Response
M211056,42,Male,Melanoma,KEYTRUDA only,44.47,33.53,1223.12,93,Progression
M211057,84,Other,Melanoma,KEYTRUDA only,45.55,42.62,,81,Progression
M211058,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.7,51.28,901.26,107,Partial Response
M211059,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,83.52,77.36,1484.53,91,Progression
M211060,32,Other,Melanoma,mrna-4157 + keytruda,39.73,28.7,1272.04,96,Progression
M211061,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.32,17.49,433.04,102,Progression
M211062,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.25,20.18,,82,Progression
M211063,50,Female,Melanoma,KEYTRUDA only,49.86,35.91,1232.26,113,Partial Response
M211064,28,Female,Melanoma,mrna-4157 + keytruda,67.33,57.53,985.34,84,Partial Response
M211065,82,Other,Melanoma,mrna-4157 + keytruda,39.29,38.73,248.23,77,Partial Response
M211066,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.17,48.22,1268.42,82,Progression
M211067,56,Other,Melanoma,mrna-4157 + keytruda,52.78,59.24,879.2,96,Partial Response
M211068,57,Other,HPV-related Cancer,mrna-4157 + keytruda,0.78,0.67,305.36,100,Partial Response
M211069,42,Male,HPV-related Cancer,mrna-4157 + keytruda,25.08,23.0,580.62,81,Stable Disease
M211070,47,Female,Melanoma,KEYTRUDA only,64.78,35.02,1150.63,105,Progression
M211071,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.49,43.04,365.74,93,Stable Disease
M211072,82,Male,Melanoma,mrna-4157 + keytruda,43.7,53.88,809.54,99,Partial Response
M211073,31,Male,HPV-related Cancer,KEYTRUDA only,46.99,46.56,917.45,78,Progression
M211074,47,Female,Melanoma,mrna-4157 + keytruda,45.94,31.03,568.72,101,Progression
M211075,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.72,63.7,842.78,109,Partial Response
M211076,80,Other,Melanoma,KEYTRUDA only,37.11,26.4,551.27,94,Stable Disease
M211077,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.57,,140.14,74,Complete Response
M211078,83,Male,Melanoma,KEYTRUDA only,62.89,40.76,1108.39,91,Stable Disease
M211079,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.54,42.75,,114,Complete Response
M211080,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.19,55.18,1392.9,84,
M211081,41,Other,HPV-related Cancer,mrna-4157 + keytruda,33.44,31.93,1233.31,89,Partial Response
M211082,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.46,41.53,1404.19,86,Stable Disease
M211083,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.8,53.43,1241.09,104,Stable Disease
M211084,42,Other,HPV-related Cancer,mrna-4157 + keytruda,34.49,31.69,1296.83,86,Partial Response
M211085,57,Male,HPV-related Cancer,KEYTRUDA only,37.54,32.98,958.98,85,Complete Response
M211086,51,Other,Melanoma,mrna-4157 + keytruda,38.02,39.57,756.52,92,Complete Response
M211087,44,Male,HPV-related Cancer,mrna-4157 + keytruda,86.84,87.36,659.53,88,Partial Response
M211088,84,Male,HPV-related Cancer,mrna-4157 + keytruda,29.71,23.8,495.63,82,Progression
M211089,80,Male,HPV-related Cancer,mrna-4157 + keytruda,62.09,50.04,838.11,97,Stable Disease
M211090,35,Other,HPV-related Cancer,KEYTRUDA only,21.69,18.68,1198.91,98,Stable Disease
M211091,67,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.35,19.43,,103,Progression
M211092,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.79,32.24,1334.29,88,Partial Response
M211093,47,Female,Melanoma,mrna-4157 + keytruda,28.66,33.17,1239.71,86,Partial Response
M211094,66,Female,Melanoma,KEYTRUDA only,42.62,34.91,1982.86,94,Progression
M211095,59,Female,HPV-related Cancer,mrna-4157 + keytruda,28.63,19.08,,100,Stable Disease
M211096,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.73,47.62,918.36,83,Stable Disease
M211097,35,Male,HPV-related Cancer,KEYTRUDA only,12.22,6.68,886.39,89,Partial Response
M211098,75,Female,HPV-related Cancer,mrna-4157 + keytruda,56.21,43.38,790.43,77,Unknown
M211099,33,Male,HPV-related Cancer,mrna-4157 + keytruda,38.61,25.49,1001.99,93,Stable Disease
M211100,68,Male,Melanoma,mrna-4157 + keytruda,78.58,47.96,1201.15,85,
M211101,33,Other,HPV-related Cancer,KEYTRUDA only,28.54,13.32,1071.7,94,Unknown
M211102,27,Female,HPV-related Cancer,KEYTRUDA only,37.49,24.61,969.14,101,Stable Disease
M211103,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.83,44.7,219.07,99,Complete Response
M211104,71,Other,HPV-related Cancer,KEYTRUDA only,72.96,72.25,886.69,86,Complete Response
M211105,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.92,15.44,1678.04,73,Partial Response
M211106,45,Male,Melanoma,mrna-4157 + keytruda,38.5,22.49,1556.98,86,Partial Response
M211107,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.06,37.62,,104,
M211108,81,Male,HPV-related Cancer,mrna-4157 + keytruda,43.79,43.28,794.87,97,Stable Disease
M211109,53,Male,HPV-related Cancer,mrna-4157 + keytruda,41.57,46.61,1284.46,95,Complete Response
M211110,60,Other,Melanoma,KEYTRUDA only,57.24,45.22,475.8,77,Stable Disease
M211111,56,Other,Melanoma,mrna-4157 + keytruda,42.59,,762.55,85,Stable Disease
M211112,26,Female,Melanoma,mrna-4157 + keytruda,107.06,92.13,1136.42,102,Partial Response
M211113,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.95,18.89,917.26,93,Partial Response
M211114,59,Male,HPV-related Cancer,KEYTRUDA only,39.21,21.35,1260.64,71,Unknown
M211115,52,Female,HPV-related Cancer,KEYTRUDA only,81.02,88.05,1325.89,100,Unknown
M211116,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.97,49.79,1362.29,89,Complete Response
M211117,57,Other,HPV-related Cancer,mrna-4157 + keytruda,38.33,19.44,1820.69,88,Partial Response
M211118,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,18.16,14.58,497.55,90,Partial Response
M211119,41,Female,HPV-related Cancer,KEYTRUDA only,64.68,38.08,930.2,72,Progression
M211120,65,Other,Melanoma,mrna-4157 + keytruda,37.92,18.16,1084.97,88,Partial Response
M211121,38,Female,HPV-related Cancer,KEYTRUDA only,20.53,21.87,1260.71,80,
M211122,73,Other,Melanoma,mrna-4157 + keytruda,31.52,20.08,1674.27,86,Partial Response
M211123,81,Male,Melanoma,mrna-4157 + keytruda,48.67,33.92,1022.9,79,
M211124,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.39,18.01,325.68,86,Complete Response
M211125,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,94.55,89.08,1281.64,97,Complete Response
M211126,42,Female,Melanoma,mrna-4157 + keytruda,31.37,28.89,895.68,88,Partial Response
M211127,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.55,28.21,394.33,73,Complete Response
M211128,63,Other,Melanoma,mrna-4157 + keytruda,52.02,36.1,722.59,93,Unknown
M211129,82,Male,Melanoma,mrna-4157 + keytruda,106.51,,1045.56,103,Complete Response
M211130,47,Other,HPV-related Cancer,mrna-4157 + keytruda,40.07,31.02,3.24,85,Complete Response
M211131,60,Male,HPV-related Cancer,mrna-4157 + keytruda,39.27,43.69,555.86,89,Partial Response
M211132,55,Other,HPV-related Cancer,KEYTRUDA only,47.43,19.68,1101.53,92,
M211133,62,Male,HPV-related Cancer,mrna-4157 + keytruda,21.47,18.64,1538.03,87,Progression
M211134,56,Male,HPV-related Cancer,mrna-4157 + keytruda,52.72,54.59,1013.83,99,Progression
M211135,32,Female,HPV-related Cancer,mrna-4157 + keytruda,52.91,43.43,1268.49,79,Stable Disease
M211136,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,18.23,10.05,274.71,98,Stable Disease
M211137,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.97,50.26,1099.11,76,Progression
M211138,56,Male,Melanoma,mrna-4157 + keytruda,48.76,49.93,1203.06,99,Complete Response
M211139,51,Female,HPV-related Cancer,mrna-4157 + keytruda,53.39,47.07,1393.62,107,Partial Response
M211140,69,Other,HPV-related Cancer,KEYTRUDA only,61.98,57.85,815.58,81,Stable Disease
M211141,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.45,,1276.3,87,Stable Disease
M211142,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.03,33.78,631.38,80,Partial Response
M211143,30,Female,Melanoma,KEYTRUDA only,85.39,34.21,794.78,88,Partial Response
M211144,70,Other,HPV-related Cancer,mrna-4157 + keytruda,62.24,61.25,1224.95,88,Unknown
M211145,59,Male,HPV-related Cancer,mrna-4157 + keytruda,31.2,34.07,951.11,90,Complete Response
M211146,72,Other,HPV-related Cancer,mrna-4157 + keytruda,59.45,58.03,1107.8,85,Partial Response
M211147,49,Other,Melanoma,KEYTRUDA only,55.19,23.26,573.42,82,Stable Disease
M211148,31,Other,Melanoma,KEYTRUDA only,94.86,94.71,1314.69,90,Progression
M211149,67,Male,HPV-related Cancer,KEYTRUDA only,67.12,44.53,1655.21,76,Progression
M211150,40,Female,Melanoma,mrna-4157 + keytruda,72.15,57.26,575.09,103,Stable Disease
M211151,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,3.18,2.8,1047.23,62,
M211152,77,Male,HPV-related Cancer,KEYTRUDA only,74.38,34.01,1544.56,94,Progression
M211153,78,Other,HPV-related Cancer,mrna-4157 + keytruda,59.48,54.41,1815.3,112,Stable Disease
M211154,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.59,35.63,1746.74,87,Partial Response
M211155,33,Male,Melanoma,mrna-4157 + keytruda,52.22,44.49,1155.06,79,
M211156,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.6,46.8,1011.79,101,
M211157,73,Male,Melanoma,mrna-4157 + keytruda,48.16,41.83,839.07,100,Stable Disease
M211158,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.25,52.26,,96,Progression
M211159,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.31,37.97,1480.67,116,Stable Disease
M211160,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.46,33.05,511.73,87,Partial Response
M211161,40,Male,Melanoma,mrna-4157 + keytruda,80.82,61.13,572.24,83,Partial Response
M211162,37,Male,HPV-related Cancer,mrna-4157 + keytruda,68.04,67.41,1299.35,70,Progression
M211163,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.07,57.42,1528.74,86,Partial Response
M211164,36,Other,HPV-related Cancer,KEYTRUDA only,96.78,70.61,1387.42,74,Partial Response
M211165,67,Male,Melanoma,mrna-4157 + keytruda,62.12,64.81,,114,Stable Disease
M211166,77,Male,HPV-related Cancer,KEYTRUDA only,49.93,56.76,709.79,94,Partial Response
M211167,66,Other,Melanoma,mrna-4157 + keytruda,41.19,26.44,1764.52,97,Progression
M211168,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.16,33.85,505.55,70,Stable Disease
M211169,50,Other,Melanoma,KEYTRUDA only,57.61,50.85,840.9,89,Progression
M211170,77,Other,HPV-related Cancer,mrna-4157 + keytruda,55.87,44.04,1027.74,87,Complete Response
M211171,60,Other,HPV-related Cancer,KEYTRUDA only,31.64,17.26,873.69,92,Stable Disease
M211172,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,10.57,11.17,653.4,75,Partial Response
M211173,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.52,,319.29,110,Stable Disease
M211174,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,70.79,48.68,1068.84,90,Partial Response
M211175,48,Female,Melanoma,mrna-4157 + keytruda,52.59,39.89,523.55,86,Progression
M211176,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.56,14.39,1175.19,87,Progression
M211177,28,Male,HPV-related Cancer,mrna-4157 + keytruda,58.48,52.68,995.36,82,Progression
M211178,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.42,30.18,1628.12,94,Complete Response
M211179,36,Female,Melanoma,mrna-4157 + keytruda,47.05,16.93,1443.19,89,
M211180,57,Male,Melanoma,mrna-4157 + keytruda,44.88,41.17,738.34,97,
M211181,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.76,43.64,397.76,98,Complete Response
M211182,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,27.32,18.5,875.36,86,Progression
M211183,36,Male,HPV-related Cancer,mrna-4157 + keytruda,48.72,51.05,1574.01,94,Unknown
M211184,55,Male,Melanoma,mrna-4157 + keytruda,78.88,45.0,540.18,93,Stable Disease
M211185,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.29,67.22,1210.29,97,Stable Disease
M211186,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.03,41.54,791.7,101,Stable Disease
M211187,45,Male,HPV-related Cancer,mrna-4157 + keytruda,42.38,30.97,874.11,87,Unknown
M211188,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.97,50.01,901.84,96,Stable Disease
M211189,84,Other,Melanoma,mrna-4157 + keytruda,70.22,48.23,804.55,89,Complete Response
M211190,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.03,16.69,1720.22,89,
M211191,65,Other,HPV-related Cancer,KEYTRUDA only,42.93,31.68,868.47,89,Progression
M211192,32,Female,Melanoma,mrna-4157 + keytruda,66.53,64.11,1209.01,76,Partial Response
M211193,71,Other,Melanoma,mrna-4157 + keytruda,53.49,41.58,,77,Partial Response
M211194,57,Female,HPV-related Cancer,mrna-4157 + keytruda,44.64,21.89,1037.85,97,Stable Disease
M211195,78,Other,HPV-related Cancer,mrna-4157 + keytruda,21.85,14.48,1229.18,83,Partial Response
M211196,44,Female,Non-small Cell Lung Cancer,KEYTRUDA only,83.33,36.68,357.85,105,Stable Disease
M211197,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.82,86.78,1045.06,78,Partial Response
M211198,64,Other,HPV-related Cancer,KEYTRUDA only,47.13,,1173.36,88,Partial Response
M211199,48,Other,Melanoma,mrna-4157 + keytruda,22.21,16.4,1318.61,81,Progression
M211200,59,Male,HPV-related Cancer,KEYTRUDA only,61.21,52.04,658.35,89,Partial Response
M211201,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.13,35.67,807.88,99,Progression
M211202,58,Male,HPV-related Cancer,KEYTRUDA only,37.66,29.35,612.6,79,Complete Response
M211203,62,Other,HPV-related Cancer,mrna-4157 + keytruda,79.48,75.61,516.18,107,Unknown
M211204,53,Other,HPV-related Cancer,KEYTRUDA only,74.5,65.0,1017.75,81,Partial Response
M211205,51,Other,HPV-related Cancer,mrna-4157 + keytruda,57.64,38.4,,87,Stable Disease
M211206,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.61,16.07,1701.6,89,Progression
M211207,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.79,42.54,658.69,85,Complete Response
M211208,32,Male,Melanoma,mrna-4157 + keytruda,67.5,57.0,1577.13,97,Complete Response
M211209,46,Female,HPV-related Cancer,mrna-4157 + keytruda,57.27,44.26,,116,Stable Disease
M211210,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.87,42.29,790.91,102,Partial Response
M211211,70,Male,Melanoma,mrna-4157 + keytruda,36.88,27.9,515.05,87,Stable Disease
M211212,74,Other,Melanoma,KEYTRUDA only,24.28,26.07,,82,Unknown
M211213,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.46,54.13,1563.59,96,Progression
M211214,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.51,42.56,1876.05,88,Stable Disease
M211215,50,Male,Melanoma,mrna-4157 + keytruda,50.96,29.88,995.83,95,Stable Disease
M211216,71,Other,HPV-related Cancer,mrna-4157 + keytruda,29.4,30.2,895.51,93,Complete Response
M211217,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.77,34.45,870.19,90,Complete Response
M211218,62,Female,Melanoma,mrna-4157 + keytruda,31.02,25.88,585.28,82,Complete Response
M211219,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.3,95.5,737.83,84,Complete Response
M211220,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.83,63.56,644.51,91,Complete Response
M211221,71,Female,Melanoma,KEYTRUDA only,30.58,30.39,854.39,86,Progression
M211222,26,Male,HPV-related Cancer,KEYTRUDA only,53.52,45.2,788.75,88,Complete Response
M211223,33,Male,Melanoma,KEYTRUDA only,80.85,90.37,718.22,84,Stable Disease
M211224,60,Male,HPV-related Cancer,mrna-4157 + keytruda,37.35,32.74,691.89,87,Complete Response
M211225,30,Other,HPV-related Cancer,mrna-4157 + keytruda,31.59,25.61,409.08,94,Progression
M211226,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.13,44.56,807.73,69,Stable Disease
M211227,84,Other,Melanoma,mrna-4157 + keytruda,72.84,79.39,984.66,103,Progression
M211228,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,85.2,95.38,711.44,76,Stable Disease
M211229,74,Female,HPV-related Cancer,mrna-4157 + keytruda,36.68,16.5,698.37,91,Stable Disease
M211230,35,Female,Melanoma,mrna-4157 + keytruda,51.64,,1602.84,109,Progression
M211231,67,Female,Melanoma,mrna-4157 + keytruda,67.26,69.09,473.4,91,Stable Disease
M211232,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.05,19.5,287.58,98,Partial Response
M211233,60,Male,HPV-related Cancer,KEYTRUDA only,56.09,38.28,1175.08,108,Partial Response
M211234,53,Other,HPV-related Cancer,mrna-4157 + keytruda,40.86,33.96,470.13,93,Stable Disease
M211235,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.67,47.79,2157.94,73,Stable Disease
M211236,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.4,38.03,714.31,95,Complete Response
M211237,82,Other,HPV-related Cancer,KEYTRUDA only,56.37,45.4,645.39,84,Complete Response
M211238,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,73.25,37.96,908.3,76,Stable Disease
M211239,52,Other,HPV-related Cancer,KEYTRUDA only,65.37,55.47,943.68,88,Progression
M211240,75,Male,HPV-related Cancer,mrna-4157 + keytruda,44.91,29.99,889.02,77,Complete Response
M211241,38,Female,HPV-related Cancer,mrna-4157 + keytruda,68.13,51.57,775.03,80,Complete Response
M211242,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.13,37.12,1064.45,87,Partial Response
M211243,33,Female,Melanoma,mrna-4157 + keytruda,59.17,55.44,534.93,89,Stable Disease
M211244,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.43,45.87,1285.95,81,Partial Response
M211245,41,Other,HPV-related Cancer,KEYTRUDA only,41.77,26.59,907.93,84,Complete Response
M211246,40,Other,Melanoma,KEYTRUDA only,69.93,46.25,814.9,73,Progression
M211247,33,Female,Melanoma,KEYTRUDA only,50.77,34.22,999.14,86,Partial Response
M211248,84,Male,HPV-related Cancer,mrna-4157 + keytruda,70.71,46.73,787.46,98,Partial Response
M211249,50,Female,HPV-related Cancer,mrna-4157 + keytruda,90.4,91.47,1383.5,81,Complete Response
M211250,78,Female,Melanoma,mrna-4157 + keytruda,37.73,30.64,1301.44,88,
M211251,73,Female,Melanoma,mrna-4157 + keytruda,43.63,46.78,1132.67,84,Partial Response
M211252,25,Male,Melanoma,KEYTRUDA only,69.72,34.32,279.05,96,Partial Response
M211253,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.93,36.92,910.47,87,Partial Response
M211254,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.41,31.75,1280.68,97,Partial Response
M211255,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.3,63.07,,87,Partial Response
M211256,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.92,10.08,321.76,105,Stable Disease
M211257,47,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.29,35.45,62.36,100,Progression
M211258,41,Other,Melanoma,KEYTRUDA only,50.26,43.59,1166.13,98,Progression
M211259,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.32,31.22,1193.49,100,Progression
M211260,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.52,26.37,492.68,87,Progression
M211261,27,Other,HPV-related Cancer,KEYTRUDA only,49.46,31.25,881.46,94,Stable Disease
M211262,55,Female,HPV-related Cancer,mrna-4157 + keytruda,47.32,46.77,948.64,88,Stable Disease
M211263,34,Male,HPV-related Cancer,KEYTRUDA only,55.08,20.77,878.27,89,Complete Response
M211264,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.09,80.12,1023.54,88,Partial Response
M211265,76,Female,HPV-related Cancer,KEYTRUDA only,17.45,13.52,1356.29,101,Complete Response
M211266,47,Other,Non-small Cell Lung Cancer,KEYTRUDA only,78.58,80.64,1305.29,93,Progression
M211267,70,Female,Melanoma,KEYTRUDA only,86.99,80.05,825.17,96,Partial Response
M211268,75,Female,Melanoma,mrna-4157 + keytruda,57.31,,46.43,94,Stable Disease
M211269,70,Other,Melanoma,mrna-4157 + keytruda,16.94,18.3,811.51,80,Partial Response
M211270,79,Other,Melanoma,mrna-4157 + keytruda,48.62,44.35,1209.48,84,Progression
M211271,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.7,68.01,603.3,105,Partial Response
M211272,68,Male,HPV-related Cancer,mrna-4157 + keytruda,50.36,56.34,1538.09,110,Complete Response
M211273,39,Female,HPV-related Cancer,KEYTRUDA only,44.01,39.36,1167.01,105,Stable Disease
M211274,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.97,25.99,575.85,95,Progression
M211275,68,Female,Melanoma,mrna-4157 + keytruda,40.29,27.42,596.96,92,Complete Response
M211276,46,Female,Melanoma,mrna-4157 + keytruda,49.2,15.81,705.95,102,Partial Response
M211277,52,Other,HPV-related Cancer,mrna-4157 + keytruda,42.47,23.48,1218.14,83,Progression
M211278,66,Female,HPV-related Cancer,KEYTRUDA only,77.07,27.2,176.29,93,Stable Disease
M211279,45,Male,Melanoma,KEYTRUDA only,31.92,20.8,1109.58,91,Stable Disease
M211280,80,Male,HPV-related Cancer,KEYTRUDA only,23.46,15.77,1265.41,90,Stable Disease
M211281,44,Other,HPV-related Cancer,KEYTRUDA only,41.59,31.68,573.57,77,Progression
M211282,83,Other,HPV-related Cancer,mrna-4157 + keytruda,54.79,43.61,1265.91,89,Partial Response
M211283,56,Male,Melanoma,mrna-4157 + keytruda,42.03,25.06,881.02,99,Complete Response
M211284,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.08,28.38,1280.22,83,Complete Response
M211285,72,Male,HPV-related Cancer,KEYTRUDA only,36.14,30.47,630.15,93,Stable Disease
M211286,41,Female,HPV-related Cancer,mrna-4157 + keytruda,50.68,55.0,212.26,86,
M211287,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.41,39.48,996.32,98,Partial Response
M211288,43,Male,HPV-related Cancer,KEYTRUDA only,78.39,71.84,873.73,89,Unknown
M211289,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.78,23.9,2008.52,85,Stable Disease
M211290,34,Female,Melanoma,KEYTRUDA only,61.84,,1229.78,80,Progression
M211291,76,Other,HPV-related Cancer,mrna-4157 + keytruda,38.01,23.89,676.03,106,Complete Response
M211292,40,Other,HPV-related Cancer,KEYTRUDA only,59.85,45.2,855.5,84,Stable Disease
M211293,56,Other,HPV-related Cancer,KEYTRUDA only,36.89,40.09,534.97,73,Stable Disease
M211294,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.22,40.57,2053.46,94,Stable Disease
M211295,63,Other,HPV-related Cancer,KEYTRUDA only,66.78,45.73,1471.15,103,Progression
M211296,66,Other,Melanoma,KEYTRUDA only,79.58,41.84,1382.92,86,Stable Disease
M211297,71,Male,Melanoma,mrna-4157 + keytruda,31.72,22.07,739.97,89,Stable Disease
M211298,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.74,28.38,1289.25,82,Partial Response
M211299,83,Other,HPV-related Cancer,KEYTRUDA only,41.34,42.4,629.55,83,Partial Response
M211300,32,Other,HPV-related Cancer,KEYTRUDA only,67.46,,1041.7,78,Progression
M211301,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.98,40.65,1149.42,79,Progression
M211302,26,Female,HPV-related Cancer,mrna-4157 + keytruda,-16.95,-10.97,,74,Unknown
M211303,43,Other,Melanoma,KEYTRUDA only,60.79,52.3,584.85,92,Stable Disease
M211304,29,Female,HPV-related Cancer,mrna-4157 + keytruda,63.99,55.99,1692.87,102,Complete Response
M211305,45,Other,HPV-related Cancer,mrna-4157 + keytruda,47.0,25.74,824.05,87,
M211306,60,Other,HPV-related Cancer,mrna-4157 + keytruda,59.94,33.98,710.88,84,Stable Disease
M211307,73,Female,Melanoma,mrna-4157 + keytruda,76.57,55.17,656.83,108,Progression
M211308,71,Other,Melanoma,mrna-4157 + keytruda,52.12,18.78,2098.5,85,Progression
M211309,69,Other,HPV-related Cancer,mrna-4157 + keytruda,41.2,20.96,782.03,90,Partial Response
M211310,28,Female,HPV-related Cancer,mrna-4157 + keytruda,40.63,32.48,942.55,90,Stable Disease
M211311,53,Female,HPV-related Cancer,mrna-4157 + keytruda,90.18,49.2,1006.36,104,Stable Disease
M211312,57,Female,HPV-related Cancer,mrna-4157 + keytruda,75.54,78.43,568.08,96,Progression
M211313,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,28.75,24.92,466.62,88,Stable Disease
M211314,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,22.31,19.5,919.23,80,Progression
M211315,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.29,56.5,1515.14,82,Stable Disease
M211316,66,Female,Melanoma,KEYTRUDA only,38.52,20.16,1955.64,98,Stable Disease
M211317,41,Male,HPV-related Cancer,mrna-4157 + keytruda,46.59,9.33,987.82,83,Progression
M211318,48,Female,HPV-related Cancer,KEYTRUDA only,42.58,35.19,428.63,77,Complete Response
M211319,73,Female,Melanoma,mrna-4157 + keytruda,32.99,22.71,1396.11,80,Complete Response
M211320,54,Female,HPV-related Cancer,KEYTRUDA only,75.5,61.19,1252.74,88,Progression
M211321,65,Other,HPV-related Cancer,mrna-4157 + keytruda,65.85,54.09,1081.03,66,Partial Response
M211322,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.04,48.81,799.11,88,Partial Response
M211323,36,Female,HPV-related Cancer,KEYTRUDA only,66.28,53.72,967.14,89,Stable Disease
M211324,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.95,50.44,1455.01,98,Complete Response
M211325,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.98,46.89,1218.05,88,Unknown
M211326,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.98,64.96,617.55,90,Progression
M211327,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,80.71,44.55,806.75,80,
M211328,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,16.62,10.05,741.15,110,Partial Response
M211329,51,Male,Melanoma,mrna-4157 + keytruda,66.8,33.8,1480.51,76,Progression
M211330,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.55,22.07,1265.2,106,Partial Response
M211331,55,Other,Melanoma,KEYTRUDA only,80.25,52.31,1115.77,89,Complete Response
M211332,46,Male,HPV-related Cancer,mrna-4157 + keytruda,57.37,29.57,969.36,100,
M211333,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.87,21.99,895.02,84,
M211334,76,Other,HPV-related Cancer,mrna-4157 + keytruda,17.73,11.68,1170.09,95,Partial Response
M211335,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.77,27.16,407.28,99,Stable Disease
M211336,36,Male,HPV-related Cancer,KEYTRUDA only,46.39,43.71,1539.05,87,Partial Response
M211337,38,Female,HPV-related Cancer,mrna-4157 + keytruda,66.93,42.43,1510.37,84,Complete Response
M211338,70,Other,HPV-related Cancer,KEYTRUDA only,3.3,2.33,800.22,80,Progression
M211339,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.79,45.96,843.85,83,Partial Response
M211340,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.28,54.59,270.53,76,
M211341,29,Male,Melanoma,mrna-4157 + keytruda,67.58,35.2,1273.18,80,Complete Response
M211342,65,Female,HPV-related Cancer,KEYTRUDA only,19.35,23.39,597.76,91,
M211343,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,22.74,20.3,1125.12,107,Stable Disease
M211344,50,Male,HPV-related Cancer,mrna-4157 + keytruda,42.35,27.73,1050.21,114,Complete Response
M211345,61,Other,Melanoma,mrna-4157 + keytruda,28.45,17.38,329.52,85,Stable Disease
M211346,69,Female,HPV-related Cancer,KEYTRUDA only,83.93,44.3,1688.7,84,Stable Disease
M211347,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.16,18.32,931.67,88,
M211348,38,Female,HPV-related Cancer,KEYTRUDA only,43.65,33.7,252.02,88,Partial Response
M211349,27,Male,HPV-related Cancer,mrna-4157 + keytruda,84.44,53.49,1497.8,87,Complete Response
M211350,30,Female,Melanoma,KEYTRUDA only,48.19,,1129.32,96,Progression
M211351,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.57,,1522.8,81,
M211352,55,Male,HPV-related Cancer,KEYTRUDA only,17.33,14.75,1213.19,95,Partial Response
M211353,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.01,40.13,1169.64,103,Partial Response
M211354,51,Male,HPV-related Cancer,mrna-4157 + keytruda,70.12,66.97,1417.64,90,Stable Disease
M211355,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.14,27.22,,93,Progression
M211356,52,Male,Melanoma,KEYTRUDA only,18.61,10.61,1131.56,105,Unknown
M211357,61,Male,Melanoma,KEYTRUDA only,12.25,9.21,1652.89,90,Stable Disease
M211358,72,Male,Melanoma,mrna-4157 + keytruda,13.13,16.65,714.64,87,Progression
M211359,72,Female,Melanoma,KEYTRUDA only,59.76,64.47,1418.61,104,Complete Response
M211360,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.11,57.2,545.98,88,Stable Disease
M211361,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.71,31.37,979.21,95,Progression
M211362,58,Female,HPV-related Cancer,mrna-4157 + keytruda,16.65,,949.47,87,Stable Disease
M211363,70,Other,Melanoma,mrna-4157 + keytruda,59.31,68.03,128.07,96,
M211364,78,Other,Melanoma,mrna-4157 + keytruda,47.15,45.63,,86,Progression
M211365,43,Other,Melanoma,mrna-4157 + keytruda,25.05,,1678.8,89,Unknown
M211366,83,Male,Melanoma,mrna-4157 + keytruda,51.93,48.5,326.33,101,Progression
M211367,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,78.57,,1175.9,88,Complete Response
M211368,30,Other,HPV-related Cancer,mrna-4157 + keytruda,12.14,10.96,512.99,108,Partial Response
M211369,55,Other,HPV-related Cancer,KEYTRUDA only,36.65,28.95,1676.55,93,Partial Response
M211370,30,Male,Melanoma,KEYTRUDA only,66.7,55.78,1008.4,85,Progression
M211371,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.71,24.13,1244.85,85,Unknown
M211372,45,Other,Melanoma,mrna-4157 + keytruda,74.21,64.74,,86,Complete Response
M211373,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.09,42.05,1308.82,96,Partial Response
M211374,81,Other,Melanoma,KEYTRUDA only,17.93,,1501.7,107,Partial Response
M211375,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.48,40.77,1750.09,89,Partial Response
M211376,25,Other,Melanoma,mrna-4157 + keytruda,10.12,12.9,797.86,90,Stable Disease
M211377,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.38,52.45,482.39,87,Progression
M211378,60,Male,Melanoma,KEYTRUDA only,78.89,50.96,889.88,84,Stable Disease
M211379,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.29,57.09,1384.28,96,Progression
M211380,69,Male,HPV-related Cancer,mrna-4157 + keytruda,68.73,40.46,1427.28,103,Stable Disease
M211381,42,Other,HPV-related Cancer,KEYTRUDA only,56.31,27.37,1348.09,76,Complete Response
M211382,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.57,52.62,902.77,81,Partial Response
M211383,74,Other,HPV-related Cancer,mrna-4157 + keytruda,41.58,41.93,831.93,90,Stable Disease
M211384,67,Other,HPV-related Cancer,KEYTRUDA only,56.37,37.67,,85,Progression
M211385,57,Female,Melanoma,KEYTRUDA only,64.31,50.34,418.51,84,Progression
M211386,81,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.11,52.4,1436.0,94,
M211387,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.05,59.12,1423.94,97,Stable Disease
M211388,74,Male,Melanoma,KEYTRUDA only,70.72,44.88,1174.05,91,Partial Response
M211389,44,Other,HPV-related Cancer,KEYTRUDA only,60.51,63.69,913.55,92,Partial Response
M211390,25,Male,Melanoma,KEYTRUDA only,24.47,23.72,1360.55,100,Complete Response
M211391,72,Female,HPV-related Cancer,mrna-4157 + keytruda,48.91,39.16,1247.31,101,Partial Response
M211392,32,Male,Melanoma,mrna-4157 + keytruda,37.16,37.34,906.57,100,Progression
M211393,44,Other,HPV-related Cancer,KEYTRUDA only,48.86,34.71,1395.14,87,Partial Response
M211394,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.03,17.3,1614.54,106,Progression
M211395,53,Female,Melanoma,mrna-4157 + keytruda,85.62,59.64,1444.99,79,Complete Response
M211396,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.08,43.22,1964.97,63,Stable Disease
M211397,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,73.34,71.2,621.61,93,Progression
M211398,74,Female,Melanoma,KEYTRUDA only,36.17,29.31,1060.18,105,Partial Response
M211399,56,Other,Melanoma,KEYTRUDA only,90.49,63.05,644.21,82,Progression
M211400,40,Female,Melanoma,mrna-4157 + keytruda,49.58,,853.42,68,Stable Disease
M211401,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.25,45.28,824.4,91,Progression
M211402,42,Other,HPV-related Cancer,KEYTRUDA only,56.75,25.15,1529.79,82,Unknown
M211403,32,Other,HPV-related Cancer,mrna-4157 + keytruda,52.75,39.75,1023.26,91,Stable Disease
M211404,61,Other,HPV-related Cancer,mrna-4157 + keytruda,66.68,33.25,595.29,105,Progression
M211405,62,Other,Melanoma,KEYTRUDA only,34.19,33.01,731.72,90,Stable Disease
M211406,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.07,33.16,1293.15,91,Stable Disease
M211407,40,Female,Melanoma,KEYTRUDA only,20.44,25.52,796.03,70,Partial Response
M211408,75,Male,HPV-related Cancer,mrna-4157 + keytruda,56.42,44.84,834.14,99,Complete Response
M211409,36,Other,HPV-related Cancer,mrna-4157 + keytruda,41.39,31.23,1014.11,82,Stable Disease
M211410,35,Female,Melanoma,KEYTRUDA only,60.33,49.8,1194.83,92,Progression
M211411,66,Male,HPV-related Cancer,mrna-4157 + keytruda,72.05,57.37,1215.34,106,Partial Response
M211412,41,Other,HPV-related Cancer,mrna-4157 + keytruda,76.97,74.16,749.95,80,Progression
M211413,61,Male,HPV-related Cancer,KEYTRUDA only,106.68,79.36,672.96,104,Stable Disease
M211414,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.28,45.65,1446.25,76,
M211415,61,Male,HPV-related Cancer,KEYTRUDA only,32.79,23.98,1481.99,89,Complete Response
M211416,38,Other,HPV-related Cancer,mrna-4157 + keytruda,65.08,69.24,994.16,95,Partial Response
M211417,40,Other,Melanoma,mrna-4157 + keytruda,47.8,42.76,586.71,85,Partial Response
M211418,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.91,58.87,1745.68,83,Partial Response
M211419,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.62,49.66,639.86,95,Progression
M211420,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.46,,539.2,90,Complete Response
M211421,29,Female,HPV-related Cancer,mrna-4157 + keytruda,56.14,44.89,,108,Complete Response
M211422,73,Female,HPV-related Cancer,KEYTRUDA only,72.61,69.77,578.43,96,Stable Disease
M211423,40,Other,Melanoma,mrna-4157 + keytruda,36.47,27.12,1033.08,77,Partial Response
M211424,52,Female,HPV-related Cancer,KEYTRUDA only,58.53,36.97,921.47,88,Partial Response
M211425,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.66,32.61,1404.26,91,Partial Response
M211426,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.63,59.58,463.11,88,Stable Disease
M211427,46,Other,Melanoma,mrna-4157 + keytruda,61.26,48.03,779.58,99,Stable Disease
M211428,33,Male,HPV-related Cancer,mrna-4157 + keytruda,43.47,31.09,780.69,86,Partial Response
M211429,32,Male,HPV-related Cancer,KEYTRUDA only,41.29,31.24,256.17,92,Partial Response
M211430,67,Male,Melanoma,KEYTRUDA only,34.75,25.11,1397.1,91,Progression
M211431,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.91,29.53,1362.96,84,Progression
M211432,41,Other,HPV-related Cancer,mrna-4157 + keytruda,55.74,,1203.12,80,Complete Response
M211433,61,Female,Melanoma,mrna-4157 + keytruda,42.74,,1383.17,89,Partial Response
M211434,80,Female,HPV-related Cancer,KEYTRUDA only,84.77,23.48,,82,Partial Response
M211435,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,20.1,16.77,969.63,109,Partial Response
M211436,39,Other,HPV-related Cancer,mrna-4157 + keytruda,48.04,39.61,1775.56,75,Progression
M211437,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.49,51.97,655.02,87,Stable Disease
M211438,57,Female,Melanoma,mrna-4157 + keytruda,42.78,43.83,643.0,90,Stable Disease
M211439,55,Other,Non-small Cell Lung Cancer,KEYTRUDA only,64.6,40.85,104.32,97,Partial Response
M211440,55,Other,HPV-related Cancer,mrna-4157 + keytruda,40.7,27.01,1186.5,84,Complete Response
M211441,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,64.12,32.63,997.07,93,Progression
M211442,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.02,37.11,1429.82,80,Stable Disease
M211443,36,Other,Melanoma,KEYTRUDA only,47.21,28.24,1187.78,96,Complete Response
M211444,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.08,56.87,680.78,88,Progression
M211445,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.23,13.11,503.73,76,Unknown
M211446,44,Other,HPV-related Cancer,KEYTRUDA only,54.23,62.71,1567.09,83,Partial Response
M211447,48,Male,HPV-related Cancer,mrna-4157 + keytruda,4.31,2.89,1302.04,87,Partial Response
M211448,34,Female,HPV-related Cancer,KEYTRUDA only,41.56,,1326.47,86,Complete Response
M211449,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.57,61.27,1234.65,89,Partial Response
M211450,35,Male,HPV-related Cancer,mrna-4157 + keytruda,88.83,67.2,1578.54,102,Partial Response
M211451,49,Other,Melanoma,KEYTRUDA only,51.98,42.91,774.15,69,
M211452,25,Other,Non-small Cell Lung Cancer,KEYTRUDA only,-7.41,-5.44,939.05,92,Progression
M211453,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.17,17.75,546.78,94,Complete Response
M211454,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.88,62.78,714.61,108,Progression
M211455,70,Male,Melanoma,KEYTRUDA only,48.8,46.19,489.54,93,Stable Disease
M211456,71,Male,HPV-related Cancer,mrna-4157 + keytruda,53.48,52.9,695.14,96,Partial Response
M211457,33,Other,Melanoma,KEYTRUDA only,63.95,35.02,1468.01,89,Stable Disease
M211458,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.44,34.83,1009.71,92,Partial Response
M211459,35,Male,Melanoma,mrna-4157 + keytruda,28.86,24.68,522.66,81,Complete Response
M211460,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.85,53.76,1098.37,86,Progression
M211461,51,Female,HPV-related Cancer,mrna-4157 + keytruda,27.18,19.86,1229.95,94,Progression
M211462,40,Male,HPV-related Cancer,KEYTRUDA only,39.01,31.01,1581.97,94,Stable Disease
M211463,27,Other,HPV-related Cancer,mrna-4157 + keytruda,25.44,,1600.31,85,Partial Response
M211464,66,Female,Melanoma,mrna-4157 + keytruda,48.52,35.01,1329.17,105,Partial Response
M211465,31,Male,Melanoma,KEYTRUDA only,34.23,34.04,1132.79,79,Progression
M211466,36,Female,Melanoma,KEYTRUDA only,54.5,60.0,1055.84,103,Stable Disease
M211467,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.13,63.68,1312.3,92,Partial Response
M211468,64,Other,HPV-related Cancer,mrna-4157 + keytruda,35.84,32.83,760.91,91,Partial Response
M211469,74,Male,HPV-related Cancer,mrna-4157 + keytruda,47.09,40.04,1360.73,79,Stable Disease
M211470,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.92,20.61,940.88,73,Complete Response
M211471,78,Other,Non-small Cell Lung Cancer,KEYTRUDA only,26.52,22.22,1176.84,86,Partial Response
M211472,81,Other,Melanoma,mrna-4157 + keytruda,45.47,34.08,1166.82,76,Partial Response
M211473,74,Male,HPV-related Cancer,KEYTRUDA only,55.5,44.91,-125.47,81,Complete Response
M211474,34,Female,HPV-related Cancer,KEYTRUDA only,66.72,40.61,633.74,78,Partial Response
M211475,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.55,46.17,538.09,77,
M211476,55,Female,Melanoma,mrna-4157 + keytruda,91.14,63.9,1119.07,92,Stable Disease
M211477,52,Female,HPV-related Cancer,mrna-4157 + keytruda,69.84,72.19,,65,Stable Disease
M211478,46,Male,HPV-related Cancer,KEYTRUDA only,38.02,47.67,1440.68,89,Stable Disease
M211479,67,Male,Melanoma,KEYTRUDA only,81.39,110.15,250.23,86,Progression
M211480,27,Female,Melanoma,KEYTRUDA only,53.92,26.27,566.85,90,Stable Disease
M211481,80,Female,HPV-related Cancer,mrna-4157 + keytruda,65.82,66.32,678.35,96,Stable Disease
M211482,58,Female,Melanoma,KEYTRUDA only,80.55,60.45,1452.55,100,Partial Response
M211483,31,Other,Melanoma,mrna-4157 + keytruda,40.7,35.3,861.13,88,Progression
M211484,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,38.96,43.18,,90,Stable Disease
M211485,63,Other,HPV-related Cancer,mrna-4157 + keytruda,60.03,48.72,1088.0,89,Partial Response
M211486,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.45,,1172.79,95,Stable Disease
M211487,45,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.76,21.8,,91,Progression
M211488,72,Other,Melanoma,KEYTRUDA only,73.97,62.49,570.92,81,Partial Response
M211489,47,Female,Melanoma,KEYTRUDA only,63.23,54.25,939.86,112,Stable Disease
M211490,29,Other,Melanoma,KEYTRUDA only,68.59,67.38,1050.21,90,Partial Response
M211491,82,Female,Melanoma,mrna-4157 + keytruda,10.94,9.6,1380.66,80,Partial Response
M211492,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.44,34.56,527.35,88,
M211493,44,Female,HPV-related Cancer,mrna-4157 + keytruda,57.19,59.92,1134.76,85,Stable Disease
M211494,43,Other,Melanoma,KEYTRUDA only,4.09,4.01,110.28,73,Partial Response
M211495,63,Male,Melanoma,mrna-4157 + keytruda,19.54,14.97,1632.78,75,Partial Response
M211496,53,Male,Melanoma,mrna-4157 + keytruda,71.0,63.73,1251.94,110,Stable Disease
M211497,59,Male,HPV-related Cancer,KEYTRUDA only,25.58,17.39,680.46,82,Partial Response
M211498,52,Other,Melanoma,mrna-4157 + keytruda,41.01,39.46,464.03,87,Stable Disease
M211499,65,Male,Melanoma,mrna-4157 + keytruda,26.07,15.89,605.06,85,Progression
M211500,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.36,40.18,1294.17,92,Stable Disease
M211501,30,Female,HPV-related Cancer,mrna-4157 + keytruda,49.01,43.8,1308.15,104,Partial Response
M211502,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.54,20.36,769.6,93,Partial Response
M211503,32,Female,HPV-related Cancer,mrna-4157 + keytruda,31.03,22.26,2108.19,93,
M211504,39,Female,Melanoma,KEYTRUDA only,50.45,49.06,847.96,78,Stable Disease
M211505,55,Male,Melanoma,KEYTRUDA only,31.23,,1302.18,73,Progression
M211506,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,9.26,6.4,905.45,82,Partial Response
M211507,62,Female,Melanoma,mrna-4157 + keytruda,76.94,58.52,1071.68,85,Partial Response
M211508,61,Male,HPV-related Cancer,KEYTRUDA only,79.9,61.86,1432.93,102,Stable Disease
M211509,57,Other,Melanoma,mrna-4157 + keytruda,56.77,46.46,1268.38,90,Partial Response
M211510,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,67.71,66.74,576.27,85,Stable Disease
M211511,65,Other,Melanoma,mrna-4157 + keytruda,65.59,46.85,684.05,84,Stable Disease
M211512,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.83,33.92,306.0,82,Progression
M211513,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,28.77,20.0,314.88,75,Progression
M211514,37,Female,HPV-related Cancer,mrna-4157 + keytruda,56.14,42.89,827.62,90,Progression
M211515,33,Female,HPV-related Cancer,mrna-4157 + keytruda,54.36,32.28,553.08,92,
M211516,46,Other,Melanoma,mrna-4157 + keytruda,79.55,56.73,771.66,102,Unknown
M211517,65,Female,Melanoma,mrna-4157 + keytruda,66.21,42.49,1309.37,105,Partial Response
M211518,48,Female,Melanoma,mrna-4157 + keytruda,37.0,26.39,1001.82,74,Stable Disease
M211519,70,Other,Melanoma,KEYTRUDA only,69.79,61.27,860.51,87,Progression
M211520,41,Female,HPV-related Cancer,mrna-4157 + keytruda,52.79,56.37,403.13,92,Stable Disease
M211521,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.28,34.61,1022.41,73,Partial Response
M211522,44,Other,HPV-related Cancer,KEYTRUDA only,34.95,31.39,592.29,83,Complete Response
M211523,39,Other,Melanoma,mrna-4157 + keytruda,57.26,39.65,686.75,91,Partial Response
M211524,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.03,54.26,1069.07,96,Partial Response
M211525,69,Male,Melanoma,KEYTRUDA only,30.89,27.72,492.71,74,Partial Response
M211526,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.26,50.36,849.72,86,Stable Disease
M211527,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.69,65.69,1160.19,76,Partial Response
M211528,41,Female,Melanoma,KEYTRUDA only,63.94,70.11,772.58,90,Partial Response
M211529,47,Female,HPV-related Cancer,mrna-4157 + keytruda,54.15,37.58,1350.51,83,Partial Response
M211530,65,Other,Melanoma,mrna-4157 + keytruda,55.69,40.18,724.7,96,Partial Response
M211531,35,Other,Melanoma,KEYTRUDA only,9.56,6.78,222.11,106,Progression
M211532,66,Female,HPV-related Cancer,KEYTRUDA only,15.31,10.56,1135.15,87,Complete Response
M211533,80,Other,Melanoma,mrna-4157 + keytruda,18.3,15.85,1256.14,85,Progression
M211534,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.55,53.66,1019.38,91,Progression
M211535,82,Male,Melanoma,mrna-4157 + keytruda,21.97,13.5,1170.15,91,Stable Disease
M211536,27,Female,HPV-related Cancer,mrna-4157 + keytruda,64.23,60.2,961.01,84,Complete Response
M211537,73,Other,HPV-related Cancer,mrna-4157 + keytruda,18.47,11.42,1283.3,89,Partial Response
M211538,28,Female,HPV-related Cancer,mrna-4157 + keytruda,34.12,27.15,1176.59,84,Partial Response
M211539,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,50.37,36.07,825.38,90,Stable Disease
M211540,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.46,57.18,1593.51,75,Progression
M211541,59,Other,Melanoma,mrna-4157 + keytruda,83.29,71.04,679.84,101,Stable Disease
M211542,60,Female,Melanoma,KEYTRUDA only,48.14,40.95,1120.48,90,Partial Response
M211543,75,Female,Melanoma,mrna-4157 + keytruda,20.83,18.35,1043.58,104,Stable Disease
M211544,62,Male,HPV-related Cancer,mrna-4157 + keytruda,63.42,34.26,939.55,97,Partial Response
M211545,48,Other,HPV-related Cancer,mrna-4157 + keytruda,46.94,26.2,873.67,95,Stable Disease
M211546,45,Female,Melanoma,KEYTRUDA only,47.75,57.3,1573.89,97,Partial Response
M211547,73,Other,Melanoma,KEYTRUDA only,32.26,21.49,1042.75,89,Stable Disease
M211548,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.19,78.76,802.23,88,Progression
M211549,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.47,73.03,607.89,85,Stable Disease
M211550,33,Other,Melanoma,mrna-4157 + keytruda,35.36,37.23,906.55,99,Stable Disease
M211551,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.13,53.95,1433.31,104,Stable Disease
M211552,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.05,29.0,709.45,83,
M211553,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.9,85.92,765.77,89,Progression
M211554,34,Other,HPV-related Cancer,mrna-4157 + keytruda,62.88,47.49,1061.99,83,Partial Response
M211555,69,Female,Melanoma,mrna-4157 + keytruda,83.22,65.54,896.42,80,Partial Response
M211556,42,Female,Melanoma,KEYTRUDA only,33.08,29.48,1256.71,107,Partial Response
M211557,80,Female,Melanoma,mrna-4157 + keytruda,42.86,32.25,1178.68,87,Progression
M211558,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.85,34.97,1034.59,99,Partial Response
M211559,34,Other,HPV-related Cancer,mrna-4157 + keytruda,47.14,26.27,1414.53,88,Partial Response
M211560,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.98,63.89,869.62,79,Partial Response
M211561,33,Female,Melanoma,mrna-4157 + keytruda,28.51,24.71,,86,Progression
M211562,47,Male,HPV-related Cancer,KEYTRUDA only,30.74,24.84,1187.49,84,
M211563,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.1,64.15,341.94,98,Partial Response
M211564,61,Other,HPV-related Cancer,KEYTRUDA only,77.73,81.44,561.97,88,Stable Disease
M211565,41,Other,HPV-related Cancer,KEYTRUDA only,39.19,31.35,492.44,106,Stable Disease
M211566,77,Male,Melanoma,mrna-4157 + keytruda,39.0,51.26,1384.72,90,Stable Disease
M211567,32,Female,Melanoma,mrna-4157 + keytruda,44.82,23.47,1756.88,83,Complete Response
M211568,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,27.63,23.6,1013.69,82,Stable Disease
M211569,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.02,32.18,1099.61,87,Complete Response
M211570,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.93,48.17,1435.13,93,Complete Response
M211571,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.36,31.08,829.29,82,Partial Response
M211572,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,93.3,62.09,952.04,83,Partial Response
M211573,35,Other,Melanoma,KEYTRUDA only,40.44,,1422.44,90,Partial Response
M211574,55,Other,HPV-related Cancer,mrna-4157 + keytruda,51.36,45.14,,85,Stable Disease
M211575,45,Female,Melanoma,KEYTRUDA only,60.85,30.31,1249.55,102,
M211576,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.96,17.69,1159.6,104,Progression
M211577,74,Female,HPV-related Cancer,mrna-4157 + keytruda,63.97,38.62,861.45,102,Partial Response
M211578,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.2,43.8,2107.83,80,Progression
M211579,82,Female,HPV-related Cancer,mrna-4157 + keytruda,-1.47,-1.27,1293.63,97,Partial Response
M211580,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.18,24.23,390.18,90,Complete Response
M211581,28,Other,Melanoma,mrna-4157 + keytruda,9.03,6.18,1224.05,87,Partial Response
M211582,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.15,31.93,731.42,101,Complete Response
M211583,59,Other,Melanoma,mrna-4157 + keytruda,49.86,38.12,923.31,100,Unknown
M211584,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.73,53.04,990.19,82,Stable Disease
M211585,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.3,36.65,1497.35,101,Partial Response
M211586,71,Female,HPV-related Cancer,mrna-4157 + keytruda,24.03,17.36,1259.98,73,Partial Response
M211587,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.28,28.74,208.65,90,
M211588,82,Other,Melanoma,mrna-4157 + keytruda,28.83,28.07,1246.6,91,Stable Disease
M211589,70,Female,Melanoma,mrna-4157 + keytruda,45.78,26.77,441.78,120,Progression
M211590,54,Male,Melanoma,mrna-4157 + keytruda,75.02,45.77,1986.21,78,Partial Response
M211591,63,Female,Melanoma,mrna-4157 + keytruda,22.0,26.58,765.83,72,Partial Response
M211592,63,Female,HPV-related Cancer,mrna-4157 + keytruda,39.72,26.31,1247.42,81,Partial Response
M211593,81,Male,Melanoma,mrna-4157 + keytruda,37.98,18.84,418.31,93,Stable Disease
M211594,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.59,24.11,968.25,101,Complete Response
M211595,52,Other,HPV-related Cancer,mrna-4157 + keytruda,33.2,29.91,,108,Progression
M211596,78,Male,Melanoma,KEYTRUDA only,37.21,23.66,1503.16,77,Complete Response
M211597,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.36,50.93,-151.69,94,Partial Response
M211598,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.57,27.57,779.94,85,Unknown
M211599,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.24,27.78,1012.18,90,Stable Disease
M211600,75,Other,Melanoma,mrna-4157 + keytruda,39.41,27.41,1183.99,92,Stable Disease
M211601,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,72.08,44.63,999.25,90,Progression
M211602,36,Male,Melanoma,KEYTRUDA only,23.35,25.06,,95,Partial Response
M211603,43,Female,Melanoma,KEYTRUDA only,8.59,6.28,1276.41,86,Partial Response
M211604,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.43,18.56,,84,Stable Disease
M211605,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.62,40.46,1042.03,88,Progression
M211606,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.01,48.37,278.62,118,Stable Disease
M211607,37,Other,HPV-related Cancer,KEYTRUDA only,81.03,35.78,,77,Complete Response
M211608,44,Male,Melanoma,KEYTRUDA only,30.23,27.21,627.75,90,Unknown
M211609,47,Female,HPV-related Cancer,mrna-4157 + keytruda,38.2,24.53,452.3,90,Progression
M211610,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.29,21.6,735.62,79,Unknown
M211611,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.34,24.23,1197.76,91,Stable Disease
M211612,30,Male,HPV-related Cancer,mrna-4157 + keytruda,43.88,39.45,1118.15,88,Complete Response
M211613,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.78,51.66,1120.54,81,Complete Response
M211614,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.22,29.99,1266.04,88,Unknown
M211615,34,Male,HPV-related Cancer,mrna-4157 + keytruda,24.39,19.99,954.69,82,Stable Disease
M211616,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.79,46.01,677.26,97,Partial Response
M211617,26,Other,HPV-related Cancer,KEYTRUDA only,64.53,59.23,511.57,83,
M211618,30,Other,HPV-related Cancer,KEYTRUDA only,81.45,79.73,1480.17,82,Stable Disease
M211619,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.37,60.69,429.99,81,Unknown
M211620,44,Male,Melanoma,mrna-4157 + keytruda,70.92,58.73,990.55,80,Stable Disease
M211621,79,Female,HPV-related Cancer,mrna-4157 + keytruda,56.36,29.15,1341.08,102,Stable Disease
M211622,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.49,33.44,463.28,81,Partial Response
M211623,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.75,40.79,1636.81,87,Stable Disease
M211624,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.7,16.93,2062.9,90,Partial Response
M211625,44,Female,HPV-related Cancer,mrna-4157 + keytruda,46.96,15.41,1013.38,100,Stable Disease
M211626,52,Other,Melanoma,mrna-4157 + keytruda,61.09,64.08,457.31,94,Partial Response
M211627,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,28.74,21.09,499.01,81,Partial Response
M211628,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,76.21,70.33,1533.83,86,Partial Response
M211629,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.56,40.47,1103.23,105,
M211630,65,Female,Melanoma,mrna-4157 + keytruda,60.92,56.13,1223.48,80,Progression
M211631,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.23,22.59,1212.31,79,Stable Disease
M211632,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.2,52.29,1523.77,89,
M211633,69,Other,HPV-related Cancer,KEYTRUDA only,50.03,44.33,1514.48,93,Complete Response
M211634,82,Other,Melanoma,mrna-4157 + keytruda,70.67,52.41,1044.71,87,Stable Disease
M211635,43,Female,Melanoma,KEYTRUDA only,49.66,34.66,1386.26,80,Partial Response
M211636,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.12,56.17,765.58,107,
M211637,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.96,13.58,,90,Stable Disease
M211638,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.46,54.39,895.52,103,Progression
M211639,26,Female,Melanoma,mrna-4157 + keytruda,51.65,51.76,1067.34,104,Partial Response
M211640,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,33.83,25.19,824.05,100,Unknown
M211641,84,Female,HPV-related Cancer,mrna-4157 + keytruda,79.03,33.68,907.6,84,Partial Response
M211642,54,Other,HPV-related Cancer,mrna-4157 + keytruda,53.67,,951.89,91,Stable Disease
M211643,63,Male,HPV-related Cancer,mrna-4157 + keytruda,55.34,43.79,638.43,87,
M211644,30,Female,Melanoma,mrna-4157 + keytruda,64.82,65.97,814.03,98,Partial Response
M211645,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.64,48.36,1037.28,103,Progression
M211646,59,Female,Melanoma,mrna-4157 + keytruda,47.67,,1244.85,83,Partial Response
M211647,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.76,26.95,983.51,72,Partial Response
M211648,82,Other,Melanoma,mrna-4157 + keytruda,19.11,13.45,729.61,98,Partial Response
M211649,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.73,48.6,1349.08,87,Stable Disease
M211650,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.1,45.69,569.87,96,Progression
M211651,25,Female,HPV-related Cancer,KEYTRUDA only,38.03,45.15,550.18,108,Partial Response
M211652,79,Other,HPV-related Cancer,mrna-4157 + keytruda,62.26,49.86,1216.97,85,Progression
M211653,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,65.37,79.13,1704.34,77,
M211654,66,Other,HPV-related Cancer,KEYTRUDA only,31.38,30.55,1174.49,78,Progression
M211655,58,Male,HPV-related Cancer,KEYTRUDA only,19.28,,1545.65,97,Partial Response
M211656,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.86,35.04,1160.16,74,
M211657,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,78.4,46.96,1239.87,87,Stable Disease
M211658,26,Other,HPV-related Cancer,KEYTRUDA only,77.66,21.66,,89,Partial Response
M211659,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.21,54.45,1193.71,109,Stable Disease
M211660,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.47,,936.4,87,Stable Disease
M211661,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,33.53,34.47,372.61,86,Partial Response
M211662,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.42,94.37,438.51,88,Stable Disease
M211663,26,Other,Melanoma,mrna-4157 + keytruda,2.95,1.49,1314.75,79,Stable Disease
M211664,31,Female,HPV-related Cancer,mrna-4157 + keytruda,66.98,36.35,1255.76,76,Partial Response
M211665,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.73,31.35,967.24,72,Progression
M211666,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.1,69.99,1400.37,87,Progression
M211667,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.35,49.95,781.76,101,Partial Response
M211668,73,Other,HPV-related Cancer,mrna-4157 + keytruda,74.04,59.19,756.95,85,Partial Response
M211669,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.06,36.29,510.2,88,Stable Disease
M211670,74,Female,HPV-related Cancer,mrna-4157 + keytruda,49.25,44.65,973.59,82,Stable Disease
M211671,78,Female,Melanoma,mrna-4157 + keytruda,38.16,34.91,646.69,84,Progression
M211672,43,Male,Melanoma,mrna-4157 + keytruda,51.8,46.58,872.61,92,Progression
M211673,38,Other,HPV-related Cancer,KEYTRUDA only,26.9,24.45,279.17,86,Complete Response
M211674,72,Female,Melanoma,KEYTRUDA only,58.32,31.95,820.64,97,Stable Disease
M211675,68,Male,Melanoma,mrna-4157 + keytruda,11.91,10.84,769.08,82,Stable Disease
M211676,50,Male,HPV-related Cancer,mrna-4157 + keytruda,54.45,46.99,1828.5,89,Partial Response
M211677,63,Female,HPV-related Cancer,mrna-4157 + keytruda,29.2,30.54,1217.87,90,Partial Response
M211678,25,Male,Melanoma,mrna-4157 + keytruda,14.86,10.85,1120.15,88,Partial Response
M211679,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.72,32.53,614.7,88,Progression
M211680,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.07,,868.88,90,Stable Disease
M211681,31,Female,Melanoma,KEYTRUDA only,25.47,17.82,956.12,90,Stable Disease
M211682,59,Female,Melanoma,KEYTRUDA only,48.25,34.1,1281.33,94,Partial Response
M211683,43,Other,HPV-related Cancer,mrna-4157 + keytruda,47.29,26.04,963.07,96,Partial Response
M211684,75,Male,HPV-related Cancer,mrna-4157 + keytruda,57.28,56.71,,92,Complete Response
M211685,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.55,16.58,245.09,96,Partial Response
M211686,58,Female,HPV-related Cancer,mrna-4157 + keytruda,61.73,47.7,774.38,88,Progression
M211687,47,Female,Melanoma,KEYTRUDA only,22.36,20.71,764.08,88,Partial Response
M211688,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.88,26.73,426.1,82,Stable Disease
M211689,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.6,35.96,938.09,94,Progression
M211690,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.3,29.74,1164.77,101,Complete Response
M211691,60,Female,HPV-related Cancer,mrna-4157 + keytruda,53.62,38.34,1253.6,97,Partial Response
M211692,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.7,41.64,1144.83,90,Partial Response
M211693,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.84,29.7,1374.32,97,Stable Disease
M211694,79,Other,Melanoma,KEYTRUDA only,35.35,26.55,776.79,92,Stable Disease
M211695,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.57,27.41,872.45,76,Progression
M211696,57,Male,Melanoma,KEYTRUDA only,14.38,16.04,,103,Partial Response
M211697,49,Other,Melanoma,KEYTRUDA only,67.24,65.11,952.35,97,
M211698,69,Female,HPV-related Cancer,KEYTRUDA only,56.03,54.17,984.02,86,Progression
M211699,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.15,14.86,791.94,98,Stable Disease
M211700,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.59,12.28,2066.36,100,Partial Response
M211701,55,Other,Melanoma,mrna-4157 + keytruda,52.28,36.55,1277.8,101,Stable Disease
M211702,51,Female,Melanoma,mrna-4157 + keytruda,52.19,40.66,225.92,103,
M211703,61,Female,HPV-related Cancer,KEYTRUDA only,73.12,41.52,709.79,98,Partial Response
M211704,68,Female,Melanoma,KEYTRUDA only,70.59,54.07,538.36,80,Partial Response
M211705,61,Other,HPV-related Cancer,mrna-4157 + keytruda,52.95,36.94,907.48,94,Progression
M211706,57,Female,HPV-related Cancer,mrna-4157 + keytruda,51.67,37.97,1255.54,87,Stable Disease
M211707,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,24.04,19.79,1245.61,77,Progression
M211708,44,Female,Melanoma,mrna-4157 + keytruda,27.12,25.29,904.9,86,
M211709,54,Male,Melanoma,mrna-4157 + keytruda,111.86,82.32,1553.53,95,Progression
M211710,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.66,70.25,,97,Partial Response
M211711,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.63,49.93,493.12,93,Partial Response
M211712,65,Other,HPV-related Cancer,mrna-4157 + keytruda,45.15,37.52,505.89,96,Unknown
M211713,73,Female,HPV-related Cancer,mrna-4157 + keytruda,79.8,59.57,,82,Partial Response
M211714,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,92.48,91.27,633.36,81,Partial Response
M211715,31,Female,HPV-related Cancer,KEYTRUDA only,22.88,14.07,1458.45,98,
M211716,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,84.94,92.44,732.38,95,Stable Disease
M211717,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.68,47.88,,110,Stable Disease
M211718,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,25.96,21.89,725.19,94,Progression
M211719,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.27,45.99,1389.59,82,Stable Disease
M211720,66,Other,Melanoma,mrna-4157 + keytruda,53.27,41.64,954.87,109,
M211721,32,Female,Melanoma,KEYTRUDA only,21.36,15.02,1359.5,77,Progression
M211722,62,Male,HPV-related Cancer,mrna-4157 + keytruda,39.09,23.78,1497.42,84,Stable Disease
M211723,40,Female,Melanoma,mrna-4157 + keytruda,70.56,58.9,466.12,85,Complete Response
M211724,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,91.0,63.48,,92,Partial Response
M211725,44,Other,Melanoma,KEYTRUDA only,67.25,59.41,1063.47,81,Partial Response
M211726,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,105.9,94.94,607.57,93,Partial Response
M211727,75,Male,HPV-related Cancer,KEYTRUDA only,37.57,25.9,1522.53,101,Stable Disease
M211728,48,Male,HPV-related Cancer,KEYTRUDA only,65.5,66.67,766.97,93,Unknown
M211729,83,Female,HPV-related Cancer,KEYTRUDA only,53.39,48.26,1354.32,77,Stable Disease
M211730,56,Male,Melanoma,KEYTRUDA only,56.02,64.47,954.0,86,Stable Disease
M211731,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.57,50.24,1388.15,74,Complete Response
M211732,81,Female,HPV-related Cancer,KEYTRUDA only,40.21,42.38,724.01,83,Partial Response
M211733,28,Male,HPV-related Cancer,KEYTRUDA only,71.62,63.04,1106.48,95,Stable Disease
M211734,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.9,25.33,461.78,102,Partial Response
M211735,52,Female,HPV-related Cancer,mrna-4157 + keytruda,49.14,53.95,1676.38,79,Partial Response
M211736,59,Female,HPV-related Cancer,KEYTRUDA only,42.74,28.31,862.22,102,Partial Response
M211737,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,16.9,21.04,525.39,111,Partial Response
M211738,71,Male,Melanoma,KEYTRUDA only,24.44,19.48,1246.95,81,Partial Response
M211739,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.11,49.98,926.22,97,Stable Disease
M211740,58,Female,Melanoma,KEYTRUDA only,21.2,19.01,722.05,83,Unknown
M211741,78,Other,HPV-related Cancer,mrna-4157 + keytruda,23.68,12.94,1155.45,90,Partial Response
M211742,33,Male,Melanoma,mrna-4157 + keytruda,53.49,44.75,751.69,89,Partial Response
M211743,36,Female,Melanoma,mrna-4157 + keytruda,46.76,33.27,942.11,107,Complete Response
M211744,58,Female,HPV-related Cancer,mrna-4157 + keytruda,81.05,52.98,,84,Stable Disease
M211745,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.69,18.58,576.76,96,Progression
M211746,27,Male,Melanoma,mrna-4157 + keytruda,26.59,23.24,826.62,96,Partial Response
M211747,43,Female,HPV-related Cancer,mrna-4157 + keytruda,45.43,26.67,1146.56,96,Unknown
M211748,62,Female,Melanoma,KEYTRUDA only,74.77,57.28,1328.59,95,Partial Response
M211749,49,Female,Melanoma,mrna-4157 + keytruda,74.21,58.58,655.83,103,Stable Disease
M211750,66,Other,HPV-related Cancer,mrna-4157 + keytruda,22.46,26.78,786.81,84,Stable Disease
M211751,60,Male,HPV-related Cancer,KEYTRUDA only,33.02,31.07,684.93,91,Complete Response
M211752,31,Other,HPV-related Cancer,mrna-4157 + keytruda,60.03,49.29,981.62,82,Progression
M211753,55,Male,HPV-related Cancer,mrna-4157 + keytruda,66.58,,1662.61,108,Stable Disease
M211754,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,6.4,6.84,,94,Complete Response
M211755,62,Other,HPV-related Cancer,KEYTRUDA only,34.71,21.75,621.66,90,Partial Response
M211756,72,Male,Melanoma,mrna-4157 + keytruda,61.42,40.75,362.04,92,Stable Disease
M211757,76,Male,Melanoma,mrna-4157 + keytruda,48.59,35.0,1221.86,78,Stable Disease
M211758,28,Male,HPV-related Cancer,mrna-4157 + keytruda,44.28,35.85,748.13,93,Stable Disease
M211759,38,Male,HPV-related Cancer,KEYTRUDA only,45.28,35.94,1114.78,94,Stable Disease
M211760,76,Female,HPV-related Cancer,mrna-4157 + keytruda,59.58,32.51,1440.93,106,Progression
M211761,66,Other,HPV-related Cancer,KEYTRUDA only,20.88,16.91,1333.31,69,Stable Disease
M211762,58,Other,Melanoma,mrna-4157 + keytruda,76.86,66.74,1112.79,96,Partial Response
M211763,25,Male,Melanoma,mrna-4157 + keytruda,66.9,42.83,880.85,87,Progression
M211764,25,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.28,10.84,1454.6,88,Complete Response
M211765,59,Female,Melanoma,mrna-4157 + keytruda,56.25,35.26,,85,Stable Disease
M211766,79,Female,Melanoma,KEYTRUDA only,77.97,85.5,938.17,92,Stable Disease
M211767,81,Female,HPV-related Cancer,KEYTRUDA only,0.28,0.28,547.97,94,Stable Disease
M211768,78,Male,HPV-related Cancer,KEYTRUDA only,11.04,6.33,,96,Progression
M211769,57,Male,Melanoma,KEYTRUDA only,42.41,26.6,1570.67,95,Complete Response
M211770,67,Other,HPV-related Cancer,mrna-4157 + keytruda,66.32,39.48,953.77,90,Complete Response
M211771,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.08,20.36,822.02,84,Partial Response
M211772,39,Male,HPV-related Cancer,KEYTRUDA only,38.38,29.29,1613.09,75,Progression
M211773,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,103.13,77.2,775.79,100,Complete Response
M211774,38,Male,HPV-related Cancer,mrna-4157 + keytruda,58.02,50.87,1018.23,97,
M211775,36,Male,Melanoma,mrna-4157 + keytruda,64.94,64.06,1290.12,115,Partial Response
M211776,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,61.73,33.54,1146.67,75,Progression
M211777,58,Male,HPV-related Cancer,mrna-4157 + keytruda,57.01,53.57,,98,Unknown
M211778,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.19,25.11,893.74,95,Progression
M211779,68,Male,HPV-related Cancer,mrna-4157 + keytruda,52.39,49.44,534.44,98,Progression
M211780,47,Female,Melanoma,mrna-4157 + keytruda,69.33,43.51,1114.72,106,Progression
M211781,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.96,34.54,1305.83,98,Partial Response
M211782,61,Female,Melanoma,mrna-4157 + keytruda,54.34,25.09,737.17,83,Stable Disease
M211783,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.85,52.08,735.36,95,Stable Disease
M211784,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,11.1,12.76,884.38,86,Stable Disease
M211785,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,76.31,94.41,1073.05,77,Unknown
M211786,59,Other,HPV-related Cancer,KEYTRUDA only,32.2,27.15,912.33,82,Partial Response
M211787,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.74,60.13,1163.5,81,Partial Response
M211788,30,Male,HPV-related Cancer,KEYTRUDA only,64.3,,878.75,88,Partial Response
M211789,55,Female,Melanoma,mrna-4157 + keytruda,25.4,23.66,855.87,78,Stable Disease
M211790,49,Other,Melanoma,mrna-4157 + keytruda,57.33,48.76,1191.26,87,Unknown
M211791,79,Male,HPV-related Cancer,mrna-4157 + keytruda,33.94,36.15,674.62,104,Partial Response
M211792,83,Other,Melanoma,KEYTRUDA only,52.78,47.26,,81,Progression
M211793,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.37,34.82,975.29,89,Partial Response
M211794,42,Other,Melanoma,KEYTRUDA only,31.63,20.12,1025.44,102,Partial Response
M211795,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.24,24.11,,94,Stable Disease
M211796,70,Female,HPV-related Cancer,mrna-4157 + keytruda,82.1,59.3,913.06,91,Progression
M211797,82,Female,Melanoma,KEYTRUDA only,56.59,57.63,1185.8,85,Stable Disease
M211798,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,64.89,57.89,967.15,84,Complete Response
M211799,67,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.35,66.57,1423.03,98,Complete Response
M211800,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.21,32.82,1135.48,81,Stable Disease
M211801,56,Other,HPV-related Cancer,mrna-4157 + keytruda,70.48,54.76,1138.56,89,Partial Response
M211802,30,Male,Melanoma,KEYTRUDA only,21.4,12.7,573.6,99,Progression
M211803,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.03,38.83,636.67,80,Complete Response
M211804,39,Female,Melanoma,mrna-4157 + keytruda,57.71,28.22,1046.84,102,Stable Disease
M211805,43,Male,Melanoma,KEYTRUDA only,50.66,24.35,1052.77,90,Complete Response
M211806,30,Female,Melanoma,mrna-4157 + keytruda,59.21,46.08,905.77,78,Complete Response
M211807,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.22,41.92,1146.66,93,Partial Response
M211808,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.38,41.18,993.2,103,Partial Response
M211809,55,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.11,27.63,784.83,88,Progression
M211810,61,Female,Melanoma,mrna-4157 + keytruda,29.37,29.34,734.56,90,
M211811,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,33.54,,252.69,111,Partial Response
M211812,54,Male,HPV-related Cancer,mrna-4157 + keytruda,43.33,40.27,1185.7,96,Partial Response
M211813,63,Male,HPV-related Cancer,mrna-4157 + keytruda,62.54,59.58,575.58,83,Complete Response
M211814,69,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.1,27.1,413.0,87,Stable Disease
M211815,63,Male,Melanoma,KEYTRUDA only,18.92,13.34,1811.01,85,Stable Disease
M211816,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,74.18,41.65,1283.38,95,Partial Response
M211817,79,Female,Melanoma,mrna-4157 + keytruda,60.77,57.08,1138.6,80,Complete Response
M211818,41,Male,Melanoma,mrna-4157 + keytruda,20.87,17.38,1177.91,95,Progression
M211819,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.2,35.8,1175.46,98,Complete Response
M211820,32,Other,HPV-related Cancer,mrna-4157 + keytruda,43.63,43.61,742.48,91,Partial Response
M211821,57,Other,Melanoma,mrna-4157 + keytruda,33.4,28.21,675.36,92,Progression
M211822,29,Other,Melanoma,mrna-4157 + keytruda,94.17,60.64,750.69,95,Unknown
M211823,73,Male,HPV-related Cancer,mrna-4157 + keytruda,23.12,18.4,1806.82,94,Partial Response
M211824,74,Female,HPV-related Cancer,KEYTRUDA only,36.81,38.53,2087.71,89,Progression
M211825,79,Female,Melanoma,mrna-4157 + keytruda,56.95,37.43,923.73,84,
M211826,37,Other,HPV-related Cancer,mrna-4157 + keytruda,54.91,29.37,924.2,79,Stable Disease
M211827,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.68,12.28,1241.97,84,Partial Response
M211828,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,25.25,19.44,1229.79,89,Stable Disease
M211829,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.41,27.58,820.97,85,Stable Disease
M211830,78,Female,Melanoma,KEYTRUDA only,47.44,13.67,952.64,68,Partial Response
M211831,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,51.17,50.42,695.25,90,Partial Response
M211832,26,Other,Melanoma,mrna-4157 + keytruda,22.76,23.48,839.33,99,Complete Response
M211833,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.57,46.52,1005.78,91,Partial Response
M211834,30,Female,Melanoma,KEYTRUDA only,74.82,56.97,256.76,99,Complete Response
M211835,66,Other,HPV-related Cancer,mrna-4157 + keytruda,22.35,9.0,710.8,95,Progression
M211836,76,Male,Melanoma,KEYTRUDA only,87.16,86.34,1519.08,103,
M211837,61,Other,HPV-related Cancer,mrna-4157 + keytruda,46.08,58.77,162.03,82,Stable Disease
M211838,82,Female,Melanoma,mrna-4157 + keytruda,40.2,21.99,1135.55,80,Progression
M211839,78,Male,Melanoma,mrna-4157 + keytruda,38.48,31.98,1350.38,91,Partial Response
M211840,58,Female,Melanoma,KEYTRUDA only,23.47,12.17,1230.41,96,Complete Response
M211841,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.65,51.92,286.95,98,Progression
M211842,79,Male,Melanoma,mrna-4157 + keytruda,56.81,58.47,275.04,84,Partial Response
M211843,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.96,21.71,86.54,96,Stable Disease
M211844,45,Other,HPV-related Cancer,mrna-4157 + keytruda,70.88,60.68,1080.94,96,Stable Disease
M211845,26,Female,Melanoma,KEYTRUDA only,32.91,19.33,567.13,80,Stable Disease
M211846,42,Other,Melanoma,mrna-4157 + keytruda,42.37,35.47,659.91,104,Progression
M211847,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,30.19,25.12,921.8,82,Stable Disease
M211848,79,Other,HPV-related Cancer,KEYTRUDA only,25.38,10.2,,79,Progression
M211849,59,Other,Melanoma,mrna-4157 + keytruda,24.15,22.61,891.48,115,Progression
M211850,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.07,78.21,888.74,97,Progression
M211851,52,Other,Melanoma,mrna-4157 + keytruda,62.08,53.3,848.31,93,
M211852,42,Other,HPV-related Cancer,KEYTRUDA only,64.08,27.82,835.82,75,Complete Response
M211853,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,9.02,8.17,855.14,108,Progression
M211854,27,Male,Melanoma,mrna-4157 + keytruda,11.11,9.61,762.25,103,Stable Disease
M211855,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,60.31,56.86,65.66,96,Partial Response
M211856,51,Other,Melanoma,mrna-4157 + keytruda,45.64,55.83,570.63,93,Unknown
M211857,84,Female,HPV-related Cancer,mrna-4157 + keytruda,29.91,22.82,1289.88,90,Progression
M211858,77,Female,Melanoma,mrna-4157 + keytruda,38.79,32.99,1156.77,86,Complete Response
M211859,74,Female,HPV-related Cancer,KEYTRUDA only,22.95,15.06,593.94,71,Partial Response
M211860,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.37,50.91,455.86,89,Complete Response
M211861,29,Female,HPV-related Cancer,mrna-4157 + keytruda,50.95,47.94,1607.82,82,Stable Disease
M211862,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.1,33.8,1293.94,82,Stable Disease
M211863,31,Other,HPV-related Cancer,KEYTRUDA only,92.26,64.87,338.41,83,
M211864,50,Male,Melanoma,KEYTRUDA only,23.45,,1541.67,102,Progression
M211865,68,Male,HPV-related Cancer,mrna-4157 + keytruda,91.55,77.27,1322.28,77,Progression
M211866,31,Male,Melanoma,KEYTRUDA only,59.53,43.58,1533.39,98,Progression
M211867,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.12,26.25,651.48,89,Progression
M211868,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.1,43.48,588.87,88,Stable Disease
M211869,59,Female,HPV-related Cancer,KEYTRUDA only,77.21,72.94,565.6,98,Progression
M211870,44,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.16,29.97,1410.18,100,Unknown
M211871,27,Other,Melanoma,mrna-4157 + keytruda,78.81,70.67,1085.42,93,Progression
M211872,44,Male,Melanoma,KEYTRUDA only,61.26,21.27,509.24,100,Partial Response
M211873,62,Male,Melanoma,mrna-4157 + keytruda,58.93,64.41,1234.94,94,Complete Response
M211874,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.76,35.08,1181.67,81,Stable Disease
M211875,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,10.78,8.04,892.11,86,Complete Response
M211876,25,Male,Melanoma,mrna-4157 + keytruda,45.02,,1617.99,84,Unknown
M211877,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.58,55.75,1535.4,97,Complete Response
M211878,72,Other,Melanoma,KEYTRUDA only,50.85,,299.73,83,Stable Disease
M211879,70,Other,Melanoma,mrna-4157 + keytruda,48.15,64.4,850.75,91,Partial Response
M211880,28,Male,Melanoma,KEYTRUDA only,110.38,77.13,1096.57,91,Complete Response
M211881,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.18,,1125.0,95,Partial Response
M211882,80,Other,Melanoma,mrna-4157 + keytruda,27.77,18.44,286.14,108,Stable Disease
M211883,73,Female,Melanoma,mrna-4157 + keytruda,83.16,84.65,869.21,80,Stable Disease
M211884,84,Female,Melanoma,mrna-4157 + keytruda,40.51,36.18,947.77,79,Partial Response
M211885,36,Female,Melanoma,mrna-4157 + keytruda,64.4,,1438.54,108,Partial Response
M211886,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.24,38.12,1744.52,93,Complete Response
M211887,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.34,33.99,928.26,88,Progression
M211888,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.86,,939.0,91,Progression
M211889,78,Other,Melanoma,mrna-4157 + keytruda,30.93,22.96,213.51,91,Stable Disease
M211890,71,Other,HPV-related Cancer,mrna-4157 + keytruda,28.03,16.47,503.75,89,Partial Response
M211891,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.52,45.1,874.7,95,Complete Response
M211892,33,Female,Melanoma,mrna-4157 + keytruda,59.91,53.85,828.27,91,Unknown
M211893,29,Female,HPV-related Cancer,KEYTRUDA only,38.77,36.53,1024.71,81,Stable Disease
M211894,47,Other,HPV-related Cancer,KEYTRUDA only,67.65,48.3,1306.2,114,Stable Disease
M211895,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.47,53.33,938.4,86,Complete Response
M211896,82,Female,Melanoma,mrna-4157 + keytruda,94.28,100.36,1148.72,88,Stable Disease
M211897,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.85,41.21,1266.15,69,Complete Response
M211898,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.65,45.45,1374.72,82,Partial Response
M211899,27,Female,HPV-related Cancer,mrna-4157 + keytruda,78.87,,840.8,74,Complete Response
M211900,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.99,45.27,1222.05,93,Progression
M211901,83,Other,Melanoma,mrna-4157 + keytruda,41.0,39.88,808.37,99,Stable Disease
M211902,58,Other,Melanoma,mrna-4157 + keytruda,78.84,66.17,,101,Stable Disease
M211903,63,Other,Melanoma,KEYTRUDA only,36.94,31.62,61.56,89,Progression
M211904,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.69,16.13,818.43,70,Partial Response
M211905,33,Male,HPV-related Cancer,mrna-4157 + keytruda,73.3,55.56,606.07,91,Stable Disease
M211906,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.88,33.65,,92,Stable Disease
M211907,36,Female,Melanoma,KEYTRUDA only,70.7,72.15,1062.73,104,Partial Response
M211908,60,Female,HPV-related Cancer,KEYTRUDA only,36.15,22.77,1055.1,96,Partial Response
M211909,47,Male,HPV-related Cancer,mrna-4157 + keytruda,65.01,44.79,634.17,105,Partial Response
M211910,40,Other,HPV-related Cancer,mrna-4157 + keytruda,51.99,26.54,958.95,89,Stable Disease
M211911,57,Male,Melanoma,KEYTRUDA only,53.3,48.8,1122.02,80,Progression
M211912,79,Female,Melanoma,KEYTRUDA only,38.45,26.68,634.78,85,Stable Disease
M211913,66,Female,Melanoma,KEYTRUDA only,73.46,89.35,945.2,109,Stable Disease
M211914,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.08,67.06,894.07,88,Complete Response
M211915,60,Other,HPV-related Cancer,mrna-4157 + keytruda,25.77,21.26,1044.27,92,Partial Response
M211916,63,Other,Melanoma,KEYTRUDA only,67.57,49.6,387.86,88,Progression
M211917,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.38,51.74,-5.77,82,Unknown
M211918,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.95,60.25,886.74,85,Progression
M211919,82,Other,HPV-related Cancer,KEYTRUDA only,22.77,24.73,935.86,76,Partial Response
M211920,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.29,96.65,622.22,99,Stable Disease
M211921,28,Female,Melanoma,mrna-4157 + keytruda,64.86,53.93,1575.39,77,Partial Response
M211922,56,Other,Melanoma,mrna-4157 + keytruda,39.15,35.55,1237.27,85,Progression
M211923,47,Male,Melanoma,KEYTRUDA only,16.86,15.82,1895.56,102,Partial Response
M211924,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,20.27,13.88,1263.29,95,Partial Response
M211925,45,Other,Melanoma,mrna-4157 + keytruda,63.82,46.08,2489.24,97,Progression
M211926,61,Female,Melanoma,KEYTRUDA only,40.32,30.79,1846.89,91,Progression
M211927,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.27,35.16,1204.33,82,Partial Response
M211928,55,Female,HPV-related Cancer,mrna-4157 + keytruda,76.89,61.43,771.87,94,Progression
M211929,58,Male,HPV-related Cancer,KEYTRUDA only,83.74,73.98,1434.72,92,
M211930,83,Female,Melanoma,mrna-4157 + keytruda,36.74,20.03,404.72,95,Partial Response
M211931,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.17,57.66,513.82,99,
M211932,34,Male,Melanoma,mrna-4157 + keytruda,59.51,52.83,816.8,83,Complete Response
M211933,75,Other,HPV-related Cancer,mrna-4157 + keytruda,46.27,47.72,730.42,93,Stable Disease
M211934,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.15,77.7,1018.36,91,Progression
M211935,61,Female,Melanoma,KEYTRUDA only,35.46,26.45,1024.86,81,Partial Response
M211936,25,Other,HPV-related Cancer,mrna-4157 + keytruda,59.26,30.05,1095.36,101,Complete Response
M211937,78,Male,Melanoma,mrna-4157 + keytruda,15.08,9.31,516.94,88,Partial Response
M211938,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.39,,32.62,96,
M211939,76,Female,HPV-related Cancer,KEYTRUDA only,89.4,79.31,1548.84,105,Partial Response
M211940,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.25,59.37,1291.88,71,
M211941,42,Other,HPV-related Cancer,mrna-4157 + keytruda,35.16,28.79,480.8,96,Partial Response
M211942,50,Female,HPV-related Cancer,KEYTRUDA only,30.75,,91.69,77,Partial Response
M211943,46,Female,Melanoma,KEYTRUDA only,36.36,33.47,1192.24,97,Stable Disease
M211944,68,Female,Melanoma,mrna-4157 + keytruda,68.71,,739.35,86,Stable Disease
M211945,44,Female,Melanoma,mrna-4157 + keytruda,52.83,33.69,1069.59,79,Partial Response
M211946,60,Male,Melanoma,KEYTRUDA only,26.29,29.09,615.4,103,Partial Response
M211947,57,Male,Melanoma,KEYTRUDA only,75.66,59.8,1369.54,104,Partial Response
M211948,48,Female,HPV-related Cancer,mrna-4157 + keytruda,42.01,45.9,880.03,92,Complete Response
M211949,60,Male,Melanoma,mrna-4157 + keytruda,57.21,,1273.27,87,Partial Response
M211950,63,Male,HPV-related Cancer,mrna-4157 + keytruda,40.77,32.83,183.28,126,Complete Response
M211951,27,Male,Melanoma,KEYTRUDA only,76.98,91.54,745.31,106,Progression
M211952,43,Female,HPV-related Cancer,mrna-4157 + keytruda,34.62,15.38,510.36,93,Stable Disease
M211953,83,Female,Melanoma,mrna-4157 + keytruda,58.06,42.19,826.26,91,Partial Response
M211954,63,Other,HPV-related Cancer,mrna-4157 + keytruda,68.2,58.81,440.23,108,Partial Response
M211955,79,Male,HPV-related Cancer,mrna-4157 + keytruda,44.83,35.79,1633.06,102,Stable Disease
M211956,34,Male,HPV-related Cancer,KEYTRUDA only,55.55,49.04,1443.94,105,Complete Response
M211957,25,Female,HPV-related Cancer,mrna-4157 + keytruda,66.94,,1155.67,76,Stable Disease
M211958,61,Female,Melanoma,mrna-4157 + keytruda,32.02,18.18,501.49,87,Stable Disease
M211959,53,Male,Melanoma,mrna-4157 + keytruda,66.67,48.25,673.54,80,Stable Disease
M211960,69,Male,HPV-related Cancer,mrna-4157 + keytruda,36.44,19.66,1237.37,76,Complete Response
M211961,31,Male,HPV-related Cancer,mrna-4157 + keytruda,68.91,75.99,1321.88,83,Partial Response
M211962,61,Male,HPV-related Cancer,KEYTRUDA only,70.5,32.97,1193.24,107,Partial Response
M211963,73,Male,Melanoma,mrna-4157 + keytruda,73.53,39.04,835.42,96,Progression
M211964,44,Female,Melanoma,KEYTRUDA only,89.75,88.32,1279.21,108,Partial Response
M211965,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.48,16.77,1326.13,91,Partial Response
M211966,84,Other,Melanoma,KEYTRUDA only,14.23,10.08,1340.31,88,Partial Response
M211967,48,Other,HPV-related Cancer,mrna-4157 + keytruda,17.99,20.55,828.06,99,Stable Disease
M211968,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.19,38.99,1064.21,104,Stable Disease
M211969,51,Other,HPV-related Cancer,mrna-4157 + keytruda,33.22,29.97,1236.69,96,Complete Response
M211970,77,Male,HPV-related Cancer,mrna-4157 + keytruda,51.26,42.49,399.58,85,Stable Disease
M211971,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.32,46.48,1198.39,95,Stable Disease
M211972,70,Other,Melanoma,KEYTRUDA only,73.44,76.71,321.96,74,Complete Response
M211973,39,Other,HPV-related Cancer,KEYTRUDA only,36.3,32.16,840.19,94,Partial Response
M211974,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.55,26.95,833.51,96,Partial Response
M211975,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.98,37.7,,83,Partial Response
M211976,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.48,37.3,1030.92,95,Progression
M211977,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.39,37.25,1533.31,99,Partial Response
M211978,46,Other,HPV-related Cancer,mrna-4157 + keytruda,70.44,83.91,778.11,93,
M211979,48,Female,Melanoma,KEYTRUDA only,50.14,41.42,686.63,69,Progression
M211980,41,Male,HPV-related Cancer,mrna-4157 + keytruda,51.65,30.38,934.91,87,Partial Response
M211981,47,Other,HPV-related Cancer,KEYTRUDA only,66.83,65.01,1443.61,80,Partial Response
M211982,74,Male,Melanoma,KEYTRUDA only,60.29,47.05,392.92,93,Stable Disease
M211983,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.2,22.0,,96,Stable Disease
M211984,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.53,32.41,1086.39,75,Partial Response
M211985,62,Other,HPV-related Cancer,KEYTRUDA only,-2.56,-2.58,117.78,82,Stable Disease
M211986,59,Female,Melanoma,KEYTRUDA only,54.66,36.23,462.21,97,Progression
M211987,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.48,34.54,1162.41,97,Stable Disease
M211988,52,Female,Melanoma,mrna-4157 + keytruda,21.06,17.77,1189.32,101,Stable Disease
M211989,55,Other,HPV-related Cancer,mrna-4157 + keytruda,48.65,51.55,,86,Stable Disease
M211990,36,Female,HPV-related Cancer,mrna-4157 + keytruda,36.68,30.81,1047.78,85,Stable Disease
M211991,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.87,51.18,801.0,82,Progression
M211992,39,Other,Melanoma,mrna-4157 + keytruda,52.08,67.25,624.75,93,Partial Response
M211993,68,Other,Melanoma,KEYTRUDA only,20.11,12.28,1150.59,83,Complete Response
M211994,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.07,13.01,1549.13,93,Partial Response
M211995,74,Female,HPV-related Cancer,KEYTRUDA only,28.27,17.85,842.5,83,Partial Response
M211996,33,Male,Melanoma,mrna-4157 + keytruda,78.69,59.96,1076.11,104,Stable Disease
M211997,68,Other,Melanoma,KEYTRUDA only,100.25,58.57,638.47,89,Progression
M211998,34,Male,Melanoma,KEYTRUDA only,80.94,48.77,1102.37,81,Partial Response
M211999,40,Male,Melanoma,mrna-4157 + keytruda,26.98,26.55,919.32,96,Partial Response
M212000,71,Male,Melanoma,KEYTRUDA only,54.04,41.95,1130.05,76,Progression
M212001,46,Other,HPV-related Cancer,KEYTRUDA only,64.43,27.48,1038.8,88,Complete Response
M212002,47,Male,Melanoma,mrna-4157 + keytruda,64.61,66.16,1371.57,83,Partial Response
M212003,45,Male,HPV-related Cancer,mrna-4157 + keytruda,93.07,111.21,914.16,88,Progression
M212004,31,Female,Melanoma,KEYTRUDA only,28.56,28.1,1259.41,102,Progression
M212005,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.44,49.26,1178.68,74,Progression
M212006,81,Other,Melanoma,mrna-4157 + keytruda,16.56,14.27,1069.39,96,Partial Response
M212007,52,Other,Melanoma,KEYTRUDA only,23.05,21.41,1676.59,94,Stable Disease
M212008,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.65,39.14,564.57,77,Stable Disease
M212009,73,Female,HPV-related Cancer,mrna-4157 + keytruda,42.13,28.26,491.27,86,Progression
M212010,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.22,19.54,1340.86,95,Complete Response
M212011,27,Other,HPV-related Cancer,KEYTRUDA only,50.67,35.07,1096.7,86,Unknown
M212012,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.49,33.39,1976.1,93,Stable Disease
M212013,37,Male,HPV-related Cancer,mrna-4157 + keytruda,83.45,69.39,639.43,98,Partial Response
M212014,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.15,50.08,1441.39,108,
M212015,51,Female,HPV-related Cancer,mrna-4157 + keytruda,26.6,16.06,1069.5,95,Progression
M212016,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.57,41.96,986.66,100,Progression
M212017,48,Male,Melanoma,mrna-4157 + keytruda,52.51,64.86,637.16,76,Stable Disease
M212018,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.96,63.39,1018.67,95,Unknown
M212019,50,Other,Melanoma,mrna-4157 + keytruda,66.23,43.37,887.78,97,Progression
M212020,58,Other,HPV-related Cancer,KEYTRUDA only,81.55,46.27,848.64,92,Complete Response
M212021,27,Male,HPV-related Cancer,mrna-4157 + keytruda,50.33,40.21,1505.21,97,Complete Response
M212022,68,Other,HPV-related Cancer,mrna-4157 + keytruda,95.3,,,85,Partial Response
M212023,78,Other,Melanoma,KEYTRUDA only,50.74,36.35,1320.82,96,Unknown
M212024,27,Male,HPV-related Cancer,KEYTRUDA only,16.24,,1152.58,74,Stable Disease
M212025,68,Other,HPV-related Cancer,mrna-4157 + keytruda,41.96,32.5,1914.28,90,Partial Response
M212026,84,Female,HPV-related Cancer,mrna-4157 + keytruda,88.55,58.64,859.72,99,Partial Response
M212027,83,Male,Melanoma,mrna-4157 + keytruda,59.87,11.7,961.32,86,Stable Disease
M212028,40,Female,Melanoma,mrna-4157 + keytruda,31.57,30.64,995.98,89,Stable Disease
M212029,43,Other,Melanoma,mrna-4157 + keytruda,87.85,,711.4,91,Progression
M212030,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.08,20.21,1085.61,108,Complete Response
M212031,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,72.82,73.1,1208.98,110,Complete Response
M212032,82,Female,HPV-related Cancer,KEYTRUDA only,22.2,16.98,1280.04,97,Stable Disease
M212033,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.15,51.02,1245.26,95,Stable Disease
M212034,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.45,60.04,359.91,104,Stable Disease
M212035,34,Male,Melanoma,KEYTRUDA only,45.03,30.27,1093.57,93,Progression
M212036,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.02,40.76,1572.49,79,Complete Response
M212037,60,Other,HPV-related Cancer,mrna-4157 + keytruda,33.07,25.18,1438.62,73,Stable Disease
M212038,27,Male,HPV-related Cancer,KEYTRUDA only,43.47,33.81,1323.98,87,Partial Response
M212039,34,Male,Melanoma,mrna-4157 + keytruda,60.26,54.26,630.13,92,Progression
M212040,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,11.51,10.08,1336.34,84,Partial Response
M212041,78,Other,Melanoma,KEYTRUDA only,40.7,36.26,1175.1,99,Progression
M212042,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.64,67.95,1501.85,89,Partial Response
M212043,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.88,43.69,1163.62,85,Partial Response
M212044,40,Other,Melanoma,mrna-4157 + keytruda,64.75,46.7,263.83,89,Partial Response
M212045,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.15,56.86,1309.6,81,Stable Disease
M212046,67,Female,Melanoma,mrna-4157 + keytruda,46.69,,1476.21,107,Complete Response
M212047,53,Male,HPV-related Cancer,KEYTRUDA only,67.76,,1178.02,77,Progression
M212048,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,89.25,77.96,720.36,93,Partial Response
M212049,28,Female,HPV-related Cancer,KEYTRUDA only,31.13,24.06,1318.1,100,Partial Response
M212050,33,Female,Melanoma,KEYTRUDA only,53.81,33.78,1135.91,91,Stable Disease
M212051,64,Other,Melanoma,KEYTRUDA only,30.9,22.85,597.96,85,Stable Disease
M212052,27,Male,Melanoma,KEYTRUDA only,37.93,37.81,303.22,84,Stable Disease
M212053,38,Female,Melanoma,mrna-4157 + keytruda,35.1,33.9,,90,Unknown
M212054,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.1,24.71,359.55,92,Partial Response
M212055,28,Female,HPV-related Cancer,mrna-4157 + keytruda,50.42,36.74,1162.67,88,Progression
M212056,35,Female,HPV-related Cancer,KEYTRUDA only,56.12,33.33,781.78,71,
M212057,50,Other,Melanoma,mrna-4157 + keytruda,53.8,58.65,532.35,93,Stable Disease
M212058,38,Other,HPV-related Cancer,KEYTRUDA only,77.86,52.62,575.88,76,Progression
M212059,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.27,45.07,1403.95,70,Partial Response
M212060,46,Female,HPV-related Cancer,mrna-4157 + keytruda,26.33,16.24,1031.68,85,Stable Disease
M212061,44,Male,HPV-related Cancer,KEYTRUDA only,36.17,25.5,754.62,83,Partial Response
M212062,59,Female,HPV-related Cancer,KEYTRUDA only,56.61,49.0,1028.74,83,Progression
M212063,84,Male,Melanoma,mrna-4157 + keytruda,51.21,29.07,26.92,96,Complete Response
M212064,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.61,29.11,1221.64,94,Stable Disease
M212065,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,78.27,58.68,1242.62,80,Progression
M212066,78,Female,Melanoma,KEYTRUDA only,72.99,59.64,801.6,96,
M212067,25,Other,Melanoma,mrna-4157 + keytruda,40.68,23.59,1265.04,98,
M212068,48,Male,HPV-related Cancer,mrna-4157 + keytruda,92.75,74.36,853.15,89,Partial Response
M212069,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.25,37.88,1813.88,91,Partial Response
M212070,49,Male,HPV-related Cancer,mrna-4157 + keytruda,43.77,35.59,1510.95,90,Stable Disease
M212071,65,Other,HPV-related Cancer,mrna-4157 + keytruda,31.43,14.73,1326.33,112,Stable Disease
M212072,29,Other,Non-small Cell Lung Cancer,KEYTRUDA only,82.26,55.6,1555.07,85,Progression
M212073,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,60.86,37.92,947.85,95,Stable Disease
M212074,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.23,23.11,1366.47,84,Complete Response
M212075,73,Other,HPV-related Cancer,mrna-4157 + keytruda,35.28,18.98,135.56,105,Complete Response
M212076,61,Other,Melanoma,KEYTRUDA only,13.32,8.39,230.34,93,Partial Response
M212077,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.87,37.83,1287.08,89,Stable Disease
M212078,35,Male,HPV-related Cancer,KEYTRUDA only,37.15,30.62,1550.91,105,Partial Response
M212079,47,Other,Melanoma,mrna-4157 + keytruda,45.3,40.55,1346.21,73,Stable Disease
M212080,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.9,46.02,803.27,54,Partial Response
M212081,48,Female,Melanoma,KEYTRUDA only,-1.49,-1.01,1138.78,100,Partial Response
M212082,27,Female,Melanoma,mrna-4157 + keytruda,31.32,17.31,229.91,90,Unknown
M212083,67,Other,HPV-related Cancer,KEYTRUDA only,80.45,,925.35,94,Partial Response
M212084,67,Female,HPV-related Cancer,mrna-4157 + keytruda,18.01,14.29,1107.17,99,Partial Response
M212085,37,Male,HPV-related Cancer,mrna-4157 + keytruda,74.26,,1266.83,82,Complete Response
M212086,29,Other,HPV-related Cancer,mrna-4157 + keytruda,34.55,21.16,898.69,85,Partial Response
M212087,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.24,37.0,684.51,77,Partial Response
M212088,51,Female,Melanoma,mrna-4157 + keytruda,43.93,32.0,688.28,93,Complete Response
M212089,62,Other,HPV-related Cancer,mrna-4157 + keytruda,72.65,63.0,373.87,92,Progression
M212090,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.32,62.39,1145.85,85,Stable Disease
M212091,68,Female,HPV-related Cancer,mrna-4157 + keytruda,72.84,54.65,1125.88,91,Stable Disease
M212092,27,Male,HPV-related Cancer,KEYTRUDA only,47.81,32.47,971.98,87,Stable Disease
M212093,33,Female,Melanoma,mrna-4157 + keytruda,63.99,48.5,1032.35,88,
M212094,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.3,36.98,1444.0,98,Stable Disease
M212095,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.13,18.63,1205.6,83,Complete Response
M212096,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.66,27.25,806.77,100,Partial Response
M212097,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.98,89.75,823.86,90,Progression
M212098,49,Other,Melanoma,mrna-4157 + keytruda,42.45,39.05,319.93,113,Partial Response
M212099,49,Female,Melanoma,mrna-4157 + keytruda,47.01,47.84,887.9,75,Stable Disease
M212100,74,Female,HPV-related Cancer,mrna-4157 + keytruda,70.72,36.47,618.4,92,Partial Response
M212101,34,Female,Melanoma,KEYTRUDA only,38.8,27.47,1920.07,95,
M212102,48,Male,Melanoma,mrna-4157 + keytruda,59.55,77.09,313.5,90,Progression
M212103,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.53,51.85,1382.44,90,Progression
M212104,35,Female,Melanoma,mrna-4157 + keytruda,7.49,7.29,819.03,98,Stable Disease
M212105,57,Female,HPV-related Cancer,KEYTRUDA only,64.48,52.81,688.14,84,Progression
M212106,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.51,45.57,1327.94,94,Stable Disease
M212107,30,Female,Melanoma,mrna-4157 + keytruda,42.7,37.71,1185.85,88,Stable Disease
M212108,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.19,46.01,1550.58,89,Progression
M212109,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.97,22.62,1653.53,78,Stable Disease
M212110,53,Male,Melanoma,KEYTRUDA only,57.07,33.4,1299.63,82,Stable Disease
M212111,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.46,80.12,722.98,102,Progression
M212112,57,Other,HPV-related Cancer,KEYTRUDA only,22.62,18.89,710.53,101,Partial Response
M212113,49,Female,HPV-related Cancer,mrna-4157 + keytruda,64.05,45.11,968.11,88,Stable Disease
M212114,72,Other,Melanoma,mrna-4157 + keytruda,68.88,42.93,1427.01,91,Partial Response
M212115,48,Male,Melanoma,mrna-4157 + keytruda,40.41,24.07,785.31,99,Partial Response
M212116,78,Other,HPV-related Cancer,mrna-4157 + keytruda,40.27,9.43,1067.26,92,Stable Disease
M212117,66,Male,HPV-related Cancer,mrna-4157 + keytruda,44.16,22.85,1179.14,82,Stable Disease
M212118,53,Female,HPV-related Cancer,KEYTRUDA only,94.09,74.74,1305.06,93,Stable Disease
M212119,61,Male,Melanoma,KEYTRUDA only,51.59,16.12,1389.54,80,Partial Response
M212120,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.11,34.25,880.94,87,Partial Response
M212121,62,Male,HPV-related Cancer,mrna-4157 + keytruda,49.17,35.65,1454.2,85,Progression
M212122,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.32,28.34,869.09,91,Stable Disease
M212123,39,Male,Melanoma,KEYTRUDA only,67.88,42.07,104.41,103,Complete Response
M212124,82,Female,HPV-related Cancer,mrna-4157 + keytruda,49.25,51.02,820.57,91,Complete Response
M212125,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.13,41.16,1057.42,100,Progression
M212126,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.98,63.45,859.49,68,Progression
M212127,58,Male,HPV-related Cancer,KEYTRUDA only,81.38,85.34,1150.7,97,Progression
M212128,48,Other,Melanoma,KEYTRUDA only,42.89,40.45,1469.0,101,Progression
M212129,73,Female,Melanoma,mrna-4157 + keytruda,66.0,67.18,828.45,97,Complete Response
M212130,26,Female,HPV-related Cancer,KEYTRUDA only,66.17,44.3,1033.05,86,Complete Response
M212131,44,Other,HPV-related Cancer,KEYTRUDA only,56.12,39.18,1005.03,100,Complete Response
M212132,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.36,44.36,1189.2,84,Partial Response
M212133,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.9,21.49,652.22,96,
M212134,29,Other,Melanoma,mrna-4157 + keytruda,27.35,23.72,1122.6,85,Complete Response
M212135,38,Other,HPV-related Cancer,mrna-4157 + keytruda,59.8,51.5,773.19,85,Stable Disease
M212136,47,Female,Melanoma,mrna-4157 + keytruda,53.64,38.73,507.5,87,Progression
M212137,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.91,49.81,988.86,87,Complete Response
M212138,63,Female,Melanoma,mrna-4157 + keytruda,37.62,19.82,617.05,98,Partial Response
M212139,35,Other,Melanoma,mrna-4157 + keytruda,42.09,24.64,1333.52,98,Complete Response
M212140,35,Male,Melanoma,KEYTRUDA only,40.56,39.14,813.19,83,Progression
M212141,35,Other,Melanoma,mrna-4157 + keytruda,42.99,27.03,899.84,89,Stable Disease
M212142,64,Other,Melanoma,mrna-4157 + keytruda,58.85,50.63,1149.35,103,Partial Response
M212143,81,Male,HPV-related Cancer,mrna-4157 + keytruda,23.82,17.52,491.97,81,Partial Response
M212144,39,Female,Melanoma,mrna-4157 + keytruda,33.67,24.82,434.0,88,Partial Response
M212145,39,Male,Melanoma,mrna-4157 + keytruda,30.43,20.52,1113.66,92,Progression
M212146,26,Male,HPV-related Cancer,KEYTRUDA only,49.16,24.54,1467.91,89,Progression
M212147,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.63,55.2,,97,Stable Disease
M212148,51,Male,HPV-related Cancer,mrna-4157 + keytruda,38.65,37.23,928.7,90,Stable Disease
M212149,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.74,66.26,,85,Complete Response
M212150,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.45,48.93,729.91,98,Partial Response
M212151,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.72,42.02,,100,Partial Response
M212152,59,Female,HPV-related Cancer,KEYTRUDA only,26.37,19.53,1006.01,112,Partial Response
M212153,78,Male,Melanoma,mrna-4157 + keytruda,63.28,69.71,1255.93,83,Progression
M212154,47,Male,HPV-related Cancer,KEYTRUDA only,64.53,64.15,1252.87,84,Stable Disease
M212155,50,Male,HPV-related Cancer,KEYTRUDA only,68.44,50.99,1013.87,94,Partial Response
M212156,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.36,37.71,602.68,86,Complete Response
M212157,29,Female,Melanoma,mrna-4157 + keytruda,52.39,42.22,807.69,92,
M212158,65,Other,Melanoma,mrna-4157 + keytruda,59.58,40.48,356.03,88,Partial Response
M212159,75,Male,Melanoma,KEYTRUDA only,46.84,49.33,873.88,80,Stable Disease
M212160,47,Male,Melanoma,mrna-4157 + keytruda,34.04,23.89,373.15,82,Complete Response
M212161,72,Other,Melanoma,KEYTRUDA only,33.32,34.52,1301.28,107,Stable Disease
M212162,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.57,36.63,1260.73,95,Partial Response
M212163,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.06,52.02,1217.68,79,Partial Response
M212164,28,Female,Melanoma,KEYTRUDA only,65.39,69.48,1454.7,78,Stable Disease
M212165,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.98,23.8,227.96,93,Complete Response
M212166,53,Other,HPV-related Cancer,mrna-4157 + keytruda,65.78,47.97,786.78,94,Progression
M212167,39,Other,HPV-related Cancer,KEYTRUDA only,65.42,49.49,809.06,80,Progression
M212168,76,Male,HPV-related Cancer,mrna-4157 + keytruda,47.08,54.35,1251.89,86,Stable Disease
M212169,59,Male,HPV-related Cancer,KEYTRUDA only,92.71,70.92,1394.63,89,Complete Response
M212170,44,Male,HPV-related Cancer,mrna-4157 + keytruda,87.08,58.79,1206.05,71,Progression
M212171,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.99,27.35,1098.02,98,Progression
M212172,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.47,33.92,871.96,80,Stable Disease
M212173,69,Other,Melanoma,mrna-4157 + keytruda,46.38,28.82,1128.15,84,Complete Response
M212174,61,Male,HPV-related Cancer,mrna-4157 + keytruda,44.14,27.57,966.96,95,Partial Response
M212175,26,Male,HPV-related Cancer,mrna-4157 + keytruda,38.39,29.92,1015.6,97,Stable Disease
M212176,26,Other,Melanoma,mrna-4157 + keytruda,27.06,24.41,1780.59,89,Stable Disease
M212177,62,Male,Melanoma,mrna-4157 + keytruda,66.21,57.14,204.19,90,Partial Response
M212178,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.86,33.58,858.59,84,Progression
M212179,83,Male,Melanoma,KEYTRUDA only,53.11,42.19,1049.13,107,Stable Disease
M212180,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.37,34.13,1357.22,91,Unknown
M212181,37,Other,Melanoma,mrna-4157 + keytruda,50.38,48.94,435.0,99,Stable Disease
M212182,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.77,53.08,740.86,87,Partial Response
M212183,82,Other,HPV-related Cancer,KEYTRUDA only,43.88,48.15,932.57,84,Partial Response
M212184,43,Female,HPV-related Cancer,KEYTRUDA only,70.92,58.22,790.48,82,Stable Disease
M212185,48,Other,Melanoma,KEYTRUDA only,89.23,70.96,526.22,76,Progression
M212186,81,Other,HPV-related Cancer,KEYTRUDA only,83.69,69.48,1098.95,86,Stable Disease
M212187,47,Other,Melanoma,mrna-4157 + keytruda,90.89,47.84,959.15,105,Partial Response
M212188,77,Male,HPV-related Cancer,mrna-4157 + keytruda,48.12,51.41,1668.11,92,Partial Response
M212189,74,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.9,46.24,475.96,81,Partial Response
M212190,25,Female,Melanoma,KEYTRUDA only,40.45,21.49,947.88,83,Progression
M212191,77,Male,HPV-related Cancer,mrna-4157 + keytruda,48.99,36.26,995.8,90,
M212192,74,Male,Melanoma,KEYTRUDA only,75.99,36.57,1166.47,85,Partial Response
M212193,56,Other,HPV-related Cancer,mrna-4157 + keytruda,60.62,58.29,1415.46,94,Stable Disease
M212194,48,Male,Melanoma,mrna-4157 + keytruda,71.24,67.1,1003.28,83,
M212195,66,Other,HPV-related Cancer,KEYTRUDA only,69.75,57.37,1237.43,102,Partial Response
M212196,38,Female,Melanoma,mrna-4157 + keytruda,61.43,44.52,1662.33,87,
M212197,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.11,16.37,1154.6,99,
M212198,65,Female,HPV-related Cancer,KEYTRUDA only,44.69,35.81,989.06,103,Partial Response
M212199,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,21.77,19.19,1468.85,95,Partial Response
M212200,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.24,48.6,636.27,109,Progression
M212201,31,Male,HPV-related Cancer,mrna-4157 + keytruda,84.18,78.82,950.92,79,Partial Response
M212202,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.13,47.42,745.13,83,Progression
M212203,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.93,63.28,1161.11,86,Partial Response
M212204,60,Female,HPV-related Cancer,mrna-4157 + keytruda,61.46,37.98,1468.76,86,Progression
M212205,59,Male,Melanoma,mrna-4157 + keytruda,32.45,24.01,970.08,94,Stable Disease
M212206,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.13,26.72,1231.31,95,Stable Disease
M212207,75,Male,HPV-related Cancer,KEYTRUDA only,60.4,32.34,1410.69,80,Partial Response
M212208,73,Other,Non-small Cell Lung Cancer,KEYTRUDA only,71.27,66.01,768.87,72,
M212209,65,Female,Melanoma,mrna-4157 + keytruda,58.03,32.86,1400.45,91,Stable Disease
M212210,51,Male,Melanoma,mrna-4157 + keytruda,55.28,33.09,249.63,107,Progression
M212211,45,Other,Melanoma,KEYTRUDA only,45.14,33.94,406.92,91,Unknown
M212212,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.57,,1119.67,100,Partial Response
M212213,57,Other,Melanoma,KEYTRUDA only,51.46,44.0,531.04,92,Stable Disease
M212214,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.65,33.5,1309.31,99,Stable Disease
M212215,33,Female,Melanoma,mrna-4157 + keytruda,19.7,16.72,1172.95,86,Partial Response
M212216,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.0,32.19,458.82,90,Stable Disease
M212217,69,Other,HPV-related Cancer,mrna-4157 + keytruda,66.59,85.64,167.15,67,Complete Response
M212218,61,Male,HPV-related Cancer,mrna-4157 + keytruda,76.35,46.06,981.99,92,Stable Disease
M212219,79,Female,HPV-related Cancer,KEYTRUDA only,77.18,48.71,1029.36,88,Complete Response
M212220,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,97.71,80.94,1180.28,96,Partial Response
M212221,25,Other,HPV-related Cancer,KEYTRUDA only,22.76,20.89,1283.72,104,Complete Response
M212222,29,Other,Melanoma,mrna-4157 + keytruda,74.16,36.58,599.88,92,Partial Response
M212223,75,Male,HPV-related Cancer,mrna-4157 + keytruda,65.14,69.7,1372.11,83,Partial Response
M212224,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.84,30.82,930.04,103,
M212225,52,Female,Melanoma,mrna-4157 + keytruda,55.34,38.2,642.31,82,Stable Disease
M212226,46,Male,HPV-related Cancer,mrna-4157 + keytruda,71.72,44.16,997.12,82,Stable Disease
M212227,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.59,30.57,563.85,114,Partial Response
M212228,65,Other,Melanoma,mrna-4157 + keytruda,44.33,41.66,284.4,79,Partial Response
M212229,35,Other,HPV-related Cancer,mrna-4157 + keytruda,52.19,39.42,1339.04,101,Partial Response
M212230,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.3,13.15,940.18,97,Progression
M212231,56,Female,HPV-related Cancer,KEYTRUDA only,66.35,43.05,1198.83,88,Stable Disease
M212232,48,Other,HPV-related Cancer,mrna-4157 + keytruda,68.8,49.82,865.33,91,Partial Response
M212233,48,Male,HPV-related Cancer,mrna-4157 + keytruda,69.3,49.95,1105.75,102,Progression
M212234,77,Other,HPV-related Cancer,mrna-4157 + keytruda,62.26,44.22,1264.9,88,Stable Disease
M212235,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.06,39.2,463.22,100,Stable Disease
M212236,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.39,42.43,467.22,83,Partial Response
M212237,78,Other,HPV-related Cancer,KEYTRUDA only,23.96,11.97,1083.69,67,Progression
M212238,83,Other,HPV-related Cancer,KEYTRUDA only,51.77,38.34,1190.07,90,Stable Disease
M212239,69,Male,Melanoma,mrna-4157 + keytruda,68.12,67.34,1212.67,98,Partial Response
M212240,43,Female,Melanoma,mrna-4157 + keytruda,58.43,54.69,1053.05,85,Partial Response
M212241,39,Male,Melanoma,mrna-4157 + keytruda,50.85,36.05,1441.39,105,Stable Disease
M212242,46,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.98,24.79,1409.7,105,Stable Disease
M212243,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,88.35,119.75,1342.76,101,Progression
M212244,46,Male,Melanoma,mrna-4157 + keytruda,38.59,19.59,1484.46,82,Complete Response
M212245,61,Female,Melanoma,KEYTRUDA only,6.17,5.59,1438.28,71,Partial Response
M212246,29,Male,HPV-related Cancer,mrna-4157 + keytruda,36.52,15.42,1545.8,105,Progression
M212247,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.7,44.45,1352.41,98,Stable Disease
M212248,84,Other,HPV-related Cancer,mrna-4157 + keytruda,70.41,48.1,1267.42,79,Progression
M212249,76,Other,HPV-related Cancer,KEYTRUDA only,52.08,34.3,261.79,95,Stable Disease
M212250,61,Male,Melanoma,mrna-4157 + keytruda,76.02,81.47,346.3,78,Partial Response
M212251,29,Male,Melanoma,mrna-4157 + keytruda,29.93,19.62,1082.62,93,Stable Disease
M212252,54,Other,Melanoma,KEYTRUDA only,62.64,47.75,569.63,98,Stable Disease
M212253,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,58.47,42.28,698.71,71,Complete Response
M212254,65,Female,Melanoma,mrna-4157 + keytruda,69.45,,,99,Stable Disease
M212255,80,Female,HPV-related Cancer,mrna-4157 + keytruda,49.69,40.47,869.5,93,Stable Disease
M212256,34,Other,Melanoma,mrna-4157 + keytruda,28.39,17.4,1354.95,85,Stable Disease
M212257,59,Other,HPV-related Cancer,KEYTRUDA only,67.62,53.61,961.05,86,Stable Disease
M212258,37,Male,HPV-related Cancer,mrna-4157 + keytruda,28.45,32.98,1079.66,112,Partial Response
M212259,73,Male,Melanoma,mrna-4157 + keytruda,74.41,62.84,1803.85,99,Stable Disease
M212260,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.81,49.59,1193.16,105,Partial Response
M212261,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,25.13,23.46,1746.59,89,Complete Response
M212262,29,Male,HPV-related Cancer,KEYTRUDA only,62.37,43.39,760.17,97,Progression
M212263,28,Female,HPV-related Cancer,mrna-4157 + keytruda,65.77,30.45,1498.71,92,Unknown
M212264,78,Male,HPV-related Cancer,mrna-4157 + keytruda,43.28,18.77,1040.11,96,Stable Disease
M212265,82,Other,Melanoma,mrna-4157 + keytruda,61.45,56.87,758.82,97,Stable Disease
M212266,54,Male,Melanoma,KEYTRUDA only,70.38,66.24,,84,Complete Response
M212267,30,Male,HPV-related Cancer,mrna-4157 + keytruda,44.84,46.11,719.33,98,Partial Response
M212268,40,Other,Melanoma,KEYTRUDA only,45.78,33.93,1489.64,76,Complete Response
M212269,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.88,35.09,,74,Stable Disease
M212270,33,Other,HPV-related Cancer,KEYTRUDA only,47.79,50.27,1132.31,100,Partial Response
M212271,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,29.16,14.14,464.82,100,Stable Disease
M212272,63,Female,HPV-related Cancer,KEYTRUDA only,51.4,56.81,1022.31,84,Stable Disease
M212273,84,Male,HPV-related Cancer,mrna-4157 + keytruda,51.69,28.19,1793.58,103,Partial Response
M212274,76,Male,Melanoma,mrna-4157 + keytruda,56.07,37.0,1207.85,100,Partial Response
M212275,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.56,70.95,1216.4,90,Partial Response
M212276,74,Male,Melanoma,KEYTRUDA only,63.33,60.34,892.71,67,
M212277,64,Other,Melanoma,mrna-4157 + keytruda,35.1,29.81,1804.46,94,Complete Response
M212278,57,Female,Melanoma,mrna-4157 + keytruda,43.95,44.17,1026.6,91,Partial Response
M212279,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.32,30.59,694.9,86,Stable Disease
M212280,61,Male,Melanoma,mrna-4157 + keytruda,54.93,14.14,1259.78,96,Partial Response
M212281,84,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.64,37.4,836.25,82,Stable Disease
M212282,79,Male,HPV-related Cancer,KEYTRUDA only,40.92,48.39,1006.51,90,Unknown
M212283,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.72,,1057.08,88,Complete Response
M212284,33,Male,Melanoma,KEYTRUDA only,52.65,54.93,290.2,85,Progression
M212285,37,Male,Melanoma,KEYTRUDA only,7.34,4.58,1041.39,100,Partial Response
M212286,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.79,86.1,,100,Complete Response
M212287,54,Other,HPV-related Cancer,mrna-4157 + keytruda,26.29,16.86,597.97,94,Partial Response
M212288,75,Other,HPV-related Cancer,mrna-4157 + keytruda,51.79,,520.68,77,
M212289,27,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.84,27.67,432.86,96,Stable Disease
M212290,42,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.57,22.73,,91,Partial Response
M212291,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,73.4,79.25,918.83,91,Stable Disease
M212292,81,Other,HPV-related Cancer,mrna-4157 + keytruda,56.84,55.44,808.47,76,Complete Response
M212293,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.85,58.13,1034.5,93,Stable Disease
M212294,56,Female,HPV-related Cancer,KEYTRUDA only,39.99,26.34,936.34,95,Stable Disease
M212295,26,Female,Melanoma,mrna-4157 + keytruda,27.7,18.22,1829.09,86,
M212296,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.63,60.6,1097.64,104,Progression
M212297,39,Other,Melanoma,mrna-4157 + keytruda,75.19,63.77,861.12,81,Stable Disease
M212298,58,Female,Melanoma,mrna-4157 + keytruda,40.64,30.9,1353.99,82,Stable Disease
M212299,43,Male,HPV-related Cancer,KEYTRUDA only,53.54,39.61,1347.88,86,Stable Disease
M212300,81,Female,HPV-related Cancer,mrna-4157 + keytruda,6.7,6.85,1555.55,105,Stable Disease
M212301,82,Female,HPV-related Cancer,KEYTRUDA only,31.19,42.34,743.27,95,Progression
M212302,39,Other,HPV-related Cancer,mrna-4157 + keytruda,56.33,29.61,1044.78,81,Stable Disease
M212303,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.08,41.5,1178.32,94,Partial Response
M212304,79,Male,Melanoma,KEYTRUDA only,47.52,42.0,,95,Stable Disease
M212305,84,Male,HPV-related Cancer,mrna-4157 + keytruda,12.41,10.97,830.08,99,Partial Response
M212306,54,Male,HPV-related Cancer,KEYTRUDA only,57.14,35.53,981.02,85,Stable Disease
M212307,68,Male,HPV-related Cancer,KEYTRUDA only,39.72,28.52,1452.37,83,Partial Response
M212308,75,Female,HPV-related Cancer,KEYTRUDA only,58.22,45.86,687.54,92,Progression
M212309,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.37,59.88,1218.86,92,Unknown
M212310,30,Male,HPV-related Cancer,KEYTRUDA only,27.5,14.58,1739.12,108,Progression
M212311,31,Female,Melanoma,mrna-4157 + keytruda,55.82,26.56,1216.29,89,Stable Disease
M212312,38,Other,HPV-related Cancer,KEYTRUDA only,85.57,45.64,282.63,72,Progression
M212313,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,79.41,86.93,1168.53,90,Partial Response
M212314,69,Male,Melanoma,mrna-4157 + keytruda,71.72,47.74,1421.54,101,Stable Disease
M212315,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.03,77.58,309.94,84,Progression
M212316,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.43,,1121.84,91,Partial Response
M212317,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.4,10.74,882.8,80,Partial Response
M212318,65,Other,Melanoma,mrna-4157 + keytruda,7.4,4.29,706.7,106,Unknown
M212319,83,Other,HPV-related Cancer,KEYTRUDA only,37.29,,589.35,101,Complete Response
M212320,28,Male,Melanoma,KEYTRUDA only,66.86,52.32,788.15,94,Stable Disease
M212321,52,Other,HPV-related Cancer,mrna-4157 + keytruda,59.87,17.42,670.2,105,Progression
M212322,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.9,49.26,1601.29,101,Unknown
M212323,58,Female,Melanoma,mrna-4157 + keytruda,47.21,14.71,1184.16,76,Stable Disease
M212324,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.83,69.57,1543.62,76,Progression
M212325,25,Other,HPV-related Cancer,mrna-4157 + keytruda,95.74,70.67,754.17,73,Unknown
M212326,68,Other,HPV-related Cancer,KEYTRUDA only,34.9,26.03,613.71,79,Complete Response
M212327,58,Female,HPV-related Cancer,mrna-4157 + keytruda,37.16,28.45,1351.26,88,Stable Disease
M212328,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,93.62,57.06,809.42,91,Stable Disease
M212329,56,Female,HPV-related Cancer,mrna-4157 + keytruda,36.83,,,98,Complete Response
M212330,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.0,73.31,996.33,92,Partial Response
M212331,44,Male,Melanoma,KEYTRUDA only,47.32,45.81,,81,Partial Response
M212332,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.12,40.71,1324.39,84,Partial Response
M212333,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.15,12.28,1154.82,90,Stable Disease
M212334,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.72,14.17,1272.98,85,Progression
M212335,73,Female,HPV-related Cancer,mrna-4157 + keytruda,64.14,60.4,1119.23,74,
M212336,58,Other,HPV-related Cancer,KEYTRUDA only,52.58,25.07,946.93,100,Complete Response
M212337,37,Female,Melanoma,KEYTRUDA only,53.12,30.98,1346.82,99,Complete Response
M212338,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.28,32.61,1266.22,87,Stable Disease
M212339,54,Female,Melanoma,KEYTRUDA only,65.37,60.51,674.97,90,Complete Response
M212340,42,Other,Melanoma,KEYTRUDA only,53.52,43.98,1243.72,96,Progression
M212341,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.52,35.36,,90,Stable Disease
M212342,74,Other,HPV-related Cancer,mrna-4157 + keytruda,62.65,40.03,1312.23,96,Stable Disease
M212343,51,Other,HPV-related Cancer,mrna-4157 + keytruda,5.93,7.22,945.59,115,Progression
M212344,56,Male,HPV-related Cancer,mrna-4157 + keytruda,17.06,16.44,680.7,84,Unknown
M212345,55,Female,Melanoma,KEYTRUDA only,29.6,20.79,578.82,71,Partial Response
M212346,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.08,50.87,1491.43,90,Complete Response
M212347,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,87.0,98.86,1152.5,85,Progression
M212348,27,Female,Melanoma,mrna-4157 + keytruda,83.41,85.48,1129.61,92,Partial Response
M212349,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.72,65.62,507.95,89,Progression
M212350,28,Female,HPV-related Cancer,KEYTRUDA only,54.18,47.35,908.5,89,Progression
M212351,77,Female,Melanoma,mrna-4157 + keytruda,76.92,37.19,1200.43,69,Unknown
M212352,80,Female,HPV-related Cancer,KEYTRUDA only,66.11,60.41,603.2,80,Stable Disease
M212353,44,Female,Melanoma,mrna-4157 + keytruda,64.07,52.91,1377.99,101,Partial Response
M212354,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,33.6,28.42,1170.12,116,Partial Response
M212355,26,Female,HPV-related Cancer,mrna-4157 + keytruda,40.01,25.61,762.34,91,Complete Response
M212356,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,0.49,0.31,875.71,95,Stable Disease
M212357,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.44,37.72,865.22,83,Stable Disease
M212358,80,Female,HPV-related Cancer,KEYTRUDA only,52.68,21.35,866.91,68,Progression
M212359,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.9,74.16,1287.33,83,Progression
M212360,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.29,39.72,741.3,97,Partial Response
M212361,38,Female,Melanoma,mrna-4157 + keytruda,64.03,36.44,1243.7,88,Partial Response
M212362,33,Female,HPV-related Cancer,mrna-4157 + keytruda,40.63,40.66,1273.45,94,Partial Response
M212363,41,Other,HPV-related Cancer,mrna-4157 + keytruda,64.71,68.51,1575.83,83,Partial Response
M212364,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.73,24.11,1064.29,105,Stable Disease
M212365,43,Other,Melanoma,KEYTRUDA only,26.43,15.24,1765.8,110,Partial Response
M212366,31,Female,Melanoma,KEYTRUDA only,62.42,46.12,1448.22,87,Partial Response
M212367,31,Male,HPV-related Cancer,KEYTRUDA only,23.6,17.92,215.94,107,Stable Disease
M212368,47,Other,HPV-related Cancer,mrna-4157 + keytruda,46.52,30.17,1194.88,103,Unknown
M212369,63,Other,HPV-related Cancer,KEYTRUDA only,80.83,58.77,1584.22,88,Stable Disease
M212370,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.9,47.87,1011.41,63,Partial Response
M212371,37,Male,HPV-related Cancer,KEYTRUDA only,34.49,24.54,1089.37,90,Complete Response
M212372,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.01,40.59,1510.89,94,Partial Response
M212373,46,Female,HPV-related Cancer,mrna-4157 + keytruda,67.35,49.46,767.4,85,Progression
M212374,60,Male,HPV-related Cancer,KEYTRUDA only,72.36,38.84,1253.28,90,Stable Disease
M212375,56,Female,Non-small Cell Lung Cancer,KEYTRUDA only,82.12,66.76,1437.76,94,Unknown
M212376,66,Female,HPV-related Cancer,KEYTRUDA only,74.17,65.03,1014.28,92,Complete Response
M212377,60,Male,HPV-related Cancer,mrna-4157 + keytruda,79.69,57.79,847.26,88,Complete Response
M212378,37,Other,HPV-related Cancer,KEYTRUDA only,21.45,17.6,483.21,93,Partial Response
M212379,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,27.99,19.82,690.07,86,Unknown
M212380,54,Male,HPV-related Cancer,KEYTRUDA only,57.05,38.5,684.33,82,Partial Response
M212381,47,Female,HPV-related Cancer,KEYTRUDA only,73.92,61.46,1337.25,93,Partial Response
M212382,72,Male,Melanoma,mrna-4157 + keytruda,27.76,19.78,1337.14,103,Partial Response
M212383,69,Female,HPV-related Cancer,mrna-4157 + keytruda,52.22,30.49,1046.0,103,Progression
M212384,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.15,32.46,1016.88,78,Stable Disease
M212385,51,Other,HPV-related Cancer,mrna-4157 + keytruda,73.76,30.14,844.79,93,Stable Disease
M212386,42,Other,Melanoma,KEYTRUDA only,53.99,66.6,1055.81,89,Unknown
M212387,79,Female,HPV-related Cancer,mrna-4157 + keytruda,48.75,36.67,694.93,86,Complete Response
M212388,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.52,53.44,1513.93,95,Unknown
M212389,68,Female,HPV-related Cancer,KEYTRUDA only,57.6,51.61,671.96,82,Complete Response
M212390,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.81,57.24,842.52,107,Partial Response
M212391,52,Female,HPV-related Cancer,mrna-4157 + keytruda,35.92,20.38,666.18,97,Stable Disease
M212392,54,Other,Melanoma,mrna-4157 + keytruda,44.3,30.71,1335.96,88,Partial Response
M212393,69,Other,HPV-related Cancer,mrna-4157 + keytruda,56.53,27.12,,75,Stable Disease
M212394,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,67.04,39.03,1363.05,80,Partial Response
M212395,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.92,,1243.81,95,Progression
M212396,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.16,,908.93,104,Partial Response
M212397,77,Other,Melanoma,mrna-4157 + keytruda,31.61,24.0,895.0,92,Partial Response
M212398,70,Male,HPV-related Cancer,mrna-4157 + keytruda,109.74,57.54,,72,Progression
M212399,67,Female,HPV-related Cancer,mrna-4157 + keytruda,73.25,63.75,1404.27,87,Partial Response
M212400,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.67,37.32,982.23,73,Stable Disease
M212401,49,Other,Melanoma,mrna-4157 + keytruda,49.22,37.62,612.97,90,Progression
M212402,57,Female,HPV-related Cancer,mrna-4157 + keytruda,54.83,63.8,1131.61,71,Partial Response
M212403,36,Male,Melanoma,mrna-4157 + keytruda,35.94,31.57,572.0,96,Progression
M212404,37,Other,Melanoma,mrna-4157 + keytruda,37.56,31.82,850.22,92,Stable Disease
M212405,26,Female,Melanoma,mrna-4157 + keytruda,71.33,59.27,1049.58,81,Partial Response
M212406,33,Female,HPV-related Cancer,mrna-4157 + keytruda,56.84,43.22,586.42,102,Partial Response
M212407,76,Other,Melanoma,mrna-4157 + keytruda,64.63,56.07,920.7,89,Complete Response
M212408,42,Female,HPV-related Cancer,mrna-4157 + keytruda,63.82,45.12,1355.13,99,Partial Response
M212409,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.74,37.46,393.16,75,Progression
M212410,84,Female,Melanoma,mrna-4157 + keytruda,58.79,53.77,708.33,96,Progression
M212411,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.53,29.61,633.88,81,Partial Response
M212412,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.56,54.81,1023.28,93,Progression
M212413,27,Female,HPV-related Cancer,mrna-4157 + keytruda,46.0,34.6,521.04,88,Complete Response
M212414,67,Female,Melanoma,KEYTRUDA only,60.71,44.36,730.58,91,
M212415,61,Other,Melanoma,mrna-4157 + keytruda,59.1,22.9,612.16,94,Progression
M212416,83,Female,HPV-related Cancer,KEYTRUDA only,51.47,36.12,853.05,103,Stable Disease
M212417,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.06,46.7,1038.52,91,Partial Response
M212418,42,Male,Melanoma,mrna-4157 + keytruda,70.43,55.82,789.6,80,Progression
M212419,57,Female,Melanoma,mrna-4157 + keytruda,50.0,63.19,30.77,92,Stable Disease
M212420,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.22,39.41,1501.5,105,Stable Disease
M212421,46,Female,Melanoma,mrna-4157 + keytruda,17.18,16.95,1030.67,92,Partial Response
M212422,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.19,65.36,953.2,69,Progression
M212423,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.65,40.14,812.0,95,Complete Response
M212424,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.75,43.02,520.51,80,Stable Disease
M212425,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,35.58,30.29,928.63,93,Partial Response
M212426,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.68,42.35,768.42,90,Stable Disease
M212427,61,Other,Melanoma,mrna-4157 + keytruda,76.31,23.67,65.51,86,Partial Response
M212428,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.84,27.08,1152.71,82,Stable Disease
M212429,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.33,44.53,1783.81,88,Progression
M212430,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.4,34.06,1413.24,103,Unknown
M212431,58,Other,HPV-related Cancer,KEYTRUDA only,53.33,33.18,523.95,100,Progression
M212432,79,Other,HPV-related Cancer,mrna-4157 + keytruda,37.09,18.28,893.97,106,Partial Response
M212433,62,Male,HPV-related Cancer,KEYTRUDA only,49.42,,780.79,91,Partial Response
M212434,36,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.39,19.79,590.92,80,Partial Response
M212435,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.86,23.51,1913.38,77,Complete Response
M212436,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.49,31.07,1253.32,92,Progression
M212437,48,Female,HPV-related Cancer,KEYTRUDA only,32.23,32.58,722.13,105,Progression
M212438,55,Male,HPV-related Cancer,mrna-4157 + keytruda,53.95,33.46,1838.61,91,Progression
M212439,53,Male,HPV-related Cancer,mrna-4157 + keytruda,53.39,33.03,374.37,85,Partial Response
M212440,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.31,41.62,888.58,105,Unknown
M212441,67,Female,HPV-related Cancer,mrna-4157 + keytruda,73.81,38.73,546.6,89,
M212442,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.95,70.73,81.49,108,Partial Response
M212443,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.75,59.16,504.61,88,Unknown
M212444,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.75,68.08,1316.89,98,Complete Response
M212445,31,Other,Melanoma,KEYTRUDA only,56.45,29.93,806.92,81,Partial Response
M212446,34,Other,HPV-related Cancer,mrna-4157 + keytruda,79.49,,,94,Complete Response
M212447,36,Other,HPV-related Cancer,KEYTRUDA only,67.7,53.21,,79,Partial Response
M212448,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.1,37.85,990.92,71,
M212449,34,Female,Melanoma,mrna-4157 + keytruda,63.33,43.28,805.63,85,Unknown
M212450,25,Female,Melanoma,mrna-4157 + keytruda,82.23,76.0,683.64,98,Progression
M212451,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.32,56.56,1912.21,78,Partial Response
M212452,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.05,25.28,652.67,80,Stable Disease
M212453,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.88,36.37,695.06,75,Partial Response
M212454,41,Other,Melanoma,mrna-4157 + keytruda,30.25,28.18,533.17,100,Progression
M212455,36,Male,HPV-related Cancer,mrna-4157 + keytruda,67.31,71.74,1062.7,98,Unknown
M212456,25,Male,HPV-related Cancer,KEYTRUDA only,47.28,45.82,1656.24,83,Stable Disease
M212457,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.97,44.87,725.67,67,Progression
M212458,55,Male,HPV-related Cancer,KEYTRUDA only,49.0,37.37,1818.16,96,Partial Response
M212459,68,Other,Melanoma,mrna-4157 + keytruda,54.25,48.8,1030.88,81,Partial Response
M212460,62,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.93,28.25,1319.94,73,Partial Response
M212461,71,Female,Melanoma,mrna-4157 + keytruda,64.01,59.66,835.69,108,Progression
M212462,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.87,15.5,655.76,99,Progression
M212463,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.87,37.0,1126.44,87,Stable Disease
M212464,44,Male,Melanoma,mrna-4157 + keytruda,47.14,48.12,1273.8,83,Partial Response
M212465,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.32,31.09,579.69,87,Stable Disease
M212466,70,Male,Melanoma,mrna-4157 + keytruda,42.2,40.15,1897.52,83,
M212467,55,Male,Melanoma,mrna-4157 + keytruda,88.06,50.21,,93,Progression
M212468,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.39,47.35,800.54,108,Progression
M212469,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.99,38.57,542.78,95,Progression
M212470,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,47.29,27.89,1575.78,90,Unknown
M212471,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.77,55.21,,88,Progression
M212472,40,Male,HPV-related Cancer,KEYTRUDA only,82.4,93.69,807.8,100,Partial Response
M212473,51,Other,HPV-related Cancer,mrna-4157 + keytruda,82.8,76.58,,84,Progression
M212474,44,Male,Melanoma,KEYTRUDA only,62.76,,1234.06,101,Complete Response
M212475,30,Male,Melanoma,mrna-4157 + keytruda,61.03,32.57,1267.19,100,Progression
M212476,69,Male,Melanoma,mrna-4157 + keytruda,24.97,21.21,941.31,86,Partial Response
M212477,66,Male,Melanoma,KEYTRUDA only,71.37,38.59,511.86,86,Complete Response
M212478,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,78.7,44.29,1958.1,76,Complete Response
M212479,65,Male,HPV-related Cancer,mrna-4157 + keytruda,16.83,12.18,911.29,87,Stable Disease
M212480,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,101.22,91.3,1358.53,87,Partial Response
M212481,29,Male,Melanoma,mrna-4157 + keytruda,42.79,40.54,793.02,102,Progression
M212482,62,Female,Melanoma,mrna-4157 + keytruda,53.41,45.21,497.23,95,Stable Disease
M212483,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.4,36.82,329.21,84,Stable Disease
M212484,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.99,47.39,624.31,90,
M212485,62,Male,Melanoma,KEYTRUDA only,52.97,44.08,422.14,104,Complete Response
M212486,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.89,39.66,307.6,73,Stable Disease
M212487,59,Female,HPV-related Cancer,mrna-4157 + keytruda,36.19,10.89,1004.36,103,Stable Disease
M212488,83,Female,Melanoma,KEYTRUDA only,22.97,16.17,1015.94,93,Progression
M212489,82,Female,HPV-related Cancer,mrna-4157 + keytruda,27.85,20.0,1429.17,81,Partial Response
M212490,78,Female,Non-small Cell Lung Cancer,KEYTRUDA only,51.11,,1353.14,59,Partial Response
M212491,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.33,57.25,996.81,73,Progression
M212492,35,Female,Melanoma,mrna-4157 + keytruda,36.29,30.34,823.87,86,Partial Response
M212493,29,Male,Melanoma,KEYTRUDA only,64.43,59.99,1075.64,84,Stable Disease
M212494,73,Male,HPV-related Cancer,KEYTRUDA only,61.66,60.02,1257.65,93,Progression
M212495,36,Male,Melanoma,mrna-4157 + keytruda,2.74,1.59,1518.77,84,Partial Response
M212496,27,Male,Melanoma,mrna-4157 + keytruda,77.0,64.25,494.95,87,Stable Disease
M212497,33,Male,HPV-related Cancer,mrna-4157 + keytruda,42.86,20.34,923.03,83,Stable Disease
M212498,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.13,29.89,1314.69,101,Partial Response
M212499,38,Male,HPV-related Cancer,mrna-4157 + keytruda,84.33,51.74,803.71,83,Partial Response
M212500,26,Female,Melanoma,KEYTRUDA only,47.33,59.71,1181.23,114,Stable Disease
M212501,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,100.01,54.4,1214.96,77,Partial Response
M212502,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.26,98.65,883.98,83,Partial Response
M212503,25,Female,HPV-related Cancer,mrna-4157 + keytruda,42.99,40.3,1314.15,76,Partial Response
M212504,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.85,62.01,,82,Complete Response
M212505,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.22,30.69,919.25,83,Complete Response
M212506,38,Other,HPV-related Cancer,mrna-4157 + keytruda,35.81,23.41,519.04,105,Unknown
M212507,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.15,,390.76,84,Stable Disease
M212508,26,Other,Melanoma,mrna-4157 + keytruda,62.78,58.12,1007.32,96,Stable Disease
M212509,50,Other,Melanoma,mrna-4157 + keytruda,69.9,52.38,1325.36,98,Complete Response
M212510,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.22,11.93,1309.09,92,Stable Disease
M212511,44,Male,HPV-related Cancer,mrna-4157 + keytruda,56.69,42.44,540.42,95,Partial Response
M212512,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.68,24.95,,78,
M212513,76,Female,HPV-related Cancer,mrna-4157 + keytruda,47.38,32.17,657.33,84,Unknown
M212514,84,Female,HPV-related Cancer,mrna-4157 + keytruda,96.91,91.97,813.0,111,Partial Response
M212515,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.96,96.5,1394.73,96,Partial Response
M212516,76,Other,HPV-related Cancer,mrna-4157 + keytruda,31.16,30.11,15.5,78,Complete Response
M212517,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,101.04,85.86,1071.92,103,Stable Disease
M212518,79,Female,HPV-related Cancer,mrna-4157 + keytruda,43.25,26.87,1263.71,88,Partial Response
M212519,65,Other,Melanoma,KEYTRUDA only,52.49,47.9,1123.36,76,Partial Response
M212520,27,Female,Melanoma,mrna-4157 + keytruda,55.45,40.02,924.5,91,Stable Disease
M212521,61,Female,Melanoma,mrna-4157 + keytruda,50.4,26.94,1050.36,86,Stable Disease
M212522,65,Female,HPV-related Cancer,KEYTRUDA only,51.55,34.96,1686.7,97,Stable Disease
M212523,61,Other,HPV-related Cancer,mrna-4157 + keytruda,36.38,28.96,1437.73,84,Partial Response
M212524,49,Other,Melanoma,KEYTRUDA only,27.13,18.16,1280.62,100,Complete Response
M212525,75,Female,Melanoma,mrna-4157 + keytruda,46.13,44.48,1175.36,88,Stable Disease
M212526,50,Female,Melanoma,KEYTRUDA only,31.32,16.71,360.39,105,Stable Disease
M212527,36,Other,HPV-related Cancer,mrna-4157 + keytruda,60.29,28.78,1376.71,69,Complete Response
M212528,71,Female,HPV-related Cancer,mrna-4157 + keytruda,62.84,73.88,1533.76,83,Stable Disease
M212529,54,Other,HPV-related Cancer,KEYTRUDA only,35.77,32.52,855.65,81,Complete Response
M212530,75,Female,HPV-related Cancer,KEYTRUDA only,84.0,65.19,1033.66,95,Complete Response
M212531,36,Female,HPV-related Cancer,mrna-4157 + keytruda,88.32,71.9,551.22,88,Complete Response
M212532,70,Female,Melanoma,mrna-4157 + keytruda,74.24,83.68,852.71,91,Stable Disease
M212533,32,Male,Melanoma,KEYTRUDA only,47.41,34.64,1043.01,82,Stable Disease
M212534,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.63,26.93,331.28,83,Progression
M212535,32,Other,HPV-related Cancer,KEYTRUDA only,56.71,22.6,526.84,98,Partial Response
M212536,49,Male,HPV-related Cancer,KEYTRUDA only,69.04,54.79,985.31,85,Unknown
M212537,30,Other,Melanoma,KEYTRUDA only,57.66,61.26,350.53,85,Partial Response
M212538,66,Male,Melanoma,mrna-4157 + keytruda,54.45,42.7,824.37,89,Progression
M212539,52,Female,HPV-related Cancer,mrna-4157 + keytruda,31.1,15.2,,81,
M212540,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.24,47.9,717.43,70,Partial Response
M212541,73,Male,HPV-related Cancer,KEYTRUDA only,69.38,40.77,1096.01,90,Stable Disease
M212542,71,Other,HPV-related Cancer,KEYTRUDA only,70.74,63.25,-90.23,90,Partial Response
M212543,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.08,61.98,941.9,92,Partial Response
M212544,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.36,29.48,499.05,86,Partial Response
M212545,47,Other,HPV-related Cancer,mrna-4157 + keytruda,72.28,66.65,394.4,80,Progression
M212546,81,Other,Melanoma,mrna-4157 + keytruda,30.58,32.19,1356.7,104,Partial Response
M212547,69,Female,HPV-related Cancer,mrna-4157 + keytruda,67.77,50.17,283.71,101,Stable Disease
M212548,44,Other,Melanoma,KEYTRUDA only,54.49,34.08,282.24,92,Progression
M212549,28,Male,Melanoma,mrna-4157 + keytruda,23.27,15.37,1318.34,87,Partial Response
M212550,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.24,31.39,1127.44,84,Stable Disease
M212551,75,Male,HPV-related Cancer,KEYTRUDA only,49.92,37.87,1453.16,104,Partial Response
M212552,26,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.42,30.47,1218.04,77,Stable Disease
M212553,27,Other,Melanoma,mrna-4157 + keytruda,8.46,2.42,1032.56,80,Partial Response
M212554,67,Male,HPV-related Cancer,KEYTRUDA only,23.55,11.17,676.32,87,Stable Disease
M212555,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.98,70.36,1525.21,81,Unknown
M212556,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.05,41.8,316.51,96,Complete Response
M212557,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.57,45.27,173.38,95,Partial Response
M212558,31,Female,Melanoma,mrna-4157 + keytruda,50.46,29.05,1254.4,85,Partial Response
M212559,28,Male,Melanoma,mrna-4157 + keytruda,19.8,16.08,,92,Partial Response
M212560,67,Female,Melanoma,KEYTRUDA only,27.6,18.36,1318.71,95,Partial Response
M212561,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.39,43.31,1059.85,85,
M212562,45,Other,HPV-related Cancer,mrna-4157 + keytruda,21.72,11.22,755.84,99,Stable Disease
M212563,72,Female,HPV-related Cancer,KEYTRUDA only,81.72,40.13,519.85,79,Stable Disease
M212564,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.35,26.87,703.52,79,Partial Response
M212565,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,76.52,88.7,1125.33,109,Stable Disease
M212566,71,Male,Melanoma,mrna-4157 + keytruda,41.35,14.21,1073.18,94,Partial Response
M212567,81,Other,Melanoma,KEYTRUDA only,73.85,62.69,402.68,87,Stable Disease
M212568,60,Female,Melanoma,mrna-4157 + keytruda,25.96,,1402.25,88,Progression
M212569,56,Other,HPV-related Cancer,mrna-4157 + keytruda,66.09,58.97,925.57,98,
M212570,43,Other,HPV-related Cancer,mrna-4157 + keytruda,53.28,42.54,1187.03,90,Complete Response
M212571,83,Female,HPV-related Cancer,mrna-4157 + keytruda,49.33,37.38,6920.4,103,Complete Response
M212572,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.94,53.75,1647.83,81,Stable Disease
M212573,42,Male,HPV-related Cancer,KEYTRUDA only,58.69,,848.88,84,Progression
M212574,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,79.04,73.08,1326.63,102,Progression
M212575,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.98,31.51,1131.41,84,Progression
M212576,48,Female,Melanoma,KEYTRUDA only,50.02,6.23,501.2,85,Progression
M212577,52,Male,HPV-related Cancer,KEYTRUDA only,50.04,40.64,1079.34,80,Complete Response
M212578,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.7,34.32,813.37,101,Progression
M212579,80,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.93,30.29,1100.42,103,Stable Disease
M212580,29,Male,HPV-related Cancer,KEYTRUDA only,2.77,2.83,819.15,92,
M212581,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.59,32.65,365.38,87,Partial Response
M212582,33,Female,HPV-related Cancer,mrna-4157 + keytruda,60.43,27.66,858.62,88,Stable Disease
M212583,30,Other,HPV-related Cancer,mrna-4157 + keytruda,79.48,8.6,950.65,73,Stable Disease
M212584,64,Female,Melanoma,KEYTRUDA only,82.0,49.29,1211.19,95,Progression
M212585,57,Female,HPV-related Cancer,mrna-4157 + keytruda,52.27,31.6,995.71,91,Partial Response
M212586,44,Male,HPV-related Cancer,mrna-4157 + keytruda,30.45,30.85,778.44,95,Complete Response
M212587,52,Female,Melanoma,KEYTRUDA only,48.62,38.34,463.62,115,Unknown
M212588,60,Female,Melanoma,mrna-4157 + keytruda,29.16,15.72,1456.17,88,Complete Response
M212589,81,Female,Melanoma,mrna-4157 + keytruda,50.1,40.85,601.85,83,Stable Disease
M212590,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.43,44.56,1073.84,96,Progression
M212591,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.27,31.71,10.61,86,Progression
M212592,49,Other,Melanoma,mrna-4157 + keytruda,19.75,16.98,671.67,105,Stable Disease
M212593,33,Other,HPV-related Cancer,mrna-4157 + keytruda,45.26,27.01,1223.65,84,Progression
M212594,33,Other,Melanoma,mrna-4157 + keytruda,37.64,31.56,1313.97,108,Progression
M212595,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,73.27,61.71,1374.35,104,Complete Response
M212596,69,Other,HPV-related Cancer,mrna-4157 + keytruda,44.86,41.24,1075.36,97,Partial Response
M212597,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.57,61.41,1407.25,81,Unknown
M212598,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,75.22,60.23,1229.81,95,Complete Response
M212599,78,Other,Melanoma,mrna-4157 + keytruda,61.85,80.38,850.89,71,Complete Response
M212600,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.31,26.01,1351.81,96,Stable Disease
M212601,42,Female,HPV-related Cancer,mrna-4157 + keytruda,92.59,94.14,921.92,97,Stable Disease
M212602,75,Other,Non-small Cell Lung Cancer,KEYTRUDA only,30.7,33.43,749.96,91,Stable Disease
M212603,51,Other,Melanoma,KEYTRUDA only,44.47,46.29,1010.2,88,Stable Disease
M212604,83,Female,HPV-related Cancer,mrna-4157 + keytruda,13.32,12.02,892.61,104,Stable Disease
M212605,28,Other,HPV-related Cancer,mrna-4157 + keytruda,71.91,,860.39,100,Complete Response
M212606,45,Male,HPV-related Cancer,KEYTRUDA only,43.65,33.08,1006.43,87,Stable Disease
M212607,43,Other,Melanoma,KEYTRUDA only,20.58,26.78,1347.75,77,Stable Disease
M212608,84,Female,Melanoma,KEYTRUDA only,17.5,16.53,1363.71,94,Stable Disease
M212609,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,70.14,51.17,264.03,105,Progression
M212610,69,Male,Melanoma,KEYTRUDA only,59.9,26.47,1477.23,88,Partial Response
M212611,54,Female,Melanoma,mrna-4157 + keytruda,59.96,54.04,405.07,111,Partial Response
M212612,56,Other,HPV-related Cancer,KEYTRUDA only,29.8,24.97,700.62,90,Progression
M212613,27,Female,Melanoma,mrna-4157 + keytruda,58.48,,469.96,95,Partial Response
M212614,71,Female,HPV-related Cancer,KEYTRUDA only,18.29,,733.5,80,Progression
M212615,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.28,42.44,848.99,99,Stable Disease
M212616,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.77,16.8,1367.71,102,Partial Response
M212617,44,Female,HPV-related Cancer,mrna-4157 + keytruda,8.95,8.11,833.08,77,Stable Disease
M212618,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,64.35,48.39,1496.08,89,Stable Disease
M212619,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.49,25.09,1838.79,95,Stable Disease
M212620,63,Male,HPV-related Cancer,KEYTRUDA only,26.29,19.24,1090.82,93,Stable Disease
M212621,55,Female,HPV-related Cancer,mrna-4157 + keytruda,45.87,30.18,309.41,106,Partial Response
M212622,37,Other,HPV-related Cancer,KEYTRUDA only,43.28,37.92,1369.73,95,Stable Disease
M212623,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.48,47.61,772.08,86,Stable Disease
M212624,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.21,39.34,1677.87,83,Stable Disease
M212625,45,Other,HPV-related Cancer,mrna-4157 + keytruda,69.07,63.9,1172.08,87,
M212626,43,Male,HPV-related Cancer,KEYTRUDA only,64.57,47.5,676.06,77,Stable Disease
M212627,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,75.25,60.9,554.51,97,Stable Disease
M212628,67,Male,Melanoma,mrna-4157 + keytruda,77.95,50.79,942.9,115,Partial Response
M212629,32,Male,HPV-related Cancer,mrna-4157 + keytruda,81.82,71.67,1018.83,99,
M212630,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.21,54.87,387.56,96,Partial Response
M212631,45,Other,HPV-related Cancer,mrna-4157 + keytruda,45.23,25.79,920.53,85,Partial Response
M212632,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.54,28.13,,91,Complete Response
M212633,58,Female,HPV-related Cancer,mrna-4157 + keytruda,85.51,,497.6,101,Stable Disease
M212634,31,Female,HPV-related Cancer,mrna-4157 + keytruda,24.55,18.89,997.57,88,Complete Response
M212635,73,Other,Melanoma,mrna-4157 + keytruda,47.96,36.03,900.15,101,Partial Response
M212636,29,Male,HPV-related Cancer,mrna-4157 + keytruda,32.49,31.02,833.43,84,Stable Disease
M212637,75,Female,HPV-related Cancer,KEYTRUDA only,68.23,70.51,1063.68,92,Stable Disease
M212638,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.42,27.05,1325.02,87,Stable Disease
M212639,47,Female,Melanoma,KEYTRUDA only,85.05,76.77,125.89,89,
M212640,81,Other,HPV-related Cancer,mrna-4157 + keytruda,75.1,34.31,1415.54,94,Stable Disease
M212641,39,Other,Melanoma,mrna-4157 + keytruda,74.0,57.71,1178.73,105,Complete Response
M212642,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.39,,951.51,87,Progression
M212643,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.4,41.61,1020.46,93,Partial Response
M212644,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.79,66.43,1449.87,106,Stable Disease
M212645,81,Other,Melanoma,mrna-4157 + keytruda,58.87,54.55,722.72,90,Progression
M212646,70,Male,HPV-related Cancer,mrna-4157 + keytruda,57.58,29.09,736.94,102,Stable Disease
M212647,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.02,,562.02,97,Stable Disease
M212648,34,Other,Melanoma,KEYTRUDA only,55.94,58.6,875.88,111,Partial Response
M212649,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.28,,1165.23,92,Progression
M212650,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.09,36.69,626.37,88,Stable Disease
M212651,79,Female,Melanoma,KEYTRUDA only,35.92,26.14,,90,Stable Disease
M212652,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.8,37.29,843.29,82,Partial Response
M212653,28,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.51,61.31,1059.91,93,Stable Disease
M212654,76,Female,HPV-related Cancer,mrna-4157 + keytruda,35.5,29.22,966.36,98,Complete Response
M212655,32,Male,Melanoma,mrna-4157 + keytruda,43.2,33.16,599.18,75,Stable Disease
M212656,44,Male,Melanoma,KEYTRUDA only,59.86,21.8,,90,Stable Disease
M212657,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.24,49.33,552.85,83,
M212658,40,Other,HPV-related Cancer,KEYTRUDA only,38.06,29.72,1119.62,78,Partial Response
M212659,66,Other,Melanoma,mrna-4157 + keytruda,68.57,52.7,755.88,101,Partial Response
M212660,59,Female,Melanoma,KEYTRUDA only,55.68,39.57,1554.87,92,Complete Response
M212661,39,Male,HPV-related Cancer,mrna-4157 + keytruda,53.85,26.74,518.28,73,Partial Response
M212662,26,Female,Melanoma,mrna-4157 + keytruda,38.56,40.16,1115.75,102,Progression
M212663,76,Other,HPV-related Cancer,mrna-4157 + keytruda,59.54,,628.48,82,Stable Disease
M212664,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.35,49.6,594.86,81,Unknown
M212665,41,Other,HPV-related Cancer,KEYTRUDA only,77.13,59.92,557.04,92,
M212666,48,Other,Melanoma,KEYTRUDA only,51.86,53.44,1101.2,90,Progression
M212667,61,Other,Melanoma,mrna-4157 + keytruda,60.81,,1189.16,118,Progression
M212668,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.92,63.18,1141.51,87,Partial Response
M212669,65,Female,Melanoma,mrna-4157 + keytruda,29.25,20.43,639.39,115,Progression
M212670,26,Other,Melanoma,mrna-4157 + keytruda,66.68,73.11,1053.13,88,Stable Disease
M212671,61,Other,Melanoma,KEYTRUDA only,43.37,26.73,1398.53,105,Progression
M212672,61,Male,Melanoma,mrna-4157 + keytruda,75.48,53.44,609.89,99,Partial Response
M212673,38,Female,HPV-related Cancer,mrna-4157 + keytruda,65.96,40.38,733.7,82,Progression
M212674,49,Female,HPV-related Cancer,KEYTRUDA only,37.01,28.58,914.43,93,Complete Response
M212675,46,Female,Melanoma,mrna-4157 + keytruda,27.06,20.89,1099.31,92,Complete Response
M212676,78,Other,HPV-related Cancer,KEYTRUDA only,46.76,49.52,1556.94,97,
M212677,42,Male,Non-small Cell Lung Cancer,KEYTRUDA only,22.3,8.32,680.71,86,Stable Disease
M212678,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.13,22.32,1206.78,96,Unknown
M212679,58,Other,Melanoma,KEYTRUDA only,30.71,28.9,866.34,102,Progression
M212680,66,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.75,30.43,807.54,100,Stable Disease
M212681,60,Male,HPV-related Cancer,mrna-4157 + keytruda,33.77,,1611.89,101,Complete Response
M212682,48,Female,HPV-related Cancer,KEYTRUDA only,68.66,70.11,1316.62,91,Stable Disease
M212683,37,Other,HPV-related Cancer,mrna-4157 + keytruda,46.8,49.26,1202.62,100,Stable Disease
M212684,28,Male,Melanoma,KEYTRUDA only,72.86,92.38,966.26,100,Progression
M212685,66,Male,Melanoma,mrna-4157 + keytruda,18.42,15.41,1251.55,81,Complete Response
M212686,34,Male,HPV-related Cancer,KEYTRUDA only,49.48,55.79,670.12,90,Complete Response
M212687,40,Male,Melanoma,KEYTRUDA only,50.34,40.6,964.67,77,Unknown
M212688,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.69,32.34,786.63,82,Stable Disease
M212689,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,26.98,21.66,2068.11,96,Partial Response
M212690,25,Male,Melanoma,KEYTRUDA only,38.2,30.67,780.46,85,Partial Response
M212691,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.27,53.96,858.94,91,Stable Disease
M212692,41,Other,Melanoma,mrna-4157 + keytruda,53.24,56.81,961.17,89,Partial Response
M212693,39,Female,Melanoma,KEYTRUDA only,43.33,42.48,1302.01,95,Complete Response
M212694,62,Male,Melanoma,mrna-4157 + keytruda,64.63,35.26,1282.97,93,Partial Response
M212695,65,Male,Melanoma,mrna-4157 + keytruda,46.51,37.08,1081.67,105,Stable Disease
M212696,61,Female,Melanoma,mrna-4157 + keytruda,58.88,49.17,550.83,84,Stable Disease
M212697,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.42,18.46,577.3,86,Partial Response
M212698,54,Male,HPV-related Cancer,mrna-4157 + keytruda,35.15,43.27,,95,Progression
M212699,34,Other,HPV-related Cancer,KEYTRUDA only,29.92,16.19,717.82,93,Partial Response
M212700,44,Other,HPV-related Cancer,KEYTRUDA only,47.2,31.57,757.86,89,Complete Response
M212701,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.2,60.12,452.13,97,Stable Disease
M212702,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.0,44.44,447.37,82,Unknown
M212703,47,Female,HPV-related Cancer,KEYTRUDA only,74.26,40.15,1128.2,107,Partial Response
M212704,25,Other,HPV-related Cancer,KEYTRUDA only,25.05,26.66,955.1,81,Stable Disease
M212705,48,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.16,35.0,1350.75,83,Progression
M212706,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.43,39.06,1108.84,81,Partial Response
M212707,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,48.25,37.6,1355.97,83,Progression
M212708,42,Male,Melanoma,mrna-4157 + keytruda,12.33,11.16,1381.63,95,Stable Disease
M212709,83,Male,Melanoma,KEYTRUDA only,29.24,25.44,1036.28,73,Progression
M212710,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.18,38.05,566.03,93,Partial Response
M212711,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.63,18.25,1444.73,96,Partial Response
M212712,51,Male,HPV-related Cancer,mrna-4157 + keytruda,62.23,65.85,253.76,96,Progression
M212713,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,97.51,51.57,1009.93,87,Stable Disease
M212714,82,Other,Melanoma,mrna-4157 + keytruda,60.91,41.62,721.22,94,
M212715,32,Other,Melanoma,mrna-4157 + keytruda,59.76,41.38,993.09,85,Partial Response
M212716,55,Other,HPV-related Cancer,mrna-4157 + keytruda,66.2,37.17,1029.65,88,Complete Response
M212717,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.43,29.3,976.15,90,Stable Disease
M212718,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.46,37.94,874.66,76,Progression
M212719,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.9,17.62,797.6,103,Stable Disease
M212720,77,Male,HPV-related Cancer,KEYTRUDA only,92.48,72.28,1811.23,77,Complete Response
M212721,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.19,57.34,926.54,91,Progression
M212722,73,Female,HPV-related Cancer,KEYTRUDA only,67.55,43.36,698.58,85,Progression
M212723,40,Other,Melanoma,KEYTRUDA only,71.98,39.86,749.23,85,Complete Response
M212724,68,Male,Melanoma,mrna-4157 + keytruda,20.09,18.51,957.71,105,Complete Response
M212725,34,Female,Melanoma,KEYTRUDA only,61.91,,1644.91,80,Stable Disease
M212726,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.37,28.6,1703.53,75,Partial Response
M212727,74,Male,HPV-related Cancer,KEYTRUDA only,51.34,33.83,849.08,88,Progression
M212728,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.58,37.47,682.72,76,Partial Response
M212729,44,Other,HPV-related Cancer,mrna-4157 + keytruda,47.81,57.26,1224.08,103,Partial Response
M212730,74,Female,HPV-related Cancer,mrna-4157 + keytruda,34.21,35.84,512.0,86,Stable Disease
M212731,33,Female,HPV-related Cancer,mrna-4157 + keytruda,50.75,44.91,1245.26,95,Stable Disease
M212732,25,Female,HPV-related Cancer,mrna-4157 + keytruda,46.61,40.51,1065.02,106,Stable Disease
M212733,75,Male,HPV-related Cancer,mrna-4157 + keytruda,43.9,32.35,652.29,78,Complete Response
M212734,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.02,,774.61,83,Progression
M212735,30,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.55,38.27,398.55,100,Progression
M212736,65,Male,Melanoma,KEYTRUDA only,64.66,50.33,732.92,87,Complete Response
M212737,84,Male,HPV-related Cancer,KEYTRUDA only,18.91,14.41,1254.5,91,Progression
M212738,52,Male,HPV-related Cancer,mrna-4157 + keytruda,49.02,25.33,922.0,93,Stable Disease
M212739,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.47,36.42,1375.66,91,
M212740,41,Male,HPV-related Cancer,KEYTRUDA only,39.96,29.28,758.75,79,
M212741,32,Other,HPV-related Cancer,mrna-4157 + keytruda,25.81,25.7,800.92,112,Partial Response
M212742,46,Male,Melanoma,mrna-4157 + keytruda,61.24,55.67,1494.8,91,Unknown
M212743,82,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.59,20.2,909.19,103,Stable Disease
M212744,67,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.83,37.98,1247.63,81,Stable Disease
M212745,61,Male,HPV-related Cancer,mrna-4157 + keytruda,98.15,81.95,1131.45,82,Complete Response
M212746,82,Other,HPV-related Cancer,mrna-4157 + keytruda,38.41,9.14,1296.34,88,Unknown
M212747,42,Other,HPV-related Cancer,KEYTRUDA only,57.66,35.42,1589.19,94,Stable Disease
M212748,67,Male,Melanoma,KEYTRUDA only,66.42,49.74,552.04,99,Partial Response
M212749,75,Female,HPV-related Cancer,KEYTRUDA only,51.22,53.15,452.54,77,Stable Disease
M212750,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.39,40.12,1010.3,81,Partial Response
M212751,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.38,42.55,851.62,84,Partial Response
M212752,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.51,22.93,624.84,83,
M212753,26,Female,HPV-related Cancer,KEYTRUDA only,60.82,40.63,1209.77,112,Complete Response
M212754,59,Male,Melanoma,mrna-4157 + keytruda,71.83,62.55,1213.82,75,Partial Response
M212755,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.13,32.65,727.69,95,Complete Response
M212756,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.34,,,86,Progression
M212757,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.65,68.23,1236.92,83,Stable Disease
M212758,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.78,48.76,1214.87,108,Stable Disease
M212759,32,Male,HPV-related Cancer,mrna-4157 + keytruda,48.14,42.64,1170.32,71,Unknown
M212760,74,Other,HPV-related Cancer,KEYTRUDA only,9.24,4.57,1418.02,86,Stable Disease
M212761,29,Other,Melanoma,KEYTRUDA only,21.83,15.31,1713.56,87,Complete Response
M212762,44,Female,Melanoma,mrna-4157 + keytruda,31.82,,1450.88,84,Complete Response
M212763,60,Male,Melanoma,mrna-4157 + keytruda,31.03,27.01,400.61,88,Complete Response
M212764,79,Other,Melanoma,KEYTRUDA only,58.06,22.82,339.28,93,Stable Disease
M212765,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,61.51,54.78,734.59,106,Complete Response
M212766,31,Other,Melanoma,mrna-4157 + keytruda,53.89,43.8,560.63,113,Partial Response
M212767,65,Male,Melanoma,mrna-4157 + keytruda,48.12,40.49,1199.4,99,Stable Disease
M212768,30,Other,HPV-related Cancer,KEYTRUDA only,44.38,30.99,1029.98,88,Partial Response
M212769,57,Female,Melanoma,mrna-4157 + keytruda,40.5,40.8,1269.75,101,Stable Disease
M212770,56,Male,HPV-related Cancer,KEYTRUDA only,37.29,28.58,1045.17,102,Stable Disease
M212771,45,Other,Melanoma,mrna-4157 + keytruda,25.38,16.01,1322.58,97,Stable Disease
M212772,32,Male,HPV-related Cancer,mrna-4157 + keytruda,19.95,17.55,1229.45,70,Progression
M212773,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.23,90.66,1588.36,104,Partial Response
M212774,31,Female,Melanoma,mrna-4157 + keytruda,67.59,77.09,1264.71,74,Partial Response
M212775,33,Other,HPV-related Cancer,KEYTRUDA only,72.74,37.41,1232.24,93,Stable Disease
M212776,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.64,32.47,834.44,92,Stable Disease
M212777,32,Male,Melanoma,mrna-4157 + keytruda,68.04,44.36,1295.21,76,Progression
M212778,33,Female,Melanoma,mrna-4157 + keytruda,65.92,59.71,586.42,83,Progression
M212779,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.8,30.85,1454.84,84,Partial Response
M212780,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,31.34,22.75,865.51,101,Progression
M212781,44,Other,Melanoma,mrna-4157 + keytruda,59.33,70.37,1463.22,96,Unknown
M212782,25,Male,HPV-related Cancer,mrna-4157 + keytruda,43.05,32.11,753.77,69,Partial Response
M212783,37,Other,HPV-related Cancer,mrna-4157 + keytruda,62.36,55.81,491.98,81,Partial Response
M212784,33,Male,HPV-related Cancer,KEYTRUDA only,42.4,16.01,1287.22,86,
M212785,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,26.31,20.7,927.19,102,Partial Response
M212786,60,Female,Melanoma,KEYTRUDA only,51.65,17.35,975.14,74,Stable Disease
M212787,64,Other,HPV-related Cancer,KEYTRUDA only,57.0,43.87,1450.31,91,Progression
M212788,63,Male,HPV-related Cancer,mrna-4157 + keytruda,32.32,31.82,761.54,101,Stable Disease
M212789,45,Male,HPV-related Cancer,mrna-4157 + keytruda,36.64,32.4,981.17,87,Partial Response
M212790,45,Female,HPV-related Cancer,KEYTRUDA only,35.76,,1020.83,86,Partial Response
M212791,52,Female,Melanoma,KEYTRUDA only,63.82,51.19,769.62,84,Stable Disease
M212792,50,Female,Melanoma,KEYTRUDA only,37.62,30.99,799.23,83,Stable Disease
M212793,42,Male,HPV-related Cancer,mrna-4157 + keytruda,59.49,58.01,,102,Partial Response
M212794,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.14,34.18,1102.18,84,Progression
M212795,30,Other,Melanoma,mrna-4157 + keytruda,26.48,15.43,712.02,93,Partial Response
M212796,59,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.03,17.41,830.66,83,Partial Response
M212797,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,10.81,10.11,933.3,111,Partial Response
M212798,33,Other,Melanoma,mrna-4157 + keytruda,57.52,44.73,968.36,80,Partial Response
M212799,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.8,19.31,837.87,107,Stable Disease
M212800,81,Other,HPV-related Cancer,KEYTRUDA only,47.27,60.45,726.63,105,Complete Response
M212801,61,Other,HPV-related Cancer,KEYTRUDA only,41.86,15.8,999.43,90,Partial Response
M212802,63,Other,Melanoma,mrna-4157 + keytruda,74.95,46.46,1729.04,101,Stable Disease
M212803,56,Other,HPV-related Cancer,mrna-4157 + keytruda,47.28,48.8,1466.91,93,Stable Disease
M212804,61,Female,HPV-related Cancer,mrna-4157 + keytruda,51.72,26.6,963.21,76,Partial Response
M212805,43,Male,HPV-related Cancer,mrna-4157 + keytruda,47.54,30.4,592.0,89,Progression
M212806,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.67,47.39,1749.41,85,Partial Response
M212807,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.66,56.73,678.46,93,Stable Disease
M212808,83,Female,Melanoma,mrna-4157 + keytruda,73.3,34.34,1177.39,90,
M212809,53,Other,Melanoma,KEYTRUDA only,6.97,4.72,913.73,82,Partial Response
M212810,51,Female,HPV-related Cancer,mrna-4157 + keytruda,80.41,86.64,237.5,92,Stable Disease
M212811,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.89,16.87,208.92,94,Unknown
M212812,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.54,42.83,673.0,115,Progression
M212813,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.99,42.99,289.55,81,Progression
M212814,76,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.54,66.72,726.36,95,Complete Response
M212815,55,Female,HPV-related Cancer,KEYTRUDA only,74.35,55.64,911.42,92,Partial Response
M212816,30,Female,Melanoma,mrna-4157 + keytruda,51.71,33.91,1744.24,79,Stable Disease
M212817,25,Male,Melanoma,KEYTRUDA only,25.55,24.78,1049.3,110,Partial Response
M212818,67,Female,Melanoma,KEYTRUDA only,46.96,40.59,1123.72,88,Complete Response
M212819,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.98,34.35,1700.91,87,Partial Response
M212820,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.29,68.55,397.66,102,Partial Response
M212821,80,Male,HPV-related Cancer,mrna-4157 + keytruda,53.74,33.49,966.06,86,Partial Response
M212822,52,Other,HPV-related Cancer,KEYTRUDA only,34.26,24.7,1075.64,95,Progression
M212823,53,Other,HPV-related Cancer,mrna-4157 + keytruda,60.33,28.88,884.6,87,Progression
M212824,26,Female,HPV-related Cancer,KEYTRUDA only,12.14,11.0,847.0,87,Complete Response
M212825,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,15.69,12.31,772.02,95,Progression
M212826,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.06,58.05,1408.83,103,
M212827,75,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.07,30.66,202.76,92,Partial Response
M212828,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.86,39.4,1133.66,75,
M212829,69,Male,Melanoma,KEYTRUDA only,42.78,27.35,,86,Partial Response
M212830,61,Other,Melanoma,mrna-4157 + keytruda,47.27,38.46,845.58,88,Stable Disease
M212831,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.9,,1315.2,82,Partial Response
M212832,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.34,,5229.5,83,Progression
M212833,68,Male,HPV-related Cancer,KEYTRUDA only,38.71,31.99,756.31,81,Partial Response
M212834,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.62,25.88,2116.45,95,Progression
M212835,53,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.66,35.12,581.67,82,Partial Response
M212836,56,Female,HPV-related Cancer,mrna-4157 + keytruda,80.01,70.24,785.6,79,Progression
M212837,66,Female,Melanoma,KEYTRUDA only,33.29,24.42,1588.55,84,Partial Response
M212838,38,Female,HPV-related Cancer,mrna-4157 + keytruda,53.86,40.08,943.29,98,Unknown
M212839,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.7,16.52,755.48,88,Progression
M212840,37,Male,Melanoma,KEYTRUDA only,64.95,72.37,2383.47,83,Progression
M212841,49,Male,Melanoma,mrna-4157 + keytruda,37.67,27.47,1332.3,76,Complete Response
M212842,53,Male,HPV-related Cancer,mrna-4157 + keytruda,55.73,38.12,1165.3,103,Stable Disease
M212843,37,Other,HPV-related Cancer,KEYTRUDA only,32.72,28.15,559.42,104,Partial Response
M212844,55,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.3,28.18,614.6,92,Complete Response
M212845,47,Male,HPV-related Cancer,KEYTRUDA only,39.86,35.72,1111.87,86,Complete Response
M212846,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,97.16,66.74,1439.6,99,Partial Response
M212847,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.02,44.32,531.48,78,Unknown
M212848,39,Male,Melanoma,mrna-4157 + keytruda,25.9,15.15,1120.31,94,Partial Response
M212849,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.09,50.43,,91,Stable Disease
M212850,60,Other,Melanoma,KEYTRUDA only,72.21,27.18,643.77,94,Stable Disease
M212851,51,Male,Melanoma,KEYTRUDA only,73.27,58.27,1072.04,81,Progression
M212852,47,Other,Melanoma,KEYTRUDA only,65.5,64.25,,90,Progression
M212853,61,Female,Melanoma,KEYTRUDA only,35.53,27.78,777.72,103,Progression
M212854,43,Female,HPV-related Cancer,mrna-4157 + keytruda,68.37,68.05,1560.51,94,
M212855,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.32,18.53,771.45,101,Progression
M212856,62,Female,Melanoma,mrna-4157 + keytruda,74.98,44.03,1121.38,99,Partial Response
M212857,69,Female,Melanoma,mrna-4157 + keytruda,60.78,48.75,427.89,94,Complete Response
M212858,39,Female,Melanoma,mrna-4157 + keytruda,71.04,48.75,1279.6,103,Partial Response
M212859,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,17.4,9.15,577.52,102,Progression
M212860,72,Other,HPV-related Cancer,mrna-4157 + keytruda,70.43,50.33,584.57,114,Stable Disease
M212861,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.72,21.35,1090.09,76,Stable Disease
M212862,58,Other,HPV-related Cancer,mrna-4157 + keytruda,26.13,29.82,1309.87,83,Complete Response
M212863,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.45,,1757.86,88,Progression
M212864,44,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.4,31.57,1405.92,93,Progression
M212865,82,Male,HPV-related Cancer,KEYTRUDA only,63.75,70.76,555.62,90,
M212866,71,Male,Melanoma,mrna-4157 + keytruda,39.2,26.64,708.73,82,Complete Response
M212867,56,Male,Melanoma,mrna-4157 + keytruda,50.75,44.21,971.8,81,Partial Response
M212868,46,Male,Melanoma,mrna-4157 + keytruda,32.23,24.9,473.24,93,Progression
M212869,26,Male,Melanoma,mrna-4157 + keytruda,57.41,39.69,1764.69,96,Partial Response
M212870,52,Other,Melanoma,mrna-4157 + keytruda,46.38,34.54,1652.22,103,Progression
M212871,46,Female,HPV-related Cancer,mrna-4157 + keytruda,39.61,31.67,809.56,96,Stable Disease
M212872,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.18,43.71,890.81,87,Progression
M212873,52,Male,HPV-related Cancer,KEYTRUDA only,48.27,40.98,846.42,89,Partial Response
M212874,45,Male,HPV-related Cancer,mrna-4157 + keytruda,21.5,13.04,985.41,92,Complete Response
M212875,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.37,35.84,1954.44,98,Progression
M212876,34,Male,Melanoma,mrna-4157 + keytruda,57.13,51.88,1111.01,87,Partial Response
M212877,41,Other,HPV-related Cancer,KEYTRUDA only,17.22,15.26,1498.46,82,Unknown
M212878,49,Male,HPV-related Cancer,mrna-4157 + keytruda,64.24,45.32,835.24,93,
M212879,27,Female,HPV-related Cancer,mrna-4157 + keytruda,48.79,43.35,1213.91,85,Complete Response
M212880,28,Male,Melanoma,mrna-4157 + keytruda,64.67,,1419.21,95,Progression
M212881,42,Other,Melanoma,KEYTRUDA only,39.9,38.73,447.2,88,Partial Response
M212882,65,Female,HPV-related Cancer,KEYTRUDA only,43.53,39.84,1314.95,99,Stable Disease
M212883,53,Female,HPV-related Cancer,KEYTRUDA only,95.6,66.83,1224.48,108,Complete Response
M212884,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.8,72.52,148.44,93,Progression
M212885,84,Female,Melanoma,mrna-4157 + keytruda,19.97,15.27,712.24,96,Stable Disease
M212886,43,Other,Melanoma,KEYTRUDA only,40.5,42.74,1032.15,89,Complete Response
M212887,29,Female,Melanoma,mrna-4157 + keytruda,38.01,,710.06,94,Complete Response
M212888,59,Female,HPV-related Cancer,KEYTRUDA only,71.33,46.18,948.88,96,
M212889,57,Male,HPV-related Cancer,mrna-4157 + keytruda,31.97,27.83,1257.27,87,Progression
M212890,55,Other,HPV-related Cancer,mrna-4157 + keytruda,71.44,68.72,250.14,86,Partial Response
M212891,25,Male,Melanoma,mrna-4157 + keytruda,50.92,43.33,959.15,99,Partial Response
M212892,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.26,37.33,1251.67,89,Complete Response
M212893,34,Male,HPV-related Cancer,KEYTRUDA only,43.47,34.01,1031.82,87,Progression
M212894,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.75,33.1,1464.3,100,Stable Disease
M212895,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.58,23.09,1752.53,88,Stable Disease
M212896,77,Other,HPV-related Cancer,mrna-4157 + keytruda,42.14,33.84,1129.05,99,Progression
M212897,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.84,55.89,640.8,93,Partial Response
M212898,78,Male,Melanoma,KEYTRUDA only,40.44,29.31,1041.89,95,Complete Response
M212899,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.92,41.4,440.76,86,Partial Response
M212900,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,30.4,19.89,907.02,89,Complete Response
M212901,51,Other,HPV-related Cancer,KEYTRUDA only,75.3,44.66,369.56,84,Progression
M212902,35,Female,HPV-related Cancer,mrna-4157 + keytruda,74.11,48.53,630.05,83,Partial Response
M212903,25,Other,Melanoma,mrna-4157 + keytruda,42.34,35.55,531.75,91,Partial Response
M212904,56,Male,HPV-related Cancer,KEYTRUDA only,18.63,11.84,880.37,87,Stable Disease
M212905,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,10.3,10.23,1274.13,95,Complete Response
M212906,41,Male,HPV-related Cancer,mrna-4157 + keytruda,76.14,92.39,1561.94,99,Partial Response
M212907,77,Other,Melanoma,KEYTRUDA only,5.62,4.7,479.62,119,Complete Response
M212908,39,Female,HPV-related Cancer,KEYTRUDA only,63.48,56.81,1618.32,99,Partial Response
M212909,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.07,,,85,Progression
M212910,66,Female,Melanoma,mrna-4157 + keytruda,38.3,30.36,1172.49,91,Stable Disease
M212911,75,Female,Melanoma,KEYTRUDA only,95.89,69.19,1022.92,98,Stable Disease
M212912,40,Female,HPV-related Cancer,mrna-4157 + keytruda,33.39,25.7,957.79,98,Stable Disease
M212913,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.99,58.28,533.04,99,Partial Response
M212914,61,Male,Melanoma,KEYTRUDA only,71.53,78.87,1508.42,93,Partial Response
M212915,82,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.05,46.97,1614.03,88,Complete Response
M212916,29,Other,Melanoma,mrna-4157 + keytruda,65.62,59.52,430.4,107,Stable Disease
M212917,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.53,50.96,1164.67,107,Progression
M212918,75,Female,HPV-related Cancer,KEYTRUDA only,70.02,51.16,1330.17,87,Complete Response
M212919,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.82,33.58,963.41,85,Complete Response
M212920,63,Other,Melanoma,mrna-4157 + keytruda,53.53,53.27,636.85,105,Unknown
M212921,64,Male,Melanoma,KEYTRUDA only,27.99,20.63,1208.41,86,
M212922,35,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.07,1.42,1407.42,88,
M212923,59,Female,HPV-related Cancer,mrna-4157 + keytruda,61.77,,772.44,88,Progression
M212924,70,Other,Melanoma,mrna-4157 + keytruda,73.93,64.2,827.52,88,Complete Response
M212925,59,Female,Melanoma,mrna-4157 + keytruda,39.01,43.43,149.89,84,Stable Disease
M212926,35,Other,HPV-related Cancer,KEYTRUDA only,31.49,19.69,1700.42,97,Stable Disease
M212927,56,Female,Melanoma,KEYTRUDA only,46.7,44.65,1280.25,85,Partial Response
M212928,25,Male,HPV-related Cancer,mrna-4157 + keytruda,64.3,84.68,729.91,110,
M212929,71,Other,HPV-related Cancer,KEYTRUDA only,36.24,20.38,507.26,106,Stable Disease
M212930,53,Female,HPV-related Cancer,mrna-4157 + keytruda,69.05,47.7,486.31,91,Stable Disease
M212931,32,Male,HPV-related Cancer,mrna-4157 + keytruda,25.25,18.11,943.6,99,Progression
M212932,53,Male,HPV-related Cancer,mrna-4157 + keytruda,37.08,37.42,1919.67,106,Complete Response
M212933,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.41,33.59,790.94,84,Progression
M212934,79,Female,Melanoma,mrna-4157 + keytruda,25.24,24.57,1369.6,88,Stable Disease
M212935,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,33.28,22.52,1270.7,83,Partial Response
M212936,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.36,40.57,685.61,91,Unknown
M212937,27,Female,HPV-related Cancer,mrna-4157 + keytruda,67.23,89.47,,96,Progression
M212938,37,Other,Melanoma,mrna-4157 + keytruda,59.49,49.2,1303.32,90,Partial Response
M212939,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,100.47,80.52,1074.87,93,Complete Response
M212940,53,Female,HPV-related Cancer,KEYTRUDA only,71.15,24.4,932.04,90,Complete Response
M212941,35,Male,Melanoma,KEYTRUDA only,41.6,37.55,1207.58,95,Unknown
M212942,72,Female,Melanoma,KEYTRUDA only,45.75,49.57,1775.15,83,Complete Response
M212943,71,Female,Melanoma,KEYTRUDA only,58.43,45.25,378.16,101,Progression
M212944,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,67.64,73.88,,96,Partial Response
M212945,64,Female,HPV-related Cancer,KEYTRUDA only,67.16,52.94,1306.9499999999998,91,Stable Disease
M212946,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.71,36.31,1147.49,94,Stable Disease
M212947,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.24,34.5,255.93,89,Stable Disease
M212948,62,Male,HPV-related Cancer,mrna-4157 + keytruda,65.78,69.18,1340.17,91,Unknown
M212949,42,Female,HPV-related Cancer,KEYTRUDA only,46.4,,394.73,77,Progression
M212950,59,Female,HPV-related Cancer,KEYTRUDA only,44.93,36.79,928.43,89,Partial Response
M212951,57,Female,Melanoma,mrna-4157 + keytruda,37.66,21.91,558.18,88,
M212952,69,Other,HPV-related Cancer,KEYTRUDA only,68.04,60.64,,89,Partial Response
M212953,27,Female,HPV-related Cancer,KEYTRUDA only,59.81,47.45,440.34,96,Progression
M212954,78,Other,Melanoma,KEYTRUDA only,45.26,53.05,307.58,98,Stable Disease
M212955,44,Other,Melanoma,mrna-4157 + keytruda,39.74,32.62,1085.82,96,Partial Response
M212956,37,Male,HPV-related Cancer,mrna-4157 + keytruda,54.42,55.02,1498.98,89,Partial Response
M212957,79,Female,Non-small Cell Lung Cancer,KEYTRUDA only,38.37,40.1,490.33,88,Unknown
M212958,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.64,32.72,808.68,92,Partial Response
M212959,66,Female,HPV-related Cancer,KEYTRUDA only,20.88,3.68,1359.15,75,Stable Disease
M212960,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.75,20.84,1361.1,99,Progression
M212961,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.93,74.55,1561.13,87,Partial Response
M212962,35,Male,Melanoma,mrna-4157 + keytruda,39.55,37.76,450.36,96,Stable Disease
M212963,75,Other,Melanoma,mrna-4157 + keytruda,57.05,29.99,351.51,80,Partial Response
M212964,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.05,61.39,1322.97,91,Stable Disease
M212965,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,98.0,71.42,830.42,85,Partial Response
M212966,53,Other,Melanoma,KEYTRUDA only,26.43,22.13,170.66,68,Unknown
M212967,51,Male,HPV-related Cancer,mrna-4157 + keytruda,26.77,14.09,1335.37,84,Unknown
M212968,67,Other,Melanoma,mrna-4157 + keytruda,18.12,9.75,747.3,83,Partial Response
M212969,58,Other,HPV-related Cancer,mrna-4157 + keytruda,51.84,40.65,653.14,104,
M212970,80,Female,HPV-related Cancer,mrna-4157 + keytruda,85.82,49.77,1218.25,89,Partial Response
M212971,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.85,39.22,725.1,89,Complete Response
M212972,59,Other,HPV-related Cancer,mrna-4157 + keytruda,82.99,83.8,288.64,110,
M212973,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.61,31.04,1303.31,84,Partial Response
M212974,73,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.48,32.6,1555.76,92,Stable Disease
M212975,82,Female,HPV-related Cancer,mrna-4157 + keytruda,51.67,61.45,1139.33,88,Partial Response
M212976,55,Female,HPV-related Cancer,mrna-4157 + keytruda,50.54,27.03,719.71,106,Unknown
M212977,48,Female,Non-small Cell Lung Cancer,KEYTRUDA only,56.07,46.39,1386.86,95,Partial Response
M212978,43,Female,Melanoma,KEYTRUDA only,49.75,44.98,1195.15,103,Partial Response
M212979,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.65,29.41,402.43,86,Partial Response
M212980,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.72,29.56,1245.65,75,Stable Disease
M212981,27,Other,HPV-related Cancer,mrna-4157 + keytruda,64.37,38.86,1605.89,91,Stable Disease
M212982,46,Other,Melanoma,KEYTRUDA only,70.79,76.26,1434.3,101,Stable Disease
M212983,84,Female,HPV-related Cancer,KEYTRUDA only,35.34,36.93,814.53,95,Stable Disease
M212984,61,Male,Melanoma,mrna-4157 + keytruda,60.76,31.52,565.51,99,Stable Disease
M212985,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.28,46.79,1164.77,82,Stable Disease
M212986,69,Other,Melanoma,mrna-4157 + keytruda,82.96,65.42,1287.59,74,Stable Disease
M212987,27,Female,Melanoma,mrna-4157 + keytruda,55.47,44.63,1108.29,105,Partial Response
M212988,49,Other,Melanoma,KEYTRUDA only,65.21,42.19,1129.05,83,Progression
M212989,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.88,,966.26,92,Progression
M212990,52,Female,HPV-related Cancer,mrna-4157 + keytruda,46.81,60.11,933.27,93,Partial Response
M212991,43,Female,HPV-related Cancer,mrna-4157 + keytruda,32.2,22.92,1184.35,102,Progression
M212992,49,Female,Melanoma,mrna-4157 + keytruda,32.98,29.88,916.14,74,Progression
M212993,55,Female,Melanoma,KEYTRUDA only,63.67,58.7,1083.76,92,Progression
M212994,61,Female,HPV-related Cancer,mrna-4157 + keytruda,78.78,94.03,920.62,92,Partial Response
M212995,32,Female,Melanoma,KEYTRUDA only,66.98,18.36,629.24,87,Partial Response
M212996,68,Female,Melanoma,KEYTRUDA only,46.11,19.28,674.23,85,Stable Disease
M212997,37,Other,Melanoma,KEYTRUDA only,60.59,52.3,1095.36,96,Partial Response
M212998,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,65.92,60.48,1125.4,75,Unknown
M212999,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.83,62.08,976.2,84,Complete Response
M213000,34,Female,HPV-related Cancer,KEYTRUDA only,55.59,29.98,1543.15,90,Partial Response
M213001,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.45,47.64,1411.72,93,Progression
M213002,61,Female,HPV-related Cancer,mrna-4157 + keytruda,59.48,42.73,809.39,89,Partial Response
M213003,36,Female,Melanoma,mrna-4157 + keytruda,13.85,12.53,545.55,93,Partial Response
M213004,53,Female,HPV-related Cancer,mrna-4157 + keytruda,40.78,34.75,841.07,66,Progression
M213005,66,Male,HPV-related Cancer,KEYTRUDA only,61.91,68.35,1099.51,102,Stable Disease
M213006,61,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.82,44.86,1471.82,89,Partial Response
M213007,43,Other,HPV-related Cancer,mrna-4157 + keytruda,39.61,30.85,628.68,76,Complete Response
M213008,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.6,54.33,,90,Stable Disease
M213009,80,Male,Melanoma,mrna-4157 + keytruda,43.79,26.46,483.23,80,Stable Disease
M213010,55,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.93,17.47,666.98,97,Partial Response
M213011,27,Female,Melanoma,mrna-4157 + keytruda,79.71,65.4,890.76,85,Complete Response
M213012,58,Male,Melanoma,KEYTRUDA only,41.53,53.18,755.26,97,Partial Response
M213013,65,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,89.48,,593.94,108,Partial Response
M213014,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.01,32.09,1134.92,80,Stable Disease
M213015,47,Male,HPV-related Cancer,mrna-4157 + keytruda,85.71,72.09,1005.54,98,Progression
M213016,37,Male,HPV-related Cancer,KEYTRUDA only,43.34,26.77,649.93,79,Partial Response
M213017,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,48.63,48.56,1555.18,85,Progression
M213018,40,Male,Melanoma,KEYTRUDA only,45.21,48.17,880.34,109,Partial Response
M213019,28,Male,Melanoma,KEYTRUDA only,21.62,21.4,781.69,94,Progression
M213020,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.08,24.2,916.98,85,Complete Response
M213021,69,Other,Melanoma,KEYTRUDA only,79.13,50.51,1332.64,94,Partial Response
M213022,30,Other,HPV-related Cancer,mrna-4157 + keytruda,20.08,13.36,1262.32,79,Complete Response
M213023,75,Male,Melanoma,mrna-4157 + keytruda,55.33,47.88,938.14,87,Stable Disease
M213024,46,Male,HPV-related Cancer,KEYTRUDA only,41.85,33.7,1105.23,96,Stable Disease
M213025,80,Female,Melanoma,KEYTRUDA only,57.03,61.43,555.06,84,Partial Response
M213026,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.39,46.08,571.77,96,
M213027,38,Female,Melanoma,KEYTRUDA only,45.27,25.93,825.34,80,Stable Disease
M213028,66,Male,HPV-related Cancer,mrna-4157 + keytruda,68.18,67.31,,106,Stable Disease
M213029,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.52,25.92,685.92,93,Progression
M213030,25,Female,Melanoma,mrna-4157 + keytruda,59.55,45.37,994.99,88,Stable Disease
M213031,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.4,36.25,512.53,102,Complete Response
M213032,52,Other,Melanoma,KEYTRUDA only,60.18,56.53,998.66,85,Complete Response
M213033,62,Male,HPV-related Cancer,mrna-4157 + keytruda,38.3,21.7,1189.05,99,
M213034,33,Other,HPV-related Cancer,KEYTRUDA only,14.65,11.93,-45.08,90,Stable Disease
M213035,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.03,23.51,1061.06,96,Partial Response
M213036,76,Other,HPV-related Cancer,KEYTRUDA only,66.29,33.09,1825.12,78,Stable Disease
M213037,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.34,38.36,1004.48,93,Progression
M213038,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.07,21.21,818.22,85,Partial Response
M213039,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.64,68.52,1032.76,79,Partial Response
M213040,62,Male,Melanoma,mrna-4157 + keytruda,62.09,34.92,1156.06,105,
M213041,65,Female,Melanoma,mrna-4157 + keytruda,49.23,23.8,1370.59,83,Partial Response
M213042,53,Male,HPV-related Cancer,mrna-4157 + keytruda,54.33,32.64,548.21,89,Complete Response
M213043,66,Female,HPV-related Cancer,KEYTRUDA only,60.19,30.16,1163.89,106,Progression
M213044,64,Male,HPV-related Cancer,mrna-4157 + keytruda,52.23,48.01,678.98,109,Complete Response
M213045,37,Male,HPV-related Cancer,mrna-4157 + keytruda,67.97,58.27,634.13,98,Progression
M213046,45,Other,HPV-related Cancer,mrna-4157 + keytruda,23.22,23.06,434.31,72,Complete Response
M213047,80,Other,Melanoma,KEYTRUDA only,119.71,99.93,-18.81,100,Partial Response
M213048,76,Male,Melanoma,mrna-4157 + keytruda,16.29,13.59,794.93,107,Progression
M213049,43,Other,HPV-related Cancer,mrna-4157 + keytruda,55.13,24.4,755.8,97,Progression
M213050,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.17,20.1,631.49,89,Stable Disease
M213051,52,Female,Melanoma,mrna-4157 + keytruda,51.25,,1511.57,85,Stable Disease
M213052,45,Male,Melanoma,mrna-4157 + keytruda,9.04,8.3,549.99,89,Partial Response
M213053,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.69,40.01,609.87,91,Stable Disease
M213054,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,77.18,63.68,989.6,70,Stable Disease
M213055,44,Male,Melanoma,KEYTRUDA only,77.4,66.06,473.78,79,Unknown
M213056,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.29,28.84,1394.08,97,Stable Disease
M213057,73,Female,HPV-related Cancer,mrna-4157 + keytruda,46.84,44.21,,78,Stable Disease
M213058,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.49,,1032.12,89,Stable Disease
M213059,79,Other,Melanoma,mrna-4157 + keytruda,63.78,59.69,138.03,92,Complete Response
M213060,45,Other,Melanoma,mrna-4157 + keytruda,43.66,35.84,726.19,89,Stable Disease
M213061,28,Male,Melanoma,KEYTRUDA only,60.78,66.37,1040.63,102,Partial Response
M213062,63,Female,Melanoma,KEYTRUDA only,63.67,47.74,678.67,107,Partial Response
M213063,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.94,24.78,757.85,76,Stable Disease
M213064,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.04,22.61,1154.52,98,Stable Disease
M213065,78,Female,HPV-related Cancer,KEYTRUDA only,41.74,34.91,515.35,94,Stable Disease
M213066,71,Other,Melanoma,mrna-4157 + keytruda,60.33,63.18,876.51,99,Partial Response
M213067,34,Female,HPV-related Cancer,KEYTRUDA only,14.54,,818.38,91,Complete Response
M213068,75,Female,Melanoma,mrna-4157 + keytruda,56.45,45.27,1033.24,100,Partial Response
M213069,54,Female,Melanoma,mrna-4157 + keytruda,36.73,23.02,916.19,94,Stable Disease
M213070,68,Female,Melanoma,KEYTRUDA only,44.67,35.22,1249.87,83,Partial Response
M213071,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,29.0,28.12,827.34,111,Progression
M213072,39,Male,Melanoma,KEYTRUDA only,37.32,30.14,1242.39,78,Progression
M213073,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.11,42.57,545.39,73,Stable Disease
M213074,62,Other,HPV-related Cancer,KEYTRUDA only,48.37,32.91,1116.03,82,Partial Response
M213075,59,Male,HPV-related Cancer,mrna-4157 + keytruda,69.21,52.36,1156.83,88,Partial Response
M213076,37,Female,HPV-related Cancer,mrna-4157 + keytruda,9.97,13.12,1160.74,103,Stable Disease
M213077,66,Male,Melanoma,KEYTRUDA only,28.36,18.01,1053.22,87,Stable Disease
M213078,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.07,61.75,1093.16,107,Unknown
M213079,32,Female,HPV-related Cancer,mrna-4157 + keytruda,30.03,16.11,1039.73,97,Partial Response
M213080,79,Other,Melanoma,KEYTRUDA only,30.48,24.31,456.37,103,Stable Disease
M213081,58,Female,HPV-related Cancer,mrna-4157 + keytruda,66.56,27.52,733.15,73,Progression
M213082,44,Female,Melanoma,mrna-4157 + keytruda,23.32,20.54,1075.55,94,Partial Response
M213083,54,Female,HPV-related Cancer,KEYTRUDA only,68.83,56.97,377.36,101,Partial Response
M213084,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.85,57.08,870.53,95,Stable Disease
M213085,49,Male,HPV-related Cancer,KEYTRUDA only,68.77,65.25,1388.26,108,Progression
M213086,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.1,57.26,687.1,104,Stable Disease
M213087,57,Female,HPV-related Cancer,KEYTRUDA only,11.67,9.12,781.26,83,Stable Disease
M213088,68,Other,HPV-related Cancer,KEYTRUDA only,23.21,18.25,1152.0,95,Complete Response
M213089,64,Male,Melanoma,mrna-4157 + keytruda,61.78,72.69,481.07,87,Complete Response
M213090,41,Other,Melanoma,mrna-4157 + keytruda,61.37,52.81,,100,Stable Disease
M213091,30,Female,HPV-related Cancer,mrna-4157 + keytruda,45.13,33.89,,82,Stable Disease
M213092,69,Other,HPV-related Cancer,KEYTRUDA only,36.61,24.6,756.14,76,Partial Response
M213093,61,Other,Melanoma,mrna-4157 + keytruda,76.37,67.78,545.63,97,Complete Response
M213094,36,Female,Melanoma,KEYTRUDA only,1.02,1.0,1325.51,91,Stable Disease
M213095,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.0,,1219.4,75,Stable Disease
M213096,51,Female,Melanoma,KEYTRUDA only,43.95,33.95,,95,Progression
M213097,80,Male,Melanoma,mrna-4157 + keytruda,58.96,27.36,1247.56,87,Partial Response
M213098,66,Other,HPV-related Cancer,KEYTRUDA only,102.36,78.67,1282.19,84,Unknown
M213099,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.3,60.04,1530.41,79,Stable Disease
M213100,47,Other,Non-small Cell Lung Cancer,KEYTRUDA only,37.87,36.77,987.18,86,Partial Response
M213101,43,Female,HPV-related Cancer,mrna-4157 + keytruda,23.13,,1345.58,75,Partial Response
M213102,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.89,28.16,1136.06,87,Complete Response
M213103,53,Other,Melanoma,mrna-4157 + keytruda,37.28,26.72,962.84,98,Progression
M213104,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.16,38.82,668.35,87,Unknown
M213105,48,Other,Melanoma,KEYTRUDA only,25.87,14.54,927.96,102,Progression
M213106,58,Other,HPV-related Cancer,KEYTRUDA only,78.0,31.22,1073.38,86,Unknown
M213107,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,90.81,46.37,729.53,85,
M213108,52,Male,Melanoma,mrna-4157 + keytruda,31.42,23.72,1313.91,90,Complete Response
M213109,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.72,40.71,1744.52,99,Partial Response
M213110,64,Male,HPV-related Cancer,mrna-4157 + keytruda,83.0,54.56,873.93,94,Partial Response
M213111,55,Other,HPV-related Cancer,mrna-4157 + keytruda,70.89,66.85,1148.43,83,Stable Disease
M213112,37,Other,HPV-related Cancer,mrna-4157 + keytruda,23.07,6.46,972.73,82,Stable Disease
M213113,68,Male,Melanoma,KEYTRUDA only,70.79,,1437.99,86,Stable Disease
M213114,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.32,34.21,748.39,87,Stable Disease
M213115,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.66,46.34,1038.16,94,Partial Response
M213116,47,Other,Melanoma,mrna-4157 + keytruda,72.58,75.28,1262.86,107,Unknown
M213117,60,Other,HPV-related Cancer,mrna-4157 + keytruda,57.31,50.52,891.55,95,Progression
M213118,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.77,33.38,1179.24,91,Stable Disease
M213119,70,Other,HPV-related Cancer,mrna-4157 + keytruda,52.59,35.07,828.78,86,Stable Disease
M213120,30,Male,HPV-related Cancer,mrna-4157 + keytruda,58.85,48.73,1007.21,78,Partial Response
M213121,80,Female,Melanoma,KEYTRUDA only,30.2,22.57,1218.27,90,Unknown
M213122,81,Other,HPV-related Cancer,KEYTRUDA only,64.19,41.66,669.71,94,
M213123,84,Other,Melanoma,KEYTRUDA only,54.27,23.64,1381.0,88,Unknown
M213124,49,Female,HPV-related Cancer,mrna-4157 + keytruda,29.63,22.53,1192.85,102,Stable Disease
M213125,57,Female,Melanoma,KEYTRUDA only,76.84,82.31,1469.51,108,Stable Disease
M213126,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.49,21.25,875.34,98,Complete Response
M213127,79,Female,Melanoma,KEYTRUDA only,34.36,21.06,1380.11,91,Partial Response
M213128,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,96.36,72.51,605.83,84,Stable Disease
M213129,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.22,55.92,1185.03,91,Stable Disease
M213130,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.88,30.39,670.04,88,Stable Disease
M213131,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.29,39.22,709.05,110,Stable Disease
M213132,78,Female,HPV-related Cancer,mrna-4157 + keytruda,69.66,40.21,,103,Stable Disease
M213133,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,47.33,33.05,767.77,93,Partial Response
M213134,29,Male,HPV-related Cancer,mrna-4157 + keytruda,57.67,54.65,639.87,101,Complete Response
M213135,31,Other,HPV-related Cancer,KEYTRUDA only,90.94,59.07,1753.63,88,Stable Disease
M213136,30,Male,HPV-related Cancer,mrna-4157 + keytruda,88.7,64.78,883.73,85,Partial Response
M213137,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.99,23.5,,88,
M213138,41,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.34,36.56,1467.56,89,Stable Disease
M213139,62,Other,HPV-related Cancer,mrna-4157 + keytruda,48.01,20.81,1189.54,86,Complete Response
M213140,29,Female,HPV-related Cancer,mrna-4157 + keytruda,28.48,17.83,809.4,96,Complete Response
M213141,46,Female,HPV-related Cancer,mrna-4157 + keytruda,48.75,40.32,1445.95,86,Partial Response
M213142,83,Female,HPV-related Cancer,mrna-4157 + keytruda,43.56,41.7,1021.32,83,Stable Disease
M213143,55,Other,Melanoma,mrna-4157 + keytruda,57.26,50.35,1190.07,77,Partial Response
M213144,71,Male,Melanoma,mrna-4157 + keytruda,87.46,61.64,1124.97,81,Partial Response
M213145,36,Male,Melanoma,KEYTRUDA only,19.42,13.76,749.42,87,Progression
M213146,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.58,29.47,186.71,83,Complete Response
M213147,71,Female,Non-small Cell Lung Cancer,KEYTRUDA only,51.57,65.39,948.48,105,Stable Disease
M213148,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.04,32.98,557.16,88,Unknown
M213149,80,Other,HPV-related Cancer,mrna-4157 + keytruda,62.1,52.59,607.71,113,
M213150,57,Male,HPV-related Cancer,KEYTRUDA only,18.57,15.92,1109.16,78,Progression
M213151,81,Female,Melanoma,KEYTRUDA only,32.45,25.52,813.59,72,Partial Response
M213152,82,Female,HPV-related Cancer,mrna-4157 + keytruda,23.46,10.37,1390.04,98,
M213153,72,Other,HPV-related Cancer,KEYTRUDA only,6.79,6.17,905.92,89,Progression
M213154,31,Female,Melanoma,KEYTRUDA only,67.16,72.17,1366.97,107,
M213155,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.26,52.48,1251.63,89,Partial Response
M213156,65,Female,HPV-related Cancer,KEYTRUDA only,69.22,66.63,1191.53,78,Complete Response
M213157,56,Other,Melanoma,mrna-4157 + keytruda,73.51,78.43,1104.49,90,Partial Response
M213158,75,Other,Melanoma,mrna-4157 + keytruda,35.95,31.84,1841.76,73,Stable Disease
M213159,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.12,63.92,1090.47,100,Partial Response
M213160,61,Male,Melanoma,KEYTRUDA only,81.36,55.92,1152.86,79,Stable Disease
M213161,69,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.46,53.11,1117.42,80,Stable Disease
M213162,84,Female,Melanoma,KEYTRUDA only,59.22,49.31,1142.24,80,Stable Disease
M213163,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.89,,1303.99,90,Partial Response
M213164,27,Male,Melanoma,mrna-4157 + keytruda,14.96,13.68,1694.3,88,Progression
M213165,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.36,37.22,807.33,105,Stable Disease
M213166,83,Male,Melanoma,KEYTRUDA only,57.94,,995.41,89,Complete Response
M213167,28,Other,HPV-related Cancer,mrna-4157 + keytruda,21.03,10.32,1250.57,92,Stable Disease
M213168,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.62,22.03,1174.36,100,Progression
M213169,33,Female,Melanoma,KEYTRUDA only,21.17,23.06,1027.95,92,Progression
M213170,40,Female,Melanoma,mrna-4157 + keytruda,36.07,19.93,,96,Stable Disease
M213171,26,Female,Melanoma,mrna-4157 + keytruda,43.28,18.51,410.78,87,Partial Response
M213172,60,Female,HPV-related Cancer,KEYTRUDA only,39.47,23.53,,81,Stable Disease
M213173,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.53,21.01,574.82,81,Stable Disease
M213174,59,Male,HPV-related Cancer,KEYTRUDA only,38.5,24.36,840.94,91,Partial Response
M213175,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.14,36.47,1138.69,95,Partial Response
M213176,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.67,43.25,708.75,70,Progression
M213177,43,Female,HPV-related Cancer,KEYTRUDA only,40.3,35.61,1480.06,104,Complete Response
M213178,53,Female,HPV-related Cancer,mrna-4157 + keytruda,53.62,52.7,665.4,87,Complete Response
M213179,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.14,57.07,777.89,105,Stable Disease
M213180,32,Other,HPV-related Cancer,KEYTRUDA only,41.08,,1229.42,91,Stable Disease
M213181,41,Female,Melanoma,mrna-4157 + keytruda,42.29,33.6,1239.91,90,Stable Disease
M213182,42,Other,Melanoma,mrna-4157 + keytruda,16.01,11.91,548.87,84,
M213183,37,Male,HPV-related Cancer,KEYTRUDA only,15.01,13.85,1089.98,82,Progression
M213184,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.45,30.49,894.49,78,Complete Response
M213185,39,Female,HPV-related Cancer,KEYTRUDA only,35.92,20.71,970.21,81,
M213186,71,Male,HPV-related Cancer,KEYTRUDA only,29.31,31.74,673.4,77,Partial Response
M213187,83,Male,HPV-related Cancer,mrna-4157 + keytruda,68.34,60.34,576.18,95,Progression
M213188,83,Male,HPV-related Cancer,mrna-4157 + keytruda,44.21,25.44,1071.19,103,Partial Response
M213189,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.17,39.35,1480.6,102,Progression
M213190,84,Female,HPV-related Cancer,KEYTRUDA only,65.14,,1220.44,83,
M213191,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.8,32.75,672.17,107,Complete Response
M213192,32,Male,Melanoma,mrna-4157 + keytruda,72.31,60.28,83.08,103,Progression
M213193,78,Male,Melanoma,KEYTRUDA only,44.16,36.58,1442.8,96,Partial Response
M213194,81,Male,Melanoma,mrna-4157 + keytruda,45.79,42.05,1021.59,86,Unknown
M213195,83,Male,Melanoma,KEYTRUDA only,40.31,44.26,851.8,90,Progression
M213196,31,Other,Melanoma,KEYTRUDA only,56.23,29.72,886.76,108,Stable Disease
M213197,40,Female,HPV-related Cancer,KEYTRUDA only,73.99,60.53,1159.29,84,Progression
M213198,83,Male,Melanoma,KEYTRUDA only,47.33,36.09,1344.65,91,Unknown
M213199,34,Other,Melanoma,mrna-4157 + keytruda,84.95,103.06,804.0,101,Partial Response
M213200,75,Male,Melanoma,mrna-4157 + keytruda,100.59,37.95,907.69,111,Complete Response
M213201,68,Female,HPV-related Cancer,mrna-4157 + keytruda,56.21,30.7,1026.89,93,Progression
M213202,82,Female,Melanoma,mrna-4157 + keytruda,41.22,35.05,863.78,67,Progression
M213203,81,Other,HPV-related Cancer,KEYTRUDA only,35.46,37.45,1042.45,79,Complete Response
M213204,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.43,78.97,1336.06,90,Partial Response
M213205,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.29,31.35,1465.18,93,Partial Response
M213206,29,Other,Melanoma,mrna-4157 + keytruda,58.11,60.7,477.95,93,Partial Response
M213207,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.66,59.18,1069.77,91,Stable Disease
M213208,56,Male,HPV-related Cancer,KEYTRUDA only,61.29,49.29,889.82,82,Progression
M213209,41,Other,Melanoma,KEYTRUDA only,16.35,12.61,982.89,96,Stable Disease
M213210,43,Female,HPV-related Cancer,mrna-4157 + keytruda,45.1,41.85,1155.53,89,Unknown
M213211,37,Other,Melanoma,mrna-4157 + keytruda,78.02,76.51,926.97,101,Partial Response
M213212,83,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.55,37.75,350.5,105,Stable Disease
M213213,81,Male,Melanoma,KEYTRUDA only,41.5,41.5,1194.9,85,Stable Disease
M213214,30,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.07,75.73,942.01,85,Complete Response
M213215,62,Other,Melanoma,KEYTRUDA only,71.25,74.93,,87,Progression
M213216,27,Male,Non-small Cell Lung Cancer,KEYTRUDA only,40.3,32.17,984.34,94,Stable Disease
M213217,33,Male,Melanoma,mrna-4157 + keytruda,55.7,41.35,207.28,80,Partial Response
M213218,27,Male,HPV-related Cancer,KEYTRUDA only,37.19,35.07,826.58,74,Progression
M213219,75,Female,HPV-related Cancer,mrna-4157 + keytruda,59.94,68.94,629.53,96,Complete Response
M213220,46,Female,HPV-related Cancer,mrna-4157 + keytruda,38.9,33.94,1359.12,85,Unknown
M213221,38,Male,Melanoma,mrna-4157 + keytruda,63.17,,1164.55,80,Stable Disease
M213222,65,Male,HPV-related Cancer,KEYTRUDA only,23.9,17.74,1050.52,84,Stable Disease
M213223,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.36,61.47,809.2,97,Progression
M213224,39,Male,HPV-related Cancer,mrna-4157 + keytruda,50.39,42.98,520.71,83,Progression
M213225,49,Female,Melanoma,KEYTRUDA only,67.22,43.97,840.03,93,Stable Disease
M213226,43,Other,Melanoma,mrna-4157 + keytruda,41.43,36.58,921.49,79,Stable Disease
M213227,58,Male,Melanoma,KEYTRUDA only,95.64,80.54,986.15,79,Partial Response
M213228,32,Other,Melanoma,KEYTRUDA only,34.49,26.6,897.35,95,Progression
M213229,70,Other,Melanoma,KEYTRUDA only,30.1,29.21,1271.92,87,Partial Response
M213230,46,Other,HPV-related Cancer,mrna-4157 + keytruda,45.62,26.79,1632.81,90,Partial Response
M213231,42,Male,HPV-related Cancer,mrna-4157 + keytruda,18.63,18.72,674.49,91,Progression
M213232,25,Male,HPV-related Cancer,KEYTRUDA only,45.91,44.83,921.63,96,Progression
M213233,48,Male,Non-small Cell Lung Cancer,KEYTRUDA only,86.55,94.39,1043.59,112,Progression
M213234,53,Other,Melanoma,KEYTRUDA only,62.91,69.56,1529.2,92,Partial Response
M213235,47,Male,HPV-related Cancer,mrna-4157 + keytruda,44.54,26.8,919.64,97,Unknown
M213236,70,Female,Melanoma,KEYTRUDA only,59.66,68.5,1288.58,88,Progression
M213237,56,Other,Melanoma,mrna-4157 + keytruda,43.88,23.51,998.04,69,Progression
M213238,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.82,47.57,1143.57,103,Stable Disease
M213239,35,Female,HPV-related Cancer,KEYTRUDA only,16.16,12.5,1041.21,99,Partial Response
M213240,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.5,41.92,428.71,99,Partial Response
M213241,34,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.2,46.44,678.98,95,Progression
M213242,47,Other,HPV-related Cancer,mrna-4157 + keytruda,29.79,22.18,1192.27,84,Stable Disease
M213243,35,Female,HPV-related Cancer,mrna-4157 + keytruda,46.04,39.55,1502.96,85,Partial Response
M213244,75,Female,HPV-related Cancer,mrna-4157 + keytruda,72.31,42.13,1621.65,84,Partial Response
M213245,51,Female,Melanoma,mrna-4157 + keytruda,64.73,39.81,766.5,104,Progression
M213246,40,Female,Melanoma,mrna-4157 + keytruda,28.22,,1292.51,107,Complete Response
M213247,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,15.33,4.15,,81,
M213248,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.07,25.91,1533.53,90,Stable Disease
M213249,25,Other,HPV-related Cancer,mrna-4157 + keytruda,26.62,17.17,854.39,98,Stable Disease
M213250,37,Female,Melanoma,mrna-4157 + keytruda,38.02,19.72,480.73,79,Stable Disease
M213251,53,Male,Melanoma,KEYTRUDA only,55.43,56.65,1256.02,90,Progression
M213252,53,Female,HPV-related Cancer,mrna-4157 + keytruda,42.35,32.33,846.55,87,Partial Response
M213253,52,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.43,26.33,640.14,86,Progression
M213254,72,Other,Melanoma,mrna-4157 + keytruda,8.38,5.36,366.69,107,Stable Disease
M213255,36,Male,HPV-related Cancer,KEYTRUDA only,63.22,50.36,942.74,84,
M213256,38,Other,Non-small Cell Lung Cancer,KEYTRUDA only,25.54,33.92,2067.7,96,Progression
M213257,52,Male,HPV-related Cancer,mrna-4157 + keytruda,35.45,11.62,1406.74,92,Partial Response
M213258,44,Female,HPV-related Cancer,mrna-4157 + keytruda,54.97,49.44,1023.89,106,
M213259,81,Male,HPV-related Cancer,KEYTRUDA only,64.54,73.26,564.15,99,Stable Disease
M213260,52,Female,Melanoma,mrna-4157 + keytruda,66.13,37.13,818.27,94,Partial Response
M213261,67,Male,HPV-related Cancer,KEYTRUDA only,44.02,39.17,1234.94,80,Stable Disease
M213262,53,Male,HPV-related Cancer,KEYTRUDA only,61.27,46.76,860.48,85,Progression
M213263,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,-26.87,-29.43,935.4,95,Complete Response
M213264,32,Other,HPV-related Cancer,mrna-4157 + keytruda,27.65,22.05,1593.82,62,Stable Disease
M213265,25,Female,HPV-related Cancer,KEYTRUDA only,25.29,19.5,1228.57,94,
M213266,63,Female,Melanoma,KEYTRUDA only,30.74,24.52,906.98,112,Progression
M213267,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.42,75.9,944.53,85,Partial Response
M213268,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.61,12.54,805.52,86,Complete Response
M213269,61,Male,HPV-related Cancer,KEYTRUDA only,46.56,38.22,403.35,75,Stable Disease
M213270,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.66,49.62,,87,Complete Response
M213271,79,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.4,48.83,1153.53,97,Progression
M213272,60,Female,HPV-related Cancer,KEYTRUDA only,60.8,43.93,5.63,99,Stable Disease
M213273,84,Other,HPV-related Cancer,mrna-4157 + keytruda,43.43,33.14,-264.87,94,Unknown
M213274,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,13.14,12.32,1219.13,98,Complete Response
M213275,56,Male,HPV-related Cancer,mrna-4157 + keytruda,38.05,30.15,1462.84,86,
M213276,80,Female,Melanoma,KEYTRUDA only,51.93,37.02,587.61,96,Progression
M213277,30,Female,HPV-related Cancer,mrna-4157 + keytruda,50.9,52.37,1145.65,76,Progression
M213278,76,Other,Melanoma,KEYTRUDA only,41.11,36.22,245.97,83,Partial Response
M213279,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.15,31.05,1060.07,108,Complete Response
M213280,53,Other,HPV-related Cancer,mrna-4157 + keytruda,27.53,27.47,762.56,89,
M213281,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.73,14.87,441.51,86,Progression
M213282,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.31,42.75,955.82,83,Partial Response
M213283,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.37,40.93,58.42,82,Partial Response
M213284,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.94,68.8,652.48,87,Partial Response
M213285,43,Female,Melanoma,KEYTRUDA only,59.04,57.89,532.69,75,Progression
M213286,54,Other,Melanoma,KEYTRUDA only,42.6,47.0,1433.73,90,Stable Disease
M213287,53,Female,Melanoma,mrna-4157 + keytruda,35.35,17.4,951.87,94,Partial Response
M213288,82,Male,HPV-related Cancer,mrna-4157 + keytruda,72.27,52.1,114.51,92,Unknown
M213289,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.44,36.28,726.46,86,Stable Disease
M213290,31,Male,HPV-related Cancer,mrna-4157 + keytruda,44.88,39.98,1724.5,94,Progression
M213291,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,87.05,69.95,1294.08,100,Complete Response
M213292,77,Female,Non-small Cell Lung Cancer,KEYTRUDA only,51.55,50.41,1387.66,85,Complete Response
M213293,44,Female,HPV-related Cancer,mrna-4157 + keytruda,53.55,46.25,991.96,95,Progression
M213294,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.59,36.7,1281.06,71,Complete Response
M213295,31,Female,Melanoma,mrna-4157 + keytruda,37.81,26.74,991.96,79,Partial Response
M213296,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.44,54.65,1004.8,75,Partial Response
M213297,27,Male,HPV-related Cancer,mrna-4157 + keytruda,55.33,37.49,899.31,92,Progression
M213298,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,55.94,56.59,1254.3,86,Partial Response
M213299,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.1,30.71,1101.18,89,Partial Response
M213300,37,Female,Melanoma,KEYTRUDA only,65.68,49.15,,89,Stable Disease
M213301,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,88.33,,1403.01,83,Partial Response
M213302,83,Male,HPV-related Cancer,mrna-4157 + keytruda,18.55,15.23,679.79,98,Partial Response
M213303,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.59,,1177.02,79,Complete Response
M213304,61,Other,HPV-related Cancer,mrna-4157 + keytruda,46.8,36.65,1103.07,98,Stable Disease
M213305,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,29.59,14.36,1460.24,83,Partial Response
M213306,65,Other,HPV-related Cancer,mrna-4157 + keytruda,71.85,43.65,404.0,95,Progression
M213307,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,9.98,10.25,1505.43,100,Progression
M213308,71,Male,HPV-related Cancer,KEYTRUDA only,75.87,56.36,1166.59,88,Complete Response
M213309,73,Female,HPV-related Cancer,KEYTRUDA only,33.77,32.63,1386.42,88,Stable Disease
M213310,66,Female,Melanoma,mrna-4157 + keytruda,72.99,38.28,643.36,85,
M213311,74,Male,Non-small Cell Lung Cancer,KEYTRUDA only,53.96,46.89,177.21,88,Progression
M213312,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.24,48.62,438.81,90,Partial Response
M213313,49,Other,HPV-related Cancer,mrna-4157 + keytruda,32.64,28.04,553.08,91,Complete Response
M213314,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.4,37.24,1348.71,104,Partial Response
M213315,48,Male,Melanoma,KEYTRUDA only,23.02,10.47,846.21,83,Stable Disease
M213316,67,Female,HPV-related Cancer,mrna-4157 + keytruda,35.93,25.24,469.13,66,Partial Response
M213317,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.68,21.06,1216.23,91,Partial Response
M213318,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.86,17.93,412.25,70,Stable Disease
M213319,28,Other,Melanoma,mrna-4157 + keytruda,87.16,78.99,1465.16,89,Progression
M213320,38,Male,HPV-related Cancer,mrna-4157 + keytruda,62.81,76.81,1336.76,101,Partial Response
M213321,77,Other,HPV-related Cancer,mrna-4157 + keytruda,44.07,39.28,1497.21,84,Stable Disease
M213322,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.56,48.96,491.85,87,Progression
M213323,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.41,20.55,133.34,80,Progression
M213324,75,Female,HPV-related Cancer,KEYTRUDA only,51.84,34.48,1502.62,91,Partial Response
M213325,56,Other,Melanoma,mrna-4157 + keytruda,24.71,26.76,633.34,95,Complete Response
M213326,29,Female,Melanoma,KEYTRUDA only,51.29,67.05,886.66,93,Progression
M213327,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,75.14,83.8,534.29,80,Stable Disease
M213328,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.62,50.83,1062.64,99,Stable Disease
M213329,70,Other,Melanoma,mrna-4157 + keytruda,60.12,53.15,167.19,94,Complete Response
M213330,35,Male,Melanoma,mrna-4157 + keytruda,7.76,5.22,,96,Progression
M213331,60,Male,Melanoma,mrna-4157 + keytruda,40.57,28.52,,99,Complete Response
M213332,76,Female,Melanoma,KEYTRUDA only,89.16,80.31,1090.19,83,Stable Disease
M213333,45,Female,Non-small Cell Lung Cancer,KEYTRUDA only,76.9,72.5,829.19,100,Partial Response
M213334,63,Other,Melanoma,KEYTRUDA only,57.85,33.41,828.6,91,Partial Response
M213335,25,Female,Melanoma,KEYTRUDA only,60.87,39.55,834.24,94,Progression
M213336,39,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.64,28.54,1340.11,82,Stable Disease
M213337,67,Male,HPV-related Cancer,KEYTRUDA only,58.49,53.18,717.35,76,Partial Response
M213338,31,Male,HPV-related Cancer,mrna-4157 + keytruda,71.44,84.06,733.34,80,Partial Response
M213339,42,Male,Melanoma,mrna-4157 + keytruda,63.02,41.75,896.21,80,Complete Response
M213340,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.52,23.78,1034.67,86,Partial Response
M213341,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.0,59.55,898.97,88,Complete Response
M213342,37,Other,Melanoma,mrna-4157 + keytruda,57.78,41.56,801.25,86,Partial Response
M213343,62,Other,HPV-related Cancer,mrna-4157 + keytruda,29.36,20.31,1012.38,94,Complete Response
M213344,69,Male,HPV-related Cancer,KEYTRUDA only,63.6,37.9,241.84,84,Stable Disease
M213345,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.99,28.27,856.55,92,Stable Disease
M213346,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.03,22.63,,83,Partial Response
M213347,43,Female,HPV-related Cancer,mrna-4157 + keytruda,40.84,40.25,1536.0,91,Stable Disease
M213348,66,Other,HPV-related Cancer,KEYTRUDA only,71.1,32.2,1840.89,81,Stable Disease
M213349,34,Other,Melanoma,KEYTRUDA only,23.79,24.25,557.89,67,Progression
M213350,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.05,54.98,566.83,86,Stable Disease
M213351,44,Male,Melanoma,mrna-4157 + keytruda,44.31,23.71,1770.94,87,Partial Response
M213352,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,69.23,47.47,611.5,104,Progression
M213353,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.13,41.15,1064.88,94,Partial Response
M213354,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,26.39,20.55,1393.95,86,Partial Response
M213355,34,Male,HPV-related Cancer,mrna-4157 + keytruda,76.96,88.81,1157.29,90,Complete Response
M213356,61,Female,Melanoma,mrna-4157 + keytruda,38.31,29.34,1410.59,89,Stable Disease
M213357,28,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.31,54.83,1341.26,88,Partial Response
M213358,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.82,36.18,1385.9,83,Partial Response
M213359,33,Male,HPV-related Cancer,mrna-4157 + keytruda,33.03,24.44,528.65,94,Stable Disease
M213360,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.54,19.25,775.42,93,Stable Disease
M213361,29,Female,HPV-related Cancer,KEYTRUDA only,18.86,11.45,1109.94,92,Progression
M213362,26,Other,HPV-related Cancer,mrna-4157 + keytruda,49.36,35.78,,101,Partial Response
M213363,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.34,27.71,491.79,84,
M213364,37,Other,HPV-related Cancer,mrna-4157 + keytruda,50.24,54.0,1935.9,96,Stable Disease
M213365,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.37,47.54,1782.65,87,Progression
M213366,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.59,59.87,1035.28,103,Progression
M213367,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,81.44,69.84,703.0,86,Unknown
M213368,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.35,37.7,968.96,78,Stable Disease
M213369,67,Other,HPV-related Cancer,mrna-4157 + keytruda,56.72,42.83,1230.75,97,Stable Disease
M213370,69,Other,Melanoma,mrna-4157 + keytruda,36.13,23.17,1064.08,68,Partial Response
M213371,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.52,36.95,372.24,84,Stable Disease
M213372,73,Male,HPV-related Cancer,KEYTRUDA only,71.56,89.92,1222.44,96,Progression
M213373,65,Male,Melanoma,mrna-4157 + keytruda,50.44,28.2,840.86,92,Stable Disease
M213374,50,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.61,49.55,705.63,75,Stable Disease
M213375,76,Male,Melanoma,mrna-4157 + keytruda,28.52,31.51,859.09,94,Progression
M213376,55,Male,HPV-related Cancer,mrna-4157 + keytruda,48.45,27.11,838.18,85,Stable Disease
M213377,29,Other,HPV-related Cancer,KEYTRUDA only,43.68,41.43,1654.64,95,Complete Response
M213378,45,Male,Non-small Cell Lung Cancer,KEYTRUDA only,33.41,29.89,1063.18,84,Complete Response
M213379,32,Female,Melanoma,mrna-4157 + keytruda,64.28,45.76,994.47,81,
M213380,41,Male,Melanoma,KEYTRUDA only,56.0,35.99,591.7,96,Complete Response
M213381,71,Female,Melanoma,mrna-4157 + keytruda,88.48,66.01,614.28,98,Partial Response
M213382,84,Female,HPV-related Cancer,KEYTRUDA only,56.82,29.97,1328.11,88,Progression
M213383,60,Male,HPV-related Cancer,mrna-4157 + keytruda,40.59,,641.79,89,Complete Response
M213384,81,Male,HPV-related Cancer,mrna-4157 + keytruda,47.87,29.73,2257.7,89,Partial Response
M213385,80,Female,Melanoma,mrna-4157 + keytruda,88.03,26.15,1322.01,80,Unknown
M213386,56,Female,Melanoma,KEYTRUDA only,38.84,36.24,1121.73,82,Complete Response
M213387,25,Female,HPV-related Cancer,KEYTRUDA only,42.29,28.07,1261.27,86,Partial Response
M213388,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.39,36.58,1249.47,99,Complete Response
M213389,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.62,36.16,1176.07,98,Stable Disease
M213390,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.69,24.68,592.0,84,Progression
M213391,37,Female,HPV-related Cancer,mrna-4157 + keytruda,16.7,6.89,752.11,93,Progression
M213392,60,Other,Melanoma,mrna-4157 + keytruda,67.72,62.26,643.09,99,Complete Response
M213393,32,Female,Melanoma,mrna-4157 + keytruda,60.27,17.88,1145.02,82,Complete Response
M213394,84,Other,HPV-related Cancer,KEYTRUDA only,55.14,,1378.45,95,Stable Disease
M213395,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.11,38.0,474.45,84,Complete Response
M213396,64,Male,Melanoma,KEYTRUDA only,67.19,42.96,1797.43,97,Complete Response
M213397,80,Female,HPV-related Cancer,KEYTRUDA only,67.0,65.05,634.0,82,Partial Response
M213398,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.75,30.19,1285.84,86,Stable Disease
M213399,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.73,42.35,1207.8,81,Stable Disease
M213400,73,Male,HPV-related Cancer,KEYTRUDA only,55.75,,555.1,97,Progression
M213401,73,Male,HPV-related Cancer,mrna-4157 + keytruda,65.14,29.63,953.31,87,Stable Disease
M213402,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.97,30.93,1028.46,80,Stable Disease
M213403,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.9,61.92,930.75,81,Complete Response
M213404,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,74.13,47.31,685.47,99,Unknown
M213405,40,Male,Melanoma,mrna-4157 + keytruda,41.38,,2184.73,95,Partial Response
M213406,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.93,27.82,1218.92,88,Stable Disease
M213407,26,Male,Melanoma,mrna-4157 + keytruda,36.19,44.5,262.6,82,Stable Disease
M213408,30,Other,Melanoma,mrna-4157 + keytruda,36.66,35.83,747.48,88,Stable Disease
M213409,70,Female,Melanoma,KEYTRUDA only,59.23,32.64,702.92,104,Stable Disease
M213410,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.25,32.74,872.73,84,Stable Disease
M213411,68,Male,Melanoma,mrna-4157 + keytruda,61.72,58.11,1182.12,90,Stable Disease
M213412,47,Other,HPV-related Cancer,KEYTRUDA only,72.73,59.17,215.76,97,Complete Response
M213413,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.46,47.07,619.06,82,Progression
M213414,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.58,60.56,1015.12,95,Complete Response
M213415,75,Other,Melanoma,mrna-4157 + keytruda,43.69,38.75,1043.03,81,Stable Disease
M213416,33,Female,HPV-related Cancer,mrna-4157 + keytruda,37.55,24.17,1447.86,88,Progression
M213417,69,Other,HPV-related Cancer,mrna-4157 + keytruda,59.16,71.85,1467.78,98,Stable Disease
M213418,65,Other,HPV-related Cancer,KEYTRUDA only,71.43,28.01,958.06,95,Partial Response
M213419,47,Female,HPV-related Cancer,mrna-4157 + keytruda,8.65,6.9,1253.91,72,Stable Disease
M213420,26,Male,HPV-related Cancer,mrna-4157 + keytruda,58.73,61.24,667.91,95,Partial Response
M213421,52,Male,Melanoma,KEYTRUDA only,33.61,33.28,906.09,98,Partial Response
M213422,51,Male,HPV-related Cancer,mrna-4157 + keytruda,53.56,41.2,1144.83,73,Progression
M213423,48,Male,HPV-related Cancer,KEYTRUDA only,71.86,77.58,786.32,99,Complete Response
M213424,46,Male,Melanoma,mrna-4157 + keytruda,64.25,74.96,916.72,93,Progression
M213425,67,Male,Melanoma,mrna-4157 + keytruda,39.41,24.31,819.54,88,Progression
M213426,53,Male,Melanoma,KEYTRUDA only,56.0,39.91,224.26,86,Stable Disease
M213427,46,Male,Melanoma,mrna-4157 + keytruda,69.65,54.33,,94,Stable Disease
M213428,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.74,41.85,1041.75,95,Stable Disease
M213429,73,Female,Melanoma,KEYTRUDA only,51.71,32.19,942.23,95,Stable Disease
M213430,65,Other,Melanoma,KEYTRUDA only,81.82,109.51,531.15,91,Partial Response
M213431,71,Male,Melanoma,KEYTRUDA only,38.2,31.04,1372.44,88,Partial Response
M213432,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.8,48.09,726.6,83,Complete Response
M213433,40,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.13,56.62,963.11,102,Stable Disease
M213434,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.36,40.99,1705.58,95,Stable Disease
M213435,34,Other,HPV-related Cancer,KEYTRUDA only,79.37,60.1,1058.2,82,
M213436,40,Other,HPV-related Cancer,KEYTRUDA only,22.44,14.06,1055.23,109,Unknown
M213437,71,Other,HPV-related Cancer,mrna-4157 + keytruda,88.91,,887.98,95,Progression
M213438,37,Male,Melanoma,mrna-4157 + keytruda,61.31,75.35,627.18,96,Partial Response
M213439,63,Other,HPV-related Cancer,KEYTRUDA only,38.78,23.76,886.36,96,Stable Disease
M213440,70,Female,HPV-related Cancer,KEYTRUDA only,60.58,44.7,724.97,90,Partial Response
M213441,46,Female,Melanoma,KEYTRUDA only,43.11,15.52,543.03,89,Partial Response
M213442,68,Other,HPV-related Cancer,KEYTRUDA only,85.32,56.14,1401.54,84,Partial Response
M213443,62,Other,HPV-related Cancer,KEYTRUDA only,27.21,17.58,968.07,87,Stable Disease
M213444,72,Male,Melanoma,mrna-4157 + keytruda,41.18,36.33,1801.06,80,Stable Disease
M213445,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.77,,1270.85,70,Progression
M213446,29,Male,HPV-related Cancer,mrna-4157 + keytruda,39.17,24.12,886.5,108,Stable Disease
M213447,70,Female,Melanoma,KEYTRUDA only,23.52,20.64,880.03,88,Complete Response
M213448,61,Female,Melanoma,KEYTRUDA only,8.81,9.27,986.69,81,
M213449,46,Male,HPV-related Cancer,KEYTRUDA only,118.45,114.26,601.54,106,Partial Response
M213450,48,Other,Melanoma,mrna-4157 + keytruda,38.94,36.36,1227.87,90,Stable Disease
M213451,80,Male,HPV-related Cancer,KEYTRUDA only,106.97,137.34,1100.92,92,Progression
M213452,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.65,19.93,,96,Progression
M213453,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.45,23.54,1136.01,84,Partial Response
M213454,80,Other,Melanoma,KEYTRUDA only,15.49,14.6,1037.99,85,Partial Response
M213455,83,Other,HPV-related Cancer,KEYTRUDA only,64.77,58.44,372.25,95,Progression
M213456,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,5.93,5.63,2610.3500000000004,82,Stable Disease
M213457,44,Male,Melanoma,mrna-4157 + keytruda,46.91,41.34,909.26,104,Partial Response
M213458,25,Male,HPV-related Cancer,KEYTRUDA only,42.78,37.4,1690.11,84,Stable Disease
M213459,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.66,9.83,658.34,80,Partial Response
M213460,72,Female,HPV-related Cancer,KEYTRUDA only,58.41,59.62,1407.48,90,Unknown
M213461,67,Male,HPV-related Cancer,mrna-4157 + keytruda,73.74,42.63,706.87,88,Stable Disease
M213462,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,69.08,59.38,913.29,89,Partial Response
M213463,29,Male,HPV-related Cancer,KEYTRUDA only,87.09,97.63,1048.52,88,Progression
M213464,62,Other,Melanoma,mrna-4157 + keytruda,30.41,25.68,1352.77,94,Complete Response
M213465,36,Other,Melanoma,mrna-4157 + keytruda,58.58,53.06,412.37,87,Stable Disease
M213466,48,Female,Melanoma,mrna-4157 + keytruda,20.16,20.37,1012.83,89,Complete Response
M213467,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.96,60.1,961.57,95,Complete Response
M213468,77,Male,Melanoma,mrna-4157 + keytruda,23.87,23.37,1410.48,71,Partial Response
M213469,38,Other,Melanoma,mrna-4157 + keytruda,67.74,52.37,1251.4,94,Partial Response
M213470,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,88.8,42.28,1568.16,80,Stable Disease
M213471,83,Other,HPV-related Cancer,mrna-4157 + keytruda,33.4,25.92,728.27,79,Stable Disease
M213472,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.45,15.56,1172.92,88,
M213473,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.99,55.2,1417.46,79,Stable Disease
M213474,78,Female,HPV-related Cancer,mrna-4157 + keytruda,54.68,,830.4,87,Complete Response
M213475,78,Male,Melanoma,KEYTRUDA only,69.38,44.32,1746.43,83,Complete Response
M213476,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.36,10.61,1253.72,82,Stable Disease
M213477,58,Female,Melanoma,KEYTRUDA only,45.0,35.82,1065.48,89,Progression
M213478,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.35,30.78,1035.56,105,Complete Response
M213479,68,Male,Melanoma,mrna-4157 + keytruda,51.5,35.96,2021.38,82,Partial Response
M213480,41,Male,Melanoma,mrna-4157 + keytruda,16.98,10.47,342.21,85,Complete Response
M213481,82,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.65,28.43,1255.52,85,Partial Response
M213482,32,Male,HPV-related Cancer,mrna-4157 + keytruda,82.54,69.35,331.9,95,Partial Response
M213483,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.73,50.82,1218.79,104,Stable Disease
M213484,39,Female,HPV-related Cancer,mrna-4157 + keytruda,51.44,41.04,1209.19,79,Progression
M213485,79,Female,Melanoma,mrna-4157 + keytruda,28.49,34.75,1282.56,100,Stable Disease
M213486,29,Female,HPV-related Cancer,KEYTRUDA only,60.34,58.56,974.72,93,Partial Response
M213487,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,43.41,32.4,948.97,97,Stable Disease
M213488,48,Female,Melanoma,KEYTRUDA only,45.77,36.18,865.58,88,Complete Response
M213489,74,Female,HPV-related Cancer,KEYTRUDA only,38.88,23.78,1491.18,99,Partial Response
M213490,51,Female,HPV-related Cancer,mrna-4157 + keytruda,21.13,14.58,738.46,100,Complete Response
M213491,61,Other,Melanoma,KEYTRUDA only,73.49,88.2,1377.75,102,Partial Response
M213492,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.56,31.48,1365.28,116,Partial Response
M213493,44,Female,Melanoma,KEYTRUDA only,31.47,32.59,1465.62,80,Partial Response
M213494,75,Other,Melanoma,KEYTRUDA only,22.86,18.07,1154.16,106,Stable Disease
M213495,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.3,27.04,1167.51,76,Complete Response
M213496,50,Female,Melanoma,mrna-4157 + keytruda,59.3,42.49,1300.18,74,Complete Response
M213497,63,Other,Melanoma,mrna-4157 + keytruda,45.26,50.13,943.08,92,Stable Disease
M213498,82,Other,HPV-related Cancer,mrna-4157 + keytruda,36.51,24.34,293.31,86,Partial Response
M213499,79,Male,Melanoma,mrna-4157 + keytruda,16.42,11.43,253.9,101,Partial Response
M213500,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.11,40.29,879.55,82,
M213501,71,Male,HPV-related Cancer,KEYTRUDA only,64.39,49.39,1589.23,102,Progression
M213502,67,Other,Melanoma,mrna-4157 + keytruda,7.35,2.11,308.26,70,Stable Disease
M213503,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,57.94,35.73,938.29,86,
M213504,67,Other,Melanoma,mrna-4157 + keytruda,48.6,48.37,801.89,103,Complete Response
M213505,77,Male,Melanoma,KEYTRUDA only,81.64,66.41,989.29,103,Partial Response
M213506,50,Female,Non-small Cell Lung Cancer,KEYTRUDA only,76.48,59.52,1238.43,77,Progression
M213507,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.0,34.6,886.68,106,Complete Response
M213508,81,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.26,68.5,1669.27,85,Unknown
M213509,31,Other,HPV-related Cancer,mrna-4157 + keytruda,69.52,68.55,953.25,88,Partial Response
M213510,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.47,32.98,1241.95,81,Stable Disease
M213511,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.49,,1099.54,76,Complete Response
M213512,84,Female,Melanoma,mrna-4157 + keytruda,45.53,27.56,1029.79,73,Progression
M213513,30,Female,Melanoma,mrna-4157 + keytruda,11.69,12.5,,87,Stable Disease
M213514,51,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.97,46.36,1057.18,91,Partial Response
M213515,77,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.83,65.59,1356.16,91,Partial Response
M213516,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,66.2,67.76,1110.24,87,
M213517,68,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.21,,1429.94,77,Partial Response
M213518,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.09,51.53,1277.8,102,Complete Response
M213519,78,Other,HPV-related Cancer,KEYTRUDA only,21.67,21.04,1268.92,84,Complete Response
M213520,52,Male,HPV-related Cancer,mrna-4157 + keytruda,78.12,62.31,626.28,103,Unknown
M213521,64,Other,HPV-related Cancer,mrna-4157 + keytruda,24.74,18.57,641.49,84,Complete Response
M213522,49,Male,HPV-related Cancer,mrna-4157 + keytruda,26.53,22.96,1478.15,106,Partial Response
M213523,58,Female,Melanoma,KEYTRUDA only,29.44,28.49,1011.94,91,Progression
M213524,45,Male,HPV-related Cancer,mrna-4157 + keytruda,41.03,14.56,1015.44,81,Complete Response
M213525,79,Male,HPV-related Cancer,mrna-4157 + keytruda,18.26,19.52,1087.3,85,Partial Response
M213526,48,Male,HPV-related Cancer,mrna-4157 + keytruda,38.2,34.18,612.1,95,Partial Response
M213527,42,Other,Non-small Cell Lung Cancer,KEYTRUDA only,61.6,48.59,1099.09,71,Stable Disease
M213528,58,Other,HPV-related Cancer,KEYTRUDA only,51.55,27.55,556.08,85,Stable Disease
M213529,33,Other,HPV-related Cancer,mrna-4157 + keytruda,50.28,47.0,1213.36,78,Complete Response
M213530,84,Female,Melanoma,KEYTRUDA only,40.43,28.49,1050.64,96,Partial Response
M213531,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.81,48.88,438.32,95,Progression
M213532,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.81,58.01,229.55,78,Partial Response
M213533,27,Male,Melanoma,KEYTRUDA only,46.35,34.97,1478.71,91,Stable Disease
M213534,50,Male,HPV-related Cancer,KEYTRUDA only,106.58,27.55,834.16,86,Progression
M213535,39,Other,HPV-related Cancer,mrna-4157 + keytruda,46.71,26.32,1531.3,96,Complete Response
M213536,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.3,,1665.48,90,Complete Response
M213537,68,Female,Melanoma,mrna-4157 + keytruda,51.23,37.59,,83,Partial Response
M213538,54,Female,Melanoma,mrna-4157 + keytruda,57.88,33.05,291.75,70,Complete Response
M213539,42,Male,Melanoma,KEYTRUDA only,70.87,35.27,943.18,90,Stable Disease
M213540,45,Other,HPV-related Cancer,mrna-4157 + keytruda,35.24,39.46,1063.83,73,Partial Response
M213541,35,Other,HPV-related Cancer,KEYTRUDA only,71.15,61.91,431.24,88,Partial Response
M213542,28,Female,Melanoma,mrna-4157 + keytruda,83.81,,443.92,85,Partial Response
M213543,51,Other,Melanoma,mrna-4157 + keytruda,26.53,21.21,716.55,87,Stable Disease
M213544,60,Other,HPV-related Cancer,mrna-4157 + keytruda,85.78,94.86,710.03,101,Progression
M213545,37,Other,Melanoma,KEYTRUDA only,27.95,19.6,1085.16,91,Progression
M213546,52,Female,HPV-related Cancer,mrna-4157 + keytruda,23.81,17.36,863.53,89,Partial Response
M213547,44,Male,Melanoma,KEYTRUDA only,65.3,36.28,889.19,83,Partial Response
M213548,67,Male,Melanoma,KEYTRUDA only,43.61,,760.48,89,Partial Response
M213549,73,Other,HPV-related Cancer,KEYTRUDA only,16.95,13.65,1630.47,96,Stable Disease
M213550,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.09,32.05,646.02,114,Partial Response
M213551,67,Other,Melanoma,KEYTRUDA only,66.63,57.14,1430.01,90,Complete Response
M213552,78,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.25,25.34,326.96,96,Stable Disease
M213553,69,Female,Non-small Cell Lung Cancer,KEYTRUDA only,27.03,15.29,1111.45,97,Progression
M213554,56,Other,Melanoma,mrna-4157 + keytruda,21.96,18.66,1278.97,91,Progression
M213555,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.19,55.07,398.56,89,Stable Disease
M213556,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.61,51.26,465.53,93,Stable Disease
M213557,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.27,42.7,1248.56,83,Partial Response
M213558,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.02,39.09,241.25,87,Progression
M213559,65,Female,HPV-related Cancer,mrna-4157 + keytruda,32.85,14.15,1018.09,89,Complete Response
M213560,38,Other,Melanoma,mrna-4157 + keytruda,63.84,60.47,1242.85,86,Partial Response
M213561,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.54,35.65,934.11,105,Progression
M213562,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,23.43,8.06,,78,Progression
M213563,30,Male,HPV-related Cancer,mrna-4157 + keytruda,55.85,55.03,926.15,93,Partial Response
M213564,31,Female,HPV-related Cancer,mrna-4157 + keytruda,61.72,62.78,553.19,80,Partial Response
M213565,40,Male,Melanoma,KEYTRUDA only,22.15,15.52,1530.75,109,Unknown
M213566,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.03,,723.01,103,Partial Response
M213567,33,Male,HPV-related Cancer,KEYTRUDA only,54.26,35.59,1443.66,80,Complete Response
M213568,51,Female,HPV-related Cancer,KEYTRUDA only,40.77,26.3,1579.2,98,Stable Disease
M213569,65,Female,HPV-related Cancer,mrna-4157 + keytruda,27.15,19.94,1024.0,92,Stable Disease
M213570,36,Male,HPV-related Cancer,mrna-4157 + keytruda,53.45,43.23,1242.73,87,Complete Response
M213571,44,Female,HPV-related Cancer,mrna-4157 + keytruda,84.6,61.67,407.39,91,
M213572,39,Male,Melanoma,mrna-4157 + keytruda,90.03,48.24,1102.34,86,Stable Disease
M213573,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.37,23.94,1231.68,92,Partial Response
M213574,69,Other,HPV-related Cancer,KEYTRUDA only,31.83,34.2,867.01,99,Partial Response
M213575,70,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,76.01,60.47,,93,Progression
M213576,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.32,40.87,,97,Progression
M213577,34,Female,Melanoma,mrna-4157 + keytruda,45.28,48.03,107.64,107,Partial Response
M213578,60,Female,HPV-related Cancer,KEYTRUDA only,64.34,37.64,1274.31,91,Stable Disease
M213579,28,Female,HPV-related Cancer,mrna-4157 + keytruda,84.13,,851.3,77,Complete Response
M213580,50,Female,Non-small Cell Lung Cancer,KEYTRUDA only,57.83,53.77,1165.49,74,Complete Response
M213581,67,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.91,38.56,,82,Stable Disease
M213582,56,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.89,50.73,1324.64,101,Partial Response
M213583,80,Female,HPV-related Cancer,mrna-4157 + keytruda,50.29,45.61,857.05,86,Partial Response
M213584,49,Other,HPV-related Cancer,KEYTRUDA only,41.5,28.72,,95,Stable Disease
M213585,46,Male,Melanoma,mrna-4157 + keytruda,69.46,53.57,1029.14,90,Stable Disease
M213586,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,20.83,15.47,1454.6,72,Complete Response
M213587,47,Male,Melanoma,KEYTRUDA only,42.87,33.8,644.58,87,Unknown
M213588,60,Male,HPV-related Cancer,mrna-4157 + keytruda,78.86,54.59,1064.12,109,Partial Response
M213589,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,5.21,2.7,826.28,96,Complete Response
M213590,69,Other,Melanoma,KEYTRUDA only,45.36,59.29,1160.08,91,Unknown
M213591,36,Other,Melanoma,KEYTRUDA only,67.22,61.01,490.83,95,
M213592,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,28.28,23.29,1062.26,79,Progression
M213593,28,Other,Melanoma,mrna-4157 + keytruda,84.68,61.92,1237.32,83,Stable Disease
M213594,54,Female,Melanoma,mrna-4157 + keytruda,19.25,12.68,1326.27,87,Stable Disease
M213595,80,Male,HPV-related Cancer,KEYTRUDA only,78.2,70.93,605.97,88,Unknown
M213596,44,Other,Melanoma,mrna-4157 + keytruda,20.12,10.82,1115.81,88,Stable Disease
M213597,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,50.02,54.74,1487.29,86,Progression
M213598,41,Other,HPV-related Cancer,mrna-4157 + keytruda,53.36,40.85,1569.85,101,Unknown
M213599,81,Female,HPV-related Cancer,mrna-4157 + keytruda,37.76,31.61,,82,Complete Response
M213600,31,Male,Non-small Cell Lung Cancer,KEYTRUDA only,9.06,5.16,1577.72,102,Progression
M213601,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.58,42.59,618.4,96,Complete Response
M213602,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.49,73.35,578.71,89,Progression
M213603,57,Other,HPV-related Cancer,mrna-4157 + keytruda,86.46,86.71,100.75,105,Progression
M213604,61,Other,HPV-related Cancer,mrna-4157 + keytruda,40.6,34.05,1568.6,82,Progression
M213605,51,Male,HPV-related Cancer,mrna-4157 + keytruda,41.6,45.08,951.97,90,Progression
M213606,54,Female,HPV-related Cancer,KEYTRUDA only,44.87,41.56,1647.99,77,Complete Response
M213607,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.2,61.02,1276.85,77,Stable Disease
M213608,55,Male,HPV-related Cancer,mrna-4157 + keytruda,21.59,16.68,700.56,89,Stable Disease
M213609,64,Female,Melanoma,mrna-4157 + keytruda,52.87,50.11,558.88,88,Stable Disease
M213610,72,Male,HPV-related Cancer,KEYTRUDA only,79.3,40.67,510.57,105,Progression
M213611,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.43,28.61,1528.06,101,Progression
M213612,71,Male,Melanoma,KEYTRUDA only,60.86,55.95,1912.47,91,Stable Disease
M213613,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.78,63.94,1014.13,103,
M213614,55,Female,Melanoma,mrna-4157 + keytruda,36.55,11.25,932.04,105,Complete Response
M213615,83,Male,HPV-related Cancer,KEYTRUDA only,69.92,81.33,1224.08,101,Partial Response
M213616,81,Female,Melanoma,KEYTRUDA only,54.72,39.68,701.08,84,Progression
M213617,57,Other,Melanoma,KEYTRUDA only,3.3,2.32,671.51,106,Partial Response
M213618,61,Female,Melanoma,mrna-4157 + keytruda,58.88,48.93,1629.65,102,Complete Response
M213619,62,Other,Melanoma,KEYTRUDA only,40.59,,854.79,85,Progression
M213620,61,Male,HPV-related Cancer,mrna-4157 + keytruda,35.87,31.2,821.68,69,Partial Response
M213621,71,Other,Melanoma,mrna-4157 + keytruda,65.57,70.53,873.22,94,Stable Disease
M213622,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.66,58.07,921.06,74,Progression
M213623,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,7.16,6.11,1262.66,75,Stable Disease
M213624,45,Female,Melanoma,mrna-4157 + keytruda,41.51,29.23,1781.14,91,Progression
M213625,40,Male,Melanoma,mrna-4157 + keytruda,81.71,75.63,744.43,94,Stable Disease
M213626,52,Female,Melanoma,KEYTRUDA only,52.91,37.01,1247.57,102,Stable Disease
M213627,44,Male,Melanoma,mrna-4157 + keytruda,39.83,38.55,144.64,95,Partial Response
M213628,72,Female,Non-small Cell Lung Cancer,KEYTRUDA only,73.43,53.68,927.14,100,Stable Disease
M213629,79,Female,Melanoma,mrna-4157 + keytruda,52.56,54.82,1545.72,84,Partial Response
M213630,29,Other,Melanoma,mrna-4157 + keytruda,36.56,16.25,856.73,98,
M213631,58,Female,Melanoma,mrna-4157 + keytruda,12.99,9.54,,95,Stable Disease
M213632,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.94,48.34,1118.94,76,Progression
M213633,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.13,51.82,472.75,90,Partial Response
M213634,36,Male,HPV-related Cancer,mrna-4157 + keytruda,42.43,32.26,1156.65,74,
M213635,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.8,45.9,,87,Unknown
M213636,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.18,,1644.3,90,Stable Disease
M213637,73,Male,Melanoma,KEYTRUDA only,61.43,41.43,1585.7,90,Stable Disease
M213638,81,Male,HPV-related Cancer,mrna-4157 + keytruda,69.59,84.06,345.47,88,Stable Disease
M213639,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.41,46.81,408.07,81,Complete Response
M213640,38,Male,HPV-related Cancer,mrna-4157 + keytruda,68.84,38.55,278.94,78,Partial Response
M213641,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,80.19,54.7,525.21,76,Partial Response
M213642,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,21.4,15.94,,89,Progression
M213643,50,Other,Melanoma,KEYTRUDA only,45.07,42.17,1308.37,83,Progression
M213644,50,Other,Melanoma,mrna-4157 + keytruda,27.48,28.56,986.09,118,Stable Disease
M213645,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.76,40.57,411.37,95,Complete Response
M213646,28,Other,HPV-related Cancer,KEYTRUDA only,52.76,42.05,1043.48,96,Progression
M213647,40,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.4,20.25,1092.96,85,Unknown
M213648,31,Female,Melanoma,mrna-4157 + keytruda,58.29,49.97,,108,Stable Disease
M213649,42,Female,HPV-related Cancer,KEYTRUDA only,57.48,47.04,927.88,96,Progression
M213650,26,Male,HPV-related Cancer,mrna-4157 + keytruda,78.64,60.08,917.33,94,Complete Response
M213651,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.68,26.56,145.82,95,
M213652,59,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.03,63.57,1588.85,85,Partial Response
M213653,55,Female,Melanoma,mrna-4157 + keytruda,26.09,7.97,,94,Stable Disease
M213654,61,Female,Melanoma,mrna-4157 + keytruda,54.94,43.76,938.49,94,Stable Disease
M213655,27,Other,HPV-related Cancer,KEYTRUDA only,46.65,35.22,988.14,85,Progression
M213656,53,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.76,,1824.94,86,Stable Disease
M213657,39,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.46,38.72,1372.46,89,Stable Disease
M213658,80,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.5,43.49,725.66,81,Progression
M213659,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,54.83,43.67,536.24,74,Stable Disease
M213660,51,Male,Melanoma,mrna-4157 + keytruda,72.8,,478.61,77,Progression
M213661,49,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.69,26.9,1164.92,90,Partial Response
M213662,29,Other,Melanoma,mrna-4157 + keytruda,70.38,55.01,584.03,71,Progression
M213663,43,Male,Melanoma,mrna-4157 + keytruda,67.32,60.98,1193.78,112,Stable Disease
M213664,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.76,18.5,788.68,83,Progression
M213665,72,Other,HPV-related Cancer,KEYTRUDA only,69.86,58.5,792.33,89,
M213666,72,Female,Melanoma,KEYTRUDA only,19.33,14.29,1252.13,92,Partial Response
M213667,61,Female,Melanoma,mrna-4157 + keytruda,63.81,33.17,538.64,90,Stable Disease
M213668,57,Female,HPV-related Cancer,KEYTRUDA only,41.5,31.01,1671.36,87,Partial Response
M213669,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.69,41.49,1109.72,95,Progression
M213670,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.6,42.02,843.18,89,Complete Response
M213671,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.69,35.47,1157.96,89,Stable Disease
M213672,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.59,63.21,71.69,83,
M213673,65,Female,Melanoma,mrna-4157 + keytruda,22.59,15.12,1020.31,91,Progression
M213674,64,Male,HPV-related Cancer,KEYTRUDA only,37.57,36.17,1771.3,87,Partial Response
M213675,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.47,51.91,1554.99,83,
M213676,34,Female,Melanoma,mrna-4157 + keytruda,23.73,18.35,912.42,98,Stable Disease
M213677,60,Male,Melanoma,mrna-4157 + keytruda,57.34,37.81,,91,Progression
M213678,28,Female,Melanoma,mrna-4157 + keytruda,1.58,1.57,993.36,85,Complete Response
M213679,63,Male,Melanoma,mrna-4157 + keytruda,96.86,98.52,832.44,84,Partial Response
M213680,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,36.41,27.03,797.29,91,Progression
M213681,69,Female,Melanoma,mrna-4157 + keytruda,35.21,25.1,918.26,89,Partial Response
M213682,49,Other,HPV-related Cancer,mrna-4157 + keytruda,30.47,30.69,67.75,76,
M213683,83,Other,HPV-related Cancer,mrna-4157 + keytruda,64.62,42.48,911.99,84,Partial Response
M213684,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.09,17.73,483.87,99,Progression
M213685,55,Other,HPV-related Cancer,KEYTRUDA only,74.34,29.89,204.56,66,Partial Response
M213686,61,Other,HPV-related Cancer,mrna-4157 + keytruda,68.42,38.91,1124.36,84,Partial Response
M213687,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.08,36.69,956.56,89,Stable Disease
M213688,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.87,45.39,878.01,74,Progression
M213689,54,Female,Non-small Cell Lung Cancer,KEYTRUDA only,52.41,37.24,976.35,93,Stable Disease
M213690,55,Other,HPV-related Cancer,KEYTRUDA only,81.16,46.29,570.59,96,Stable Disease
M213691,79,Female,HPV-related Cancer,mrna-4157 + keytruda,42.57,38.36,710.97,74,Progression
M213692,51,Other,HPV-related Cancer,mrna-4157 + keytruda,52.48,22.19,562.79,105,Stable Disease
M213693,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.41,21.27,667.66,85,Progression
M213694,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.08,42.17,622.3,91,Partial Response
M213695,57,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,6.19,4.7,540.72,91,Complete Response
M213696,53,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.2,36.85,380.49,102,Progression
M213697,37,Female,Melanoma,mrna-4157 + keytruda,66.45,50.17,1720.13,88,Stable Disease
M213698,35,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.46,40.06,1294.17,107,Complete Response
M213699,78,Female,HPV-related Cancer,mrna-4157 + keytruda,22.72,13.11,388.74,99,Complete Response
M213700,55,Female,Melanoma,mrna-4157 + keytruda,66.38,45.48,1305.73,81,Stable Disease
M213701,37,Male,HPV-related Cancer,mrna-4157 + keytruda,67.96,69.14,1699.57,97,Partial Response
M213702,74,Other,HPV-related Cancer,KEYTRUDA only,23.87,13.71,352.84,86,Complete Response
M213703,64,Other,HPV-related Cancer,KEYTRUDA only,34.75,34.76,371.51,98,Stable Disease
M213704,55,Male,HPV-related Cancer,mrna-4157 + keytruda,61.64,24.01,1103.06,74,Progression
M213705,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.85,14.65,357.81,82,Stable Disease
M213706,29,Female,HPV-related Cancer,mrna-4157 + keytruda,13.63,5.25,867.86,104,Partial Response
M213707,58,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.6,53.51,853.43,103,Stable Disease
M213708,73,Female,HPV-related Cancer,mrna-4157 + keytruda,27.13,31.08,,95,Stable Disease
M213709,76,Other,Melanoma,mrna-4157 + keytruda,59.18,51.45,561.95,94,Stable Disease
M213710,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.74,20.24,652.81,105,Partial Response
M213711,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.74,45.49,1106.9,80,Complete Response
M213712,59,Male,HPV-related Cancer,KEYTRUDA only,42.29,38.12,1052.27,90,Stable Disease
M213713,33,Other,HPV-related Cancer,mrna-4157 + keytruda,24.67,25.23,1169.82,94,Partial Response
M213714,58,Other,Melanoma,mrna-4157 + keytruda,37.0,27.73,1502.21,93,Complete Response
M213715,61,Other,HPV-related Cancer,mrna-4157 + keytruda,36.94,26.15,798.59,90,Progression
M213716,77,Other,Melanoma,KEYTRUDA only,40.01,,990.37,82,Complete Response
M213717,25,Male,Melanoma,mrna-4157 + keytruda,56.16,56.17,1568.26,78,Progression
M213718,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.86,31.26,710.22,85,Stable Disease
M213719,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,102.18,36.42,1393.9,95,Progression
M213720,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.98,20.28,1105.35,98,Partial Response
M213721,65,Female,HPV-related Cancer,mrna-4157 + keytruda,51.76,29.35,1411.09,81,Stable Disease
M213722,46,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.07,44.47,1177.91,81,Progression
M213723,73,Female,Melanoma,KEYTRUDA only,36.47,26.3,-9.43,81,Complete Response
M213724,74,Other,Melanoma,mrna-4157 + keytruda,26.57,23.68,1548.15,91,Progression
M213725,49,Female,Melanoma,KEYTRUDA only,67.54,47.86,621.6,97,Unknown
M213726,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.95,33.51,1419.58,72,Stable Disease
M213727,41,Male,Non-small Cell Lung Cancer,KEYTRUDA only,30.11,25.66,1704.73,85,Stable Disease
M213728,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.15,27.43,737.72,83,Progression
M213729,47,Male,Melanoma,mrna-4157 + keytruda,73.77,,1285.59,101,Partial Response
M213730,66,Female,HPV-related Cancer,KEYTRUDA only,48.81,56.47,849.71,98,Progression
M213731,45,Female,HPV-related Cancer,KEYTRUDA only,68.35,42.16,882.3,101,Progression
M213732,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.57,17.84,1004.67,90,Stable Disease
M213733,81,Male,HPV-related Cancer,KEYTRUDA only,63.26,34.97,1732.62,92,Unknown
M213734,69,Male,Melanoma,mrna-4157 + keytruda,96.06,71.15,30.69,108,Progression
M213735,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,41.22,37.12,1134.93,83,Partial Response
M213736,56,Female,HPV-related Cancer,mrna-4157 + keytruda,49.47,19.03,921.27,94,Complete Response
M213737,56,Male,Melanoma,KEYTRUDA only,75.51,53.16,377.56,101,Partial Response
M213738,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.07,57.99,2054.32,106,Stable Disease
M213739,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.31,57.62,1576.84,100,Partial Response
M213740,60,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.7,50.7,570.12,87,Unknown
M213741,81,Other,Melanoma,mrna-4157 + keytruda,84.9,92.07,970.38,106,Partial Response
M213742,70,Other,HPV-related Cancer,KEYTRUDA only,51.93,33.01,1066.84,108,Partial Response
M213743,50,Female,Melanoma,mrna-4157 + keytruda,20.14,10.36,1008.59,92,Progression
M213744,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.39,21.62,881.35,90,Progression
M213745,53,Other,HPV-related Cancer,mrna-4157 + keytruda,37.97,31.23,1311.49,91,Stable Disease
M213746,55,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.09,19.25,1206.74,84,Partial Response
M213747,30,Female,HPV-related Cancer,KEYTRUDA only,49.45,49.61,1229.64,105,Partial Response
M213748,27,Male,Melanoma,mrna-4157 + keytruda,35.17,31.21,1457.78,80,Stable Disease
M213749,42,Other,HPV-related Cancer,mrna-4157 + keytruda,37.77,23.47,1261.91,100,Partial Response
M213750,36,Male,HPV-related Cancer,KEYTRUDA only,55.52,33.12,894.17,112,Stable Disease
M213751,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.53,31.51,1086.6,90,Progression
M213752,45,Female,HPV-related Cancer,mrna-4157 + keytruda,27.4,28.04,356.67,95,Complete Response
M213753,34,Female,HPV-related Cancer,KEYTRUDA only,58.95,47.66,640.04,87,Stable Disease
M213754,45,Female,HPV-related Cancer,mrna-4157 + keytruda,43.91,42.34,805.99,85,Progression
M213755,66,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,-0.83,-0.92,1132.27,93,Stable Disease
M213756,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.48,35.96,540.56,97,
M213757,25,Male,HPV-related Cancer,KEYTRUDA only,59.88,63.27,403.57,93,Progression
M213758,67,Female,Melanoma,mrna-4157 + keytruda,47.15,47.38,655.6,90,Partial Response
M213759,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.78,38.23,1103.21,84,Progression
M213760,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.63,41.53,,101,Stable Disease
M213761,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.46,53.1,339.7,93,Complete Response
M213762,29,Female,Melanoma,mrna-4157 + keytruda,77.53,57.95,-189.05,81,Progression
M213763,63,Other,Melanoma,mrna-4157 + keytruda,56.69,54.87,,90,Stable Disease
M213764,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.16,46.72,1445.22,82,
M213765,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.84,41.62,1052.43,76,Partial Response
M213766,33,Female,Melanoma,KEYTRUDA only,82.7,80.42,1381.78,78,Stable Disease
M213767,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.64,47.98,738.71,93,Unknown
M213768,70,Other,Melanoma,KEYTRUDA only,22.14,6.14,662.28,94,Partial Response
M213769,57,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.22,38.76,841.25,89,Partial Response
M213770,56,Male,HPV-related Cancer,mrna-4157 + keytruda,41.01,,,82,Partial Response
M213771,32,Male,HPV-related Cancer,mrna-4157 + keytruda,38.06,29.03,350.3,76,Stable Disease
M213772,75,Other,HPV-related Cancer,mrna-4157 + keytruda,22.39,21.31,1634.71,98,Stable Disease
M213773,64,Other,Melanoma,mrna-4157 + keytruda,56.62,43.74,1291.38,72,Unknown
M213774,33,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.63,,1173.94,104,Complete Response
M213775,41,Other,Melanoma,KEYTRUDA only,52.99,52.93,,103,Progression
M213776,35,Other,HPV-related Cancer,mrna-4157 + keytruda,51.09,45.78,658.68,110,Stable Disease
M213777,74,Female,Melanoma,mrna-4157 + keytruda,46.43,34.08,556.59,79,Progression
M213778,74,Female,Melanoma,mrna-4157 + keytruda,14.36,12.35,1114.58,100,Complete Response
M213779,54,Male,HPV-related Cancer,mrna-4157 + keytruda,9.64,5.17,855.45,88,Progression
M213780,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.38,37.75,1244.35,89,Stable Disease
M213781,70,Female,Melanoma,mrna-4157 + keytruda,30.74,26.1,853.04,102,Progression
M213782,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,25.42,,1480.94,73,Progression
M213783,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.17,48.1,1194.61,111,Partial Response
M213784,72,Female,HPV-related Cancer,mrna-4157 + keytruda,56.48,53.06,593.01,88,Complete Response
M213785,36,Female,HPV-related Cancer,KEYTRUDA only,47.71,45.78,746.99,79,Stable Disease
M213786,46,Male,HPV-related Cancer,KEYTRUDA only,78.04,52.36,1203.49,82,Stable Disease
M213787,36,Male,HPV-related Cancer,mrna-4157 + keytruda,14.55,12.71,890.97,88,Complete Response
M213788,54,Male,HPV-related Cancer,mrna-4157 + keytruda,22.87,20.19,683.23,102,Stable Disease
M213789,54,Female,HPV-related Cancer,mrna-4157 + keytruda,56.07,18.57,1373.95,89,Complete Response
M213790,80,Male,HPV-related Cancer,KEYTRUDA only,70.97,35.6,705.7,88,Partial Response
M213791,29,Female,HPV-related Cancer,mrna-4157 + keytruda,82.71,95.4,1019.75,95,Stable Disease
M213792,69,Other,HPV-related Cancer,mrna-4157 + keytruda,67.79,57.27,1323.26,76,Partial Response
M213793,47,Female,HPV-related Cancer,KEYTRUDA only,72.37,,609.45,101,Unknown
M213794,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.58,54.97,987.0,78,Complete Response
M213795,45,Other,HPV-related Cancer,mrna-4157 + keytruda,59.65,65.55,,102,Partial Response
M213796,62,Male,Melanoma,KEYTRUDA only,7.53,6.79,695.6,90,Complete Response
M213797,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,8.03,5.3,1288.44,112,Complete Response
M213798,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.86,63.76,1049.3,78,Partial Response
M213799,53,Female,Melanoma,mrna-4157 + keytruda,17.85,1.85,1078.15,102,Progression
M213800,27,Female,HPV-related Cancer,KEYTRUDA only,53.61,17.44,904.41,98,Partial Response
M213801,69,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.06,32.41,892.17,101,Stable Disease
M213802,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.68,27.56,960.39,80,Progression
M213803,51,Female,Melanoma,mrna-4157 + keytruda,40.31,34.61,844.45,94,Partial Response
M213804,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.02,56.05,822.47,81,Partial Response
M213805,81,Other,Melanoma,KEYTRUDA only,37.86,36.12,1364.27,104,Stable Disease
M213806,54,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.46,46.85,360.83,85,Complete Response
M213807,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.89,38.16,1456.19,88,Stable Disease
M213808,70,Female,HPV-related Cancer,KEYTRUDA only,31.88,,1241.04,91,Stable Disease
M213809,66,Female,HPV-related Cancer,KEYTRUDA only,48.75,44.83,1073.26,96,Progression
M213810,45,Other,Melanoma,mrna-4157 + keytruda,79.86,67.99,715.33,78,Stable Disease
M213811,34,Female,Melanoma,mrna-4157 + keytruda,53.01,,989.07,82,Unknown
M213812,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,63.89,,655.53,89,Partial Response
M213813,51,Male,HPV-related Cancer,mrna-4157 + keytruda,37.13,35.12,644.22,77,Complete Response
M213814,71,Male,Melanoma,mrna-4157 + keytruda,20.21,14.88,844.47,86,Stable Disease
M213815,26,Male,HPV-related Cancer,KEYTRUDA only,47.82,28.81,559.29,79,Progression
M213816,48,Male,Melanoma,mrna-4157 + keytruda,62.15,40.35,1204.65,72,Progression
M213817,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,11.56,7.23,1408.58,97,Stable Disease
M213818,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.23,54.79,1247.82,90,
M213819,81,Female,Melanoma,mrna-4157 + keytruda,66.59,55.55,1094.64,86,Complete Response
M213820,64,Male,Melanoma,mrna-4157 + keytruda,56.21,39.32,1546.19,91,Unknown
M213821,58,Other,HPV-related Cancer,mrna-4157 + keytruda,33.59,32.15,1241.76,91,Complete Response
M213822,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,60.2,66.7,210.98,85,Partial Response
M213823,49,Male,HPV-related Cancer,mrna-4157 + keytruda,31.18,34.74,519.83,89,Progression
M213824,41,Other,Melanoma,mrna-4157 + keytruda,70.82,13.54,1124.43,94,Partial Response
M213825,45,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.51,53.82,999.61,96,Progression
M213826,70,Female,HPV-related Cancer,KEYTRUDA only,29.8,31.22,442.08,89,Complete Response
M213827,83,Other,HPV-related Cancer,mrna-4157 + keytruda,45.89,26.84,1198.76,95,Stable Disease
M213828,39,Male,Melanoma,mrna-4157 + keytruda,30.81,30.38,1678.2,106,Unknown
M213829,36,Male,HPV-related Cancer,mrna-4157 + keytruda,60.86,47.13,610.93,91,Partial Response
M213830,28,Male,HPV-related Cancer,KEYTRUDA only,57.62,54.7,873.99,93,Complete Response
M213831,35,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.67,32.78,1797.61,91,Complete Response
M213832,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.88,38.3,563.72,93,Stable Disease
M213833,63,Other,HPV-related Cancer,KEYTRUDA only,44.99,29.38,606.76,84,Progression
M213834,51,Male,HPV-related Cancer,mrna-4157 + keytruda,117.58,126.4,718.86,88,Partial Response
M213835,70,Other,Melanoma,mrna-4157 + keytruda,60.11,29.14,1693.73,96,Progression
M213836,29,Other,Melanoma,mrna-4157 + keytruda,53.41,68.14,968.9,90,Partial Response
M213837,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.64,48.47,1528.9,94,Partial Response
M213838,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.4,29.11,771.2,80,Stable Disease
M213839,64,Female,Melanoma,mrna-4157 + keytruda,82.37,69.27,741.87,73,Partial Response
M213840,44,Female,Melanoma,KEYTRUDA only,59.84,47.21,1290.73,83,Stable Disease
M213841,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.48,50.7,1208.28,98,Partial Response
M213842,71,Male,HPV-related Cancer,KEYTRUDA only,61.79,37.42,960.06,88,Complete Response
M213843,43,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.3,72.94,896.59,86,Stable Disease
M213844,31,Female,Melanoma,mrna-4157 + keytruda,61.13,45.11,1479.75,83,Partial Response
M213845,44,Male,HPV-related Cancer,mrna-4157 + keytruda,77.72,80.18,81.8,80,Stable Disease
M213846,62,Female,HPV-related Cancer,KEYTRUDA only,76.98,39.82,179.74,102,Stable Disease
M213847,65,Other,HPV-related Cancer,KEYTRUDA only,36.56,31.04,592.85,82,Stable Disease
M213848,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.52,46.44,990.44,92,Complete Response
M213849,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.99,52.56,,90,Partial Response
M213850,33,Male,HPV-related Cancer,KEYTRUDA only,39.69,32.3,996.86,92,Partial Response
M213851,75,Female,Melanoma,mrna-4157 + keytruda,43.93,,1355.98,99,Partial Response
M213852,43,Male,HPV-related Cancer,mrna-4157 + keytruda,49.16,38.37,1792.86,94,Partial Response
M213853,75,Male,Melanoma,KEYTRUDA only,53.51,40.55,422.33,91,Stable Disease
M213854,46,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.08,41.05,1257.32,76,Partial Response
M213855,61,Male,HPV-related Cancer,KEYTRUDA only,57.19,67.67,1120.1,96,Stable Disease
M213856,55,Female,Non-small Cell Lung Cancer,KEYTRUDA only,65.77,68.07,,79,Progression
M213857,81,Male,HPV-related Cancer,KEYTRUDA only,26.54,16.55,433.55,85,Unknown
M213858,83,Male,Melanoma,KEYTRUDA only,42.83,44.13,1491.88,105,Complete Response
M213859,77,Other,Non-small Cell Lung Cancer,KEYTRUDA only,29.85,18.54,,90,Complete Response
M213860,83,Other,HPV-related Cancer,mrna-4157 + keytruda,35.46,30.43,1346.02,106,Stable Disease
M213861,73,Male,HPV-related Cancer,KEYTRUDA only,72.41,62.39,737.29,101,Stable Disease
M213862,60,Other,HPV-related Cancer,mrna-4157 + keytruda,35.78,29.65,1042.18,96,Partial Response
M213863,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.21,38.82,254.54,93,Partial Response
M213864,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.1,37.23,1002.87,84,Stable Disease
M213865,35,Other,Melanoma,KEYTRUDA only,53.69,33.94,1036.09,82,Progression
M213866,73,Other,Melanoma,KEYTRUDA only,34.63,35.18,329.12,79,Unknown
M213867,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,98.84,78.39,1540.81,97,
M213868,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.88,60.83,1672.25,101,
M213869,82,Male,Melanoma,mrna-4157 + keytruda,32.32,24.23,1234.76,94,Partial Response
M213870,71,Female,Melanoma,mrna-4157 + keytruda,56.46,70.97,1325.41,79,Partial Response
M213871,50,Other,Melanoma,mrna-4157 + keytruda,69.59,54.34,904.53,98,Partial Response
M213872,69,Female,HPV-related Cancer,mrna-4157 + keytruda,71.08,76.97,460.76,105,Unknown
M213873,57,Female,Melanoma,mrna-4157 + keytruda,50.2,53.79,1542.83,92,Stable Disease
M213874,59,Other,Melanoma,KEYTRUDA only,83.82,82.93,524.14,101,Partial Response
M213875,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.68,34.4,1024.59,93,Progression
M213876,39,Female,HPV-related Cancer,KEYTRUDA only,40.03,30.98,1544.31,77,Stable Disease
M213877,49,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.63,,1161.39,94,Partial Response
M213878,54,Female,Melanoma,mrna-4157 + keytruda,44.46,,1039.08,94,Progression
M213879,78,Female,Melanoma,KEYTRUDA only,26.14,,1298.56,98,Partial Response
M213880,45,Other,HPV-related Cancer,mrna-4157 + keytruda,45.91,45.49,1021.87,79,Partial Response
M213881,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.29,25.26,1016.55,82,Stable Disease
M213882,37,Female,HPV-related Cancer,mrna-4157 + keytruda,42.8,40.39,511.83,78,Stable Disease
M213883,39,Female,HPV-related Cancer,KEYTRUDA only,24.82,28.35,,70,Stable Disease
M213884,78,Female,Melanoma,mrna-4157 + keytruda,70.68,47.25,1782.21,91,Stable Disease
M213885,62,Female,HPV-related Cancer,mrna-4157 + keytruda,56.36,51.81,241.04,83,Stable Disease
M213886,45,Other,Melanoma,KEYTRUDA only,37.43,,697.7,80,Partial Response
M213887,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.15,32.18,715.17,74,Complete Response
M213888,76,Male,Melanoma,KEYTRUDA only,39.5,34.56,615.67,84,Partial Response
M213889,60,Other,HPV-related Cancer,mrna-4157 + keytruda,55.67,34.94,975.1,72,Partial Response
M213890,46,Male,Non-small Cell Lung Cancer,KEYTRUDA only,76.89,39.81,1007.65,102,Stable Disease
M213891,51,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.24,45.33,661.65,86,
M213892,68,Female,Non-small Cell Lung Cancer,KEYTRUDA only,19.97,17.73,1816.3,101,Partial Response
M213893,55,Male,Melanoma,mrna-4157 + keytruda,30.99,23.39,1124.17,86,Stable Disease
M213894,57,Other,Melanoma,KEYTRUDA only,41.85,32.36,1133.46,76,Progression
M213895,27,Male,Non-small Cell Lung Cancer,KEYTRUDA only,37.24,22.3,1519.27,83,Partial Response
M213896,63,Male,HPV-related Cancer,KEYTRUDA only,55.83,7.02,517.79,96,Stable Disease
M213897,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.04,44.99,,84,Partial Response
M213898,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.45,21.12,729.05,101,Partial Response
M213899,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.71,31.08,770.87,90,Partial Response
M213900,40,Female,Melanoma,KEYTRUDA only,27.13,21.53,1592.48,90,Progression
M213901,36,Other,HPV-related Cancer,mrna-4157 + keytruda,38.38,25.62,,100,Partial Response
M213902,32,Other,Melanoma,mrna-4157 + keytruda,61.73,55.24,1647.17,112,Stable Disease
M213903,84,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.63,48.82,1040.25,92,Stable Disease
M213904,37,Other,HPV-related Cancer,KEYTRUDA only,50.8,29.83,1300.33,87,Progression
M213905,64,Male,Melanoma,mrna-4157 + keytruda,35.95,,1222.37,75,Progression
M213906,82,Other,Melanoma,KEYTRUDA only,60.98,66.94,-14.91,73,Stable Disease
M213907,80,Female,Melanoma,mrna-4157 + keytruda,9.28,4.29,1334.82,85,Complete Response
M213908,68,Male,Melanoma,KEYTRUDA only,57.74,29.84,688.58,85,Progression
M213909,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.38,17.08,534.72,93,Progression
M213910,83,Female,Melanoma,mrna-4157 + keytruda,36.93,31.17,722.73,95,Complete Response
M213911,58,Male,Melanoma,mrna-4157 + keytruda,26.49,24.26,96.89,79,Partial Response
M213912,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.16,27.8,855.74,84,Progression
M213913,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,80.91,,1228.48,91,Progression
M213914,68,Other,Melanoma,mrna-4157 + keytruda,28.96,18.89,144.67,104,Progression
M213915,57,Female,Melanoma,KEYTRUDA only,11.85,8.54,1315.9,104,Complete Response
M213916,50,Other,Melanoma,mrna-4157 + keytruda,49.65,31.07,1285.3,86,Partial Response
M213917,55,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.72,50.25,1228.35,88,Progression
M213918,81,Other,Melanoma,KEYTRUDA only,54.08,45.17,893.9,79,Complete Response
M213919,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.22,48.59,914.37,84,Complete Response
M213920,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.17,22.94,595.24,84,Stable Disease
M213921,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.27,15.57,850.99,83,Progression
M213922,70,Male,HPV-related Cancer,KEYTRUDA only,57.61,44.77,745.7,93,Complete Response
M213923,44,Other,Non-small Cell Lung Cancer,KEYTRUDA only,74.66,86.26,1092.16,108,Partial Response
M213924,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.04,41.65,620.8,87,Progression
M213925,56,Other,Melanoma,KEYTRUDA only,55.77,36.16,966.58,114,Complete Response
M213926,39,Other,HPV-related Cancer,KEYTRUDA only,50.89,23.89,1251.79,102,Partial Response
M213927,33,Male,Melanoma,mrna-4157 + keytruda,70.38,64.81,959.8,85,Partial Response
M213928,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.25,55.5,595.05,84,
M213929,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.74,,930.62,79,Progression
M213930,67,Male,HPV-related Cancer,mrna-4157 + keytruda,16.57,9.26,1650.59,105,Progression
M213931,27,Female,Melanoma,KEYTRUDA only,72.94,46.62,1496.3,96,Progression
M213932,78,Male,Non-small Cell Lung Cancer,KEYTRUDA only,85.32,67.75,569.08,88,Stable Disease
M213933,81,Female,HPV-related Cancer,mrna-4157 + keytruda,48.62,33.65,911.09,94,Complete Response
M213934,62,Female,HPV-related Cancer,mrna-4157 + keytruda,22.88,19.42,927.05,76,Complete Response
M213935,69,Male,Melanoma,KEYTRUDA only,39.68,37.86,962.31,86,Progression
M213936,75,Female,Melanoma,mrna-4157 + keytruda,42.58,32.2,528.78,87,Partial Response
M213937,57,Female,Non-small Cell Lung Cancer,KEYTRUDA only,24.18,,1185.94,108,Complete Response
M213938,25,Female,Melanoma,KEYTRUDA only,68.81,54.08,656.3,82,Partial Response
M213939,48,Female,Melanoma,KEYTRUDA only,117.4,56.25,,94,Progression
M213940,25,Other,HPV-related Cancer,mrna-4157 + keytruda,42.45,34.04,385.08,93,Partial Response
M213941,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.84,14.86,1053.85,84,Partial Response
M213942,84,Other,HPV-related Cancer,mrna-4157 + keytruda,34.05,20.69,1308.9,95,Progression
M213943,40,Other,HPV-related Cancer,mrna-4157 + keytruda,35.56,20.48,679.93,96,
M213944,25,Female,HPV-related Cancer,mrna-4157 + keytruda,75.63,58.96,1451.1,74,Stable Disease
M213945,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.67,34.72,554.09,74,Partial Response
M213946,30,Male,HPV-related Cancer,mrna-4157 + keytruda,56.2,63.09,1139.9,82,Partial Response
M213947,67,Other,HPV-related Cancer,mrna-4157 + keytruda,72.86,85.34,1002.92,88,Complete Response
M213948,48,Other,HPV-related Cancer,mrna-4157 + keytruda,46.56,,1179.02,83,Complete Response
M213949,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.84,38.27,801.43,90,Stable Disease
M213950,37,Female,HPV-related Cancer,KEYTRUDA only,49.46,57.83,1880.61,97,Progression
M213951,49,Female,HPV-related Cancer,mrna-4157 + keytruda,65.44,67.36,964.47,72,
M213952,68,Female,Melanoma,mrna-4157 + keytruda,54.38,50.48,559.81,82,Progression
M213953,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.36,39.93,1753.06,94,Partial Response
M213954,71,Other,Melanoma,mrna-4157 + keytruda,43.88,42.51,1533.48,83,Stable Disease
M213955,31,Male,HPV-related Cancer,KEYTRUDA only,57.01,54.79,606.68,108,Complete Response
M213956,58,Other,HPV-related Cancer,mrna-4157 + keytruda,30.42,21.69,1146.16,98,Stable Disease
M213957,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.05,51.31,439.92,91,Partial Response
M213958,70,Other,Melanoma,mrna-4157 + keytruda,65.65,55.43,81.64,96,Partial Response
M213959,45,Male,HPV-related Cancer,mrna-4157 + keytruda,38.86,,1016.88,83,Stable Disease
M213960,75,Female,Melanoma,mrna-4157 + keytruda,8.28,,638.6,106,Unknown
M213961,39,Female,Melanoma,mrna-4157 + keytruda,71.14,79.59,1207.93,85,Partial Response
M213962,51,Male,Melanoma,mrna-4157 + keytruda,53.9,37.01,1582.81,99,Progression
M213963,70,Female,Melanoma,mrna-4157 + keytruda,20.79,16.83,639.88,81,Unknown
M213964,61,Other,HPV-related Cancer,mrna-4157 + keytruda,52.52,38.83,1454.13,114,Stable Disease
M213965,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,53.14,37.04,1240.71,102,Progression
M213966,53,Male,Melanoma,mrna-4157 + keytruda,4.14,2.87,1523.02,93,Complete Response
M213967,25,Male,HPV-related Cancer,mrna-4157 + keytruda,47.13,45.24,632.29,96,Partial Response
M213968,45,Female,HPV-related Cancer,KEYTRUDA only,64.25,52.69,1583.24,98,Partial Response
M213969,83,Other,Melanoma,mrna-4157 + keytruda,61.31,48.58,1112.97,85,Stable Disease
M213970,35,Male,Melanoma,mrna-4157 + keytruda,35.07,27.01,1109.8,81,Progression
M213971,63,Male,Melanoma,mrna-4157 + keytruda,29.99,14.69,694.59,97,Stable Disease
M213972,58,Male,HPV-related Cancer,KEYTRUDA only,80.79,40.07,375.53,101,Stable Disease
M213973,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.01,47.34,,85,Progression
M213974,73,Other,Melanoma,mrna-4157 + keytruda,65.92,52.8,,104,Complete Response
M213975,70,Male,HPV-related Cancer,mrna-4157 + keytruda,31.88,19.66,,108,Stable Disease
M213976,64,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.64,44.33,1185.56,95,Stable Disease
M213977,47,Other,HPV-related Cancer,mrna-4157 + keytruda,21.28,15.84,429.0,88,Partial Response
M213978,46,Female,HPV-related Cancer,mrna-4157 + keytruda,37.98,27.77,1054.37,101,Partial Response
M213979,39,Other,HPV-related Cancer,KEYTRUDA only,44.92,54.22,985.72,86,Partial Response
M213980,44,Female,Melanoma,mrna-4157 + keytruda,5.72,5.45,1064.91,95,Progression
M213981,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.19,24.26,543.94,103,Stable Disease
M213982,55,Other,HPV-related Cancer,KEYTRUDA only,45.64,32.5,713.02,108,Partial Response
M213983,77,Female,HPV-related Cancer,mrna-4157 + keytruda,67.35,66.88,1305.88,103,Progression
M213984,55,Female,Melanoma,mrna-4157 + keytruda,49.04,47.6,,88,Progression
M213985,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.34,29.91,959.3,80,Progression
M213986,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,46.06,34.12,464.62,87,Stable Disease
M213987,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.31,70.92,1503.26,87,Progression
M213988,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,73.8,68.67,1003.45,89,Progression
M213989,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,66.09,69.86,1700.34,74,Progression
M213990,32,Female,Non-small Cell Lung Cancer,KEYTRUDA only,39.13,38.1,663.45,86,Stable Disease
M213991,59,Male,HPV-related Cancer,mrna-4157 + keytruda,63.02,37.1,943.25,107,Progression
M213992,36,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.94,,926.75,76,Unknown
M213993,54,Male,HPV-related Cancer,mrna-4157 + keytruda,75.43,61.67,877.48,88,Partial Response
M213994,81,Other,HPV-related Cancer,KEYTRUDA only,20.98,16.32,1657.55,99,Complete Response
M213995,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.38,42.55,1071.08,99,Progression
M213996,43,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.15,39.53,,78,Partial Response
M213997,59,Other,Melanoma,KEYTRUDA only,23.15,8.71,1450.2,78,Stable Disease
M213998,80,Other,Melanoma,KEYTRUDA only,39.66,25.66,1559.97,88,Partial Response
M213999,29,Other,HPV-related Cancer,KEYTRUDA only,34.49,11.99,403.51,92,Stable Disease
M214000,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,90.76,82.13,-69.35,84,Complete Response
M214001,34,Other,HPV-related Cancer,KEYTRUDA only,44.53,44.08,509.42,88,Stable Disease
M214002,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.51,40.53,1450.97,106,Stable Disease
M214003,66,Female,Melanoma,mrna-4157 + keytruda,34.71,17.63,1122.47,89,Complete Response
M214004,40,Male,Melanoma,KEYTRUDA only,37.46,17.44,1349.52,89,Stable Disease
M214005,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.87,,393.28,80,Complete Response
M214006,31,Other,HPV-related Cancer,KEYTRUDA only,7.7,5.45,895.37,111,Partial Response
M214007,25,Female,Melanoma,mrna-4157 + keytruda,48.02,34.31,486.73,102,Complete Response
M214008,35,Other,HPV-related Cancer,mrna-4157 + keytruda,30.86,30.97,842.15,89,Progression
M214009,38,Other,HPV-related Cancer,KEYTRUDA only,39.98,38.0,932.83,92,Partial Response
M214010,63,Female,HPV-related Cancer,mrna-4157 + keytruda,46.65,35.74,,86,
M214011,41,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.54,17.17,566.48,78,Partial Response
M214012,73,Male,HPV-related Cancer,KEYTRUDA only,34.52,26.94,1297.61,76,Complete Response
M214013,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.92,32.62,952.16,90,Complete Response
M214014,27,Female,HPV-related Cancer,mrna-4157 + keytruda,59.15,59.49,426.85,85,Stable Disease
M214015,53,Other,HPV-related Cancer,mrna-4157 + keytruda,56.42,46.47,861.38,82,Stable Disease
M214016,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.72,45.83,896.45,90,Partial Response
M214017,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.4,55.19,788.41,96,Progression
M214018,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.59,31.44,634.39,79,Stable Disease
M214019,39,Female,HPV-related Cancer,mrna-4157 + keytruda,74.96,53.28,1333.41,92,Complete Response
M214020,34,Male,Melanoma,mrna-4157 + keytruda,47.92,33.26,1115.05,81,Progression
M214021,39,Female,Non-small Cell Lung Cancer,KEYTRUDA only,21.88,,1339.33,98,Partial Response
M214022,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,29.35,19.8,1093.8,87,Progression
M214023,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.51,12.13,774.58,85,Stable Disease
M214024,36,Male,Melanoma,KEYTRUDA only,30.56,21.65,,94,Progression
M214025,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.07,57.16,334.32,88,Stable Disease
M214026,83,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.91,63.33,,91,Complete Response
M214027,80,Other,Melanoma,mrna-4157 + keytruda,43.59,30.54,898.96,76,Partial Response
M214028,68,Female,Melanoma,mrna-4157 + keytruda,55.86,48.79,690.02,82,Partial Response
M214029,39,Female,HPV-related Cancer,mrna-4157 + keytruda,56.6,54.74,735.57,97,Progression
M214030,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.51,39.66,590.57,96,Complete Response
M214031,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.06,-2.05,1027.36,87,Partial Response
M214032,38,Other,Melanoma,KEYTRUDA only,28.51,11.66,978.94,84,Stable Disease
M214033,56,Other,Melanoma,mrna-4157 + keytruda,49.28,17.8,1277.77,71,Unknown
M214034,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,90.3,75.92,1266.95,94,Stable Disease
M214035,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.83,22.13,1140.5,99,Progression
M214036,59,Male,Melanoma,mrna-4157 + keytruda,49.73,60.49,273.31,70,
M214037,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.61,32.48,1214.31,67,Stable Disease
M214038,83,Other,HPV-related Cancer,mrna-4157 + keytruda,48.8,15.08,607.14,115,Partial Response
M214039,50,Female,HPV-related Cancer,KEYTRUDA only,57.67,59.83,1034.16,82,Complete Response
M214040,40,Other,HPV-related Cancer,KEYTRUDA only,45.71,45.14,860.17,91,Stable Disease
M214041,56,Male,HPV-related Cancer,mrna-4157 + keytruda,76.19,73.41,1250.18,91,Complete Response
M214042,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.68,31.42,1337.19,97,Complete Response
M214043,26,Male,Non-small Cell Lung Cancer,KEYTRUDA only,83.48,64.9,931.31,97,Complete Response
M214044,39,Other,HPV-related Cancer,mrna-4157 + keytruda,43.56,24.42,1177.05,86,Partial Response
M214045,40,Female,Non-small Cell Lung Cancer,KEYTRUDA only,25.36,15.95,1141.82,89,Stable Disease
M214046,25,Female,Non-small Cell Lung Cancer,KEYTRUDA only,38.82,36.56,1472.6,93,Stable Disease
M214047,63,Female,HPV-related Cancer,KEYTRUDA only,30.82,20.57,203.89,90,Progression
M214048,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.86,58.18,1124.75,83,Progression
M214049,27,Female,Melanoma,KEYTRUDA only,40.15,33.86,625.8,98,Stable Disease
M214050,66,Male,HPV-related Cancer,mrna-4157 + keytruda,67.78,70.34,958.32,85,Progression
M214051,49,Other,HPV-related Cancer,KEYTRUDA only,60.97,33.29,1100.86,91,Complete Response
M214052,50,Female,HPV-related Cancer,KEYTRUDA only,16.94,9.42,770.84,92,Stable Disease
M214053,71,Female,HPV-related Cancer,mrna-4157 + keytruda,92.21,68.89,1282.23,91,Complete Response
M214054,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,17.55,23.13,1144.47,97,Stable Disease
M214055,45,Female,HPV-related Cancer,mrna-4157 + keytruda,44.55,41.48,450.18,85,Progression
M214056,56,Female,HPV-related Cancer,mrna-4157 + keytruda,59.27,67.49,1178.03,87,Stable Disease
M214057,69,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.86,25.37,1219.54,83,Partial Response
M214058,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.64,44.41,887.65,103,Stable Disease
M214059,57,Female,Melanoma,KEYTRUDA only,14.21,10.75,914.92,80,Unknown
M214060,49,Male,Melanoma,KEYTRUDA only,83.46,74.12,1220.31,83,Progression
M214061,83,Other,HPV-related Cancer,mrna-4157 + keytruda,24.45,21.99,,106,Partial Response
M214062,75,Other,Melanoma,mrna-4157 + keytruda,78.38,69.49,657.86,86,Progression
M214063,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.22,53.4,1415.43,90,Stable Disease
M214064,37,Male,Melanoma,KEYTRUDA only,19.04,20.55,998.72,91,Partial Response
M214065,74,Female,Melanoma,mrna-4157 + keytruda,38.69,17.66,1455.43,96,Partial Response
M214066,52,Other,Melanoma,mrna-4157 + keytruda,88.96,65.3,1269.36,90,Progression
M214067,59,Other,HPV-related Cancer,KEYTRUDA only,41.95,37.75,1176.61,81,Unknown
M214068,35,Other,Melanoma,mrna-4157 + keytruda,20.86,9.12,909.68,94,Partial Response
M214069,71,Male,Melanoma,mrna-4157 + keytruda,67.0,53.15,1319.06,94,Partial Response
M214070,70,Male,HPV-related Cancer,KEYTRUDA only,57.34,51.06,535.58,88,Progression
M214071,36,Other,HPV-related Cancer,mrna-4157 + keytruda,62.33,56.23,947.02,77,Complete Response
M214072,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.14,5.13,96.81,92,Stable Disease
M214073,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.57,49.26,1073.19,88,Partial Response
M214074,67,Female,HPV-related Cancer,KEYTRUDA only,44.86,39.06,1084.68,87,Stable Disease
M214075,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,6.82,5.33,,103,Partial Response
M214076,43,Male,HPV-related Cancer,mrna-4157 + keytruda,21.72,10.56,735.56,88,Progression
M214077,36,Other,Melanoma,KEYTRUDA only,46.62,42.81,-40.33,99,Stable Disease
M214078,34,Male,HPV-related Cancer,mrna-4157 + keytruda,19.87,9.98,889.2,95,Progression
M214079,45,Other,HPV-related Cancer,mrna-4157 + keytruda,19.96,14.91,1128.82,83,Partial Response
M214080,57,Other,HPV-related Cancer,mrna-4157 + keytruda,17.25,13.04,1436.54,84,Unknown
M214081,66,Female,HPV-related Cancer,KEYTRUDA only,83.43,78.19,239.72,100,Complete Response
M214082,72,Female,HPV-related Cancer,mrna-4157 + keytruda,47.21,48.96,1071.73,93,Partial Response
M214083,45,Other,Melanoma,KEYTRUDA only,6.08,5.65,1271.08,94,Stable Disease
M214084,43,Male,HPV-related Cancer,mrna-4157 + keytruda,69.56,57.44,723.99,93,Stable Disease
M214085,52,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.63,25.63,842.63,93,Stable Disease
M214086,36,Male,HPV-related Cancer,mrna-4157 + keytruda,34.22,26.43,726.64,83,Unknown
M214087,63,Female,HPV-related Cancer,mrna-4157 + keytruda,35.8,43.24,1547.05,85,
M214088,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.84,37.03,1585.44,109,Stable Disease
M214089,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.26,71.59,,83,Progression
M214090,65,Male,Melanoma,mrna-4157 + keytruda,14.24,4.35,,78,Progression
M214091,80,Male,HPV-related Cancer,KEYTRUDA only,74.16,68.11,1062.32,95,Stable Disease
M214092,44,Female,HPV-related Cancer,KEYTRUDA only,56.26,46.36,1009.11,96,Partial Response
M214093,44,Other,Melanoma,mrna-4157 + keytruda,38.87,39.85,605.51,82,Progression
M214094,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,61.27,48.31,869.51,82,Unknown
M214095,70,Male,Melanoma,mrna-4157 + keytruda,53.82,,1318.66,81,Progression
M214096,82,Female,Melanoma,mrna-4157 + keytruda,32.03,12.45,1178.6,68,Stable Disease
M214097,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.94,44.17,1480.06,90,Partial Response
M214098,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.08,16.29,1495.94,99,Partial Response
M214099,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.61,30.34,674.92,71,Stable Disease
M214100,54,Other,HPV-related Cancer,KEYTRUDA only,39.33,32.11,1294.45,106,Stable Disease
M214101,83,Other,HPV-related Cancer,KEYTRUDA only,5.22,3.99,801.97,103,Partial Response
M214102,34,Female,Melanoma,KEYTRUDA only,59.57,50.91,1227.54,88,Stable Disease
M214103,84,Other,Melanoma,mrna-4157 + keytruda,57.43,30.11,893.9,101,Progression
M214104,64,Female,Melanoma,KEYTRUDA only,49.96,42.65,241.0,88,Stable Disease
M214105,52,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.67,43.09,1089.57,93,Progression
M214106,68,Female,HPV-related Cancer,mrna-4157 + keytruda,52.48,46.43,,108,Partial Response
M214107,75,Male,Melanoma,mrna-4157 + keytruda,26.81,23.77,1254.32,77,Stable Disease
M214108,31,Male,HPV-related Cancer,KEYTRUDA only,43.06,47.42,678.8,86,Stable Disease
M214109,82,Male,HPV-related Cancer,mrna-4157 + keytruda,60.52,52.25,1262.8,103,Partial Response
M214110,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.32,85.72,867.6,101,Complete Response
M214111,81,Other,HPV-related Cancer,mrna-4157 + keytruda,62.34,58.93,1038.55,77,Progression
M214112,48,Female,HPV-related Cancer,KEYTRUDA only,62.16,53.98,592.07,83,Progression
M214113,76,Male,HPV-related Cancer,mrna-4157 + keytruda,86.84,61.61,531.81,89,Partial Response
M214114,44,Male,HPV-related Cancer,KEYTRUDA only,77.46,57.48,1185.86,93,Stable Disease
M214115,50,Other,Melanoma,mrna-4157 + keytruda,74.34,54.77,1662.73,101,
M214116,68,Female,Melanoma,KEYTRUDA only,33.1,42.57,669.52,76,Complete Response
M214117,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,73.96,33.81,363.04,87,Complete Response
M214118,69,Male,Melanoma,KEYTRUDA only,53.8,35.99,1062.4,86,
M214119,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.53,16.8,538.18,81,Stable Disease
M214120,38,Other,HPV-related Cancer,KEYTRUDA only,37.73,26.9,526.99,80,Partial Response
M214121,37,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.32,17.13,937.67,96,Unknown
M214122,28,Other,Non-small Cell Lung Cancer,KEYTRUDA only,78.77,43.63,879.76,93,Complete Response
M214123,39,Male,Melanoma,KEYTRUDA only,27.66,21.95,2039.7,93,Partial Response
M214124,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.94,43.92,1196.13,91,Partial Response
M214125,81,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.63,,1201.13,87,Progression
M214126,26,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.59,33.28,860.79,99,Complete Response
M214127,72,Other,Melanoma,mrna-4157 + keytruda,71.4,,128.56,84,Progression
M214128,60,Female,HPV-related Cancer,mrna-4157 + keytruda,35.69,27.27,1518.51,71,Stable Disease
M214129,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.18,15.33,1528.7,77,Partial Response
M214130,28,Male,HPV-related Cancer,mrna-4157 + keytruda,45.71,30.06,1193.9,68,Partial Response
M214131,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.59,89.02,513.35,82,Complete Response
M214132,39,Female,Melanoma,KEYTRUDA only,59.16,35.18,1179.43,102,Partial Response
M214133,68,Female,HPV-related Cancer,mrna-4157 + keytruda,71.75,47.87,1195.38,92,Stable Disease
M214134,44,Male,HPV-related Cancer,KEYTRUDA only,49.29,43.42,1147.72,86,Partial Response
M214135,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,96.1,86.76,1228.06,95,
M214136,31,Female,Melanoma,KEYTRUDA only,71.79,44.74,1129.69,82,Partial Response
M214137,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.83,45.97,1463.17,89,
M214138,70,Male,Melanoma,KEYTRUDA only,29.9,11.91,1483.56,100,Partial Response
M214139,36,Male,Non-small Cell Lung Cancer,KEYTRUDA only,24.92,23.92,677.01,91,Complete Response
M214140,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.29,27.02,1188.25,96,Partial Response
M214141,30,Male,HPV-related Cancer,mrna-4157 + keytruda,66.61,55.63,1060.59,80,Partial Response
M214142,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.09,,1139.36,88,Complete Response
M214143,27,Female,Melanoma,KEYTRUDA only,21.22,,594.85,108,Progression
M214144,65,Female,Melanoma,KEYTRUDA only,21.75,19.25,1143.11,102,Partial Response
M214145,80,Male,Melanoma,mrna-4157 + keytruda,37.53,26.49,922.92,80,Complete Response
M214146,34,Male,HPV-related Cancer,KEYTRUDA only,50.52,25.7,1622.14,93,Progression
M214147,30,Other,HPV-related Cancer,KEYTRUDA only,47.45,34.35,424.3,98,Partial Response
M214148,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.39,44.73,891.09,89,Partial Response
M214149,76,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.35,31.62,1149.99,95,Complete Response
M214150,75,Female,HPV-related Cancer,mrna-4157 + keytruda,40.14,29.81,,95,Partial Response
M214151,66,Female,HPV-related Cancer,KEYTRUDA only,62.8,57.92,1386.31,98,Stable Disease
M214152,71,Female,Melanoma,KEYTRUDA only,15.45,14.25,1132.97,102,Stable Disease
M214153,79,Other,Melanoma,mrna-4157 + keytruda,65.13,40.68,1289.45,67,Stable Disease
M214154,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.99,86.45,719.3,96,Partial Response
M214155,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.63,48.2,1087.11,83,Stable Disease
M214156,40,Male,Melanoma,mrna-4157 + keytruda,35.5,31.36,1295.19,90,Partial Response
M214157,47,Male,HPV-related Cancer,mrna-4157 + keytruda,25.37,27.41,1039.43,101,
M214158,64,Male,Melanoma,KEYTRUDA only,60.56,33.54,628.38,84,Progression
M214159,71,Other,HPV-related Cancer,mrna-4157 + keytruda,27.09,30.3,828.79,92,Complete Response
M214160,36,Female,HPV-related Cancer,KEYTRUDA only,64.42,50.28,1076.64,112,Unknown
M214161,76,Other,Non-small Cell Lung Cancer,KEYTRUDA only,76.95,,1051.05,78,Partial Response
M214162,25,Other,HPV-related Cancer,KEYTRUDA only,65.48,55.49,698.07,76,Complete Response
M214163,72,Other,Non-small Cell Lung Cancer,KEYTRUDA only,59.41,36.14,1458.42,81,Partial Response
M214164,61,Male,Melanoma,mrna-4157 + keytruda,23.08,18.34,901.65,103,Stable Disease
M214165,50,Female,HPV-related Cancer,KEYTRUDA only,66.75,25.86,243.72,102,Stable Disease
M214166,72,Other,Melanoma,mrna-4157 + keytruda,30.31,24.76,891.49,98,Partial Response
M214167,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.14,,664.71,93,Partial Response
M214168,62,Other,HPV-related Cancer,mrna-4157 + keytruda,64.38,63.42,963.92,90,Stable Disease
M214169,40,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.81,,572.98,83,Partial Response
M214170,71,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,99.41,81.63,708.13,82,Partial Response
M214171,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.37,46.54,537.04,103,Stable Disease
M214172,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.29,41.17,1315.99,95,Stable Disease
M214173,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.07,51.68,640.21,87,Stable Disease
M214174,55,Other,Melanoma,KEYTRUDA only,69.05,62.26,1059.65,77,Unknown
M214175,46,Male,Melanoma,mrna-4157 + keytruda,57.52,59.4,343.83,89,Stable Disease
M214176,37,Female,HPV-related Cancer,mrna-4157 + keytruda,50.93,37.08,1516.55,108,Partial Response
M214177,37,Other,HPV-related Cancer,mrna-4157 + keytruda,82.38,83.69,,108,
M214178,76,Female,HPV-related Cancer,mrna-4157 + keytruda,36.24,32.21,794.48,96,Progression
M214179,80,Female,Melanoma,mrna-4157 + keytruda,34.13,29.15,717.47,91,Partial Response
M214180,34,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.77,29.23,,86,
M214181,47,Female,HPV-related Cancer,KEYTRUDA only,13.4,13.79,129.35,98,Progression
M214182,72,Male,Melanoma,mrna-4157 + keytruda,39.85,43.16,835.32,84,Stable Disease
M214183,37,Male,HPV-related Cancer,KEYTRUDA only,36.62,22.64,1083.36,96,Partial Response
M214184,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.15,32.41,758.57,97,Stable Disease
M214185,25,Other,HPV-related Cancer,mrna-4157 + keytruda,53.63,37.83,1841.39,89,Unknown
M214186,81,Male,HPV-related Cancer,KEYTRUDA only,29.04,20.01,206.89,79,Progression
M214187,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.59,63.07,746.03,72,Progression
M214188,32,Other,HPV-related Cancer,mrna-4157 + keytruda,50.53,36.65,675.39,99,Progression
M214189,78,Female,HPV-related Cancer,mrna-4157 + keytruda,70.26,50.63,249.58,95,Unknown
M214190,44,Male,Melanoma,mrna-4157 + keytruda,43.99,37.82,621.55,106,
M214191,62,Male,Melanoma,mrna-4157 + keytruda,45.93,38.83,397.8,96,Partial Response
M214192,42,Female,HPV-related Cancer,KEYTRUDA only,86.5,67.41,1627.79,95,Stable Disease
M214193,67,Male,HPV-related Cancer,mrna-4157 + keytruda,66.65,53.82,1042.18,107,Stable Disease
M214194,75,Female,HPV-related Cancer,KEYTRUDA only,44.87,34.76,1156.47,79,Progression
M214195,46,Other,Melanoma,mrna-4157 + keytruda,17.19,14.19,710.3,103,Progression
M214196,72,Male,Melanoma,mrna-4157 + keytruda,56.4,44.05,920.12,80,Partial Response
M214197,81,Male,Melanoma,KEYTRUDA only,44.36,19.05,424.42,76,Complete Response
M214198,29,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,14.55,12.82,358.45,90,Complete Response
M214199,50,Male,Melanoma,KEYTRUDA only,44.49,35.73,,83,Progression
M214200,77,Other,HPV-related Cancer,KEYTRUDA only,36.77,25.1,883.14,68,Stable Disease
M214201,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.22,25.64,442.55,98,Stable Disease
M214202,34,Female,Melanoma,KEYTRUDA only,80.37,77.99,1204.79,101,Partial Response
M214203,37,Other,HPV-related Cancer,KEYTRUDA only,75.06,64.36,933.9,86,Partial Response
M214204,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.36,28.99,1496.28,90,Complete Response
M214205,36,Male,Melanoma,KEYTRUDA only,88.52,74.23,991.21,94,Stable Disease
M214206,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,24.79,28.69,1594.66,87,
M214207,82,Female,Melanoma,mrna-4157 + keytruda,1.9,1.35,911.1,97,Complete Response
M214208,41,Other,Melanoma,KEYTRUDA only,43.5,34.89,1895.85,88,Partial Response
M214209,80,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.28,32.28,,98,Stable Disease
M214210,54,Female,HPV-related Cancer,KEYTRUDA only,59.42,52.54,1474.61,73,Partial Response
M214211,47,Female,Melanoma,mrna-4157 + keytruda,54.51,31.22,1305.73,97,Stable Disease
M214212,41,Female,Melanoma,mrna-4157 + keytruda,11.22,11.1,1304.77,92,Partial Response
M214213,26,Other,HPV-related Cancer,KEYTRUDA only,35.05,20.01,1068.8,101,Stable Disease
M214214,50,Female,HPV-related Cancer,mrna-4157 + keytruda,67.66,57.73,943.21,86,Progression
M214215,73,Male,HPV-related Cancer,KEYTRUDA only,63.19,48.69,886.84,78,Partial Response
M214216,46,Other,Melanoma,KEYTRUDA only,28.51,15.99,1182.92,81,Unknown
M214217,38,Female,Melanoma,KEYTRUDA only,65.72,43.32,1686.15,90,Stable Disease
M214218,50,Female,HPV-related Cancer,KEYTRUDA only,42.74,32.47,924.28,104,Complete Response
M214219,46,Male,HPV-related Cancer,mrna-4157 + keytruda,31.65,23.33,1027.33,99,Stable Disease
M214220,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.92,41.5,789.44,84,Partial Response
M214221,73,Female,Melanoma,KEYTRUDA only,41.22,19.1,1291.34,103,Partial Response
M214222,63,Female,Melanoma,KEYTRUDA only,53.1,51.92,983.9,92,Progression
M214223,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.21,26.52,952.3,81,Stable Disease
M214224,29,Other,Melanoma,mrna-4157 + keytruda,63.83,43.68,1692.62,91,Partial Response
M214225,79,Other,Melanoma,mrna-4157 + keytruda,58.5,46.88,718.47,92,Progression
M214226,76,Female,HPV-related Cancer,mrna-4157 + keytruda,66.95,44.78,899.17,81,Partial Response
M214227,41,Other,HPV-related Cancer,KEYTRUDA only,45.39,32.05,759.07,84,Stable Disease
M214228,43,Male,HPV-related Cancer,mrna-4157 + keytruda,19.39,21.33,1094.2,89,Partial Response
M214229,59,Male,Melanoma,KEYTRUDA only,63.47,72.91,1238.54,92,
M214230,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.2,29.33,853.44,97,Complete Response
M214231,52,Male,HPV-related Cancer,KEYTRUDA only,64.67,22.78,1550.82,89,Stable Disease
M214232,69,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.75,57.01,1173.67,93,Partial Response
M214233,47,Male,Melanoma,mrna-4157 + keytruda,18.93,9.0,970.3,86,Partial Response
M214234,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.12,53.85,,94,Complete Response
M214235,65,Other,Melanoma,KEYTRUDA only,86.91,61.96,702.44,90,Partial Response
M214236,25,Female,Melanoma,KEYTRUDA only,71.1,84.24,1267.29,101,Stable Disease
M214237,32,Female,HPV-related Cancer,KEYTRUDA only,28.75,24.26,1021.5,89,Stable Disease
M214238,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.86,50.65,734.8,79,Partial Response
M214239,43,Other,Melanoma,mrna-4157 + keytruda,29.47,20.23,219.47,86,Stable Disease
M214240,46,Other,HPV-related Cancer,mrna-4157 + keytruda,67.02,20.56,1547.33,91,Partial Response
M214241,31,Other,Non-small Cell Lung Cancer,KEYTRUDA only,35.52,15.94,528.94,87,Unknown
M214242,36,Other,HPV-related Cancer,mrna-4157 + keytruda,26.78,22.23,834.87,91,Complete Response
M214243,58,Female,HPV-related Cancer,mrna-4157 + keytruda,86.39,71.76,1253.75,78,Stable Disease
M214244,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,60.25,27.39,1788.57,90,Partial Response
M214245,27,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.41,31.53,373.48,83,Stable Disease
M214246,39,Other,Melanoma,mrna-4157 + keytruda,41.38,17.46,1186.29,93,Unknown
M214247,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.17,31.02,,81,Complete Response
M214248,68,Other,HPV-related Cancer,KEYTRUDA only,41.21,,1774.6,74,Stable Disease
M214249,44,Female,Melanoma,mrna-4157 + keytruda,55.84,31.63,1231.37,91,Stable Disease
M214250,58,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.44,21.38,43.83,94,Complete Response
M214251,50,Female,Melanoma,KEYTRUDA only,35.01,31.22,1146.27,87,Stable Disease
M214252,29,Male,Melanoma,KEYTRUDA only,84.44,,,100,Partial Response
M214253,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.01,31.14,962.89,102,Stable Disease
M214254,51,Male,Melanoma,mrna-4157 + keytruda,59.2,45.42,1056.95,90,Partial Response
M214255,60,Male,Melanoma,mrna-4157 + keytruda,14.84,10.1,1020.01,98,Stable Disease
M214256,64,Other,HPV-related Cancer,mrna-4157 + keytruda,54.65,48.37,825.39,96,Stable Disease
M214257,26,Female,HPV-related Cancer,KEYTRUDA only,31.82,23.48,979.09,92,Partial Response
M214258,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,51.02,42.3,1154.71,86,Stable Disease
M214259,50,Male,HPV-related Cancer,KEYTRUDA only,69.69,71.81,1284.56,87,Partial Response
M214260,34,Female,HPV-related Cancer,KEYTRUDA only,62.51,56.82,678.0,80,Complete Response
M214261,66,Other,HPV-related Cancer,KEYTRUDA only,73.52,66.97,829.41,88,Partial Response
M214262,62,Male,HPV-related Cancer,mrna-4157 + keytruda,28.45,33.52,545.19,94,Complete Response
M214263,83,Male,HPV-related Cancer,mrna-4157 + keytruda,44.0,17.87,1588.53,79,
M214264,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.34,63.18,,87,Partial Response
M214265,56,Female,HPV-related Cancer,mrna-4157 + keytruda,40.73,31.03,992.71,70,Complete Response
M214266,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.92,30.91,845.47,92,Partial Response
M214267,35,Male,HPV-related Cancer,KEYTRUDA only,58.02,44.48,730.4,95,Progression
M214268,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.58,36.83,746.6,99,Partial Response
M214269,39,Other,HPV-related Cancer,mrna-4157 + keytruda,43.61,30.54,803.85,96,Partial Response
M214270,32,Other,HPV-related Cancer,mrna-4157 + keytruda,71.74,56.38,713.62,89,Stable Disease
M214271,80,Other,HPV-related Cancer,KEYTRUDA only,9.73,10.4,66.06,99,Progression
M214272,63,Other,Melanoma,mrna-4157 + keytruda,51.42,25.56,1649.48,100,Partial Response
M214273,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.11,33.3,666.8,88,Partial Response
M214274,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.43,25.45,617.9,81,Stable Disease
M214275,40,Other,HPV-related Cancer,mrna-4157 + keytruda,103.67,30.22,1543.85,122,Progression
M214276,25,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.46,52.39,977.35,86,Complete Response
M214277,55,Female,HPV-related Cancer,KEYTRUDA only,81.56,32.0,1178.59,78,Stable Disease
M214278,26,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.93,35.59,880.95,97,Partial Response
M214279,47,Other,Melanoma,mrna-4157 + keytruda,50.59,40.39,,89,Partial Response
M214280,39,Male,HPV-related Cancer,KEYTRUDA only,79.95,91.01,856.03,105,Stable Disease
M214281,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.07,36.76,1923.74,76,Stable Disease
M214282,37,Female,Melanoma,mrna-4157 + keytruda,101.26,83.03,1049.04,89,Partial Response
M214283,57,Male,HPV-related Cancer,KEYTRUDA only,52.46,42.64,1278.6,89,Stable Disease
M214284,81,Other,HPV-related Cancer,KEYTRUDA only,4.3,3.14,499.82,88,Complete Response
M214285,64,Female,HPV-related Cancer,mrna-4157 + keytruda,67.63,60.01,442.73,85,Unknown
M214286,72,Female,Melanoma,mrna-4157 + keytruda,35.99,20.47,,95,Progression
M214287,33,Female,HPV-related Cancer,KEYTRUDA only,-16.92,-11.85,1785.96,93,Stable Disease
M214288,53,Other,Melanoma,mrna-4157 + keytruda,46.18,34.69,1132.08,82,Unknown
M214289,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.83,44.84,1040.87,98,Complete Response
M214290,79,Other,Melanoma,KEYTRUDA only,45.96,45.36,1169.56,92,Partial Response
M214291,47,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.84,35.69,711.1,77,Stable Disease
M214292,35,Male,Non-small Cell Lung Cancer,KEYTRUDA only,76.1,53.95,762.15,102,Complete Response
M214293,53,Male,Melanoma,KEYTRUDA only,31.27,26.33,1504.77,120,Complete Response
M214294,82,Female,Melanoma,mrna-4157 + keytruda,32.58,13.96,1037.45,91,Progression
M214295,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.65,47.57,655.77,73,Partial Response
M214296,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.67,82.16,1142.71,91,Stable Disease
M214297,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.4,37.67,532.25,94,Partial Response
M214298,83,Female,Melanoma,mrna-4157 + keytruda,56.74,35.96,1082.41,89,
M214299,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.58,45.13,1188.35,88,Stable Disease
M214300,71,Other,HPV-related Cancer,KEYTRUDA only,54.12,52.04,1309.76,94,Partial Response
M214301,76,Male,Melanoma,mrna-4157 + keytruda,56.7,54.95,1515.45,72,Stable Disease
M214302,50,Female,Non-small Cell Lung Cancer,KEYTRUDA only,21.31,17.29,303.33,92,Complete Response
M214303,83,Male,HPV-related Cancer,KEYTRUDA only,40.74,37.12,1612.09,92,Partial Response
M214304,31,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.13,29.08,1577.76,100,Unknown
M214305,31,Male,HPV-related Cancer,mrna-4157 + keytruda,96.23,94.51,1463.06,86,Progression
M214306,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.86,35.79,,84,Progression
M214307,64,Female,Melanoma,KEYTRUDA only,58.64,54.68,1218.59,91,Complete Response
M214308,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.92,50.73,961.84,90,Progression
M214309,60,Other,HPV-related Cancer,KEYTRUDA only,43.8,20.92,1125.63,95,Partial Response
M214310,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.63,70.2,1303.08,95,Progression
M214311,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.86,34.23,1115.33,80,Progression
M214312,72,Female,HPV-related Cancer,mrna-4157 + keytruda,32.99,21.4,1408.2,86,Stable Disease
M214313,47,Female,HPV-related Cancer,mrna-4157 + keytruda,32.17,20.02,877.68,101,Stable Disease
M214314,52,Male,Melanoma,KEYTRUDA only,39.81,29.98,1377.35,93,Stable Disease
M214315,75,Male,HPV-related Cancer,mrna-4157 + keytruda,45.01,57.02,1573.51,80,Partial Response
M214316,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,44.7,45.61,891.68,62,Partial Response
M214317,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.48,62.8,1566.43,93,Stable Disease
M214318,59,Other,Melanoma,KEYTRUDA only,47.81,34.63,1452.8,89,Stable Disease
M214319,65,Female,HPV-related Cancer,mrna-4157 + keytruda,34.93,28.14,732.8,86,Stable Disease
M214320,58,Female,HPV-related Cancer,mrna-4157 + keytruda,78.78,55.48,754.34,81,Partial Response
M214321,73,Other,HPV-related Cancer,mrna-4157 + keytruda,40.94,31.37,1228.75,83,Stable Disease
M214322,63,Other,HPV-related Cancer,KEYTRUDA only,-20.0,-15.33,1776.69,71,Partial Response
M214323,84,Other,HPV-related Cancer,KEYTRUDA only,65.62,47.04,1748.71,89,Stable Disease
M214324,29,Male,Melanoma,KEYTRUDA only,37.93,34.03,940.95,103,Stable Disease
M214325,71,Male,HPV-related Cancer,KEYTRUDA only,34.01,26.68,923.0,74,Partial Response
M214326,71,Other,Melanoma,KEYTRUDA only,65.28,37.99,1065.77,89,Complete Response
M214327,74,Male,HPV-related Cancer,mrna-4157 + keytruda,59.47,58.22,1414.37,101,Unknown
M214328,59,Other,HPV-related Cancer,mrna-4157 + keytruda,10.89,10.39,1186.82,94,Stable Disease
M214329,33,Female,Melanoma,mrna-4157 + keytruda,22.74,25.38,360.93,73,Progression
M214330,40,Female,HPV-related Cancer,mrna-4157 + keytruda,38.71,24.31,,88,Partial Response
M214331,63,Female,HPV-related Cancer,mrna-4157 + keytruda,41.21,24.91,381.71,96,Partial Response
M214332,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,71.96,63.53,678.33,99,Progression
M214333,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.75,17.66,1281.18,79,Complete Response
M214334,70,Female,Melanoma,mrna-4157 + keytruda,21.52,13.5,1455.26,91,
M214335,84,Other,Melanoma,mrna-4157 + keytruda,51.84,26.72,1441.63,79,Stable Disease
M214336,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.55,49.67,1286.25,95,Progression
M214337,38,Male,HPV-related Cancer,KEYTRUDA only,13.61,5.54,1027.2,87,Complete Response
M214338,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,22.46,15.63,1612.96,77,Progression
M214339,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.76,66.83,406.64,91,Complete Response
M214340,59,Male,Melanoma,KEYTRUDA only,30.04,30.12,1619.35,85,Partial Response
M214341,60,Male,HPV-related Cancer,mrna-4157 + keytruda,66.89,57.05,826.55,107,Complete Response
M214342,80,Male,Melanoma,mrna-4157 + keytruda,74.1,77.25,811.65,94,Partial Response
M214343,50,Male,Melanoma,KEYTRUDA only,70.51,53.19,951.3,77,Partial Response
M214344,42,Male,Melanoma,KEYTRUDA only,47.43,,736.91,100,Partial Response
M214345,31,Female,Non-small Cell Lung Cancer,KEYTRUDA only,24.24,21.31,1818.93,115,Progression
M214346,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.18,26.25,693.5,77,Stable Disease
M214347,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.35,17.13,1518.79,91,Stable Disease
M214348,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.27,52.66,1237.27,94,Complete Response
M214349,64,Female,Melanoma,mrna-4157 + keytruda,65.36,41.68,970.62,88,Stable Disease
M214350,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,84.02,87.78,1351.47,84,Progression
M214351,41,Other,HPV-related Cancer,mrna-4157 + keytruda,62.15,48.1,1232.01,92,Partial Response
M214352,50,Other,Melanoma,KEYTRUDA only,22.45,11.31,1476.76,81,Partial Response
M214353,40,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.04,57.9,1484.75,94,Stable Disease
M214354,69,Male,Melanoma,KEYTRUDA only,52.82,63.25,268.41,90,Complete Response
M214355,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,71.81,43.65,667.79,89,Stable Disease
M214356,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.99,50.45,896.33,85,Progression
M214357,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.65,29.59,1540.32,88,Stable Disease
M214358,48,Other,Melanoma,mrna-4157 + keytruda,40.89,30.5,1203.27,85,Partial Response
M214359,34,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.25,,239.31,78,Unknown
M214360,62,Female,Melanoma,mrna-4157 + keytruda,35.56,38.5,1342.54,79,Progression
M214361,56,Female,HPV-related Cancer,mrna-4157 + keytruda,66.58,44.22,687.05,92,Stable Disease
M214362,75,Other,Melanoma,mrna-4157 + keytruda,56.78,69.29,328.32,103,Stable Disease
M214363,70,Male,Melanoma,mrna-4157 + keytruda,30.44,31.99,316.67,87,Complete Response
M214364,42,Other,Melanoma,mrna-4157 + keytruda,39.49,27.35,1291.54,79,Progression
M214365,56,Other,HPV-related Cancer,KEYTRUDA only,52.68,51.46,790.62,79,Partial Response
M214366,31,Other,HPV-related Cancer,KEYTRUDA only,78.28,81.9,1184.02,96,Progression
M214367,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.3,60.93,810.3,79,
M214368,28,Male,Melanoma,mrna-4157 + keytruda,39.35,,810.31,96,Partial Response
M214369,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.65,35.27,1042.03,72,Progression
M214370,53,Male,Melanoma,KEYTRUDA only,48.92,38.95,1339.39,78,Complete Response
M214371,29,Female,Melanoma,KEYTRUDA only,41.44,37.04,,95,Stable Disease
M214372,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.36,37.67,680.6,87,Progression
M214373,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.96,47.32,522.97,76,Stable Disease
M214374,43,Male,HPV-related Cancer,mrna-4157 + keytruda,65.12,74.21,799.09,101,Complete Response
M214375,52,Female,Melanoma,KEYTRUDA only,48.39,51.4,1021.13,97,Progression
M214376,71,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.69,46.39,719.53,89,Partial Response
M214377,67,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.81,,1345.41,101,Complete Response
M214378,73,Other,Melanoma,mrna-4157 + keytruda,62.54,32.97,1084.67,89,Partial Response
M214379,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.99,43.9,768.83,82,Stable Disease
M214380,64,Other,HPV-related Cancer,mrna-4157 + keytruda,17.93,9.77,1059.11,98,Progression
M214381,74,Female,HPV-related Cancer,mrna-4157 + keytruda,67.41,30.66,853.71,93,
M214382,47,Male,HPV-related Cancer,mrna-4157 + keytruda,44.38,34.94,821.35,86,
M214383,64,Other,Non-small Cell Lung Cancer,KEYTRUDA only,12.03,8.72,1570.42,84,Stable Disease
M214384,78,Female,HPV-related Cancer,mrna-4157 + keytruda,74.47,30.65,642.29,84,Partial Response
M214385,62,Other,Melanoma,mrna-4157 + keytruda,77.56,68.88,,85,Stable Disease
M214386,49,Male,Melanoma,mrna-4157 + keytruda,56.36,,958.92,96,Partial Response
M214387,25,Other,HPV-related Cancer,mrna-4157 + keytruda,82.18,59.82,591.68,73,Progression
M214388,63,Male,HPV-related Cancer,mrna-4157 + keytruda,62.73,41.99,1372.88,112,Complete Response
M214389,26,Male,HPV-related Cancer,KEYTRUDA only,44.41,,641.56,99,Stable Disease
M214390,38,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.57,32.84,1107.81,88,Partial Response
M214391,26,Female,HPV-related Cancer,KEYTRUDA only,45.18,,982.38,73,Complete Response
M214392,81,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.83,51.27,884.71,111,
M214393,26,Female,Melanoma,mrna-4157 + keytruda,69.05,78.87,1230.07,86,Progression
M214394,61,Other,Melanoma,mrna-4157 + keytruda,37.66,15.66,1503.63,91,Stable Disease
M214395,35,Female,Melanoma,mrna-4157 + keytruda,51.83,28.35,1346.02,95,Progression
M214396,39,Female,HPV-related Cancer,mrna-4157 + keytruda,23.08,15.91,967.37,92,Unknown
M214397,33,Male,HPV-related Cancer,KEYTRUDA only,48.26,45.62,923.09,87,Progression
M214398,78,Female,Non-small Cell Lung Cancer,KEYTRUDA only,36.47,19.02,779.42,79,Partial Response
M214399,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.32,18.73,2018.55,80,Complete Response
M214400,54,Other,Melanoma,mrna-4157 + keytruda,84.71,39.48,,105,Partial Response
M214401,78,Other,HPV-related Cancer,mrna-4157 + keytruda,76.8,55.08,509.95,112,
M214402,51,Other,HPV-related Cancer,mrna-4157 + keytruda,38.88,36.09,874.93,110,Complete Response
M214403,32,Female,Melanoma,KEYTRUDA only,69.14,38.59,1586.86,95,Stable Disease
M214404,52,Male,HPV-related Cancer,mrna-4157 + keytruda,23.27,,585.52,98,
M214405,39,Female,Melanoma,mrna-4157 + keytruda,40.55,35.89,1525.78,97,Stable Disease
M214406,30,Female,Melanoma,mrna-4157 + keytruda,26.98,28.67,611.0,95,Partial Response
M214407,41,Other,Melanoma,mrna-4157 + keytruda,57.09,28.68,757.53,89,Partial Response
M214408,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.8,64.14,717.03,89,
M214409,72,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.66,14.0,486.96,84,Stable Disease
M214410,43,Female,Melanoma,mrna-4157 + keytruda,13.77,15.65,849.1,94,Progression
M214411,38,Female,Melanoma,mrna-4157 + keytruda,36.06,17.92,996.22,76,Stable Disease
M214412,60,Other,HPV-related Cancer,mrna-4157 + keytruda,40.96,32.02,,82,Progression
M214413,76,Female,HPV-related Cancer,KEYTRUDA only,50.97,,626.95,97,Progression
M214414,71,Male,Melanoma,mrna-4157 + keytruda,47.67,44.64,,89,Stable Disease
M214415,35,Male,Melanoma,mrna-4157 + keytruda,56.03,58.42,473.25,98,Progression
M214416,68,Other,HPV-related Cancer,mrna-4157 + keytruda,6.91,6.09,607.51,92,Stable Disease
M214417,62,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.97,31.7,1645.81,90,Partial Response
M214418,78,Female,Melanoma,mrna-4157 + keytruda,53.23,20.13,859.02,85,Partial Response
M214419,27,Female,Melanoma,KEYTRUDA only,49.39,28.87,692.54,82,Stable Disease
M214420,39,Male,Melanoma,KEYTRUDA only,58.89,50.21,185.52,78,Partial Response
M214421,74,Female,Melanoma,KEYTRUDA only,23.21,17.29,1092.46,102,Stable Disease
M214422,54,Other,Melanoma,KEYTRUDA only,46.81,43.17,734.15,109,Complete Response
M214423,48,Other,HPV-related Cancer,mrna-4157 + keytruda,63.1,56.44,888.21,72,Complete Response
M214424,56,Female,Melanoma,KEYTRUDA only,40.12,29.13,1144.46,82,Partial Response
M214425,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.46,39.99,538.34,94,Complete Response
M214426,83,Female,Melanoma,mrna-4157 + keytruda,60.95,,852.22,93,Progression
M214427,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,70.65,73.2,947.72,78,Progression
M214428,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.86,34.58,966.35,78,Partial Response
M214429,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.12,53.52,1547.07,95,Complete Response
M214430,68,Male,Melanoma,KEYTRUDA only,36.63,27.8,97.18,100,Partial Response
M214431,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,74.62,,1464.07,97,Progression
M214432,82,Male,HPV-related Cancer,KEYTRUDA only,-2.86,-2.05,740.36,94,Stable Disease
M214433,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.15,28.79,1286.53,93,Partial Response
M214434,25,Female,Melanoma,KEYTRUDA only,61.3,84.02,825.19,77,Partial Response
M214435,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.53,33.09,371.42,89,Partial Response
M214436,67,Male,HPV-related Cancer,mrna-4157 + keytruda,52.73,48.53,245.63,74,Stable Disease
M214437,62,Male,HPV-related Cancer,mrna-4157 + keytruda,37.71,32.51,895.84,95,Progression
M214438,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.93,24.41,1160.98,102,Stable Disease
M214439,52,Other,HPV-related Cancer,mrna-4157 + keytruda,10.02,5.61,569.83,89,Complete Response
M214440,74,Other,HPV-related Cancer,mrna-4157 + keytruda,36.09,30.8,833.0,95,
M214441,77,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,85.71,74.6,1173.96,106,Partial Response
M214442,32,Other,HPV-related Cancer,KEYTRUDA only,57.59,55.6,842.78,103,Complete Response
M214443,76,Male,Melanoma,KEYTRUDA only,22.15,16.07,814.73,115,Stable Disease
M214444,45,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.29,29.87,495.78,98,Partial Response
M214445,82,Other,HPV-related Cancer,mrna-4157 + keytruda,70.22,58.92,1032.2,95,Unknown
M214446,56,Other,Non-small Cell Lung Cancer,KEYTRUDA only,65.61,61.24,1079.08,106,Progression
M214447,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,36.95,18.78,1180.76,88,Stable Disease
M214448,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.1,34.8,1285.99,107,Progression
M214449,42,Male,HPV-related Cancer,KEYTRUDA only,46.91,55.29,1263.52,79,Progression
M214450,33,Other,HPV-related Cancer,mrna-4157 + keytruda,60.82,43.57,1122.35,83,Progression
M214451,81,Other,HPV-related Cancer,KEYTRUDA only,15.38,11.4,1232.33,81,Progression
M214452,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,84.68,,2029.25,86,Partial Response
M214453,63,Female,HPV-related Cancer,mrna-4157 + keytruda,90.16,82.5,774.41,95,Partial Response
M214454,79,Female,Melanoma,KEYTRUDA only,58.72,51.36,1333.96,85,Stable Disease
M214455,70,Male,Non-small Cell Lung Cancer,KEYTRUDA only,57.79,50.75,1455.39,99,Progression
M214456,77,Male,HPV-related Cancer,mrna-4157 + keytruda,62.67,43.78,261.15,95,Partial Response
M214457,65,Male,Melanoma,mrna-4157 + keytruda,36.08,35.76,704.67,95,Stable Disease
M214458,57,Male,Non-small Cell Lung Cancer,KEYTRUDA only,29.3,23.0,797.88,84,Stable Disease
M214459,27,Male,HPV-related Cancer,mrna-4157 + keytruda,55.66,48.84,971.17,95,Stable Disease
M214460,63,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.47,34.29,788.56,103,Progression
M214461,49,Male,HPV-related Cancer,mrna-4157 + keytruda,49.43,36.28,1241.05,107,Partial Response
M214462,65,Female,Melanoma,mrna-4157 + keytruda,65.65,,,82,Partial Response
M214463,66,Female,HPV-related Cancer,KEYTRUDA only,63.16,43.75,769.76,87,Partial Response
M214464,26,Female,Melanoma,KEYTRUDA only,54.05,,1207.52,92,Stable Disease
M214465,51,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,2.88,1.28,793.19,102,Stable Disease
M214466,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,68.42,79.21,753.05,92,Stable Disease
M214467,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.83,39.21,302.84,75,Stable Disease
M214468,31,Male,Melanoma,KEYTRUDA only,48.79,60.37,1484.79,76,Progression
M214469,37,Male,Melanoma,mrna-4157 + keytruda,58.9,53.12,390.56,90,Partial Response
M214470,72,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.15,54.59,738.24,88,Progression
M214471,73,Male,HPV-related Cancer,mrna-4157 + keytruda,73.22,52.95,776.06,90,Partial Response
M214472,46,Male,Melanoma,mrna-4157 + keytruda,46.98,32.63,632.67,81,Stable Disease
M214473,37,Other,Melanoma,mrna-4157 + keytruda,65.4,50.49,714.84,103,Stable Disease
M214474,39,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.34,38.94,1431.35,83,Complete Response
M214475,75,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.65,28.02,1642.63,94,Partial Response
M214476,57,Other,HPV-related Cancer,mrna-4157 + keytruda,3.04,1.92,1473.91,90,Complete Response
M214477,76,Female,HPV-related Cancer,KEYTRUDA only,74.19,39.45,778.83,91,Partial Response
M214478,65,Female,Non-small Cell Lung Cancer,KEYTRUDA only,71.26,73.94,768.17,88,Complete Response
M214479,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.36,38.04,1031.01,100,Progression
M214480,28,Male,Melanoma,KEYTRUDA only,70.94,71.64,974.33,87,Partial Response
M214481,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.87,46.17,1601.57,98,Progression
M214482,79,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.63,58.49,1780.19,91,Partial Response
M214483,70,Female,Melanoma,mrna-4157 + keytruda,76.64,30.23,10.23,111,Progression
M214484,72,Other,Melanoma,mrna-4157 + keytruda,63.93,,868.58,84,Unknown
M214485,46,Female,Melanoma,mrna-4157 + keytruda,16.22,16.97,1324.05,104,Progression
M214486,34,Female,Melanoma,KEYTRUDA only,100.97,71.52,927.73,94,Complete Response
M214487,44,Other,Melanoma,KEYTRUDA only,66.07,60.2,1105.51,111,Partial Response
M214488,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.03,37.79,1088.04,95,Partial Response
M214489,32,Other,HPV-related Cancer,mrna-4157 + keytruda,42.51,34.99,,81,Partial Response
M214490,57,Other,HPV-related Cancer,KEYTRUDA only,68.84,62.55,318.43,99,Complete Response
M214491,35,Female,HPV-related Cancer,mrna-4157 + keytruda,61.32,33.42,497.81,95,Partial Response
M214492,61,Other,Non-small Cell Lung Cancer,KEYTRUDA only,32.58,29.61,957.47,87,Progression
M214493,40,Female,HPV-related Cancer,KEYTRUDA only,67.43,61.1,1088.06,91,Stable Disease
M214494,74,Female,Melanoma,KEYTRUDA only,73.61,,1256.85,94,Progression
M214495,60,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.43,52.12,965.84,104,Progression
M214496,71,Female,Melanoma,mrna-4157 + keytruda,54.78,21.74,,79,Complete Response
M214497,79,Other,Melanoma,mrna-4157 + keytruda,33.38,29.08,1156.7,105,Complete Response
M214498,48,Male,HPV-related Cancer,mrna-4157 + keytruda,52.68,52.03,616.36,93,Stable Disease
M214499,66,Female,HPV-related Cancer,KEYTRUDA only,39.99,18.53,1720.27,95,Unknown
M214500,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.25,51.52,1323.78,102,Progression
M214501,32,Male,HPV-related Cancer,mrna-4157 + keytruda,82.49,60.14,1439.52,87,Stable Disease
M214502,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,78.59,67.21,1317.69,93,Stable Disease
M214503,77,Other,Melanoma,KEYTRUDA only,69.23,77.85,1848.47,109,Stable Disease
M214504,43,Male,HPV-related Cancer,mrna-4157 + keytruda,70.01,51.19,1220.72,94,Stable Disease
M214505,77,Male,HPV-related Cancer,KEYTRUDA only,36.73,26.19,901.49,101,Progression
M214506,26,Female,Melanoma,mrna-4157 + keytruda,50.19,50.14,1237.5,91,Partial Response
M214507,30,Other,Melanoma,KEYTRUDA only,49.55,43.88,318.42,102,Progression
M214508,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,27.39,23.2,157.57,76,Partial Response
M214509,46,Other,Melanoma,mrna-4157 + keytruda,51.45,33.18,430.43,90,Progression
M214510,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.57,64.99,609.31,78,Partial Response
M214511,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,11.57,9.97,919.1,80,Unknown
M214512,52,Male,HPV-related Cancer,KEYTRUDA only,21.65,19.73,1183.77,88,Stable Disease
M214513,70,Other,HPV-related Cancer,KEYTRUDA only,44.49,37.74,1374.19,87,Partial Response
M214514,74,Other,HPV-related Cancer,mrna-4157 + keytruda,-0.84,-0.56,1519.92,94,Stable Disease
M214515,58,Female,Melanoma,mrna-4157 + keytruda,17.74,13.59,552.35,99,Stable Disease
M214516,75,Male,Melanoma,mrna-4157 + keytruda,32.11,22.52,1212.23,85,Progression
M214517,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.55,31.28,1092.07,82,Complete Response
M214518,38,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.5,25.12,1239.44,85,Stable Disease
M214519,78,Female,HPV-related Cancer,mrna-4157 + keytruda,67.09,39.74,554.3,101,Complete Response
M214520,53,Female,HPV-related Cancer,mrna-4157 + keytruda,74.86,41.6,756.43,77,Partial Response
M214521,46,Female,HPV-related Cancer,mrna-4157 + keytruda,58.09,,209.19,85,Partial Response
M214522,30,Other,Melanoma,KEYTRUDA only,41.6,43.94,813.3,102,Stable Disease
M214523,65,Other,HPV-related Cancer,mrna-4157 + keytruda,51.7,23.52,-79.5,100,Partial Response
M214524,34,Female,Melanoma,KEYTRUDA only,37.47,34.79,1409.97,93,Stable Disease
M214525,66,Other,HPV-related Cancer,KEYTRUDA only,58.82,58.7,1445.66,91,Complete Response
M214526,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.74,21.47,384.14,94,Unknown
M214527,42,Male,Melanoma,KEYTRUDA only,33.43,26.86,1068.33,96,Progression
M214528,47,Male,HPV-related Cancer,mrna-4157 + keytruda,73.38,55.27,,92,Partial Response
M214529,54,Male,Melanoma,KEYTRUDA only,61.06,42.23,199.13,86,Partial Response
M214530,35,Female,Melanoma,mrna-4157 + keytruda,66.13,53.74,1768.27,77,Stable Disease
M214531,39,Other,HPV-related Cancer,mrna-4157 + keytruda,32.71,30.93,1339.18,102,Stable Disease
M214532,71,Male,HPV-related Cancer,mrna-4157 + keytruda,37.84,35.64,1017.45,91,Stable Disease
M214533,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.96,39.56,910.57,92,Partial Response
M214534,68,Female,Melanoma,KEYTRUDA only,43.86,54.14,767.23,96,Progression
M214535,84,Female,HPV-related Cancer,KEYTRUDA only,38.2,42.61,568.17,92,Unknown
M214536,63,Female,Melanoma,mrna-4157 + keytruda,56.56,32.75,,102,Stable Disease
M214537,42,Other,HPV-related Cancer,mrna-4157 + keytruda,30.47,23.25,604.73,80,Partial Response
M214538,48,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.37,64.93,1271.78,93,Stable Disease
M214539,59,Other,HPV-related Cancer,KEYTRUDA only,44.92,32.19,935.52,83,Complete Response
M214540,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,75.09,83.64,1087.47,91,Stable Disease
M214541,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.38,41.37,1691.46,122,Stable Disease
M214542,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.47,36.13,547.11,107,Stable Disease
M214543,27,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.3,25.47,1117.49,88,Partial Response
M214544,29,Other,Non-small Cell Lung Cancer,KEYTRUDA only,63.94,,1266.01,80,Complete Response
M214545,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.69,46.54,1282.45,77,Stable Disease
M214546,54,Other,HPV-related Cancer,KEYTRUDA only,63.54,44.86,359.86,99,Progression
M214547,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.36,27.54,1355.23,90,Partial Response
M214548,83,Male,HPV-related Cancer,KEYTRUDA only,11.26,6.82,585.82,103,Complete Response
M214549,46,Other,HPV-related Cancer,KEYTRUDA only,38.62,26.53,1441.52,78,Unknown
M214550,31,Female,Melanoma,KEYTRUDA only,81.69,,815.67,97,Complete Response
M214551,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.93,30.52,480.92,103,Progression
M214552,63,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.02,40.84,1183.34,83,
M214553,38,Other,HPV-related Cancer,mrna-4157 + keytruda,77.72,46.56,1153.61,91,
M214554,69,Other,HPV-related Cancer,KEYTRUDA only,5.99,4.27,1036.79,91,
M214555,73,Male,Melanoma,KEYTRUDA only,21.61,13.98,1141.52,88,
M214556,66,Female,Melanoma,mrna-4157 + keytruda,37.6,36.87,1271.62,104,
M214557,31,Male,Melanoma,mrna-4157 + keytruda,69.7,64.4,639.67,103,Progression
M214558,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.04,36.77,883.68,72,Partial Response
M214559,69,Male,Melanoma,mrna-4157 + keytruda,42.54,33.16,1916.47,88,Complete Response
M214560,47,Male,Melanoma,mrna-4157 + keytruda,33.35,34.67,786.24,103,Complete Response
M214561,73,Other,HPV-related Cancer,mrna-4157 + keytruda,72.14,64.08,1004.68,93,Complete Response
M214562,71,Other,HPV-related Cancer,mrna-4157 + keytruda,28.14,17.92,1064.58,105,Unknown
M214563,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.6,25.56,357.19,88,Partial Response
M214564,78,Other,HPV-related Cancer,KEYTRUDA only,38.73,27.49,744.33,77,Progression
M214565,81,Male,Melanoma,KEYTRUDA only,87.77,50.31,1314.42,67,Partial Response
M214566,52,Female,HPV-related Cancer,KEYTRUDA only,68.15,48.52,1128.84,108,Partial Response
M214567,43,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.37,28.74,1754.38,105,Progression
M214568,66,Other,Non-small Cell Lung Cancer,KEYTRUDA only,81.18,35.94,1056.88,97,Stable Disease
M214569,64,Other,HPV-related Cancer,mrna-4157 + keytruda,44.66,33.74,371.25,94,Progression
M214570,42,Female,Melanoma,mrna-4157 + keytruda,33.74,44.72,923.15,83,
M214571,77,Other,Melanoma,KEYTRUDA only,29.42,21.34,938.66,77,Stable Disease
M214572,43,Female,Melanoma,mrna-4157 + keytruda,81.79,64.26,212.47,102,Complete Response
M214573,62,Male,Melanoma,mrna-4157 + keytruda,70.65,,1225.72,75,Stable Disease
M214574,29,Male,HPV-related Cancer,mrna-4157 + keytruda,76.05,44.47,198.58,73,Progression
M214575,30,Male,Melanoma,mrna-4157 + keytruda,54.22,55.96,842.32,82,Partial Response
M214576,65,Other,HPV-related Cancer,mrna-4157 + keytruda,21.14,19.58,,101,
M214577,30,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,16.05,6.84,824.49,83,Progression
M214578,25,Male,HPV-related Cancer,mrna-4157 + keytruda,36.8,32.9,1443.33,98,Stable Disease
M214579,47,Other,Non-small Cell Lung Cancer,KEYTRUDA only,58.54,34.99,1310.32,88,Stable Disease
M214580,84,Male,Non-small Cell Lung Cancer,KEYTRUDA only,9.24,6.33,346.66,97,Complete Response
M214581,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,70.2,44.91,1033.34,90,Stable Disease
M214582,81,Male,Melanoma,KEYTRUDA only,49.14,53.25,582.85,84,Stable Disease
M214583,60,Other,HPV-related Cancer,mrna-4157 + keytruda,72.06,43.3,586.71,85,Complete Response
M214584,45,Other,HPV-related Cancer,KEYTRUDA only,65.56,35.62,835.64,84,Partial Response
M214585,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.61,37.14,598.44,97,Complete Response
M214586,65,Other,HPV-related Cancer,KEYTRUDA only,46.76,42.7,795.55,82,Progression
M214587,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.76,16.82,487.56,83,Stable Disease
M214588,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,38.83,30.69,850.2,94,Partial Response
M214589,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.73,,1307.32,84,Partial Response
M214590,47,Male,Melanoma,KEYTRUDA only,69.39,64.49,499.28,96,Progression
M214591,35,Other,Melanoma,KEYTRUDA only,50.32,45.56,911.06,94,Stable Disease
M214592,44,Male,HPV-related Cancer,KEYTRUDA only,51.77,29.39,826.58,76,Stable Disease
M214593,47,Other,HPV-related Cancer,KEYTRUDA only,75.02,69.96,571.3,100,Partial Response
M214594,49,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.3,33.66,506.04,87,Complete Response
M214595,60,Other,Melanoma,mrna-4157 + keytruda,54.72,46.98,1646.05,81,Complete Response
M214596,34,Female,HPV-related Cancer,mrna-4157 + keytruda,19.36,18.22,390.66,92,Progression
M214597,69,Other,Melanoma,KEYTRUDA only,71.98,70.09,685.05,84,Partial Response
M214598,40,Female,HPV-related Cancer,mrna-4157 + keytruda,67.94,50.59,390.82,97,Progression
M214599,34,Other,Melanoma,KEYTRUDA only,62.2,47.5,766.81,74,Progression
M214600,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.22,43.37,1124.45,74,Stable Disease
M214601,30,Other,HPV-related Cancer,KEYTRUDA only,37.2,,898.21,79,Stable Disease
M214602,77,Female,Melanoma,mrna-4157 + keytruda,60.59,57.76,519.31,105,Complete Response
M214603,67,Other,Melanoma,mrna-4157 + keytruda,66.67,59.18,1065.16,97,Partial Response
M214604,61,Male,HPV-related Cancer,mrna-4157 + keytruda,23.17,23.17,1520.79,93,Progression
M214605,64,Other,Melanoma,KEYTRUDA only,27.71,14.85,1474.33,90,Complete Response
M214606,39,Male,HPV-related Cancer,KEYTRUDA only,55.77,44.94,766.82,70,Stable Disease
M214607,44,Female,HPV-related Cancer,mrna-4157 + keytruda,54.86,47.47,1245.96,94,Complete Response
M214608,78,Male,HPV-related Cancer,mrna-4157 + keytruda,84.36,60.56,746.56,78,Complete Response
M214609,50,Female,Melanoma,mrna-4157 + keytruda,78.1,75.61,1538.13,83,Partial Response
M214610,73,Other,Melanoma,mrna-4157 + keytruda,26.72,19.88,1001.7,100,Stable Disease
M214611,46,Male,Melanoma,KEYTRUDA only,68.99,63.85,966.18,101,Complete Response
M214612,49,Other,Melanoma,mrna-4157 + keytruda,45.75,31.52,561.14,95,Stable Disease
M214613,40,Male,Melanoma,KEYTRUDA only,37.98,31.27,284.61,72,Progression
M214614,67,Other,HPV-related Cancer,mrna-4157 + keytruda,50.23,49.45,313.9,91,Partial Response
M214615,77,Other,HPV-related Cancer,mrna-4157 + keytruda,51.68,36.84,240.72,85,Progression
M214616,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.29,25.02,1527.44,89,Stable Disease
M214617,74,Female,Melanoma,mrna-4157 + keytruda,57.57,,1227.29,84,Partial Response
M214618,54,Other,Non-small Cell Lung Cancer,KEYTRUDA only,42.08,39.51,923.53,80,Complete Response
M214619,59,Female,Melanoma,KEYTRUDA only,79.23,41.41,1282.91,92,Stable Disease
M214620,30,Other,Melanoma,KEYTRUDA only,31.36,22.66,1255.18,95,Partial Response
M214621,61,Female,HPV-related Cancer,KEYTRUDA only,41.56,42.53,883.42,81,Partial Response
M214622,47,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.73,34.82,729.18,101,Progression
M214623,54,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.44,37.01,706.25,88,Stable Disease
M214624,58,Female,Non-small Cell Lung Cancer,KEYTRUDA only,92.33,61.73,1071.92,83,Unknown
M214625,25,Male,HPV-related Cancer,mrna-4157 + keytruda,32.35,32.05,687.4,91,Stable Disease
M214626,40,Other,Melanoma,mrna-4157 + keytruda,44.73,50.26,,105,Complete Response
M214627,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.48,48.13,745.14,85,Complete Response
M214628,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.32,19.83,879.26,80,Unknown
M214629,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.42,35.85,959.96,104,Stable Disease
M214630,46,Female,HPV-related Cancer,KEYTRUDA only,64.3,56.53,701.69,78,Partial Response
M214631,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.25,24.61,1461.41,93,Stable Disease
M214632,31,Male,Melanoma,mrna-4157 + keytruda,24.14,20.05,1691.81,73,Unknown
M214633,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.56,27.44,,93,Progression
M214634,80,Other,HPV-related Cancer,KEYTRUDA only,19.8,18.81,1175.86,70,Progression
M214635,44,Female,HPV-related Cancer,mrna-4157 + keytruda,42.62,19.85,1301.4,69,Stable Disease
M214636,63,Female,Melanoma,KEYTRUDA only,98.11,,1034.35,84,Progression
M214637,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.83,17.78,1406.99,101,Complete Response
M214638,34,Female,HPV-related Cancer,KEYTRUDA only,33.58,25.23,-80.21,89,Stable Disease
M214639,83,Female,Non-small Cell Lung Cancer,KEYTRUDA only,53.55,38.76,1142.33,85,Complete Response
M214640,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.28,36.83,1455.64,67,Progression
M214641,69,Other,HPV-related Cancer,mrna-4157 + keytruda,47.04,46.8,1081.79,94,Partial Response
M214642,74,Other,Non-small Cell Lung Cancer,KEYTRUDA only,15.87,13.36,546.77,98,Complete Response
M214643,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.42,25.01,800.85,76,Stable Disease
M214644,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,69.17,55.81,1577.41,89,Partial Response
M214645,75,Female,HPV-related Cancer,mrna-4157 + keytruda,72.38,61.54,1043.22,105,Complete Response
M214646,84,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,19.14,21.48,661.2,74,Progression
M214647,54,Female,Melanoma,KEYTRUDA only,68.99,76.82,664.31,97,Stable Disease
M214648,53,Male,Melanoma,mrna-4157 + keytruda,65.07,59.88,907.72,91,Partial Response
M214649,29,Other,HPV-related Cancer,KEYTRUDA only,51.26,43.89,703.32,84,Partial Response
M214650,43,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.75,45.14,923.55,79,Partial Response
M214651,56,Male,Melanoma,mrna-4157 + keytruda,65.92,60.22,,97,Stable Disease
M214652,59,Other,Melanoma,mrna-4157 + keytruda,33.86,26.34,1343.67,95,Stable Disease
M214653,57,Other,HPV-related Cancer,mrna-4157 + keytruda,86.38,63.09,590.38,93,Complete Response
M214654,50,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.49,47.16,1392.68,96,Partial Response
M214655,48,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.21,74.99,1084.5,78,Partial Response
M214656,32,Other,Non-small Cell Lung Cancer,KEYTRUDA only,81.2,75.58,1044.24,85,Stable Disease
M214657,72,Female,HPV-related Cancer,KEYTRUDA only,53.15,66.52,1099.28,102,Partial Response
M214658,84,Other,HPV-related Cancer,KEYTRUDA only,53.16,19.08,1337.43,85,Partial Response
M214659,75,Female,Melanoma,mrna-4157 + keytruda,6.86,3.52,1272.04,78,Partial Response
M214660,57,Other,Melanoma,mrna-4157 + keytruda,62.16,53.98,533.48,96,Partial Response
M214661,40,Male,Melanoma,mrna-4157 + keytruda,68.58,59.39,1063.25,86,Partial Response
M214662,74,Other,Melanoma,KEYTRUDA only,48.91,40.68,1588.67,83,Stable Disease
M214663,80,Female,Melanoma,KEYTRUDA only,70.9,87.91,585.87,81,Stable Disease
M214664,78,Other,Melanoma,mrna-4157 + keytruda,65.73,44.43,1173.77,98,Partial Response
M214665,61,Other,Melanoma,mrna-4157 + keytruda,88.72,71.78,1052.25,87,Complete Response
M214666,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.18,26.46,1495.25,103,Stable Disease
M214667,61,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.3,42.1,1022.46,102,Stable Disease
M214668,65,Female,Melanoma,mrna-4157 + keytruda,91.83,74.13,1054.47,90,Partial Response
M214669,32,Other,HPV-related Cancer,mrna-4157 + keytruda,62.91,64.49,1558.73,86,Complete Response
M214670,41,Female,HPV-related Cancer,KEYTRUDA only,44.99,31.06,1283.23,88,Partial Response
M214671,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.92,23.82,1034.36,99,Stable Disease
M214672,48,Female,Melanoma,KEYTRUDA only,65.06,50.2,952.29,85,Stable Disease
M214673,76,Female,Melanoma,KEYTRUDA only,45.66,19.4,1085.96,73,Partial Response
M214674,46,Other,HPV-related Cancer,mrna-4157 + keytruda,55.06,68.87,982.06,119,Stable Disease
M214675,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.86,33.57,396.77,94,Progression
M214676,83,Female,HPV-related Cancer,KEYTRUDA only,35.63,28.27,465.4,91,Complete Response
M214677,78,Other,Melanoma,mrna-4157 + keytruda,60.52,55.73,598.73,91,Progression
M214678,79,Other,HPV-related Cancer,KEYTRUDA only,81.44,65.9,1117.46,80,Stable Disease
M214679,51,Female,HPV-related Cancer,mrna-4157 + keytruda,76.01,68.53,1239.94,112,Complete Response
M214680,44,Other,Melanoma,KEYTRUDA only,71.31,95.68,719.24,73,Complete Response
M214681,45,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.35,37.33,526.41,86,Complete Response
M214682,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.47,54.22,1486.43,101,Stable Disease
M214683,46,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.37,,376.87,93,Stable Disease
M214684,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,32.82,37.65,321.14,92,Progression
M214685,40,Female,Melanoma,mrna-4157 + keytruda,63.93,59.67,384.0,77,Unknown
M214686,56,Male,Non-small Cell Lung Cancer,KEYTRUDA only,65.44,59.55,348.84,97,Complete Response
M214687,57,Male,Melanoma,mrna-4157 + keytruda,27.1,21.8,823.96,81,Partial Response
M214688,33,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,21.59,13.87,1215.58,100,Partial Response
M214689,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.74,21.92,1083.38,83,Stable Disease
M214690,65,Other,Melanoma,mrna-4157 + keytruda,54.74,33.9,831.05,91,Stable Disease
M214691,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.68,13.62,1015.4,84,Partial Response
M214692,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.72,22.62,1011.33,102,Unknown
M214693,41,Male,Melanoma,KEYTRUDA only,44.14,29.27,1050.68,89,Complete Response
M214694,80,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.23,57.64,1485.26,93,
M214695,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.88,27.02,1119.02,91,Partial Response
M214696,84,Other,Melanoma,KEYTRUDA only,56.59,52.12,1416.72,98,Stable Disease
M214697,82,Male,Melanoma,mrna-4157 + keytruda,45.77,40.9,1179.45,72,Partial Response
M214698,28,Male,HPV-related Cancer,KEYTRUDA only,49.54,33.28,743.26,90,Unknown
M214699,57,Female,Melanoma,mrna-4157 + keytruda,19.51,15.88,1040.7,76,Stable Disease
M214700,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.18,38.04,547.35,96,Progression
M214701,84,Other,HPV-related Cancer,mrna-4157 + keytruda,71.17,78.12,339.62,92,Progression
M214702,65,Female,Melanoma,mrna-4157 + keytruda,29.06,20.14,432.36,86,Partial Response
M214703,61,Other,HPV-related Cancer,KEYTRUDA only,66.56,60.23,670.17,78,Progression
M214704,42,Other,HPV-related Cancer,mrna-4157 + keytruda,45.37,39.46,941.77,105,Complete Response
M214705,54,Male,HPV-related Cancer,mrna-4157 + keytruda,97.16,95.78,1354.93,88,Partial Response
M214706,57,Male,Melanoma,mrna-4157 + keytruda,60.05,44.51,1174.29,86,Progression
M214707,42,Male,HPV-related Cancer,mrna-4157 + keytruda,61.3,68.09,2085.52,83,Stable Disease
M214708,71,Other,HPV-related Cancer,mrna-4157 + keytruda,58.52,56.03,1233.57,80,Progression
M214709,84,Other,Melanoma,mrna-4157 + keytruda,37.69,34.67,815.04,86,Partial Response
M214710,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.01,19.47,1486.17,84,
M214711,27,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.19,43.97,1697.68,89,Complete Response
M214712,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.48,59.39,1203.96,84,Progression
M214713,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,66.17,37.88,460.54,88,Stable Disease
M214714,26,Female,Melanoma,mrna-4157 + keytruda,32.71,24.26,1220.81,92,Partial Response
M214715,34,Other,Melanoma,mrna-4157 + keytruda,60.51,43.24,760.45,92,Partial Response
M214716,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,64.6,41.58,388.91,87,
M214717,63,Female,Melanoma,mrna-4157 + keytruda,37.42,,442.77,100,Stable Disease
M214718,62,Male,Melanoma,mrna-4157 + keytruda,49.21,46.71,1593.45,90,Complete Response
M214719,54,Other,Melanoma,KEYTRUDA only,36.43,33.7,808.66,94,Stable Disease
M214720,65,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,40.02,30.97,548.3,87,Stable Disease
M214721,36,Female,Melanoma,KEYTRUDA only,56.24,40.65,270.8,96,Unknown
M214722,34,Female,HPV-related Cancer,KEYTRUDA only,26.91,31.48,1482.63,77,Progression
M214723,54,Female,HPV-related Cancer,mrna-4157 + keytruda,65.71,73.34,857.58,79,Partial Response
M214724,75,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.43,28.44,1123.44,93,Stable Disease
M214725,72,Female,HPV-related Cancer,KEYTRUDA only,18.96,17.44,924.69,92,Partial Response
M214726,76,Other,HPV-related Cancer,mrna-4157 + keytruda,17.01,19.9,,90,Stable Disease
M214727,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,56.89,60.86,1442.77,81,Stable Disease
M214728,75,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.8,13.91,804.74,82,Partial Response
M214729,73,Other,Melanoma,KEYTRUDA only,17.37,13.87,1363.5,115,Stable Disease
M214730,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.68,27.94,985.74,116,Complete Response
M214731,70,Female,Melanoma,mrna-4157 + keytruda,42.73,32.75,1467.13,76,Stable Disease
M214732,66,Female,Melanoma,mrna-4157 + keytruda,71.27,49.31,,80,Partial Response
M214733,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.78,,559.68,87,Partial Response
M214734,43,Male,Melanoma,mrna-4157 + keytruda,29.42,,,79,Partial Response
M214735,53,Male,HPV-related Cancer,mrna-4157 + keytruda,52.71,32.06,1108.77,90,Stable Disease
M214736,30,Female,HPV-related Cancer,mrna-4157 + keytruda,90.26,67.14,1520.21,86,Complete Response
M214737,59,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.32,31.76,1243.91,105,Stable Disease
M214738,56,Male,Melanoma,mrna-4157 + keytruda,76.59,96.24,1094.96,84,Partial Response
M214739,47,Male,Non-small Cell Lung Cancer,KEYTRUDA only,52.66,38.81,793.23,85,Stable Disease
M214740,47,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.07,62.94,998.91,99,Complete Response
M214741,66,Male,Non-small Cell Lung Cancer,KEYTRUDA only,32.93,31.31,801.38,84,Stable Disease
M214742,31,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.01,46.79,416.18,62,Stable Disease
M214743,29,Male,HPV-related Cancer,mrna-4157 + keytruda,24.16,31.61,1193.79,79,Partial Response
M214744,42,Male,Melanoma,KEYTRUDA only,63.21,81.6,1428.71,89,Partial Response
M214745,51,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.53,37.55,1074.27,92,Stable Disease
M214746,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,44.6,10.15,1324.19,107,Stable Disease
M214747,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.83,40.21,1142.07,93,Partial Response
M214748,78,Male,Melanoma,mrna-4157 + keytruda,71.89,46.76,1214.14,84,Partial Response
M214749,29,Female,HPV-related Cancer,mrna-4157 + keytruda,45.61,31.35,957.23,91,Unknown
M214750,70,Female,HPV-related Cancer,mrna-4157 + keytruda,21.29,14.4,967.71,80,Complete Response
M214751,55,Female,Melanoma,KEYTRUDA only,67.79,66.48,981.75,94,Progression
M214752,59,Male,HPV-related Cancer,mrna-4157 + keytruda,85.6,57.15,,87,
M214753,80,Other,Melanoma,mrna-4157 + keytruda,51.72,48.39,753.7,81,Unknown
M214754,38,Female,HPV-related Cancer,mrna-4157 + keytruda,36.4,28.29,1087.2,84,Unknown
M214755,45,Female,Melanoma,mrna-4157 + keytruda,45.11,37.1,812.04,86,
M214756,34,Female,Melanoma,KEYTRUDA only,54.44,48.56,863.85,97,Stable Disease
M214757,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.1,57.84,852.67,86,Stable Disease
M214758,35,Male,Melanoma,mrna-4157 + keytruda,69.89,79.24,981.19,88,Complete Response
M214759,46,Male,Melanoma,mrna-4157 + keytruda,42.84,35.12,1223.39,88,Stable Disease
M214760,66,Male,Melanoma,mrna-4157 + keytruda,55.95,39.0,1403.98,77,Progression
M214761,28,Female,Non-small Cell Lung Cancer,KEYTRUDA only,88.24,97.57,416.33,95,Unknown
M214762,68,Female,HPV-related Cancer,KEYTRUDA only,78.25,62.9,1273.22,84,Partial Response
M214763,70,Other,Melanoma,KEYTRUDA only,22.89,27.43,151.43,95,
M214764,39,Female,Melanoma,KEYTRUDA only,67.71,49.61,1255.11,91,Progression
M214765,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.63,57.62,541.8,85,Partial Response
M214766,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.3,21.58,1151.98,70,Partial Response
M214767,37,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.2,54.14,1185.07,98,Complete Response
M214768,82,Other,Melanoma,KEYTRUDA only,43.03,46.11,484.61,90,Partial Response
M214769,75,Female,HPV-related Cancer,KEYTRUDA only,112.05,107.94,1073.15,99,Complete Response
M214770,69,Other,Melanoma,mrna-4157 + keytruda,43.61,29.62,1207.92,97,Partial Response
M214771,74,Male,Melanoma,mrna-4157 + keytruda,49.86,48.68,964.67,91,Stable Disease
M214772,65,Male,Melanoma,KEYTRUDA only,50.32,21.92,1329.59,86,Partial Response
M214773,67,Female,Non-small Cell Lung Cancer,KEYTRUDA only,49.87,46.55,1775.08,75,Partial Response
M214774,61,Female,Melanoma,mrna-4157 + keytruda,56.4,47.75,286.18,89,Progression
M214775,29,Male,Non-small Cell Lung Cancer,KEYTRUDA only,77.31,77.77,1222.8,94,
M214776,71,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.48,52.66,1319.3,77,Partial Response
M214777,63,Other,Non-small Cell Lung Cancer,KEYTRUDA only,39.42,37.8,1220.49,85,
M214778,44,Female,Melanoma,mrna-4157 + keytruda,58.39,47.79,1016.58,97,Progression
M214779,74,Other,Melanoma,mrna-4157 + keytruda,67.22,18.79,764.4,93,Stable Disease
M214780,61,Other,HPV-related Cancer,mrna-4157 + keytruda,39.19,27.31,1122.61,110,Partial Response
M214781,26,Female,Melanoma,mrna-4157 + keytruda,34.7,31.17,1496.68,79,Unknown
M214782,41,Male,HPV-related Cancer,mrna-4157 + keytruda,46.49,33.57,1047.48,85,Stable Disease
M214783,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,28.46,11.64,726.24,73,
M214784,58,Female,Melanoma,KEYTRUDA only,28.88,24.33,624.27,94,Complete Response
M214785,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.05,29.9,1500.41,91,Progression
M214786,30,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,26.38,20.36,1149.01,87,Partial Response
M214787,25,Female,HPV-related Cancer,mrna-4157 + keytruda,41.43,38.41,1534.39,79,Unknown
M214788,27,Other,HPV-related Cancer,mrna-4157 + keytruda,16.75,10.12,1024.6,104,Partial Response
M214789,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.84,83.51,72.26,106,Stable Disease
M214790,35,Male,HPV-related Cancer,KEYTRUDA only,64.72,53.8,382.63,104,Stable Disease
M214791,66,Female,HPV-related Cancer,mrna-4157 + keytruda,84.85,65.0,1025.25,91,Partial Response
M214792,42,Other,Melanoma,KEYTRUDA only,69.76,29.37,1030.45,98,Stable Disease
M214793,38,Male,HPV-related Cancer,mrna-4157 + keytruda,39.74,39.25,752.52,84,Partial Response
M214794,61,Female,Melanoma,mrna-4157 + keytruda,68.71,63.51,1488.43,80,Stable Disease
M214795,36,Male,HPV-related Cancer,KEYTRUDA only,56.26,45.89,957.12,74,Stable Disease
M214796,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.22,16.2,813.19,92,Partial Response
M214797,66,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.53,70.5,1434.81,95,Stable Disease
M214798,26,Other,Melanoma,mrna-4157 + keytruda,40.91,,977.07,98,Progression
M214799,34,Female,Melanoma,mrna-4157 + keytruda,47.55,37.88,592.93,89,Stable Disease
M214800,79,Other,Non-small Cell Lung Cancer,KEYTRUDA only,31.06,20.32,899.12,77,Partial Response
M214801,66,Male,Melanoma,KEYTRUDA only,17.56,11.16,1364.92,97,Partial Response
M214802,57,Male,Melanoma,mrna-4157 + keytruda,92.86,60.99,1010.21,103,Partial Response
M214803,77,Male,Melanoma,mrna-4157 + keytruda,46.38,47.69,671.86,98,Complete Response
M214804,64,Other,HPV-related Cancer,KEYTRUDA only,38.86,28.69,919.28,89,Progression
M214805,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,93.53,86.18,679.88,78,Progression
M214806,41,Male,Melanoma,KEYTRUDA only,74.47,84.1,1300.83,97,Partial Response
M214807,37,Female,Melanoma,mrna-4157 + keytruda,53.13,35.52,1310.04,87,Progression
M214808,66,Male,Melanoma,mrna-4157 + keytruda,59.66,68.55,720.6,85,Partial Response
M214809,56,Other,HPV-related Cancer,mrna-4157 + keytruda,74.76,54.12,1654.61,94,Unknown
M214810,36,Female,Melanoma,KEYTRUDA only,58.4,56.61,471.31,92,Complete Response
M214811,71,Female,Melanoma,mrna-4157 + keytruda,33.12,32.74,854.55,84,Progression
M214812,66,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.65,26.74,1117.39,100,Partial Response
M214813,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,38.2,36.7,642.16,89,Stable Disease
M214814,77,Female,Melanoma,mrna-4157 + keytruda,42.79,,553.86,74,Progression
M214815,72,Other,Melanoma,KEYTRUDA only,25.68,19.64,299.61,89,Complete Response
M214816,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,56.26,29.54,992.94,94,Partial Response
M214817,37,Other,HPV-related Cancer,mrna-4157 + keytruda,25.66,17.17,641.46,103,Partial Response
M214818,54,Female,Melanoma,KEYTRUDA only,64.95,59.77,1291.62,64,Complete Response
M214819,82,Other,Non-small Cell Lung Cancer,KEYTRUDA only,70.32,49.92,888.52,75,Progression
M214820,30,Male,Non-small Cell Lung Cancer,KEYTRUDA only,39.72,29.49,1237.56,94,Stable Disease
M214821,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,56.6,47.7,1080.54,94,Partial Response
M214822,37,Other,Melanoma,KEYTRUDA only,32.2,23.98,872.5,86,
M214823,55,Other,Melanoma,KEYTRUDA only,70.03,36.9,935.17,81,Partial Response
M214824,48,Female,Melanoma,KEYTRUDA only,26.89,31.07,692.65,88,Complete Response
M214825,44,Male,Melanoma,mrna-4157 + keytruda,38.61,24.46,1907.21,105,Stable Disease
M214826,58,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.27,47.19,553.96,95,Partial Response
M214827,69,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.04,29.21,,95,Partial Response
M214828,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,39.86,22.43,803.76,80,Stable Disease
M214829,64,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,34.35,,1499.28,73,Stable Disease
M214830,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,82.73,74.38,1380.59,94,Stable Disease
M214831,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,43.51,21.44,880.15,89,Stable Disease
M214832,44,Male,Non-small Cell Lung Cancer,KEYTRUDA only,54.25,51.01,1116.7,95,Stable Disease
M214833,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.07,33.42,258.18,94,Stable Disease
M214834,50,Other,Non-small Cell Lung Cancer,KEYTRUDA only,15.32,,971.41,89,Progression
M214835,68,Male,Melanoma,mrna-4157 + keytruda,75.99,76.04,901.99,95,Partial Response
M214836,57,Female,Melanoma,mrna-4157 + keytruda,88.98,93.96,1181.61,108,Complete Response
M214837,30,Other,Non-small Cell Lung Cancer,KEYTRUDA only,82.02,81.02,269.76,84,Complete Response
M214838,34,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.12,28.31,428.51,82,Partial Response
M214839,77,Male,HPV-related Cancer,KEYTRUDA only,26.45,20.49,1003.97,111,Progression
M214840,78,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.06,41.05,760.63,75,Stable Disease
M214841,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.0,70.18,1486.07,97,Partial Response
M214842,74,Male,HPV-related Cancer,mrna-4157 + keytruda,34.67,34.37,388.38,79,Partial Response
M214843,40,Male,HPV-related Cancer,mrna-4157 + keytruda,41.49,28.77,1070.15,88,Progression
M214844,50,Female,HPV-related Cancer,KEYTRUDA only,29.22,30.23,1393.47,79,Stable Disease
M214845,40,Other,HPV-related Cancer,mrna-4157 + keytruda,66.12,76.51,635.31,83,Stable Disease
M214846,51,Other,HPV-related Cancer,mrna-4157 + keytruda,75.08,,962.02,91,Stable Disease
M214847,60,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,27.09,26.34,,94,Partial Response
M214848,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.03,63.76,1315.39,99,Partial Response
M214849,77,Other,Melanoma,KEYTRUDA only,42.98,51.87,993.54,101,Progression
M214850,59,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.73,43.93,1125.21,85,Partial Response
M214851,74,Other,Melanoma,mrna-4157 + keytruda,62.69,52.34,1433.84,103,Partial Response
M214852,56,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.25,26.4,892.26,95,Progression
M214853,60,Female,Non-small Cell Lung Cancer,KEYTRUDA only,61.47,59.43,574.93,90,Complete Response
M214854,83,Female,HPV-related Cancer,mrna-4157 + keytruda,61.14,43.42,1329.05,91,Stable Disease
M214855,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.18,45.13,1241.29,75,Partial Response
M214856,35,Other,Melanoma,KEYTRUDA only,16.41,13.28,437.2,91,Progression
M214857,39,Other,HPV-related Cancer,mrna-4157 + keytruda,61.56,66.58,736.02,103,Partial Response
M214858,61,Female,Melanoma,mrna-4157 + keytruda,90.68,72.65,1009.56,89,
M214859,27,Other,Melanoma,mrna-4157 + keytruda,57.81,52.94,828.0,82,Complete Response
M214860,26,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.61,62.88,914.72,92,Partial Response
M214861,53,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.02,35.72,454.63,85,Progression
M214862,83,Other,HPV-related Cancer,mrna-4157 + keytruda,-1.8,-0.66,1519.42,110,Partial Response
M214863,59,Male,HPV-related Cancer,mrna-4157 + keytruda,43.67,26.91,619.32,85,Complete Response
M214864,48,Other,HPV-related Cancer,KEYTRUDA only,57.72,59.54,646.94,95,Complete Response
M214865,44,Other,HPV-related Cancer,mrna-4157 + keytruda,49.76,,1853.58,92,Stable Disease
M214866,33,Male,Melanoma,mrna-4157 + keytruda,28.19,24.77,1137.67,98,Partial Response
M214867,55,Other,HPV-related Cancer,KEYTRUDA only,63.97,52.48,1018.12,108,Partial Response
M214868,26,Other,HPV-related Cancer,KEYTRUDA only,27.97,19.72,843.46,99,Stable Disease
M214869,25,Female,Melanoma,mrna-4157 + keytruda,63.79,43.91,1080.09,88,Partial Response
M214870,71,Male,Non-small Cell Lung Cancer,KEYTRUDA only,72.69,66.19,1515.19,95,Stable Disease
M214871,52,Female,HPV-related Cancer,mrna-4157 + keytruda,31.53,25.63,1736.14,93,Partial Response
M214872,29,Male,HPV-related Cancer,KEYTRUDA only,51.7,45.64,1348.47,83,Stable Disease
M214873,57,Other,Melanoma,mrna-4157 + keytruda,16.6,14.01,1103.29,94,Unknown
M214874,34,Male,HPV-related Cancer,mrna-4157 + keytruda,61.1,56.72,750.92,86,Partial Response
M214875,66,Other,HPV-related Cancer,KEYTRUDA only,51.28,36.21,1071.1,78,Partial Response
M214876,51,Male,HPV-related Cancer,KEYTRUDA only,56.72,43.68,1188.72,92,Partial Response
M214877,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.72,39.59,1477.99,90,Complete Response
M214878,42,Male,Melanoma,mrna-4157 + keytruda,57.12,,771.18,90,
M214879,44,Other,HPV-related Cancer,KEYTRUDA only,33.12,24.27,747.95,107,Partial Response
M214880,49,Female,HPV-related Cancer,KEYTRUDA only,76.13,91.52,954.58,97,Progression
M214881,76,Female,Melanoma,mrna-4157 + keytruda,34.05,28.54,485.75,100,Progression
M214882,52,Female,Melanoma,mrna-4157 + keytruda,72.27,57.48,761.01,79,Stable Disease
M214883,45,Male,HPV-related Cancer,KEYTRUDA only,29.03,35.81,1442.01,80,Complete Response
M214884,28,Other,HPV-related Cancer,mrna-4157 + keytruda,73.13,64.63,802.46,104,
M214885,42,Female,Non-small Cell Lung Cancer,KEYTRUDA only,79.98,43.26,888.54,84,Partial Response
M214886,79,Female,Melanoma,mrna-4157 + keytruda,65.79,36.67,415.51,98,Partial Response
M214887,52,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.64,37.53,1179.1,101,Stable Disease
M214888,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.58,53.63,582.2,87,Stable Disease
M214889,50,Other,HPV-related Cancer,mrna-4157 + keytruda,57.41,16.13,935.5,99,Partial Response
M214890,34,Male,Melanoma,KEYTRUDA only,10.87,11.36,1173.42,91,Stable Disease
M214891,64,Other,HPV-related Cancer,mrna-4157 + keytruda,46.45,30.4,579.95,90,Partial Response
M214892,66,Female,Melanoma,mrna-4157 + keytruda,55.81,,983.37,75,Partial Response
M214893,65,Female,Melanoma,mrna-4157 + keytruda,46.24,50.17,249.18,94,Progression
M214894,72,Male,Melanoma,mrna-4157 + keytruda,67.04,69.78,1684.87,94,Partial Response
M214895,81,Female,Melanoma,KEYTRUDA only,43.05,41.33,515.64,93,Progression
M214896,42,Female,Melanoma,mrna-4157 + keytruda,64.35,38.14,853.61,85,Stable Disease
M214897,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.29,89.67,701.42,91,Partial Response
M214898,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.17,58.84,1416.15,88,Complete Response
M214899,35,Female,Melanoma,KEYTRUDA only,40.62,25.09,18.58,113,Progression
M214900,62,Other,HPV-related Cancer,mrna-4157 + keytruda,28.97,17.66,1077.71,97,Stable Disease
M214901,69,Other,Melanoma,mrna-4157 + keytruda,66.83,45.35,931.69,90,Progression
M214902,65,Male,HPV-related Cancer,mrna-4157 + keytruda,30.55,14.97,1257.03,88,Partial Response
M214903,65,Female,HPV-related Cancer,mrna-4157 + keytruda,34.42,20.65,457.45,95,Partial Response
M214904,63,Female,Non-small Cell Lung Cancer,KEYTRUDA only,22.0,18.86,1085.65,85,Stable Disease
M214905,65,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.76,42.95,737.67,95,Progression
M214906,49,Other,Melanoma,KEYTRUDA only,40.43,26.84,728.61,90,Complete Response
M214907,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.63,44.55,575.17,83,Complete Response
M214908,82,Male,Non-small Cell Lung Cancer,KEYTRUDA only,44.18,21.81,185.45,99,Stable Disease
M214909,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,41.31,42.93,1101.32,92,Partial Response
M214910,35,Other,Melanoma,mrna-4157 + keytruda,26.9,22.49,904.07,97,Partial Response
M214911,35,Female,HPV-related Cancer,mrna-4157 + keytruda,60.5,27.38,1431.84,96,Stable Disease
M214912,79,Male,HPV-related Cancer,mrna-4157 + keytruda,61.77,56.21,1350.7,94,Partial Response
M214913,48,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.74,61.77,352.3,96,Partial Response
M214914,54,Male,Melanoma,mrna-4157 + keytruda,64.97,36.11,670.58,92,Complete Response
M214915,40,Female,Melanoma,mrna-4157 + keytruda,19.93,12.72,1368.59,89,Stable Disease
M214916,30,Other,Melanoma,mrna-4157 + keytruda,19.44,9.43,357.47,104,Progression
M214917,26,Female,HPV-related Cancer,KEYTRUDA only,43.27,22.49,756.43,88,Complete Response
M214918,29,Male,Melanoma,KEYTRUDA only,45.48,29.86,314.42,86,Partial Response
M214919,46,Other,HPV-related Cancer,mrna-4157 + keytruda,43.66,37.72,1139.0,85,Stable Disease
M214920,30,Other,Melanoma,KEYTRUDA only,50.62,62.52,1110.45,85,Stable Disease
M214921,59,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.65,44.6,592.12,106,Stable Disease
M214922,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.23,37.17,1375.39,102,Stable Disease
M214923,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,30.67,30.1,1228.48,91,Progression
M214924,38,Other,Melanoma,mrna-4157 + keytruda,93.03,110.14,1565.45,108,Progression
M214925,80,Male,HPV-related Cancer,KEYTRUDA only,83.5,63.93,1018.68,87,Partial Response
M214926,25,Female,HPV-related Cancer,mrna-4157 + keytruda,52.37,41.39,449.28,92,Stable Disease
M214927,28,Other,Melanoma,KEYTRUDA only,60.2,49.72,968.12,92,Stable Disease
M214928,45,Male,Non-small Cell Lung Cancer,KEYTRUDA only,47.99,26.2,1245.67,91,Complete Response
M214929,40,Other,Melanoma,mrna-4157 + keytruda,61.47,,1112.61,75,Stable Disease
M214930,43,Female,Melanoma,mrna-4157 + keytruda,32.21,24.05,970.71,105,Complete Response
M214931,77,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.22,43.72,1668.16,101,Partial Response
M214932,81,Male,Melanoma,KEYTRUDA only,70.92,63.86,864.5,86,Stable Disease
M214933,67,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.64,21.87,947.88,86,Partial Response
M214934,55,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,64.85,62.59,1479.27,97,Partial Response
M214935,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.5,60.53,598.7,91,Partial Response
M214936,82,Male,HPV-related Cancer,mrna-4157 + keytruda,45.96,14.52,-256.88,82,Partial Response
M214937,52,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.33,58.98,574.79,79,Progression
M214938,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,3.66,3.17,767.65,95,
M214939,51,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,94.47,61.12,1033.28,90,Progression
M214940,34,Male,Melanoma,mrna-4157 + keytruda,27.63,18.38,1650.07,82,Progression
M214941,50,Male,HPV-related Cancer,mrna-4157 + keytruda,17.91,10.46,1092.92,79,Progression
M214942,26,Female,Melanoma,KEYTRUDA only,55.24,44.54,1349.47,95,Partial Response
M214943,53,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.94,28.71,1482.33,90,Stable Disease
M214944,48,Other,HPV-related Cancer,mrna-4157 + keytruda,49.19,34.79,871.48,79,Progression
M214945,42,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.49,41.55,623.01,95,
M214946,72,Other,HPV-related Cancer,mrna-4157 + keytruda,32.87,29.52,1431.53,85,Complete Response
M214947,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.23,31.78,1131.67,81,Stable Disease
M214948,66,Female,HPV-related Cancer,KEYTRUDA only,41.17,34.92,894.9,91,
M214949,76,Male,Melanoma,mrna-4157 + keytruda,48.85,48.82,1112.97,105,Progression
M214950,63,Female,HPV-related Cancer,KEYTRUDA only,0.94,1.01,821.64,94,Partial Response
M214951,82,Other,HPV-related Cancer,KEYTRUDA only,40.89,25.58,1509.02,99,Complete Response
M214952,59,Male,HPV-related Cancer,mrna-4157 + keytruda,62.06,43.21,1043.83,94,Progression
M214953,36,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.3,57.13,1102.34,89,Progression
M214954,66,Male,HPV-related Cancer,mrna-4157 + keytruda,8.93,4.99,344.0,108,Progression
M214955,66,Male,Melanoma,mrna-4157 + keytruda,4.13,2.02,818.61,95,Progression
M214956,60,Female,HPV-related Cancer,KEYTRUDA only,80.46,58.01,1305.25,84,Stable Disease
M214957,75,Male,HPV-related Cancer,KEYTRUDA only,76.01,39.85,1272.3,100,Partial Response
M214958,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,45.52,55.16,1247.11,93,Stable Disease
M214959,66,Other,Melanoma,KEYTRUDA only,61.28,67.27,970.83,93,Partial Response
M214960,46,Male,HPV-related Cancer,KEYTRUDA only,32.47,,1757.46,104,Partial Response
M214961,33,Female,Melanoma,KEYTRUDA only,67.46,68.98,773.38,107,Partial Response
M214962,78,Other,HPV-related Cancer,KEYTRUDA only,23.51,16.21,1594.92,93,
M214963,74,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,65.79,55.56,1090.3,91,Complete Response
M214964,47,Other,Melanoma,KEYTRUDA only,44.04,39.74,1148.23,82,Partial Response
M214965,63,Other,Melanoma,mrna-4157 + keytruda,33.09,36.47,1608.01,95,Partial Response
M214966,82,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.8,72.17,551.18,97,Partial Response
M214967,31,Other,HPV-related Cancer,KEYTRUDA only,54.69,36.01,1266.69,93,Progression
M214968,61,Female,Non-small Cell Lung Cancer,KEYTRUDA only,67.99,46.34,423.75,87,Progression
M214969,75,Male,HPV-related Cancer,KEYTRUDA only,27.49,12.47,882.43,105,Stable Disease
M214970,76,Female,Melanoma,mrna-4157 + keytruda,58.09,44.38,1146.87,81,Stable Disease
M214971,65,Other,Melanoma,mrna-4157 + keytruda,57.94,47.89,714.99,93,Stable Disease
M214972,53,Male,HPV-related Cancer,KEYTRUDA only,86.25,89.24,1153.53,94,Progression
M214973,35,Female,HPV-related Cancer,KEYTRUDA only,64.17,62.29,835.49,76,Complete Response
M214974,78,Male,Melanoma,mrna-4157 + keytruda,3.62,2.66,803.72,83,Stable Disease
M214975,42,Male,HPV-related Cancer,KEYTRUDA only,44.45,34.68,1050.69,81,Partial Response
M214976,70,Female,Melanoma,KEYTRUDA only,85.81,80.49,1639.41,84,Stable Disease
M214977,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,52.05,54.61,1581.47,101,Progression
M214978,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.11,33.82,797.6,87,Partial Response
M214979,75,Female,Non-small Cell Lung Cancer,KEYTRUDA only,73.13,46.05,1415.71,100,Stable Disease
M214980,60,Other,Non-small Cell Lung Cancer,KEYTRUDA only,40.9,34.55,1742.58,105,Progression
M214981,65,Male,Melanoma,KEYTRUDA only,56.45,47.39,-139.25,96,Complete Response
M214982,43,Male,HPV-related Cancer,KEYTRUDA only,39.26,47.76,1136.59,96,Stable Disease
M214983,60,Other,Melanoma,mrna-4157 + keytruda,45.97,33.14,1248.62,89,
M214984,37,Other,Non-small Cell Lung Cancer,KEYTRUDA only,54.68,45.39,1722.31,80,Partial Response
M214985,68,Male,HPV-related Cancer,KEYTRUDA only,14.78,11.57,1429.69,79,Stable Disease
M214986,42,Male,Melanoma,mrna-4157 + keytruda,51.2,26.25,1099.57,92,Stable Disease
M214987,80,Female,Melanoma,mrna-4157 + keytruda,66.29,50.59,930.06,102,Unknown
M214988,62,Female,Melanoma,KEYTRUDA only,27.89,19.74,1285.55,85,Progression
M214989,37,Male,HPV-related Cancer,mrna-4157 + keytruda,37.76,38.85,222.54,90,Partial Response
M214990,39,Male,Melanoma,mrna-4157 + keytruda,59.7,,1027.49,70,Partial Response
M214991,82,Male,HPV-related Cancer,mrna-4157 + keytruda,21.6,25.84,1655.77,96,Partial Response
M214992,60,Female,Melanoma,mrna-4157 + keytruda,71.11,28.25,506.37,96,Stable Disease
M214993,62,Other,Non-small Cell Lung Cancer,KEYTRUDA only,44.9,43.61,1027.73,95,Stable Disease
M214994,82,Female,Melanoma,mrna-4157 + keytruda,41.83,37.1,1051.01,93,Complete Response
M214995,64,Male,Melanoma,KEYTRUDA only,23.38,16.43,1112.8,75,Partial Response
M214996,52,Male,HPV-related Cancer,mrna-4157 + keytruda,80.18,,1025.68,73,
M214997,71,Other,HPV-related Cancer,mrna-4157 + keytruda,56.43,46.2,863.56,108,Partial Response
M214998,54,Female,HPV-related Cancer,KEYTRUDA only,53.64,27.68,552.85,89,Partial Response
M214999,75,Other,Melanoma,KEYTRUDA only,59.36,54.35,1966.88,96,Partial Response
M202180,79,Other,HPV-related Cancer,mrna-4157 + keytruda,24.3,20.29,1356.97,70,Progression
M202229,32,Female,Melanoma,mrna-4157 + keytruda,37.14,,1577.82,103,
M213686,61,Other,HPV-related Cancer,mrna-4157 + keytruda,68.42,38.91,1124.36,84,Partial Response
M209670,54,Female,HPV-related Cancer,KEYTRUDA only,39.73,6.48,513.85,88,Progression
M201754,43,Other,HPV-related Cancer,KEYTRUDA only,10.2,8.4,967.05,83,Partial Response
M204877,66,Male,HPV-related Cancer,mrna-4157 + keytruda,23.67,14.24,1213.02,86,Partial Response
M209655,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,46.33,43.0,814.09,81,Progression
M202063,40,Male,Melanoma,mrna-4157 + keytruda,72.2,69.77,1367.62,93,Progression
M208511,35,Other,Non-small Cell Lung Cancer,KEYTRUDA only,49.34,46.14,855.42,104,Partial Response
M201001,54,Male,Melanoma,mrna-4157 + keytruda,17.51,4.75,1344.58,92,Progression
M202879,49,Female,Non-small Cell Lung Cancer,KEYTRUDA only,66.97,73.46,1450.0,96,Progression
M213273,84,Other,HPV-related Cancer,mrna-4157 + keytruda,43.43,33.14,-264.87,94,Unknown
M203659,82,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,52.67,41.51,1188.81,95,Progression
M210274,50,Other,HPV-related Cancer,KEYTRUDA only,65.39,64.31,644.48,88,Stable Disease
M212590,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.43,44.56,1073.84,96,Progression
M208297,75,Other,HPV-related Cancer,mrna-4157 + keytruda,58.5,40.07,2336.14,94,Complete Response
M206244,80,Female,Non-small Cell Lung Cancer,KEYTRUDA only,32.66,20.31,1953.85,90,Partial Response
M206199,60,Male,HPV-related Cancer,mrna-4157 + keytruda,68.73,,609.06,100,Partial Response
M214190,44,Male,Melanoma,mrna-4157 + keytruda,43.99,37.82,621.55,106,
M210133,37,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,23.05,16.69,765.24,102,Stable Disease
M207119,70,Other,HPV-related Cancer,mrna-4157 + keytruda,42.88,50.01,1792.34,96,
M202941,49,Male,HPV-related Cancer,mrna-4157 + keytruda,71.22,69.52,953.85,86,Stable Disease
M203160,70,Male,HPV-related Cancer,KEYTRUDA only,31.06,26.24,400.23,91,Progression
M212414,67,Female,Melanoma,KEYTRUDA only,60.71,44.36,730.58,91,
M205608,42,Female,Non-small Cell Lung Cancer,KEYTRUDA only,1.41,1.09,594.02,81,Partial Response
M200052,74,Female,Melanoma,KEYTRUDA only,59.96,32.52,1068.51,75,Stable Disease
M203584,49,Male,HPV-related Cancer,KEYTRUDA only,43.02,37.62,771.11,76,Complete Response
M210657,45,Female,HPV-related Cancer,KEYTRUDA only,61.61,52.09,1261.06,73,Stable Disease
M211516,46,Other,Melanoma,mrna-4157 + keytruda,79.55,56.73,771.66,102,Unknown
M211237,82,Other,HPV-related Cancer,KEYTRUDA only,56.37,45.4,645.39,84,Complete Response
M202193,83,Female,HPV-related Cancer,KEYTRUDA only,31.73,28.15,1053.32,95,Partial Response
M206928,49,Other,Melanoma,mrna-4157 + keytruda,46.97,42.62,1366.82,79,Stable Disease
M211006,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,64.61,48.57,357.85,96,Stable Disease
M202630,57,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.21,20.14,,104,Progression
M204741,32,Female,HPV-related Cancer,KEYTRUDA only,51.59,37.23,924.44,98,
M206620,54,Other,Melanoma,KEYTRUDA only,28.45,29.54,818.51,109,Stable Disease
M208578,59,Female,Melanoma,mrna-4157 + keytruda,41.28,24.98,646.12,91,Unknown
M205538,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,90.87,47.77,1709.01,94,Partial Response
M207468,64,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.7,45.19,37.98,105,Stable Disease
M210420,39,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.54,67.63,944.13,92,Progression
M210842,83,Other,Non-small Cell Lung Cancer,KEYTRUDA only,55.61,36.27,990.61,92,Progression
M201374,79,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,51.24,45.78,1684.92,86,Progression
M206079,68,Male,Non-small Cell Lung Cancer,KEYTRUDA only,42.81,32.22,1272.34,92,Complete Response
M208850,41,Other,HPV-related Cancer,KEYTRUDA only,60.04,31.3,2008.72,97,Partial Response
M207480,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,38.55,45.84,1446.92,97,Partial Response
M205433,78,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,110.22,89.33,1319.39,97,Progression
M204477,81,Female,HPV-related Cancer,mrna-4157 + keytruda,39.48,35.41,1544.85,86,Stable Disease
M209569,64,Male,Non-small Cell Lung Cancer,KEYTRUDA only,51.73,26.92,455.77,85,Partial Response
M200909,77,Male,HPV-related Cancer,KEYTRUDA only,13.94,11.17,1454.73,92,Complete Response
M211736,59,Female,HPV-related Cancer,KEYTRUDA only,42.74,28.31,862.22,102,Partial Response
M203488,46,Other,Melanoma,KEYTRUDA only,42.41,30.51,637.02,86,Stable Disease
M211545,48,Other,HPV-related Cancer,mrna-4157 + keytruda,46.94,26.2,873.67,95,Stable Disease
M211310,28,Female,HPV-related Cancer,mrna-4157 + keytruda,40.63,32.48,942.55,90,Stable Disease
M209466,26,Female,Melanoma,mrna-4157 + keytruda,59.63,48.38,1100.6,82,Stable Disease
M205282,44,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,86.7,67.77,1152.97,102,Stable Disease
M213178,53,Female,HPV-related Cancer,mrna-4157 + keytruda,53.62,52.7,665.4,87,Complete Response
M214145,80,Male,Melanoma,mrna-4157 + keytruda,37.53,26.49,922.92,80,Complete Response
M207799,36,Other,HPV-related Cancer,mrna-4157 + keytruda,35.6,21.83,1107.4,86,
M208912,46,Female,Melanoma,mrna-4157 + keytruda,44.22,33.75,1584.32,94,Partial Response
M203278,26,Male,Melanoma,mrna-4157 + keytruda,52.73,41.85,763.52,80,Progression
M203529,31,Male,HPV-related Cancer,KEYTRUDA only,47.49,32.14,565.62,85,
M213559,65,Female,HPV-related Cancer,mrna-4157 + keytruda,32.85,14.15,1018.09,89,Complete Response
M214612,49,Other,Melanoma,mrna-4157 + keytruda,45.75,31.52,561.14,95,Stable Disease
M208867,61,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.0,48.85,1436.07,82,
M210110,75,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.15,65.69,1451.43,96,Complete Response
M202693,71,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.51,,1002.17,91,Complete Response
M212856,62,Female,Melanoma,mrna-4157 + keytruda,74.98,44.03,1121.38,99,Partial Response
M209806,80,Male,HPV-related Cancer,mrna-4157 + keytruda,19.9,,453.35,89,Progression
M208316,60,Female,Melanoma,mrna-4157 + keytruda,66.13,60.1,1184.8,82,Stable Disease
M203249,43,Female,Melanoma,KEYTRUDA only,76.14,54.76,1560.18,76,Progression
M214283,57,Male,HPV-related Cancer,KEYTRUDA only,52.46,42.64,1278.6,89,Stable Disease
M200683,65,Female,HPV-related Cancer,mrna-4157 + keytruda,9.44,7.24,949.92,82,Partial Response
M214340,59,Male,Melanoma,KEYTRUDA only,30.04,30.12,1619.35,85,Partial Response
M212971,43,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.85,39.22,725.1,89,Complete Response
M203980,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.5,60.98,986.4,95,Stable Disease
M214792,42,Other,Melanoma,KEYTRUDA only,69.76,29.37,1030.45,98,Stable Disease
M212773,73,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,81.23,90.66,1588.36,104,Partial Response
M200739,27,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,17.66,16.17,1222.62,107,Stable Disease
M202723,67,Male,HPV-related Cancer,KEYTRUDA only,24.37,15.4,1211.74,82,Stable Disease
M200700,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,71.13,47.05,1023.42,96,Complete Response
M207322,76,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,42.15,,1199.32,103,Partial Response
M202570,50,Male,HPV-related Cancer,KEYTRUDA only,32.52,33.72,1163.12,101,Partial Response
M206982,60,Other,HPV-related Cancer,mrna-4157 + keytruda,65.93,18.62,416.44,83,Progression
M214535,84,Female,HPV-related Cancer,KEYTRUDA only,38.2,42.61,568.17,92,Unknown
M214811,71,Female,Melanoma,mrna-4157 + keytruda,33.12,32.74,854.55,84,Progression
M207647,56,Male,Melanoma,mrna-4157 + keytruda,23.96,15.79,1147.0,106,Complete Response
M203785,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,20.71,,1688.69,87,Complete Response
M200211,30,Other,HPV-related Cancer,KEYTRUDA only,51.74,40.38,1102.74,83,Unknown
M209065,65,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,73.67,65.92,984.35,93,Progression
M213489,74,Female,HPV-related Cancer,KEYTRUDA only,38.88,23.78,1491.18,99,Partial Response
M205001,32,Male,Melanoma,KEYTRUDA only,63.56,57.42,1064.72,118,Partial Response
M212032,82,Female,HPV-related Cancer,KEYTRUDA only,22.2,16.98,1280.04,97,Stable Disease
M214664,78,Other,Melanoma,mrna-4157 + keytruda,65.73,44.43,1173.77,98,Partial Response
M205827,77,Male,Melanoma,KEYTRUDA only,54.68,50.07,891.56,80,Complete Response
M212024,27,Male,HPV-related Cancer,KEYTRUDA only,16.24,,1152.58,74,Stable Disease
M208406,84,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,93.37,107.31,1327.73,81,Progression
M207395,77,Female,Melanoma,KEYTRUDA only,33.38,19.85,1836.61,78,Complete Response
M209548,58,Female,Melanoma,mrna-4157 + keytruda,65.01,68.38,895.76,89,Partial Response
M213257,52,Male,HPV-related Cancer,mrna-4157 + keytruda,35.45,11.62,1406.74,92,Partial Response
M212367,31,Male,HPV-related Cancer,KEYTRUDA only,23.6,17.92,215.94,107,Stable Disease
M212890,55,Other,HPV-related Cancer,mrna-4157 + keytruda,71.44,68.72,250.14,86,Partial Response
M205677,57,Male,HPV-related Cancer,mrna-4157 + keytruda,55.11,50.88,702.97,101,Progression
M214090,65,Male,Melanoma,mrna-4157 + keytruda,14.24,4.35,,78,Progression
M201795,66,Female,Melanoma,KEYTRUDA only,34.9,32.2,579.83,83,Complete Response
M213258,44,Female,HPV-related Cancer,mrna-4157 + keytruda,54.97,49.44,1023.89,106,
M212694,62,Male,Melanoma,mrna-4157 + keytruda,64.63,35.26,1282.97,93,Partial Response
M206344,27,Other,Non-small Cell Lung Cancer,KEYTRUDA only,19.53,20.37,904.62,104,
M212143,81,Male,HPV-related Cancer,mrna-4157 + keytruda,23.82,17.52,491.97,81,Partial Response
M206429,40,Male,Melanoma,KEYTRUDA only,24.72,21.21,1308.82,104,Partial Response
M200595,82,Other,HPV-related Cancer,mrna-4157 + keytruda,80.3,55.48,1668.91,86,Stable Disease
M209723,70,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,99.68,67.44,907.45,68,Stable Disease
M205620,84,Male,HPV-related Cancer,mrna-4157 + keytruda,52.44,60.29,1019.92,88,Unknown
M209984,53,Other,Melanoma,KEYTRUDA only,21.93,,1270.63,87,Stable Disease
M214375,52,Female,Melanoma,KEYTRUDA only,48.39,51.4,1021.13,97,Progression
M210050,60,Other,HPV-related Cancer,mrna-4157 + keytruda,11.89,4.37,1067.4,70,Stable Disease
M207712,29,Other,Melanoma,mrna-4157 + keytruda,10.85,9.42,483.95,90,Unknown
M203289,50,Male,HPV-related Cancer,mrna-4157 + keytruda,30.95,32.07,1066.75,96,
M205648,76,Other,Melanoma,mrna-4157 + keytruda,56.08,50.41,1549.95,84,
M200396,54,Other,HPV-related Cancer,mrna-4157 + keytruda,59.62,45.25,901.22,86,Partial Response
M213956,58,Other,HPV-related Cancer,mrna-4157 + keytruda,30.42,21.69,1146.16,98,Stable Disease
M209031,25,Female,HPV-related Cancer,mrna-4157 + keytruda,18.4,19.9,908.22,92,Partial Response
M212062,59,Female,HPV-related Cancer,KEYTRUDA only,56.61,49.0,1028.74,83,Progression
M206186,43,Other,HPV-related Cancer,KEYTRUDA only,75.35,89.67,1243.95,93,Complete Response
M205440,72,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.19,30.87,1184.56,82,Progression
M202410,35,Female,Melanoma,KEYTRUDA only,60.98,59.39,733.98,108,Stable Disease
M213794,44,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,60.58,54.97,987.0,78,Complete Response
M210972,64,Other,HPV-related Cancer,KEYTRUDA only,47.09,42.54,986.82,82,Progression
M206498,48,Male,HPV-related Cancer,KEYTRUDA only,40.06,43.62,1179.5,97,Unknown
M209546,81,Other,HPV-related Cancer,KEYTRUDA only,73.1,52.16,670.28,83,Stable Disease
M203208,71,Male,Melanoma,mrna-4157 + keytruda,24.19,22.39,1531.27,98,Complete Response
M211636,50,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.12,56.17,765.58,107,
M212427,61,Other,Melanoma,mrna-4157 + keytruda,76.31,23.67,65.51,86,Partial Response
M212561,35,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.39,43.31,1059.85,85,
M202341,68,Female,Melanoma,mrna-4157 + keytruda,49.22,36.59,858.61,88,Stable Disease
M205901,53,Other,Non-small Cell Lung Cancer,KEYTRUDA only,62.33,54.83,-154.35,71,
M202608,70,Other,HPV-related Cancer,KEYTRUDA only,47.74,41.21,876.3,102,Partial Response
M205048,53,Male,Non-small Cell Lung Cancer,KEYTRUDA only,62.88,56.05,735.64,81,
M208278,56,Male,Melanoma,KEYTRUDA only,28.67,23.98,1137.0,87,Progression
M202090,50,Female,Melanoma,KEYTRUDA only,18.17,10.45,1585.62,98,Stable Disease
M206422,36,Other,HPV-related Cancer,KEYTRUDA only,39.39,36.04,1011.03,92,Stable Disease
M214530,35,Female,Melanoma,mrna-4157 + keytruda,66.13,53.74,1768.27,77,Stable Disease
M209641,72,Female,Melanoma,mrna-4157 + keytruda,78.53,59.44,392.4,93,Complete Response
M210874,68,Female,HPV-related Cancer,KEYTRUDA only,51.0,46.56,940.61,73,Partial Response
M207749,38,Female,Melanoma,mrna-4157 + keytruda,-1.19,-0.51,1204.11,78,Unknown
M206390,60,Male,Melanoma,mrna-4157 + keytruda,56.97,46.85,582.09,88,Partial Response
M203007,48,Male,Melanoma,mrna-4157 + keytruda,19.22,11.05,1519.06,82,Complete Response
M210109,65,Other,Melanoma,mrna-4157 + keytruda,44.86,30.97,245.28,79,Partial Response
M205790,32,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.02,62.7,1360.97,87,
M202460,44,Male,HPV-related Cancer,KEYTRUDA only,64.82,59.35,599.71,86,Stable Disease
M213637,73,Male,Melanoma,KEYTRUDA only,61.43,41.43,1585.7,90,Stable Disease
M205277,60,Male,Melanoma,mrna-4157 + keytruda,57.85,52.6,765.84,85,Progression
M200463,47,Female,HPV-related Cancer,mrna-4157 + keytruda,62.21,42.78,1453.03,96,Progression
M202600,63,Male,Melanoma,mrna-4157 + keytruda,57.08,36.61,949.34,93,Partial Response
M208159,37,Other,Melanoma,KEYTRUDA only,56.58,45.99,255.25,107,Partial Response
M204904,43,Male,Melanoma,KEYTRUDA only,60.13,40.03,434.56,89,Progression
M204552,31,Other,Melanoma,KEYTRUDA only,84.65,69.21,370.57,87,Partial Response
M200310,32,Male,Non-small Cell Lung Cancer,KEYTRUDA only,25.47,20.28,626.75,84,Complete Response
M200936,32,Male,HPV-related Cancer,KEYTRUDA only,54.58,52.5,630.08,92,Complete Response
M204803,45,Male,Melanoma,KEYTRUDA only,82.17,39.08,1621.72,106,Stable Disease
M207766,58,Other,HPV-related Cancer,KEYTRUDA only,39.41,47.55,1262.65,87,Progression
M201298,33,Male,HPV-related Cancer,KEYTRUDA only,73.57,41.16,919.51,76,Stable Disease
M203556,70,Male,Melanoma,mrna-4157 + keytruda,41.8,27.15,678.1,87,Stable Disease
M204131,33,Other,Non-small Cell Lung Cancer,KEYTRUDA only,86.3,,1123.6,79,Partial Response
M214707,42,Male,HPV-related Cancer,mrna-4157 + keytruda,61.3,68.09,2085.52,83,Stable Disease
M204099,59,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,83.87,80.42,1180.66,81,Stable Disease
M206670,73,Female,Melanoma,KEYTRUDA only,71.83,27.27,972.79,101,Partial Response
M206562,40,Male,Melanoma,KEYTRUDA only,47.66,42.46,1151.53,85,Stable Disease
M203177,54,Other,Melanoma,mrna-4157 + keytruda,52.92,35.6,1429.32,92,Partial Response
M203214,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,18.5,12.29,559.58,72,Stable Disease
M208938,66,Male,Melanoma,mrna-4157 + keytruda,30.17,29.13,1242.39,88,
M211134,56,Male,HPV-related Cancer,mrna-4157 + keytruda,52.72,54.59,1013.83,99,Progression
M203622,29,Male,Melanoma,mrna-4157 + keytruda,28.25,27.74,1041.16,101,Complete Response
M210390,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,57.9,,903.77,93,Stable Disease
M212322,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,74.9,49.26,1601.29,101,Unknown
M212452,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.05,25.28,652.67,80,Stable Disease
M209703,41,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.68,65.1,1506.48,92,Stable Disease
M202691,31,Female,Melanoma,mrna-4157 + keytruda,37.57,20.98,986.93,89,Complete Response
M205041,64,Female,HPV-related Cancer,mrna-4157 + keytruda,73.7,66.64,928.0,89,Progression
M203793,62,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.15,31.24,1193.17,74,Complete Response
M206160,47,Female,Non-small Cell Lung Cancer,KEYTRUDA only,92.63,82.69,1202.8,84,Complete Response
M206221,79,Female,HPV-related Cancer,mrna-4157 + keytruda,50.84,32.09,1435.98,93,Complete Response
M204978,69,Male,HPV-related Cancer,mrna-4157 + keytruda,84.32,45.39,-239.48,87,Partial Response
M212969,58,Other,HPV-related Cancer,mrna-4157 + keytruda,51.84,40.65,653.14,104,
M209708,68,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.56,44.61,1457.38,97,Stable Disease
M210395,77,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.36,81.94,1638.59,96,
M211480,27,Female,Melanoma,KEYTRUDA only,53.92,26.27,566.85,90,Stable Disease
M209415,42,Male,Melanoma,KEYTRUDA only,47.87,27.91,1238.37,85,Progression
M210039,68,Other,Non-small Cell Lung Cancer,KEYTRUDA only,41.11,44.16,1101.78,95,Unknown
M212061,44,Male,HPV-related Cancer,KEYTRUDA only,36.17,25.5,754.62,83,Partial Response
M205394,33,Male,Non-small Cell Lung Cancer,KEYTRUDA only,58.48,28.61,1601.44,93,
M203908,46,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.1,37.31,1652.16,81,Stable Disease
M207990,32,Female,HPV-related Cancer,KEYTRUDA only,81.73,58.65,1037.26,85,Stable Disease
M202032,30,Male,Melanoma,mrna-4157 + keytruda,41.45,26.56,1192.63,79,Stable Disease
M200325,71,Female,HPV-related Cancer,KEYTRUDA only,58.6,42.77,999.56,84,Stable Disease
M209376,54,Male,Non-small Cell Lung Cancer,KEYTRUDA only,41.11,36.2,893.63,90,Stable Disease
M210891,50,Female,Melanoma,KEYTRUDA only,29.95,21.48,1136.9,73,Stable Disease
M203272,47,Other,HPV-related Cancer,mrna-4157 + keytruda,55.87,44.0,5473.85,87,Stable Disease
M207736,38,Other,Melanoma,KEYTRUDA only,84.52,92.86,1237.78,106,Partial Response
M206782,43,Female,Non-small Cell Lung Cancer,KEYTRUDA only,37.76,20.73,1149.39,89,Complete Response
M210632,76,Other,HPV-related Cancer,mrna-4157 + keytruda,58.05,42.74,1155.87,100,Unknown
M214785,80,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.05,29.9,1500.41,91,Progression
M211005,69,Other,HPV-related Cancer,mrna-4157 + keytruda,50.28,42.07,1536.21,68,Stable Disease
M207897,80,Other,Melanoma,mrna-4157 + keytruda,30.63,30.25,507.76,97,Unknown
M201906,26,Male,Melanoma,mrna-4157 + keytruda,23.11,16.78,1146.8,97,Partial Response
M207842,60,Other,HPV-related Cancer,KEYTRUDA only,53.53,47.29,995.23,87,Partial Response
M206484,79,Female,HPV-related Cancer,mrna-4157 + keytruda,78.09,,,72,Stable Disease
M208893,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,7.98,5.61,,90,Complete Response
M201121,46,Female,HPV-related Cancer,mrna-4157 + keytruda,44.6,36.76,1345.36,100,Stable Disease
M207286,43,Female,HPV-related Cancer,mrna-4157 + keytruda,59.51,,727.77,81,Stable Disease
M200024,34,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.97,27.12,991.05,94,Partial Response
M200679,26,Female,Melanoma,mrna-4157 + keytruda,46.85,29.62,1381.21,94,Partial Response
M202854,49,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,53.45,52.01,330.84,91,Complete Response
M206874,31,Male,Melanoma,mrna-4157 + keytruda,60.23,34.39,795.44,90,Progression
M201141,83,Male,Melanoma,KEYTRUDA only,77.56,54.64,1333.86,80,Progression
M208716,47,Other,Melanoma,mrna-4157 + keytruda,91.37,71.65,793.03,96,Complete Response
M207089,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,63.1,36.91,1213.09,97,Partial Response
M202000,25,Other,Melanoma,KEYTRUDA only,49.17,40.51,1415.87,91,Complete Response
M214605,64,Other,Melanoma,KEYTRUDA only,27.71,14.85,1474.33,90,Complete Response
M205855,55,Male,Melanoma,mrna-4157 + keytruda,46.52,54.17,883.7,94,Partial Response
M207396,76,Female,HPV-related Cancer,KEYTRUDA only,63.74,75.58,844.08,91,Partial Response
M212000,71,Male,Melanoma,KEYTRUDA only,54.04,41.95,1130.05,76,Progression
M212332,83,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,48.12,40.71,1324.39,84,Partial Response
M204418,47,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,71.87,71.94,864.49,76,Progression
M204623,52,Other,Non-small Cell Lung Cancer,KEYTRUDA only,24.21,,1532.47,95,
M212228,65,Other,Melanoma,mrna-4157 + keytruda,44.33,41.66,284.4,79,Partial Response
M209951,81,Other,HPV-related Cancer,KEYTRUDA only,15.22,14.06,1295.52,91,Partial Response
M208991,33,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,84.28,75.26,846.57,89,Progression
M202679,74,Female,Melanoma,KEYTRUDA only,56.42,45.47,244.51,82,Partial Response
M200605,37,Female,HPV-related Cancer,mrna-4157 + keytruda,27.47,,824.95,83,Stable Disease
M204499,62,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.17,30.56,402.69,99,
M201700,31,Male,HPV-related Cancer,mrna-4157 + keytruda,61.72,36.25,466.08,101,Stable Disease
M204213,82,Female,Melanoma,KEYTRUDA only,40.44,32.3,1285.07,89,Partial Response
M201160,28,Male,Melanoma,mrna-4157 + keytruda,69.04,63.15,1324.03,86,Progression
M201271,59,Other,HPV-related Cancer,KEYTRUDA only,85.32,32.83,623.76,88,Complete Response
M206539,59,Female,HPV-related Cancer,KEYTRUDA only,45.38,37.86,555.55,92,Partial Response
M205342,29,Male,Melanoma,KEYTRUDA only,18.7,15.39,700.07,97,Partial Response
M207199,77,Female,Melanoma,KEYTRUDA only,57.85,45.92,621.57,94,Partial Response
M202680,74,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.33,43.62,1911.88,89,Partial Response
M214756,34,Female,Melanoma,KEYTRUDA only,54.44,48.56,863.85,97,Stable Disease
M205283,82,Female,Melanoma,mrna-4157 + keytruda,69.1,30.66,1083.86,87,Stable Disease
M204378,32,Other,HPV-related Cancer,KEYTRUDA only,49.51,6.29,807.06,100,
M213119,70,Other,HPV-related Cancer,mrna-4157 + keytruda,52.59,35.07,828.78,86,Stable Disease
M214255,60,Male,Melanoma,mrna-4157 + keytruda,14.84,10.1,1020.01,98,Stable Disease
M207873,79,Male,HPV-related Cancer,mrna-4157 + keytruda,39.31,29.0,842.28,85,Partial Response
M201292,35,Other,Melanoma,mrna-4157 + keytruda,47.78,35.79,1569.21,78,Partial Response
M213596,44,Other,Melanoma,mrna-4157 + keytruda,20.12,10.82,1115.81,88,Stable Disease
M205943,81,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,47.73,46.86,2041.52,99,Complete Response
M210266,45,Female,Melanoma,mrna-4157 + keytruda,31.82,34.19,1037.2,89,Partial Response
M206343,68,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.03,52.62,740.57,89,Progression
M202884,35,Other,HPV-related Cancer,mrna-4157 + keytruda,45.9,44.31,1329.78,116,Unknown
M200576,69,Other,HPV-related Cancer,mrna-4157 + keytruda,35.44,40.45,853.37,106,Stable Disease
M204548,80,Male,HPV-related Cancer,KEYTRUDA only,37.84,19.85,1001.82,78,Stable Disease
M204336,37,Female,Melanoma,KEYTRUDA only,69.87,61.84,,97,Stable Disease
M210289,35,Male,HPV-related Cancer,KEYTRUDA only,53.91,45.11,1404.81,86,Complete Response
M208279,53,Other,Melanoma,KEYTRUDA only,71.69,56.43,1791.69,101,Progression
M200680,41,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,36.81,42.38,1851.8,78,Complete Response
M206166,71,Other,Melanoma,KEYTRUDA only,65.86,,1218.47,93,Partial Response
M203963,76,Female,HPV-related Cancer,mrna-4157 + keytruda,31.31,28.22,1276.82,90,Stable Disease
M208544,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,114.57,102.14,860.27,77,Stable Disease
M202607,42,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,24.18,25.78,1323.09,87,Stable Disease
M211861,29,Female,HPV-related Cancer,mrna-4157 + keytruda,50.95,47.94,1607.82,82,Stable Disease
M209775,64,Female,Non-small Cell Lung Cancer,KEYTRUDA only,34.39,28.82,827.49,84,
M201094,32,Female,Melanoma,KEYTRUDA only,44.14,40.53,1719.17,78,
M200588,60,Female,Melanoma,KEYTRUDA only,17.34,10.89,1050.52,87,Stable Disease
M202093,69,Male,HPV-related Cancer,mrna-4157 + keytruda,43.38,40.97,1174.67,93,Stable Disease
M201261,32,Male,HPV-related Cancer,mrna-4157 + keytruda,70.02,,1388.77,97,Stable Disease
M207389,43,Female,Non-small Cell Lung Cancer,KEYTRUDA only,55.57,31.6,958.17,81,Partial Response
M207613,73,Other,Melanoma,mrna-4157 + keytruda,68.3,47.12,,94,Complete Response
M207096,62,Female,Non-small Cell Lung Cancer,KEYTRUDA only,85.91,87.39,958.84,87,Progression
M206231,68,Other,HPV-related Cancer,mrna-4157 + keytruda,31.92,27.77,1392.34,110,Stable Disease
M201740,51,Female,HPV-related Cancer,KEYTRUDA only,39.53,32.63,941.57,98,Stable Disease
M201852,41,Other,Melanoma,mrna-4157 + keytruda,71.13,66.59,803.74,91,Partial Response
M200309,25,Male,Non-small Cell Lung Cancer,KEYTRUDA only,59.43,39.5,787.42,96,Complete Response
M213837,73,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.64,48.47,1528.9,94,Partial Response
M213586,38,Male,Non-small Cell Lung Cancer,KEYTRUDA only,20.83,15.47,1454.6,72,Complete Response
M206555,34,Male,HPV-related Cancer,KEYTRUDA only,69.22,52.98,559.07,91,Partial Response
M200715,27,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,95.92,59.57,942.01,84,Partial Response
M201570,31,Female,HPV-related Cancer,mrna-4157 + keytruda,87.12,74.83,1549.15,98,Stable Disease
M205200,38,Other,HPV-related Cancer,mrna-4157 + keytruda,68.57,52.18,697.08,108,Progression
M202319,34,Male,HPV-related Cancer,mrna-4157 + keytruda,26.58,22.26,760.53,103,Stable Disease
M204533,77,Female,Melanoma,mrna-4157 + keytruda,3.36,2.82,1064.69,85,Stable Disease
M208154,25,Female,HPV-related Cancer,mrna-4157 + keytruda,53.41,47.79,1330.07,72,Progression
M200408,25,Male,Melanoma,KEYTRUDA only,75.26,42.18,1140.4,89,Complete Response
M213182,42,Other,Melanoma,mrna-4157 + keytruda,16.01,11.91,548.87,84,
M205511,43,Male,Melanoma,mrna-4157 + keytruda,54.58,44.51,1096.6,77,Progression
M212363,41,Other,HPV-related Cancer,mrna-4157 + keytruda,64.71,68.51,1575.83,83,Partial Response
M212909,46,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.07,,,85,Progression
M207908,79,Other,Melanoma,KEYTRUDA only,49.23,57.64,1196.88,89,Unknown
M200822,66,Other,Melanoma,mrna-4157 + keytruda,48.79,47.51,997.71,79,Stable Disease
M213962,51,Male,Melanoma,mrna-4157 + keytruda,53.9,37.01,1582.81,99,Progression
M211814,69,Other,Non-small Cell Lung Cancer,KEYTRUDA only,45.1,27.1,413.0,87,Stable Disease
M200410,64,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.19,61.08,656.87,100,Unknown
M207963,74,Female,HPV-related Cancer,KEYTRUDA only,26.41,21.04,1577.62,85,Partial Response
M214585,38,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,37.61,37.14,598.44,97,Complete Response
M208949,49,Male,Non-small Cell Lung Cancer,KEYTRUDA only,34.38,29.49,473.09,90,Stable Disease
M203789,66,Female,HPV-related Cancer,mrna-4157 + keytruda,91.04,71.22,1496.0,73,Stable Disease
M205839,45,Other,HPV-related Cancer,mrna-4157 + keytruda,43.47,33.76,1524.25,102,Partial Response
M211370,30,Male,Melanoma,KEYTRUDA only,66.7,55.78,1008.4,85,Progression
M213748,27,Male,Melanoma,mrna-4157 + keytruda,35.17,31.21,1457.78,80,Stable Disease
M202292,76,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,55.41,41.22,1404.88,97,Progression
M203933,25,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,45.91,33.26,885.01,85,Stable Disease
M208649,25,Female,Melanoma,KEYTRUDA only,66.47,47.5,998.66,88,Stable Disease
M202031,48,Other,HPV-related Cancer,mrna-4157 + keytruda,74.79,26.93,2101.34,97,Progression
M207634,70,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.33,34.14,265.36,99,Partial Response
M205842,82,Female,Melanoma,mrna-4157 + keytruda,52.94,47.52,1376.2,93,Stable Disease
M205678,26,Female,Non-small Cell Lung Cancer,KEYTRUDA only,63.6,30.48,717.92,95,Progression
M205252,62,Other,Melanoma,KEYTRUDA only,47.75,43.25,1651.91,83,Partial Response
M203481,77,Female,HPV-related Cancer,KEYTRUDA only,53.23,29.87,437.27,108,Complete Response
M211789,55,Female,Melanoma,mrna-4157 + keytruda,25.4,23.66,855.87,78,Stable Disease
M211948,48,Female,HPV-related Cancer,mrna-4157 + keytruda,42.01,45.9,880.03,92,Complete Response
M209588,77,Female,Melanoma,mrna-4157 + keytruda,70.86,64.79,1335.6,83,Progression
M207772,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.09,58.86,918.69,79,Stable Disease
M207819,28,Other,Melanoma,KEYTRUDA only,34.57,41.06,707.12,94,Unknown
M211738,71,Male,Melanoma,KEYTRUDA only,24.44,19.48,1246.95,81,Partial Response
M207351,40,Other,Non-small Cell Lung Cancer,KEYTRUDA only,68.58,50.37,1006.54,99,Complete Response
M205580,40,Male,Melanoma,mrna-4157 + keytruda,60.81,51.1,,85,Partial Response
M203723,70,Female,Melanoma,mrna-4157 + keytruda,59.8,40.08,,81,Partial Response
M207200,51,Other,Non-small Cell Lung Cancer,KEYTRUDA only,92.61,81.35,,74,Complete Response
M203870,63,Male,Non-small Cell Lung Cancer,KEYTRUDA only,68.15,73.64,748.94,93,Complete Response
M214393,26,Female,Melanoma,mrna-4157 + keytruda,69.05,78.87,1230.07,86,Progression
M209930,45,Other,HPV-related Cancer,mrna-4157 + keytruda,29.61,30.49,1196.37,99,Unknown
M210080,76,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,69.37,44.34,749.02,83,Partial Response
M202459,37,Male,HPV-related Cancer,KEYTRUDA only,20.65,17.44,1134.41,85,Progression
M206092,31,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.42,36.28,775.08,71,Progression
M204180,82,Female,Non-small Cell Lung Cancer,KEYTRUDA only,45.39,33.87,586.92,88,Stable Disease
M201144,26,Male,Melanoma,mrna-4157 + keytruda,67.94,58.46,1737.02,90,Partial Response
M202485,80,Other,Melanoma,mrna-4157 + keytruda,78.72,57.8,1328.7,90,Partial Response
M210020,46,Male,Melanoma,mrna-4157 + keytruda,43.69,38.98,779.15,93,Stable Disease
M213609,64,Female,Melanoma,mrna-4157 + keytruda,52.87,50.11,558.88,88,Stable Disease
M210652,31,Female,HPV-related Cancer,mrna-4157 + keytruda,55.1,38.29,1025.63,76,Complete Response
M211903,63,Other,Melanoma,KEYTRUDA only,36.94,31.62,61.56,89,Progression
M210960,50,Male,Non-small Cell Lung Cancer,KEYTRUDA only,49.5,55.7,943.59,81,Unknown
M200538,70,Female,HPV-related Cancer,mrna-4157 + keytruda,47.18,54.91,1623.77,79,
M206919,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,12.12,12.38,,90,Partial Response
M206083,29,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,62.88,24.84,1662.04,91,Complete Response
M204618,74,Female,Melanoma,mrna-4157 + keytruda,75.99,79.82,1907.32,83,Partial Response
M201245,73,Female,Melanoma,mrna-4157 + keytruda,43.48,30.23,764.16,97,Progression
M205831,63,Female,Melanoma,mrna-4157 + keytruda,39.65,30.99,1521.69,97,Stable Disease
M207526,72,Male,Melanoma,KEYTRUDA only,29.66,32.79,1191.34,86,Partial Response
M213931,27,Female,Melanoma,KEYTRUDA only,72.94,46.62,1496.3,96,Progression
M202677,58,Male,Melanoma,mrna-4157 + keytruda,60.07,,1437.81,93,Stable Disease
M202787,45,Male,HPV-related Cancer,mrna-4157 + keytruda,52.26,44.28,,79,Stable Disease
M203550,42,Other,HPV-related Cancer,mrna-4157 + keytruda,27.14,29.54,1415.92,86,Unknown
M211344,50,Male,HPV-related Cancer,mrna-4157 + keytruda,42.35,27.73,1050.21,114,Complete Response
M212486,57,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,56.89,39.66,307.6,73,Stable Disease
M209259,63,Female,HPV-related Cancer,KEYTRUDA only,38.77,31.02,874.25,87,Progression
M200430,36,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.5,85.59,1143.72,103,Complete Response
M206188,26,Female,Melanoma,mrna-4157 + keytruda,65.92,55.11,1203.17,103,Partial Response
M205981,83,Other,HPV-related Cancer,KEYTRUDA only,24.91,14.5,1028.08,90,Partial Response
M206700,73,Male,Non-small Cell Lung Cancer,KEYTRUDA only,46.79,43.75,1465.95,102,Stable Disease
M212135,38,Other,HPV-related Cancer,mrna-4157 + keytruda,59.8,51.5,773.19,85,Stable Disease
M205532,36,Other,HPV-related Cancer,mrna-4157 + keytruda,96.65,72.59,1120.92,84,Partial Response
M205640,58,Male,Non-small Cell Lung Cancer,KEYTRUDA only,35.58,27.37,1032.18,100,Complete Response
M208570,79,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,72.88,55.27,983.64,102,Complete Response
M205050,66,Other,HPV-related Cancer,KEYTRUDA only,4.56,2.66,943.64,77,Stable Disease
M214907,32,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,59.63,44.55,575.17,83,Complete Response
M209339,38,Other,HPV-related Cancer,mrna-4157 + keytruda,23.54,14.42,1287.64,86,Unknown
M200721,79,Other,HPV-related Cancer,mrna-4157 + keytruda,67.41,47.82,841.99,102,Partial Response
M214709,84,Other,Melanoma,mrna-4157 + keytruda,37.69,34.67,815.04,86,Partial Response
M204451,32,Male,Melanoma,KEYTRUDA only,69.41,49.98,1103.75,63,Complete Response
M203250,84,Other,Non-small Cell Lung Cancer,KEYTRUDA only,67.26,59.33,876.25,81,Progression
M200356,43,Male,HPV-related Cancer,mrna-4157 + keytruda,75.48,62.63,1272.99,76,Partial Response
M210600,76,Other,Melanoma,KEYTRUDA only,92.28,60.48,,93,Partial Response
M213683,83,Other,HPV-related Cancer,mrna-4157 + keytruda,64.62,42.48,911.99,84,Partial Response
M213468,77,Male,Melanoma,mrna-4157 + keytruda,23.87,23.37,1410.48,71,Partial Response
M205708,73,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,58.24,,1116.44,82,
M203106,73,Female,Non-small Cell Lung Cancer,KEYTRUDA only,42.98,34.59,679.39,81,Complete Response
M202819,79,Other,HPV-related Cancer,KEYTRUDA only,46.82,40.85,137.78,98,Complete Response
M214135,34,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,96.1,86.76,1228.06,95,
M206815,72,Female,Melanoma,KEYTRUDA only,36.65,,553.14,99,Progression
M206159,37,Female,Melanoma,KEYTRUDA only,97.25,71.13,990.82,94,Progression
M205345,26,Female,HPV-related Cancer,mrna-4157 + keytruda,56.65,31.94,1846.32,77,Unknown
M203420,58,Other,Melanoma,KEYTRUDA only,107.75,104.02,838.92,104,Progression
M206406,78,Other,Melanoma,KEYTRUDA only,47.07,41.08,1177.53,88,Stable Disease
M207660,76,Other,HPV-related Cancer,mrna-4157 + keytruda,43.02,40.35,1321.18,96,Partial Response
M210379,55,Female,HPV-related Cancer,mrna-4157 + keytruda,13.33,15.73,1651.36,87,Stable Disease
M206095,45,Male,HPV-related Cancer,mrna-4157 + keytruda,76.22,82.75,1532.85,95,Partial Response
M213909,58,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.38,17.08,534.72,93,Progression
M210479,53,Female,Melanoma,KEYTRUDA only,48.1,38.27,512.87,92,Stable Disease
M205876,36,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,35.77,25.86,1291.24,99,Stable Disease
M202591,84,Female,Melanoma,mrna-4157 + keytruda,23.17,17.37,868.89,101,Stable Disease
M205280,80,Male,HPV-related Cancer,mrna-4157 + keytruda,50.21,56.1,365.87,82,Partial Response
M212351,77,Female,Melanoma,mrna-4157 + keytruda,76.92,37.19,1200.43,69,Unknown
M203570,45,Male,Melanoma,mrna-4157 + keytruda,30.53,23.59,842.12,92,Complete Response
M210915,47,Male,HPV-related Cancer,mrna-4157 + keytruda,43.32,43.19,1326.89,89,Progression
M204062,83,Female,HPV-related Cancer,mrna-4157 + keytruda,39.54,22.0,512.84,100,Partial Response
M202247,67,Other,HPV-related Cancer,mrna-4157 + keytruda,22.05,13.91,1324.35,97,Complete Response
M210943,54,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,68.14,56.3,469.47,79,Partial Response
M207150,74,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,77.29,83.12,896.24,85,Complete Response
M212087,32,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,46.24,37.0,684.51,77,Partial Response
M201629,46,Male,HPV-related Cancer,KEYTRUDA only,17.4,12.7,552.42,74,Complete Response
M206649,54,Female,Melanoma,KEYTRUDA only,46.08,44.14,558.47,87,Partial Response
M205883,56,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,33.4,22.46,1348.16,78,Stable Disease
M202734,49,Other,HPV-related Cancer,KEYTRUDA only,64.9,,1145.36,75,Stable Disease
M209486,50,Other,Melanoma,KEYTRUDA only,67.09,52.29,1134.95,95,Stable Disease
M206892,36,Other,HPV-related Cancer,mrna-4157 + keytruda,40.57,37.77,678.22,97,Partial Response
M214329,33,Female,Melanoma,mrna-4157 + keytruda,22.74,25.38,360.93,73,Progression
M206460,71,Other,HPV-related Cancer,mrna-4157 + keytruda,33.47,28.28,1397.0,91,Partial Response
M204822,64,Female,Melanoma,mrna-4157 + keytruda,37.28,33.76,1685.03,85,Stable Disease
M210736,28,Male,Melanoma,mrna-4157 + keytruda,41.12,29.61,840.47,89,
M208689,42,Male,Non-small Cell Lung Cancer,mrna-4157 + keytruda,31.38,25.28,1239.63,100,Partial Response
M201921,28,Male,Melanoma,mrna-4157 + keytruda,61.05,48.79,1519.0,92,Progression
M204061,73,Male,HPV-related Cancer,mrna-4157 + keytruda,91.7,56.85,,86,Complete Response
M208976,36,Male,Melanoma,KEYTRUDA only,50.74,39.42,842.18,100,Progression
M212371,37,Male,HPV-related Cancer,KEYTRUDA only,34.49,24.54,1089.37,90,Complete Response
M206409,33,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,54.2,56.65,772.78,102,Partial Response
M210760,61,Female,Melanoma,KEYTRUDA only,34.32,38.88,791.71,74,Complete Response
M205624,31,Other,Melanoma,KEYTRUDA only,58.73,57.42,1848.91,85,Stable Disease
M205721,74,Male,Melanoma,mrna-4157 + keytruda,59.76,37.51,634.34,84,Stable Disease
M206619,64,Other,Melanoma,mrna-4157 + keytruda,86.26,37.32,990.35,87,Stable Disease
M209604,74,Male,Melanoma,KEYTRUDA only,69.8,49.32,1531.65,108,Unknown
M207935,33,Male,HPV-related Cancer,mrna-4157 + keytruda,59.28,43.55,988.23,95,Complete Response
M212423,37,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,43.65,40.14,812.0,95,Complete Response
M205825,63,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.18,60.64,1135.11,88,Complete Response
M202047,58,Male,Melanoma,KEYTRUDA only,78.63,59.34,799.84,103,Partial Response
M208329,54,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,80.15,79.47,1167.85,93,Complete Response
M210742,55,Female,Non-small Cell Lung Cancer,mrna-4157 + keytruda,50.95,35.31,358.54,86,Stable Disease
M208691,29,Female,Non-small Cell Lung Cancer,KEYTRUDA only,-9.31,-9.39,914.62,84,Complete Response
M200382,29,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,78.82,84.12,1099.55,87,Complete Response
M212884,38,Female,Non-small Cell Lung Cancer,KEYTRUDA only,74.8,72.52,148.44,93,Progression
M207079,72,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,61.06,28.35,1075.33,101,Complete Response
M203692,37,Other,HPV-related Cancer,mrna-4157 + keytruda,66.91,61.23,,88,Progression
M206644,60,Other,HPV-related Cancer,KEYTRUDA only,93.76,102.68,1193.11,87,Complete Response
M214725,72,Female,HPV-related Cancer,KEYTRUDA only,18.96,17.44,924.69,92,Partial Response
M210261,69,Female,HPV-related Cancer,mrna-4157 + keytruda,61.53,59.08,928.54,75,Stable Disease
M200569,53,Female,HPV-related Cancer,KEYTRUDA only,44.35,38.94,,85,Complete Response
M206490,83,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,97.36,60.98,1433.71,98,Complete Response
M208330,37,Female,Non-small Cell Lung Cancer,KEYTRUDA only,50.33,52.79,663.17,75,Partial Response
M204245,41,Other,Non-small Cell Lung Cancer,KEYTRUDA only,48.82,52.78,853.48,76,Progression
M207680,38,Male,HPV-related Cancer,mrna-4157 + keytruda,52.46,36.36,1021.65,96,Stable Disease
M210219,81,Female,HPV-related Cancer,mrna-4157 + keytruda,35.49,28.68,1420.48,82,Stable Disease
M212114,72,Other,Melanoma,mrna-4157 + keytruda,68.88,42.93,1427.01,91,Partial Response
M209026,37,Male,Melanoma,KEYTRUDA only,44.42,27.01,911.36,85,Stable Disease
M203341,44,Male,HPV-related Cancer,mrna-4157 + keytruda,54.26,35.22,837.88,83,Progression
M213974,73,Other,Melanoma,mrna-4157 + keytruda,65.92,52.8,,104,Complete Response
M210254,78,Female,Melanoma,mrna-4157 + keytruda,75.59,62.97,946.53,96,Stable Disease
M208530,55,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,49.97,40.19,854.15,112,Stable Disease
M207809,39,Male,Non-small Cell Lung Cancer,KEYTRUDA only,67.45,58.52,979.34,104,Complete Response
M210912,46,Other,Melanoma,mrna-4157 + keytruda,45.41,38.49,130.75,76,Partial Response
M202477,44,Female,Non-small Cell Lung Cancer,KEYTRUDA only,40.46,25.34,996.59,107,Partial Response
M206554,65,Other,Non-small Cell Lung Cancer,KEYTRUDA only,34.46,18.33,856.88,79,Progression
M200279,49,Other,Melanoma,mrna-4157 + keytruda,74.99,64.31,1108.56,100,Progression
M205358,52,Other,HPV-related Cancer,mrna-4157 + keytruda,66.38,68.51,1161.81,83,
M202907,32,Male,HPV-related Cancer,KEYTRUDA only,60.2,42.97,861.18,91,Stable Disease
M205582,28,Other,Non-small Cell Lung Cancer,mrna-4157 + keytruda,67.66,64.59,43.17,101,Partial Response
M204409,56,Female,Melanoma,mrna-4157 + keytruda,43.76,36.29,1178.2,89,Progression
M203458,56,Male,Melanoma,mrna-4157 + keytruda,66.73,53.72,577.87,106,Stable Disease
M202676,36,Male,Melanoma,mrna-4157 + keytruda,58.47,79.44,809.45,85,Progression
M204863,64,Female,HPV-related Cancer,mrna-4157 + keytruda,84.97,38.86,,76,Partial Response
M210303,59,Other,Melanoma,mrna-4157 + keytruda,65.15,60.7,155.12,92,Partial Response
